#Promethease tab-genotype 0.1.163 2015-09-09 22:52 #Column-names Name Magnitude Repute PopulationFreq Orientation GMAF Summary Description rs2066847(C;C) 4.0 Bad plus 0.007805 35x higher risk for Crohn's disease 35x higher risk for Crohn's disease gs151 3.0 Bad CYP2C19 Intermediate Metabolizer CYP2C19 Intermediate Metabolizer. Your body breaks down some medicines at a slightly slower than normal rate (which is represented by gs150). Individuals with gs152 genotypes have even slower metabolism. *anti-epileptics (such as diazepam, phenytoin, and phenobarbitone) *anti-depressants (such as amitriptyline and clomipramine) *anti-platelet drug clopidogrel (Plavix) *anti-ulcer proton pump inhibitors like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid) *hormones (estrogen, progesterone). gs227 3.0 fully heterozygous, age related tasting variation You are heterozygous at all 3 of the SNPs which are known to influence the ability to taste bitterness. This means you are better than average at detecting bitter tastes while young, but that this ability will decrease to less than average during adulthood. As a child you will probably hate brussel sprouts, and by early adulthood will discover that olives and brussel sprouts now taste good. A 2010 study shows the change bitter sensitivity which occurs over the lifespan (from bitter sensitive to less so) is more common in people with this genoset. Children with this genotype could perceive a bitter taste at lower PROP concentrations than could heterozygous adults. The threshold for adolescents was intermediate. The 3 SNPs are rs10246939, rs1726866, rs713598 in the gene TAS2R38. rs2981582(C;T) 3.0 Bad 41.6% minus 0.405 1.3x higher risk of ER+ breast cancer 1.3x higher risk of ER+ breast cancer rs7294919(C;T) 3.0 Good plus 0.2117 Moderately enhanced hippocampal volume Moderately enhanced hippocampal volume rs12979860(T;T) 3.0 Bad plus 0.3388 ~20-25% of such hepatitis C patients respond to treatment ~20-25% of such hepatitis C patients respond to treatment This is considered an unfavorable response genotype for hepatitis C patients considering the use of PEG-interferon-alpha containing therapeutic treatment. This basically means the odds of a successful response are lower than for patients with the rs12979860(C;C) genotype. rs8099917(G;G) 3.0 Bad 2.7% plus 0.1382 lower odds of responding to PEG-IFNalpha/RBV treatment lower odds of responding to PEG-IFNalpha/RBV treatment Substantially lower odds of responding to PEG-IFNalpha/RBV treatment for hepatitis C. rs2180439(T;T) 3.0 Bad 38.1% plus 0.4421 2x increased risk of Male Pattern Baldness. 2x increased risk of Male Pattern Baldness. Verified in Europeans and Asians. Family Tree DNA reports this SNP as more likely to go bald, but 23andMe doesn't mention it. rs3815148(C;C) 3.0 Bad 4.4% plus 0.1864 1.34x increased risk of Osteoarthritis 1.34x increased risk of Osteoarthritis Osteoarthritis rs4244285(A;G) 3.0 Bad plus 0.1983 poorer metabolizer of several popular medicines; patients prescribed Plavix get less benefit, and have higher risk for adverse cardiovascular events poorer metabolizer of several popular medicines; patients prescribed Plavix get less benefit, and have higher risk for adverse cardiovascular events rs2383206(G;G) 3.0 Bad 24.6% plus 0.4917 1.7x increased risk for heart disease 1.7x increased risk for heart disease 23andMe blog People with this genotype and a long history of high blood sugar are at 7x risk of CAD rs1333049(C;G) 3.0 Bad plus 0.4334 1.5x increased risk for CAD 1.5x increased risk for CAD 1.5x higher risk for coronary artery disease rs1801133(T;T) 3.0 Bad 8.8% minus 0.3246 homozygous for C677T of MTHFR = 10-20% efficiency in processing folic acid = high homocysteine, low B12 and folate levels homozygous for C677T of MTHFR = 10-20% efficiency in processing folic acid = high homocysteine, low B12 and folate levels This is the homozygous form of the C677T allele for the MTHFR gene. It is found in approximately * 15% of Hispanic Americans * 12% of Caucasian Americans * 12% of Japanese * 6% of Germans * 3% of Asians * 2% of African Americans * 1% of Sub-Saharan Africans Numerous health effects are associated with this variant. * Hyperhomocysteinemia and neurologic disorders: a review. (2014). A review. Certain genetic factors also cause elevated homocysteine levels, such as C667T substitution of the gene encoding methylenetetrahydrofolate reductase. Elevated homocysteine has been observed in several medical conditions, such as cardiovascular disorders, atherosclerosis, myocardial i... rs1801282(C;G) 3.0 Bad 15.9% plus 0.06612 watch out for high fat in diet watch out for high fat in diet rs2145418(G;T) 3.0 Bad minus 0.2557 5.0x increased thyroid cancer risk 5.0x increased thyroid cancer risk Relatively common rs1021737(T;T) 3.0 Bad 7.1% plus 0.2259 significantly higher plasma total homocysteine concentration significantly higher plasma total homocysteine concentration rs7754840(C;G) 3.0 Bad plus 0.4068 1.3x increased risk for type-2 diabetes 1.3x increased risk for type-2 diabetes rs1799945(C;G) 3.0 Bad 35.6% plus 0.08356 One copy of H63D, carrier of hemochromatosis, likely unaffected unless also C282Y carrier. One copy of H63D, carrier of hemochromatosis, likely unaffected unless also C282Y carrier. You are a carrier for rs1799945(G) H63D Hereditary hemochromatosis. You are unlikely to be affected unless also a carrier of rs1800562(A) C282Y, but others in your family may be. This is a treatable condition. rs75932628(C;T) 3.0 Bad plus 0.002755 risk of Alzheimer's disease risk of Alzheimer's disease rs1800497(C;T) 2.9 Bad minus 0.2961 A1/A2: Bad at avoidance of errors. 0.5x lower OCD risk, 0.87x lower Tardive Diskinesia risk, higher ADHD risk. More Alcohol Dependence. Lower risk of Postoperative Nausea. Increased obesity. Bupropion... A1/A2: Bad at avoidance of errors. 0.5x lower OCD risk, 0.87x lower Tardive Diskinesia risk, higher ADHD risk. More Alcohol Dependence. Lower risk of Postoperative Nausea. Increased obesity. Bupropion is not effective. The DRD2 TaqIA A1/A2 version causes less dopamine receptors. Doesn't learn from mistakes well. Reduced response to errors and increased addictive behavior Men may have half the risk of Obsessive Compulsive Disorder but higher risk of ADHD. Women have lower Persistence. 0.87x reduced risk of Tardive Diskinesia when taking dopamine receptor antagonists. Slightly increased risk of alcoholism and smoking addiction. Slower recovery from traumatic brain injury. Lower risk of postoperative nausea within 6 hours of surgery. Bupropion (Wellbutrin, Budeprion, Prexaton, Elontril, Aple... rs1799930(A;A) 2.8 Bad 11.5% plus 0.2456 Increased risk of hearing loss Increased risk of hearing loss 15.2x risk of Age Related Hearing Impairment(ARHI), also known as presbycusis. This applies to the European and Turkish, but not Finnish populations. rs53576(A;G) 2.8 Bad plus 0.4128 Lack of empathy? Lack of empathy? You have a SNP in the oxytocin receptor which may make you less empathetic than most people. When under stress you may have more difficulty recognizing the emotional state of others which impacts loneliness, parenting, and socializing skills. Some studies have suggested that the A;G genotype is associated with an intermediate level of empathy (compared to the G;G and A;A genotypes), although most report that A;G and A;A individuals have similar levels of empathy and stress handling capabilities. rs6983267(G;T) 2.7 Bad 54.9% plus 0.4366 1.3x risk of prostate cancer; aspirin reduces risk of colorectal cancer 1.3x risk of prostate cancer; aspirin reduces risk of colorectal cancer Increased risk for prostate cancer and in women other types of cancer. Aspirin has been reported to help reduce the risk somewhat when taken by carriers of this genotype. gs296 2.6 Good Lower heart attack risk than average You are in the ~30 % of people (depending on the population studied) who carry two minor alleles at two SNPs, rs1108580 and rs1611115. This genoset is reported as having 0.59x the risk of a heart attack or cardiovascular incident compared to people who carry zero of the minor alleles for these two SNPs, based on a study of 3,000 African-Americans enrolled in the Jackson Heart Study. gs157 2.5 more stimulated by coffee You appear to have a common genotype in the gene CYP1A2 which metabolizes coffee more slowly than some other forms. The same amount of caffeine will tend to have more stimulating effect on slow metabolizers than on fast metabolizers. Ciprofloxacin is also metabolized by CYP1A2, but is unclear if your genotype should influence its effect. gs242 2.5 Bad increase risk of prostate cancer patients dying of the disease You have at least 3 of the 5 genotypes which increase, by approximately 25%, the risk of prostate cancer patients dying of the disease. This does not increase your risk of getting prostate cancer, however. gs256 2.5 Blue eyes thumb Heterozygous for what calls blue eye color haplotype #1. It seems 'blue', might be overstating it. In the eye color research community, there seems to be a distinction between the dark brown eyes typical for asian and african ancestry, and 'blue' for lighter eyes found in europeans. gs277 2.5 Bad Increased risk of Atrial Fibrillation in one of the 2 SNPs mentioned by 23andMe. The more important of the two atrial fibrillation SNPs mentioned by 23andMe has one defective copy. This slightly affects the formation of the heart and increases risk of Atrial Fibrillation (quivering of the top part of the heart) that 23andMe reports. It also seems to increase the risk of Cardioembolic ischemic stroke (blocked blood flow to the brain) although 23andMe doesn't mention that. The risk is highest for men. Based on several quality studies, and confirmed for Europeans and Asians. It's recommended to eat a heart-healthy diet, and only drink alcohol in moderation, to lower the risk. rs12803066(A;G) 2.5 Bad 9.5% plus 0.1442 increased risk of myopia increased risk of myopia rs10748045(G;G) 2.5 Bad 10.6% plus 1.78x risk of Suicidal ideation in depression or bipolar disorder 1.78x risk of Suicidal ideation in depression or bipolar disorder Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. 237 European ancestry cases, 510 European ancestry controls rs7984966(C;C) 2.5 Bad 4.9% plus 0.2144 ADHD in adults ADHD in adults This variation in the HTR2A gene has been found to affect susceptibility to ADHD in adults. rs11672691(G;G) 2.5 Bad 51.3% plus 0.449 1.39x increased risk for PCSM in patients with prostate cancer 1.39x increased risk for PCSM in patients with prostate cancer For a person already diagnosed with prostate cancer, this relatively common genotype is associated with a more aggressive form of the cancer and an increased risk (by 1.39x) of dying from causes related to the cancer. rs6441286(G;G) 2.5 Bad 13.4% plus 0.3806 3.08x chance of developing primary biliary cirrhosis 3.08x chance of developing primary biliary cirrhosis rs9886784(A;C) 2.5 Bad 35.4% plus 0.2296 3.23x risk for Alzheimer's disease 3.23x risk for Alzheimer's disease rs9886784, a intergenic SNP on chromosome 9, is reported to influence the risk for Alzheimer's disease based on a study of ~1100 Canadian patients. The risk allele is (A); the odds ratio is 3.23 (CI: 1.79 - 5.84). rs12777823(A;G) 2.5 Bad plus 0.2213 Avoid Plavix, higher risk for adverse cardiovascular events. Avoid Plavix, higher risk for adverse cardiovascular events. Neighboring rs4244285 is a more reliable predictor, but this genotype is linked to being a poor metabolizer of several popular medicines; patients prescribed Plavix (Clopidogrel) have higher risk for adverse cardiovascular events. rs7574865(G;T) 2.5 Bad plus 0.2493 1.3x risk of rheumatoid arthritis; 1.55x risk of SLE; 1.42x risk of Sjögren's syndrome; increased risk of type-1 diabetes; and increased risk of primary biliary cirrhosis. 1.3x risk of rheumatoid arthritis; 1.55x risk of SLE; 1.42x risk of Sjögren's syndrome; increased risk of type-1 diabetes; and increased risk of primary biliary cirrhosis. rs1061170(C;T) 2.5 Bad 58.3% plus 0.2778 2.5x risk for AMD; higher mortality among nonagenarians 2.5x risk for AMD; higher mortality among nonagenarians To minimize your risk of age related macular degeneration, consider a diet rich in vitamins C and E, lutein, zeaxanthin and the minerals zinc and copper, such as kale, spinach and broccoli. source rs1129844(A;G) 2.5 Good plus 0.1396 Delays Onset of AD Delays Onset of AD Evidence suggests that the AG allele of rs1129844 might delay AD onset by up to 10 years. It is not clear whether an AD risk benefit might result from the AA genotype. http://www.sciencedaily.com/releases/2015/09/150901140757.htm http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2015131a.html rs806368(C;C) 2.5 Bad 4.4% plus 0.275 Associated with Alcohol Dependence; associated with nicotine dependence (female) Associated with Alcohol Dependence; associated with nicotine dependence (female) Cannabinoid Receptor 1 Gene is Associated with Alcohol Dependence. Alcoholic patients with TGT haplotype (corresponding to rs6454674-rs1049353-rs806368 polymorphisms in this order) were less prone to have AD (p = 0.017). TGC haplotype were more likely to develop AD. Cannabinoid receptor 1 gene association with nicotine dependence. the associations were female specific. Haplotype 1-1-2 of markers rs2023239-rs12720071-rs806368(C) was associated with nicotine dependence and FTND score in the 2 samples (P < .001 and P = .009, respectively). rs1143679(A;G) 2.4 Bad plus 0.08815 1.78x increased risk for SLE 1.78x increased risk for SLE rs944289(T;T) 2.2 Bad 38.9% plus 0.4288 2.6x increased thyroid cancer risk 2.6x increased thyroid cancer risk rs2305089(T;T) 2.2 Bad 35.1% plus 0.3903 higher risk for chordoma higher risk for chordoma rs1136287(T;T) 2.2 Bad 48.7% plus 0.3526 3.9x increased risk of wet ARMD 3.9x increased risk of wet ARMD age related macular degeneration rs9264942(C;C) 2.2 Good 9.7% plus 0.3485 90% reduction in HIV viral load 90% reduction in HIV viral load The rs9264942(C;C) genotype is reported to be associated with a 90% reduction in viral load in HIV-infected individuals. See also rs9264942 and HIV. rs3761847(A;G) 2.1 Bad plus 0.4816 1.32 x risk of rheumatoid arthritis. 1.32 x risk of rheumatoid arthritis. A common genetic variant at the TRAF1-C5 locus on chromosome 9 is associated with an increased risk of anti-CCP-positive rheumatoid arthritis. rs3761847, a SNP located between two genes associated with chronic inflammation (TRAF1 and C5), is associated with increased risk of anti CCP-positive rheumatoid arthritis. The risk allele is (G); the odds ratio reported is 1.32 (95% confidence interval, 1.23 to 1.42; P=4x10-14) . rs2511989(A;G) 2.1 Good 40.7% minus 0.3228 0.63x decreased age-related macular degeneration risk 0.63x decreased age-related macular degeneration risk rs1815739(C;T) 2.1 Good plus 0.3742 Mix of muscle types. Likely sprinter. Mix of muscle types. Likely sprinter. Normal for white people. One working and one defective copy of the gene for alpha-actinin-3 in fast-twitch muscle fibres. This genotype may indicate somewhat impaired muscles, however many sprinters and some endurance athletes have this. rs17563(C;C) 2.1 Bad 37.2% minus 0.3714 Risk for otosclerosis Risk for otosclerosis rs8085664(A;A) 2.1 Good 10.6% plus 0.3012 0.61x reduced risk of Male Pattern Baldness. 0.61x reduced risk of Male Pattern Baldness. Discovered by 23andWe based on customer surveys, and considered preliminary research. rs2254958(C;T) 2.1 Bad minus 0.4316 1.24x increased risk for Alzheimer's 1.24x increased risk for Alzheimer's rs801114(G;G) 2.1 Bad 9.8% plus 0.4867 1.28x increased Basal Cell Carcinoma risk. 1.28x increased Basal Cell Carcinoma risk. Increased risk of this kind of skin cancer. This is the most common kind of cancer in the United States. This kind has less danger of metastasizing, but still needs to be treated if it occurs. Note that if you have both the Basal Cell Carcinoma mutations, your combined risk would be 2.68x. rs7837688(G;G) 2.1 Bad 85.0% plus 0.1097 1.7x increased risk for prostate cancer 1.7x increased risk for prostate cancer rs2383207(G;G) 2.1 Bad 22.1% plus 0.3324 increased risk for heart disease increased risk for heart disease rs1333048(C;C) 2.1 Bad 22.1% plus 0.4541 1.5x increased coronary artery disease risk; 2x increased periodontitis risk 1.5x increased coronary artery disease risk; 2x increased periodontitis risk 2x increased risk of periodontitis and coronary heart disease as discussed at 23andMe blog rs6742078(T;T) 2.1 Bad 8.0% plus 0.3035 +16% bilirubin levels increased risk of gallstones +16% bilirubin levels increased risk of gallstones rs560887(G;G) 2.1 Bad 44.6% minus 0.1515 Avg. fasting Plasma Glucose 5.18 mmol/L (93 mg/dl). Avg. fasting Plasma Glucose 5.18 mmol/L (93 mg/dl). Slightly higher blood glucose. Fasting Plasma Glucose is the amount of sugar in your blood when you wake up. It's required to power your body, but too much is very bad for you. Fasting plasma glucose between 5.6 mmol/L and 6.9 mmol/L (101 – 125 mg/dl) is considered pre-diabetes. Fasting plasma glucose higher than 7 mmol/L (126 mg/dl) is considered diabetes. rs646776(A;A) 2.1 Bad 54.9% minus 0.2121 1.2x risk of coronary artery disease 1.2x risk of coronary artery disease rs762551(A;C) 2.1 plus 0.3522 Carrier of one CYP1A2*1F allele; Slow Caffeine Metabolizer. Carrier of one CYP1A2*1F allele; Slow Caffeine Metabolizer. One copy of the slow caffeine metaboliser SNP, and one copy of the fast version. This makes you more strongly affected by drinking coffee, as caffeine is broken down slower in the liver. Supposedly this increases the risk of heart attacks, although other studies show caffeine is generally good for the heart. It also makes caffeine more effective at preventing Breast Cancer, Alzheimer's Disease, and Parkinson's disease. Too much caffeine will shrink your breasts. rs2229765(A;A) 2.1 Bad 15.0% plus 0.371 Low IGF-1 level, linked to number of diseases Low IGF-1 level, linked to number of diseases rs2229765(A;A) associated with ischemic stroke (OR = 1.641, P = 0.022) in a Chinese population After adjustment for smoking, alcohol drinking, history of hypertension, and body mass index, IGF-1R AA genotype was still significantly associated with an increased risk of IS (OR = 1.787, P = 0.029), compared with IGF-1R GG. The frequency of A-allele in advanced CRC was significantly higher then early CRC (52 vs. 37.7, OR = 1.78). According to genotype serum IGF-1 levels was significantly decreased in patients with GG genotype then patients with dominant genotypes. Our results showed a relationship between the +3179G>A polymorphism of the IGF-1R and serum IGF-1 with the progression of colorectal carcinoma. rs708272(C;T) 2.1 minus 0.3792 No reduction in heart disease risk from drinking alcohol No reduction in heart disease risk from drinking alcohol This is the genotype known as B1B2, and as reported in the Mehlig et al. 2014 article, from a risk for coronary heart disease perspective this genotype is the same as the B1B1 genotype in showing no decrease in risk from consuming alcohol. rs3129934(C;C) 2.1 Good 66.1% plus 0.1428 Normal lower risk of Multiple Sclerosis. Normal lower risk of Multiple Sclerosis. rs3775291(A;G) 2.1 Good 47.8% minus 0.2502 0.71x decreased risk for dry age related macular degeneration 0.71x decreased risk for dry age related macular degeneration gs154 2.0 Bad NAT2 Slow metabolizer Most non-Scandinavian Caucasians and approximately half of African-Americans are slow metabolizers. This variation is important because of its primary role in the deactivation of many chemicals in the body's environment, including those produced by caffeine and cigarettes as well as aromatic amine and hydrazine drugs used medicinally. In general, slow metabolizers have higher rates of certain types of cancer and are more susceptible to side effects from chemicals metabolized by NAT2. This prediction and that of gs156 of NAT2 metabolizer phenotype is based on using 2 SNPs, rs1041983 and rs1801280. An alternative prediction of NAT2 metabolizer status based on using more SNPs (6) is used by genosets gs138, gs139, and gs140. gs179 2.0 CYP2D6*41 CYP2D6*41 decreased metabolism gs181 2.0 CYP2D6*2 CYP2D6*2 normal metabolism gs239 2.0 Bad Reduced conversion of beta-carotene to retinol Female volunteers carrying at least one T in SNPs Rs7501331 and Rs12934922 show a 69% lower ability to convert Beta-carotene into retinyl esters. gs244 2.0 Bad 2x increased risk for esophageal squamous cell cancer among Han Chinese You have a total of 3 or 4 SNP variants (out of 6) associated in Han Chinese with increased risk for esophageal squamous cell cancer, which reportedly places you on average at about double the risk (2x) of developing the disease, if you are of Chinese ancestry. Smoking and alcohol use will apparently increase your risk further. rs4149268(A;G) 2.0 Good 39.8% minus 0.421 associated with higher HDL cholesterol associated with higher HDL cholesterol rs1537415(G;G) 2.0 Bad 18.6% minus 0.3131 2x increased risk for periodontitis 2x increased risk for periodontitis rs3793784(C;G) 2.0 Bad minus 0.2723 1.5x risk for ARMD 1.5x risk for ARMD rs7089814(C;T) 2.0 49.6% plus 0.4536 1.1x breast size (bigger breast size) 1.1x breast size (bigger breast size) rs3758391(C;C) 2.0 Bad 54.9% plus 0.4729 Normal (worse) aging. Normal (worse) aging. This is the less beneficial version of the SIRT1 longevity gene, which doesn't extend lifespan. It is normal in non-Asians. It has more cognitive decline with age. Taking resveratrol is also believed to increase longevity via the SIRT1 gene, so it might (or might not) be possible to mitigate this with resveratrol supplements or some other SIRT1 activator. rs2298566(A;C) 2.0 42.5% plus 0.2236 increased risk of coronary heart disease; better response to statins increased risk of coronary heart disease; better response to statins rs2420946(C;T) 2.0 Bad plus 0.4362 1.20x risk for breast cancer 1.20x risk for breast cancer rs1219648(A;G) 2.0 Bad 41.6% plus 0.4008 1.20x risk for breast cancer 1.20x risk for breast cancer rs4073582(A;A) 2.0 Good 15.0% plus lower risk for gout lower risk for gout rs1042838(G;T) 2.0 Bad minus 0.09504 1.28x risk for endometrial ovarian cancer; overlaps with rs608995 1.28x risk for endometrial ovarian cancer; overlaps with rs608995 rs3819331(C;T) 2.0 Bad plus 0.1377 increased risk of autism increased risk of autism Increased risk of autism.[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784255/] rs2965667(T;T) 2.0 Good 98.3% common/normal; aspirin use reduces colorectal cancer risk a bit common/normal; aspirin use reduces colorectal cancer risk a bit rs10468017(C;T) 2.0 Good 52.7% plus 0.2094 associated with higher HDL cholesterol associated with higher HDL cholesterol rs6311(C;T) 2.0 Good 52.2% plus 0.4376 Normal risk of sexual dysfunction when taking SSRI Antidepressants. Normal risk of sexual dysfunction when taking SSRI Antidepressants. rs58920878(C;G) 2.0 Bad plus 0.343 slight (~1.5x) increase in colorectal cancer risk slight (~1.5x) increase in colorectal cancer risk see discussion at rs58920878 rs2230199(C;G) 2.0 Bad minus 0.0978 1.6x+ risk of ARMD 1.6x+ risk of ARMD rs6511720(G;T) 2.0 Good 15.9% plus 0.08173 Slightly lower odds of developing CHD. Slightly lower odds of developing CHD. rs25487(A;G) 2.0 Bad minus 0.2631 2x higher risk for skin cancer; possibly other cancers 2x higher risk for skin cancer; possibly other cancers rs2547231(T;T) 2.0 64.3% minus Increased blood metabolite levels Increased blood metabolite levels 5alpha-androstan-3beta,17beta-diol disulfate - 0.081 unit increase X-12850 - 0.059 unit increase X-12456 - 0.041 unit increase X-11440/4-androsten-3beta,17beta-diol disulfate 2 - 0.141 unit increase rs201571(T;T) 2.0 Bad 32.4% plus 0.494 more likely to go bald more likely to go bald more likely to go bald rs3746444(C;T) 2.0 Bad minus 0.1814 ~1.2x increased risk for cancer ~1.2x increased risk for cancer rs4654748(C;T) 2.0 46.9% plus 0.4141 1.45 ng/mL lower Vitamin B6 blood concentration 1.45 ng/mL lower Vitamin B6 blood concentration rs358806(C;C) 2.0 Bad 59.3% plus 0.1873 1.78x increased risk of developing Type-2 diabetes 1.78x increased risk of developing Type-2 diabetes rs4402960(G;T) 2.0 Bad 39.8% plus 0.343 1.2x increased risk for type-2 diabetes 1.2x increased risk for type-2 diabetes rs6807362(C;C) 2.0 Bad 29.2% plus 0.4059 increased autism risk increased autism risk rs10936599(T;T) 2.0 Bad 7.1% plus 0.3035 shorter telomeres, shorter life? shorter telomeres, shorter life? rs699(C;T) 2.0 Bad 43.4% minus 0.3384 increased risk of hypertension increased risk of hypertension rs2073963(G;T) 2.0 Bad plus 0.4444 increased risk of baldness increased risk of baldness rs7794745(T;T) 2.0 Bad 10.6% plus 0.4766 slightly increased risk for autism slightly increased risk for autism rs7807268(C;G) 2.0 Bad plus 0.4931 1.3x risk for Crohn's disease 1.3x risk for Crohn's disease rs1454292(T;T) 2.0 35.2% plus 0.3733 straighter hair straighter hair rs189798(C;T) 2.0 Good 33.6% minus 0.3815 decreased high myopia risk decreased high myopia risk Less risk of high myopia (in French people). 34.2% of French people without high myopia have T here, but only 21.1% of controls do.(table) rs7816345(T;T) 2.0 0.0% plus 0.2691 0.72x breast size (smaller breast size) 0.72x breast size (smaller breast size) rs10086908(C;T) 2.0 Bad plus 0.2769 1.7x increased risk for prostate cancer 1.7x increased risk for prostate cancer rs13254738(A;C) 2.0 Bad plus 0.4752 1.18x prostate cancer risk 1.18x prostate cancer risk rs9642880(T;T) 2.0 Bad 20.4% plus 0.4963 1.5x increased bladder cancer risk 1.5x increased bladder cancer risk rs6997709(G;T) 2.0 Bad 37.2% plus 0.1869 1.2x higher risk for hypertension 1.2x higher risk for hypertension rs2274223(A;G) 2.0 Bad 49.6% plus 0.2764 1.5x increased risk for stomach & esophageal cancer (seen in Han Chinese) 1.5x increased risk for stomach & esophageal cancer (seen in Han Chinese) rs12248560(C;T) 2.0 43.1% plus 0.1524 CYP2C19*17 ultra fast metabolizer; drug metabolism effects; also 0.77x decreased breast cancer risk CYP2C19*17 ultra fast metabolizer; drug metabolism effects; also 0.77x decreased breast cancer risk rs2811712(A;A) 2.0 Bad 86.7% plus 0.1616 Normal (higher) risk of physical impairment with age. Normal (higher) risk of physical impairment with age. This causes physical problems for older people, and Cerebral Small Vessel Disease in the brain. rs10757272(T;T) 2.0 Bad 21.2% plus 0.4738 1.54x increased risk for Coronary artery disease 1.54x increased risk for Coronary artery disease rs10757278(A;G) 2.0 Bad 50.0% plus 0.4279 1.3x risk for Heart Attack. Normal risk for Abdominal Aortic Aneurysm and Brain Aneurysm. 1.3x risk for Heart Attack. Normal risk for Abdominal Aortic Aneurysm and Brain Aneurysm. One copy of an SNP that increases risk of Myocardial Infarction (Heart Attack) and other Coronary Heart Disease. It has been shown that regularly eating raw vegetables and fruit can reduce the risk to the same level as people without this SNP. This SNP also has the normal medium risk of abdominal aortic aneurysm (weakened artery to abdomen and legs) or brain aneurysm (weakened artery to brain). rs1585215(A;G) 2.0 Bad minus 0.292 2x increased risk for Hodgkin lymphoma 2x increased risk for Hodgkin lymphoma rs629242(C;T) 2.0 Bad 31.0% plus 0.2562 somewhat higher risk for prostate cancer somewhat higher risk for prostate cancer rs1434536(A;A) 2.0 Bad 24.8% minus 0.4307 1.94x increased breast cancer risk 1.94x increased breast cancer risk rs4307059(C;C) 2.0 Good 12.4% plus 0.2365 Reduced Autism risk Reduced Autism risk rs2200733(C;T) 2.0 Bad 19.5% plus 0.2709 1.4x increased risk of Atrial Fibrillation and ischemic stroke. 1.4x increased risk of Atrial Fibrillation and ischemic stroke. One defective copy. This affects the formation of the heart and gives a higher risk of Atrial Fibrillation (quivering of the top part of the heart), and Cardioembolic and Ischemic strokes (blocked blood flow to the brain). Based on several quality studies, and confirmed for Europeans and Asians. It's recommended to eat a heart-healthy diet, and only drink alcohol in moderation, to lower the risk. rs12037606(A;A) 2.0 Bad 13.3% plus 0.3388 1.52x risk of developing Crohn's disease 1.52x risk of developing Crohn's disease rs7594645(A;G) 2.0 Good 4.6% plus rs966423(C;T) 2.0 Bad 55.8% plus 0.3696 Possible elevated thyroid cancer risk Possible elevated thyroid cancer risk After combining the results, three variants were shown to associate with thyroid cancer: rs966423 on 2q35 (OR = 1.34; P(combined) = 1.3 × 10(-9)), rs2439302 on 8p12 (OR = 1.36; P(combined) = 2.0 × 10(-9)) and rs116909374 on 14q13.3 (OR = 2.09; P(combined) = 4.6 × 10(-11)), a region previously reported to contain an uncorrelated variant conferring risk of thyroid cancer. rs887829(A;A) 2.0 Good 8.0% minus 0.3108 Higher levels of serum bilirubin, associated with lower risk for coronary artery disease Higher levels of serum bilirubin, associated with lower risk for coronary artery disease rs2056202(C;C) 2.0 Bad 77.0% plus 0.2259 common but increased risk of autism common but increased risk of autism rs3821236(A;G) 2.0 Bad plus 0.309 1.4x higher risk of lupus 1.4x higher risk of lupus increased risk of Systemic lupus erythematosus. rs3928305(A;A) 2.0 3.1% plus 0.03835 Derived value Derived value rs6700998(G;T) 2.0 Good plus 0.4086 Normal risk of Atopic Dermatitis. Normal risk of Atopic Dermatitis. This seems to be a proxy that 23andMe uses for the filaggrin gene variants that they can't measure directly. rs744373(C;T) 2.0 Bad 39.8% minus 0.3714 1.17x risk of Alzheimer's 1.17x risk of Alzheimer's rs763110(C;T) 2.0 Good 48.6% plus 0.4311 ~0.80x reduced cancer risk ~0.80x reduced cancer risk rs13376333(T;T) 2.0 Bad 14.2% plus 0.2199 ~2x higher risk of atrial fibrillation ~2x higher risk of atrial fibrillation rs2987983(C;T) 2.0 Bad 39.8% minus 0.3907 1.2x increased risk of prostate cancer 1.2x increased risk of prostate cancer This genotype is at increased risk of prostate cancer Recommendation: To reduce the risk eat a diet rich in phytoestrogens such as flax seed rs4779584(C;T) 2.0 Bad plus 0.4578 1.23x risk for colorectal cancer 1.23x risk for colorectal cancer see discussion at rs4779584 rs2073711(C;T) 2.0 Good 40.7% minus 0.4858 Back Pain: lower risk of Lumbar Disc Disease. Back Pain: lower risk of Lumbar Disc Disease. This appears to reduce the risk of LDD, at least in Japanese people and women. rs6498169(A;A) 2.0 Bad 37.5% plus 0.3972 >1.14x risk of multiple sclerosis >1.14x risk of multiple sclerosis rs17221417(G;G) 2.0 Bad 7.1% plus 0.1451 1.9x higher risk for Crohn's disease 1.9x higher risk for Crohn's disease rs2066843(T;T) 2.0 Bad 6.3% plus 0.1295 4.09x higher risk for Crohn's disease 4.09x higher risk for Crohn's disease rs5882(A;G) 2.0 Good plus 0.4481 Lower risk of dementia and Alzheimer's disease. Higher good cholesterol. Lower risk of dementia and Alzheimer's disease. Higher good cholesterol. One copy of a longevity gene. This seems to raise HDL ('good') cholesterol, and reduce the risk of dementia and Alzheimer's disease. It may slightly increase longevity. It has been particularly studied in Ashkenazi Jews. rs9938025(A;G) 2.0 plus Unknown effect Unknown effect rs7501331(C;T) 2.0 Bad 49.5% plus 0.1621 Reduced conversion of beta-carotene to retinol Reduced conversion of beta-carotene to retinol Reduced BCMO1 activity results in 32% lower ability to convert Beta-carotene to retinyl esters and higher serum beta-carotene levels. See also rs12934922. rs1042522(G;G) 2.0 Bad 61.5% minus 0.3981 Common variant. Slightly shorter lifespan. Common variant. Slightly shorter lifespan. Chemotherapy is less effective. Accelerated lung decline in smokers. African Americans have 2.15x risk of dying from colo-rectal cancer. rs7221412(G;G) 2.0 22.1% plus 0.3324 Late riser. Wakes up 1 hour later than those with AA genotype. Late riser. Wakes up 1 hour later than those with AA genotype. Research also suggests, then you while most people are more likely to die shortly before 11am, you are more likely to die later in the day. http://www.theatlantic.com/health/archive/2012/11/you-are-most-likely-to-die-at-11-am/265427/ rs6505162(A;C) 2.0 Good 58.0% plus 0.4885 0.58x decreased risk for esophageal cancer 0.58x decreased risk for esophageal cancer rs1024611(C;T) 2.0 Bad 50.4% minus 0.4054 increased risk of exercise induced ischemia increased risk of exercise induced ischemia rs7216389(T;T) 2.0 Bad 21.2% plus 0.3655 1.5x increased risk for Childhood Asthma. 1.5x increased risk for Childhood Asthma. rs4794067(C;C) 2.0 4.4% plus 0.2185 2.1x risk for Aspirin Induced Asthma. But possibly lower risk of lupus and intractable Graves' disease. 2.1x risk for Aspirin Induced Asthma. But possibly lower risk of lupus and intractable Graves' disease. Only tested in Asians. Might not be true for other races. rs17250932(C;C) 2.0 Good plus 0.1377 Reduced risk of lupus and intractable Graves' disease. Reduced risk of lupus and intractable Graves' disease. This lowers the risk of lupus, and increases the chance of remission in Graves' disease. But it may also require rs4794067(C;C) to have the effect. Only verified in Asians. rs1050631(C;T) 2.0 Bad minus 0.2837 Mean Survival Time of 25 months for esophageal squamous-cell carcinoma Mean Survival Time of 25 months for esophageal squamous-cell carcinoma rs1050152(C;T) 2.0 Bad 57.5% plus 0.1846 2.1x increased risk of Crohn's disease 2.1x increased risk of Crohn's disease rs2243250(T;T) 2.0 Good 1.8% plus 0.4844 0.33x decreased risk for myocardial infarction if younger than 50 0.33x decreased risk for myocardial infarction if younger than 50 rs3212227(A;C) 2.0 Bad minus 0.3384 Significantly increased risk of developing cervical cancer Significantly increased risk of developing cervical cancer rs198846(A;G) 2.0 29.2% plus 0.124 rs7743761(A;C) 2.0 Bad plus 0.3402 4.6x increased risk of Ankylosing Spondylitis. 4.6x increased risk of Ankylosing Spondylitis. Substantially increased (but still only 0.5%) risk of this rare autoimmune disease that causes inflammation of the spine and joints. Based on preliminary research. Age of onset is usually between 15 and 25, so if you are older than that, there's not much need for worry. rs6457617(C;T) 2.0 Bad 51.3% plus 0.4389 2.3x risk of rheumatoid arthritis 2.3x risk of rheumatoid arthritis rs7774434(C;C) 2.0 Bad 17.6% plus 0.4435 Increased risk of developing primary biliary cirrhosis Increased risk of developing primary biliary cirrhosis rs13153971(C;T) 2.0 Bad plus 0.3609 Normal (higher) risk of Asthma. Normal (higher) risk of Asthma. This is normal for white people. But this (C;T) has 1.58x the risk compared to T;T (normal for non-white people). Tested in Koreans. rs6897932(C;T) 2.0 Bad 32.7% plus 0.191 1.3x increased risk for multiple sclerosis 1.3x increased risk for multiple sclerosis rs383830(A;A) 2.0 Bad 61.9% minus 0.208 1.9x risk 1.9x risk 1.9x higher risk for coronary artery disease rs4633(C;T) 2.0 Bad 45.9% plus 0.3903 higher risk for endometrial cancer higher risk for endometrial cancer rs2156921(A;G) 2.0 Bad plus 0.3609 1.29x increased risk for depression 1.29x increased risk for depression rs738409(C;G) 2.0 Bad 41.5% minus 0.2842 increased liver fat, odds of alcoholic liver disease increased liver fat, odds of alcoholic liver disease rs2223841(G;G) 2.0 Good 10.8% minus 0.3011 less likely to go bald less likely to go bald less likely to experience baldness before age 40 rs7927894(C;T) 1.9 Good 43.4% plus 0.2819 Normal risk of Atopic Dermatitis. Normal risk of Atopic Dermatitis. rs7923837(A;G) 1.9 Bad plus 0.427 1.6x risk for T2D 1.6x risk for T2D rs10033464(G;G) 1.9 Good 82.3% plus 0.1635 0.92x decreased risk of Atrial Fibrillation and cardioembolic stroke. 0.92x decreased risk of Atrial Fibrillation and cardioembolic stroke. This is the normal version which makes the heart form properly and makes people slightly less likely to get Atrial Fibrillation (quivering of the top chambers of the heart caused by chaotic electrical signals) and less likely to have a cardioembolic stroke (blocked blood flow to the brain). But also check the other SNP nearby (rs2200733) which affects Atrial Fibrillation even more. 23andMe gave this a 4 star confidence rating as it has been heavily studied. It has been confirmed in Europeans. rs4950928(C;C) 1.9 Bad 65.5% plus 0.208 Normal (higher) risk of Asthma. Normal (higher) risk of Asthma. rs4474514(A;A) 1.8 Bad 65.5% plus 0.3567 >3x increased testicular cancer risk for men >3x increased testicular cancer risk for men found in 65% of caucasians but linked 3x higher risk of testicular cancer than the (G;G) form. rs37973(A;G) 1.8 Bad plus 0.3921 Among asthmatics, 1.5x more likely to show less response to inhaled glucocorticoids Among asthmatics, 1.5x more likely to show less response to inhaled glucocorticoids rs7538876(A;G) 1.8 plus 0.3168 Normal risk of Basal Cell Carcinoma. Normal risk of Basal Cell Carcinoma. Normal risk for this kind of skin cancer. gs232 1.7 possible low pain sensitivity suggests you may be able to tolerate more pain than most people. However phased data may be necessary to increase certainty. See also gs232 gs233 gs234 gs235 gs234 1.7 Bad possible high pain sensitivity suggests you may be able to tolerate less pain than most people. However phased data may be necessary to increase certainty. See also gs232 gs233 gs234 gs235 rs4132601(G;T) 1.7 Bad plus 0.2254 somewhat (1.7x) increased risk for acute lymphoblastic leukemia somewhat (1.7x) increased risk for acute lymphoblastic leukemia see discussion at rs4132601 rs7192(G;T) 1.7 Bad plus 0.3678 1.7x increased risk for developing a peanut allergy 1.7x increased risk for developing a peanut allergy In populations of European ancestry, the rs7192(T) allele is associated with somewhat increased risk for developing peanut allergies. gs236 1.6 Alzheimer's related haplotype A single paper suggests that chinese with the haplotype rs8003602(C) and rs3783320(G) may be at higher risk of Alzheimer's disease. From the abstract alone it is unknown what the risk is, but until shown othrwise, assume is is a very small increased risk such as 1.1x. implicates the haplotype rs8003602(C) and rs3783320(G) with Alzheimer's disease in Chinese subjects. See also gs230 rs1057868(T;T) 1.6 plus 0.2879 1.6x higher overall CYP3A activity 1.6x higher overall CYP3A activity rs3775948(C;G) 1.6 Bad minus 0.3237 slightly higher risk for gout slightly higher risk for gout rs33980500(C;T) 1.6 Bad plus 0.08173 1.6x increase in risk for psoriatic arthritis 1.6x increase in risk for psoriatic arthritis gs247 1.5 Bad Parkinson's Disease Risk 23andMe Patent Granted : rs10513789(T) increased risk of developing Parkinson's Disease GenomicsLawReport points out that the originally proposed version considered all of these to indicate increased risk of PD *rs6599389(A) *rs873785(A) *rs11248060(T) *rs6812193(C) *rs4130047(C) *rs7451962(A) *rs4397141(C) gs248, gs249 and gs250 rs4149274(C;T) 1.5 Good minus 0.2897 associated with higher HDL (good) cholesterol associated with higher HDL (good) cholesterol rs10980705(C;T) 1.5 Bad 38.9% plus 0.1924 2.3x increased risk for knee osteoarthritis 2.3x increased risk for knee osteoarthritis rs10993994(C;T) 1.5 Bad minus 0.4734 increased prostate cancer risk (odds ratio 1.2) increased prostate cancer risk (odds ratio 1.2) Compared to the (C;C) genotype for this SNP, (C;T) genotypes are estimated to be at 1.2x increased risk for prostate cancer. rs12252(C;T) 1.5 Bad minus 0.2144 carrier of one allele linked to greater influenza susceptibility carrier of one allele linked to greater influenza susceptibility Carrying one copy of the rs12252(C) allele does not seem to make a person more susceptible to influenza, however, carrying two copies does, so this (C;T) genotype is tagged as a (unaffected) carrier of an allele linked to influenza susceptibility. rs3782179(T;T) 1.5 Bad 65.5% plus 0.3567 common, but increased risk of testicular cancer common, but increased risk of testicular cancer rs6591536(A;G) 1.5 plus 0.3747 more able to detect β-ionone (floral) fragrance more able to detect β-ionone (floral) fragrance rs3851179(A;G) 1.5 Good minus 0.3297 0.85x decreased risk for Alzheimer's disease 0.85x decreased risk for Alzheimer's disease rs4585(T;T) 1.5 Bad 27.4% plus 0.4793 slightly poorer (0.75x) response to metformin in type 2 diabetics slightly poorer (0.75x) response to metformin in type 2 diabetics rs1154155(G;T) 1.5 Bad plus 0.2365 1.94x increased risk for narcolepsy 1.94x increased risk for narcolepsy rs1994090(G;T) 1.5 Bad 32.7% plus 0.135 Slightly increased risk of developing Parkinson's Disease Slightly increased risk of developing Parkinson's Disease rs11171739(C;T) 1.5 Bad 47.8% plus 0.4573 1.34x risk of developing Type-1 diabetes 1.34x risk of developing Type-1 diabetes rs1042725(C;T) 1.5 42.5% plus 0.4325 ~0.4cm taller ~0.4cm taller 0.4cm taller than average rs995030(G;G) 1.5 Bad 66.4% plus 0.3388 non-protective against testicular cancer non-protective against testicular cancer rs1012053(A;A) 1.5 Bad 77.0% plus 0.2548 Normal (higher) risk of Bipolar Disorder. Normal (higher) risk of Bipolar Disorder. This is the most common version of this SNP, so most people have this. But it is suspected of having a higher risk of Bipolar Disorder compared to the other rare versions of this SNP. rs4939883(C;C) 1.5 Good 64.6% plus 0.2346 associated with higher HDL cholesterol associated with higher HDL cholesterol rs4464148(C;T) 1.5 Bad plus 0.2121 1.10x increased risk for colorectal cancer 1.10x increased risk for colorectal cancer rs13181(G;T) 1.5 Bad plus 0.2369 1.12x increased risk for cutaneous melanoma 1.12x increased risk for cutaneous melanoma rs3745516(A;G) 1.5 Bad 36.3% plus 0.4968 Slightly increased risk of developing primary biliary cirrhosis Slightly increased risk of developing primary biliary cirrhosis rs3843763(C;T) 1.5 Bad plus 0.3182 Slightly lower HDL ('Good') Cholesterol. Slightly lower HDL (%22Good%22) Cholesterol. This slightly reduces levels of good HDL cholesterol in your blood. And that's usually bad, because HDL cholesterol actually cleans your arteries and transports cholesterol out of your body. Things that can help raise HDL cholesterol if it is too low include: quitting smoking, losing weight, exercise, and niacin (vitamin B3). rs4027132(A;G) 1.5 Bad plus 0.4702 1.39x increased risk of developing bipolar disorder 1.39x increased risk of developing bipolar disorder rs642961(A;G) 1.5 Bad 33.9% plus 0.1736 1.68x increased risk of cleft lip 1.68x increased risk of cleft lip rs729302(A;C) 1.5 Good 46.0% plus 0.2723 0.89x decreased risk of developing rheumatoid arthritis 0.89x decreased risk of developing rheumatoid arthritis rs1975197(C;T) 1.5 Bad minus 0.2089 1.3x increased risk of developing restless legs syndrome 1.3x increased risk of developing restless legs syndrome rs2280714(A;G) 1.5 Bad 52.2% minus 0.4082 1.4x increased risk of SLE 1.4x increased risk of SLE rs10260404(C;T) 1.5 Bad plus 0.2888 1.20x risk of developing ALS 1.20x risk of developing ALS rs2007153(A;G) 1.5 minus 0.3875 normal risk of schizophrenia in limited study normal risk of schizophrenia in limited study rs4977574(G;G) 1.5 Bad 21.2% plus 0.4169 Most studies find a somewhat elevated (~1.5x) risk for myocardial infarction Most studies find a somewhat elevated (~1.5x) risk for myocardial infarction rs710521(A;G) 1.5 minus 0.2305 Normal risk of developing bladder cancer. Normal risk of developing bladder cancer. This is the normal risk of bladder cancer, particularly in Europeans and in people who already have tumors with low risk of progression. rs4538475(A;G) 1.5 Bad 29.2% plus 0.3127 Slightly increased risk of developing Parkinson's Disease Slightly increased risk of developing Parkinson's Disease rs17319721(A;G) 1.5 Bad plus 0.2764 reported to have some negative associations with kidney function reported to have some negative associations with kidney function Although it is a fairly common genotype in Caucasians, donor kidneys with this genotype appear to be rejected in transplant cases roughly twice as much as (G;G) donor kidneys. rs2736990(C;T) 1.5 Bad minus 0.4045 Slightly increased risk of developing Parkinson's Disease Slightly increased risk of developing Parkinson's Disease rs6532197(A;G) 1.5 Bad 15.0% plus 0.2029 Slightly increased risk of developing Parkinson's Disease Slightly increased risk of developing Parkinson's Disease rs6435862(G;T) 1.5 Bad 44.6% plus 0.2075 1.7x higher risk of aggressive neuroblastoma 1.7x higher risk of aggressive neuroblastoma rs2241880(C;T) 1.5 Bad 56.2% minus 0.3889 1.4x increased risk for Crohn's disease in Caucasians 1.4x increased risk for Crohn's disease in Caucasians rs3087243(A;G) 1.5 Bad plus 0.3242 increased risk for auto-immune diseases increased risk for auto-immune diseases rs3790565(C;T) 1.5 Bad 42.0% plus 0.3232 Slightly increased risk of developing primary biliary cirrhosis Slightly increased risk of developing primary biliary cirrhosis rs16944(A;G) 1.5 Bad 45.1% plus 0.4651 Minorly increased risk of mental illness and osteoarthritis Minorly increased risk of mental illness and osteoarthritis rs11465770(C;T) 1.5 15.0% plus 0.0404 possibly lower risk of Crohn's Disease (OR=0.30) possibly lower risk of Crohn's Disease (OR=0.30) rs3125923(A;G) 1.5 Bad 28.8% plus slightly (50%) increased risk for Taxane-induced peripheral neuropathy slightly (50%) increased risk for Taxane-induced peripheral neuropathy Slightly (50%) increased risk for peripheral neuropathy in patients undergoing chemotherapeutic treatment involving Taxane rs12593813(A;G) 1.5 Good 50.0% plus 0.4545 0.71x risk for restless legs 0.71x risk for restless legs rs11635424(A;G) 1.5 Good 48.7% plus 0.4545 0.70x risk for restless legs 0.70x risk for restless legs rs420259(C;T) 1.5 Good 31.0% minus 0.3434 Possibly reduced risk of Bipolar Disorder. Possibly reduced risk of Bipolar Disorder. This appears to lower the risk of Bipolar Disorder compared to the more common version of the gene, based on preliminary research. rs140701(A;G) 1.5 Bad 52.2% minus 0.4862 Increased risk for anxiety disorders Increased risk for anxiety disorders rs9303277(C;T) 1.5 Bad 56.6% plus 0.4858 Slightly increased risk of developing primary biliary cirrhosis Slightly increased risk of developing primary biliary cirrhosis rs27388(A;G) 1.5 Bad plus 0.4959 Slightly increased risk of developing schizophrenia Slightly increased risk of developing schizophrenia rs10464059(A;G) 1.5 Bad plus 0.2277 Slightly increased risk of developing Parkinson's Disease Slightly increased risk of developing Parkinson's Disease rs872071(A;G) 1.5 Bad 48.7% plus 0.3251 ~1.5x increased risk for chronic lymphocytic leukemia ~1.5x increased risk for chronic lymphocytic leukemia rs6908425(C;T) 1.5 Bad plus 0.2172 1.63x increased risk of developing Crohn's disease 1.63x increased risk of developing Crohn's disease rs807701(C;T) 1.5 Bad minus 0.4178 Slightly increased dyslexia risk Slightly increased dyslexia risk rs12212067(G;T) 1.5 Mixed plus 0.1336 Lower inflammatory response Lower inflammatory response Associated with worse outcomes for malaria patients, but better outcomes for rheumatoid arthritis and Crohn's disease patients. rs309375(T;T) 1.5 Bad 33.6% minus 0.2259 Larger mosquito bites Larger mosquito bites rs924607(T;T) 1.5 Bad 16.8% plus in childhood acute lymphoblastic leukemia patients, worse response to vincristine in childhood acute lymphoblastic leukemia patients, worse response to vincristine (T;T) pediatric ALL patients being treated with vincristine have twice the risk of developing peripheral neuropathies compared to (C;C) and (C;T) patients, based on a preliminary study of ~300 patients. rs464049(C;C) 1.5 Good 21.2% minus 0.4197 decreased risk of schizophrenia in limited study decreased risk of schizophrenia in limited study rs30187(C;T) 1.5 Bad plus 0.4114 1.4x higher risk for Ankylosing Spondylitis. 1.4x higher risk for Ankylosing Spondylitis. Higher, but still very low, risk (0.14%) of this rare autoimmune disease that causes inflammation of the spine and joints. rs1135840(C;G) 1.5 minus 0.4008 Carrier of at least one CYP2D6 variants (non-CYP2D6*1) Carrier of at least one CYP2D6 variants (non-CYP2D6*1) rs1801157(A;G) 1.4 Bad 34.5% minus 0.208 1.4x higher risk for breast cancer 1.4x higher risk for breast cancer rs1545843(A;A) 1.4 Bad 23.0% plus 0.4904 1.4x increased risk for depression (for those under 55) 1.4x increased risk for depression (for those under 55) rs10050860(C;T) 1.4 Good 37.2% plus 0.1322 0.71x lower risk for Ankylosing Spondylitis. 0.71x lower risk for Ankylosing Spondylitis. Very low risk (about 0.07%) of the rare autoimmune disease that causes inflammation of the spine and joints. Based on preliminary research. rs6010620(G;G) 1.4 Bad 55.0% plus 0.314 1.4x higher risk for glioma development; but this is the common allele 1.4x higher risk for glioma development; but this is the common allele rs1047286(C;T) 1.3 Bad minus 0.08586 1.3x increased risk for age-related macular degeneration 1.3x increased risk for age-related macular degeneration rs2295490(A;G) 1.3 Bad 20.5% plus 0.1552 1.32x increased risk of early-onset type-2 diabetes 1.32x increased risk of early-onset type-2 diabetes rs1260326(C;T) 1.3 Bad plus 0.3848 slightly higher risk for gout slightly higher risk for gout rs4295627(G;T) 1.3 Bad plus 0.202 1.3x higher risk for glioma development 1.3x higher risk for glioma development rs356219(A;G) 1.3 Bad plus 0.4922 1.3x increased risk for Parkinson's disease 1.3x increased risk for Parkinson's disease rs2059693(C;T) 1.3 Bad 39.3% plus 0.309 1.3x increased risk for testicular cancer 1.3x increased risk for testicular cancer rs2024513(A;G) 1.3 45.1% plus 0.2759 1.3x higher risk for schizophrenia (among Han Chinese) 1.3x higher risk for schizophrenia (among Han Chinese) rs13361189(C;T) 1.3 Bad plus 0.2746 1.3x increased risk for Crohn's disease 1.3x increased risk for Crohn's disease rs4958847(A;G) 1.3 Bad plus 0.3526 1.3x increased risk for Crohn's disease 1.3x increased risk for Crohn's disease rs498422(A;C) 1.3 Bad minus 0.1538 slightly higher risk for infertility in Chinese men slightly higher risk for infertility in Chinese men A 2012 study of Han Chinese men showed slightly increased risk (odds ratio 1.42) for nonobstructive azoospermia (very low sperm count) and thus infertility for the rarer rs498422(C) SNP. rs3129878(C;C) 1.3 Bad 3.5% plus 0.3108 slightly higher risk for infertility in Chinese men slightly higher risk for infertility in Chinese men A 2012 study of Han Chinese men showed slightly increased risk (odds ratio 1.32) for nonobstructive azoospermia (very low sperm count) and thus infertility for the rarer rs3129878(C) SNP. rs1800454(A;G) 1.3 23.9% minus 0.1538 carrier carrier Since this comes from omim, it's supposed to be a rare disorder, but HapMap shows that variation is common rs2736100(G;T) 1.3 Bad minus 0.4477 1.3x higher risk for glioma development 1.3x higher risk for glioma development rs1042713(A;G) 1.3 Bad plus 0.4706 1.3x increased risk that pediatric inhaler use may make asthma worse 1.3x increased risk that pediatric inhaler use may make asthma worse gs184 1.2 Good Able to taste bitterness. Normal tasting ability for bitterness. This makes turnip, cabbage, brussels sprouts, broccoli, and other cruciferous vegetables taste more interesting and less horribly bland. Coffee and dark beers also tastes more bitter. You can taste propylthiouracil (PROP), PTC, and related chemicals. On the other hand, you can't taste the unpleasant bitterness of the tropical fruit from the Bignay tree, it will taste sweet to you. You probably eat healthier. rs498872(C;T) 1.2 Bad 39.8% minus 0.2328 1.2x higher risk for glioma development 1.2x higher risk for glioma development rs11190302(C;T) 1.2 Bad 47.8% plus 0.3393 rs4320932(A;G) 1.2 Good minus 0.258 0.87x decreased risk for ovarian cancer 0.87x decreased risk for ovarian cancer rs449647(A;T) 1.2 Bad minus 0.1758 Possibly lower levels of ApoE Possibly lower levels of ApoE rs9858542(A;G) 1.2 Bad plus 0.2199 1.1x risk Crohn's Disease 1.1x risk Crohn's Disease rs35677470(A;G) 1.2 Bad plus 2x higher risk for scleroderma 2x higher risk for scleroderma rs6968865(A;T) 1.2 41.4% plus 0.4793 Associated with (slightly) increased coffee consumption Associated with (slightly) increased coffee consumption rs2252586(A;G) 1.2 Bad 40.2% minus 0.2089 1.2x higher risk for glioma development 1.2x higher risk for glioma development rs2814707(A;G) 1.2 Bad 28.3% minus 0.1754 1.2x increased risk for ALS 1.2x increased risk for ALS rs10516487(C;T) 1.2 Bad minus 0.2245 slightly higher risk for lupus slightly higher risk for lupus Slightly higher risk for lupus. This finding has been replicated across several populations, but in all, the effect is fairly small. rs2056116(A;G) 1.2 Bad 45.1% plus 0.3072 1.18x risk for breast cancer 1.18x risk for breast cancer rs689466(A;G) 1.2 minus 0.2534 1.2x higher risk for inflammatory bowel diseases 1.2x higher risk for inflammatory bowel diseases rs4795067(A;G) 1.2 Bad 43.4% plus 0.2847 slight increase in risk for psoriatic arthritis slight increase in risk for psoriatic arthritis rs419788(A;G) 1.2 Bad minus 0.2199 2.0x risk for lupus 2.0x risk for lupus rs2076295(G;T) 1.2 Bad plus 0.4536 One copy of the risk allele (G), slightly increased risk for pulmonary fibrosis One copy of the risk allele (G), slightly increased risk for pulmonary fibrosis rs5370(G;T) 1.2 Bad 30.1% plus 0.2057 possibly lower HDL cholesterol in women possibly lower HDL cholesterol in women One report indicates that women (but not men) with this genotype may have slightly lower levels of HDL cholesterol, but other reports have not observed this. rs6048(G;G) 1.2 Good 26.2% plus 0.1578 slightly lower risk (10-20%) of deep vein thrombosis slightly lower risk (10-20%) of deep vein thrombosis rs748404(C;T) 1.15 Bad plus 0.1524 very slightly increased risk (1.15) for lung cancer very slightly increased risk (1.15) for lung cancer rs11037909(C;T) 1.1 Bad plus 0.2966 1.27x type II diabetes risk 1.27x type II diabetes risk rs3740878(A;G) 1.1 Bad minus 0.2874 1.26x type II diabetes risk 1.26x type II diabetes risk rs610932(C;C) 1.1 Bad 17.0% minus 0.4219 rs11172113(C;T) 1.1 Good plus 0.3898 0.9x lower risk for migraines 0.9x lower risk for migraines rs11110912(C;G) 1.1 Bad 35.4% plus 0.1061 1.3x high blood pressure risk 1.3x high blood pressure risk rs795484(G;G) 1.1 Good 45.5% minus Normal morphine dose requirement and postoperative pain in tonsillectomy and adenoidectomy Normal morphine dose requirement and postoperative pain in tonsillectomy and adenoidectomy rs838133(C;C) 1.1 25.9% minus 0.2525 Lower odds preferring sweet snack Lower odds preferring sweet snack rs363050(A;G) 1.1 plus 0.4729 The (A;G) genotype averages 2.8 PIQ points higher than the (G;G), but averages 2.84 PIQ points lower than (A;A) genotype rs713598(C;G) 1.1 Good 51.6% minus 0.4692 Can taste bitter. Can taste bitter. Normal tasting ability for bitterness. This makes turnip, cabbage, brussels sprouts, broccoli, and other cruciferous vegetables taste more interesting and less horribly bland. Coffee and dark beers also tastes more bitter. You can taste propylthiouracil (PROP), PTC, and related chemicals. On the other hand, you can't taste the unpleasant bitterness of the tropical fruit from the Bignay tree, it will taste sweet to you. You probably eat healthier. rs4496877(G;T) 1.1 plus 0.2199 For type-1 diabetics, 1.3x increased nephropathy risk For type-1 diabetics, 1.3x increased nephropathy risk rs1229984(G;G) 1.1 100.0% minus 0.2117 normal oral/throat cancer risk; more frequent alcohol consumption normal oral/throat cancer risk; more frequent alcohol consumption rs7568369(G;T) 1.1 Good 0.0% plus 0.3122 0.90x reduced risk of obesity 0.90x reduced risk of obesity rs13387042(A;G) 1.1 Bad 48.7% plus 0.4481 1.12x increased risk for breast cancer 1.12x increased risk for breast cancer rs1344706(G;T) 1.1 Bad 52.3% minus 0.3453 1.1x increased risk for schizophrenia 1.1x increased risk for schizophrenia rs2651899(A;G) 1.1 Bad minus 0.4995 1.1x higher risk for migraines 1.1x higher risk for migraines rs7171755(A;A) 1.1 Bad 16.8% plus 0.4853 very slight descrease in cortical thickness and IQ; see full description very slight descrease in cortical thickness and IQ; see full description rs249954(C;T) 1.1 Bad minus 0.3338 slight if any increased risk of Breast Cancer slight if any increased risk of Breast Cancer rs2653349(G;G) 1.1 Bad 70.5% plus 0.1286 2-6x increased risk for cluster headaches 2-6x increased risk for cluster headaches rs31489(A;A) 1.1 16.1% plus 0.3503 Reduced lung cancer risk? Reduced lung cancer risk? rs16891982(G;G) 1.1 96.8% plus 0.4408 Generally European; Light skin; Possibly an increased risk of melanoma Generally European; Light skin; Possibly an increased risk of melanoma This SNP is associated with skin, hair, and eye colour, and risk of melanoma. Individuals with the G;G genotype are generally of European descent and have fair skin. In a population-based case-control study investigating a number of pigmentation-related SNPs and their correlation with cutaneous malignant melanoma (CMM) in a Caucasian Australian population, rs16891982 (variant F374L) was found to be associated with odds ratios of 3.44, 2.86, 1.68, and 1.68 for all study subjects (1,738 CMM cases and 4,517 controls); subjects with northern European ancestry (1,438 cases and 3,098 controls); northern European subjects adjusted for hair, eye, and skin colour; and northern European subjects adjusted for the MC1R genotype, r... rs2291834(C;T) 1.05 Bad plus 0.4568 very slightly higher risk for myocardial infarction very slightly higher risk for myocardial infarction rs4420065(C;C) 46.0% plus 0.4614 rs12753193(A;A) 46.9% plus 0.4541 rs4384209(G;G) 64.6% plus 0.3967 rs7523412(A;G) plus rs357564(A;A) 6.3% plus 0.382 rs1547201(C;T) minus 0.4894 rs6477872(C;T) 38.1% plus 0.174 rs2061634(C;C) 5.3% minus 0.2479 rs1475545(A;A) 20.4% minus 0.4656 rs2808668(C;T) 50.8% plus 0.3567 rs755109(C;T) plus 0.2649 rs3176658(C;C) 76.9% minus 0.1713 rs1800975(C;T) minus 0.3466 rs10986018(C;T) plus rs3780422(A;A) minus 0.3903 rs2491397(T;T) 28.6% plus 0.3893 rs4743056(C;T) 44.2% plus 0.494 rs2779562(C;T) plus 0.4421 rs2808566(G;T) 47.7% plus 0.4431 rs10819643(G;G) 2.7% plus rs10115383(G;G) 51.3% plus 0.3407 rs1572983(T;T) 43.4% plus 0.3829 rs10819937(G;G) 73.8% plus 0.2658 rs11788456(A;G) plus 0.494 rs17189632(A;T) plus 0.3627 rs10121600(C;T) 43.1% plus 0.3535 rs10989591(C;T) 41.6% plus 0.2998 rs10989692(A;G) plus rs2210533(C;T) 38.1% minus 0.1428 rs1342899(A;A) 3.6% minus 0.2245 rs12551906(A;G) plus 0.1699 rs1526267(G;G) 69.2% minus 0.3388 rs1131339(A;G) 54.0% plus 0.4394 rs12686676(A;G) 53.2% plus 0.4394 rs10819699(G;G) 52.4% plus 0.4385 rs10760706(T;T) 41.6% plus 0.2971 rs13287980(A;G) plus 0.2525 rs2274870(A;A) plus rs2472476(A;A) 37.2% minus rs363717(A;A) 66.4% minus 0.1515 rs2230808(G;G) 61.9% minus 0.4109 rs4149310(A;T) 27.0% minus 0.4536 rs2230806(A;A) 4.5% minus 0.4192 rs2249891(A;G) 16.8% plus 0.331 rs16922670(C;T) plus 0.214 rs1450679(A;A) 68.1% minus rs12686004(A;G) plus 0.118 rs1883025(A;G) 31.0% minus 0.2815 rs2575876(A;G) plus 0.2525 rs4149263(C;T) 33.6% minus rs9969729(A;G) plus 0.3554 rs4742971(G;T) 14.2% plus 0.1892 rs7861820(C;C) 20.4% plus 0.3365 rs2090409(G;T) minus 0.3669 age at menarche ~1 month later on average age at menarche ~1 month later on average rs1858231(C;T) 27.4% minus rs1746825(C;C) plus 0.348 rs817826(T;T) 71.7% plus 0.1763 rs1467311(C;T) minus rs865686(T;T) 39.8% plus 0.3191 rs676256(T;T) 36.8% plus rs1930095(G;G) 31.0% minus 0.4178 rs10512385(A;G) 16.8% plus 0.1208 rs643410(C;C) 87.6% plus 0.05464 rs1003346(G;T) minus rs7027110(A;G) plus 0.1841 rs4743034(A;G) plus 0.2466 rs10980926(A;G) 47.7% plus 0.4775 rs10441737(C;T) 35.4% plus 0.4784 rs2273788(C;T) 43.4% plus 0.2429 rs10125054(A;G) plus rs787274(C;C) 86.4% plus rs6477998(A;C) plus 0.4711 rs2839874(G;G) 10.6% plus rs7868992(A;A) 49.6% plus 0.4582 rs1249719(A;G) minus rs2025875(A;A) 60.2% plus rs2301241(C;T) minus 0.3939 rs7042161(C;T) plus 0.2548 rs17650(A;G) plus rs2274158(G;T) 36.9% plus 0.2351 rs4978584(C;T) 36.3% plus 0.2383 rs10982256(C;T) 46.0% plus 0.4008 1.3x risk 1.3x risk rs10982287(A;G) plus rs10817638(A;G) 46.0% plus rs1249744(G;G) 4.4% plus 0.2484 rs753085(T;T) 6.2% minus 0.2323 rs946053(G;G) 21.2% plus 0.2975 rs4979459(T;T) 35.4% plus 0.4844 rs7849556(A;A) 61.5% plus 0.1887 rs10817669(A;A) 58.4% plus 0.2957 rs10759734(A;A) 62.8% plus 0.1915 rs10982396(C;C) 80.2% plus 0.05234 rs10733612(C;C) 63.1% plus 0.2084 rs13321(C;G) 36.9% minus 0.3283 rs2104772(A;T) minus 0.4789 rs1330363(A;G) 49.6% minus 0.4082 rs4979427(C;T) plus rs7851259(A;G) 50.4% plus rs7847271(A;G) plus 0.1612 rs10982724(C;T) plus 0.2103 rs9409154(C;T) plus 0.2576 rs12006166(A;T) 33.8% plus 0.09091 rs13290997(G;G) 29.2% plus 0.4229 rs10983238(C;G) 33.6% plus 0.1455 rs803917(C;T) minus 0.2916 rs6478282(G;T) 47.3% plus 0.2994 rs4838255(A;A) 79.0% plus 0.1097 rs2226006(T;T) 21.2% plus 0.4812 rs2771051(T;T) 37.2% plus 0.4945 rs1985317(A;A) 33.0% minus 0.4004 rs1329060(G;G) 72.3% minus rs1329057(A;A) 62.8% minus rs751543(A;G) 37.2% minus 0.3489 rs7852872(C;G) 47.7% plus 0.3834 rs6478241(G;G) 38.9% plus 0.4522 rs10759930(C;T) 46.4% plus 0.3875 rs2737191(A;G) 38.4% plus rs2770150(A;G) minus 0.1515 rs10759931(A;G) plus 0.3866 rs2737190(A;A) 46.9% plus 0.4605 rs1927914(T;T) 46.9% minus 0.461 rs2770146(C;T) minus 0.1621 rs1927911(C;C) 54.9% minus 0.3857 normal normal rs2149356(C;C) 56.9% minus 0.45 rs5030728(A;G) plus 0.1621 rs913930(C;T) minus rs10115586(C;C) 43.1% plus 0.247 rs12379034(A;G) 23.9% plus rs10985070(A;C) plus rs2072438(C;T) plus rs881375(C;C) 38.9% plus 0.3044 rs2416804(C;G) plus 0.4518 rs7021206(A;A) 38.9% plus 0.326 rs1930780(G;G) 38.9% plus 0.3035 rs2416806(C;C) 31.7% plus 0.3264 rs1572299(A;G) minus 0.2466 rs11789399(A;G) plus 0.2461 rs10435884(C;T) 28.3% plus 0.2227 rs17582214(A;T) 33.9% plus 0.2264 rs16909449(C;T) plus 0.2002 rs10733648(C;C) 38.1% plus 0.3324 rs10760130(A;G) plus 0.4522 rs10818488(A;G) Bad 53.8% plus 0.4908 1.4x increased risk for rheumatoid arthritis 1.4x increased risk for rheumatoid arthritis rs2416808(A;G) plus 0.4504 rs2900180(C;C) 38.1% plus 0.3333 rs2300929(C;T) plus 0.2089 rs10985112(A;G) plus 0.1552 rs35061590(G;T) 15.0% plus 0.0303 rs13290547(C;T) 15.0% plus 0.0326 rs10985375(A;C) plus 0.1492 rs10760187(C;T) plus 0.3669 rs3818638(G;G) 50.4% minus rs7856367(T;T) 23.9% plus rs883484(A;G) minus 0.2668 rs1330344(A;G) minus 0.3173 rs10306122(C;T) plus 0.1281 rs1213266(G;G) 87.6% plus rs1771889(G;G) 15.4% plus 0.3375 rs555996(C;G) 37.2% plus 0.169 rs7040561(A;A) 66.2% plus 0.09688 rs4838320(C;C) 83.2% plus 0.1111 rs10987149(A;A) 46.9% plus rs888219(G;T) 35.4% minus 0.2883 rs758970(C;T) 46.2% minus rs7859156(C;C) 53.8% plus 0.1869 rs12342373(A;G) plus rs4130590(A;G) 46.9% plus 0.3994 rs7029536(C;T) 43.4% plus 0.343 rs514024(A;A) 40.7% plus 0.4826 rs10818684(T;T) 58.4% plus 0.382 rs2479106(A;G) 41.6% plus 0.3852 rs10818894(A;G) plus rs2807580(A;G) minus 0.1933 rs458046(A;T) 42.9% plus 0.4495 rs11355458(-;C) plus 0.2681 rs17840761(C;T) minus 0.4633 rs2241941(C;T) plus rs10834691(T;T) 29.2% plus 0.4458 rs6484176(C;T) plus 0.2544 rs293974(T;T) 8.0% minus 0.2608 rs10835187(T;T) 30.1% plus 0.3953 rs7481311(C;C) 61.1% plus 0.2691 rs11030096(C;C) 18.6% plus 0.3228 rs1519480(T;T) 47.8% plus 0.4366 rs7124442(T;T) 47.8% plus 0.2943 rs11030101(A;T) 48.4% plus 0.3113 rs12788764(C;T) plus rs11030107(A;G) 43.1% plus 0.1377 rs10835210(A;C) plus 0.2865 rs7103411(T;T) 56.6% plus 0.2562 rs7103873(C;G) plus rs61888800(G;T) plus 0.1364 rs2049046(A;T) minus 0.4527 rs988748(C;C) 61.9% minus 0.2567 rs10767664(A;A) 67.2% plus 0.2562 rs2030324(C;T) 53.2% minus 0.4578 rs28722151(C;G) plus rs12273363(C;T) plus 0.1134 rs1491850(C;T) plus 0.3921 rs1491851(C;C) 21.4% plus 0.3407 rs3026398(C;T) minus 0.1864 rs12421026(C;T) 53.1% plus 0.4444 rs1506(T;T) 72.3% minus 0.3173 rs3026393(G;T) 53.1% minus 0.4509 rs2071754(A;A) 69.9% minus 0.354 rs685428(T;T) 60.2% minus 0.2493 rs2030323(G;G) 63.1% minus 0.2539 rs514644(C;T) plus rs545610(C;C) 39.8% plus 0.2144 rs163879(T;T) 46.0% plus 0.4164 rs962369(A;G) minus 0.1892 rs652722(A;G) 40.7% minus 0.3508 rs16754(A;G) minus 0.3223 rs3930513(G;T) minus rs5030141(A;C) 29.2% minus rs1799925(C;T) minus 0.3154 rs7943316(T;T) 52.3% plus 0.4894 rs2300181(A;G) 35.7% minus 0.2172 rs5028798(G;T) plus 0.3476 rs286913(C;T) 8.0% minus 0.06015 rs286905(C;C) 64.6% minus 0.2534 rs1355223(C;C) 32.7% minus 0.3264 rs5030320(A;G) minus rs5030317(C;G) 42.3% minus rs12793173(C;C) 6.2% plus 0.163 rs2732552(A;G) minus 0.4449 rs2785197(C;T) 53.1% minus 0.4504 rs996076(C;T) minus 0.4031 rs713330(C;T) 44.6% plus 0.2006 rs12419062(A;G) 42.5% plus 0.4486 rs8193(C;T) 49.1% plus 0.3196 rs13347(C;T) 29.5% plus 0.3457 rs10768122(A;G) 48.7% plus 0.3439 rs3838796(-;T) minus rs1885343(A;G) plus 0.3705 rs4534557(C;G) 48.4% plus 0.3646 rs1559759(G;T) minus 0.186 rs507230(A;A) 28.3% plus 0.3512 rs2785173(T;T) 0.0% minus 0.157 rs1425802(G;G) 8.0% minus 0.2961 rs187116(C;T) 1.0 minus 0.4683 among patients with gastric cancer, risk for more aggressive form? among patients with gastric cancer, risk for more aggressive form? rs353644(G;G) 18.6% minus 0.4835 rs11033013(C;G) plus 0.2319 rs10767942(C;T) plus 0.3646 rs10767971(C;T) plus 0.365 rs554518(G;G) 72.6% minus 0.09137 rs769214(A;A) 42.5% plus 0.4775 rs11185660(C;T) plus 0.2975 rs10881583(C;T) plus 0.3696 rs1045570(G;T) plus 0.1552 rs3132291(C;T) minus 0.4027 rs748964(C;G) 24.6% plus 0.1295 rs3118523(A;G) plus 0.2452 rs61735045(A;G) plus 0.02525 rs12722(C;T) 59.6% plus 0.3714 rs1071583(C;C) 38.1% plus 0.3627 rs2989727(T;T) 36.3% plus 0.478 rs3849221(A;C) 44.6% plus 0.4449 rs10776934(G;T) plus 0.3108 rs7860634(A;G) plus 0.4578 rs7849585(T;T) 9.2% plus 0.4421 rs12338076(C;C) 12.4% plus 0.4656 rs3118515(A;G) plus 0.3205 rs3132306(A;G) minus 0.2934 rs1536482(A;G) plus 0.3535 rs11787792(A;G) plus rs10870077(C;G) 50.8% plus 0.3641 rs10781499(A;G) plus 0.365 rs4077515(A;G) 52.2% minus 0.3669 rs10781500(C;T) 53.1% plus 0.3655 rs3124591(C;T) plus rs13290979(A;G) 44.2% plus 0.4178 rs7852970(A;A) plus 0.4077 rs11145951(C;T) plus 0.3747 rs57024841(A;A) plus 0.4022 rs3750518(A;G) 46.9% minus 0.4812 rs4880213(T;T) 11.5% plus 0.4715 rs12246027(A;G) plus rs17221323(C;T) plus 0.08356 rs877282(C;T) minus 0.0932 rs4636297(G;G) plus 0.3168 rs11599315(C;T) 49.6% plus 0.343 rs2805533(T;T) 25.7% minus 0.455 rs17293817(A;G) plus rs2999399(T;T) 65.5% plus 0.2241 rs12360000(A;G) plus rs12571964(C;T) 25.7% plus 0.1635 rs729397(C;G) minus 0.2245 rs9329300(C;C) 96.9% plus rs7896691(T;T) 75.0% plus 0.1198 rs4880487(C;T) 42.0% plus 0.2006 rs17135159(A;C) 32.3% plus 0.2612 rs1570854(C;T) 45.9% plus 0.4812 rs7092929(C;C) 69.9% plus 0.3278 rs6601764(T;T) 1.0 Good 26.5% plus 0.3669 Normal risk of developing Crohn's disease Normal risk of developing Crohn's disease rs2031573(A;G) 23.0% minus 0.1051 rs2031577(C;C) 54.9% minus 0.4403 rs10458787(G;G) 49.6% plus 0.1988 rs2165953(C;T) minus rs1391511(C;C) 35.4% minus 0.4421 rs12416000(A;G) 1.0 plus 0.1143 mixed homo-sapiens (human) and Neanderthal mixed homo-sapiens (human) and Neanderthal rs2904804(T;T) 34.8% plus 0.3026 rs2518049(A;G) 22.1% plus 0.1134 rs7899101(C;T) 38.9% plus rs705469(C;C) 15.9% plus 0.32 rs705471(G;G) 15.9% plus 0.3223 rs2380205(C;T) 49.6% plus 0.3825 rs2296139(A;G) 26.8% minus 0.1988 rs7911500(C;T) 20.4% plus 0.07163 rs12722605(A;T) minus 0.08861 rs2025345(G;G) 25.7% plus 0.3503 rs7072398(A;A) 34.5% plus 0.4793 rs4749924(A;C) 43.4% plus rs2256774(A;G) minus 0.3338 rs706779(A;G) minus 0.4711 rs2797501(A;A) 76.1% plus 0.1414 rs706778(A;G) 43.4% minus 0.4844 rs3134883(C;T) minus 0.2149 rs3118470(C;T) plus 0.3186 rs7072793(C;T) plus 0.4532 rs4147359(A;G) plus 0.3343 rs7090512(C;T) 36.3% plus 0.3471 rs4749955(T;T) 31.9% plus 0.4128 rs11594656(A;T) plus 0.1602 rs12570744(C;T) 20.4% plus 0.2847 rs6602217(C;T) plus 0.1203 rs2462692(C;C) 85.0% minus 0.03949 rs11255291(T;T) 21.2% plus 0.3912 rs403029(C;C) 51.3% plus 0.2351 rs501764(T;T) 64.0% plus 0.1042 rs1269486(G;G) 51.3% plus 0.1873 rs1399180(C;C) 63.7% plus 0.2273 rs3781093(A;G) minus rs7077335(A;A) 98.2% plus 0.1878 rs947474(A;A) 72.6% plus 0.1997 rs4750316(G;G) 69.9% plus 0.2144 rs4558075(T;T) 69.9% plus rs500766(C;T) 47.3% plus 0.2548 rs11259403(C;T) 38.9% plus 0.4839 rs571715(T;T) 65.2% plus 0.2695 rs444929(T;T) 59.6% plus rs422628(T;T) 55.8% plus rs706771(A;A) 10.6% plus 0.3375 rs10795668(A;A) 9.8% plus 0.27 rs827382(T;T) 63.9% plus 0.264 rs11255841(A;A) plus rs73635312(A;G) plus rs2388896(A;G) 45.1% plus 0.32 rs10508372(A;G) plus 0.2709 rs962993(T;T) 15.0% plus 0.2681 rs3824662(G;T) minus 0.2158 rs3824660(A;G) minus rs570613(A;G) 44.2% minus 0.3627 rs17515642(A;A) 3.1% plus 0.08219 rs10905651(A;G) plus 0.4472 rs7097577(T;T) 100.0% plus 0.03994 rs7092703(T;T) 20.0% plus 0.3099 rs62209(G;T) 32.1% plus 0.2837 rs3740194(C;T) plus rs7920721(A;G) 48.7% plus rs10795917(A;G) plus 0.3627 rs10906115(G;G) 12.4% plus 0.3655 rs12779790(A;G) 28.6% plus 0.1731 rs10491003(A;A) 0.0% minus rs10906142(A;G) plus 0.3453 rs525455(A;A) 31.9% plus 0.4366 rs1561570(C;T) plus 0.4518 rs1095368(C;C) 29.2% plus 0.4022 rs1747683(C;C) 23.1% minus 0.4201 rs56161216(A;G) plus rs10906466(G;G) 46.9% plus 0.3636 rs2278871(C;T) 18.6% plus 0.2149 rs7900873(A;G) plus 0.4123 rs7094179(A;C) plus 0.4293 rs10906189(A;A) 27.4% plus 0.4959 rs7909670(T;T) 17.9% plus 0.4679 rs7893395(C;T) 31.0% plus 0.3242 rs10904850(A;G) plus 0.208 rs6602175(T;T) 45.1% plus 0.4197 rs1801222(C;T) 42.5% minus 0.2305 rs10904887(C;T) plus rs10904908(A;G) 49.2% plus rs1926736(C;T) 40.7% minus 0.4169 rs4373814(C;C) 12.3% plus 0.4853 rs2357790(C;C) 13.3% plus 0.4945 rs10764319(T;T) 4.4% plus 0.3705 rs11259365(C;G) plus 0.1469 rs11259474(C;C) 0.0% plus 0.2971 rs2297882(A;G) 35.4% plus 0.2925 rs2069036(C;T) plus rs10740993(T;T) 15.0% plus 0.4757 rs7069292(T;T) plus 0.1905 rs7099380(A;G) plus 0.3792 rs2357928(A;G) plus 0.3792 rs61839258(G;T) plus 0.169 rs11014166(A;T) 50.8% plus 0.2034 rs7076247(C;C) 37.2% plus 0.3572 rs8181477(A;C) 47.8% plus rs10829156(C;C) 62.8% plus 0.1777 rs4634985(C;T) plus 0.4353 rs2482109(T;T) minus 0.2098 rs1571942(C;T) 28.3% minus 0.1455 rs7094131(T;T) 28.8% plus 0.4931 rs1054052(A;A) 50.8% plus 0.4366 rs722258(T;T) 12.6% plus 0.4293 rs7893600(C;C) 100.0% plus rs11013962(G;G) 31.9% plus 0.4821 rs2484873(C;T) 12.4% minus 0.2062 rs11014249(G;G) 12.3% plus rs1536836(C;T) 49.2% minus rs2096176(T;T) 20.4% plus rs1805398(T;T) 2.7% plus 0.1515 rs12219125(G;T) 29.2% plus 0.1391 rs3847375(A;C) plus 0.2599 rs7072776(G;G) 54.0% plus 0.2966 rs746203(A;A) 28.3% minus 0.4389 rs992990(A;A) 10.8% plus 0.3852 rs8190748(G;G) 9.7% plus 0.4449 rs786870(G;G) 58.0% minus 0.1501 rs11006923(C;T) plus 0.1474 rs2153299(A;G) minus rs11007350(C;T) 54.5% plus 0.3774 rs788076(A;G) plus 0.0629 rs4387258(A;G) plus rs2368392(C;T) minus 0.2975 rs3006564(C;T) plus 0.4376 rs1042058(C;C) 40.7% plus 0.4284 rs399593(T;T) 70.8% plus 0.2314 rs11008222(A;A) 29.2% plus rs10763642(A;G) plus rs4317882(A;G) plus 0.1736 rs17468(C;T) minus rs2230396(A;C) 20.4% minus 0.242 rs1412115(A;G) minus 0.4389 rs7905537(A;C) 30.1% plus 0.2461 rs10763976(A;G) plus 0.3861 rs1352(C;T) plus rs1779876(G;T) plus 0.1543 rs1360573(A;G) 32.7% plus 0.1956 rs1148259(G;T) 45.1% minus 0.4867 intermediate sphingomyelin ratios intermediate sphingomyelin ratios rs1200821(C;T) 43.1% minus 0.477 rs2994684(C;T) plus 0.1575 rs1250307(T;T) 98.5% minus 0.2346 rs2484992(G;G) 98.2% minus 0.2374 rs2484990(G;G) 98.5% minus 0.2383 rs1775715(G;G) 22.1% plus 0.4894 rs2506030(A;G) 50.4% plus rs1864410(A;C) minus rs2506004(G;T) minus 0.2599 rs2505535(C;T) 48.7% minus 0.2576 rs2565206(A;C) minus 0.3379 rs1800860(A;G) 48.2% plus 0.225 10% smaller kidneys as newborns 10% smaller kidneys as newborns rs2742234(T;T) 60.2% plus 0.3058 rs1255372(C;C) 38.1% plus 0.3039 rs1800861(A;A) minus 0.2773 rs2075912(C;C) 68.1% plus 0.2392 rs2565200(G;G) 68.1% minus rs754618(A;G) 37.2% minus 0.2374 rs2291427(G;G) 39.8% plus rs4838605(C;T) 42.5% plus 0.4766 rs10776612(C;T) 57.8% plus 0.4536 rs10776614(C;C) 66.4% plus 0.1639 rs11101442(C;T) 44.2% plus 0.2833 rs2671692(A;A) 42.5% plus 0.4706 rs4253132(T;T) 74.3% minus 0.1345 rs4253079(A;C) minus 0.1033 rs9326506(A;C) 48.2% plus 0.45 1.3x risk 1.3x risk rs898549(C;T) 55.8% plus rs2047009(A;C) minus rs10508881(A;G) 48.7% plus 0.4931 rs266093(G;G) 38.5% plus 0.3251 rs2297630(A;G) plus 0.1993 rs266085(C;T) plus 0.4013 rs2839693(G;G) 83.3% minus 0.1423 rs885834(A;G) plus 0.3838 rs1880676(A;G) plus 0.1524 rs3810950(A;G) plus 0.1515 rs2177369(C;T) Good minus 0.2787 normal normal rs3123078(C;T) 50.4% minus 0.4518 rs7920517(A;G) minus 0.4752 rs10763546(C;G) 50.4% minus 0.4692 rs10669586(CT;CT) rs12770171(C;T) minus rs7085433(A;G) minus 0.1019 rs2574975(A;G) minus 0.2925 rs10821905(A;G) plus 0.1731 rs6479874(C;C) 74.5% plus 0.09688 rs7898516(C;T) plus 0.4789 rs293314(C;T) 13.3% plus rs11001560(C;C) 25.7% plus rs1569198(G;G) 18.6% plus 0.3609 rs2222800(A;C) 46.9% plus rs7904463(C;T) 54.1% minus 0.4109 rs1373004(C;C) 78.4% minus 0.2511 rs583012(A;A) 38.1% plus 0.1635 rs17345(A;T) plus rs2384375(G;G) 42.2% plus rs11004085(T;T) 33.6% plus rs2384437(T;T) 26.6% plus rs7476422(T;T) 52.2% plus rs1930146(C;T) 54.0% plus rs10740609(A;T) plus 0.168 rs1916521(A;A) 12.6% minus 0.3535 rs16907840(C;T) 29.5% plus 0.1423 rs7096206(C;G) plus 0.1832 rs11003125(C;G) plus 0.3375 rs6480975(C;C) 65.1% plus 0.2126 rs3107503(G;G) 38.1% plus 0.359 rs11005694(C;G) 42.6% plus rs4462262(C;T) plus 0.3471 rs17625382(A;G) plus rs2306604(C;T) 40.7% minus 0.461 rs7085387(A;G) plus 0.3792 Rs7085387 is an A/G variant located on chromosome 10 and has been linked to migraines without aura rs10509091(G;T) plus 0.3958 rs7084402(A;G) 53.1% plus 0.4959 rs1658442(C;T) minus 0.4426 rs4948317(C;T) 46.0% plus rs1907926(A;G) minus rs1171617(A;A) 65.5% minus rs1171615(A;A) 65.5% minus rs1171614(G;G) 65.2% minus 0.1671 rs6479779(G;G) 45.1% plus 0.388 rs2893880(C;C) 64.6% minus 0.3278 rs7073837(C;C) 41.6% plus 0.3567 rs10994982(A;G) 54.0% plus 0.4761 rs10740055(A;C) plus 0.4738 rs7090445(T;T) 48.7% plus rs10821936(T;T) 47.8% plus 0.3108 normal normal rs10761600(A;T) 52.3% plus 0.3393 rs4948496(C;C) 18.2% plus 0.41 rs3125734(C;C) 42.5% plus 0.3508 rs3808942(T;T) 62.8% plus 0.2833 rs10761570(G;T) plus 0.4256 rs10761571(A;C) 50.8% plus 0.3701 rs7896712(A;T) plus 0.3705 rs7911302(A;C) 48.7% plus 0.404 rs2675609(C;T) plus 0.4311 rs10822013(C;T) 54.0% plus 0.4197 rs16917302(A;C) 12.4% plus 0.2043 rs7922449(C;C) plus rs2393903(G;G) 34.5% minus rs10995245(A;A) 14.3% plus rs10761659(A;G) Bad 57.5% plus 0.4982 1.2x risk 1.2x risk rs224136(C;T) 26.5% plus 0.3577 rs442309(T;T) 21.4% plus rs1444418(C;T) 18.6% minus 0.2746 rs224278(C;T) 50.4% plus 0.449 rs1412554(T;T) 29.2% plus 0.4518 rs1509957(C;C) 28.6% plus 0.45 rs10761670(T;T) 28.6% plus 0.4509 rs10822136(C;T) 5.9% plus 0.2314 rs4379723(C;T) plus 0.3907 rs6479891(C;C) 75.9% plus 0.2011 rs10761731(A;T) 44.3% plus 0.3581 rs7075195(A;G) 41.7% plus 0.3567 rs10740118(C;G) plus rs12355784(A;C) plus 0.382 rs2393967(A;C) 48.4% plus 0.2282 rs7923609(A;G) 40.7% plus 0.3802 rs7910927(G;T) plus 0.3797 rs10995356(A;G) plus 0.3338 rs10995439(A;G) plus 0.3338 rs7896783(A;G) plus rs938036(C;T) plus rs7900909(C;T) plus 0.2415 rs1786929(C;T) 41.6% minus 0.2847 rs1471384(A;A) 66.4% minus rs16922827(G;T) plus 0.1341 rs10762058(C;G) 32.3% plus 0.2204 rs7909235(G;T) 44.0% plus rs7902091(A;C) plus 0.3499 rs7894483(T;T) 54.9% plus 0.4729 rs2893923(C;T) 46.0% plus 0.2713 rs10761779(A;G) 41.6% plus 0.3857 rs10822184(C;T) plus 0.45 rs2394443(C;C) plus rs7896005(G;G) 51.3% plus 0.3747 rs7069102(G;G) 61.9% plus 0.4738 rs10997870(T;T) 51.3% plus 0.3751 rs1467568(G;G) 60.0% plus rs10997875(C;C) 54.9% plus 0.4706 rs6480314(A;A) 72.6% plus 0.1552 rs7916697(G;G) 62.8% plus 0.4229 rs1900005(G;G) 73.8% minus 0.41 rs5030882(T;T) 91.2% plus 0.1001 rs932658(G;G) minus rs1802295(C;T) 38.4% plus 0.1781 rs4746822(C;T) 34.9% plus 0.4904 rs16926246(C;T) 21.9% plus 0.09963 rs2278744(A;G) minus rs1599711(C;T) 43.2% minus 0.2539 rs4553261(A;G) 44.2% plus rs2812533(C;T) plus rs4746003(C;T) 33.6% plus 0.2475 rs10159477(A;G) plus 0.09871 rs7072268(C;T) plus 0.4862 rs1417939(C;T) minus rs1341667(A;G) minus 0.3673 rs7077164(T;T) 6.4% plus 0.3926 rs4747011(C;C) 88.4% plus 0.06887 rs1904589(C;T) plus 0.3434 rs10999409(C;C) 32.7% plus 0.4793 rs3758562(A;A) 44.2% plus 0.298 rs10823607(C;T) plus 0.1749 rs4747096(G;G) 5.4% plus 0.2342 rs10509328(C;T) plus 0.1157 rs1891159(G;G) 54.9% plus rs16928529(G;T) 47.8% plus 0.4091 rs2252996(A;A) 77.9% plus 0.3554 rs1084004(C;C) 79.6% plus rs1417210(T;T) 77.9% minus 0.1768 rs877783(C;T) 46.0% minus 0.4215 rs1625975(A;G) 12.4% plus rs1816002(C;T) plus 0.4559 rs3740129(A;A) plus 0.287 rs4148943(T;T) 30.2% plus 0.3586 rs4148945(T;T) 24.8% plus 0.2686 rs4148947(C;C) 24.8% plus 0.3177 rs4148950(A;A) 24.8% plus 0.3154 rs1871450(A;A) 25.0% plus 0.3154 rs730720(A;A) 25.7% minus 0.3595 rs12418(A;A) 24.8% plus 0.3145 rs1245582(A;A) 43.4% minus rs1678618(G;G) 34.4% plus 0.3122 rs3752752(G;G) 46.9% minus 0.4215 rs1867982(G;G) 81.0% plus 0.146 rs10824026(A;A) 67.9% plus 0.3669 rs2227564(C;C) 58.4% plus 0.2029 rs4065(T;T) 36.9% plus 0.4178 rs6688(T;T) 59.3% minus 0.3535 rs7924176(A;G) 45.1% plus 0.2222 rs11001178(C;T) plus 0.343 rs10740455(A;T) 16.5% plus rs10509373(C;T) plus 0.2305 rs11001819(A;A) 24.8% plus 0.3246 rs2116830(A;C) 38.9% minus 0.09504 rs1245541(T;T) 15.3% minus 0.2718 rs2165047(A;G) 42.5% minus 0.2718 rs1248634(C;T) minus 0.259 rs754466(A;T) 36.0% minus 0.1901 rs2395528(C;C) 64.1% plus 0.2176 rs7900239(G;G) 78.8% plus 0.1947 rs704017(A;G) 43.1% plus rs704010(A;G) minus 0.2952 rs1250009(C;T) minus 0.2961 rs703970(C;C) 33.0% plus 0.3875 rs1878001(A;A) 9.2% minus 0.2952 rs10128264(C;C) 28.6% plus rs11593576(T;T) 16.8% plus 0.2677 rs1250546(C;C) 17.7% minus 0.3453 rs1250544(T;T) 14.2% minus 0.3182 rs1250540(C;C) 15.4% minus 0.315 rs942793(C;C) minus 0.4463 rs12355688(T;T) 0.0% plus 0.1437 rs1250552(C;C) 17.7% minus 0.4197 rs1965708(A;C) minus rs1059046(A;C) minus rs2789679(A;T) 50.4% plus 0.4141 rs1953600(C;T) 50.4% plus 0.4169 rs2573346(A;G) plus 0.4151 rs2784773(C;T) plus 0.3255 rs1049550(C;T) minus 0.4247 0.62x reduced risk for sarcoidosis 0.62x reduced risk for sarcoidosis rs2993763(A;G) plus rs2236568(A;C) plus rs6586030(G;G) 67.3% plus 0.07897 rs6586111(C;T) plus 0.4013 rs1051246(C;T) 25.7% minus 0.1469 rs2243639(C;T) plus 0.258 rs7078012(C;T) 25.7% plus 0.169 rs10887344(A;G) plus 0.4357 rs1329201(A;G) 38.9% minus 0.2222 rs9787485(C;T) 32.7% plus rs1649942(T;T) 53.1% minus 0.2553 rs1937970(A;G) 41.6% plus 0.4807 rs677221(G;G) 10.6% minus 0.4518 rs504522(C;T) 54.9% plus 0.3669 rs474018(A;G) 54.9% plus 0.3687 rs2483295(C;G) plus 0.3669 rs1484170(C;T) plus 0.129 rs2224865(T;T) 36.3% plus 0.3531 rs12573606(A;A) 36.3% plus 0.4421 rs11201887(C;C) 41.5% plus 0.4417 rs2607839(T;T) 55.8% minus 0.2167 rs3814614(C;C) 25.7% minus 0.3669 rs10458771(G;G) 83.1% plus rs7075426(A;G) plus 0.4646 rs7095025(C;T) 34.5% plus 0.3136 rs11202221(G;T) plus rs11202222(C;G) 24.6% plus 0.2943 rs7915137(C;T) plus rs10788528(A;G) plus 0.2782 rs7922846(A;T) 37.5% plus 0.4862 rs10887741(C;T) plus 0.337 rs2673836(A;G) plus 0.1116 rs555895(G;T) plus 0.4339 rs532678(C;T) 51.3% plus 0.4389 rs10509540(C;T) plus 0.236 rs10887800(G;G) 23.4% plus 0.4614 rs2296545(C;G) 50.8% plus 0.4711 rs2576178(C;T) 38.9% minus 0.3609 rs1926203(G;T) minus 0.4601 rs4869(C;T) plus 0.4376 rs1800682(C;T) 57.5% minus 0.4761 rs1571013(A;G) 49.2% plus rs2147420(C;T) 56.9% minus 0.489 rs4406737(A;G) 55.8% plus 0.4922 rs2296603(A;G) 48.4% minus 0.4169 rs7901656(C;T) plus 0.3476 rs2296600(C;G) 43.1% minus 0.4077 rs7920888(C;T) plus 0.4408 rs2071509(C;G) 55.0% minus 0.4472 rs11203042(C;T) plus rs1412444(A;G) 50.4% minus 0.3779 rs2246942(A;G) 45.8% plus 0.3884 rs2246833(C;T) 49.6% plus 0.3843 rs1051338(A;C) minus 0.275 rs2296616(C;T) minus rs11185777(A;G) plus rs2250245(C;T) 43.4% minus 0.3728 rs2250149(C;T) plus 0.3301 rs2234978(C;T) plus 0.236 rs1571019(C;T) minus 0.4555 rs4934436(C;T) 44.6% plus 0.3104 rs2251101(C;T) 32.8% plus 0.1648 rs551266(A;G) 31.9% minus 0.1139 rs1887922(C;T) 26.2% plus 0.1139 rs7899603(C;G) plus 0.4651 rs4646957(C;T) 44.2% plus 0.4394 rs7078413(A;C) 52.2% plus 0.2824 rs11187061(C;T) plus 0.1166 rs11187065(C;T) plus 0.1419 rs4646953(A;G) plus 0.1414 rs11603023(C;T) plus rs4938642(C;G) plus 0.09275 rs948414(C;T) plus 0.4311 rs10790289(C;T) 48.2% plus 0.489 rs2195525(C;T) 54.0% plus 0.4073 rs1944511(A;G) minus 0.1841 rs2084898(A;G) plus 0.08402 rs4245040(C;C) 52.2% plus 0.2144 rs1954787(C;C) 23.9% plus 0.4679 ~10% more likely to respond to citalopram ~10% more likely to respond to citalopram rs12800734(A;A) 32.7% plus 0.4862 rs4936613(G;G) 75.9% plus 0.1093 rs8551(C;T) plus 0.4284 rs643788(C;T) plus 0.4302 rs72991(A;A) 45.5% minus 0.3255 rs1699102(T;T) 49.1% plus 0.4541 rs1010159(A;A) 44.6% minus 0.4876 rs1784933(A;A) 90.3% plus rs629367(A;A) 75.4% plus rs2272094(G;G) 53.1% plus 0.4128 rs12364988(C;C) 25.9% plus 0.4522 rs6589964(C;C) 25.7% plus 0.4683 rs1461496(A;G) 47.8% plus 0.3159 rs10893081(T;T) plus 0.3595 normal normal rs17744026(G;T) plus rs12807809(C;T) plus 0.213 rs12541(A;G) minus rs7925879(A;G) 44.1% plus 0.371 rs4606490(C;T) 50.8% plus 0.4573 rs3802905(C;G) 47.6% plus 0.3205 rs6590109(A;G) plus 0.3792 rs4408325(A;A) plus rs12273350(A;A) 32.7% plus 0.3099 rs1783925(C;T) 39.3% minus 0.2989 rs2155388(G;G) 59.3% plus 0.2865 rs548181(G;G) 79.6% plus 0.1657 rs521102(T;T) 26.5% minus 0.4325 pancreatic cancer patients respond poorer to combined therapy pancreatic cancer patients respond poorer to combined therapy rs472926(A;A) 71.7% minus 0.1442 rs512577(A;G) 46.8% minus 0.4261 rs1695739(A;G) 38.9% plus 0.1584 rs651922(C;T) 43.8% minus 0.2309 rs10893506(C;C) 16.2% plus 0.4853 rs4937126(A;A) 7.1% plus 0.3719 rs2236653(T;T) 17.7% plus 0.4692 rs11220082(C;T) 54.9% plus 0.4706 rs4935969(T;T) 17.7% plus 0.494 rs4529890(C;C) 72.6% plus rs7116606(C;T) plus rs6590357(C;T) plus 0.1451 rs7118824(G;T) plus 0.1483 rs7118833(C;T) plus 0.163 rs10894147(C;T) 19.5% plus 0.1047 rs11222084(A;T) 41.6% plus 0.2222 rs7481514(G;G) 39.8% plus 0.2443 rs1550976(C;C) 49.6% plus 0.1823 rs7114000(A;G) 46.9% plus 0.2759 rs1128334(A;G) 17.7% minus 0.1777 rs4937333(C;T) plus rs7117932(C;T) 36.5% plus rs4937362(C;C) 37.5% plus 0.4619 rs73013527(T;T) plus 0.3558 rs4936059(A;G) 51.8% plus rs7930515(A;C) 43.4% plus 0.3154 rs654723(A;A) 46.0% plus 0.4968 rs1238566(A;G) 50.4% plus 0.3912 rs881333(C;G) 43.1% minus rs1939992(C;T) plus 0.1919 rs620875(G;T) 22.1% minus 0.07071 rs4529888(A;G) plus 0.2397 rs2322978(G;G) 41.6% plus rs10893845(G;T) plus 0.3476 rs6590322(T;T) 34.8% plus 0.4931 rs6590330(A;G) plus 0.2071 rs12574073(C;T) 17.7% plus rs10893872(C;T) plus 0.4247 rs3824789(C;T) minus rs7902871(A;G) 28.3% plus rs2490286(G;G) 65.2% plus 0.2264 rs7078219(A;A) 16.8% plus 0.4068 rs11190134(A;A) 15.5% plus 0.3893 rs4409764(G;G) 32.1% plus 0.4949 rs10883365(A;A) 1.0 Good 31.9% plus 0.4752 Normal risk of developing Crohn's disease Normal risk of developing Crohn's disease rs12412391(G;G) 8.0% plus rs6584283(C;C) 32.7% plus 0.4385 rs11190140(C;C) 31.9% plus 0.4486 rs11190141(T;T) plus 0.4275 rs888208(C;C) 8.0% minus 0.2778 rs4488133(T;T) 7.1% plus rs6584202(A;A) 4.4% plus rs2801405(T;T) 73.5% plus 0.2443 rs1804689(A;A) minus 0.3072 rs10786436(T;T) 8.8% plus 0.4371 rs2281636(G;G) 37.2% plus rs3740058(C;T) minus 0.2773 rs3740057(A;G) minus 0.3921 rs10883421(A;G) 52.4% plus 0.3907 rs10883437(A;T) plus 0.3981 rs7084921(C;T) 46.0% plus 0.3962 rs4462272(C;T) plus rs11597390(A;G) plus 0.2534 rs11597086(C;C) 15.0% plus 0.2227 rs11591741(C;C) 13.8% plus 0.2277 rs2804402(C;T) minus 0.3572 rs3740066(A;G) Bad 50.8% minus 0.3044 1.6x risk for ICP 1.6x risk for ICP rs12762549(C;G) 41.1% plus 0.4848 rs3829160(A;A) 17.7% plus 0.376 rs2234970(C;C) 11.6% plus 0.4238 rs1056890(C;T) minus 0.2622 rs927821(T;T) 72.6% minus rs7078511(A;A) 30.8% plus 0.4054 rs12414407(C;C) 44.2% plus 0.2934 rs3850699(C;T) 39.8% minus 0.2603 rs10883783(A;A) 7.9% plus 0.2236 rs3781287(C;C) 18.6% minus rs743572(G;G) 15.9% plus 0.4201 rs6162(A;A) 18.5% plus 0.4288 rs9527(A;G) 36.6% minus 0.1809 rs11190604(G;G) 5.3% plus 0.1488 rs4919510(C;G) 28.3% plus 0.3466 rs807029(A;G) 43.1% minus rs7897947(G;T) plus 0.2782 rs7085104(A;G) 37.2% plus 0.3907 rs12416687(C;T) plus rs3740400(A;C) minus 0.4141 rs3740392(A;G) minus rs11191439(C;T) plus 0.08173 rs10748835(A;G) plus 0.4298 rs1890185(A;G) 47.7% plus 0.4311 rs7914558(A;G) plus 0.4293 rs1712517(A;G) 52.2% minus 0.4917 rs729211(A;G) minus 0.3797 rs2986017(C;T) plus 0.1506 no clear risk no clear risk rs3814219(A;G) plus 0.2094 rs10786775(C;C) 81.7% plus 0.1263 rs11191865(A;A) 29.2% plus 0.416 rs9419958(C;C) 72.3% plus 0.2057 rs9420907(A;A) 75.9% plus 0.2057 rs4919694(C;T) plus rs4387287(C;C) 84.6% plus 0.2998 rs805698(T;T) 100.0% plus 0.1589 rs10883969(C;T) 43.4% plus 0.3356 rs515910(A;G) 57.5% plus 0.4637 rs156697(C;T) 50.4% minus 0.4288 rs10786828(G;G) 30.1% plus 0.4747 rs7894737(A;A) 35.0% plus 0.326 rs17116350(C;T) plus 0.2342 rs2486152(G;G) 82.8% plus rs7907690(G;G) 28.3% plus 0.4844 rs601883(C;G) 17.7% minus 0.1924 rs11193561(C;T) 38.4% plus 0.2397 rs1834180(A;G) plus rs4244274(C;C) 67.0% plus rs17095355(C;T) 19.5% plus 0.2553 rs10509906(C;G) plus rs3731566(A;A) plus 0.1878 normal normal rs716595(A;G) plus 0.1483 rs1358030(C;T) minus 0.4945 rs2039964(A;G) plus 0.354 rs2065779(C;G) plus 0.2911 rs869244(A;A) 11.8% plus 0.371 rs10885122(G;G) 80.0% plus 0.2649 rs2255141(A;G) 36.9% plus 0.242 rs2419621(C;T) 37.2% plus 0.219 rs7342028(G;T) 40.2% plus 0.4146 rs941827(C;T) plus 0.219 rs7094463(G;G) 26.5% plus rs6585194(G;G) 7.7% plus 0.3613 rs11196172(A;G) plus rs11195062(A;C) plus rs521674(A;T) plus 0.4931 rs1800544(C;G) plus 0.4812 rs553668(C;T) 26.5% minus 0.2902 rs602618(A;C) plus 0.4867 rs12573128(A;G) 19.5% plus 0.4219 rs7917983(C;T) plus 0.3705 rs290489(G;G) 5.3% plus 0.3655 rs1472750(C;C) 75.2% plus 0.06428 rs7907519(C;C) 27.6% plus 0.287 rs3124740(C;C) 35.4% minus 0.4431 rs10787498(G;G) 9.7% plus 0.3425 rs12247479(A;G) plus rs3981351(T;T) 54.0% minus 0.303 rs2782980(C;T) plus 0.2893 rs7076938(C;T) 39.8% plus 0.2952 rs11196218(A;A) 9.8% plus 0.2346 rs290475(T;T) 55.8% plus rs10885997(A;G) 50.8% plus 0.3269 rs1665650(A;G) minus 0.3301 rs740363(T;T) 23.9% minus 0.3223 rs1626678(A;A) 23.9% plus 0.3214 rs363227(C;T) plus 0.2498 rs363276(C;T) plus 0.2796 rs181500(A;A) 35.4% minus 0.3838 rs4752066(G;T) 13.3% plus 0.05234 rs11198013(C;T) 22.1% plus rs181654(A;G) 40.0% plus 0.337 rs1801253(C;G) plus 0.2975 depends on rs1801252 depends on [[rs1801252]] rs10885531(C;T) 45.1% plus 0.4573 rs4751674(C;T) plus 0.2847 rs10490919(C;C) 26.8% minus 0.4688 rs12413355(G;G) 61.9% plus 0.219 rs1925265(A;G) 49.6% plus 0.3338 rs10886159(C;T) plus rs12413624(A;T) plus 0.3503 rs10787899(A;G) plus 0.4826 rs3824830(A;G) 51.3% plus 0.3333 rs1397615(C;C) plus rs2234962(C;T) plus 0.09963 rs17621444(C;T) 37.2% plus 0.1593 rs2919009(A;A) 2.7% minus 0.1878 rs4752485(T;T) 41.9% plus 0.298 rs12218935(C;T) plus 0.3609 rs10749408(C;T) 44.2% plus 0.2585 rs11199914(C;T) 40.2% plus 0.4027 rs3135831(T;T) 16.8% minus rs4752566(T;T) 18.8% plus 0.494 rs1047100(G;G) 53.1% minus rs2912791(C;C) 35.7% minus 0.3696 rs7895676(C;T) plus 0.376 1.20x increased breast cancer risk 1.20x increased breast cancer risk rs10736303(A;G) plus 0.3774 rs11200014(A;G) plus 0.3379 1.20x risk for breast cancer 1.20x risk for breast cancer rs2981579(C;T) 38.1% minus 0.4853 1.20x risk for breast cancer 1.20x risk for breast cancer rs7085142(C;C) 38.7% plus 0.4747 rs3943077(G;G) 52.5% plus rs17102287(C;T) plus 0.2236 rs3135718(A;G) minus 0.4555 rs10510102(A;G) minus 0.1593 rs4146894(A;G) 46.9% minus 0.4991 2.6x risk for AMD 2.6x risk for AMD rs6585827(A;G) plus 0.4945 rs10510110(C;T) plus rs2014307(A;C) minus 0.3641 rs2981745(C;C) Good plus 0.3127 normal normal rs17542768(A;G) 22.1% plus 0.09963 rs1078806(C;T) 38.9% minus 0.3343 rs2981578(A;G) 44.6% minus 0.3779 1.20x increased breast cancer risk 1.20x increased breast cancer risk rs2981575(C;T) minus 0.4633 rs2912774(A;C) minus rs2981804(A;A) 29.5% plus 0.4734 rs7069346(A;A) 39.7% plus 0.4013 rs10794595(C;C) 36.3% plus 0.3039 rs2282015(A;C) minus 0.4261 rs3740540(C;T) minus rs10901850(C;T) 45.1% plus 0.3682 rs989507(C;C) 60.0% plus rs10901513(C;T) plus 0.3287 rs1278279(A;G) plus 0.2736 rs1871054(C;T) 48.7% plus 0.4871 rs11523871(A;A) 42.9% plus 0.3007 normal normal rs3013236(T;T) 42.9% plus 0.3017 rs1551678(G;G) 37.5% plus 0.4963 rs12778749(T;T) 51.3% plus rs7902734(A;G) plus 0.3122 rs9418832(G;G) 85.8% plus 0.08356 rs4363506(C;C) 15.2% plus 0.4789 rs6482992(C;C) 47.5% plus 0.4298 rs749141(A;G) minus rs4751072(A;G) plus rs1625649(G;G) minus 0.3852 rs477692(G;G) 19.5% minus 0.4509 rs7087131(A;G) plus 0.1635 rs11016883(C;G) plus 0.3425 rs3740199(G;G) 29.7% plus 0.4518 rs658986(C;C) 100.0% plus rs7094308(C;T) plus rs10741243(C;G) 9.2% plus 0.1804 rs11018023(A;A) 3.1% plus 0.2489 rs954820(A;G) plus 0.275 rs2995300(A;C) plus 0.1538 rs2275725(A;G) 18.9% plus 0.09183 rs2298122(G;T) 31.0% plus 0.2388 rs1536827(C;T) 17.9% plus 0.2071 rs1803965(C;T) 14.1% plus 0.1469 rs12917(C;T) 19.1% plus 0.1506 rs9804200(C;T) 33.3% plus 0.4174 rs4751178(G;G) 46.0% plus 0.2769 rs4750829(G;G) 86.6% plus 0.101 rs4838767(A;A) 98.4% plus 0.1116 rs6413420(G;T) 14.2% plus 0.0303 carrier of one CYP2E1*7_-71G>T allele carrier of one CYP2E1*7_-71G>T allele rs915906(C;T) 31.9% plus 0.3411 rs1536826(A;C) 40.2% plus 0.4431 rs12628(C;T) 36.3% minus 0.2971 rs702966(C;C) 3.1% minus 0.2787 rs1131665(G;G) minus 0.2792 rs1061502(G;G) minus 0.2782 rs7108757(A;G) minus 0.1837 rs7932167(A;C) 41.1% minus 0.2837 rs762502(C;T) plus 0.3205 rs10751667(A;T) plus rs2396545(C;T) minus 0.2314 rs868903(C;C) 25.2% plus 0.4532 rs2014486(A;G) 54.9% plus 0.4449 rs2735733(C;T) 50.4% plus 0.4784 rs3793964(C;T) plus rs3817198(C;T) plus 0.2084 rs10769945(C;T) 40.7% plus 0.3627 rs3741219(C;T) 39.8% minus rs217727(C;T) minus rs2067051(A;G) 41.6% minus 0.3448 rs2839698(C;T) minus 0.3485 rs2251375(A;C) plus 0.4408 rs2107425(C;T) 42.3% plus 0.4164 rs10732516(A;G) plus 0.3476 rs4930103(A;G) plus 0.4536 rs5743899(A;A) 67.0% minus 0.3214 rs5743894(A;G) minus 0.08678 rs4929984(A;C) plus 0.4123 rs4930144(A;G) 40.7% plus rs6578985(A;G) 46.0% plus 0.3471 rs6578987(C;T) 46.0% plus 0.3489 rs1003484(A;G) plus 0.3636 rs10770140(C;T) 50.9% plus 0.3549 rs10770125(A;G) 45.1% plus 0.3848 rs3741208(C;T) 31.1% minus 0.3421 rs3741205(G;T) minus 0.3384 rs7924316(G;T) plus 0.4725 rs689(A;A) minus 0.3352 rs3842727(A;A) 46.4% minus 0.3485 rs2070762(C;T) 53.2% minus 0.4325 rs680(A;G) minus 0.2851 rs4366464(G;G) minus rs10770141(A;G) 46.9% plus 0.3604 rs6578993(C;C) 83.1% plus 0.1474 rs7111341(C;T) 43.4% plus 0.253 rs7126629(A;A) 49.2% plus rs7127900(G;G) 59.3% plus 0.2502 rs2521263(G;G) 90.3% plus 0.2759 rs11022157(A;A) 14.2% plus rs708564(T;T) 67.3% plus rs2301696(C;G) plus 0.3581 rs800344(G;G) 94.7% plus 0.2006 rs6356(A;G) 39.8% minus 0.4187 rs800345(C;C) 87.6% plus 0.2351 rs800348(C;T) 44.6% plus 0.3108 rs2074238(C;T) plus 0.04178 rs757092(A;G) plus 0.4789 rs179429(A;G) 31.9% plus 0.1391 rs163184(G;T) plus rs2237895(A;C) plus 0.3476 rs1048047(A;G) plus 0.3916 rs3847646(C;T) 29.2% plus 0.388 rs7481584(A;G) plus rs739401(A;A) 28.3% minus 0.4927 rs11026091(A;A) 22.3% plus 0.4835 rs685782(C;T) plus rs12806698(A;C) plus 0.2126 rs9937(A;G) plus 0.4017 rs231362(C;C) 26.2% minus 0.3191 rs231906(C;T) minus 0.4591 rs108961(A;G) 57.1% minus rs2237878(A;G) plus 0.1396 rs151290(C;C) 60.0% plus 0.3618 rs163182(C;G) plus 0.4118 rs3886223(G;T) 40.6% plus 0.3003 rs10500641(C;T) 26.2% plus 0.1956 rs7948471(A;G) plus 0.4068 rs372091(C;C) 100.0% minus 0.01837 rs979752(C;T) minus 0.2732 rs79243044(C;T) plus rs7108470(A;G) 47.8% plus 0.4913 rs1063303(C;G) plus rs4758405(A;G) plus 0.5 rs1051992(C;C) 29.7% minus 0.4665 rs1042858(A;A) plus 0.1575 rs2278170(C;T) 35.4% plus 0.2792 rs713040(G;G) plus 0.2603 rs1488864(C;C) 87.6% minus rs1050239(A;G) plus 0.18 rs72921001(A;C) 1.0 plus 0.3067 Less likely to think cilantro tastes like soap Less likely to think cilantro tastes like soap rs7107418(A;G) 1.0 52.7% plus 0.3067 Less likely to think cilantro tastes like soap Less likely to think cilantro tastes like soap rs878860(C;T) 55.2% plus 0.371 rs2272382(G;G) 50.8% minus 0.3687 higher body mass index higher body mass index rs2272383(A;A) 41.5% plus 0.4394 normal risk normal risk rs4758317(A;C) plus 0.4871 rs442264(A;G) plus 0.4683 rs4929949(C;C) 30.9% plus 0.4564 rs4929923(C;C) 45.1% plus 0.4591 rs11042023(C;C) 45.1% plus 0.4624 rs2555155(T;T) 32.7% minus 0.4963 rs963167(C;C) 74.3% minus 0.1598 rs1867138(C;T) 30.1% minus 0.2424 rs1867137(C;T) minus 0.2424 rs3814700(A;G) minus 0.1322 rs11042725(A;C) plus 0.3765 rs4910118(C;T) 3.1% plus 0.1116 rs4444073(A;C) 54.9% plus 0.343 rs2923084(A;G) 23.9% plus 0.3618 rs7940646(C;C) 58.6% plus 0.1566 rs4909945(C;C) 52.7% plus 0.1579 rs2018368(G;G) 31.9% plus 0.3219 rs2403221(A;A) 47.3% plus rs10734652(C;T) 59.3% plus 0.494 rs11042937(T;T) 31.9% plus 0.331 rs16909324(C;T) 21.5% plus 0.1446 rs11022095(A;G) 57.4% plus 0.3444 rs7396187(C;G) 30.0% plus 0.1699 rs1994318(A;A) 51.8% plus 0.4908 rs17477949(C;T) 48.2% plus 0.2107 rs7944031(A;G) 18.6% plus rs10766071(A;A) 95.4% plus rs2722769(C;G) 56.6% plus 0.3269 rs6486120(G;T) plus rs4757144(A;G) plus 0.4091 rs3816358(G;T) minus rs2278749(A;G) 40.0% minus 0.1538 rs969485(A;A) 50.4% plus 0.4013 rs2290035(A;T) plus 0.4017 rs6254(A;G) 51.3% minus 0.2112 rs2036417(A;G) 52.2% plus 0.4738 rs7125774(C;T) 51.3% plus 0.4164 rs9630182(C;T) plus 0.4715 rs7950226(A;A) 23.0% plus 0.4353 rs2618516(C;T) plus 0.3072 rs2970332(A;G) plus 0.3623 rs1007392(C;T) 47.7% minus rs11023332(C;G) plus 0.354 rs1993116(C;T) 47.8% minus 0.337 rs10500804(G;T) plus 0.3531 rs12794714(A;G) plus 0.3512 rs10741657(A;G) 45.3% plus 0.3338 rs2060793(A;G) 46.9% plus 0.3613 rs10766197(A;G) plus 0.3393 rs1553005(C;G) plus 0.3145 rs11023100(A;G) plus 0.4265 rs7117858(A;G) plus 0.2608 rs7108738(G;T) plus 0.2365 rs1401454(A;G) 53.1% minus rs4756846(C;T) plus 0.06566 rs216489(A;A) 32.7% plus rs1027617(A;G) plus rs11024060(C;T) plus rs6486330(C;T) plus rs11024097(C;T) 42.0% plus rs4356203(G;G) 18.6% plus 0.2815 rs3781719(C;T) 43.4% minus 0.3145 2x increased hypertension risk 2x increased hypertension risk rs7114467(A;G) plus 0.393 rs713503(G;T) 47.8% minus 0.4063 rs1557765(G;G) 32.7% minus rs5210(A;G) plus 0.466 rs5215(T;T) 32.7% plus 0.2801 rs757110(T;T) 35.1% minus 0.2856 rs916829(C;C) 74.8% minus rs2108977(C;C) plus 0.4862 rs7933505(A;G) plus 0.3407 rs1799913(A;C) minus 0.3581 rs1800532(A;C) 41.6% minus 0.3581 rs684302(C;T) 44.6% plus rs7130929(A;C) plus rs4537731(C;T) plus 0.4128 rs2468844(A;A) 87.7% minus 0.1988 rs874957(A;G) 38.1% plus 0.4201 rs1064074(C;G) 36.5% minus 0.4353 rs2278732(C;T) minus 0.309 rs4757710(C;C) 46.9% plus 0.2883 rs10832983(A;A) 38.9% plus 0.3949 rs10766504(C;T) 46.4% plus 0.2452 rs7932938(G;G) 29.2% plus 0.4096 rs4627050(A;G) 43.4% plus 0.3641 rs874426(G;T) minus 0.3912 rs10741780(C;C) 75.9% plus 0.2493 rs7128099(A;A) 67.3% plus 0.4146 rs7131332(A;G) 38.1% plus 0.4467 rs4353250(C;T) plus 0.1938 rs4150642(C;G) plus rs9783347(A;G) 41.5% plus 0.292 rs10128711(C;C) 55.0% plus 0.4821 rs1945771(A;A) 10.8% plus 0.3003 rs1793004(C;G) 33.6% minus 0.3512 ? ? rs8176785(A;G) plus 0.3136 rs73469144(A;C) plus rs11026407(A;C) plus rs11026412(A;G) plus 0.2254 rs7111546(C;T) 21.2% plus 0.2048 rs712022(T;T) 22.1% minus 0.4532 rs7116456(C;C) 100.0% plus rs4561213(G;G) 41.9% plus 0.4334 rs2227508(A;T) minus 0.1309 rs976748(T;T) 63.1% minus 0.08999 rs1012356(A;T) plus 0.4867 rs2046068(G;T) minus 0.264 rs2227491(A;G) minus 0.4578 rs317689(A;G) plus 0.23 rs315122(G;T) minus 0.23 rs1373453(C;T) 20.5% minus 0.1612 rs398702(T;T) 71.7% plus 0.08081 rs2175711(A;T) 36.9% minus 0.2397 rs2203231(A;G) minus 0.1249 rs1398599(A;C) 23.2% minus 0.2342 rs11178391(C;T) 22.1% plus 0.264 rs1495377(C;G) Bad minus 0.3462 1.3x risk 1.3x risk rs4760790(A;G) 35.4% plus 0.2296 rs1463335(A;T) plus 0.4063 rs1843809(T;T) 79.6% plus 0.1947 rs7955501(A;A) 46.2% plus 0.4155 rs1386496(T;T) 79.6% minus 0.1529 rs1386494(G;G) 78.5% minus 0.1451 rs1386493(C;C) 76.1% minus 0.2259 rs2171363(C;C) 45.5% minus 0.4169 rs7963720(T;T) 45.1% plus 0.4688 rs4760816(T;T) 45.1% plus 0.4747 rs7305115(G;G) 45.5% plus 0.4734 risk of suicide behavior risk of suicide behavior rs1007023(T;T) 80.5% plus 0.1359 rs7961581(C;T) 43.4% plus 0.2342 rs4448731(C;T) plus 0.3848 rs4341581(T;T) plus 0.01882 rs10748185(A;G) plus 0.4008 rs4565946(C;T) 45.1% plus 0.2998 rs4760820(G;G) 27.0% plus 0.2287 rs1386498(G;G) 47.5% plus 0.4986 rs1473473(T;T) minus 0.1768 rs1487276(G;G) 78.8% minus 0.1768 rs1487275(T;T) 62.8% minus 0.3246 rs1386486(C;C) 53.8% minus 0.4839 rs1386483(G;G) 53.1% minus 0.4839 rs1386482(C;C) 53.8% minus 0.4848 rs10879357(G;G) 46.9% plus 0.4513 rs4469933(T;T) 53.8% plus 0.4839 rs4290270(T;T) 53.8% plus 0.4949 rs7311660(A;G) 40.7% plus 0.4789 rs2279244(C;T) 32.7% plus 0.2048 rs7307780(C;T) 29.2% plus 0.1791 rs1368578(A;G) 41.5% plus rs2669010(A;G) 50.4% plus 0.4743 rs17788937(A;G) plus 0.1166 rs10735416(C;C) 47.3% plus rs1245810(C;C) 47.8% plus rs1245819(A;A) 47.8% plus rs7955732(T;T) 13.3% plus 0.2548 rs10879490(A;T) plus rs10879517(A;G) 43.4% plus 0.2443 rs1154865(C;G) 31.2% plus 0.2029 rs10506701(A;C) minus 0.1134 rs1268463(C;C) 47.3% minus rs1245840(T;T) 47.8% plus rs3782181(A;A) 65.5% plus 0.3586 rs4590952(G;G) plus 0.3503 rs2046971(G;G) 66.2% minus 0.3567 rs2070759(A;C) 48.7% minus 0.4862 rs7136259(C;T) plus 0.4096 rs10858945(A;G) 47.8% plus 0.477 rs10745527(T;T) 45.1% plus 0.3526 rs811(A;A) 35.9% minus 0.2208 rs11114027(G;T) 26.5% plus 0.1028 rs7138951(A;A) 81.4% plus rs10492002(A;G) 42.9% minus 0.2094 rs1921045(C;T) 42.5% minus 0.4348 rs12426725(A;G) plus 0.1556 rs7137515(A;G) 32.3% plus 0.3595 rs12317459(A;G) plus 0.1639 rs4761097(A;A) 26.5% plus rs6539870(G;G) 12.3% plus 0.2773 rs7968722(T;T) 12.3% plus 0.2833 rs2307220(G;T) 25.9% minus 0.3779 rs7305141(A;A) 69.0% plus 0.1598 rs4842318(C;T) 47.8% plus 0.4582 rs10778699(A;G) plus 0.281 rs1163662(A;G) minus 0.3834 rs2682818(C;C) plus 0.2314 rs1163656(C;C) 58.9% plus 0.4417 rs4354668(G;T) plus 0.41 rs1923295(C;C) 18.6% plus 0.4454 rs10768140(G;T) plus 0.4927 rs650950(A;G) minus 0.2668 rs1358054(G;T) minus 0.4403 rs331463(T;T) 76.6% plus rs5030411(T;T) 35.4% minus 0.4812 rs3740955(A;G) 38.9% plus 0.4091 rs391317(A;T) 33.8% plus 0.2948 rs16930685(C;C) 0.0% plus 0.1827 rs4755404(C;C) plus 0.4109 rs10836945(C;C) 96.9% plus 0.2309 rs7951105(G;G) 92.3% plus rs12808199(A;A) 37.2% plus 0.4582 rs2862035(C;C) 95.2% minus 0.04454 rs980952(G;G) 95.4% plus 0.04408 rs1484948(C;T) plus 0.2011 rs7480010(A;G) plus 0.4045 rs10501293(G;T) plus 0.2029 rs10838125(C;C) plus rs5004866(A;T) plus 0.4628 rs1113132(C;G) minus 0.2865 rs12421995(A;G) plus 0.3636 rs730129(C;C) 42.5% minus 0.2975 rs835784(A;G) 46.0% plus 0.416 rs7951911(A;G) 21.4% plus 0.1974 rs17723470(C;T) 45.1% plus 0.1648 rs1488665(G;T) plus 0.1933 rs10838524(G;G) 24.8% plus 0.3453 rs4237643(A;C) minus rs7932905(A;G) plus 0.4008 rs11037575(C;T) plus 0.4527 rs11605924(C;C) 75.9% plus 0.3283 rs7117404(A;G) 21.4% plus 0.07713 rs747650(A;G) Bad 45.1% minus Higher risk of acne occurrences in Chinese Han population Higher risk of acne occurrences in Chinese Han population rs1060573(C;T) 45.1% minus rs2167079(A;G) 41.8% minus 0.494 rs10838681(A;G) plus 0.4284 rs3758673(C;T) 42.3% plus rs11039155(A;G) plus 0.07851 rs2279238(A;G) 25.7% minus 0.348 rs7120118(C;T) plus 0.4637 rs1449626(A;C) plus rs7932354(C;C) 64.6% plus 0.4513 rs2070852(C;C) 53.1% plus 0.4481 rs3136516(A;A) 30.1% plus 0.3058 rs1007738(A;A) 65.5% plus 0.4187 rs2306029(C;C) 31.0% plus 0.3522 rs4548577(C;T) plus 0.314 rs7935346(A;G) 37.4% plus 0.4679 rs1057233(C;T) minus 0.3173 rs10769258(C;T) 44.2% plus 0.3191 rs4752829(A;G) plus 0.332 rs10838708(A;G) plus 0.3508 rs4752856(A;G) plus 0.2828 rs3817334(C;T) 50.4% plus 0.3522 rs10838738(A;G) 46.0% plus 0.2837 rs10838798(G;T) plus 0.393 rs3942852(C;T) 34.5% plus 0.275 rs2270993(C;T) minus 0.1524 rs1449627(G;T) plus rs10838687(G;T) plus 0.382 rs4752904(C;G) plus 0.438 rs11039571(A;G) plus 0.1965 rs12282928(A;G) 40.7% plus 0.3398 rs1351696(G;G) 75.4% plus rs7395662(G;G) 40.7% plus 0.4619 rs1945213(C;C) 47.8% minus 0.2502 rs11228719(C;T) 30.2% plus 0.377 rs1397048(A;G) 49.6% minus 0.466 rs9943582(C;T) plus 0.3301 rs10501367(C;C) 46.9% plus 0.2608 rs2270992(A;G) minus 0.4949 rs7119375(G;G) 46.9% plus 0.2259 rs11229030(T;T) 43.4% plus 0.36 rs2511988(C;T) 36.6% minus 0.4908 rs10896794(C;T) plus 0.2043 rs8373(A;G) 36.3% plus 0.2222 rs496601(G;G) plus 0.1171 rs7943953(G;T) plus 0.3774 rs670139(A;C) 43.4% minus 0.3999 rs600550(C;T) 43.4% plus 0.3981 rs2649663(A;G) plus 0.1717 rs2244169(A;T) plus 0.3669 rs2509897(C;G) 33.3% minus 0.2222 rs2511990(C;T) 42.5% minus 0.3664 rs1005510(C;T) minus 0.4982 rs1562990(A;A) 22.3% plus 0.3356 rs4938933(T;T) 22.1% plus 0.3705 rs595018(G;G) 69.0% minus 0.1538 rs533116(C;T) 46.0% plus 0.2208 rs17824933(C;G) 35.9% plus 0.1111 rs929230(A;G) plus 0.1116 rs11230563(C;T) 46.0% plus 0.3499 rs2074225(T;T) 16.9% plus 0.4559 rs12360861(A;G) plus rs4939490(C;G) 58.2% plus 0.3765 rs650258(C;T) plus 0.2773 rs508970(C;C) 39.1% minus rs7935082(C;C) 35.4% plus 0.3719 rs7126354(T;T) 36.3% plus 0.3567 rs4939364(G;G) 51.3% plus 0.3747 rs1941027(T;T) 92.3% plus rs7930940(A;G) 40.2% plus 0.2782 rs174548(C;G) 44.2% plus 0.3439 intermediate phosphatidylcholine values intermediate phosphatidylcholine values rs174549(A;G) plus 0.3081 rs174550(C;T) plus 0.3297 rs174553(A;G) plus 0.3292 rs174555(C;T) plus rs174556(C;T) 45.1% plus rs174561(C;T) plus 0.3081 rs3834458(-;T) plus 0.331 rs99780(C;T) plus 0.4082 rs1535(A;G) Good 43.4% plus 0.3494 4+ IQ points for breastfeeding 4+ IQ points for breastfeeding rs174535(C;T) plus 0.3567 rs174536(A;C) 44.6% plus 0.3329 rs174537(G;T) 44.2% plus 0.3329 common; higher LDL-C and total cholesterol common; higher LDL-C and total cholesterol rs102275(A;G) minus 0.4821 rs4246215(G;T) 46.0% plus 0.3393 rs174541(C;T) plus 0.3393 rs174545(C;G) 45.9% plus 0.3297 rs174546(C;T) 43.4% plus 0.3297 rs174547(C;T) plus 0.3297 rs174601(A;G) 44.6% minus 0.494 rs174448(C;T) minus 0.3756 rs1000778(A;G) 43.8% plus 0.4431 rs174468(A;G) plus 0.1915 rs174479(C;G) 38.5% minus 0.2167 rs2727261(G;G) 83.2% minus 0.3967 rs10792320(C;C) 5.3% plus 0.4293 rs1675126(G;G) 83.2% minus rs2463822(G;G) 76.1% minus 0.08356 rs174572(C;T) plus 0.185 rs174574(A;C) 44.5% plus 0.4624 rs174575(C;G) 44.6% plus 0.2328 rs2727270(C;T) 20.0% plus rs2727271(A;T) 21.7% plus rs174577(A;C) plus 0.41 rs174578(A;T) plus rs174583(C;T) 43.4% plus 0.3972 rs10792367(G;G) 15.9% plus 0.4417 rs4366490(C;C) 63.5% plus rs10897449(T;T) 25.7% plus 0.2847 rs4980524(G;T) 44.4% minus 0.377 rs6591838(A;G) plus 0.2052 rs2236647(C;T) 46.0% plus 0.4936 rs2236648(C;T) 46.0% plus 0.3792 rs2244621(A;G) 25.9% minus 0.2925 rs477895(T;T) minus 0.2567 rs559928(C;C) 65.5% plus 0.1864 rs575134(C;C) 100.0% minus rs544978(A;A) 44.6% plus 0.2098 rs2186410(A;G) plus 0.1056 rs542269(T;T) 49.2% plus 0.1837 rs589691(T;T) 79.6% plus 0.3563 rs606458(A;A) 79.6% minus 0.3361 rs2959656(G;G) 98.2% minus 0.1543 rs470763(A;G) minus 0.489 rs12803915(A;G) plus 0.1648 rs17146964(A;G) 37.2% plus 0.1763 rs600231(A;G) 39.8% plus rs6591182(G;T) plus 0.4316 rs2448490(A;G) plus 0.2635 normal normal rs478304(A;C) minus rs7124676(A;G) plus 0.2622 rs17300741(A;G) 44.2% plus 0.337 rs2078267(A;G) 43.4% minus 0.2548 rs11231825(C;C) 54.0% plus rs506338(C;C) 53.6% plus rs504915(A;A) 58.5% plus 0.3999 rs478607(A;A) 74.3% plus 0.2557 rs11227306(A;C) plus 0.3209 rs545500(C;G) minus 0.4454 rs660118(C;G) minus 0.4045 rs679581(A;G) 61.6% plus 0.4334 rs564343(G;G) minus 0.4192 rs7122539(A;G) plus 0.4444 rs7112925(C;T) 50.5% plus 0.3448 rs593982(C;T) minus 0.2759 rs642803(C;T) 57.5% plus 0.4353 rs308309(A;A) 54.9% minus 0.1653 rs491347(C;T) minus 0.3131 rs599083(G;T) plus 0.3425 rs525592(A;G) minus rs12272917(C;T) plus rs2187331(A;A) 62.8% minus 0.1391 rs948854(A;A) minus 0.3095 rs560096(C;C) 78.8% plus 0.2975 rs3750965(A;G) 39.8% plus 0.2548 rs35264875(A;T) 31.7% plus 0.1015 rs11228565(A;G) plus 0.1226 rs7928739(A;C) plus 0.4619 rs4930561(A;G) plus 0.4371 rs312009(C;C) 63.1% plus 0.2121 rs4988300(G;T) 45.1% plus 0.4311 rs634008(C;T) 44.2% plus 0.4536 rs7102705(A;G) 32.7% plus 0.2773 rs1485993(C;T) 41.1% minus 0.3994 rs1352075(C;T) 41.6% plus 0.4986 rs647451(C;T) plus rs602652(A;G) plus 0.4858 rs9344(A;G) plus 0.4206 rs649392(A;G) plus 0.4123 rs3212891(A;C) plus 0.3792 rs678653(C;G) 39.7% plus 0.4284 rs4084127(C;T) minus 0.2994 rs7931342(G;G) 30.1% plus 0.4885 rs10896449(G;G) 30.0% plus 0.4063 rs11228583(T;T) 26.2% plus rs10796849(G;G) 74.2% plus 0.3907 rs3802780(C;T) minus 0.1579 rs525304(A;A) 32.7% minus 0.343 rs471931(T;T) 35.4% plus 0.3535 rs1790329(C;T) 6.7% minus 0.1791 rs11606033(A;G) 35.9% plus 0.4931 rs7944926(A;G) 37.5% plus 0.4715 rs12785878(G;T) 37.2% plus 0.4715 rs2276360(C;G) plus 0.4853 rs12800438(A;G) plus rs2282618(A;G) minus 0.1736 rs3794060(C;T) 37.2% plus rs3017493(A;G) plus 0.08861 rs3781913(A;C) minus 0.4706 rs11603160(C;T) 22.3% plus 0.1006 rs1791933(C;C) 93.8% plus 0.1855 rs4944831(T;T) 69.0% plus 0.1708 rs4944832(A;A) 19.6% plus 0.2943 rs10751226(C;T) 27.0% plus 0.1639 rs544115(A;G) minus 0.2507 rs472112(A;A) 27.4% minus 0.3829 rs606452(C;C) 71.7% plus 0.3214 rs634552(G;G) 71.9% plus 0.3145 rs7104908(A;G) plus 0.4137 rs7130588(A;G) 40.7% plus 0.208 rs7936562(C;C) 38.9% plus 0.45 rs2155219(T;T) 27.4% plus 0.4954 rs7927997(C;T) 43.8% plus 0.2723 rs660339(C;T) minus 0.4316 rs659366(C;T) 43.4% plus 0.4155 rs591758(C;G) plus 0.4798 rs653529(A;G) minus 0.4816 rs15763(C;T) 36.3% minus 0.2815 rs647126(A;G) 55.4% plus 0.4219 rs1726745(A;G) minus 0.4633 rs2075577(C;T) minus 0.4031 rs3824999(C;C) 23.0% minus 0.3825 rs1052030(C;T) plus 0.4853 rs2276288(A;T) plus 0.4068 rs948962(G;T) minus 0.4775 rs1385600(C;T) 23.0% minus 0.3232 rs4945261(A;G) plus 0.2268 rs7101429(A;G) Good 23.0% plus 0.2254 0.70x reduced risk for Alzheimer's risk 0.70x reduced risk for Alzheimer's risk rs7115850(C;G) plus 0.3182 rs2373115(G;T) minus 0.292 normal normal rs10899489(A;C) plus 0.286 rs11236809(G;T) plus 0.1451 rs11237828(C;T) plus rs7102569(A;G) 32.7% plus rs1357339(A;C) plus 0.07392 rs2032381(A;C) 17.7% minus 0.1299 rs2298668(C;C) 1.5% minus 0.1383 rs7104980(G;G) 19.5% plus 0.4697 rs10792665(T;T) 8.1% plus rs11233413(C;C) 8.0% plus 0.2603 rs4293143(G;T) plus 0.191 rs2116483(A;A) 41.6% minus 0.3751 rs1151200(A;G) minus rs530965(A;G) 46.9% minus 0.4949 rs790356(G;G) 27.4% plus 0.3898 rs1452928(C;G) minus 0.1993 rs17148090(A;G) 8.0% plus 0.08264 rs10792830(A;G) plus 0.4706 rs10792832(A;G) 36.9% plus rs10898459(C;C) 16.8% plus rs1870323(A;G) 42.9% plus rs12797615(C;T) plus 0.1602 rs6592362(A;G) 32.4% plus 0.4073 rs217115(C;C) 70.3% plus rs217116(G;G) 68.1% plus rs10898392(G;T) 53.1% plus 0.4362 rs588076(C;G) minus rs592297(C;T) 28.3% plus 0.2117 rs621942(G;T) minus 0.2218 rs536841(C;T) 43.4% plus 0.3343 rs541458(C;T) 43.4% plus 0.3728 rs561655(A;G) plus 0.359 rs10831496(A;G) 43.4% plus 0.4252 rs1042602(A;C) plus 0.1823 None rs1488902(C;T) plus 0.3999 rs2130017(G;T) minus 0.2617 rs1528753(C;C) 64.3% plus 0.3223 rs4491175(C;C) 37.5% plus 0.4954 rs1350445(T;T) 49.2% minus 0.2567 rs7120482(A;G) plus 0.1648 rs17630638(C;T) 36.3% plus rs2658782(G;T) plus 0.1492 rs2605593(C;G) 48.4% plus 0.4201 rs518167(G;G) 95.3% plus rs10765819(A;A) 29.2% plus rs10830228(G;G) 40.7% plus 0.4334 rs556477(A;G) plus 0.3173 rs11020821(A;C) plus 0.259 rs2212361(C;T) plus 0.2208 rs508485(T;T) 18.9% plus 0.4734 rs10831284(A;G) plus 0.208 rs541821(A;G) plus 0.3655 rs1939875(C;C) 47.8% minus 0.253 rs11021499(A;G) plus 0.371 rs11021504(A;T) plus 0.3365 rs16924603(C;T) plus 0.1915 rs3758785(A;G) 46.0% plus 0.2296 rs485842(A;G) 40.0% minus 0.2603 rs483905(C;T) minus 0.2567 rs2509843(C;T) 47.8% minus 0.3916 rs952700(A;G) plus 0.2929 rs10501927(G;T) plus rs6590474(C;C) 39.8% plus 0.2534 rs12273744(A;G) 42.0% plus 0.3448 rs12277155(C;T) plus 0.3343 rs888597(A;G) 41.1% plus 0.3343 rs737583(C;T) minus 0.3343 rs737582(C;T) minus 0.3365 rs6590489(C;T) plus 0.3255 rs2405657(G;G) 48.2% plus 0.4096 rs12287931(A;G) plus 0.3219 rs3909276(C;T) 42.9% minus 0.3219 rs12289401(A;G) 44.6% plus 0.3476 rs633185(G;G) 54.7% minus 0.348 rs608995(T;T) plus 0.2824 rs484389(C;C) 8.8% minus 0.2916 rs561650(C;T) plus 0.1093 rs4258342(A;G) 40.0% plus 0.3255 rs4269885(A;G) plus 0.4573 rs7125266(A;G) plus 0.3655 rs7114978(A;T) plus 0.3264 rs1377580(C;T) plus 0.3264 rs1035339(C;T) 39.8% plus 0.3182 rs6590495(C;T) plus 0.3255 rs12282593(A;G) 37.5% plus 0.3297 rs1833489(C;T) plus 0.3287 rs7947224(C;T) plus 0.3255 rs11222291(C;T) plus 0.3255 rs1042839(C;T) minus rs578029(T;T) 50.0% plus 0.2185 rs666553(C;T) 26.2% plus 0.1786 rs565186(C;T) plus rs529359(A;A) 39.1% minus rs3740753(C;G) plus rs499590(A;A) 44.2% minus rs474320(A;T) 21.5% minus rs568157(A;G) 55.8% plus rs12366144(G;G) 8.8% plus 0.2686 rs11225055(C;T) plus rs10895304(A;G) 24.6% plus 0.2287 rs516693(A;G) 26.2% minus rs572483(A;G) minus 0.2704 rs543215(A;A) 68.1% plus rs613120(C;C) minus rs590688(G;G) 27.7% plus 0.4013 rs11224592(C;T) plus 0.2888 rs2292730(A;G) 49.6% plus rs1320632(T;T) 80.5% plus 0.05923 rs5854(C;T) minus 0.2406 rs514921(A;G) 38.9% plus 0.2208 rs475007(A;T) 42.2% plus 0.4922 rs1144393(C;C) 12.4% plus 0.2103 rs470206(G;G) 100.0% minus 0.05647 rs11225434(C;C) 31.9% plus 0.3994 rs7926920(A;A) 31.9% plus 0.3985 rs10502001(C;T) 33.9% plus 0.1777 rs11568818(A;G) minus 0.3324 rs11225703(C;T) 46.0% plus 0.309 rs716274(G;G) 32.7% plus 0.4343 rs7118412(G;G) 35.4% plus 0.4619 rs12805875(G;G) 35.4% plus 0.4725 rs4554859(T;T) 35.4% plus 0.4729 rs1917445(A;A) 29.2% minus 0.4651 rs974819(G;G) 63.3% minus 0.4183 rs2220377(A;A) 29.5% minus 0.4513 rs3809021(A;C) minus 0.3747 rs11226373(A;G) 19.5% plus 0.1474 rs3819089(A;G) 24.8% minus rs2252070(C;T) minus 0.3627 rs1785882(T;T) 36.1% plus 0.4275 rs3170(A;A) 6.2% minus rs11601239(G;G) 20.4% plus 0.449 rs10895959(A;G) plus 0.3737 rs10431058(T;T) 16.4% plus 0.4821 rs183460(C;C) 26.5% plus 0.4839 rs228589(A;A) 20.6% minus 0.4729 rs625120(G;G) minus 0.4894 rs228590(C;C) 26.5% minus rs228591(G;G) minus 0.4757 rs600931(A;A) 26.5% minus 0.4899 rs664677(T;T) 27.4% plus 0.3875 rs624366(C;C) 25.0% plus 0.4982 rs1801516(A;G) plus 0.07897 normal normal rs611646(A;T) minus 0.3811 rs609429(G;G) minus 0.4798 rs227060(C;T) 37.2% plus 0.3058 rs227062(A;A) 27.0% plus 0.477 rs373759(A;G) 37.2% minus 0.3049 rs10890920(A;G) plus 0.4972 rs4754373(C;T) 25.9% plus 0.2314 rs7101378(A;G) plus 0.3388 rs746463(C;T) 41.6% plus 0.2323 rs7945071(G;T) 31.9% plus rs1469170(C;T) 42.5% minus 0.4899 rs7130173(C;C) 58.4% plus 0.3131 rs10891246(G;G) plus 0.298 rs664982(A;A) minus 0.4793 rs227092(T;T) 25.9% plus 0.4913 rs652311(A;A) 26.5% plus 0.4798 rs4938723(C;C) 12.4% plus 0.3076 rs2070894(C;T) minus 0.2626 rs14133(C;G) minus 0.2617 rs762550(G;G) 29.2% minus 0.2842 rs650461(C;G) 41.3% minus 0.4839 rs2303436(A;G) 40.7% minus 0.3792 rs627441(A;G) minus 0.483 rs10789859(C;T) plus rs3882891(A;C) 44.2% minus 0.4982 rs549908(G;T) plus 0.2337 rs4938534(A;G) plus 0.4518 rs360722(G;G) minus 0.253 rs2043055(A;G) 51.3% plus rs7106524(A;G) plus rs360717(A;G) plus 0.2277 rs360718(A;C) 34.5% plus 0.2291 rs187238(C;G) minus 0.2277 hypertension not a risk factor for sudden cardiac death hypertension not a risk factor for sudden cardiac death rs1946518(G;T) plus 0.4637 rs1946519(A;C) 45.1% plus 0.4628 rs360719(A;G) plus 0.2277 rs1290349(A;C) plus 0.2287 rs7123686(A;C) 48.7% plus 0.3981 rs2250417(A;G) minus 0.3407 rs7105881(C;C) 38.9% plus 0.3815 rs1436109(A;C) 19.5% minus 0.08815 rs965560(C;T) minus rs61902539(G;T) plus rs4938016(C;G) plus 0.449 rs2734848(A;A) 60.7% minus 0.2011 rs11214105(A;G) plus rs2115763(A;T) 51.6% minus 0.2819 rs2234689(G;G) 61.1% minus 0.1396 rs1554929(A;G) 58.4% minus 0.2686 rs2242592(C;T) minus 0.489 rs2734842(C;G) minus 0.4848 rs6279(C;G) minus 0.4752 rs6276(C;T) minus 0.4844 rs2734841(G;T) 47.7% minus 0.461 rs1124493(G;T) plus 0.4761 rs6277(C;T) Bad minus 0.2732 1.4x higher schizophrenia risk 1.4x higher schizophrenia risk rs6275(C;T) 48.7% minus 0.4729 rs1076562(A;G) 36.3% plus 0.4187 rs4436578(C;T) 22.1% plus 0.3489 rs17601612(C;G) plus rs11214613(A;G) 26.8% plus 0.2342 rs6589377(A;G) plus 0.2135 rs7952106(T;T) 40.7% plus 0.2521 rs3891484(C;T) 17.7% minus 0.1625 rs10789970(T;T) 13.3% plus rs3758987(A;G) minus 0.3067 rs1176744(G;T) 40.7% minus 0.343 rs2276307(A;G) 32.7% plus 0.1882 rs12363125(C;T) 51.3% plus 0.3163 rs2734839(A;G) 50.0% minus 0.3678 rs1800498(C;T) minus 0.3315 rs3782025(T;T) 30.1% minus 0.4252 rs1672717(T;T) 31.9% minus 0.2723 rs1062613(C;C) 59.8% plus 0.2337 rs1985242(T;T) 46.4% plus 0.4183 rs2276302(A;A) 46.9% plus 0.2893 rs10160548(T;T) 46.9% plus 0.45 rs17116334(T;T) 1.8% plus 0.141 rs1941404(C;T) 41.6% minus 0.4403 rs2847476(C;T) 46.0% minus 0.3811 rs4466877(A;G) plus 0.1823 rs9326244(C;T) 23.4% plus 0.191 rs1712790(C;T) plus 0.4063 rs4936323(G;T) plus rs6589488(A;T) plus 0.0629 rs7950069(A;G) plus 0.3866 rs220842(T;T) 98.4% plus rs7118530(C;T) plus 0.3076 rs12221649(C;T) plus 0.123 rs2085421(A;G) 46.0% plus 0.4715 rs7483296(A;T) 33.8% plus 0.09366 rs490592(G;T) 30.1% minus 0.1791 rs7941534(A;G) 37.2% plus 0.1506 rs4938303(T;T) 58.2% plus 0.4082 rs9326246(G;G) 95.2% plus rs6589564(G;G) 92.2% plus rs2160669(T;T) 92.3% plus rs220836(A;A) 67.3% minus rs7396835(C;C) 82.0% plus 0.208 rs1263177(C;T) plus 0.3806 rs5104(A;A) minus 0.2103 rs5092(A;A) Bad minus 0.2507 more likely to gain weight if taking olanzapine more likely to gain weight if taking olanzapine rs2542051(A;C) plus 0.4656 rs2854117(A;G) minus 0.455 rs2854116(A;G) minus 0.494 rs4520(C;C) plus 0.3779 rs5128(G;G) 83.2% minus 0.191 rs2070665(C;C) 84.1% minus 0.1804 rs2075290(T;T) 92.1% plus 0.1318 rs603446(T;T) 18.6% plus 0.3131 rs3741298(A;A) 65.5% minus 0.3255 rs651821(T;T) 88.5% plus 0.1589 rs10750097(A;A) plus 0.3416 rs1263173(A;A) 59.8% plus 0.4394 rs613808(G;G) plus 0.4265 rs2727784(A;G) minus 0.3976 rs10047462(T;T) 92.3% plus 0.2282 rs2075292(T;T) 77.9% plus 0.2401 rs533556(C;C) 47.3% plus 0.3696 rs12269901(C;G) plus 0.3949 rs7112513(G;G) 79.6% plus 0.2521 rs535860(A;T) 20.6% plus 0.1143 rs638405(C;G) 47.6% plus 0.4876 normal risk normal risk rs11216435(C;T) 24.8% plus 0.2599 rs497768(C;G) 60.3% plus 0.4247 rs3135932(A;G) 37.2% plus 0.08264 rs2228055(A;G) 8.3% plus 0.1217 rs7120173(G;T) plus 0.09871 rs507080(A;G) plus rs558907(A;G) plus 0.3526 rs494459(C;T) minus 0.405 rs10892279(A;G) plus 0.2268 rs1784300(A;T) 46.2% plus 0.3691 rs638893(T;T) 61.9% minus 0.2048 rs10892301(A;G) plus rs3922(C;T) 52.7% minus 0.4573 rs2509049(C;T) 57.5% plus 0.4256 rs12279572(A;G) 43.4% plus 0.2245 rs17122021(C;T) 45.1% plus 0.4399 rs502514(C;T) plus rs3918342(C;T) 44.2% plus 0.4688 rs1421292(A;T) plus 0.3783 rs7327673(A;G) 34.5% plus rs7336109(C;T) 49.6% plus 0.3177 rs488248(T;T) 49.6% plus 0.2713 rs1330950(A;A) 25.7% plus rs9558942(C;T) plus rs1830756(A;C) plus 0.2539 rs957788(A;G) minus 0.287 rs2036707(A;G) plus 0.1947 rs1509091(T;T) 84.6% plus rs1549059(C;C) 50.0% plus 0.4284 rs12871532(C;C) 21.2% plus 0.4881 rs1041569(A;T) plus 0.1556 rs9514828(C;T) 41.6% plus 0.3531 rs10508198(C;G) plus 0.1979 rs10492418(G;T) 48.2% minus 0.3604 rs17485138(T;T) 8.1% plus 0.1731 rs4773082(C;T) plus 0.3499 rs754204(C;T) 42.2% plus 0.3737 rs7323507(C;T) 39.8% plus rs1192201(A;A) 86.7% plus rs565470(C;T) 46.0% minus rs605143(A;G) 54.0% minus rs494558(T;T) 100.0% plus 0.1272 rs4773144(A;G) 48.7% plus 0.4073 rs3809346(C;T) minus 0.4068 rs1756091(C;C) 70.8% plus 0.1295 rs1163623(T;T) 70.8% plus 0.1327 rs9577381(T;T) 64.4% plus 0.3843 rs753180(G;G) 45.8% plus rs726455(T;T) 27.0% plus 0.4233 rs9549447(T;T) 29.2% plus rs1278769(A;G) 35.4% plus 0.2351 rs4907479(A;G) plus rs4773330(G;G) 72.3% plus 0.1336 rs1361542(G;G) 70.8% plus 0.1322 rs10665(A;G) 17.9% plus 0.1015 rs2181540(A;G) minus 0.1281 rs555212(G;G) 54.0% plus 0.2617 rs510317(G;G) plus rs561241(A;G) minus 0.1028 rs6041(A;G) plus 0.09642 rs6046(C;T) minus 0.09412 rs693335(C;G) plus 0.4348 rs3211770(A;G) plus 0.08861 rs9329350(A;G) 12.4% minus 0.101 rs7400002(C;T) minus rs9604529(C;T) 23.0% minus 0.2002 rs872072(A;G) plus 0.4862 rs1878703(C;C) minus rs1760944(C;C) 35.4% minus 0.4073 rs3136817(C;T) plus 0.2227 rs1130409(G;T) plus 0.4426 rs12147450(C;T) plus 0.1345 rs1243647(C;T) 31.9% minus 0.2603 rs3024718(A;G) 21.2% plus 0.1942 rs3024731(A;T) 33.8% plus 0.3861 rs10131141(T;T) 45.0% plus 0.3508 rs8005354(C;T) plus 0.343 rs1003349(G;T) 44.2% plus 0.3127 rs2236303(C;T) 48.7% plus 0.3159 rs743257(C;T) plus 0.4128 rs997154(A;G) plus 0.1901 rs4982731(T;T) 41.6% plus 0.3017 normal normal rs2239633(C;T) minus 0.3848 rs1055061(A;G) 8.0% minus 0.0932 rs10137082(C;T) 28.4% plus 0.2231 rs2073342(C;G) 40.0% plus 0.3379 rs2233860(C;G) plus 0.1722 rs2234632(G;T) plus 0.2456 rs2234636(C;T) plus 0.3163 rs17197037(A;G) plus 0.4261 rs10132760(A;C) 40.0% plus rs2877649(C;C) 94.7% plus rs1800875(A;A) minus 0.337 rs4982958(T;T) 39.8% plus 0.4325 rs8192917(A;G) 34.5% minus 0.2851 rs7144366(C;C) 40.7% plus 0.4949 rs8192916(C;C) 40.2% minus 0.4931 rs854384(C;C) 60.9% plus 0.1212 rs11850957(C;T) 35.4% plus 0.2617 rs10147992(A;G) 48.2% plus 0.4867 rs862946(A;G) minus rs718433(A;A) 40.7% plus rs1474476(G;G) 82.3% plus 0.1345 rs12589282(A;C) 48.7% plus 0.4348 rs227869(A;A) 28.3% plus rs12587781(G;T) Bad plus 0.292 1.79x increased risk for narcolepsy in Europeans and 1.34x in Asians 1.79x increased risk for narcolepsy in Europeans and 1.34x in Asians rs992564(G;T) 10.6% plus 0.2241 rs12421680(A;G) plus 0.4821 rs6590611(G;T) plus 0.3113 rs11222869(A;G) 57.5% plus 0.4982 rs4468361(C;C) 48.7% plus 0.3788 rs1784519(C;T) 29.2% minus 0.2346 rs2078454(A;C) plus 0.2502 rs12791420(A;T) 48.7% plus 0.2534 rs1682859(G;T) minus 0.4169 rs1031381(A;G) minus 0.4109 rs1940033(C;T) 51.3% plus 0.3884 rs7928758(G;T) plus rs10774021(C;T) 39.8% plus 0.472 rs11613331(A;G) plus rs7969761(C;T) 43.8% plus rs11062357(C;T) plus rs2107612(A;G) plus rs2107614(C;T) plus rs765250(A;G) 46.0% minus 0.2925 rs1012729(A;G) plus 0.2865 altered pediatric blood pressure altered pediatric blood pressure rs880054(A;G) 45.5% minus 0.4242 rs2011738(G;G) 10.6% plus 0.4697 rs557881(C;C) 0.0% minus 0.4977 rs499368(G;T) minus 0.4614 rs12828016(G;T) 46.9% plus 0.3861 rs2301880(C;T) 39.8% plus 0.2461 rs1051669(A;G) 38.4% minus 0.2456 rs10849605(C;T) plus 0.4486 rs6489769(C;T) 41.6% plus rs2887571(A;G) 38.1% plus 0.213 rs10848554(C;G) 27.7% plus 0.1818 rs1058322(C;T) 47.7% plus 0.2681 rs11061973(A;G) plus 0.1625 rs767870(C;T) minus 0.2534 rs1044471(C;T) 47.8% plus 0.3669 rs2887631(A;A) 56.6% plus rs10848635(A;T) plus rs11571378(A;T) minus rs1006737(A;G) plus 0.3049 rs2159100(C;T) 43.4% plus 0.3053 rs4765905(C;G) plus 0.3035 rs4765913(A;T) 36.7% plus 0.1465 rs7312105(A;G) 39.8% plus 0.3301 rs2302729(C;T) plus 0.3177 rs10848704(T;T) 54.0% plus 0.2663 rs2968909(C;G) 31.9% minus 0.3834 rs1051375(A;G) plus 0.4311 rs1990330(G;G) 58.4% minus rs12425451(T;T) 57.6% plus 0.3829 rs878962(A;C) 45.1% minus 0.4913 rs4766152(C;C) 30.4% plus 0.4495 rs887304(A;G) minus 0.1543 rs216026(G;T) plus rs10744625(T;T) 75.2% plus rs12827476(C;C) 39.3% plus 0.3788 rs10774214(C;C) 41.1% plus 0.4394 rs1049606(T;T) 40.2% plus 0.3838 rs3217869(A;G) plus 0.3907 rs3217901(A;G) 42.5% plus 0.3916 rs4625554(A;G) 42.5% plus 0.3113 rs7961824(C;T) plus 0.2149 rs11063112(A;T) plus rs3832879(-;C) minus rs10849061(C;T) 57.9% plus 0.3999 rs888468(A;G) 43.4% minus rs10849138(C;C) 30.8% plus 0.4904 rs2286580(A;G) 47.8% plus 0.3861 rs16932667(G;T) plus 0.4798 rs2284136(T;T) 12.4% plus 0.4339 rs10744676(T;T) 83.9% plus 0.09642 rs3741930(C;T) 46.8% plus 0.5 rs1860420(C;C) 27.7% minus 0.3471 rs4930767(C;T) plus 0.4444 rs12812339(A;C) 40.0% plus 0.1387 rs6332(A;A) 24.8% plus 0.4917 rs6489630(C;C) 65.5% plus 0.2654 rs1800380(A;G) minus rs11614912(A;G) 31.0% plus 0.1244 rs1063857(C;T) 46.0% minus 0.3434 rs1063856(A;G) minus 0.343 rs216293(G;T) 52.2% plus 0.472 rs1800378(A;G) minus 0.4775 rs7965413(T;T) plus rs1558324(C;T) minus 0.4775 rs7342306(A;G) plus 0.3223 rs12579350(A;G) plus 0.1139 rs216311(A;G) minus 0.27 rs10849441(A;G) plus 0.3664 rs1800693(C;C) minus 0.3173 rs1800692(C;C) minus 0.3081 rs1860545(T;T) 23.0% minus 0.2475 rs4149577(T;T) 32.7% minus 0.4109 rs4149576(A;A) 24.8% minus 0.2567 rs767455(C;C) 29.2% plus 0.3237 rs4149570(C;C) minus 0.3154 rs4149569(C;C) minus rs2228576(G;G) 55.4% minus 0.281 rs10849432(T;T) plus rs2364480(A;C) plus 0.1809 rs11616188(A;G) plus 0.1933 rs7311174(T;T) 55.6% plus 0.2103 rs2072374(C;C) 57.1% plus 0.2107 rs1136666(C;G) 45.9% plus 0.2548 rs1129649(C;T) plus 0.3632 rs5441(A;G) plus 0.241 rs7973719(C;T) 50.0% plus 0.4242 rs12828421(C;T) plus 0.4376 rs12307997(A;A) 80.0% plus 0.169 rs11055786(C;T) plus rs10845990(G;G) 30.4% plus 0.4665 rs2377422(T;T) 53.1% plus 0.4376 rs4264222(C;T) plus 0.2204 rs7134303(A;G) plus 0.1938 rs870849(C;T) plus 0.3356 rs3213427(C;C) 18.6% plus 0.2805 rs3741920(C;T) 45.1% plus 0.4513 rs226380(G;T) 50.9% minus 0.4614 rs6487679(T;T) 72.1% plus 0.1814 rs10771431(A;G) plus 0.4683 rs7397814(C;C) 57.8% plus 0.1056 rs4763655(A;G) plus 0.343 1.10x risk 1.10x risk rs3764021(A;A) 20.4% minus 0.4683 rs10466829(A;A) 25.7% plus 0.4977 rs7309123(C;C) 24.6% plus 0.3398 rs3901533(G;G) 52.7% minus 0.4844 rs3901532(A;A) 52.7% minus rs3759277(C;T) minus 0.4559 rs3832852(-;CCATA) minus rs12303914(G;G) 40.3% plus 0.3935 rs10743889(G;T) plus 0.241 rs1049174(G;G) 51.6% minus 0.4348 0.48x reduced risk for colorectal cancer 0.48x reduced risk for colorectal cancer rs2255336(G;G) 67.3% minus 0.236 rs2617160(T;T) 48.7% plus 0.3646 rs2617171(G;G) 49.2% plus 0.4559 rs2734440(A;A) 45.1% minus 0.4669 rs2418087(C;T) plus 0.2727 rs1015443(C;T) plus 0.4591 rs3736235(G;G) 23.9% minus 0.3466 rs3736234(T;T) 23.9% minus 0.3471 rs3736232(C;C) 18.8% minus 0.3466 rs10845271(T;T) 11.7% plus 0.4114 rs10772420(A;G) plus 0.4995 Median more intense perception of quinine Median more intense perception of quinine rs1031391(C;G) minus rs71455379(C;G) plus rs2908835(A;G) 38.1% minus 0.2782 rs2187642(A;C) 53.1% plus 0.4757 rs2856321(A;G) plus 0.4697 rs2724635(C;T) minus 0.4605 rs7314811(C;T) plus 0.3958 rs1376251(C;T) 45.3% plus 0.3981 rs10845498(A;A) 67.7% plus rs11612508(A;G) 39.8% plus 0.1786 rs747726(C;T) minus 0.2635 rs12822507(G;G) 12.4% plus 0.3444 rs3759216(A;G) plus 0.3944 rs36228499(G;T) minus 0.3976 rs34329(C;G) plus rs899435(G;T) minus 0.4536 rs11055387(C;G) plus 0.09045 rs1993508(C;G) plus 0.3563 rs890(G;G) 32.7% minus 0.3283 rs1806194(C;C) 24.8% plus 0.2328 rs11055612(C;T) 53.1% plus rs6488619(T;T) 58.9% plus 0.1657 rs10845840(C;T) plus 0.3163 rs220599(A;G) plus 0.4628 rs7301328(C;G) plus 0.4036 rs17221259(C;T) plus rs1457614(A;A) 69.9% plus 0.2608 rs4236(G;G) 10.6% minus 0.3535 rs1800801(T;T) minus 0.2713 rs2430692(G;G) 13.7% plus rs1861577(C;T) plus 0.2824 rs993694(A;A) 46.2% plus 0.3209 rs10772939(C;C) 31.0% plus 0.3774 rs1513049(G;G) 96.9% minus 0.146 rs10219673(A;T) plus rs1706631(A;T) 43.4% minus 0.455 rs12422552(C;G) plus 0.2906 rs3213764(G;G) 29.5% plus 0.4706 rs4764124(C;T) 42.5% plus 0.4605 rs11276(A;A) 11.6% minus 0.2801 rs2098435(A;A) 15.6% plus rs1186300(C;T) 42.0% plus rs10770612(A;G) 35.4% plus 0.2016 rs10841496(A;C) plus 0.4477 rs10841530(A;G) 49.2% plus rs11045392(C;T) plus 0.3994 rs10770704(C;T) plus 0.449 rs10770705(A;C) 39.8% plus 0.2713 rs3794271(C;T) minus 0.4031 rs10444412(C;C) 34.9% plus 0.4784 rs4149117(G;G) 72.3% plus 0.2911 rs7311358(A;A) 75.0% plus 0.2906 rs11044045(C;T) 29.2% plus rs6486986(G;T) 26.5% plus 0.2378 rs4762767(C;T) 39.8% minus 0.3274 rs2417940(G;G) 72.3% minus 0.2392 rs10841753(C;C) 3.5% plus rs2306283(C;C) 16.8% minus 0.405 rs11045818(A;G) plus rs11045819(A;C) plus 0.07851 rs2291075(C;T) 44.1% plus 0.449 rs704178(C;G) plus rs704180(A;G) 53.8% plus rs4148649(G;G) 2.7% minus 0.2227 rs2955503(A;A) 50.4% plus 0.4444 rs2216228(C;C) 0.0% plus 0.2181 rs11046966(C;T) plus 0.2433 rs11046992(A;A) 7.1% plus 0.2401 rs10842262(C;G) plus 0.489 rs11046205(A;G) plus 0.1584 rs9266(C;C) 28.6% minus 0.4458 rs712(G;G) 27.4% minus 0.4725 rs7965364(T;T) 81.2% plus 0.3122 rs1049380(A;A) 57.5% minus 0.3981 rs10771279(C;T) plus 0.4945 rs7955200(T;T) 50.4% plus 0.4931 rs10771283(A;A) 58.4% plus 0.3531 rs7138744(A;G) 39.8% plus rs7979575(C;G) 24.6% plus 0.2287 rs1464500(G;T) 40.2% plus 0.1543 rs1522232(C;C) 23.9% plus 0.3912 rs2306074(A;G) minus 0.416 rs10842994(C;T) 32.7% plus rs4420311(A;G) plus rs258401(G;T) plus 0.2062 rs7313833(A;G) plus 0.4068 rs1979679(G;G) 7.1% minus rs2638953(G;G) 41.5% minus 0.2456 rs10843215(C;T) 8.8% plus rs1606355(C;T) minus rs4931170(G;G) 14.2% plus rs2046383(G;G) 4.4% plus 0.2948 rs1157480(A;G) minus 0.1887 rs1151008(G;T) 44.2% plus 0.3926 rs1144713(G;G) 38.9% plus 0.421 rs161976(C;T) 47.7% minus rs7964407(A;G) minus 0.3209 rs522958(C;T) plus 0.3503 rs10844154(A;C) 49.6% plus 0.3788 rs261902(C;C) 68.1% minus 0.1832 rs11051970(T;T) 13.0% plus 0.3691 rs1454933(A;C) 15.9% plus 0.152 rs7980799(A;C) 47.8% plus 0.2089 rs9300212(C;C) 63.1% plus 0.4118 rs6582630(A;G) plus 0.3067 rs826838(C;T) 52.5% plus 0.4155 rs7308720(C;G) 15.2% plus 0.1015 rs708224(A;G) 44.2% plus 0.466 rs7133914(A;G) plus 0.09963 rs11564148(A;T) plus 0.2755 rs3761863(G;G) 46.7% minus 0.4495 rs10467147(A;G) plus rs1458175(G;G) 28.3% minus 0.3228 rs1796390(C;T) plus 0.2369 rs1167125(A;A) 82.3% plus 0.06198 rs905080(C;G) 47.8% plus 0.1671 rs1027615(A;G) plus 0.168 rs10785430(A;G) plus rs275380(G;G) 95.4% minus 0.06061 rs4251513(C;G) plus 0.3871 rs4251545(A;G) plus 0.1501 rs2933353(C;C) 54.5% plus 0.3108 rs312274(A;T) minus rs312273(C;T) minus 0.466 rs1373549(C;T) 54.0% minus 0.3058 rs2074193(G;G) 4.6% plus 0.169 rs7307902(C;T) plus 0.3384 rs757281(C;C) minus 0.1708 rs4760636(C;C) 61.9% plus 0.1841 rs7965281(G;G) 31.2% plus 0.3916 rs7968585(T;T) 33.3% plus 0.4596 rs11574143(A;G) 15.0% minus 0.1414 rs10880908(C;T) plus 0.4532 rs886441(T;T) 69.9% minus 0.2176 rs2189480(A;A) 12.4% minus 0.4403 rs3819545(C;T) 43.4% minus 0.4353 rs2228570(C;C) 37.2% minus 0.3466 rs2408876(C;C) plus 0.3852 rs2238136(A;G) 30.1% minus 0.1905 rs1989969(C;T) minus 0.3843 rs2238135(C;G) minus 0.2456 ? ? rs11168287(A;G) plus 0.4954 rs4334089(A;G) plus rs3847987(A;C) plus 0.1478 rs739837(T;T) 37.2% plus 0.4803 rs731236(C;T) Good 43.4% minus 0.264 rs7975232(A;A) 37.2% plus 0.4959 rs757343(A;G) 18.8% minus 0.1478 rs1544410(A;G) Bad 43.4% minus 0.2649 Intermediate risk of low bone mineral density disorders Intermediate risk of low bone mineral density disorders rs2239185(T;T) minus 0.4803 rs7975128(A;G) plus 0.2654 rs7305032(A;A) 43.1% plus 0.4656 rs11168268(T;T) 37.2% minus rs2248098(C;C) 37.2% minus rs2239182(A;G) minus 0.4458 rs2107301(C;T) minus 0.3572 ? ? rs2239181(G;T) 20.7% minus 0.1478 rs1540339(A;G) 40.7% minus 0.4164 rs2239179(A;G) minus 0.3388 rs12717991(A;G) 40.9% minus 0.4486 rs3737548(A;C) minus 0.2167 rs1793953(C;T) minus 0.4637 rs954326(A;C) 40.7% minus 0.2837 rs1635529(C;C) minus 0.286 rs1793933(A;A) 71.2% minus 0.2989 rs3803183(T;T) minus 0.3049 rs11168618(C;T) 50.4% plus rs7312017(C;G) plus 0.3503 rs10783219(A;T) plus 0.3122 rs11568820(A;G) 33.6% minus 0.4151 rs7976091(C;T) plus 0.4123 rs4760674(C;C) 38.9% plus 0.2392 rs10875712(G;G) 41.6% plus 0.2176 rs2276455(T;T) minus 0.4206 rs3741627(G;T) plus 0.3586 rs1051886(C;T) minus 0.3595 rs10875943(C;T) plus 0.4656 rs7138803(A;G) plus 0.292 rs7132908(A;G) plus 0.2681 rs297941(A;G) 56.6% plus 0.4725 rs467323(A;A) 61.1% minus 0.4325 rs706793(C;T) minus 0.2681 rs7972465(T;T) 38.7% plus 0.2998 rs7136702(C;C) 35.4% plus 0.4637 rs7968440(A;G) 40.6% plus rs422982(T;T) 61.9% minus rs10875976(A;G) plus 0.3765 rs1601012(A;C) 36.7% plus 0.2782 rs303810(C;T) 26.5% minus 0.2484 rs60637(A;C) plus 0.4279 rs2277382(C;T) 15.0% plus 0.07759 rs1894035(A;G) minus 0.202 rs3660(C;G) 43.1% minus 0.41 rs6580873(A;C) 34.5% plus 0.07897 rs17655565(C;T) plus rs3887954(C;C) 52.3% plus 0.4353 rs7959052(C;T) plus 0.2328 rs3951439(T;T) 100.0% plus rs2272306(A;G) plus rs1465073(C;G) 44.4% minus 0.3999 rs2016266(A;A) 46.9% plus 0.3623 rs10876432(A;A) 50.4% plus 0.2833 rs2120991(A;C) plus 0.2264 rs894734(G;G) 43.4% plus 0.3691 rs1443512(C;C) 63.7% plus 0.3067 rs920778(T;T) 44.2% minus rs2241820(T;T) 37.2% plus 0.3834 rs2638525(A;G) plus 0.1896 rs9658625(A;G) 11.5% plus 0.09871 rs3087404(A;G) minus 0.4403 rs2029167(A;A) plus 0.4853 rs7296239(C;T) plus 0.4591 rs1920045(A;G) 41.6% minus 0.4481 rs10506328(C;C) 38.9% plus 0.1703 rs10876550(A;A) 29.2% plus 0.3154 rs12230513(A;G) 20.4% plus rs3138144(C;G) minus 0.3714 rs705702(A;G) minus 0.2365 rs773125(A;G) plus 0.3407 rs7297662(A;G) plus rs773115(G;G) minus rs10876864(A;G) plus 0.4518 rs1701704(A;C) minus 0.2397 rs2456973(G;T) 32.8% minus 0.2424 rs4326844(G;G) 31.2% plus 0.314 rs1153188(A;A) 8.0% minus 0.1804 rs2292239(A;C) Bad minus 0.3338 1.3x risk 1.3x risk rs11171846(C;T) 16.8% plus 0.04775 rs7302060(C;T) plus 0.404 rs2657888(G;G) 38.1% plus 0.3788 rs941207(G;G) 4.8% plus 0.2043 rs2950390(T;T) 13.3% plus 0.2888 rs10459247(C;T) plus 0.2245 rs10876920(C;T) 43.8% plus 0.4766 rs12367822(G;T) 33.9% plus 0.2401 rs1131017(C;G) 38.7% plus 0.4509 rs715948(G;G) 40.7% minus 0.3384 rs1799986(C;T) 25.7% plus 0.1047 rs1678542(C;C) 11.5% minus 0.4793 rs1678536(G;G) 7.7% plus 0.309 rs10876994(C;C) 6.2% plus 0.3049 rs4646536(C;C) 11.5% minus 0.4054 rs3782130(C;C) plus 0.3577 rs703842(C;C) 11.5% minus 0.4187 rs3842936(C;T) minus 0.4729 rs703817(A;G) 48.7% minus 0.3283 rs324015(A;G) minus 0.2842 rs841718(C;T) minus 0.4444 rs2198776(A;A) 18.6% minus 0.3393 rs11174267(A;G) 51.3% plus rs10784285(C;T) 52.7% plus rs11615916(A;G) 28.3% plus 0.08907 rs10877839(C;C) 11.7% plus 0.3021 rs10877887(C;T) plus 0.405 rs2029721(A;G) plus 0.2502 rs549433(C;T) plus rs1273109(A;G) 22.1% plus 0.1777 rs276000(C;C) 100.0% plus rs7974425(T;T) 100.0% plus 0.02571 rs2655898(A;G) minus 0.3494 rs1587097(C;T) 13.5% plus rs10784339(C;G) plus rs1042615(C;C) 25.0% minus 0.3792 rs3021529(C;T) minus rs10784502(C;T) Good 41.6% plus 0.3567 Slightly higher intracranial volume Slightly higher intracranial volume rs1351394(C;T) plus 0.3301 rs8756(A;C) plus 0.3278 rs7968682(G;T) 39.8% plus 0.3329 rs10400419(C;C) 35.4% plus 0.3567 rs4026608(C;T) 50.8% plus 0.4844 rs1732887(C;T) minus 0.2144 rs1624395(A;G) 49.6% plus 0.4284 rs1370128(C;T) plus 0.4991 rs790006(A;G) 38.1% minus rs6581580(G;T) plus 0.3866 rs7313765(A;G) plus 0.3067 rs1147098(C;T) minus 0.4467 rs1445442(A;G) plus 0.3848 rs1596725(A;C) 48.7% plus 0.3343 rs6581612(A;A) 52.3% plus 0.2213 rs12229918(C;C) 17.7% plus 0.2686 rs1494508(C;C) 42.3% minus 0.494 rs2358944(A;G) plus 0.4784 rs1082714(C;T) 49.5% plus 0.4702 rs10878640(G;T) 44.2% plus 0.3099 rs7134599(A;G) plus 0.2185 rs1558744(A;G) plus 0.3292 rs12321565(C;T) plus 0.0831 rs2069727(A;G) minus 0.2704 rs2069718(C;C) 30.1% minus 0.3834 rs1861493(A;A) 41.5% plus 0.2645 rs1861494(T;T) 38.1% plus 0.2746 rs2430561(A;T) plus 0.2686 rs2227485(C;T) minus 0.4986 rs2227480(A;G) minus 0.1267 rs12313946(A;A) 13.3% plus 0.3852 rs937283(A;G) plus 0.3356 rs2870820(C;T) 51.3% plus rs1695147(T;T) 71.7% plus rs1690916(A;G) plus 0.3072 rs9943849(T;T) 7.1% plus 0.2406 rs10784762(C;T) 47.3% plus 0.3953 rs12367448(A;C) plus 0.1263 rs2069707(C;G) minus 0.02617 rs2069705(T;T) 34.5% minus 0.4839 rs1179246(A;C) 51.3% plus 0.483 rs1182844(A;T) plus 0.3251 rs1994198(C;T) 51.8% plus 0.4146 rs10519225(A;G) plus 0.2273 rs9920722(C;T) 49.2% plus 0.3356 rs7170426(A;G) 43.4% plus 0.3682 rs1365505(C;T) 45.1% plus rs12913823(C;T) 47.8% plus 0.1749 rs12594956(A;C) plus 0.4284 rs7174015(A;G) plus rs11070795(A;G) minus 0.3228 rs616256(A;G) 51.3% plus 0.4316 rs2414059(A;T) minus 0.4982 rs2725544(A;C) plus 0.1924 rs7174839(C;G) plus 0.4835 rs17520378(C;G) plus 0.08632 rs7163283(A;G) 48.4% plus 0.399 rs11635825(C;T) plus 0.1313 rs934635(A;G) plus 0.1175 rs4646(A;C) 38.1% plus 0.3214 rs17601241(A;G) plus 0.07576 rs6493487(A;G) plus 0.2264 rs2414095(A;G) 38.1% plus rs17703883(C;T) plus 0.2195 rs727479(G;T) minus 0.315 rs10459592(G;T) plus 0.4532 rs12591359(A;G) plus 0.483 rs2470152(T;T) 21.2% minus 0.4876 rs4775899(C;T) plus 0.4458 rs8035452(C;T) plus rs3803369(A;G) minus 0.1584 rs1004984(C;T) minus 0.4008 rs1004982(A;G) minus 0.4073 rs2445762(C;T) plus rs2470144(A;G) minus 0.3655 rs12148477(A;G) 42.0% plus rs719714(C;T) 8.8% minus 0.112 rs1897031(T;T) 72.3% minus 0.2025 rs11071033(C;T) plus 0.427 rs10518765(A;C) 36.3% plus 0.1387 rs3848140(A;G) plus 0.4224 rs600753(C;T) plus 0.4697 rs12899331(A;G) plus rs11071200(A;C) plus 0.1648 rs8032158(C;T) plus 0.3085 rs6493858(A;A) 26.1% plus rs4774925(C;T) plus 0.4646 rs744318(A;C) minus 0.2916 rs937254(A;G) plus 0.4977 rs7169289(A;G) plus 0.2011 rs4646642(C;T) 50.5% minus 0.427 rs3784259(A;G) 50.4% minus 0.405 rs1441815(G;T) minus 0.4582 rs4646580(C;T) 59.7% minus 0.4219 rs2704188(C;T) minus 0.4096 rs4775041(C;G) plus 0.2112 intermediate phosphatidylethanolamine values intermediate phosphatidylethanolamine values rs2043085(A;G) minus 0.4734 rs1532085(A;G) 55.8% plus 0.4458 rs1550576(T;T) 0.0% plus 0.1827 rs920915(C;G) 45.3% plus 0.4105 rs12912233(T;T) 20.0% plus 0.3393 rs7168987(T;T) 9.7% plus 0.2107 rs11631179(C;C) 4.6% plus 0.2534 rs3884558(G;G) 80.5% plus 0.2984 rs4775413(T;T) 31.2% plus 0.3691 rs12592967(T;T) 32.1% plus 0.4036 rs4143844(G;T) 12.5% minus 0.04637 rs17271305(A;G) 46.2% plus 0.2599 rs1436958(G;T) 51.3% plus 0.3641 rs7178424(C;T) 58.4% plus 0.4215 rs261336(T;T) 66.4% minus 0.2029 rs4775065(G;G) 61.6% plus 0.2851 rs8028759(T;T) 44.6% plus 0.3843 rs9652472(A;A) 93.8% plus 0.3012 rs7170178(A;A) 43.5% plus 0.3857 rs3743266(G;G) 8.0% minus 0.2934 rs340005(A;A) 38.5% plus 0.2649 rs339969(A;A) 39.8% plus 0.2617 rs340029(T;T) 39.3% plus 0.2466 rs3784609(A;G) 26.1% minus 0.1272 rs12591650(A;G) 28.3% plus 0.2204 rs12914272(A;G) 49.2% plus rs1482057(G;G) 61.6% minus rs7164773(T;T) 24.8% plus 0.4646 rs7179456(G;T) 48.7% plus 0.4247 rs10519005(C;T) 49.1% plus rs1630535(G;G) 80.5% plus 0.202 rs11853426(C;T) 43.5% plus 0.4518 rs11857380(G;T) plus 0.1543 rs588136(T;T) 57.5% plus rs473224(C;C) 66.4% minus 0.09871 rs2217235(C;T) 49.2% minus rs11104870(T;T) 46.8% plus 0.4192 rs10777288(A;A) 70.8% plus 0.2902 rs3832846(GG;GG) minus rs3759222(C;C) 84.1% minus 0.3104 rs516115(A;G) minus 0.399 rs10777317(C;T) plus 0.4399 rs12146838(A;T) plus rs337656(A;G) 34.5% minus 0.1612 rs337663(A;G) 50.4% plus 0.4031 rs454217(C;T) 55.8% plus rs10219495(C;T) plus 0.05051 rs1847461(C;T) minus 0.152 rs7953508(C;T) 39.8% plus 0.3444 rs10859563(C;G) 38.9% plus 0.4334 rs3847794(C;T) 46.9% minus rs1520724(A;G) 43.8% minus 0.405 rs249153(C;T) plus rs7135847(T;T) 63.7% plus 0.08402 rs17356907(A;G) 38.9% plus 0.2727 rs6538678(A;G) 38.1% plus rs1036429(C;T) plus 0.2277 rs7297245(C;T) 33.6% plus 0.1093 rs1836127(G;T) 46.4% plus 0.3526 rs4761659(C;C) 85.0% plus rs2540477(T;T) 62.8% minus 0.3384 rs2660845(A;A) 55.8% plus 0.3949 rs2540475(C;T) minus 0.1988 rs2660869(C;G) minus 0.07071 rs11108495(C;T) plus 0.4385 rs6538761(C;C) 37.2% plus rs7953959(T;T) 35.4% plus 0.4931 rs11109072(A;C) plus 0.152 rs2036225(T;T) 22.3% plus 0.4715 rs10860392(C;T) 50.4% plus 0.287 rs1978331(C;T) 52.7% minus 0.4711 rs2540493(G;T) minus 0.1148 rs2247570(A;G) minus 0.2686 rs2660898(G;T) plus 0.3182 rs2660899(G;G) 67.3% plus 0.2691 rs2373011(C;G) 60.2% minus 0.4555 rs10745877(A;A) 40.2% plus 0.4995 rs11110099(A;A) 28.3% plus 0.4073 rs11110385(C;T) 48.7% plus rs11110386(C;T) plus rs10860603(A;G) plus 0.3448 rs35724(C;C) 38.5% minus 0.4467 rs2290720(A;G) 49.5% minus rs4622329(A;G) plus 0.4899 rs1961649(A;T) minus 0.05877 rs7971536(A;T) plus 0.4004 rs1996656(A;G) plus 0.1497 rs4764695(A;G) 46.0% plus 0.4141 rs2946834(C;T) 36.3% minus 0.3953 rs5742714(C;G) 10.5% minus 0.1088 rs6220(A;G) plus 0.3526 rs1520220(C;G) plus 0.3012 rs5742694(G;T) minus 0.2172 rs5742678(C;G) 29.2% minus 0.3343 rs972936(A;G) minus 0.3329 rs7136446(C;T) 33.6% plus 0.2925 rs2373584(A;G) 37.2% plus 0.4178 rs35747(A;A) minus 0.3182 rs855203(T;T) 85.0% minus rs7964748(G;G) 5.3% plus 0.2176 rs2172873(C;T) minus 0.1327 rs1722387(G;G) 73.5% minus rs3817446(G;G) 6.2% minus rs2037639(A;G) plus rs10860936(C;T) plus rs11111419(A;T) 41.1% plus rs2291854(C;T) 38.3% minus 0.1837 rs5742632(C;T) 31.9% minus rs2195239(C;G) 29.2% minus 0.3287 rs5742629(A;G) minus 0.3499 rs7956547(C;T) plus 0.2277 rs35767(C;C) 77.0% minus 0.2819 rs10861032(C;C) 1.8% plus 0.2847 rs2374327(A;A) 53.3% minus 0.18 rs167715(T;T) 72.3% minus 0.07346 rs1564892(C;T) 25.0% minus 0.461 rs77724872(C;T) plus rs2272495(C;T) minus 0.1915 rs10219670(A;A) plus 0.3857 rs2067615(A;T) 45.0% plus 0.3981 rs1053051(C;T) plus 0.4073 rs2287161(C;G) 59.3% minus 0.4123 rs4964805(C;G) 32.7% minus 0.3347 rs8192440(C;C) 37.2% minus 0.2135 rs1861591(A;G) minus 0.399 rs7313402(A;A) 20.4% plus 0.4931 rs1878022(C;T) 40.7% plus 0.32 rs918304(T;T) 98.4% plus 0.001377 rs2228315(A;G) 15.9% minus 0.1758 rs4623951(C;T) 45.1% plus 0.2893 rs2070586(A;G) plus 0.3026 rs2111902(G;T) plus 0.455 rs3918346(C;T) minus 0.4128 rs3825251(C;T) 27.4% minus 0.292 rs3890995(C;T) plus 0.2103 rs3809236(C;T) minus rs2337395(C;T) plus 0.4082 rs246079(A;G) 52.3% plus 0.4109 rs2268388(C;T) minus 0.1584 rs2268387(C;T) 49.1% minus 0.309 rs2239607(C;T) 33.8% minus 0.1841 rs2300453(A;C) minus 0.1933 rs3742026(C;G) minus 0.3434 rs2241220(C;C) 73.5% plus 0.2089 rs4766587(A;G) plus 0.2695 rs2284689(C;C) 67.3% minus 0.2406 rs2284685(C;G) minus 0.3099 rs3742023(A;G) 46.0% minus 0.2837 rs6606697(A;G) 49.6% plus 0.4045 rs9593(A;T) 55.4% minus 0.4862 rs7134594(C;T) 46.0% plus 0.4858 rs59227481(A;G) plus rs1861809(C;C) 27.4% minus 0.2759 rs4766646(A;T) plus 0.3522 rs10849915(C;T) plus 0.3618 rs10774610(C;T) plus 0.326 rs3847953(A;A) 7.1% minus 0.4073 rs933399(A;A) 2.7% plus 0.4169 rs10774624(A;A) 100.0% plus 0.2222 rs9943753(G;G) 48.7% plus 0.3232 rs2338104(C;G) 48.7% plus 0.4674 rs4766578(A;A) 31.7% plus 0.2259 rs10774625(G;G) 31.9% plus 0.225 rs653178(T;T) minus 0.219 rs601663(G;G) minus 0.3935 rs659964(C;G) minus 0.2029 rs6490294(A;C) plus 0.489 rs737280(G;G) 10.6% minus rs2238151(C;C) 12.4% plus 0.3512 rs2238152(G;T) 39.7% plus 0.1965 rs441(C;T) plus 0.197 rs739496(A;G) 35.4% plus rs3803064(T;T) 23.0% minus 0.4421 rs10774670(A;G) 38.5% plus 0.3356 rs1131454(A;G) plus 0.4867 rs10774671(A;G) plus 0.3604 rs1051042(C;G) plus 0.2181 rs2660(A;G) plus 0.2176 rs2285932(A;G) minus 0.1749 rs15895(C;C) 38.9% minus 0.1685 rs2384207(A;G) minus 0.2254 rs883079(A;G) 37.2% minus 0.3949 rs968529(C;C) 85.7% plus rs16941669(G;T) plus rs9971942(C;T) 34.8% plus rs4767364(A;A) 9.7% plus 0.4054 rs2301756(C;T) 22.1% minus 0.3926 rs11066320(G;G) 41.6% plus 0.2025 rs12423190(C;T) plus 0.1336 rs7958372(C;T) 28.1% plus 0.4008 rs17824620(A;C) plus 0.2521 rs59336(A;T) minus 0.4807 rs1910047(A;T) 36.5% minus 0.1758 rs1896312(A;A) 38.5% minus 0.3664 rs2384550(A;G) plus 0.287 rs10850408(C;T) 47.3% plus 0.2649 rs2194980(G;G) 40.7% plus 0.3893 rs35444(C;T) 50.4% minus 0.3691 rs1292011(C;T) 50.4% minus 0.3673 rs7315438(C;T) 54.0% plus 0.4555 rs3825214(A;G) plus 0.2704 rs7312625(A;G) plus 0.2957 rs1895585(C;T) 33.8% minus 0.2961 rs11067228(A;G) 46.0% plus 0.3618 rs6490121(A;A) 38.1% plus 0.3829 rs2293050(A;G) 48.2% minus 0.4242 rs2139733(A;T) minus 0.4169 rs7977109(A;G) plus 0.3641 rs1879417(T;T) 31.0% plus 0.4454 rs12828172(T;T) 14.4% plus 0.3306 rs1846644(G;G) 15.9% minus 0.3196 rs1604079(A;A) 17.7% minus 0.3287 rs4767551(T;T) 17.2% plus 0.4105 rs10774929(T;T) 17.5% plus 0.4096 rs1111599(G;G) 20.4% minus 0.4233 rs2134143(A;A) 17.2% minus 0.4187 rs2134142(C;C) 19.5% minus 0.4302 rs7974925(A;A) 15.9% plus 0.3398 rs561712(A;G) 44.6% minus 0.3343 rs7308402(A;G) plus 0.2029 rs1483757(A;G) 48.2% plus 0.45 rs1520811(C;T) minus 0.1965 rs9658281(A;G) 48.2% minus 0.1983 rs3782218(C;T) 33.8% plus rs1004356(C;T) plus rs10507279(A;G) plus rs7965602(T;T) 68.5% plus 0.2704 rs1997111(G;G) 48.7% minus 0.3774 rs202984(G;G) plus 0.2805 rs203332(A;G) plus 0.483 rs440299(A;G) 54.9% plus 0.4408 rs10744743(C;G) 41.5% plus 0.3636 rs3847960(A;T) plus 0.3531 rs11065028(T;T) plus rs6489785(C;T) plus 0.2603 rs2650000(G;G) 41.6% minus 0.3274 rs4304868(G;T) minus 0.1947 rs2393791(A;G) 53.1% minus 0.3926 rs7310409(A;G) 52.2% plus 0.3935 rs2259816(A;C) 51.3% minus 0.3669 rs735396(A;G) minus 0.3673 rs1169310(A;G) plus 0.3669 rs1169313(C;T) plus 0.3682 rs591874(A;C) plus 0.4059 rs208294(G;G) 26.5% minus 0.4614 rs7958311(A;G) plus 0.2893 rs2701175(A;A) plus 0.3572 rs7953249(A;G) plus 0.427 rs2251468(T;T) 41.6% minus 0.3154 rs1621388(C;T) minus 0.3085 rs2686342(A;A) 63.7% plus 0.2631 rs10849893(G;G) 15.4% plus 0.2663 rs74421874(A;G) plus 0.3035 rs3825172(C;T) 49.2% plus 0.3035 rs7314056(C;C) 77.0% plus rs7961894(C;T) 19.6% plus 0.04224 rs493519(C;C) 77.0% plus rs1718119(C;T) minus 0.3081 rs1880030(T;T) 18.6% minus 0.3893 rs1043763(A;A) 56.6% plus 0.3274 rs11608363(T;T) plus 0.483 rs6489188(C;C) plus 0.2332 rs7296418(T;T) 43.8% plus 0.3246 rs1727307(G;G) 42.5% plus 0.3283 rs1727313(C;C) 53.1% minus rs786425(A;A) 34.4% plus 0.4449 rs6488898(A;G) plus 0.02755 rs7978454(A;G) 38.2% plus 0.3765 rs10773046(G;G) 18.6% plus rs4765127(G;T) 50.4% plus 0.2842 rs1187415(C;G) plus rs1716403(A;G) minus 0.2365 rs12582168(C;T) plus 0.2668 rs838880(T;T) 49.6% plus 0.4757 rs838895(C;G) plus 0.432 rs1790100(T;T) 57.8% plus 0.3136 rs11532322(G;G) plus rs16917496(T;T) plus 0.4692 rs10773568(A;A) 31.9% plus 0.393 rs10847697(A;G) plus 0.1253 rs1385374(C;T) 22.1% plus 0.1253 rs10744391(A;G) plus 0.2511 rs12824981(C;T) 48.7% plus 0.2502 rs7309727(C;C) 56.6% plus 0.2635 rs11060369(A;C) 40.7% plus 0.4261 rs7979367(G;T) 47.8% plus rs11615979(C;T) 46.9% plus 0.3503 rs4759659(A;A) 21.2% plus 0.2695 rs4765623(C;T) Bad 44.2% plus 0.3907 more likely to gain weight if taking olanzapine more likely to gain weight if taking olanzapine rs1043607(A;G) plus rs10773338(A;G) plus rs7296262(C;T) plus 0.4642 rs7301826(C;T) 67.9% plus 0.4311 rs7304057(A;G) plus 0.1276 rs14035(T;T) 9.7% plus 0.2971 rs7299940(G;G) 31.0% plus 0.4692 rs4759802(G;G) 69.2% plus 0.1795 rs1569019(T;T) 0.9% minus 0.05326 rs1976930(T;T) minus 0.06015 rs885389(G;G) 45.5% plus 0.4215 rs10773920(A;C) 50.4% plus 0.3186 rs1982526(A;T) minus 0.2121 rs10773771(T;T) 33.6% plus 0.4982 rs1464108(A;C) 40.7% plus 0.2815 rs877098(C;T) 46.9% minus 0.4242 rs7989332(C;C) 47.3% plus 0.2314 rs4770049(T;T) 90.8% plus rs9506514(A;A) 42.5% plus 0.4927 rs735539(C;C) 59.3% minus 0.4564 rs17064136(A;G) plus rs9788333(C;G) 52.4% plus 0.2567 rs9552416(C;T) 12.5% plus 0.05693 rs1974047(A;G) plus 0.382 rs6598163(A;G) plus 0.4642 rs2306536(C;T) 28.6% plus 0.1662 ? ? rs2306541(A;G) plus 0.2433 rs4770403(A;G) plus 0.1497 rs4770433(A;G) 46.9% plus 0.3549 rs10162002(A;G) plus 0.1648 rs753955(C;C) 45.1% minus 0.4408 rs7324557(A;G) 45.5% plus 0.2961 rs9318086(A;G) 48.7% plus 0.4518 rs17079928(A;G) plus 0.2576 rs9805786(T;T) 38.9% plus 0.36 rs9581094(C;T) plus 0.09183 rs2483374(C;C) 20.5% plus rs263930(C;G) 45.8% minus 0.3558 rs7999075(A;A) 84.1% plus rs7318731(C;C) 36.9% plus 0.3531 rs4770394(A;A) 94.7% plus 0.1497 rs7322916(A;A) plus 0.4463 rs4770837(G;G) 48.7% plus 0.2626 rs9319321(A;T) 36.3% plus 0.2668 rs9512637(C;T) plus 0.4683 rs4771122(A;G) plus 0.2355 rs9512755(C;T) 23.9% plus rs9512900(C;T) plus 0.1653 rs2293941(A;A) 5.3% plus 0.2938 rs4769585(C;T) 57.1% plus 0.3168 rs9513070(A;G) plus rs9582036(A;C) plus rs9554320(A;C) 54.0% plus rs4770877(A;G) 46.0% plus 0.4853 rs9507577(G;T) 55.8% plus 0.4642 rs3751397(A;A) 33.8% plus 0.4646 rs7337610(C;C) 36.9% plus 0.4927 rs2296283(T;T) 30.8% minus 0.4481 rs722503(A;G) 37.2% minus 0.2792 rs3794405(C;T) 33.6% plus rs4771249(C;G) plus 0.2516 rs600640(C;T) minus 0.3714 rs678714(A;T) minus rs664393(A;G) minus rs9579199(A;A) 61.9% plus rs9319425(C;T) 53.1% plus 0.4288 rs2296188(C;C) 77.0% plus 0.2888 rs7324547(G;G) 61.9% plus 0.3673 rs17086609(A;G) 38.9% plus 0.2998 rs1161463(C;C) 57.1% minus 0.41 rs2479768(G;G) 97.3% plus rs2388082(C;G) 20.0% plus 0.1198 rs2892463(G;T) 50.4% plus 0.4936 rs9314986(G;T) 49.6% plus 0.258 rs7335631(A;A) 75.2% plus rs6490455(C;C) plus rs1412125(C;T) 55.4% plus rs17216473(A;G) plus 0.1648 rs954108(T;T) 35.4% plus 0.4086 rs4076128(A;G) 33.8% plus 0.4183 normal normal rs17222919(G;T) plus 0.1607 rs4293222(C;G) 41.5% plus 0.4715 rs10507391(A;T) 43.4% plus 0.489 1.24x increased stroke risk for males 1.24x increased stroke risk for males rs12429692(A;T) 36.3% plus 0.2668 rs3885907(A;C) plus rs3922435(C;C) 98.5% plus 0.03811 rs4360791(A;G) plus 0.4403 rs9551963(C;C) 33.3% plus 0.4692 rs9315050(A;G) 9.2% plus 0.0978 rs4769060(A;G) 49.6% plus 0.3356 rs12876893(A;G) plus rs1326306(G;G) 60.0% minus rs362(G;T) plus 0.3393 rs9534262(C;C) 26.5% plus rs4942486(C;C) 25.7% plus rs10492396(A;G) plus rs718444(A;G) 48.4% minus 0.2998 rs7332115(G;T) plus 0.2998 rs526906(C;C) 71.7% minus 0.2842 rs525014(C;C) 46.0% minus 0.4096 rs9542236(C;T) plus 0.2429 rs571118(G;G) 23.9% minus 0.4467 rs577912(C;C) 72.6% minus 0.1873 rs7323281(G;G) plus 0.3118 rs648202(C;C) 72.6% plus 0.27 rs650439(A;A) 72.6% plus 0.2227 rs643780(G;G) 72.6% plus 0.2264 rs17051917(C;T) 19.4% plus 0.1129 rs20411(A;C) minus 0.4357 rs2051090(C;T) minus 0.3756 rs6563210(A;G) 40.0% plus 0.3531 rs1328641(A;G) 42.5% minus rs7327064(C;T) 36.0% plus 0.1373 rs6563386(C;G) 50.0% plus rs1590305(A;G) 14.2% minus 0.2415 rs9547970(G;G) plus 0.3466 rs2555603(G;T) 31.9% minus 0.1827 rs571411(A;A) 96.5% plus rs17798800(C;T) 31.0% plus 0.1529 rs9548050(A;G) 50.9% plus rs9548119(A;A) 1.6% plus 0.2296 rs9594293(A;G) plus 0.2254 rs1945502(A;A) 39.8% minus rs9315702(A;C) plus 0.286 rs9603616(T;T) plus 0.264 rs9315762(C;T) 25.7% plus 0.1928 rs10492681(C;G) plus 0.3062 rs7325568(C;T) 52.2% plus 0.3838 rs7319926(G;G) 23.9% plus 0.494 rs2721068(C;T) plus 0.4821 rs2297627(C;T) 56.2% minus rs1900442(C;T) plus rs9532969(T;T) 13.8% plus rs9525562(A;A) plus rs6561030(A;A) 0.9% plus 0.2172 rs1170191(C;C) 73.5% minus 0.2681 rs9525584(C;C) 20.4% plus 0.3994 rs180870(A;G) plus rs913246(A;A) 97.3% minus 0.02479 rs941823(G;G) 62.8% minus 0.2117 rs2755237(C;C) 0.0% plus 0.2328 rs2721051(A;A) 0.0% minus 0.07713 rs9533095(T;T) plus rs9594751(C;T) 34.5% plus 0.1396 rs9525625(C;T) plus 0.3742 rs9594759(C;T) 48.2% plus 0.4229 rs2062305(A;G) plus 0.3783 rs1021188(T;T) 76.6% plus 0.2429 rs9525638(C;T) plus 0.3714 rs17536328(C;T) 47.8% plus rs9533156(C;T) plus 0.4582 rs9525641(C;T) plus rs9533089(A;A) 10.8% plus 0.2778 rs9533090(T;T) 18.5% plus 0.3177 rs9594738(T;T) 16.8% plus 0.32 rs1324015(G;G) 35.4% plus 0.3448 rs9533425(C;G) plus 0.08678 rs3088362(A;C) plus 0.2034 rs3764147(G;G) 8.0% plus 0.3026 rs9525916(A;T) plus rs9533799(A;C) plus 0.2672 rs1926447(C;C) 51.3% minus rs7324845(A;G) plus 0.1703 rs9590974(A;A) 37.5% plus rs2277438(A;A) plus 0.2365 rs2277439(A;A) 72.6% plus rs2324851(C;C) 72.3% minus rs2148072(A;G) plus rs2148073(C;C) 72.3% plus 0.2456 rs2875459(A;G) 39.1% minus rs2200287(C;T) minus rs9533166(C;T) plus rs7322347(A;T) plus 0.4307 rs1923886(T;T) 24.8% plus 0.3623 rs1745837(T;T) 47.8% plus 0.3026 rs2296972(G;G) 49.1% minus 0.3434 rs2224721(A;C) minus 0.3154 rs9316233(C;G) 39.7% plus 0.264 rs659734(C;T) minus 0.07071 rs1928042(A;A) 57.5% minus 0.2107 rs2770296(T;T) 56.6% plus 0.2342 rs1928040(C;T) minus 0.4458 rs2770304(C;T) 41.1% plus 0.3595 rs927544(T;T) 57.5% minus 0.2599 rs594242(C;C) 70.3% minus 0.1299 rs6313(C;T) Bad minus 0.4288 higher risk for RA higher risk for RA rs8001976(C;T) 52.3% plus 0.4371 rs2031532(A;G) 46.9% plus 0.2117 rs3765526(A;G) plus 0.4564 rs9526569(C;T) 51.8% plus 0.3554 rs1046295(A;G) plus 0.4775 rs3803185(A;G) minus 0.3081 rs9535307(C;C) 71.4% plus 0.1175 rs3736830(C;C) 65.1% plus 0.3586 rs806321(A;A) 26.5% minus 0.4692 rs201789(C;C) 51.3% plus 0.4357 rs1575891(C;C) 53.1% plus 0.3168 rs7999699(A;G) plus rs9316500(G;T) plus 0.3783 rs1239947(C;T) minus 0.2548 rs9316505(A;G) plus 0.4086 rs7325564(C;T) plus 0.3196 rs732774(A;A) 31.0% minus 0.4803 rs1061472(G;G) 30.1% minus 0.4927 rs7999812(C;C) 16.7% plus rs9535826(G;G) 29.2% plus rs9535828(A;A) 29.2% plus rs9536318(A;A) 64.5% plus 0.2346 rs1262778(A;A) 58.5% minus 0.2208 rs9568797(T;T) 38.9% plus rs9568867(A;G) plus 0.1515 rs2806731(T;T) 54.9% plus 0.2815 rs6561750(T;T) 38.1% plus 0.4812 rs9536591(A;C) 44.2% plus 0.4972 rs9596905(A;G) plus 0.1286 rs2315885(A;G) minus rs1512651(A;A) 23.9% plus 0.4936 rs1340573(A;A) 82.3% plus 0.0877 rs12585963(A;G) plus 0.354 rs9568856(A;G) plus 0.2351 rs4886238(A;A) 10.8% plus 0.2424 rs3106598(A;G) plus 0.449 rs1000589(G;T) 61.3% plus 0.4729 rs11148643(C;C) 20.4% plus rs9571178(A;A) 20.4% plus rs4261405(C;C) 18.5% plus rs9598783(G;G) 18.5% plus rs2220327(C;C) 20.4% plus rs1340319(G;G) 20.4% minus rs1333026(G;G) 71.4% plus 0.1373 rs11619878(A;G) plus 0.3719 rs1585440(A;A) 12.5% minus 0.2709 rs2204037(C;T) 49.1% minus 0.2934 rs3119939(C;T) plus 0.2438 rs2875517(A;A) 88.5% plus 0.06795 rs2066219(A;A) minus 0.2713 rs2593525(T;T) 100.0% minus rs352236(T;T) 100.0% plus rs9572182(C;C) 34.5% plus rs1928007(A;A) 81.0% plus 0.1488 rs9592783(A;A) 6.2% plus 0.2208 rs9599848(A;G) 50.9% plus rs9919839(C;T) 17.9% plus 0.1685 rs584480(T;T) 20.3% plus 0.3792 rs626277(C;C) 15.9% plus 0.3742 rs1937506(A;G) plus 0.2236 1.3x risk 1.3x risk rs287354(C;T) 45.5% minus 0.3696 rs287474(A;T) plus 0.3949 rs58090485(-;A) plus rs9600079(T;T) 21.4% plus 0.4394 rs1330082(C;C) minus 0.3219 rs1886449(C;T) 22.1% plus 0.2181 rs9318225(C;T) plus 0.4105 rs1887346(C;T) minus 0.2984 rs1886512(A;T) plus 0.3567 rs9565072(C;C) 47.3% plus 0.4082 rs8000245(C;T) 18.6% plus 0.1584 rs12429889(C;T) plus 0.2617 rs9652236(G;T) 23.9% plus 0.2608 rs4083578(C;C) 62.8% minus 0.4931 rs1924966(G;T) plus rs7330796(C;T) plus rs9543976(A;A) 75.2% plus 0.3026 rs2073831(C;T) 36.6% plus 0.3604 rs1279386(A;T) minus 0.4881 rs975739(A;C) 40.7% minus 0.4894 rs5351(A;G) minus 0.4509 rs3027111(C;T) 27.7% plus 0.2925 rs3759475(C;T) 50.0% minus rs9574124(C;G) plus 0.4573 rs4304924(A;A) 24.8% plus rs1062087(A;G) 15.9% minus 0.2815 rs2184180(G;T) plus 0.3462 rs9574309(C;T) plus 0.4389 rs7319358(C;T) 52.2% plus rs7990916(C;C) 42.9% plus rs12431307(A;G) plus rs9574565(C;T) plus 0.298 rs1359790(C;T) minus 0.2346 rs534870(A;A) 51.8% plus 0.3159 rs1930336(G;G) 58.4% minus rs11149178(A;G) plus 0.2672 rs9545740(A;G) plus rs17074565(G;G) 0.9% plus 0.1038 rs4128764(A;G) 31.8% plus 0.2006 rs9601248(C;T) 50.9% plus 0.4646 rs2039553(G;G) 28.8% plus 0.3875 rs7981942(A;C) 35.4% plus 0.4141 rs4134351(G;G) 68.8% minus 0.2943 rs9546711(A;G) plus 0.225 rs7984869(G;T) 46.9% plus 0.4096 rs969962(C;T) 33.6% plus 0.1529 rs7326018(T;T) 17.7% plus 0.3669 1.8x increased risk for multiple sclerosis 1.8x increased risk for multiple sclerosis rs1327328(C;C) 17.7% minus 0.3802 normal normal rs2882281(C;G) 54.9% plus 0.3797 rs828200(T;T) 100.0% plus rs61970269(T;T) plus 0.3682 rs6492538(C;C) 82.4% plus rs6563353(T;T) 2.7% plus 0.1511 rs7322083(G;G) 64.6% plus 0.259 rs3864180(A;G) 65.6% plus rs7987675(T;T) 8.8% plus 0.2865 rs4771859(C;C) 33.6% plus 0.3411 rs9523762(A;G) plus 0.4376 rs9523787(G;T) 27.4% plus 0.1272 rs7988257(A;C) plus 0.3182 rs9523848(G;T) 43.1% plus 0.3669 rs17702471(A;G) 35.4% plus 0.1437 rs1328369(A;G) 54.1% minus 0.376 rs553717(A;G) 23.9% minus 0.174 rs11839514(A;G) 49.6% plus 0.4096 rs7998314(C;C) 65.5% plus 0.3609 rs9524260(A;G) 54.9% plus 0.2994 rs1572050(C;T) minus 0.1662 rs9301951(C;T) plus 0.1281 rs727299(A;G) 11.0% minus 0.06107 rs9302001(C;T) 46.0% plus 0.3136 rs1729786(A;G) 49.6% minus 0.2934 rs1926657(C;C) 68.1% plus 0.2567 rs4148441(C;T) 12.4% minus 0.123 rs7989336(A;G) plus 0.4706 rs4771996(A;A) 58.4% plus rs7995215(A;G) 57.5% plus 0.286 rs285098(C;C) 51.6% plus 0.4288 rs9556893(C;G) plus 0.4036 rs688872(C;T) 44.2% minus 0.3214 rs9584805(A;G) 46.0% plus 0.253 rs9517302(A;G) 29.2% plus rs912330(C;T) 40.7% plus 0.2837 rs2297322(C;T) 21.2% plus 0.2755 rs9513584(A;A) 60.4% plus 0.4582 rs7999348(A;A) 59.3% plus 0.4798 rs2770228(A;A) 96.5% plus rs1337791(C;C) 61.1% minus 0.2562 rs9585056(C;T) 35.4% plus 0.2466 rs9513627(A;A) 79.6% plus rs9513675(A;G) plus rs7992643(C;G) plus 0.4986 rs2184971(C;T) 51.3% minus 0.4486 rs9554711(A;G) 37.7% plus 0.3838 rs2044117(A;G) minus 0.1345 rs9557635(A;G) 47.8% plus 0.2309 rs2152324(A;A) 67.3% plus 0.1566 rs1335587(A;G) 38.9% minus rs2018836(G;G) 45.1% plus 0.3347 rs2094258(A;G) 27.4% minus 0.236 rs751402(C;C) 63.4% minus 0.2906 rs2296147(C;T) plus 0.3035 rs1047768(C;T) plus 0.4881 rs17655(C;G) minus 0.3774 rs873601(A;G) plus 0.4559 rs4771450(A;G) plus 0.3994 rs583464(A;A) minus 0.3292 rs9557704(A;T) 44.5% plus 0.3072 rs11618212(A;G) 38.9% plus 0.152 rs7331194(C;C) 9.4% plus rs3916965(A;A) minus 0.3857 rs3916967(G;G) 11.5% minus 0.3861 rs2391191(A;A) 11.8% plus 0.3861 rs3918341(G;G) 19.6% plus 0.4091 rs1935062(C;C) plus 0.382 rs7139958(A;A) 10.8% plus 0.3976 rs9558571(T;T) 9.8% plus 0.3535 rs9558575(G;G) plus 0.399 rs3916970(A;A) 14.2% minus 0.3875 rs778293(A;G) 51.3% minus 0.438 rs365990(A;G) 41.6% plus 0.36 rs452036(A;G) plus 0.3522 rs223116(G;G) 60.7% plus 0.4343 rs12436436(C;T) plus 0.1589 rs1950500(A;G) minus 0.3466 rs6576132(A;C) plus rs12431702(A;A) 33.8% plus 0.4725 rs225848(T;T) 90.8% minus 0.07025 rs1045644(G;G) 42.5% plus 0.4665 rs7142881(A;A) 32.7% plus 0.4789 rs915071(C;T) 43.4% plus 0.3972 rs17522122(G;T) 58.7% plus rs12146962(C;C) 9.1% plus 0.4252 rs17460823(A;G) plus 0.0427 rs7151302(C;T) 17.2% plus rs243286(A;G) minus 0.4518 rs12587311(C;T) plus 0.489 rs1956388(C;T) minus rs2038256(G;T) plus 0.1616 rs8004379(A;C) 15.6% plus 0.1786 rs1200332(C;C) 59.8% plus rs12586317(C;C) 0.0% plus 0.2273 rs8008319(A;A) 68.8% plus 0.1832 rs7157492(A;A) 50.0% plus 0.2117 rs4981283(G;G) 20.0% plus 0.4339 rs696(A;A) 15.9% minus rs8904(T;T) 16.1% minus 0.4233 rs2233406(C;T) minus 0.2277 rs1958581(C;C) 90.8% plus rs3138053(A;G) minus 0.2277 rs12590640(C;T) 51.8% plus 0.3655 rs2076751(G;T) minus 0.1056 rs17104630(A;G) 7.7% plus 0.09688 rs2073247(C;T) plus 0.3439 rs17176643(A;C) plus 0.3453 rs1998359(C;G) 32.7% plus 0.1749 rs1950952(C;G) plus 0.4605 rs1140952(A;G) 1.5% plus 0.4298 rs1959947(G;G) 50.4% plus 0.3893 rs1537424(A;G) 43.4% minus 0.4885 rs12883384(C;C) 38.1% plus 0.4656 rs11627056(A;G) plus rs961616(C;C) 15.0% plus 0.3604 rs7159841(T;T) 59.5% plus 0.2971 rs1160351(G;T) 35.4% minus 0.3857 rs7144383(A;A) plus 0.05234 rs4143912(C;T) 38.5% minus 0.4729 rs7151223(A;A) 11.6% plus 0.2787 rs1584157(A;A) 12.4% plus 0.2759 rs2352904(A;C) 44.6% plus 0.4936 rs1612141(C;T) minus 0.2259 rs2154294(C;T) 54.9% minus 0.3967 rs7158872(G;T) 52.3% plus 0.3838 rs2352908(G;T) plus rs8013477(C;C) 4.6% plus 0.2732 rs1265879(G;G) 68.1% plus 0.2732 rs3015469(T;T) 37.2% minus rs2073347(T;T) 59.3% plus 0.2314 rs8012283(A;G) 29.2% plus rs10145182(A;T) plus 0.2328 rs8019546(A;G) plus 0.4256 rs17252296(A;C) 39.1% plus 0.1598 rs7140150(C;T) 42.5% plus 0.4435 rs1006973(G;G) 58.0% minus 0.3352 rs3751464(C;C) 62.8% plus 0.3444 rs3783412(C;T) 51.3% minus rs8015138(A;C) plus 0.3012 rs730532(C;T) minus 0.3898 rs708486(C;T) 45.1% minus 0.2865 rs210359(C;C) 89.3% plus 0.09183 rs2855532(T;T) minus 0.4252 rs2761884(T;T) plus 0.3659 rs2143963(T;T) 100.0% plus rs4293296(A;G) plus 0.2397 rs17127713(A;G) 3.1% plus rs7142517(A;C) plus 0.208 rs17128050(C;T) plus rs12147422(C;T) plus 0.2511 rs745080(C;T) minus 0.3871 rs8008270(C;T) plus 0.1589 rs3783637(C;T) 16.8% plus 0.1795 rs8004018(A;G) 17.0% plus rs2878172(A;G) 42.5% plus 0.4118 rs17128077(C;T) 23.0% plus rs1952438(C;T) minus rs1009977(G;T) plus 0.4219 rs4644(A;C) plus 0.2925 rs4652(A;C) 46.7% plus 0.4564 rs2274273(C;T) minus 0.3274 rs8017172(A;G) plus rs945270(C;G) 49.2% minus rs405460(G;T) minus 0.4192 rs216518(A;C) plus 0.1336 rs7154773(C;C) 5.4% plus 0.3871 rs1254319(A;G) plus 0.4371 rs2093210(C;T) 50.0% plus 0.3838 rs33912345(A;C) plus 0.3852 rs10483727(C;T) plus 0.3857 rs6573333(G;G) 99.1% plus 0.1198 rs3783819(C;T) 54.0% minus rs7141238(G;T) plus rs710865(C;C) 16.1% minus 0.4334 rs9701796(C;G) plus rs11583804(A;G) plus 0.4472 rs1190739(C;C) 94.6% plus 0.1167 rs2740980(G;G) plus 0.01179 rs1059703(T;T) 72.3% minus 0.4305 rs3810651(A;A) 41.5% plus 0.4601 rs5936441(T;T) 28.6% plus 0.3996 rs422187(C;C) 17.7% plus rs9786712(G;G) 100.0% plus rs6637197(T;T) 10.9% plus rs1139916(G;G) 54.9% minus 0.312 rs10856240(C;C) 63.1% plus 0.4589 rs2734647(C;C) 72.3% plus 0.3277 rs381365(C;C) 75.4% minus 0.1941 rs2740981(A;A) plus 0.2428 [haplogroup:P] rs4828696(C;C) 55.8% plus rs2664170(A;A) 58.5% plus 0.3162 rs17435(A;A) 68.8% plus 0.4825 normal normal rs7067305(G;G) plus rs9786140(G;G) 34.5% plus rs9786706(C;C) plus rs13305774(G;G) plus 0.2874 rs1734792(C;C) Bad 74.3% plus 0.3718 1.4x increased risk for lupus 1.4x increased risk for lupus rs9786426(G;G) plus rs9785971(G;G) plus 0.2525 rs4898368(T;T) plus 0.4178 rs5987194(G;G) plus rs7892988(T;T) plus rs34173183(G;G) minus rs9785956(A;A) plus rs7067251(G;G) plus 0.009302 rs11799151(G;G) plus rs6530605(C;C) plus 0.2766 [haplogroup:P] rs11799152(A;A) plus 0.01345 rs2032624(C;C) 69.0% plus 0.2407 [haplogroup:R1] rs2032636(G;G) 100.0% plus 0.006637 rs16648(AG;AG) plus rs11799149(A;A) plus rs7067387(T;T) plus rs7892854(T;T) plus rs35285796(C;C) plus rs8085804(C;T) 35.4% plus 0.433 rs10438933(A;G) 23.0% plus 0.1024 rs10502675(C;T) 42.5% plus 0.2622 rs7242481(A;G) plus 0.3356 rs3947413(T;T) 22.1% plus 0.3994 rs4799710(A;G) 48.4% plus 0.3554 rs7231412(C;T) plus 0.2691 rs4799915(T;T) 40.7% plus 0.4008 rs12963484(T;T) 23.4% plus 0.4646 rs998124(A;G) 24.1% plus 0.1065 rs9304270(C;T) 17.7% plus rs1346987(G;T) minus 0.2769 rs8094794(C;T) 31.0% plus rs4939827(C;T) 1.0 Good plus 0.3811 0.86x decreased risk for colorectal cancer 0.86x decreased risk for colorectal cancer rs2048485(C;T) 25.7% plus 0.2006 rs10502861(T;T) 10.6% plus 0.3003 rs2162440(C;T) 28.3% minus 0.2833 rs12606301(A;G) plus 0.2332 rs8090196(C;T) 10.9% plus 0.1887 rs7235755(A;G) 28.3% plus 0.2548 rs7235528(C;T) plus 0.3471 rs11874712(A;A) 16.9% plus 0.2264 rs346221(C;T) minus rs346452(A;G) plus rs10775480(C;C) 41.7% plus rs11874392(A;T) 46.0% plus 0.4734 rs16949646(C;G) plus 0.3691 rs1450425(G;G) 56.6% minus rs75949023(A;G) plus 0.02388 rs6507931(T;T) 33.6% plus 0.4224 rs4503880(C;C) 56.2% plus 0.186 rs9947954(C;C) 15.0% plus 0.4564 rs674210(A;G) 49.6% minus 0.3191 rs7238033(C;C) 41.5% plus 0.2966 rs7227483(G;G) 51.8% plus 0.2622 rs7232775(T;T) 49.6% plus 0.2039 rs2187375(C;C) 62.9% minus rs11082671(A;G) plus 0.3916 rs2097055(C;C) 25.0% plus 0.4954 rs7236632(A;A) 70.8% plus 0.2438 rs12455557(C;T) 20.4% plus rs2576037(A;G) 42.5% minus 0.427 rs7240004(G;G) 12.5% plus 0.4522 rs1941958(A;G) 44.2% plus 0.4972 rs7229639(G;G) 83.2% plus 0.1419 rs1398217(C;G) plus 0.4151 rs6507875(C;G) plus rs6507874(C;T) plus rs645088(C;T) plus 0.3209 rs1893379(C;T) minus 0.309 rs8085824(C;T) plus rs642698(G;T) 50.9% minus 0.3118 rs357894(T;T) 42.9% plus 0.4954 rs7228085(G;G) plus 0.4178 rs9951026(A;A) 23.0% plus 0.4504 rs17750015(C;T) plus 0.2769 rs4149601(A;A) 10.6% plus 0.2925 rs12953717(C;T) 45.1% plus 0.3251 1.11x increased risk for colorectal cancer 1.11x increased risk for colorectal cancer rs674351(A;G) plus 0.3388 rs1787200(A;A) 77.9% plus 0.3485 rs555879(C;T) minus 0.4715 rs2337107(A;G) 46.9% minus 0.4995 rs7240405(G;G) 65.5% plus 0.129 rs1036935(G;G) minus 0.1896 rs585344(C;T) minus 0.3186 rs8094493(G;T) plus 0.4275 rs1970671(C;G) 41.5% minus 0.3122 rs9951150(A;G) 42.5% plus 0.4798 rs884205(G;G) 51.3% minus 0.1882 rs2270954(C;C) 77.9% plus 0.1671 rs4940203(C;T) 58.5% plus rs584087(A;G) 48.7% minus 0.3186 rs4041245(C;T) plus 0.427 rs12604483(A;T) 46.2% plus 0.4692 rs654136(A;G) minus 0.4871 rs768048(C;T) 28.0% plus 0.1919 rs1351435(G;G) 98.5% plus rs12606138(A;G) 38.1% plus 0.1736 rs3865418(C;T) plus 0.4747 1.3x increased risk for hypertension 1.3x increased risk for hypertension rs2229080(G;G) 16.9% plus 0.4568 rs603097(T;T) 67.3% minus rs12454023(C;T) 41.4% plus 0.4853 rs2331841(A;G) plus 0.3912 rs549476(G;G) 22.1% plus 0.3613 rs1452787(A;G) 39.1% plus 0.2796 rs1805034(T;T) 23.2% plus 0.3953 rs1344011(C;T) 40.9% plus rs2032366(A;G) 43.4% minus 0.3797 rs62094879(C;T) plus 0.09826 rs8094327(A;G) 40.7% plus 0.1524 rs7614(C;T) minus 0.3572 rs1978503(A;G) 30.1% plus 0.169 rs488846(C;C) 6.2% plus 0.186 rs956572(G;G) 31.0% plus 0.377 rs2288774(C;C) 19.5% plus 0.4784 rs602422(C;C) 5.3% minus rs2958182(A;T) 40.7% plus 0.2447 rs12454712(C;T) plus 0.3701 rs949037(C;T) minus 0.382 rs1462129(C;T) plus 0.4463 rs2874116(A;A) 21.5% plus 0.3384 rs2288775(A;G) 25.7% plus 0.2879 rs7238078(G;T) plus 0.2259 rs4553720(C;T) plus 0.3572 rs7243091(A;A) 9.7% plus 0.1901 rs4368253(C;T) plus 0.3264 rs2957128(A;G) 54.0% plus 0.4848 rs591166(A;T) minus rs8099014(A;A) 55.8% plus 0.3457 rs12956925(A;G) plus 0.1322 rs12955474(C;T) plus rs4257308(C;T) plus 0.2195 rs2957137(T;T) 40.7% plus 0.4316 rs12964056(A;G) plus 0.4013 rs7226991(A;G) plus 0.2493 rs6567355(A;A) 43.5% plus rs2289519(C;C) plus rs694419(C;C) 26.2% plus 0.3586 rs8089104(T;T) 27.7% plus 0.4899 rs8083511(A;C) 25.7% plus 0.3434 rs899967(C;G) 43.1% plus 0.399 rs3018362(G;G) 36.6% plus 0.416 rs1943199(C;C) 95.6% minus rs8099213(C;T) 43.2% plus 0.494 rs7239261(A;C) 59.3% plus rs2279115(A;C) minus 0.4458 rs7236090(C;C) 26.5% plus 0.3774 rs605920(C;C) 40.0% minus 0.3802 rs1720843(C;G) 20.6% plus 0.2617 rs1559806(C;T) minus 0.4867 rs17086172(C;T) plus 0.073 rs3744941(C;C) 49.6% plus 0.32 rs337718(C;C) 53.1% plus 0.3352 rs9945924(A;G) plus 0.2663 rs470490(G;T) 44.2% plus 0.3196 rs637644(C;T) 45.1% minus rs9966483(A;A) plus 0.2227 rs2032224(A;A) 52.2% plus rs1539893(T;T) 72.6% minus rs10513968(A;G) 52.2% plus rs2660917(C;T) plus 0.2126 rs6103(C;G) 33.6% plus 0.3301 rs9961113(C;T) plus 0.3774 rs8083346(G;T) plus 0.2773 rs11663206(C;C) 72.3% plus 0.2397 rs2469434(G;G) minus 0.4128 rs1704734(T;T) 71.9% plus 0.2185 rs9951602(C;T) 19.5% plus 0.2117 rs12982744(C;G) 53.8% plus 0.2585 rs9945428(A;C) plus 0.4155 rs1550650(G;G) 46.9% plus 0.3912 rs13353224(A;G) 10.8% plus 0.06841 rs2278331(C;C) 8.9% minus 0.3811 rs2156107(T;T) 90.2% plus rs4892247(T;T) plus 0.2957 rs12326088(G;T) plus rs9951925(A;C) plus 0.4688 rs123698(C;C) 30.2% plus 0.2938 rs5376(A;A) minus rs2217560(A;A) 78.8% plus 0.2296 rs1539909(G;G) 80.5% minus 0.135 rs470131(A;C) 21.2% plus rs34794968(A;A) plus 0.3237 rs1640262(C;T) plus 0.4527 rs9947276(T;T) 48.2% plus rs1943940(G;G) 14.2% minus rs1015820(A;G) plus rs6566810(T;T) plus 0.2048 rs12971120(A;G) 29.5% plus 0.2043 rs9951586(T;T) 65.5% plus rs757229(C;C) plus 0.449 rs1812680(A;G) 40.7% minus rs11085226(G;G) 0.0% plus 0.07392 rs2302217(A;G) plus 0.3838 rs1017745(T;T) 28.6% plus 0.3939 rs4890912(A;G) plus rs5374(C;C) 45.5% plus rs12604675(G;G) 56.9% plus 0.2925 rs7241993(T;T) 9.2% plus 0.3843 rs3787016(C;T) 32.7% minus 0.27 rs12978500(A;C) plus 0.2957 rs11666067(A;C) plus 0.4495 rs879564(C;T) 48.7% minus rs4891159(A;G) plus 0.3696 rs2002842(A;C) plus 0.4858 rs3746162(A;A) 6.7% minus rs351974(C;C) 8.0% plus 0.3393 rs4919908(T;T) 25.7% plus 0.4284 rs10419707(T;T) 80.5% plus rs4147929(G;G) plus rs4919910(C;T) 44.2% plus 0.4307 rs6510827(C;T) plus 0.3407 rs344555(A;G) minus 0.2365 rs17764205(G;T) plus 0.2961 rs11673509(C;T) 15.2% plus rs12610495(A;G) 43.4% plus 0.2057 rs6510683(A;C) 18.6% plus rs2074451(G;G) 23.0% plus rs2269879(C;C) 84.1% plus 0.197 rs1142530(C;T) 52.7% plus 0.444 rs757228(G;G) 19.8% plus 0.4467 rs2306969(A;G) 43.4% plus rs2523178(G;G) 45.1% plus 0.3242 rs7258846(G;T) plus 0.4449 rs3745571(G;G) 46.0% minus 0.4881 rs3745568(A;C) minus 0.06703 rs2617822(A;A) 75.2% plus 0.2466 rs163913(C;T) 38.1% plus 0.2328 rs2967605(A;G) 29.2% minus 0.3085 rs12459350(A;G) 57.5% plus rs263063(C;T) plus rs428253(G;G) 7.7% minus 0.3035 rs11669592(A;G) 45.1% plus 0.4444 rs2059807(A;G) minus 0.449 rs1044250(C;T) 51.3% plus 0.2544 rs4804416(G;T) plus 0.365 rs4523(C;C) 93.5% minus 0.45 rs1143699(C;T) minus 0.0932 rs17271883(C;T) 44.2% plus 0.4807 rs1978237(G;G) 44.6% plus 0.2631 rs4807015(C;T) plus 0.4091 rs8111933(C;C) 32.3% plus 0.359 rs7255436(A;C) plus 0.4633 rs4072910(C;G) plus 0.3724 rs186715(G;T) minus 0.4949 rs2546133(C;C) 90.2% plus 0.04086 rs480208(A;G) plus 0.4206 rs10500204(A;C) 45.1% plus 0.2314 rs2252673(C;C) 67.7% minus 0.3719 rs7248637(G;G) 77.9% plus 0.214 rs11569536(C;T) minus rs2287886(A;G) 43.4% plus 0.4197 rs1035942(C;T) 42.2% minus 0.2567 rs1559168(A;A) 76.9% minus 0.1019 rs8112555(G;G) plus 0.2732 rs1423096(A;G) minus 0.1074 rs735240(A;G) plus rs2164983(A;A) 3.2% plus 0.186 rs339392(G;T) 35.4% plus 0.236 rs2115386(A;G) 53.8% minus 0.4963 rs4804800(A;A) 72.6% plus 0.2071 rs2278236(C;T) minus 0.4096 rs11465413(A;T) 14.2% minus 0.1694 rs2233678(C;G) plus 0.1226 rs2233679(C;T) 43.4% plus 0.4578 rs7248104(A;G) plus rs12984523(C;T) plus 0.4564 rs12151144(A;C) 18.8% plus 0.1873 rs10414255(C;C) 8.8% plus 0.4036 rs3745369(C;G) plus 0.4109 rs8012(A;G) plus rs759920(A;G) 44.2% plus 0.4582 rs11668477(A;G) 29.5% plus 0.2966 rs1808536(G;G) 62.5% plus 0.3301 rs2569512(A;G) minus 0.2801 rs2569507(C;T) minus rs1133330(A;A) 12.5% minus 0.258 rs2288349(A;G) plus 0.2989 rs7249094(A;A) 11.5% plus 0.4353 rs2240927(C;T) 40.7% plus 0.4986 rs2233789(C;T) plus 0.3058 rs1551570(C;T) 45.1% plus rs8101866(C;T) 44.6% plus 0.466 rs8101626(A;G) plus 0.3062 rs2547065(C;G) 44.6% minus 0.376 rs7255721(C;C) 57.1% plus 0.1478 rs2121133(A;G) 53.8% plus 0.2241 rs11668618(C;T) 31.9% plus 0.1235 rs10417578(C;T) plus rs8112063(T;T) 33.6% plus 0.4807 rs12984471(C;G) plus 0.208 rs2189784(A;G) plus 0.3526 rs281439(C;G) plus 0.3352 rs2304240(A;G) 31.0% plus 0.1616 rs1529729(C;T) minus 0.3866 rs2288904(A;G) minus 0.213 rs892085(C;T) minus rs2228671(C;T) 15.9% plus 0.05739 rs2738450(A;C) plus 0.332 rs3826784(A;G) 44.2% plus rs2228611(A;G) minus 0.4628 rs2162560(A;G) plus rs7255045(A;G) plus 0.4132 rs7254215(A;A) 68.1% plus 0.2443 rs55791371(A;C) plus 0.07943 rs1054487(T;T) 14.2% minus 0.3219 rs4804611(A;G) 36.3% plus 0.2181 rs1122608(G;T) 35.4% plus 0.1391 rs11085735(C;C) 83.0% plus 0.06841 rs7247513(T;T) 49.6% plus 0.4578 rs3093158(A;A) minus 0.4123 rs1003723(C;T) 53.7% plus 0.2819 rs1433099(G;G) 48.7% minus 0.3416 rs5930(A;G) 48.2% plus rs5927(G;G) 52.2% plus rs3962158(C;T) minus 0.2828 rs8110862(A;C) plus 0.3237 rs3745453(C;T) 43.2% minus 0.3242 rs1044009(T;T) 58.4% minus rs2074902(C;T) plus 0.1226 rs895819(C;T) plus 0.3572 rs1558139(A;G) plus 0.4293 rs2108622(C;T) 32.1% plus 0.2153 None rs8108738(A;A) 25.0% plus 0.4904 rs14158(A;G) plus 0.2489 rs1054486(C;G) minus 0.2305 rs6523(A;G) minus 0.3118 rs12327666(A;G) plus 0.06657 rs4804146(C;T) 26.5% plus rs1290617(G;G) 16.1% plus 0.3581 rs7248363(C;C) 61.1% plus 0.2984 rs875622(C;C) 59.3% minus 0.3278 rs773902(A;G) plus rs3093135(A;T) 22.1% minus 0.1226 rs1273516(A;G) plus 0.3834 rs10427027(C;T) plus 0.1896 rs741702(C;C) 41.6% plus 0.2966 rs2683037(A;A) 8.0% plus 0.2025 rs3794987(C;C) 32.7% minus 0.3843 rs10404998(C;T) plus 0.4256 rs7260598(A;G) 24.8% plus 0.1483 rs412658(C;T) 48.2% minus 0.4146 rs1272(G;G) 61.8% minus 0.1713 rs10421916(A;G) 44.6% plus 0.3159 rs265548(C;T) plus 0.4784 rs12327843(C;T) plus rs1060463(A;G) 41.6% minus 0.494 rs11666579(G;T) 46.4% plus 0.4298 rs10416963(A;G) plus rs2363956(G;T) plus 0.4504 rs2303745(A;A) 73.2% minus 0.275 rs7250346(C;G) 29.7% plus rs3093105(G;T) minus 0.1566 rs10411936(G;G) 52.2% plus 0.3958 rs33428(A;G) 36.3% plus 0.3701 rs8105767(G;G) 5.4% plus rs12609479(A;A) plus rs10414410(A;C) plus rs8100241(A;G) plus 0.4339 rs438421(A;G) 27.7% plus 0.2971 rs8108174(A;T) plus 0.4633 rs11670734(C;G) 43.4% plus 0.3499 rs2011503(C;C) 69.9% plus rs4808709(A;G) 30.1% plus rs11668609(C;G) plus 0.3274 rs2905424(C;C) 42.5% plus rs2279008(A;G) minus 0.2617 rs4808260(C;G) 33.9% plus 0.3168 rs888663(G;T) 27.4% plus 0.1511 rs8111948(A;G) 51.3% plus rs4808870(C;C) 83.1% plus 0.1065 rs7249142(A;G) 42.5% plus 0.314 rs8102137(C;T) plus 0.1736 rs4808793(C;G) plus 0.2957 rs1059369(A;T) minus 0.286 rs931608(A;C) 24.6% plus 0.1272 rs1227732(G;T) plus 0.163 rs36686(A;G) plus 0.2534 rs1975174(A;C) 56.2% minus 0.3903 rs1406(G;T) minus rs8102476(T;T) 24.8% plus 0.4591 rs736289(C;C) 6.2% plus 0.4614 rs10425935(A;G) 18.6% plus rs8101143(A;A) 51.3% plus 0.1846 rs1865075(A;G) minus 0.4362 rs259251(C;T) minus 0.4086 rs8113142(C;T) plus 0.2681 rs4141232(C;T) plus 0.1501 rs997669(A;G) minus 0.2218 ? ? rs72010703(-;AGTT) plus rs8102754(A;T) plus rs995834(A;A) 52.2% plus 0.455 rs731839(C;T) minus 0.4091 rs10416218(C;T) plus 0.4325 rs398426(A;C) 41.1% minus 0.2075 rs6509942(T;T) plus rs7245959(C;T) plus rs8101881(C;T) 51.3% plus 0.4711 rs1078373(A;G) plus 0.3026 rs10416265(A;G) 33.6% plus rs33436(C;T) 46.0% minus 0.4624 rs3218036(A;G) plus 0.174 rs10403021(C;T) 43.4% plus 0.3356 rs10410544(C;C) 33.6% plus 0.2392 rs231591(C;C) 26.6% minus 0.4362 rs12460876(C;T) plus 0.4509 rs8106493(C;T) 33.9% plus 0.1644 rs973009(A;A) 77.0% plus 0.09458 rs4805834(C;C) 75.4% plus 0.08264 rs10411210(C;T) 16.8% plus 0.213 rs73039434(G;T) plus 0.1419 rs11673011(A;G) plus 0.2686 rs3786897(A;G) 49.6% plus 0.4458 rs11084753(A;G) 44.2% plus 0.4096 rs8182584(G;T) plus 0.4766 rs11666638(A;G) plus 0.2704 rs889140(C;T) minus rs4805885(C;T) plus 0.4775 rs10413500(C;G) 26.2% plus 0.1419 rs3136641(T;T) 6.2% plus 0.2544 rs8100085(A;T) plus 0.3751 rs13343954(C;T) plus rs4803480(G;G) 60.7% plus 0.152 rs12611334(C;G) 44.2% plus 0.2378 rs10407640(A;A) 63.7% plus 0.348 rs2233152(A;G) plus 0.1074 rs2546057(G;T) 46.9% minus 0.3489 rs890934(G;T) 42.5% plus 0.3503 rs4803219(T;T) plus rs2317314(T;T) 35.1% plus 0.4233 rs720308(A;G) 31.9% plus 0.1474 rs955155(T;T) 7.7% minus 0.1745 rs166988(T;T) minus 0.4008 rs29941(C;T) 38.7% minus 0.3972 rs2109075(C;T) 56.2% plus 0.4665 rs8105790(C;C) 6.6% plus 0.1731 rs4803217(A;A) plus rs10404257(A;G) plus 0.461 rs3733829(C;T) 45.1% minus 0.3026 rs4806073(C;T) plus 0.163 rs7248668(A;A) 0.0% plus 0.1382 rs12979618(T;T) plus rs2290692(G;G) 25.4% minus 0.4458 rs9676717(C;C) 18.6% plus 0.3792 rs7246657(C;T) plus 0.3067 rs1110627(G;G) 28.3% minus 0.4063 rs11881222(G;G) 13.8% plus 0.2576 rs12980602(C;C) 8.8% plus 0.2319 rs12980275(G;G) 8.8% plus 0.314 rs28416813(G;G) plus 0.3301 rs4803221(G;G) plus rs7260329(A;G) plus 0.3113 rs11083475(A;G) plus 0.3747 rs3810153(A;G) 49.6% plus rs405509(G;T) minus 0.4931 rs8107107(T;T) 80.5% plus rs10403955(G;T) plus 0.2778 rs7257602(G;G) 19.5% plus 0.4247 rs7251246(T;T) 23.0% plus 0.4454 rs8103033(A;G) plus 0.2893 rs2279344(A;A) 35.4% plus 0.2792 rs2279345(C;C) 35.4% plus 0.2998 rs2604894(C;T) minus 0.4068 rs7937(C;T) 52.2% plus 0.4816 rs969531(G;G) 46.0% minus 0.2608 rs3745274(G;T) 39.8% plus 0.2677 rs8192719(C;T) 41.6% plus 0.2727 rs8102683(C;T) plus 0.2167 rs8109525(A;G) 43.1% plus 0.326 rs4802101(C;C) plus 0.2966 rs28399433(G;T) 1.0 minus 0.1336 Reduced CYP2A6 metabolism; impaired nicotine metabolism? Reduced CYP2A6 metabolism; impaired nicotine metabolism? rs2061332(A;C) 29.2% plus 0.4118 rs8099939(G;T) plus 0.416 rs887391(T;T) 57.5% plus 0.348 rs1428922(A;G) plus rs4803419(C;T) plus 0.3081 rs2607420(T;T) 50.0% minus 0.2365 rs4105144(C;T) plus rs344781(T;T) 66.4% plus 0.2511 rs1709084(A;G) 15.9% plus 0.1162 rs1990932(A;G) 47.8% plus 0.4366 rs3760982(A;G) 56.6% plus 0.3618 rs741780(A;G) minus rs2279343(A;G) plus rs10119(C;T) minus rs3213245(T;T) minus 0.3085 rs644148(G;T) plus 0.2521 rs4459653(C;T) 30.1% plus 0.2902 rs3746319(C;T) 28.3% minus 0.3664 rs17318596(A;A) 8.9% plus 0.3898 rs2278422(C;G) minus 0.4463 rs440446(C;G) Bad plus 0.3838 increased risk in men for biliary conditions increased risk in men for biliary conditions rs2061333(C;T) 28.3% plus 0.3448 rs238406(G;T) plus 0.377 rs35136575(C;G) plus 0.1699 rs12611088(A;G) plus rs8100239(A;T) plus 0.3944 rs1160985(C;T) 46.0% plus 0.4568 rs4251805(A;G) minus 0.03214 rs25486(A;G) 50.4% minus 0.2805 rs3213255(T;T) 37.2% minus 0.3113 rs2282695(C;G) 42.9% plus 0.365 rs238415(C;G) 51.9% minus 0.3476 rs4802207(C;T) 31.2% plus 0.4284 rs7255066(C;T) plus 0.4614 rs238405(A;T) 61.9% plus 0.3792 rs4802234(G;T) 43.4% plus 0.4307 rs2965169(G;T) 49.6% minus 0.494 rs8101149(A;G) plus 0.4178 rs2927438(G;G) 58.0% plus rs3810291(A;G) plus 0.4045 rs8106922(A;G) 45.1% plus rs439401(C;T) plus 0.3944 rs17356664(C;T) 42.5% plus 0.1901 rs1871045(C;T) 43.4% plus 0.3949 rs50872(A;G) minus 0.208 rs50871(A;C) minus 0.3315 rs6859(G;G) 31.0% plus 0.3898 rs157580(A;G) plus 0.371 rs4803770(C;G) 39.3% plus 0.287 rs238416(A;G) minus 0.3278 rs2395(A;G) 49.2% plus 0.41 rs1799787(A;G) minus 0.1823 rs3810366(C;G) plus rs238403(C;T) plus 0.3747 rs2159324(C;T) plus 0.3315 rs1366444(C;C) 57.1% minus 0.3104 rs8111589(T;T) 26.5% plus 0.4862 rs3786749(C;C) plus rs838145(T;T) 23.1% minus 0.1965 rs1049739(A;G) 44.2% plus rs10423928(A;T) plus 0.1928 rs1126510(C;T) 42.5% minus 0.2415 rs3810294(C;T) 23.1% plus 0.1226 rs307896(C;T) minus 0.123 rs296381(A;A) 63.7% minus rs1800437(C;G) Bad plus 0.1818 0.72x risk for heart disease 0.72x risk for heart disease rs20580(A;A) 23.9% minus rs156641(T;T) minus 0.3609 rs281408(A;C) plus rs11453459(-;G) plus 0.1731 rs10500298(C;C) 12.3% plus 0.3646 rs11671664(A;G) plus 0.1887 rs2032809(A;G) minus 0.3402 rs2287019(C;T) 28.2% plus 0.1703 rs8108269(G;G) 5.4% plus rs8102595(A;A) 85.0% plus rs3745760(G;G) 7.1% minus 0.3448 rs1035938(T;T) 8.2% plus 0.3196 rs3936340(A;A) 81.4% minus 0.07668 rs1052667(C;T) 44.4% plus rs7251(C;G) 50.8% minus 0.444 rs4645878(A;G) 21.2% plus 0.09275 rs7254232(G;G) 9.8% plus rs156640(G;G) 16.9% minus 0.4366 rs182420(T;T) minus 0.1598 rs296396(G;G) 70.3% minus rs7248320(A;A) 38.9% plus rs8100261(C;C) 25.0% plus 0.2782 rs753307(C;T) 51.3% plus 0.4362 rs2043211(A;T) 40.7% plus 0.331 rs266882(A;A) plus 0.3967 rs8103851(G;G) 13.4% plus rs1058205(T;T) 73.5% plus 0.3237 rs3730862(C;T) minus rs3730859(C;T) minus 0.3701 rs6509365(A;G) 41.6% plus 0.3659 rs1654431(A;A) 18.6% plus 0.4931 rs1043558(A;A) 54.0% minus 0.3177 rs1009316(C;T) plus 0.1644 rs281380(C;T) plus 0.4798 rs3745706(A;G) minus 0.3595 rs8111500(A;A) 15.2% plus rs281377(C;T) 45.1% plus 0.461 rs524(A;G) 34.9% minus 0.3375 rs2695121(C;C) plus 0.2539 rs266849(A;A) 70.8% plus 0.2337 rs1701930(A;G) 54.9% plus 0.4826 rs1800447(C;T) 13.8% minus 0.06152 rs838147(C;C) 24.8% minus 0.2713 rs838143(C;T) minus rs2303759(G;T) plus 0.27 rs952108(C;T) minus 0.4821 rs2230267(C;C) plus rs3764618(A;G) plus rs631717(A;A) 19.6% plus rs11880923(C;T) plus rs10424878(A;G) 47.8% plus 0.3526 rs3746722(A;G) plus 0.2089 rs2664156(C;C) 66.1% plus rs3865444(G;T) minus 0.2378 rs2230245(C;T) plus 0.06244 rs3865443(A;A) minus 0.3526 rs11669977(A;G) 32.1% plus 0.1708 rs12104272(A;G) plus 0.432 rs12976445(C;C) plus 0.4334 rs56151148(C;T) plus 0.03673 rs2739476(A;G) 38.5% plus 0.405 rs12459419(C;T) plus 0.2383 rs8102150(C;G) 3.5% plus rs2304204(A;G) minus 0.3779 rs198978(G;T) plus rs2304206(C;T) minus rs2248949(C;C) 29.4% minus rs1405655(C;T) plus 0.3517 rs1298062(A;G) 39.8% plus rs3826656(A;A) 67.3% plus 0.3361 rs56225452(T;T) plus 0.1621 rs1671153(T;T) 65.5% plus 0.2383 rs1042229(G;T) 53.1% minus 0.4022 rs1354774(C;T) 50.4% minus 0.4481 rs2455069(A;G) 46.0% plus 0.3489 rs454006(C;C) 2.7% plus rs35112940(A;G) plus 0.1038 rs198977(C;T) 41.6% plus 0.2893 rs36498(C;T) 18.6% plus 0.2654 rs10404486(T;T) 3.6% plus 0.1694 rs6509701(C;T) 36.6% plus 0.4348 rs254262(G;G) minus 0.2847 rs269949(A;G) plus 0.4252 rs3760738(A;G) 47.8% plus 0.3209 rs2965260(G;G) 80.5% minus 0.1534 rs1130426(T;T) 36.3% minus 0.4633 rs11084337(T;T) 38.1% plus 0.4821 rs7595(T;T) 70.8% plus 0.2622 rs192808(A;G) minus 0.1938 rs2304167(T;T) 65.5% plus 0.2383 rs1654410(C;T) 51.3% plus 0.4995 rs103294(C;T) 27.4% plus 0.3012 rs4806660(C;T) plus 0.2961 rs16986856(A;C) plus rs7246479(G;T) plus 0.4679 rs11668344(A;G) 40.0% plus 0.286 rs1061684(C;T) plus rs2866112(C;G) plus rs386000(C;G) minus 0.3792 rs1654416(T;T) 66.4% plus 0.2181 rs12610286(G;G) 4.4% plus 0.3627 rs6509940(C;T) 56.2% plus rs16985478(A;G) plus rs1654419(G;G) 65.2% plus 0.2277 rs1172822(C;T) 46.0% plus 0.2691 rs1048055(G;T) 37.1% minus 0.2704 rs6084946(C;G) plus 0.2906 rs4756(G;G) 4.6% minus 0.3352 rs2281808(C;T) plus 0.2567 rs910080(A;G) 38.2% plus 0.4669 rs970084(A;G) plus rs299175(C;T) minus 0.4137 rs310460(A;A) minus rs12461110(A;G) plus 0.2429 rs306450(C;C) 11.5% minus 0.45 rs2236554(A;T) plus 0.2943 rs1029273(T;T) 36.9% plus 0.4279 rs586446(T;T) 77.9% plus 0.07438 rs214782(A;A) 71.9% plus 0.2332 rs6112821(C;C) 93.8% plus rs6054706(C;T) 56.8% plus 0.472 rs13036722(C;T) plus rs6051520(G;G) 5.3% plus 0.3563 rs2235749(A;G) plus 0.4784 rs44707(A;C) minus 0.4242 rs2756271(C;C) 36.3% minus 0.4123 rs11672517(A;G) plus 0.2553 rs397020(C;C) minus 0.4711 rs2144151(G;T) plus 0.4343 rs13042885(C;T) 37.2% plus 0.4224 rs6136489(G;T) plus 0.4509 rs3197744(G;T) 38.5% plus 0.4275 rs893184(G;G) 89.1% minus 0.1377 rs1533087(A;G) minus 0.4927 rs13042395(C;T) 11.5% plus 0.1249 rs910079(A;G) 36.3% plus 0.4789 rs6045784(C;T) plus 0.09504 rs156339(C;T) minus rs13043330(C;C) 31.9% plus 0.3981 rs597980(C;T) minus 0.3802 rs3761243(A;C) 38.5% plus 0.3494 rs2282018(T;T) 36.3% plus rs1997794(C;T) plus 0.4109 rs1810636(G;T) 50.4% minus 0.3802 rs6133175(G;G) 8.8% plus 0.3724 rs6042507(G;T) plus 0.06887 rs4987219(C;G) 44.6% minus 0.4573 rs961253(A;C) plus 0.2874 rs3761218(T;T) 29.2% plus 0.337 normal normal rs1799990(G;G) 13.3% plus 0.2631 normal normal confers susceptibility for the development of sporadic CJD rs2787093(C;T) 19.4% plus rs6107516(A;A) 8.8% plus 0.1869 rs512625(A;G) 39.8% plus 0.2686 rs2326373(G;G) 74.3% plus rs6049839(G;T) 57.5% plus 0.3476 rs6116569(C;T) plus 0.4431 rs238295(A;G) minus 0.3388 rs1110277(A;G) 45.5% plus 0.4027 rs2740210(T;T) 8.0% minus rs6085533(A;T) plus rs6076960(C;C) 23.0% plus rs6085920(A;T) plus 0.2181 rs6056209(A;A) 24.3% plus 0.4206 rs1741344(T;T) 40.7% plus 0.3053 rs2740204(A;A) 10.6% minus 0.3531 rs2326679(T;T) 52.2% plus 0.1924 rs1556832(C;T) 54.0% plus 0.3609 rs2787094(C;G) plus 0.3081 rs628977(C;T) plus 0.3365 rs755662(A;T) 38.5% plus rs2145272(A;G) plus 0.292 rs6052699(A;G) plus 0.404 rs1715364(C;C) 18.6% plus 0.3999 rs235753(T;T) 11.5% minus 0.4692 rs159788(A;G) 18.8% plus 0.1754 rs25406(C;T) minus 0.3935 rs6053283(A;A) 6.3% plus 0.1731 rs8636(C;T) plus 0.2704 rs4813802(G;T) plus 0.2548 rs6104690(A;G) plus rs7271920(C;T) 20.4% plus rs2072910(C;T) plus 0.2677 rs236114(G;G) 61.1% minus 0.1079 rs1884302(C;T) plus 0.4302 rs3787283(C;T) 46.0% minus 0.3875 rs6056891(A;A) 54.9% plus 0.2622 rs967417(C;T) minus 0.4949 rs355527(A;G) minus 0.214 rs6108461(A;G) 47.7% plus 0.4541 rs6054906(A;A) 24.8% plus 0.4435 rs6054512(C;T) 40.2% plus 0.2755 rs235770(C;T) plus 0.2759 rs2145270(C;T) 48.7% plus 0.3343 rs235768(A;T) 27.7% plus rs363039(C;T) minus 0.4467 rs6060373(A;G) 42.5% plus 0.4298 rs235754(C;C) minus 0.4233 rs6087099(G;G) 80.5% plus 0.1253 rs2180566(C;T) 53.2% plus 0.4146 rs362584(A;G) plus 0.2314 rs1327235(A;G) 49.6% plus 0.4679 rs362988(A;G) plus 0.4601 rs6039763(A;G) 42.7% plus 0.4022 rs6077414(C;C) 76.9% plus 0.04913 rs6049375(C;T) 7.1% plus 0.1983 rs2273061(A;G) plus 0.4835 rs364585(G;G) 29.2% plus rs6040399(T;T) 53.6% plus 0.3783 rs1040923(G;T) 42.0% plus rs1884136(A;C) 19.5% minus 0.123 rs3746544(A;C) 46.0% minus 0.2934 rs3790160(C;T) plus 0.4123 rs362990(A;T) 38.1% plus 0.1928 rs1413020(G;G) 0.0% plus 0.09917 rs680379(G;G) 30.4% plus 0.3329 rs6124509(A;G) 44.6% plus 0.2323 rs6042314(C;C) 65.1% plus 0.2135 rs4814176(C;C) 29.7% plus rs362614(C;C) 58.4% minus 0.2764 rs199307(A;G) plus 0.2805 rs1998076(G;G) 33.9% plus 0.3806 rs6080699(C;G) plus 0.2493 rs2424234(C;T) plus 0.0551 rs6075982(C;T) 34.5% plus 0.3159 rs168622(G;G) 31.9% plus 0.3306 rs4815191(C;C) 46.9% plus 0.2075 rs6046396(A;A) 49.6% plus 0.3274 rs2208059(C;T) plus 0.2222 rs6040449(A;A) 39.8% plus rs4814920(T;T) 69.8% plus rs6110278(T;T) 8.0% plus 0.3237 rs6081541(A;G) 39.3% plus rs6079395(A;G) plus 0.404 rs6080100(C;T) plus 0.2268 rs2749812(G;G) 63.7% plus 0.1529 rs6048205(A;G) 8.8% plus 0.123 rs742614(A;G) 44.2% plus 0.4334 rs6059244(A;G) 53.2% plus 0.376 rs6047116(A;G) 43.4% plus rs12480819(G;G) 6.2% plus 0.3655 rs6059101(C;T) 32.7% plus rs6058017(A;G) plus 0.2893 rs911119(T;T) 51.7% plus 0.2383 rs2424577(A;A) 41.6% plus 0.4444 rs6137726(A;C) plus rs2567608(A;G) minus 0.4908 rs158676(A;G) plus 0.3361 rs844917(C;C) 70.8% plus rs1158167(A;A) 59.8% plus 0.2548 rs2424460(C;T) plus rs4811196(A;A) 56.6% plus 0.1795 rs6029526(A;A) 20.0% plus 0.3733 rs2749817(C;C) 39.3% plus rs6088813(A;C) plus 0.4073 rs2281558(T;T) 7.1% plus rs406193(C;C) 76.9% plus 0.06795 rs819146(G;T) 19.5% plus 0.287 rs6138150(C;T) plus 0.2172 rs291700(C;T) plus 0.4155 rs6138482(C;T) 33.6% plus 0.2645 rs1044573(G;G) 27.9% plus 0.4247 rs2251252(A;G) plus rs736824(A;G) minus rs867186(A;G) 17.7% plus 0.08402 EPCR H3 haplotype; reduced or increased risk of VTE? EPCR H3 haplotype; reduced or increased risk of VTE? rs819134(A;G) plus 0.2686 rs6088765(G;G) 15.0% plus 0.4908 rs2284378(C;C) 47.8% plus 0.225 rs1291142(A;G) 49.6% plus 0.4922 rs9574(G;G) 34.9% plus 0.449 normal risk for VTE normal risk for VTE rs819171(C;T) plus 0.2608 rs143384(C;T) 46.9% minus 0.4862 rs2889849(C;C) 74.3% plus 0.1405 rs2295888(A;G) 16.9% plus 0.129 rs224333(A;G) plus 0.4633 rs819147(C;T) 19.5% plus 0.2865 rs6072081(A;G) 50.4% plus 0.4449 rs7265992(A;G) plus rs926391(C;T) 53.1% minus 0.433 rs2425637(G;T) 53.1% plus 0.4242 rs6060278(C;T) plus 0.2163 rs6017996(A;G) plus 0.2144 rs2069952(T;T) 34.9% plus rs8115854(A;G) 40.7% plus 0.3095 rs2235611(G;G) 80.5% minus 0.1455 rs3212183(C;T) 53.1% plus 0.3223 rs6017342(A;C) 52.2% plus 0.2906 rs4812712(A;C) plus rs460869(A;G) plus 0.393 rs452159(A;C) 44.6% minus rs244072(A;G) minus 0.163 rs1008953(G;G) 62.5% minus 0.2677 rs5629(A;C) 29.2% minus 0.2222 rs11696845(C;T) 52.7% plus 0.3131 rs244076(A;G) minus 0.2213 rs6103489(T;T) plus 0.45 rs2076546(C;T) 15.9% minus 0.1226 rs20544(T;T) plus 0.2805 rs745975(A;G) 38.1% minus 0.1896 rs11594(A;C) plus 0.1024 rs2227290(A;C) 43.4% minus 0.3099 rs383112(C;T) plus 0.4017 rs6064045(C;T) 45.1% plus 0.3861 rs2903908(C;T) plus 0.2668 rs1569723(A;A) 55.8% plus 0.2443 rs237484(A;G) minus 0.4105 rs446112(A;G) 44.6% plus 0.3939 rs4239702(C;C) 50.9% plus rs11699311(A;T) plus 0.02525 rs4810479(T;T) 57.5% plus 0.4229 rs4629(G;T) minus 0.4513 rs6124715(C;G) 46.9% plus 0.326 rs913678(C;T) plus 0.3724 rs4810485(G;G) 54.1% plus 0.2521 rs878131(C;T) 41.6% minus 0.275 rs1883832(C;C) 54.9% plus 0.2429 rs6066084(A;G) plus 0.3797 rs7274072(A;G) plus 0.2346 rs6123045(T;T) 10.7% plus 0.2736 rs237450(C;T) minus 0.146 rs6017787(G;T) plus 0.3875 rs4810685(C;T) plus 0.3678 rs6012564(A;G) Bad plus increased proneness to anger increased proneness to anger rs11086243(T;T) 15.4% plus 0.3733 rs2248359(C;T) 48.7% plus 0.4389 rs1042523(A;G) 48.7% plus 0.3214 rs230014(A;G) minus 0.4674 rs6020611(G;G) 46.2% plus 0.3554 rs4811117(G;T) plus 0.1428 rs1060402(A;G) plus 0.4908 rs13041126(C;C) 8.0% plus 0.275 rs927650(C;T) plus 0.3673 rs6013509(A;G) plus 0.3196 rs2041278(G;G) 53.1% plus 0.4247 rs59972978(A;T) plus 0.2149 rs6127698(G;T) 43.4% plus 0.4421 rs4811340(C;C) 11.5% plus rs2296241(A;A) 25.7% plus 0.472 rs4925189(A;G) plus 0.2052 rs4925295(A;A) 74.1% plus 0.1084 rs6070346(C;T) plus 0.2185 rs6064389(T;T) 20.4% plus 0.478 rs6068020(C;T) plus 0.4192 rs6091737(C;T) plus 0.2971 rs2179706(C;T) 47.8% plus 0.4963 rs1570669(A;G) 41.6% plus 0.4646 rs2073145(A;A) 52.2% minus 0.4233 rs6128112(C;C) 71.7% plus 0.2815 rs2276498(C;G) 24.3% minus 0.1534 rs157640(G;T) plus rs11698685(A;G) plus 0.2562 rs13037755(C;T) 37.2% plus rs2064863(C;C) 38.9% minus 0.388 rs6027511(C;T) plus 0.1469 rs6022786(A;G) 46.9% plus 0.4371 rs6024938(C;T) 55.8% plus 0.3444 rs331615(A;T) plus 0.4913 rs6123837(A;G) plus 0.3779 rs127430(A;G) 25.5% plus 0.2397 rs186660(C;T) plus 0.4881 rs6064391(T;T) 27.7% plus 0.4692 rs11700100(C;T) plus rs182784(A;G) 56.6% plus 0.483 rs213032(C;T) plus rs3122605(A;A) plus 0.08494 rs6667202(A;C) plus 0.3067 rs12409577(A;T) 45.1% plus 0.3242 rs2243188(C;C) 60.2% plus rs2243191(C;C) 59.3% plus 0.3526 rs1713239(G;G) 69.2% minus 0.1827 rs1400986(C;T) 20.4% plus 0.2332 rs2981573(A;A) 58.4% plus 0.354 rs3762344(A;G) plus 0.4371 rs1150253(C;T) minus 0.3613 rs3024493(G;T) minus 0.0854 rs3024492(A;T) minus 0.1079 rs1554286(C;C) 69.0% minus 0.3811 rs1518111(G;G) 62.8% minus 0.4022 rs3024491(T;T) 26.5% minus rs2222202(T;T) 26.5% minus 0.2842 rs3905011(C;T) 53.1% minus 0.3935 rs599021(A;C) plus 0.3246 rs10779646(A;A) 48.4% plus rs11583745(C;T) plus 0.4444 rs6686529(C;C) 60.9% plus 0.2663 rs7549184(A;A) 61.5% plus rs1579634(A;G) minus 0.3632 rs945453(T;T) 10.7% plus 0.3907 rs2377360(A;A) 62.8% plus 0.3352 rs1497828(C;G) 34.8% plus 0.3191 rs2048332(C;T) minus 0.3237 rs1159268(A;G) plus rs1704198(C;C) 54.9% minus rs340849(G;T) minus 0.3811 rs17762192(C;G) plus rs340874(G;G) 31.2% minus 0.3806 rs17042140(C;T) plus rs438034(C;T) 46.9% minus 0.3792 poorer survival rate if breast cancer patient poorer survival rate if breast cancer patient rs6695352(C;C) 23.0% plus 0.3999 rs12131478(A;G) plus 0.3113 rs12039875(C;C) 45.5% plus 0.4343 rs6540679(G;G) 81.4% plus 0.1791 rs7527798(C;T) plus 0.141 rs4844614(G;T) 27.4% plus 0.3264 rs2724384(A;A) 63.4% plus 0.1579 rs7545126(C;T) 16.8% plus rs2745967(A;G) plus 0.3393 rs11578508(A;G) 50.8% plus 0.2346 rs17259784(C;G) plus 0.08815 rs12130212(A;T) plus 0.3586 rs2566(C;T) minus 0.3053 rs2235543(C;T) plus 0.2782 rs3008621(A;G) plus 0.07576 rs6683071(A;G) 27.4% plus 0.1855 rs5744174(C;T) 46.4% minus 0.2759 rs851139(C;T) minus 0.247 rs5744105(C;G) minus 0.3636 rs4285687(A;G) plus 0.4421 rs2800237(A;G) minus 0.3163 rs2800230(C;T) 50.9% minus 0.2736 rs10737416(A;C) plus 0.3852 rs2230419(A;A) 73.5% minus 0.2231 rs10800485(T;T) 48.7% plus 0.331 rs3795443(A;G) 23.0% plus 0.1405 rs4653643(A;G) 43.4% plus 0.3347 rs6751(C;T) minus 0.3356 rs10799319(A;G) 43.8% plus 0.3324 rs7555139(A;G) plus 0.3237 rs576861(C;T) 43.4% plus 0.3333 rs487591(A;G) minus 0.2718 rs16845098(C;T) plus 0.2424 rs1494373(G;G) 1.8% minus 0.1708 rs2642442(T;T) 50.9% plus 0.2323 rs6693017(G;T) plus 0.253 rs12073837(C;T) 38.1% plus 0.258 rs11118620(C;T) plus 0.3246 rs7542375(G;T) plus rs12724393(G;G) 21.5% plus rs11118838(C;C) 33.9% plus rs6691170(G;T) 37.2% plus 0.2608 rs873549(A;A) 53.1% minus 0.292 rs2605100(G;G) 44.2% plus 0.2199 rs12022722(T;T) 20.4% plus 0.3232 rs11118316(A;A) 16.7% plus 0.32 rs1417066(T;T) 31.0% minus 0.371 rs1539241(A;G) 23.0% plus 0.2677 rs4129024(A;G) minus 0.07713 rs45514798(A;G) plus 0.07622 rs3024505(C;T) minus 0.09091 rs3024498(A;G) minus 0.1322 rs3024496(C;C) 26.5% minus 0.3113 rs3024495(A;G) 33.8% minus 0.08632 rs1878672(G;G) 26.5% minus 0.2943 rs12742393(A;C) 44.2% plus 0.3737 rs386231(A;G) 39.8% minus 0.3095 rs1625579(A;A) 69.6% minus 0.1882 rs1198588(T;T) 1.8% minus 0.1814 rs2893397(C;T) plus 0.3535 rs1151640(G;G) 20.4% minus 0.4394 rs3811444(C;T) 40.6% plus 0.2309 rs11204546(C;C) plus rs11542478(C;C) 0.9% plus 0.1051 rs300774(G;T) 19.5% minus 0.1786 rs10167992(C;C) 72.6% plus 0.08999 rs4643574(G;G) 85.0% plus 0.2149 rs2947411(C;C) 73.5% minus 0.1662 rs939583(A;A) 74.3% minus rs10495822(G;T) 44.2% plus rs11683103(A;A) 48.7% plus 0.3678 rs13402855(C;T) plus 0.2645 rs7562790(G;T) plus 0.472 rs848512(C;C) 46.4% minus rs2540923(C;C) minus rs2041840(G;G) minus rs2373000(C;T) 53.6% plus rs3770748(C;T) 23.0% minus 0.2732 1.26x risk for lower bone mineral density 1.26x risk for lower bone mineral density rs1879282(T;T) 62.8% plus 0.247 rs6752303(C;C) 12.4% plus rs1514687(C;C) 72.7% minus rs2048722(C;C) 25.7% minus 0.461 rs1126797(C;T) plus 0.376 rs732609(A;C) 39.8% plus 0.4706 rs10199521(A;G) 33.9% minus 0.2516 rs2598592(C;T) 43.1% plus 0.3163 rs13403149(C;T) minus rs10865541(C;T) plus rs3820897(G;G) 65.5% minus rs11123610(A;A) 38.9% plus rs11675434(C;T) 50.4% plus rs2071403(A;G) 45.1% plus rs1075309(A;G) 46.0% minus rs2140855(T;T) 45.1% plus 0.4178 rs772451(C;T) minus 0.3352 rs12692386(G;G) plus 0.4187 rs12474969(A;G) plus 0.1566 rs1524668(A;C) 47.8% plus 0.4757 rs6432018(A;C) plus 0.4826 rs6734469(A;G) plus 0.4761 rs2357266(C;T) 47.8% minus 0.3531 rs16865717(C;T) plus 0.3287 rs6741819(C;T) 43.4% plus 0.2544 rs7591996(C;C) 15.0% plus 0.3765 rs11902236(C;T) 43.4% plus 0.3044 rs13394619(A;G) plus 0.377 rs13412852(C;T) 54.0% plus 0.2461 rs17551536(A;G) 31.0% plus 0.1309 rs10929808(A;G) plus 0.2117 rs1534422(A;G) plus 0.4467 rs10198628(A;G) 37.5% plus 0.3719 rs1598106(C;C) 30.8% minus 0.3522 rs1568282(A;G) 15.9% minus 0.118 rs1130609(G;T) plus 0.3462 rs4142237(A;G) 29.2% plus 0.3714 rs12692432(C;T) plus 0.4293 rs978906(G;G) 18.6% minus 0.3921 rs2230774(A;A) minus 0.4261 rs6716724(G;G) 74.3% plus 0.2273 rs11686574(G;G) 38.9% plus 0.4683 rs12470971(A;G) plus 0.3554 rs11693809(C;C) plus 0.4242 rs3102947(G;G) 72.3% minus 0.1602 rs9636252(C;C) 44.6% plus 0.4068 rs4077468(A;G) 46.0% plus 0.3379 rs28536160(A;G) minus 0.1543 rs28373064(A;G) 24.1% minus 0.1818 rs33976516(C;G) minus 0.04362 rs33985287(C;T) plus 0.2365 rs28418396(A;T) minus rs2483058(C;G) 41.0% minus 0.4293 rs6427340(C;T) plus 0.4509 rs13401(A;G) plus 0.4027 rs4657139(T;T) 44.6% plus 0.4059 rs1415259(A;G) 48.7% minus 0.4775 rs7520966(C;T) plus 0.3343 rs1368882(T;T) 21.2% minus rs704920(A;G) plus 0.4307 rs6768330(A;A) plus 0.1304 rs6773576(G;G) 65.5% plus 0.1699 rs9825041(G;G) 91.7% plus 0.1511 rs2742417(C;T) 46.0% plus 0.4252 rs2234358(G;T) plus 0.4637 rs1545985(A;G) Bad plus 0.1919 somewhat higher risk for prostate cancer somewhat higher risk for prostate cancer rs13323323(G;T) 38.1% plus 0.1919 rs3732860(C;T) plus 0.3237 rs7650267(C;T) plus 0.1295 rs12636651(C;T) plus 0.3889 rs3091250(G;T) plus 0.3453 rs3091312(A;T) plus 0.3434 rs1799864(A;G) Good plus 0.169 rs6441975(A;C) 38.1% plus 0.2066 rs1015164(A;G) 37.2% plus 0.2039 rs7430431(C;T) plus 0.2603 rs10514713(A;C) plus 0.3512 rs8180040(A;T) plus 0.3792 rs12487736(C;T) plus 0.4761 rs12490383(C;T) plus rs319690(C;C) minus 0.3494 rs9876781(A;G) plus 0.3825 rs9990343(A;G) 47.8% plus 0.3843 rs6441961(C;C) 47.3% plus 0.2718 rs2228563(A;G) 0.0% minus rs35623035(A;G) plus rs7617480(A;C) 38.9% plus 0.1846 rs1050450(C;T) minus 0.2493 rs1800668(C;T) minus 0.2346 rs3811699(A;G) minus rs3448(C;T) plus 0.1758 rs1987628(C;T) minus 0.2342 rs9858280(C;T) plus 0.2502 rs9822268(A;G) plus 0.2351 rs3197999(C;T) minus 0.2153 rs11706052(A;G) 23.0% plus 0.07254 rs4974081(C;T) 35.4% plus 0.1249 rs9858213(G;T) 49.5% plus 0.2158 rs2236957(A;G) 35.5% plus 0.3737 rs2239751(A;C) minus 0.1593 rs414171(A;T) 36.9% minus 0.2998 rs1031925(G;G) 74.3% minus rs1605070(T;T) 43.1% minus rs13326165(G;G) 61.9% plus rs6765687(C;T) 47.8% plus 0.1928 rs2710322(A;G) minus 0.14 rs9847710(C;C) 21.2% plus 0.4945 rs1128535(A;G) 56.2% minus 0.393 0.77x risk for Crohn's disease 0.77x risk for Crohn's disease rs6762477(A;G) plus 0.2879 rs2013208(A;G) 51.3% minus rs1046956(A;T) plus 0.2374 rs12632110(A;G) 49.6% plus 0.4394 rs312480(C;C) minus 0.1318 rs312486(G;G) 52.3% minus 0.1887 rs9841978(A;G) plus 0.3154 rs12487452(C;G) 24.8% plus 0.298 rs893363(A;A) minus 0.3508 rs14165(C;C) 50.0% minus 0.1543 rs6445606(T;T) 45.1% plus 0.1676 rs12676(G;G) minus 0.1607 rs7626693(T;T) 25.7% plus 0.4275 rs2336725(T;T) 33.6% plus 0.4555 rs2564921(G;G) 33.6% minus 0.455 rs4687717(C;C) 37.5% plus rs4687718(G;G) 78.8% plus 0.2048 rs11711956(G;G) 10.6% plus rs1375515(A;G) 39.8% minus 0.427 rs13074914(A;G) plus 0.2071 rs1820616(C;C) 93.7% plus rs4955826(C;T) 47.8% plus 0.3838 rs1795648(A;A) 53.1% plus 0.3228 rs2054989(A;G) 35.4% plus 0.3627 rs9835332(C;G) plus 0.2833 rs6773931(A;C) plus 0.3324 rs1025689(G;G) 6.3% minus 0.4564 rs13100723(C;T) 9.4% plus rs7646054(A;G) Bad 38.4% plus 0.3122 increased osteoporosis risk increased osteoporosis risk rs1110866(C;C) 16.9% plus 0.3476 rs2062583(G;T) 42.5% plus 0.219 rs4640525(C;G) plus 0.4899 rs1916284(A;G) minus 0.494 rs6768930(C;C) 20.4% plus 0.4063 rs17058639(C;T) plus rs1057719(A;G) 39.8% plus rs1043045(C;T) plus rs3772219(G;T) 40.7% minus 0.4059 rs1623879(C;T) 25.7% minus 0.2975 rs73081554(C;T) plus rs2176082(C;T) minus 0.3136 rs6445975(G;T) 38.9% plus 0.3242 rs13315591(C;T) plus 0.1088 rs6771019(A;G) plus 0.4793 rs6763159(C;C) 26.5% plus rs1550922(A;A) 21.4% plus 0.332 rs1825630(A;A) 18.6% minus 0.4642 rs4502542(C;C) 100.0% plus 0.03214 rs931317(A;G) 35.4% plus 0.1726 rs13077017(T;T) 7.7% plus 0.1474 rs6925(A;A) 18.6% plus 0.4573 rs10510837(A;G) plus 0.09688 rs2107561(C;T) minus rs11130874(A;G) 38.1% plus 0.168 rs7614311(A;C) 36.6% plus rs831574(C;T) 43.4% minus rs831571(C;C) 60.2% plus 0.2392 rs153734(A;A) 56.6% minus 0.3292 rs1035275(C;C) 21.0% plus 0.3113 rs6795735(C;T) 46.0% plus 0.3439 rs7638389(A;A) 65.5% plus 0.3278 rs3914188(C;G) minus 0.3017 rs2178403(C;T) 38.9% minus 0.2195 rs6141(A;A) 24.8% minus 0.3797 rs3930234(A;G) minus 0.1125 rs4686760(A;G) plus 0.3627 rs7647854(A;A) 67.3% plus 0.2135 rs7374394(T;T) 76.1% plus 0.2865 rs7629245(C;T) 25.7% plus 0.1304 rs1470579(A;C) Bad 39.8% plus 0.4123 1.2x increased risk for type-2 diabetes 1.2x increased risk for type-2 diabetes rs1402000(C;T) plus 0.2493 rs6443930(C;G) plus 0.4683 rs6766410(A;A) 12.4% plus 0.4949 rs6807670(A;A) 33.9% plus 0.3448 rs7627615(A;G) plus 0.2548 rs6806377(G;G) 25.7% plus rs843358(C;T) 50.4% minus 0.3714 rs4912474(A;C) plus 0.3848 rs6782299(T;T) 66.2% plus 0.1529 rs1879248(A;A) 58.4% minus 0.1561 rs4859146(T;T) 62.5% plus 0.4118 rs4859147(C;C) 50.0% plus 0.3751 rs2270968(C;C) 42.9% minus 0.4775 rs12493050(A;A) 61.9% plus 0.2461 rs4473559(G;G) 100.0% plus rs13073838(C;C) 18.6% plus 0.197 rs7635818(C;C) 19.5% plus 0.2994 rs1516459(C;C) plus 0.05142 rs13064369(T;T) 28.6% plus 0.455 rs9836484(A;G) plus 0.3567 rs331142(G;T) minus 0.3388 rs12495133(A;C) plus 0.2879 rs1455832(C;T) minus 0.2287 rs2311350(C;T) minus 0.2727 rs7617400(C;T) 25.7% plus rs649851(G;T) plus 0.4224 rs17518584(C;T) 47.8% plus rs3849491(G;G) 37.5% minus 0.4522 rs264537(C;G) 43.1% minus rs7428796(C;T) plus 0.4757 rs7628864(A;G) 32.7% plus 0.4982 rs9757252(C;T) plus 0.4826 rs7642134(A;G) 51.3% plus 0.4812 rs2660753(C;T) plus 0.2681 rs17023900(A;G) 12.4% plus 0.07805 rs9284813(A;G) 22.1% plus 0.2429 rs17181170(A;G) plus 0.337 rs7629490(C;T) 42.9% plus 0.3411 rs2055109(A;A) 61.9% minus 0.1515 rs2880961(C;T) 42.5% plus 0.3719 rs11127958(A;T) 51.3% plus 0.2957 rs9836340(A;G) 40.2% plus 0.2801 rs4857304(G;T) 41.6% plus 0.4679 rs832032(A;A) 62.8% plus 0.1676 rs9833094(C;T) 44.2% plus rs616597(G;G) 63.7% minus 0.2259 rs600718(T;T) 67.7% plus 0.2291 rs10212363(A;G) plus 0.2011 rs1694189(T;T) plus 0.1511 rs1397924(C;T) 44.2% plus 0.4027 rs4856162(A;G) plus 0.4408 rs7632427(C;T) plus 0.3884 rs17374916(A;G) 37.2% plus 0.2185 rs9879532(C;T) 38.9% plus 0.4913 rs9821642(A;G) 49.2% plus 0.4004 rs10937540(C;T) 47.8% plus 0.4403 rs6775909(C;T) plus 0.4959 rs12485744(C;T) plus 0.3535 rs7628767(A;G) plus 0.4963 rs10511217(C;T) 37.2% plus 0.3535 rs4493441(A;G) plus 0.4945 rs2685056(C;T) minus rs9810233(A;G) 36.3% plus 0.3324 rs6437585(C;T) 19.5% plus 0.1074 rs7612581(G;T) plus 0.4702 rs9820695(A;G) plus 0.4458 rs679711(C;T) plus 0.4141 rs10934011(G;G) 50.4% plus 0.2787 rs76884941(G;T) plus 0.02847 rs56238310(A;C) plus 0.02847 rs951660(C;C) 81.4% plus 0.1249 rs16859140(C;T) plus rs2705520(C;C) 97.2% minus 0.01928 rs9657904(C;T) plus 0.3104 rs6437740(C;T) plus 0.2149 rs2593957(C;C) 23.9% plus rs1164064(A;G) plus 0.3751 rs1002979(C;C) 30.8% plus 0.4298 rs1025398(A;G) minus 0.3246 rs1486012(T;T) 31.2% plus 0.4522 rs2087017(A;A) 33.6% plus rs4646996(A;A) minus rs2251177(T;T) 100.0% plus rs2630349(A;G) 13.3% plus 0.146 rs2630351(A;G) 13.3% plus 0.08907 rs167771(A;G) plus 0.348 rs324032(A;G) plus 0.1364 rs167770(A;G) plus 0.4013 rs1488193(C;T) 8.8% minus 0.1304 rs7611694(A;C) 51.3% plus 0.4656 rs13092825(C;T) plus 0.124 rs324029(A;G) 38.1% plus 0.4118 rs9825563(A;G) 39.8% plus 0.3466 rs905568(C;G) 41.3% plus 0.3655 rs3732782(A;C) minus 0.3223 rs1875517(C;T) minus 0.3903 rs4404477(A;G) 25.7% minus 0.27 rs488628(C;T) minus 0.264 rs10511378(A;G) minus 0.124 rs4687833(C;T) plus rs10934490(G;G) plus 0.3609 rs11712165(G;T) plus 0.3035 rs1132200(A;G) 23.0% minus 0.08678 rs2293370(C;T) minus 0.2103 rs4688011(A;G) plus 0.174 rs16824395(A;G) 9.7% plus rs1521418(C;G) plus rs13088089(A;C) 42.0% plus 0.1804 rs7632070(G;G) 36.9% plus rs9870146(C;T) 39.8% plus 0.4614 rs1676232(A;A) 48.2% plus 0.4013 rs1599795(A;T) plus rs7628626(C;C) 57.5% plus rs6804441(A;G) 20.4% plus 0.1846 rs7648642(A;C) 49.6% plus rs2222631(C;T) minus rs1523130(G;G) 42.0% minus 0.4761 rs1523127(T;T) 44.2% minus 0.4578 rs12488820(C;C) 41.6% plus 0.4807 rs2472671(T;T) 80.5% plus 0.2153 rs2461823(G;G) 38.9% minus 0.3871 rs7643645(G;G) 7.7% plus 0.3209 rs3732359(A;A) 77.5% plus 0.4031 rs7431209(A;G) 48.2% plus 0.2489 rs2199503(A;G) minus rs334543(A;C) plus 0.2837 rs796825(A;G) minus 0.281 rs2255543(T;T) 50.0% minus 0.2635 rs322458(A;G) 54.7% minus 0.3425 rs2257212(A;G) 54.0% minus 0.4908 rs1143671(C;T) 54.0% plus 0.4908 rs1143672(A;G) plus 0.4908 rs4285028(A;C) 37.2% plus 0.1938 rs6805251(C;C) 42.7% plus 0.4449 rs13320980(C;T) plus 0.1726 rs2681424(C;T) plus 0.4601 rs2681411(A;G) plus 0.4784 rs9282641(A;G) plus 0.05005 rs1129055(A;G) plus 0.3324 rs17281995(C;G) plus 0.1028 rs1256196(A;T) 40.0% plus 0.3035 rs2650951(C;T) 12.5% plus 0.1152 rs790116(C;G) minus 0.472 rs790123(A;G) minus 0.4968 rs3792366(A;G) plus 0.478 rs2877716(C;C) 55.8% plus 0.1814 rs9883204(C;C) 49.1% plus 0.2048 rs820336(A;G) 31.2% minus 0.3903 rs16834817(A;G) 13.8% plus 0.1061 rs6810298(A;G) plus 0.3825 rs7652589(A;G) 44.3% plus 0.4219 rs1501899(A;G) plus 0.4109 rs1801726(C;C) 90.8% plus 0.07668 rs13083990(C;T) plus 0.3453 rs6810306(A;G) plus 0.365 rs11712039(C;T) 60.0% plus 0.1864 rs11712619(C;T) 58.5% plus 0.1777 rs7620580(A;G) plus 0.2332 rs2010099(C;T) 22.1% plus rs10512627(C;C) 26.2% plus 0.3751 rs2270778(C;T) plus rs1127717(G;G) 1.8% minus rs9637365(C;T) plus 0.4977 rs17286604(C;T) 54.9% plus 0.191 rs4234218(C;G) plus 0.3655 rs13067260(G;G) plus rs1444768(C;T) minus 0.4656 rs1444754(C;T) 47.8% plus 0.4835 rs9877457(G;G) 27.0% plus 0.4803 rs1154988(A;A) 63.1% plus rs645040(T;T) 61.9% plus 0.2071 rs511154(G;G) 65.6% plus 0.2319 rs9844666(A;G) plus 0.09183 rs9826828(A;G) plus 0.01102 rs6766709(T;T) 61.6% plus 0.2544 rs9826507(A;A) plus 0.3049 rs9846480(A;G) 52.2% plus 0.404 rs3755751(C;T) minus 0.3154 rs1880669(A;G) minus rs1534166(A;G) 36.0% plus 0.2544 rs2280673(C;C) 44.6% plus 0.4408 rs10935120(G;G) 46.9% plus 0.3196 rs3732568(C;C) 76.8% minus 0.2787 rs11929692(A;G) plus 0.4444 rs7644369(C;T) 46.9% plus 0.432 rs2030737(A;A) 24.8% minus 0.3747 rs6766459(T;T) 38.9% plus 0.3035 rs6449157(A;G) plus 0.4109 rs6449159(A;G) plus 0.4004 rs7672947(C;G) plus 0.4004 rs6823361(A;G) 47.7% plus 0.4114 rs6836706(A;T) plus 0.4008 rs10018204(C;T) 49.2% plus 0.3999 rs6839490(C;G) 46.2% plus 0.4008 rs6449171(C;T) plus 0.3907 rs6449172(A;T) 47.7% plus 0.4013 rs6449174(C;T) 46.0% plus 0.3912 rs4312757(A;T) plus 0.4004 rs6814664(C;T) 46.9% plus 0.3976 rs17185835(G;T) plus 0.3994 rs6449155(G;T) plus 0.3999 rs17185870(A;C) plus 0.3994 rs6815001(C;G) plus 0.4008 rs6849729(C;T) plus 0.4004 rs6843873(A;C) 48.4% plus 0.4004 rs6844316(A;G) 47.7% plus 0.3994 rs6834893(C;T) 48.4% plus 0.4004 rs2018643(A;G) minus 0.4027 rs4621431(A;G) plus 0.4027 rs4339211(C;T) 50.0% plus 0.4054 rs7686538(C;T) 53.6% plus 0.3875 rs4580649(A;G) plus 0.3944 rs12498150(C;T) 46.2% plus 0.4045 rs12498956(A;C) plus 0.4045 rs13328050(G;T) 44.0% plus 0.4045 rs1079128(A;G) minus 0.4137 rs1502172(A;G) 38.9% plus 0.416 rs1199337(C;G) minus rs1199333(A;A) 64.6% minus rs940187(G;G) 64.6% minus 0.2677 rs4894410(G;G) 93.8% plus 0.06152 rs1044826(A;G) 33.6% minus rs2118981(A;G) minus 0.3462 rs295490(T;T) 77.9% plus rs190910(A;T) 43.5% plus 0.3916 rs176990(G;T) plus 0.3907 rs2306374(C;T) plus 0.08402 rs9818870(C;T) 30.1% plus 0.09137 rs361072(A;A) 27.4% plus 0.2984 rs9857275(A;A) 10.6% plus 0.1951 rs6440003(A;A) 19.5% plus 0.4816 rs6763931(A;A) 20.0% plus 0.4821 rs724016(G;G) 18.8% plus 0.4977 rs1991431(A;A) 24.6% plus 0.4467 rs6776003(A;A) 28.6% plus 0.4821 rs295301(A;A) 12.3% plus 0.3866 rs347685(A;A) 54.9% plus 0.2645 rs1802904(A;G) 26.5% minus 0.09734 rs13091637(C;T) 30.0% plus 0.1497 rs6439924(A;C) 26.8% plus rs11708189(A;A) 43.4% plus 0.4651 rs908821(C;T) 35.4% minus 0.3333 rs16851055(A;G) plus 0.2388 rs2227928(C;T) Bad 57.5% minus 0.3825 poorer response to pancreatic cancer combined treatment poorer response to pancreatic cancer combined treatment rs6782400(A;C) plus 0.3811 rs953239(A;C) 52.2% plus 0.4178 rs17572584(C;T) 18.6% plus 0.09458 rs894177(A;A) 48.7% plus 0.2452 rs9810857(A;G) 46.9% plus 0.3118 rs1393072(C;C) 57.5% plus rs2800(C;T) 50.4% plus 0.3921 rs9828519(A;G) plus rs2166775(A;G) plus 0.3926 rs800082(C;T) 52.2% plus 0.3724 rs2687855(A;G) plus 0.3999 rs1913185(G;T) plus rs9832727(C;G) 47.7% plus 0.3338 rs1912785(A;G) plus 0.4669 rs1492078(G;G) minus rs3772633(A;G) minus 0.1699 rs2276736(C;C) minus 0.3843 rs3772630(G;G) minus 0.4316 rs3772627(C;C) minus 0.4293 rs389566(T;T) 50.8% plus 0.3168 rs5182(T;T) 28.6% plus 0.4747 rs4301033(A;G) plus 0.101 rs1841770(G;T) 51.3% plus 0.2902 rs1388623(A;C) minus 0.2185 rs1388622(A;G) minus 0.2185 rs7634096(C;T) 32.3% plus 0.2663 rs7637803(C;T) 31.9% plus 0.2337 rs9859538(A;G) plus 0.332 rs1907637(A;G) 30.1% plus rs6798928(T;T) 44.6% plus 0.4045 rs1351267(A;G) 46.0% minus 0.4486 rs6785504(G;T) 46.9% plus 0.4738 rs573872(G;T) plus 0.2006 rs1012583(A;G) plus 0.1635 rs12107539(A;G) 46.9% plus rs6809699(A;C) 31.9% plus 0.1097 rs6785930(A;G) plus 0.264 rs2046934(C;T) minus 0.1529 rs10935838(A;G) plus 0.1515 rs7615865(C;T) plus 0.2158 rs181696(A;G) minus 0.4527 rs13068223(A;G) 53.1% plus rs12638253(T;T) 20.7% plus 0.4963 rs7624327(A;G) plus 0.08861 rs2362965(A;T) plus 0.4022 rs7646881(A;C) plus 0.1575 rs2222328(A;G) minus 0.2025 rs9811792(C;T) 39.8% plus 0.4601 rs4680534(C;T) plus 0.3361 rs6794649(C;G) plus 0.2158 rs989692(C;C) 23.9% plus 0.41 rs1836915(C;T) plus 0.1061 rs701109(A;G) 58.4% minus 0.4242 rs9847915(T;T) 46.0% plus rs33999879(A;G) minus rs12493123(A;A) 0.0% plus 0.3453 rs1425609(A;G) plus 0.3264 rs9824150(A;T) plus 0.1538 rs16833934(A;G) 49.2% plus rs7427021(A;G) 46.4% plus 0.4385 rs4387996(A;G) 42.9% plus 0.332 rs1523288(A;G) 46.2% minus 0.3664 rs582054(A;T) plus 0.4885 rs583911(A;G) plus 0.4637 rs829508(A;G) 37.6% minus 0.3352 rs1355534(A;G) minus 0.3338 rs4680662(A;G) 36.9% plus 0.3375 rs4263329(A;A) 80.5% plus 0.1359 rs4680612(A;A) 87.7% plus 0.0629 rs4365667(A;C) plus rs509208(C;G) plus 0.1703 rs2863389(C;T) 20.4% plus 0.1469 rs12489747(A;G) plus 0.08356 rs9871556(C;T) plus 0.343 rs6445035(A;G) plus 0.1612 rs3495(A;G) minus 0.3329 rs1803274(A;G) 30.8% minus 0.1607 possible increased Alzheimer's risk possible increased Alzheimer's risk rs1918974(T;T) 32.3% plus 0.3632 rs1344555(C;T) minus 0.3558 rs13097028(T;T) 8.8% plus rs12638862(G;G) 7.1% plus 0.3306 rs12696304(G;G) 1.0 7.1% plus 0.4683 Prone to aging faster, at least in European populations? Prone to aging faster, at least in European populations? rs2293607(G;G) minus 0.3026 rs1317082(G;G) 7.1% plus 0.3035 rs6793295(C;C) 7.1% plus 0.4261 rs10936601(T;T) 7.1% plus 0.4669 rs6774494(A;G) plus 0.4862 rs419076(C;C) 31.7% plus 0.4164 rs448378(A;A) 25.7% plus 0.416 rs16847897(C;C) 9.7% plus 0.4008 rs1920116(T;T) 9.8% minus rs3913363(C;T) 37.7% plus 0.4972 rs4535251(C;T) plus 0.404 rs7652177(G;G) 26.2% plus 0.3884 rs2054399(A;A) minus 0.3421 rs13100616(A;G) 44.2% plus rs7621329(C;T) 25.0% plus rs4855094(A;G) plus 0.07943 rs6443624(A;C) plus rs7646409(C;T) plus 0.2149 rs9866361(A;G) plus 0.2043 rs870995(A;C) plus 0.4826 rs7612445(G;T) 23.9% plus 0.2424 rs7630877(A;G) plus 0.2612 rs2948694(A;G) 13.5% plus 0.1763 increased risk for heavy alcohol consumption increased risk for heavy alcohol consumption rs9819506(C;T) 44.2% plus 0.3646 rs6445063(C;T) plus 0.1125 rs1131580(C;T) minus 0.3522 rs2286983(C;T) minus 0.2911 rs534654(C;C) 68.1% minus 0.1469 rs6858749(C;C) 31.9% plus rs6832769(A;G) plus 0.2998 rs3749474(C;T) 50.0% plus 0.3852 rs3736544(A;G) 45.3% plus 0.2961 rs2412646(C;T) plus rs1554483(C;G) 36.9% plus 0.3866 1.8x higher risk for obesity if in haplotype 1.8x higher risk for obesity if in haplotype rs3817444(A;C) 51.8% plus rs12649507(A;G) plus 0.3613 rs4864548(A;G) plus 0.3861 1.8x higher risk for obesity if in haplotype 1.8x higher risk for obesity if in haplotype rs2237028(A;C) minus 0.3834 rs1531289(G;G) 50.4% minus 0.2893 rs17709898(G;G) 15.0% plus rs1870378(A;A) 5.3% minus rs6828477(T;T) 29.2% plus rs34231037(A;G) plus 0.01377 rs1870377(A;A) 6.2% plus 0.2346 rs11941492(C;T) 33.6% plus 0.247 rs11133360(C;T) 49.1% plus rs7667298(C;C) 18.2% plus 0.45 rs2898681(A;A) 2.7% plus 0.236 rs2412488(G;G) 52.2% plus 0.3301 rs1364989(G;G) 69.0% minus rs35597368(C;T) plus 0.1653 rs9312648(C;T) plus 0.3664 rs218237(C;T) 17.7% plus 0.2342 rs218238(A;T) 38.5% plus 0.3939 rs172629(C;G) 17.7% plus 0.2273 rs2537859(C;T) 54.0% plus 0.4977 rs3819392(C;T) minus 0.2525 rs11712263(C;T) 47.2% plus rs7646507(A;A) 89.4% plus rs11709498(C;C) 41.1% plus rs1488564(A;G) 42.9% plus rs976683(A;G) 40.2% minus 0.4601 rs13074924(A;G) 54.0% plus 0.3127 rs1463525(C;T) plus 0.3577 rs2042126(G;T) plus 0.489 rs6771725(G;T) 47.8% plus 0.3223 rs7612209(A;A) 45.1% plus 0.4725 rs10936632(A;C) plus 0.3595 rs6444931(A;A) 69.9% plus 0.1708 rs4955755(A;G) plus 0.4848 rs8192675(A;G) minus 0.3926 rs2088885(A;C) plus 0.4982 rs12035879(A;G) plus rs10799915(C;C) 15.1% plus 0.3728 rs3001089(C;C) minus rs1361277(A;A) 66.2% minus rs535043(C;T) minus 0.3333 rs4659583(C;C) 34.2% plus 0.4587 rs11805657(C;C) 81.0% plus 0.124 rs670659(C;T) 40.6% plus 0.3365 rs6697953(C;T) plus 0.2681 rs1053221(A;G) minus 0.1331 rs1053183(C;T) 38.4% minus 0.3196 rs9782914(C;T) plus rs10926554(A;C) plus rs1342866(T;T) 66.4% plus 0.169 rs3902093(G;T) minus 0.1364 rs10495471(A;G) 20.4% plus 0.14 rs4659996(A;G) plus 0.4601 rs7544372(T;T) 69.6% plus 0.2672 rs1573073(G;G) 56.2% plus 0.3471 rs10495476(A;A) 56.6% plus 0.3434 rs1342449(C;C) 56.6% plus 0.2681 rs716743(T;T) 56.6% minus 0.2392 rs1380304(T;T) 55.8% plus 0.2833 rs6703335(G;G) 33.0% plus 0.4302 rs897959(T;T) 51.3% plus 0.4564 rs4430311(T;T) 46.9% plus 0.4518 rs10927101(A;C) plus 0.4862 rs476141(A;C) 46.9% minus 0.3324 rs3101457(C;T) minus 0.1758 rs3102460(C;T) 34.5% plus 0.2897 rs10924270(G;G) 25.7% plus 0.4904 rs2027432(C;T) 29.2% minus 0.1373 rs7512998(C;T) 30.9% plus 0.1359 rs1047840(A;G) plus 0.3609 rs1776148(A;G) 44.2% plus 0.2948 rs3806268(A;G) plus 0.4109 rs1539019(A;C) minus 0.3522 rs12239046(C;T) plus 0.4022 rs10157379(C;T) 46.9% plus rs10754558(C;G) plus 0.3558 rs4353135(G;T) 42.5% plus 0.3118 rs4604732(T;T) 61.5% plus rs7550918(C;T) 28.6% plus 0.2571 rs1881797(C;T) 17.0% plus 0.2374 rs851797(C;C) minus 0.3737 rs10803016(T;T) 20.4% plus 0.4605 rs2653165(T;T) 47.8% minus rs2919024(C;T) 3.2% minus 0.03122 rs1439523(A;G) minus 0.1244 rs1538774(G;G) 100.0% plus rs268786(T;T) 99.1% minus 0.05831 rs10754602(A;T) plus rs3765097(T;T) plus rs1478912(C;C) 31.0% plus 0.4045 rs2253273(C;C) minus rs2819770(A;A) 7.1% minus 0.1524 rs2056387(A;A) 9.8% plus 0.2443 rs2819742(G;G) 39.8% plus 0.2185 rs693421(A;C) minus 0.41 rs2499604(A;G) 46.9% minus 0.4697 rs3768080(A;G) 57.4% plus 0.3613 rs10754833(C;T) plus 0.3581 rs911271(C;C) 31.9% plus 0.3921 rs966365(C;T) minus 0.2323 rs4659682(A;G) 48.7% plus 0.3003 rs1770449(A;G) minus 0.259 rs4659744(C;G) plus 0.3609 rs2853523(A;C) 46.0% plus 0.2645 rs1050993(A;G) 46.0% plus 0.2645 rs6683225(C;T) plus rs1597921(T;T) plus 0.02709 rs2123536(G;G) 92.9% minus 0.2268 rs10199768(G;T) 54.5% plus 0.2617 rs1367117(A;G) plus 0.2052 rs934197(A;G) plus 0.2084 rs515135(C;T) minus 0.2433 rs562338(C;T) 26.5% minus 0.2461 rs541041(C;T) minus 0.2305 rs312985(C;T) 32.7% minus rs4635554(G;T) plus 0.393 rs506585(A;G) plus 0.1887 rs219553(C;T) minus 0.3402 rs1117324(T;T) 88.5% plus 0.1703 rs271738(A;G) plus 0.3586 rs744487(G;T) 44.6% minus 0.2746 rs11581667(C;T) 44.6% plus 0.2727 rs514230(A;T) 55.9% minus 0.3292 rs2069084(T;T) 77.0% minus 0.107 rs6429082(C;C) 21.2% plus 0.444 rs291353(A;G) 42.0% minus 0.3021 rs1395(A;G) plus rs6717980(C;T) plus 0.3751 rs11126936(G;T) 34.5% plus rs1728918(A;G) 42.0% plus 0.2264 rs6547626(C;T) 46.0% plus 0.4073 rs2303369(C;T) 47.7% plus 0.3081 rs780094(A;G) minus 0.3857 metabolic consequences metabolic consequences rs780093(C;T) minus 0.3811 rs1260333(C;T) 50.0% minus 0.4513 rs1919128(A;G) 32.7% plus 0.3274 rs13022873(A;C) 32.8% plus 0.3549 rs4666002(C;G) plus 0.3264 rs1049817(C;T) 47.8% minus 0.4045 rs4665972(C;T) plus 0.3806 rs3749147(C;T) minus 0.23 rs7601155(C;T) 8.0% plus rs925255(A;G) 52.2% minus 0.3237 rs6547853(A;G) plus 0.2654 rs9679162(T;T) 12.4% plus rs1862981(C;C) 21.2% minus 0.3926 rs6543610(C;C) 99.1% plus rs625132(G;G) 72.6% plus 0.1575 rs619002(A;A) 63.7% minus 0.1152 rs644926(G;G) 63.7% minus 0.1143 rs1366813(C;C) 60.2% plus rs3736594(G;G) 52.2% minus 0.4628 rs7574920(C;G) plus 0.3967 rs12470143(T;T) 30.1% plus 0.4096 rs4952197(G;G) 66.1% plus 0.2378 rs2268797(T;T) 50.8% plus 0.477 rs2300701(G;G) 40.2% plus 0.405 rs2208532(A;A) 37.5% plus 0.4229 rs523349(C;C) 64.6% plus 0.3425 rs632148(G;G) 60.3% plus 0.3563 rs676033(G;G) 63.1% minus rs559555(T;T) 44.6% minus rs2266917(T;T) 48.7% plus 0.2759 rs3768647(C;G) plus rs1137(C;C) 64.9% plus 0.4757 rs681900(A;G) minus 0.2011 rs6741029(G;T) plus 0.3765 rs735668(A;C) 50.0% plus 0.3196 rs3755468(C;T) plus rs2583526(A;G) 52.2% minus rs436000(A;C) 49.5% minus 0.332 rs10204325(C;T) 51.4% plus 0.2773 rs7595103(A;G) plus 0.2314 rs11683503(C;T) plus rs2421095(A;G) plus 0.1221 rs1876487(G;T) 44.6% minus 0.3802 rs6546886(C;T) plus 0.3659 rs612224(A;A) minus 0.3021 rs542631(G;G) 96.5% plus 0.1033 rs1545552(A;G) 48.6% plus 0.1722 rs6714546(A;G) 38.6% plus 0.1547 rs41464348(T;T) 24.8% minus 0.4766 rs13407683(A;G) plus rs6733379(G;T) 38.1% plus 0.2259 rs6543833(G;G) 44.6% plus 0.3434 rs4670779(C;T) 44.6% plus 0.2167 rs162555(A;G) minus 0.1217 rs162551(C;T) minus rs3134628(C;C) 35.7% minus rs12621103(C;C) 38.1% plus rs13024811(C;C) 38.1% plus rs2037875(T;T) 30.1% minus rs10197412(A;A) 30.1% plus rs6715866(T;T) 31.0% plus rs2044853(G;G) plus 0.06979 rs960902(A;A) 25.7% plus 0.4885 rs604381(G;T) minus rs12479213(A;C) plus 0.2824 rs7587205(G;T) 36.9% plus 0.3448 rs3749056(G;G) 80.5% minus rs10865170(A;C) plus 0.432 rs4952590(C;T) 21.2% plus 0.298 rs1440095(C;T) plus 0.4936 rs924114(A;A) 18.8% minus 0.4215 rs7590268(G;T) plus 0.1667 rs1465618(A;G) minus 0.3173 rs6732426(C;T) 56.6% plus 0.4164 rs1368086(A;G) 30.8% minus 0.1699 rs725238(A;G) 43.4% minus 0.3609 rs4131229(C;T) 40.7% minus 0.4224 rs4148211(A;G) 48.7% plus 0.4412 rs4305317(G;G) 19.5% plus rs4953076(C;C) 61.5% plus 0.3558 rs7579899(G;G) 39.8% plus 0.4389 rs9679290(C;C) 22.1% plus 0.4656 rs4953346(G;G) plus 0.466 rs12617313(T;T) 19.5% plus 0.3219 rs4953354(A;G) 21.5% plus rs10187368(A;G) plus rs815815(A;A) 66.4% minus 0.1478 rs7565161(G;G) 50.0% plus 0.3678 rs1421(A;G) minus 0.1221 rs698761(A;G) plus 0.4573 rs698813(C;C) minus rs2341459(C;C) 51.8% plus 0.3852 rs528301(A;G) plus 0.2043 rs12373805(A;G) plus rs10495928(G;G) 5.4% plus 0.2952 rs4953318(C;C) 9.2% plus 0.371 rs10168349(C;C) 9.2% plus 0.2938 rs11894252(C;C) 39.3% plus 0.4376 rs4299376(G;T) 45.1% plus 0.1726 rs6544713(C;T) plus 0.1736 rs4245791(C;T) 43.2% plus 0.1676 rs13387221(A;G) plus 0.2851 rs920520(C;T) plus 0.4844 rs2540226(G;T) 49.6% minus 0.3774 rs75847378(A;G) plus rs404005(T;T) 44.2% plus 0.4665 rs861019(A;G) 38.9% plus 0.3981 rs861020(A;G) 33.6% plus 0.1818 rs12569232(C;C) 4.6% plus 0.1097 rs10863936(A;A) 25.5% plus 0.3531 rs6540731(A;G) plus 0.3682 rs6694514(C;T) plus 0.4325 rs3002288(A;A) 8.6% plus 0.3292 rs4655303(A;T) 48.2% plus 0.3972 rs17706439(A;G) plus 0.1001 rs7529925(T;T) 62.8% plus 0.2089 rs12029406(C;T) 54.9% plus 0.4541 rs3762397(A;G) 61.5% minus rs2816958(C;T) 17.3% minus 0.1221 rs7512898(G;T) 46.9% plus 0.4545 rs28829049(C;T) plus rs10915864(G;G) 5.3% plus rs1051740(C;C) 12.4% plus 0.3163 rs2260863(C;G) plus 0.2534 rs360057(G;T) plus rs1223245(A;G) 47.7% plus rs8679(C;C) 5.3% minus 0.1331 rs2271347(A;A) 4.5% plus 0.1331 rs3219119(A;A) 36.5% minus 0.4343 rs3219090(G;G) 42.5% minus 0.4637 rs1925714(G;G) 75.0% plus rs2639703(C;T) plus 0.4054 1.1x risk 1.1x risk rs17503834(C;T) plus 0.06657 rs7079(A;C) 40.7% minus 0.2025 rs2478545(C;T) minus 0.3411 rs6687360(C;T) 44.2% plus 0.494 rs4762(C;T) Bad minus 0.1038 1.9x risk for pre-eclampsia 1.9x risk for pre-eclampsia rs3889728(A;G) 22.4% minus 0.3104 increased risk for preeclamppsia increased risk for preeclamppsia rs2493134(C;T) plus 0.3402 rs5051(C;T) 40.7% plus 0.3356 increased risk for hypertension increased risk for hypertension rs5050(G;T) plus 0.174 rs2493137(C;T) plus 0.4913 rs12049351(C;G) 40.2% plus 0.225 rs348334(A;G) plus 0.2576 rs10495285(C;G) 49.1% minus rs2144300(T;T) 30.6% plus 0.3558 rs4846914(A;A) 31.2% plus 0.3673 rs10127775(T;T) 31.2% plus 0.3669 rs10489615(G;G) 31.0% plus 0.4284 rs4846922(C;C) 40.2% plus 0.3581 rs3761944(C;G) plus 0.4197 rs12403575(G;G) 14.2% plus rs1760217(C;T) 37.2% minus 0.2167 rs828054(A;C) 49.6% minus rs11587873(C;T) 38.4% plus rs1973993(C;T) plus 0.438 rs1555543(A;C) 55.8% plus 0.4013 rs10783071(A;A) 85.0% plus rs10747493(T;T) 69.9% plus rs11804321(C;T) plus 0.101 rs6901250(A;G) plus 0.3471 rs1413845(A;A) 46.9% minus 0.4444 rs281868(A;A) minus 0.3935 rs89107(A;A) 32.3% plus 0.3944 rs937091(G;T) minus 0.4761 rs2789047(A;C) plus rs11154022(G;G) 55.0% plus 0.3219 rs11154027(C;C) 35.0% plus 0.3939 rs9490306(A;C) plus 0.1322 rs13192613(G;T) 48.7% plus 0.1699 rs873460(C;T) minus 0.2911 rs941815(G;G) 29.2% minus 0.4568 rs25422(A;G) 26.5% minus 0.1474 rs531930(G;G) 56.6% plus rs504008(G;G) 66.4% minus 0.393 rs9398764(A;G) 41.6% plus rs11154271(T;T) 65.5% plus 0.1561 rs1777220(A;A) 16.8% minus rs549438(A;A) minus 0.3756 rs490361(C;C) 6.2% plus 0.2388 rs10485179(A;A) 46.0% minus 0.3223 rs1268121(A;G) minus 0.08815 rs9491140(C;T) 46.9% plus 0.3613 rs6900796(C;T) plus 0.2847 rs9388489(G;G) 16.8% plus 0.4394 rs4273712(G;G) 8.0% plus 0.3053 rs4549631(C;C) 22.1% plus 0.3944 rs1262476(C;C) 54.0% minus rs13209747(C;T) 46.9% plus rs972275(C;G) 53.8% minus 0.4389 rs1936800(C;T) 58.5% plus 0.4954 rs9491696(C;G) 60.9% plus 0.4564 rs9491697(A;G) 50.4% plus 0.4275 rs7741021(A;C) 62.5% plus rs6569474(A;T) 53.6% plus 0.4784 rs1361108(T;T) 17.7% plus 0.4178 rs4418209(G;G) 15.6% plus rs2130604(G;G) 35.9% plus rs1490388(T;T) 17.7% plus 0.4389 rs1490384(T;T) 18.5% plus 0.4238 rs2180341(A;G) plus 0.2608 rs6569479(C;T) plus 0.2603 rs12194062(C;T) 41.6% plus 0.1359 rs7755729(C;T) 54.0% plus rs2275215(C;T) plus 0.3531 rs9375674(G;G) 31.0% plus 0.4421 rs6569648(C;T) 34.5% plus 0.1212 rs7745274(A;G) plus 0.4399 rs6899976(A;G) plus 0.4224 rs10447419(A;C) plus 0.3072 rs3813359(C;T) 16.8% minus rs4897475(G;G) 60.0% plus 0.1529 rs6941712(C;T) plus 0.2782 rs6908917(C;C) 60.2% plus 0.2865 rs602848(G;G) 65.5% plus 0.1772 rs4629710(A;G) plus 0.09917 rs2807278(C;T) plus 0.2691 rs943003(A;A) 49.1% minus 0.32 rs2021966(C;C) 22.1% minus rs1974201(C;G) minus 0.3921 rs6907728(A;C) 22.2% plus rs1582055(C;C) 58.5% plus 0.1621 rs9388856(A;T) 38.9% plus 0.4481 rs1360756(C;T) 38.9% plus 0.4509 rs9388857(G;T) plus 0.45 rs9321334(G;G) 3.5% plus rs6902875(G;G) 5.3% plus rs4897574(T;T) 9.7% plus rs589756(A;C) plus 0.1327 rs9399032(A;T) plus 0.4752 rs4305745(A;G) plus 0.494 rs4305746(A;G) plus 0.4936 rs2272996(C;T) plus 0.2736 rs1208285(C;C) 16.8% plus 0.2842 rs9402571(G;T) Good plus 0.2603 slightly decreased risk for type-2 diabetes slightly decreased risk for type-2 diabetes rs6917644(A;G) 25.9% plus 0.09734 rs6918698(C;G) plus 0.4986 ~normal risk ~normal risk rs9493150(C;G) plus 0.2548 rs2151532(C;T) minus 0.1543 rs11966728(C;T) plus 0.214 rs1931002(A;G) minus rs9493857(A;G) 30.8% plus 0.3669 rs1763500(T;T) 92.0% minus 0.07346 rs9402592(A;G) plus 0.444 rs9321453(C;T) plus 0.2342 rs2049953(A;C) plus 0.2039 rs2297339(A;A) plus 0.4435 rs28384513(C;C) minus 0.2893 rs7745098(T;T) 23.9% plus rs6929404(A;A) 10.5% plus 0.3012 rs9321490(C;T) plus 0.2971 rs1743966(C;T) 23.9% minus rs210937(C;T) minus rs947583(C;T) plus 0.2929 rs9389370(C;G) 39.8% plus 0.259 rs560713(A;C) 43.4% plus rs797558(C;G) 18.8% plus 0.1758 rs703193(C;T) 19.5% plus 0.2594 rs7775356(A;A) 34.4% plus 0.3352 rs35898099(A;G) plus 0.1589 rs6937795(A;C) 44.6% plus rs3807989(G;G) 31.9% plus 0.4449 rs11773845(A;A) 31.9% plus 0.4454 rs7795356(C;C) 62.8% plus 0.1777 rs38845(A;G) 44.6% plus 0.3944 rs38850(A;G) plus 0.1437 rs38855(A;G) 50.5% plus 0.4486 rs38857(C;T) plus 0.2332 rs10215153(A;G) plus rs2237717(C;T) plus 0.3705 rs2402118(A;C) 43.4% plus 0.2029 rs4236601(A;G) plus 0.2094 rs1997623(C;C) plus 0.1685 rs4730775(T;T) 23.0% plus 0.3545 rs2896218(A;A) 27.4% plus 0.3806 rs41997(A;G) 52.8% plus 0.275 rs2106595(A;A) 12.4% plus 0.2649 rs6466686(T;T) 42.5% plus 0.4114 rs4295599(C;C) 59.3% plus 0.3352 rs12531086(A;A) 59.3% plus 0.3471 rs728115(A;G) plus 0.2204 rs10253361(C;T) 46.9% plus 0.4233 rs193688(C;T) plus 0.3733 rs1621(A;G) plus 0.3012 rs41741(G;T) 49.6% plus 0.3021 rs42336(A;G) 46.4% plus 0.3747 rs2429582(C;T) 42.1% plus 0.3044 rs2299472(A;C) plus rs2288549(C;T) 36.0% minus 0.1777 rs6971091(A;G) plus 0.1534 >2x increased risk for familial obesity >2x increased risk for familial obesity rs4728142(A;G) plus 0.2961 rs3757385(A;C) minus 0.4968 rs752637(A;G) minus 0.4995 rs3807306(A;C) 52.7% minus 0.3494 rs11761199(A;G) 49.6% plus rs11971186(A;G) 44.2% plus 0.359 rs12164089(C;C) 13.8% plus 0.3315 rs322812(C;T) plus 0.4146 rs791595(A;G) 25.7% plus rs10487506(A;G) plus 0.4417 rs7799039(A;G) plus 0.4334 rs4731426(C;G) plus 0.4931 rs12706832(A;G) 49.6% plus 0.4972 rs3828942(A;G) plus 0.444 rs6466832(C;T) plus rs846672(A;C) 42.5% plus 0.2948 rs4727963(C;T) 58.4% plus 0.3907 rs9649465(A;G) plus 0.4408 rs1100508(C;G) 55.8% minus rs7802263(T;T) 61.9% plus 0.2355 rs17246404(C;T) 45.1% plus 0.2052 rs1419607(A;G) 47.6% plus rs1034576(G;G) 55.8% plus 0.2833 rs2073067(C;G) 46.9% minus 0.3099 rs803422(C;C) 46.0% minus 0.1391 rs963193(A;C) minus 0.4008 rs9479055(A;C) plus 0.382 rs11155795(A;G) plus 0.3926 rs6909279(C;G) plus 0.3811 rs851987(C;C) 51.3% minus 0.3843 rs3020331(C;T) 54.9% plus rs2941740(C;T) 40.3% minus 0.337 rs851982(C;T) plus 0.2773 rs1159327(A;G) 44.5% minus 0.2847 rs3020348(A;C) plus 0.4307 rs7646(C;T) 38.1% minus 0.2057 rs2982552(C;T) minus rs1999805(C;T) minus 0.4876 rs2152750(A;G) minus 0.4683 rs2504063(A;G) 46.9% plus 0.4206 rs827422(A;A) minus 0.449 rs827421(T;T) 30.8% minus rs2431260(C;G) minus 0.3163 rs9397456(A;G) 37.5% plus 0.2622 rs1801132(C;G) plus 0.2617 rs3020314(C;T) 35.4% plus 0.433 0.64x reduced lymphoma risk 0.64x reduced lymphoma risk rs3020377(A;G) plus rs3020317(T;T) 77.0% plus 0.2929 rs1884051(A;G) plus 0.4343 rs985192(C;C) 74.1% plus rs2982694(T;T) 77.9% plus 0.1832 rs985694(C;C) 74.3% plus 0.2507 rs1709183(A;G) 46.9% minus 0.3985 rs9322336(C;T) 39.8% plus 0.2287 rs1913474(C;T) 41.5% minus 0.2769 rs2347867(A;G) plus 0.4417 rs726281(A;G) plus rs3020328(C;T) 32.8% plus 0.494 rs7757956(A;T) plus 0.1377 rs722208(A;G) 36.9% plus 0.4123 rs722207(A;G) plus 0.3788 rs1569788(C;T) plus 0.4132 rs9340969(C;T) plus 0.4123 rs2207396(A;G) plus 0.2277 rs2982896(C;T) 42.2% plus 0.1919 rs3798577(C;T) plus 0.4399 rs2747648(T;T) 90.8% plus rs910416(C;T) 50.8% plus 0.4449 rs2295193(A;G) plus 0.3595 rs1322512(T;T) 54.0% minus 0.3379 rs596359(T;T) minus 0.4674 rs926778(A;C) plus rs2982712(C;T) plus 0.3554 rs2186141(G;G) 25.4% minus 0.4339 rs9384169(C;C) 10.6% plus rs9478495(A;A) 2.7% plus rs1074287(G;G) 3.1% plus 0.287 rs510769(A;A) 4.4% minus 0.2185 rs524731(A;A) 2.7% plus rs3823010(A;G) plus rs3778150(C;T) plus rs9478503(C;T) plus rs3778151(C;T) plus 0.1657 rs3778157(C;T) plus rs1937579(A;A) 47.7% minus 0.2084 rs6900489(C;G) plus rs540825(A;A) 58.5% minus 0.1263 rs675026(C;C) 36.9% minus 0.2415 rs562859(A;A) 37.2% minus rs2236256(A;C) plus 0.4711 rs9397738(A;G) plus 0.1267 rs231950(A;G) plus 0.3926 rs9384488(A;G) plus 0.4798 rs9365723(G;G) 31.9% plus 0.4913 rs2171209(A;G) minus 0.3751 rs563649(A;G) 11.6% minus 0.1042 rs2075572(C;G) plus 0.4036 rs1738074(A;G) minus 0.4412 rs212402(C;T) minus rs394581(C;T) 47.8% plus 0.2654 rs2842992(T;T) 60.2% minus 0.3338 rs4342445(A;A) 8.0% plus 0.2801 rs6917589(C;C) 8.0% plus rs2842980(A;A) 60.2% minus 0.292 rs5746136(A;A) 10.6% minus 0.3214 rs416572(A;G) minus rs998075(C;T) 51.3% minus 0.4302 rs3777411(A;G) 22.1% minus rs3777404(C;T) minus 0.1763 rs628031(A;G) 44.6% plus 0.3021 rs622342(A;C) plus 0.2713 rs651164(G;G) 41.6% plus 0.3682 rs316006(A;A) 64.1% plus rs316020(C;C) 81.4% minus rs316019(G;T) 17.7% minus 0.1221 rs220721(A;G) 36.3% minus 0.3811 rs6917747(A;G) plus 0.07668 rs1003737(C;C) minus 0.4587 rs8191754(C;G) 27.7% plus 0.1419 rs1570070(A;G) 44.2% plus rs78797168(A;G) plus rs3120139(C;T) minus 0.1497 rs172722(G;G) minus 0.4738 rs2504916(T;T) 60.3% minus 0.1515 rs2292334(C;T) minus 0.3434 rs2048327(A;G) minus 0.3223 rs1810126(A;G) 52.2% minus 0.3278 rs3088442(A;G) plus 0.3214 rs6919346(C;T) plus 0.0854 rs7767084(C;T) plus 0.1575 rs10755578(C;G) 47.8% plus 0.4118 rs6415084(C;T) plus 0.3329 rs7770628(C;T) 52.2% plus 0.2888 rs402219(C;T) 42.5% minus 0.3159 rs3798943(C;T) plus rs7755681(C;T) 43.1% plus 0.337 rs992037(C;T) plus 0.2805 intermediate lysine values intermediate lysine values rs926849(A;A) 52.2% minus 0.2741 rs9456721(C;C) 34.5% plus 0.41 rs4709583(G;G) plus rs6902041(A;G) plus 0.4504 rs2023004(G;G) 13.8% minus 0.3604 rs1084651(A;G) plus rs783147(C;T) minus 0.4114 rs7744433(C;T) plus 0.2282 rs1333955(A;G) minus 0.4141 rs1040079(C;T) minus 0.2971 rs10945919(A;G) 53.1% plus 0.3462 rs227458(C;C) 74.3% plus 0.05877 rs519595(C;C) 82.5% minus 0.1988 rs545099(A;A) 96.8% minus rs7762160(C;C) 20.4% plus 0.3462 rs753760(G;G) 7.9% plus 0.2824 rs9356058(C;T) 36.9% plus 0.3021 rs6456042(C;C) 39.8% plus 0.2948 rs6915183(A;G) 53.1% plus 0.2943 rs2236313(C;T) plus 0.4385 rs2149085(C;T) plus 0.393 rs1819333(G;T) plus 0.3935 rs415890(C;G) plus 0.3935 rs2301436(A;G) 39.8% minus 0.3875 rs6902119(C;T) plus rs3093024(A;G) 42.5% plus 0.393 rs1854853(A;G) 45.1% plus rs10946216(C;T) plus 0.4027 rs1056053(A;A) 39.8% minus 0.2851 rs1571878(C;T) 46.2% plus rs11575088(A;C) plus rs9364220(A;G) plus 0.3673 rs9455973(A;G) plus 0.2612 rs2095019(A;C) 18.6% plus rs8089(G;T) Bad 38.9% minus 0.1823 slightly increased heart attack risk slightly increased heart attack risk rs6422747(A;A) 23.9% plus 0.3278 rs6422748(C;C) plus 0.3457 rs9406328(A;A) plus 0.3503 rs3093023(A;G) plus 0.3398 rs12190007(A;G) plus 0.2769 rs438465(C;T) plus 0.2718 rs924043(C;C) 79.6% plus 0.3866 rs2103816(T;T) 44.2% minus 0.4238 rs1997243(A;G) 28.3% plus rs1133043(C;G) 55.6% plus rs10275044(T;T) 66.2% plus 0.4995 rs10277115(T;T) 61.5% plus 0.4651 rs13241427(T;T) 65.5% plus rs6942930(A;G) plus 0.4541 rs7452888(A;G) 44.4% plus 0.3655 rs4721135(A;G) 42.2% plus 0.3903 rs10275045(C;T) 37.2% plus rs4332037(C;T) 31.0% plus 0.1538 rs12699477(C;T) plus 0.3205 rs12666575(C;T) 46.0% plus 0.3264 rs6461049(C;T) 40.2% plus rs4721295(G;T) plus rs1107592(C;T) 44.2% minus 0.416 rs4866(A;G) plus 0.02663 rs6952809(C;C) 40.7% plus 0.3136 rs6952808(C;G) plus 0.3907 rs7805247(T;T) 72.3% plus 0.08356 rs4722404(C;T) plus 0.4004 rs936909(C;T) 24.8% minus 0.1657 rs687464(A;G) 43.1% plus rs10488360(A;A) 8.0% plus 0.3618 rs314590(A;A) 82.5% plus 0.1428 rs10216189(A;G) plus rs6977940(G;T) 12.3% plus 0.1152 rs1805319(G;G) 71.0% minus 0.157 rs2228005(G;G) 71.0% minus rs7797466(A;G) plus 0.208 rs10259085(C;T) 59.5% plus 0.4017 rs1299548(C;T) minus 0.4495 rs10486158(C;T) 36.3% plus 0.3131 rs4140804(A;A) plus rs12702661(G;G) 68.1% plus 0.225 rs37972(C;T) plus 0.3742 rs59072263(G;T) plus 0.1556 rs6463768(G;G) 93.2% plus rs765855(A;G) 47.8% plus 0.3012 rs836478(A;A) 23.0% minus 0.3448 rs702485(G;G) 22.1% plus rs12702595(A;C) plus rs2349775(A;G) plus 0.1267 rs10486275(C;C) 19.5% plus 0.2309 rs1371737(A;C) 32.8% plus 0.4711 rs1526538(T;T) 42.5% minus rs769111(A;C) minus 0.4109 rs1035147(G;T) 28.3% minus 0.1286 rs3735222(T;T) 16.8% minus rs2240571(C;C) 28.3% plus rs2240572(G;G) 20.0% plus rs732577(A;A) 27.9% minus 0.4013 rs7781293(A;A) 48.2% plus 0.4605 rs4628172(G;G) 75.2% plus 0.3058 rs1295371(A;G) minus 0.2374 rs2882834(G;G) 15.9% plus 0.2378 rs4720952(A;G) plus 0.4224 rs2074597(G;T) minus 0.3242 rs10278557(A;G) plus 0.2502 rs2159222(A;T) 27.7% plus 0.191 rs1525739(C;C) 22.1% minus 0.3797 rs6961860(T;T) 17.7% plus 0.4164 rs4410790(C;T) plus 0.4899 rs6968554(A;G) 46.0% plus rs12670403(A;C) plus 0.4279 rs13236243(A;A) 48.7% plus 0.3751 rs10250822(T;T) 61.7% plus 0.2516 rs1476080(C;C) 39.8% minus 0.4821 rs6960165(A;A) 58.9% plus 0.1809 rs10270805(A;G) 15.0% plus 0.04408 rs12699800(C;T) 45.5% plus 0.4692 rs10253216(A;G) plus 0.3613 rs7811989(G;G) 52.7% plus 0.2388 rs10499504(A;G) 33.6% plus 0.1235 rs4142995(G;T) 47.3% plus rs213273(A;A) 87.5% plus rs2240419(G;G) 55.8% minus 0.2048 rs2853552(C;C) 48.7% minus rs4470914(C;T) 27.7% plus 0.2264 rs6977660(C;T) 26.2% plus 0.3499 rs6954796(G;G) 75.0% plus 0.2066 rs3735615(G;G) 32.3% plus 0.3742 rs975263(T;T) 2.7% minus 0.4219 rs10226084(C;T) plus rs1919314(A;T) 18.6% plus 0.2011 rs1990172(G;G) 5.3% minus 0.4045 rs10950821(C;G) 38.5% plus 0.3815 rs12155172(A;G) 29.2% plus 0.1855 rs10950840(T;T) 53.6% plus 0.2406 rs2285947(A;A) 22.1% plus 0.4096 rs6461593(C;T) plus 0.1662 rs4487645(A;C) plus 0.2268 rs1522280(A;G) minus rs2097677(A;G) plus 0.2218 rs7805828(A;G) plus 0.3439 rs1880242(G;T) 51.3% plus 0.4784 rs3095008(T;T) 15.5% minus 0.3921 rs2056576(C;T) 38.9% plus 0.2599 rs1800797(A;G) 43.4% plus 0.1818 rs1800795(C;G) 43.4% plus 0.185 complex; see details complex; see details rs2069832(A;G) 43.4% plus 0.1837 rs2069833(C;T) 49.2% plus 0.1832 rs1474347(G;T) minus rs2069840(C;G) 40.7% plus 0.2172 rs1554606(G;T) plus 0.2672 rs2069845(A;G) plus 0.2704 rs10242595(A;G) plus 0.4421 rs7801406(A;G) 42.5% plus 0.1754 rs10216322(A;A) 4.4% plus rs156299(A;C) minus rs16147(G;G) 30.1% minus 0.4449 rs5573(A;A) 14.3% plus 0.4504 rs5574(T;T) 25.7% plus 0.4151 rs754554(A;C) 24.8% minus 0.242 rs2710994(C;T) 25.7% plus 0.3916 rs39453(C;T) plus 0.3136 rs2240727(A;A) 8.8% minus rs2286503(A;A) 17.5% minus rs156429(C;T) minus 0.4697 rs375092(A;C) 24.8% plus rs12700667(A;A) 58.0% plus 0.4972 rs10261878(C;C) 80.0% plus 0.1956 rs4722551(C;T) plus rs745580(T;T) 22.1% minus 0.4683 rs4722585(A;G) plus rs886716(A;G) 42.0% plus 0.3118 rs7804356(C;T) plus 0.1717 rs10486483(A;G) plus 0.1708 rs6668(C;T) plus 0.2181 rs2428431(C;G) 40.6% plus 0.2006 rs17151904(A;G) plus 0.2984 rs975369(A;G) plus 0.1736 rs2301720(A;C) 25.7% plus rs7810502(A;G) plus rs3801776(A;G) 45.1% plus 0.3007 rs3779456(C;C) 28.3% plus 0.4073 rs4722672(C;T) 30.1% plus 0.3163 rs17428471(G;T) 15.4% plus rs849136(A;G) 40.7% plus 0.174 rs864745(A;G) minus 0.3549 rs849140(C;T) plus 0.3705 rs2230229(A;A) 69.0% minus 0.1006 rs20575(C;G) 41.7% minus 0.4275 rs6557634(A;G) minus rs4242392(C;T) plus rs10503733(A;A) 8.0% minus 0.2897 rs2228013(C;T) minus 0.0225 rs13259668(A;C) 46.0% plus 0.298 rs11781622(A;A) 54.7% plus 0.1956 rs1457266(C;C) 44.2% minus 0.4743 rs1379357(C;G) minus 0.4761 rs6557786(A;G) plus rs11994014(G;G) 68.1% plus rs2979704(T;T) 77.0% plus rs1059111(T;T) 76.2% minus rs17763685(C;T) 18.6% plus 0.06015 rs218869(A;A) 57.7% plus rs10109414(C;T) 50.0% plus 0.3196 rs17786744(A;G) 49.2% plus 0.3407 rs1013209(C;T) 27.0% plus 0.3049 rs11135910(C;T) 27.4% plus 0.09229 rs1048101(C;T) 49.6% minus 0.3604 rs13278849(A;A) 55.8% plus rs2221894(A;G) plus 0.3264 rs7844537(G;G) 90.6% plus rs13251954(G;G) 60.2% plus 0.4904 rs2954793(C;T) 45.3% plus 0.2342 rs11987193(C;C) 53.1% plus rs12548021(A;G) 46.9% plus 0.3058 rs10091038(A;C) 49.1% plus 0.3981 rs9693444(A;C) 47.8% plus 0.3338 rs309844(A;G) minus 0.1511 rs9331896(A;A) 41.6% minus rs569214(G;T) 48.7% plus 0.3545 rs4732812(C;T) 35.4% plus 0.2401 rs2614046(C;T) plus 0.1584 rs2241802(A;G) 46.0% plus 0.4573 rs2323019(A;G) plus 0.4385 rs352203(C;T) 46.0% plus 0.3701 rs880481(A;G) minus 0.4665 rs352428(A;G) 26.5% plus 0.1001 rs1113990(C;G) 40.0% minus 0.4545 rs1446682(T;T) 3.5% minus 0.1584 rs28834970(C;T) plus rs3735757(G;G) 67.2% minus rs2279590(G;G) 45.3% minus 0.2631 rs7982(C;C) minus 0.348 rs1532277(C;C) plus 0.2562 rs1532278(C;C) 42.0% plus 0.2815 rs17426222(C;T) 44.2% plus 0.2006 rs4732957(C;C) plus 0.3517 rs4732682(C;T) 50.0% plus 0.4421 rs573514(C;T) 50.0% minus 0.3586 rs1383914(A;G) minus 0.4835 rs574584(A;A) minus 0.135 rs573542(A;A) 92.0% minus 0.1038 rs3808585(C;T) 40.7% plus 0.2916 rs1003247(A;G) minus rs7777593(G;T) plus 0.4522 rs4504543(C;T) plus 0.3664 rs1425132(G;G) 27.7% plus 0.4027 rs1721400(C;T) plus 0.1396 rs6959212(C;T) plus 0.3517 rs1524058(C;T) plus 0.4174 rs4723738(A;G) 50.4% plus 0.4454 rs11984145(C;T) 13.3% plus 0.04224 rs7801303(G;G) 21.2% plus rs1079866(C;G) 24.8% minus 0.135 rs4724055(T;T) 94.7% plus rs2598116(G;T) 19.5% minus 0.1455 rs1802073(A;C) 47.7% minus 0.4927 rs2722280(C;T) 16.9% plus rs1668357(A;A) 81.5% minus 0.1754 rs2877098(C;C) 49.2% plus 0.3384 rs10486722(T;T) 47.8% plus 0.4316 rs12701937(T;T) 17.7% plus 0.292 rs3735361(C;T) 41.6% plus 0.332 rs3823720(A;G) plus 0.2709 rs929387(C;T) minus 0.4206 rs6463089(A;G) plus 0.08127 rs3801192(C;T) 16.8% plus 0.07622 rs2049622(A;A) 24.8% plus 0.478 rs4724100(C;T) plus 0.4178 rs7791745(C;C) 61.9% plus rs4520070(T;T) 16.9% plus 0.3981 rs2024125(C;T) minus 0.3912 rs6972429(C;T) 39.1% plus 0.3926 rs699512(A;A) 54.0% plus 0.2089 rs2877262(C;C) plus 0.4284 rs2690381(A;A) 4.4% minus 0.241 rs3757840(A;C) minus 0.4316 rs1127065(A;G) 49.1% minus 0.3485 rs217434(A;G) 32.7% plus rs2072183(C;G) minus 0.2723 rs17655652(C;T) plus rs2107732(A;G) plus 0.04683 rs35539615(C;G) plus 0.2837 rs1995051(A;G) 48.6% plus 0.309 rs3110697(G;G) 27.4% plus 0.3962 rs2854747(T;T) 1.0 0.0% minus 0.3857 2743.02ng/mL of IGFBP-3 in plasma 2743.02ng/mL of IGFBP-3 in plasma Highest Insulin-like Growth Factor Binding Protein 3 (IGFBP-3) levels in plasma. The geometric mean (average) amount of IGFBP-3 in blood plasma for people with this SNP is 2743.02 nanograms per milliliter (for all races). 95% of people with this are in the range 2635.04ng/mL to 2855.43ng/mL. rs2854746(G;G) minus 0.4826 rs2854744(A;A) minus 0.4513 rs2132570(C;C) minus 0.2126 rs2960436(A;A) plus 0.4467 rs11977526(A;A) 11.5% plus 0.4803 rs788748(A;G) 42.5% plus rs700750(G;T) minus rs700752(C;G) 53.1% minus 0.3108 rs1370916(C;T) 48.7% plus rs11767191(C;T) plus 0.4164 rs7805803(A;G) plus 0.3384 rs2366293(C;G) plus rs17664743(A;G) plus 0.3485 rs1456893(A;G) plus 0.3857 rs1456896(A;G) 47.8% minus 0.4008 rs10276619(A;G) plus 0.4541 rs1722146(C;T) 24.8% minus 0.14 rs7784776(G;G) 19.5% plus 0.4844 rs6583437(A;G) plus 0.3994 rs6421315(C;G) plus 0.4389 rs12718597(A;C) plus 0.298 rs12718598(C;C) 23.4% plus 0.4816 rs11978267(A;G) 46.0% plus 0.2282 rs2060762(G;G) 75.2% plus 0.2222 rs3757472(G;T) minus 0.3696 rs11761683(C;T) 38.1% plus 0.3283 rs12718541(A;G) 52.5% plus 0.4633 rs1451371(C;T) plus 0.4096 rs1470750(C;G) 42.9% minus 0.2681 rs3735273(A;G) 35.4% minus 0.2787 rs998850(C;G) minus 0.4096 rs11974297(A;G) plus 0.4784 rs11980379(C;T) plus rs6964969(A;G) 46.0% plus 0.2254 rs10272724(C;T) plus rs2044859(A;G) minus 0.3838 rs2329340(C;T) 40.7% plus 0.348 rs1451375(A;C) plus 0.3384 rs921451(C;T) plus 0.3384 rs3837091(-;AGAG) minus rs2237457(C;T) 50.4% plus rs2190503(C;C) 77.9% minus rs1174864(C;T) minus 0.4376 rs6593122(C;T) 38.9% plus 0.1598 rs679830(C;C) 86.4% plus rs6946131(C;C) 20.4% plus rs712830(C;C) plus 0.1111 rs723526(G;G) 61.8% plus 0.09504 rs12535536(A;G) plus rs2302535(A;C) 35.4% plus 0.4169 rs10248619(C;C) 61.9% plus 0.2433 rs2282930(A;G) plus rs35205176(A;T) plus rs406001(C;C) 88.7% plus 0.05785 rs6964705(A;C) plus 0.4568 rs2072454(C;T) 49.6% plus 0.4545 rs730437(A;C) 54.1% plus 0.4522 rs2075110(C;T) 49.6% plus rs4947986(A;G) plus 0.332 rs17337023(A;T) plus 0.3828 rs2017000(A;G) 40.7% plus rs9642393(C;T) plus rs1050171(A;A) 33.8% plus 0.4183 rs845561(T;T) 60.2% plus rs7799627(A;G) plus 0.2328 rs759158(T;T) 35.9% plus 0.3549 rs12718945(G;T) plus 0.4743 rs6970262(A;G) 46.0% plus rs9656709(A;C) 44.2% plus rs7806994(A;T) plus rs940494(A;G) 33.6% plus 0.1483 rs4870684(C;T) 33.6% plus 0.4628 rs6956675(G;G) 59.3% plus rs10266483(G;G) 43.1% plus 0.3618 rs4718142(C;T) plus rs17711722(C;T) 50.4% plus rs11763147(A;G) 50.0% plus 0.4389 rs4947534(C;C) 57.8% plus rs4948102(G;G) plus rs801193(G;T) minus 0.4559 rs10263935(A;G) plus 0.455 rs4718428(G;G) 5.6% plus 0.4679 rs7807441(T;T) 36.3% plus 0.4587 rs1403155(A;G) plus 0.07989 rs6945541(C;T) 59.3% plus 0.2319 rs11765886(C;T) plus 0.2952 rs6943555(A;T) plus 0.3393 rs734930(G;G) 23.0% minus 0.4706 rs1525293(C;T) 48.7% plus 0.3453 rs9530(C;T) 49.6% minus 0.4183 rs875971(C;T) plus 0.4504 rs11766496(C;G) plus 0.1304 rs12699131(G;G) 33.0% plus 0.4954 rs12539316(A;G) 37.2% plus 0.2447 rs2286276(A;G) 37.5% minus 0.2406 rs1051921(C;T) minus 0.1304 rs13247874(C;T) plus 0.1318 rs13226650(A;G) 27.4% plus 0.1763 rs17145750(C;T) 22.1% plus 0.1244 rs7798357(C;G) plus 0.241 rs4719147(G;T) plus 0.4334 rs799161(A;G) minus rs4363087(C;C) 9.2% plus 0.3884 rs941298(C;T) minus 0.242 rs4078435(C;T) 43.4% plus 0.3035 rs2071307(A;G) plus 0.2553 rs2856728(T;T) 71.7% plus rs3757587(C;T) 27.4% plus 0.1061 rs34208922(-;A) plus 0.2773 rs8326(C;G) plus 0.1974 rs6460071(A;G) plus 0.2034 rs7800944(C;T) plus 0.2397 rs710968(C;T) minus 0.236 rs2527367(T;T) 54.9% plus rs13447(C;T) plus rs1167796(A;G) 43.4% plus 0.3007 rs13240755(A;A) 39.8% plus 0.4688 rs4732513(T;T) 39.8% plus 0.4688 rs2868370(T;T) 1.5% minus 0.1667 rs7789940(G;G) 1.6% plus 0.3402 rs758944(T;T) 2.7% minus 0.3402 rs6955651(C;C) 59.4% plus 0.3636 rs3864639(C;T) 30.3% plus 0.1791 rs4727380(C;C) plus rs6465825(C;T) plus 0.3691 rs848452(C;T) plus 0.1529 rs4729938(C;C) 38.9% plus 0.3471 rs757863(A;G) 55.8% plus 0.3838 rs2691528(T;T) 61.9% plus 0.2792 rs2691543(C;T) 15.4% plus 0.04913 rs7779014(T;T) 1.5% plus 0.3398 rs17149161(A;A) 1.5% plus 0.3398 rs7785088(A;G) 41.5% plus 0.4155 rs2190665(C;G) 36.0% plus 0.478 rs13246026(A;C) plus 0.3269 rs4731111(A;G) 34.5% plus rs6466884(C;T) plus rs7803811(A;C) plus rs17802148(C;T) plus rs7805663(A;G) 28.3% plus rs10486920(A;G) plus rs9640699(A;C) 54.0% plus 0.4674 rs2215379(C;T) plus 0.253 rs2160322(C;G) plus 0.4669 rs7803705(A;G) 42.5% plus 0.2241 rs2523189(C;T) 50.4% plus rs2886609(A;G) minus rs12706724(G;G) 56.8% plus rs4731302(C;T) 41.6% plus rs11760281(A;G) 48.4% plus 0.4513 rs1761667(A;G) plus 0.4279 rs10499859(A;G) 46.2% plus 0.382 rs1527479(A;G) minus 0.3916 rs3211883(A;T) 19.0% plus 0.3017 rs3211892(A;G) 5.3% plus 0.08494 rs2366858(A;A) 99.1% plus 0.05785 rs4236644(G;G) 52.2% plus 0.3678 rs500454(C;C) 98.5% minus rs1743(A;T) 36.4% plus 0.2383 rs4732402(C;G) plus 0.2383 rs1194197(A;G) minus 0.4252 rs2074724(C;T) 34.4% plus rs5745718(A;C) minus 0.1607 rs12536657(A;G) 36.3% plus 0.1276 rs12540393(C;T) 35.9% plus 0.2062 rs17427817(C;G) 39.8% plus 0.1584 rs9642131(G;T) 40.7% plus 0.1956 rs797821(G;G) 39.8% minus 0.3779 rs797820(T;T) 55.8% minus 0.1598 rs10235789(C;C) 26.2% plus 0.3154 rs447(C;C) minus 0.1511 rs488333(A;G) plus 0.2397 rs7800072(G;G) 15.9% plus 0.3049 rs12176601(A;T) 29.2% plus 0.2815 rs1029564(G;T) plus 0.2149 rs2190208(C;T) plus 0.4637 rs3735520(C;T) minus 0.4578 rs11978472(C;C) 23.9% plus 0.3691 rs10262537(C;T) 39.8% plus rs2373124(A;G) plus rs2708553(C;T) plus rs12673599(C;C) 73.5% plus rs1554888(T;T) 73.5% plus rs274618(A;T) plus 0.2388 rs274622(C;T) 47.8% plus 0.2654 rs13242038(C;T) 37.5% plus 0.1543 rs724226(A;G) plus 0.241 rs2189812(C;G) 39.8% plus 0.146 rs917071(C;T) 39.3% plus rs41440(G;G) 7.2% plus rs1468412(A;T) 43.1% plus 0.3512 rs1989796(C;C) plus 0.4568 rs1476587(A;G) 20.4% plus 0.1758 rs58238559(C;T) plus 0.005969 rs1045642(C;C) 1.0 15.0% minus 0.3967 increased risk of cannabis dependence, lower (normal) cancer risk increased risk of cannabis dependence, lower (normal) cancer risk '''Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence.''' (2009). Patients with cannabis dependence (n=40) had a significantly higher 3435C allele frequency (62.5% versus 43.8% respectively, P=0.017) and CC genotype (50% versus 20%, P=0.005, OR=4.00 [1.50-10.60). The CC genotype was independently associated with cannabis dependence. This is the first time a significant specific genetic marker has been shown in cannabis dependence. ABCB1 polymorphisms may alter Delta9THC distribution, its psychoactive effects and individual vulnerability to dependence. rs2032582(G;G) 1.0 25.7% minus 0.3402 normal. better response to atorvastatin. greater severity of delusions in male schizophrenics. normal. better response to atorvastatin. greater severity of delusions in male schizophrenics. '''Association study between the MDR1 gene and clinical characteristics in schizophrenia.''' (2014). Male schizophrenic carriers of the G allele of variant rs2032582 exhibit greater severity of delusions. rs2235046(G;G) 25.7% minus 0.4421 rs2091766(T;T) 14.2% plus 0.3829 rs2235035(T;T) 4.4% minus 0.2888 rs10276036(T;T) 26.5% plus 0.4357 rs1476455(A;C) plus 0.2149 rs17327442(A;T) plus 0.169 rs1202186(A;G) 46.0% minus 0.2461 rs1029421(G;G) 21.4% minus 0.3577 rs2285647(C;T) minus 0.2769 rs1981529(T;T) 53.8% plus 0.1602 rs3899697(A;T) plus rs6973392(C;T) 8.1% plus 0.1745 rs4728702(T;T) 35.9% plus rs1859023(C;T) 52.8% minus 0.3026 rs2232157(G;T) plus 0.4022 rs2232158(C;G) plus 0.4036 rs2888830(A;A) 46.9% plus 0.3535 rs2540552(A;G) 50.9% minus 0.3623 rs7808587(A;A) 23.0% plus rs2282972(T;T) 15.0% plus rs2961024(A;A) 50.0% minus rs6465348(G;G) 13.8% plus 0.3522 rs2040494(T;T) 27.0% plus 0.2883 rs42648(A;G) 50.8% plus 0.4118 rs7780752(C;C) 11.5% plus 0.2493 rs4517(A;C) minus rs180273(C;T) 26.2% minus 0.1579 rs180242(A;T) minus 0.3572 rs9918668(A;G) plus 0.4959 rs10487245(A;G) plus rs7792596(C;T) plus 0.388 rs42517(A;G) 23.8% plus 0.2034 rs445(C;T) 26.5% plus 0.1795 rs441051(C;T) plus 0.1869 rs2621215(G;T) 25.0% plus 0.1896 rs854547(A;G) plus 0.4702 rs854548(A;G) 46.9% plus 0.2971 rs3735590(C;T) minus 0.1575 rs854555(A;C) 51.3% plus 0.4715 rs662(A;G) minus 0.4835 0.65x lower risk of ovarian cancer; higher risk of coronary heart disease in some studies; somewhat reduced PON catalytic efficiency 0.65x lower risk of ovarian cancer; higher risk of coronary heart disease in some studies; somewhat reduced PON catalytic efficiency rs2057681(A;G) 46.9% plus 0.4784 rs854560(A;T) plus 0.2052 higher risk for heart disease, diabetic retinopathy higher risk for heart disease, diabetic retinopathy rs854563(A;G) plus 0.1997 rs42524(C;G) 24.6% plus 0.1474 rs705381(C;C) 0.0% plus 0.2388 normal normal rs854571(C;T) plus 0.3531 rs854572(C;G) 54.9% plus 0.4004 rs10487132(A;G) 55.8% plus 0.1956 rs17884563(A;T) minus 0.09045 rs987539(C;T) 54.0% plus 0.3485 rs12704795(G;T) plus 0.225 rs11981433(C;T) plus 0.225 rs11982486(C;T) plus 0.1951 rs4729189(A;A) 64.1% plus 0.2112 rs4729260(C;C) 56.2% plus 0.2502 rs10429035(A;G) plus rs4727338(C;C) 53.1% plus 0.2502 rs7781370(C;C) 51.3% plus 0.2479 rs12669076(C;T) 43.1% plus 0.2084 rs7794886(C;T) plus rs12056091(A;G) plus rs13475(A;G) plus rs1229542(T;T) minus 0.1979 rs13438327(A;G) plus 0.0854 rs1488515(G;T) plus 0.1951 rs6465657(C;T) 52.2% plus 0.2801 rs10211(A;A) 89.4% minus 0.2865 rs4727443(A;A) 16.8% plus 0.4109 rs999885(T;T) 29.7% minus 0.4674 rs1476679(C;T) 40.7% plus rs10247962(A;A) 68.1% plus rs7385804(A;A) 39.7% plus 0.3131 rs4434553(A;G) 50.4% plus rs9649213(A;G) 40.7% plus 0.4757 rs9297145(A;A) 46.0% plus 0.2906 rs2075672(C;C) 38.9% minus 0.3186 rs1734907(C;C) 69.6% minus 0.1331 rs1617640(T;T) 34.5% minus 0.3379 rs507392(T;T) 34.5% minus 0.3416 rs551238(A;A) 34.5% minus 0.3388 rs2227684(A;A) 15.9% plus 0.4353 rs2070683(T;T) plus 0.4275 rs2227694(G;G) plus 0.1019 rs11178(C;C) 15.9% plus 0.4362 rs7242(G;G) 15.9% plus 0.4371 rs1722229(T;T) plus rs2229864(C;T) 50.0% minus 0.4256 rs1008126(A;G) 44.2% minus rs13245899(A;G) 25.7% plus 0.2259 rs6976053(T;T) 18.6% plus 0.4982 rs2073559(C;T) 48.7% plus 0.472 rs607755(A;G) 50.4% plus 0.4651 rs3914132(T;T) 1.0 68.1% plus 0.1823 Normal otosclerosis risk Normal otosclerosis risk rs6951651(C;C) 10.6% plus 0.4697 rs2299403(G;T) 30.8% plus rs4298437(C;T) plus 0.2346 rs4073894(A;G) minus 0.1318 rs6968355(C;T) plus 0.09458 rs13438712(C;T) plus rs1319501(C;T) 31.9% plus 0.1635 rs362719(A;C) plus 0.3439 rs9770242(A;C) plus 0.1483 rs342275(T;T) 21.2% plus 0.2773 rs342293(G;G) 22.1% plus 0.3489 rs342296(A;A) 22.1% plus 0.3466 rs17398575(A;G) plus 0.1639 rs17477177(C;T) plus 0.1465 rs3752645(A;G) plus rs3757713(G;G) 3.5% minus 0.1391 rs4730250(G;G) 3.5% plus 0.1157 rs2072064(A;A) 4.6% plus 0.2309 rs2188561(A;A) plus 0.2149 rs2108225(A;A) 23.9% plus 0.4706 rs4730273(A;C) plus 0.2948 rs4380874(C;T) plus 0.2755 rs4730276(A;G) plus 0.3333 rs4510766(A;G) 48.7% plus 0.3834 rs6949033(C;T) plus 0.4242 rs886774(A;G) plus 0.2975 rs4598195(A;C) 44.2% plus 0.3278 rs10953541(T;T) 6.2% plus 0.1368 rs2158836(A;G) 42.5% plus 0.3026 rs382140(G;G) 66.4% plus 0.2507 rs1034825(T;T) 24.6% plus 0.4353 rs193451(G;G) 21.5% plus 0.2833 rs10277209(T;T) 74.3% plus 0.152 rs10953615(A;G) 53.1% plus 0.2319 rs2692877(A;A) 13.1% plus rs6968385(C;T) 53.8% plus 0.477 rs4730430(C;T) 56.2% plus 0.3893 rs10279573(C;T) 23.9% plus 0.1878 rs37648(A;A) 18.5% minus 0.4224 rs2300045(C;C) 26.5% plus 0.4642 rs10255299(A;G) plus 0.09091 rs6956741(A;G) 9.8% plus 0.08081 rs6968084(C;T) 23.0% plus rs3807213(A;C) 46.9% minus 0.4679 rs7817(C;T) 50.0% plus 0.3967 rs5009270(A;G) plus rs10229603(C;T) plus 0.2567 rs2253478(A;G) 43.5% plus 0.3549 rs12533005(C;G) plus 0.4164 rs61159171(C;T) plus 0.3898 rs2396753(A;C) plus 0.371 rs17137124(C;T) plus 0.4692 rs1229761(G;T) minus 0.2043 rs1456031(C;T) plus 0.4284 rs7784447(A;G) plus rs1918526(T;T) 100.0% minus rs2270188(G;T) 49.6% plus 0.4596 rs1052990(G;T) plus 0.3113 rs17588172(G;T) plus rs4742170(C;T) 51.3% plus 0.4444 rs10975514(A;G) plus rs11792633(C;T) plus 0.4027 rs1929992(A;G) minus 0.4045 rs10975519(C;T) 46.4% plus 0.3962 rs7044343(C;T) 50.0% plus 0.4977 rs10815468(C;G) plus 0.466 rs1340513(C;T) minus 0.303 rs10975990(A;G) plus 0.4881 rs10758821(G;T) 52.2% plus 0.4265 rs1407862(C;T) minus 0.4555 rs722628(A;A) 15.0% plus 0.377 rs1887867(C;T) plus 0.4614 rs2381628(C;T) plus 0.2052 rs842304(A;C) plus 0.4532 rs10758892(A;A) 90.3% plus 0.1079 rs16924631(C;G) plus 0.2089 rs1535480(G;G) 16.8% plus 0.4798 rs4562389(C;C) 46.9% plus 0.3421 rs1556032(T;T) 30.1% plus 0.4187 rs10961780(G;T) plus 0.2383 rs10756650(A;G) plus rs471364(A;G) 19.5% minus 0.1028 rs643531(A;C) plus 0.09826 rs686030(A;C) plus rs581080(C;G) plus 0.2369 rs2245641(C;C) 59.5% plus 0.2378 rs4401971(G;G) 44.2% plus rs10738445(C;C) 73.5% plus rs10756819(A;G) plus rs2153271(A;G) 53.1% minus 0.3595 rs12350739(A;G) plus rs3814113(C;T) plus 0.3953 0.8x decreased risk for ovarian cancer 0.8x decreased risk for ovarian cancer rs4961511(G;T) 49.1% plus 0.4215 rs606382(G;G) plus rs1755289(C;C) 37.2% plus 0.4399 rs1755271(A;G) minus rs12351590(A;A) 91.2% plus 0.2475 rs1325154(T;T) 81.4% plus 0.1166 rs2733832(T;T) 37.2% plus 0.2792 rs1063380(C;C) 48.7% plus 0.3476 rs1953021(G;T) 43.4% plus rs1324183(C;C) 57.1% plus 0.2172 rs973117(G;T) minus 0.4646 rs10759102(A;A) 9.7% plus 0.3797 rs294845(C;C) minus 0.2865 rs294856(A;C) 53.1% plus rs2475335(T;T) 72.6% plus 0.2805 rs649891(A;G) minus 0.4995 rs10809457(G;T) 48.3% plus rs2146180(A;A) 35.1% plus rs9299075(G;G) 46.9% plus 0.2599 rs10815798(A;G) 45.5% plus 0.4435 rs10481625(C;C) 47.7% plus 0.2406 rs7787531(T;T) 79.6% plus 0.1065 rs11556924(C;T) 54.0% plus 0.1919 rs2171492(G;T) 53.1% plus 0.3292 rs4731702(C;T) 56.4% plus 0.3737 rs972283(A;G) 52.3% plus 0.3365 rs205763(A;G) 36.3% plus 0.2548 rs2048672(G;T) minus 0.4917 rs6944165(A;A) 2.7% plus 0.2989 rs1013368(C;T) plus 0.3021 rs10954213(A;G) plus 0.4683 rs11770589(A;G) plus rs13242262(A;T) 51.8% plus 0.4679 rs11979476(G;T) plus 0.2764 rs10954361(A;G) plus rs1364505(A;G) plus 0.3026 rs958408(C;T) 35.4% minus 0.1846 rs10488172(G;T) plus 0.2819 rs763645(C;T) 53.2% plus 0.4477 rs9640883(A;G) plus 0.3104 rs4732038(C;C) 31.0% plus 0.4826 rs17169635(C;T) 36.3% plus rs4294134(A;G) 25.0% plus 0.315 rs12534221(A;C) plus 0.1703 rs11761231(C;T) plus 0.4334 rs1455858(G;G) 35.5% minus 0.3655 rs1824024(T;T) 39.3% minus 0.416 rs2061174(T;T) 44.6% minus 0.4697 rs8191992(A;T) plus 0.4743 rs6980334(A;A) 51.3% plus rs2035647(G;G) 55.4% plus rs10255295(A;G) 18.6% plus 0.08861 rs1874326(G;G) 71.7% plus 0.2392 rs3800569(A;G) 35.4% minus 0.2094 rs3807153(C;T) 1.0 5.3% minus 0.07805 carrier of a benign change carrier of a benign change rs2030712(T;T) 23.4% plus 0.3696 rs10277664(C;T) 47.8% plus rs194151(A;A) minus rs4725563(C;T) 31.0% plus 0.2397 rs6962291(A;T) plus 0.4063 rs11977670(A;G) plus rs10487888(A;G) 56.6% minus 0.2971 rs1285933(A;G) plus 0.4472 rs10258719(G;G) 48.2% plus 0.3411 rs10273639(C;T) plus 0.4513 rs6947538(C;C) 0.9% plus rs11771145(A;A) 11.5% plus rs10244837(A;A) 9.2% plus 0.4545 rs10500171(A;G) 48.7% plus 0.4495 rs10273775(A;G) 46.0% plus 0.45 rs2107856(A;C) 40.7% minus 0.3287 rs887569(A;A) 55.6% minus 0.2645 rs734004(G;G) 35.7% minus 0.3168 rs734005(T;T) 44.6% minus 0.2787 rs2072407(C;C) 39.8% minus 0.3007 rs6464926(C;T) 51.3% plus 0.4233 rs3757441(T;T) 61.9% plus rs12670401(C;T) plus 0.4242 rs6950683(C;C) plus rs2141388(C;T) 40.7% plus 0.3287 rs851715(A;A) 46.0% minus 0.2548 risk of speech development delay and/or impairment risk of speech development delay and/or impairment rs10246256(C;T) 41.5% plus 0.2975 None rs2710117(A;T) plus 0.365 None rs2538958(A;G) 55.4% minus 0.2704 rs2214681(C;C) 31.9% minus 0.4426 rs4549702(C;G) 47.8% plus 0.4197 rs3807375(A;G) 50.4% minus 0.4219 rs3778872(C;G) 23.1% minus 0.236 rs1800783(A;T) 50.8% plus 0.332 rs1800779(A;G) plus 0.2502 rs2070744(C;T) 0.0% plus 0.2571 None rs1541861(A;A) plus rs1800780(A;G) plus 0.41 rs822552(C;G) 29.0% plus 0.2796 rs354033(C;T) minus 0.2025 rs4721(C;C) 8.8% minus 0.472 rs17173608(G;T) plus 0.08907 lower visceral adipose tissue lower visceral adipose tissue rs6598(A;G) plus 0.3613 rs714885(A;G) minus 0.3095 rs2071514(A;G) plus 0.2911 rs1049748(C;T) plus 0.4945 rs1049793(C;G) 34.4% plus 0.4215 rs2071517(A;G) plus 0.3021 rs956642(A;G) plus 0.36 rs4725982(C;T) 31.0% plus 0.3682 rs2853792(A;A) plus rs3918181(A;G) plus 0.2994 rs3918188(A;C) plus 0.2998 rs2853796(G;T) 47.8% plus rs743507(A;A) 62.8% minus 0.2443 rs1808593(T;T) 68.3% plus rs9278(A;G) minus 0.09412 rs2069459(A;C) minus 0.3815 rs891507(C;C) 75.0% plus 0.0831 rs1549759(G;G) 75.4% plus 0.08494 rs3793336(T;T) 74.3% minus 0.1051 rs13232179(A;T) plus 0.2048 rs17173197(T;T) 18.6% plus rs10480300(C;T) 41.5% plus 0.18 rs7805747(A;G) plus 0.1979 rs10224002(A;G) 44.6% plus 0.2507 rs7795096(C;T) plus 0.3838 rs718282(C;C) minus rs3218499(C;G) 30.6% minus 0.1524 rs3218408(G;T) 32.7% minus 0.1465 rs2040639(A;G) minus 0.3705 rs10234749(G;T) plus 0.2626 rs1860746(A;C) minus 0.1483 rs6977820(C;C) 49.6% plus 0.4017 rs10239794(C;C) 40.7% plus 0.4642 average average rs3807218(G;G) 90.3% plus 0.1864 rs12666280(C;T) plus 0.3967 rs1800883(C;G) plus 0.4472 rs6320(A;T) plus 0.2764 rs2969540(C;T) 19.5% plus rs1345514(C;T) 49.6% plus 0.2227 rs758316(T;T) 45.1% minus rs3735653(A;A) 0.0% minus 0.4646 rs3824068(A;A) minus 0.4091 rs1861972(A;A) plus 0.2181 rs1861960(G;G) 61.1% plus 0.3641 rs1233560(T;T) 23.9% minus 0.4633 rs208684(A;A) 50.4% plus 0.2681 rs10949808(G;G) 28.3% plus 0.3402 rs6459804(T;T) 20.4% plus 0.4252 rs3800855(C;G) 28.6% minus 0.2328 rs2730245(C;G) plus 0.3595 rs2730220(C;C) 83.2% plus 0.1983 rs2730260(A;A) 71.7% minus 0.2691 rs17665859(C;T) plus 0.06841 rs6943029(A;G) plus 0.1951 rs10267337(A;C) 6.2% plus rs10226930(C;T) plus 0.06107 rs722782(C;C) 80.5% plus 0.242 rs17669535(C;G) 19.5% plus 0.09504 rs11986414(G;G) 64.6% plus 0.2677 rs4376531(C;G) 0.0% minus 0.2245 rs2280887(C;G) plus 0.2245 rs6558578(G;T) plus rs2924914(A;G) minus 0.2332 rs73660619(C;T) plus 0.1088 rs1442407(G;T) 23.0% plus rs2551043(C;T) 61.6% minus 0.359 rs995322(G;G) 85.0% plus 0.208 rs28680850(A;G) plus rs2449215(C;T) 32.7% minus rs1529316(C;T) 50.4% plus 0.3829 rs4875284(T;T) 98.4% plus 0.01056 rs4395908(G;G) plus rs2407314(C;G) plus 0.4706 rs1504771(A;T) 45.1% minus 0.4362 rs1714746(C;T) minus 0.4881 rs13259289(C;T) plus rs6558872(A;G) plus rs980238(A;C) plus 0.3728 rs4875102(A;G) plus 0.3604 rs2469383(G;G) 8.0% minus 0.286 rs1154053(C;C) 62.5% plus 0.1837 rs2616984(A;G) 47.8% plus 0.2144 rs62494762(C;C) plus 0.2117 rs2840445(A;G) plus 0.3604 rs2442513(A;A) 99.1% minus 0.07117 rs930557(C;C) 60.0% plus 0.3163 rs2440399(A;A) 61.1% minus 0.4017 rs2442496(C;C) 61.1% minus 0.3999 rs10112481(G;T) 48.7% plus rs7816936(C;T) plus 0.4256 rs1031309(G;G) 64.6% minus 0.3875 rs1868554(T;T) 55.4% minus 0.371 rs2442599(T;T) 55.4% minus rs2442598(G;G) 52.3% minus 0.3306 rs13269021(G;T) 43.4% plus rs2959799(C;T) 41.6% minus 0.4275 rs2013938(A;G) 44.2% plus 0.4279 rs11362(A;G) 1.0 45.1% minus 0.404 rs1799946(A;G) 44.2% minus 0.4219 rs2738113(A;A) 33.6% minus 0.4481 rs4300027(C;C) 32.7% plus 0.3512 rs332034(C;T) minus 0.1341 rs1045529(C;T) 49.6% plus 0.4536 rs330071(C;T) minus rs6984305(T;T) 80.0% plus 0.1139 rs4841132(G;G) 86.2% plus 0.08264 rs4240624(A;A) 86.2% plus 0.09871 rs1461729(C;C) 84.1% minus 0.0955 rs2055729(A;A) 51.3% plus 0.489 rs55864141(C;T) plus 0.3292 rs656319(A;G) minus 0.4128 rs545854(G;G) 67.3% minus 0.2181 rs4840463(C;C) 53.1% plus rs1484642(C;C) 85.0% plus 0.07438 rs11775334(A;G) 45.1% plus 0.4541 rs6999631(C;C) 96.5% plus 0.1547 rs6601427(C;T) plus 0.4045 rs4509385(C;T) 50.8% minus 0.4977 rs6601306(T;T) 87.6% plus rs6601327(A;A) 37.2% plus 0.4885 rs12545912(T;T) 58.4% plus 0.2718 rs7812879(C;C) 77.0% plus 0.1818 rs2254546(G;G) 77.0% plus 0.1694 rs2736340(C;T) 38.9% plus 0.3792 rs13277113(A;G) plus 0.377 rs4840568(A;G) plus 0.4426 rs2618476(C;T) plus 0.3838 rs1600249(A;C) 25.0% minus 0.3531 rs2248932(C;T) 40.2% minus 0.4954 rs2243407(C;C) 52.8% plus rs13273672(C;T) plus 0.3944 rs4281086(A;A) 33.0% plus 0.3489 rs4841398(C;T) 23.2% plus rs6601530(A;G) plus 0.4215 rs4240671(A;G) plus rs2293855(A;A) 14.2% plus 0.4036 rs804292(T;T) 48.7% minus rs2645430(C;T) minus rs2645424(C;C) 39.8% minus 0.4665 rs1296028(A;G) 37.2% plus 0.1635 rs8898(A;G) minus rs13332(A;C) minus rs4831837(A;A) 33.9% plus 0.45 rs6989010(G;T) 3.1% plus rs804280(T;T) 24.1% minus 0.2989 rs1466785(C;T) 46.9% plus 0.3857 rs2946505(A;C) minus 0.281 rs2460905(A;G) plus rs12541254(A;G) plus 0.2778 rs289585(A;G) 26.5% minus 0.101 rs9886428(A;G) plus 0.3292 rs1903595(C;T) 45.5% minus 0.174 rs7837164(T;T) 71.4% plus 0.2305 rs11203649(C;T) plus 0.2342 rs11989868(A;C) 31.0% plus rs4427170(T;T) 21.4% plus 0.4605 rs4831760(C;T) plus 0.2365 rs240657(A;A) minus 0.1451 rs1671400(C;C) 80.5% minus rs1962772(C;T) 44.2% plus rs13256095(G;T) 23.9% plus rs7829987(G;T) plus rs2299587(G;T) plus 0.3255 rs7830490(A;G) 43.4% plus 0.4247 rs1071645(A;G) 46.9% minus 0.4238 rs3753116(A;G) 46.9% plus 0.4224 rs3753118(T;T) plus 0.3802 rs1721082(A;T) 44.1% minus 0.3737 rs1721100(C;G) 39.6% minus 0.4137 rs1989754(C;G) plus 0.405 rs13271465(C;T) plus rs7006687(C;T) 42.5% plus 0.4256 rs1041983(T;T) 11.5% plus 0.3572 rs721399(A;A) 47.8% minus rs4921913(T;T) 58.7% plus rs335251(G;G) 15.4% minus 0.4683 rs6586714(G;G) 90.8% plus 0.1318 rs15561(A;C) 31.8% plus 0.4288 rs7833787(A;G) 42.2% plus rs4921617(C;T) 38.1% plus 0.478 rs920590(C;T) plus 0.3949 rs263(C;T) 26.5% plus 0.2374 rs283(A;G) 31.1% minus rs285(C;T) 35.4% plus 0.4458 rs320(G;T) plus 0.2525 rs326(A;G) 35.4% plus 0.3457 lower HDL cholesterol lower HDL cholesterol rs331(A;G) plus 0.2695 rs2638663(G;T) plus rs13702(A;G) minus 0.332 rs15285(A;G) 35.4% minus 0.3292 rs2197089(T;T) 31.0% minus 0.455 rs10105606(A;C) plus 0.3788 rs17489268(A;T) plus 0.2443 rs17411031(C;G) 31.9% plus 0.2452 rs2083637(C;T) 31.9% minus 0.2365 rs1441756(G;T) 34.4% minus 0.2107 rs1390943(G;T) plus 0.3953 rs4922199(A;C) 38.9% plus 0.3834 rs10111661(A;G) plus 0.455 rs11985951(C;T) plus rs7015657(C;G) 33.8% plus 0.3444 rs4078157(G;G) 42.4% minus 0.3274 rs17581368(A;C) plus 0.4219 rs4715(A;A) 6.2% plus 0.2126 rs12541335(A;G) 53.1% plus 0.2378 rs9644568(A;G) plus 0.1084 rs11780915(A;G) plus 0.3811 rs1879793(C;T) minus 0.433 rs10108011(A;G) plus 0.3196 rs13271367(A;G) 53.1% plus 0.3921 rs1075534(A;G) 45.1% plus 0.4688 rs11998649(C;C) 61.4% plus 0.2897 rs6557600(A;G) 25.8% plus rs1047275(C;G) minus 0.4683 rs13265018(G;G) 81.0% plus 0.1226 rs883429(C;T) 46.4% plus 0.2837 rs4460370(C;T) minus 0.3104 rs11785599(C;T) plus 0.3825 rs1047266(C;T) minus 0.1258 rs4259415(G;G) 22.1% minus 0.3264 rs1129424(T;T) minus 0.2567 rs2461483(C;T) 48.6% plus 0.4063 rs7430(C;G) plus 0.4068 rs391957(C;T) plus 0.2677 rs536861(A;C) 54.9% plus 0.4729 rs4837192(A;A) 75.2% plus 0.253 rs7865146(T;T) 46.0% plus 0.4229 rs2502731(C;T) 46.0% plus 0.359 rs3003609(C;T) 48.7% plus 0.4706 ? ? rs11539570(G;T) minus 0.00551 rs15676(C;T) minus rs2293968(C;T) minus 0.405 rs2280841(G;G) 61.9% minus 0.3292 rs2259043(C;T) 37.2% minus 0.4348 rs941960(C;C) 55.9% minus 0.337 rs7849270(G;G) 56.6% plus rs10988217(G;G) 42.5% plus 0.3857 rs4837240(G;G) 71.7% plus 0.2801 rs913275(A;A) 47.6% plus 0.4201 rs4836694(C;G) plus 0.2916 rs4740294(G;G) 74.3% plus 0.1864 rs7034356(G;G) 74.3% plus 0.1635 rs569434(C;T) minus 0.3682 rs11243897(A;G) 43.1% plus 0.3673 rs12552369(A;G) plus 0.3563 rs10988449(C;T) 23.9% plus 0.1685 rs7866070(A;G) 34.5% plus 0.4339 rs10901212(A;A) 63.7% plus rs739398(A;A) plus 0.4972 rs77905(C;C) 22.1% minus 0.3545 rs7021663(C;T) plus 0.2328 rs756777(A;G) 31.9% plus 0.2309 rs3780792(A;G) 45.1% plus 0.23 rs10785877(A;G) plus 0.315 rs881658(A;G) 40.0% minus 0.3691 rs881657(C;T) 40.0% minus 0.3641 rs11185659(C;T) 22.1% plus 0.1827 rs7864987(C;T) plus 0.2925 rs493014(T;T) 41.6% plus 0.3095 rs1805352(A;C) plus 0.4063 rs3132297(C;T) 30.2% minus 0.157 rs3132296(A;G) 44.6% minus 0.3921 rs3118529(C;T) 43.4% plus 0.4197 rs3118536(A;C) 26.8% plus 0.1579 rs3118570(A;C) 33.8% minus 0.1566 rs1536475(A;G) 30.6% plus 0.1763 rs3132293(A;G) minus 0.1882 decreased risk of Alzheimer's disease decreased risk of Alzheimer's disease rs4240711(A;G) plus 0.4463 rs4842194(C;T) 51.3% plus 0.4417 rs3118667(T;T) 26.4% plus rs4962153(G;G) 69.6% plus 0.1598 rs1989787(C;T) minus 0.1713 rs1611115(C;T) plus 0.2075 normal normal rs1108580(A;G) 50.9% plus 0.4376 rs5320(A;G) plus 0.1056 rs2519152(A;G) minus 0.3315 rs1076160(A;A) 27.4% minus 0.4146 rs512770(G;G) 67.0% plus rs574347(T;T) 48.7% plus rs2073828(A;A) 9.8% plus rs500498(C;T) plus rs630014(C;T) 51.3% minus 0.4605 rs7030248(A;G) plus rs7025162(C;T) 26.1% plus rs12681963(C;C) 79.5% plus 0.2016 rs10096097(A;A) 1.0 Good 49.6% plus 0.4949 normal Anorexia Nervosa risk normal Anorexia Nervosa risk rs2978263(G;G) 66.4% minus 0.2631 rs2253409(G;G) 55.4% minus 0.2002 rs2553268(A;C) 41.5% minus 0.2787 rs1346044(C;T) plus 0.1827 rs2575029(C;T) plus 0.1309 rs4733263(A;A) 36.3% plus 0.4867 rs1354336(T;T) 68.8% plus 0.186 rs1462872(C;C) 76.6% minus 0.3797 rs383632(C;C) 76.6% plus 0.2351 rs1462891(C;C) 65.5% plus 0.3852 rs2979481(C;T) plus 0.4963 rs10503871(C;T) 45.1% plus rs10097555(A;A) 35.4% plus rs16879552(C;T) 5.3% plus 0.2433 rs7835688(C;G) plus 0.3352 rs2439312(C;C) 58.0% minus 0.1938 rs7825175(A;G) plus 0.1515 rs2439305(C;T) minus 0.4017 rs2439302(C;G) minus 0.4013 rs3924999(C;T) minus 0.4114 rs1386438(G;T) plus 0.4545 rs12542743(C;T) plus rs1462906(C;C) 96.9% plus 0.1786 rs10093107(C;T) 50.4% plus 0.3976 rs9297216(C;T) 26.9% plus 0.2231 rs1534587(A;G) minus 0.3269 rs7814403(C;T) plus 0.427 rs13365225(G;G) 0.0% plus rs1015003(G;T) minus 0.3733 rs6996321(G;G) 42.5% plus 0.399 rs764059(A;A) 74.1% plus 0.1616 rs11780123(A;A) 82.3% plus 0.2567 rs7832232(A;G) 47.8% plus 0.4417 rs1349547(C;T) 33.9% plus 0.4927 rs7820268(T;T) 8.0% plus rs10958605(A;C) plus 0.371 rs11786458(G;T) 36.7% plus 0.4229 rs2722425(G;G) 81.4% minus 0.2466 rs3242(T;T) 10.8% minus 0.2287 rs921142(A;G) minus 0.332 rs11337(G;G) 92.3% plus rs3213849(A;A) plus 0.3159 rs930828(C;C) plus 0.3292 rs881301(C;C) 18.3% plus 0.3407 rs516946(G;G) 66.4% minus rs515071(C;C) 66.4% minus 0.2222 rs3136717(C;T) 22.1% plus rs2953983(C;T) minus 0.2433 rs2073664(C;T) minus 0.2443 rs3763511(C;T) minus 0.2406 rs7842601(T;T) 60.7% plus 0.3191 rs13273442(G;G) 60.2% plus 0.3214 rs1451240(G;G) 59.5% plus 0.3315 rs13277254(A;A) plus 0.3219 rs6474412(T;T) 66.7% plus 0.3292 rs6474413(T;T) 60.2% plus 0.343 rs2020918(C;T) 44.6% minus 0.2824 rs2272733(C;T) plus rs4950(A;A) minus 0.3618 rs4954(A;A) 93.8% plus 0.1258 rs58810682(T;T) plus 0.1552 rs7003908(A;A) 42.0% plus 0.2906 normal normal rs12155623(A;T) 54.9% plus 0.4013 rs10504073(T;T) 30.1% plus rs310558(T;T) minus 0.2746 rs7821565(C;T) plus 0.2971 rs10504130(A;G) plus 0.1299 rs7822058(C;T) plus rs1425902(A;A) 50.4% plus rs963549(C;T) 25.9% plus 0.2328 rs702764(C;T) plus 0.2328 rs6473797(C;C) 3.1% plus 0.3916 rs2292399(A;G) 51.3% plus 0.3163 rs10958369(A;G) plus 0.3949 rs11773966(C;C) 93.7% plus 0.01102 rs2859998(A;G) plus 0.3678 rs2081687(A;G) minus 0.2645 rs8192879(A;A) 17.0% minus 0.3485 rs1457043(A;A) 38.9% minus 0.4821 rs8192870(C;C) 46.9% minus 0.2447 rs3808607(T;T) 44.2% plus 0.45 rs3824260(G;G) 44.2% plus 0.4316 rs7833904(T;T) 33.8% plus rs1125226(A;A) minus 0.4986 rs1023652(C;C) 33.8% plus 0.3186 rs2622590(C;T) minus rs4737395(A;A) 77.0% plus 0.1263 rs6983130(A;G) 26.2% plus 0.1662 rs12545109(A;C) 38.1% plus rs3110127(C;T) 54.9% plus 0.4881 rs4737547(A;G) 48.4% plus 0.4541 rs12541902(A;C) 46.2% plus 0.2227 rs10098647(C;T) plus 0.4752 rs6984526(T;T) 19.5% plus 0.4812 rs10957125(G;T) plus 0.3999 rs4738824(A;G) plus 0.1758 rs12681792(A;C) plus 0.2397 rs7830371(T;T) 37.2% plus rs10089517(A;A) 1.7% plus 0.3485 rs7837791(T;T) 20.4% plus 0.4568 rs2882926(T;T) 81.5% plus rs4617146(C;T) 29.2% plus 0.2686 rs3780126(C;T) minus 0.4105 rs12115114(A;G) 25.7% plus 0.09826 rs2980003(A;G) 37.0% minus 0.2897 rs6472235(G;G) 15.6% plus 0.3967 rs4601292(A;G) plus 0.3494 rs13279522(C;T) plus 0.3567 rs1030420(C;T) 26.5% plus rs2303519(C;T) 22.1% plus 0.197 rs10112574(A;G) plus rs7825271(G;T) 25.7% plus rs16935279(C;T) plus rs2912522(A;G) plus 0.3196 rs1319036(A;A) 60.0% minus 0.3889 rs2623047(C;T) 51.3% minus rs13273088(A;A) 63.7% plus 0.2094 rs4737999(G;G) 50.4% plus 0.2287 rs6990375(A;G) plus 0.3535 rs12680109(C;C) 9.7% plus rs7010162(T;T) 15.9% plus 0.3659 rs2926702(A;G) 19.5% minus 0.1887 rs10504473(A;C) 22.5% plus rs10091374(A;T) plus 0.4871 rs13272623(G;T) plus 0.1878 rs4737277(C;G) plus 0.4679 rs11465996(C;G) 44.6% plus rs4471028(G;T) plus 0.3306 rs6472903(T;T) 62.8% plus 0.09229 rs2943559(A;G) 14.2% plus 0.1235 rs2941484(T;T) 19.5% plus 0.4931 rs2922763(A;A) 44.6% minus 0.2695 rs2383876(A;A) 49.2% minus 0.2769 rs12679254(C;T) 38.9% plus 0.3214 rs4738119(A;A) 18.5% plus 0.3053 rs3779748(C;T) plus 0.4509 rs2218488(T;T) 68.1% plus 0.1575 rs10957550(A;G) plus rs13263568(G;T) plus 0.08127 rs7834018(C;T) 16.8% plus 0.2557 rs1963982(C;T) 50.0% minus 0.4077 rs2247572(C;T) 31.0% plus 0.2351 rs2306494(C;T) minus 0.4656 rs7821178(A;C) plus 0.4224 rs1520333(C;T) 35.4% minus 0.4151 rs10957961(A;G) 59.4% plus rs998731(C;T) 53.1% plus 0.2911 rs11987678(C;T) plus 0.1249 rs6473223(C;C) 36.9% plus 0.4477 rs7009110(C;T) plus 0.4858 rs4308687(A;G) plus 0.4578 rs5003154(C;T) plus rs10113213(C;C) plus rs7846385(C;T) plus 0.2199 rs6473015(A;C) 44.2% plus 0.2204 rs2219968(A;G) plus 0.3554 rs7839040(A;A) 20.0% plus rs7820074(C;T) plus 0.377 rs725605(A;A) 34.5% minus 0.4339 rs1532423(C;C) 33.0% minus 0.3714 rs10102392(A;G) 35.4% plus rs285406(G;G) 85.6% minus 0.03857 rs4961206(G;T) plus 0.3421 rs3735967(C;T) minus 0.3779 rs12543318(A;C) plus 0.3916 rs1824717(A;G) minus 0.4408 rs6473383(A;G) plus 0.1501 rs1375785(C;C) 78.8% plus 0.1607 rs1467251(A;G) minus 0.1671 rs10429371(T;T) 67.3% plus 0.3017 rs13294589(A;G) 37.2% plus 0.1749 rs2046315(C;C) 77.3% minus 0.3182 rs160441(C;T) plus 0.3962 rs42490(A;G) plus 0.4343 rs7015630(C;T) plus 0.287 rs1063054(A;C) minus 0.315 rs1401862(G;G) 64.2% minus 0.4362 rs2176771(A;C) plus 0.4568 rs2735383(C;G) 46.0% plus 0.309 rs1061302(A;G) minus rs709816(A;G) 40.7% plus rs1805794(C;G) 40.7% plus 0.3329 rs1027730(C;T) minus rs278567(C;T) plus 0.3448 rs278600(C;C) 68.1% minus 0.1391 rs7387468(G;T) 52.3% plus 0.4835 rs829751(G;G) 54.0% plus 0.1295 rs2930961(C;T) plus 0.4073 rs4392868(G;G) 54.5% plus 0.1276 rs7000734(A;A) 54.0% plus 0.1226 rs3104964(C;T) minus 0.438 rs1800645(A;T) 35.4% minus 0.2925 rs4493873(C;C) 52.2% plus 0.3889 rs6468544(C;G) 45.1% plus 0.241 rs2444896(A;C) plus 0.2553 rs13278732(C;T) 41.1% plus 0.1722 rs2071598(A;C) 32.7% minus 0.1869 rs959695(A;G) minus 0.4137 rs6511(C;C) 27.9% plus 0.365 rs3108919(C;T) plus 0.5 rs931812(C;T) 49.6% plus 0.2314 rs1264202(G;G) 41.6% minus 0.3545 rs6982567(C;T) 26.5% plus 0.247 rs7814319(C;T) 45.5% plus rs2640806(G;T) minus rs1835740(A;G) 1.0 minus 0.3343 unreplicated, higher risk for migraine unreplicated, higher risk for migraine rs678347(T;T) 54.0% minus 0.4477 rs517811(C;T) minus 0.4298 rs2511714(G;T) plus 0.3343 rs6998277(C;T) plus 0.236 rs2679757(G;G) 16.9% plus 0.3242 rs6983777(A;G) 46.4% plus 0.4798 rs3808553(G;T) 47.8% minus rs2458413(A;G) 46.9% minus 0.3554 rs4734782(A;A) 57.5% plus 0.4178 rs4734806(A;G) 33.6% plus rs10955255(A;G) 38.4% plus 0.3687 rs284489(A;G) 45.1% plus 0.4435 rs284495(C;T) plus 0.4467 rs9297357(C;T) 52.2% plus 0.2681 rs12541635(C;T) 47.8% plus rs638203(C;T) 41.6% minus 0.4394 rs1322048(A;G) 40.7% minus 0.3196 rs2981205(A;G) 28.8% minus 0.1657 rs6993449(C;G) 49.1% plus 0.4394 rs1460237(T;T) minus rs1996720(A;G) 36.9% minus 0.3939 rs10505182(A;C) 41.8% minus 0.1391 rs60336366(A;G) plus rs1912816(C;T) 38.1% minus 0.3535 rs6469488(A;A) 82.3% plus rs218361(C;T) minus 0.489 rs2293889(G;T) plus 0.2525 rs800586(T;T) 51.7% minus 0.489 rs13279799(C;T) plus rs2163870(A;G) 46.9% plus rs11987235(A;A) 67.3% plus 0.4141 rs6469656(A;A) 86.2% plus rs13250873(A;A) 38.9% plus 0.4238 rs10812428(C;T) 48.2% plus 0.4073 rs16888927(C;T) 32.7% minus 0.1864 rs16888997(A;G) minus 0.1864 rs16889040(A;G) minus 0.1864 rs3019885(G;T) plus 0.3439 rs4876662(G;G) 69.9% plus 0.3039 rs2466295(A;A) 31.0% minus 0.4132 rs11558471(G;G) 4.4% plus 0.2874 rs17667932(C;C) 0.9% plus 0.06795 rs4355801(A;G) 55.4% plus 0.3039 rs4876869(A;G) plus 0.3232 rs2073618(C;G) minus 0.3567 rs2073617(C;T) minus rs10505348(C;T) plus 0.2984 rs7839059(A;C) plus 0.3733 rs2062375(C;G) plus 0.3104 rs2062377(A;T) minus 0.3095 rs6469792(C;T) plus 0.3893 rs11995824(C;G) 50.8% plus 0.3512 rs7459527(C;C) 100.0% plus rs6469804(A;G) plus 0.2773 rs6993813(C;T) plus 0.3788 rs10955924(A;C) plus 0.3962 rs2450083(C;T) plus rs1364705(C;T) 42.5% minus 0.2755 rs2071518(C;T) 34.5% plus 0.2916 rs10102546(C;T) 49.6% plus rs7005380(A;G) plus 0.253 rs4455882(A;G) 46.0% plus 0.388 rs6469937(A;G) plus 0.3972 rs4424296(C;T) 55.4% plus rs3870371(A;C) plus 0.4141 rs279612(A;G) 20.3% plus 0.03903 rs7846389(A;C) plus rs956225(A;G) 24.8% plus 0.1166 rs907121(C;T) 45.1% plus 0.4532 rs4871297(A;G) plus 0.4504 rs6470120(A;G) plus rs10108684(A;G) plus 0.1938 rs7844465(G;T) plus rs2294015(A;A) 35.4% minus 0.3586 rs11989782(A;A) 5.4% plus 0.14 rs17232789(C;C) 18.6% plus 0.4417 rs10088262(A;G) 39.3% plus 0.4504 rs2116081(C;C) 28.6% plus rs11781525(A;G) plus 0.01653 rs11776042(A;G) plus rs3201475(C;T) 46.9% plus rs2001945(C;G) plus 0.3939 rs2001844(C;T) 58.5% minus rs6982636(A;G) plus rs4512366(A;G) plus 0.1635 rs2980879(A;A) 38.5% minus 0.3021 rs2954021(A;G) 64.6% plus 0.438 rs2954026(G;G) 40.0% plus 0.2365 rs17321515(A;G) 52.2% plus 0.4917 rs2954029(A;T) 56.9% plus 0.4412 rs2954033(G;G) 40.0% plus 0.2365 rs6987702(C;T) plus 0.4793 rs2954038(A;A) 41.5% plus 0.2433 rs4360309(T;T) 30.5% plus rs4006531(C;T) minus rs1906493(A;C) 27.7% minus 0.1111 rs12543663(A;A) 49.6% plus rs13252298(G;G) 12.4% plus 0.2599 rs7007694(T;T) 70.8% plus rs1456315(G;G) 40.7% minus 0.4968 rs2466035(C;T) plus 0.4509 rs921720(C;C) 36.3% minus 0.4454 rs4871611(A;A) 36.3% plus 0.4307 rs1551398(T;T) 36.3% minus 0.4311 rs283720(A;G) 40.7% plus 0.4568 rs16902094(A;G) plus 0.1653 rs13281615(A;G) 44.6% plus 0.4826 rs10505477(C;T) 53.1% minus 0.461 rs10505476(A;G) 34.5% minus 0.3356 rs10808556(C;T) 50.4% plus 0.4444 rs7013278(C;T) plus 0.3682 rs7837328(A;G) 51.3% plus 0.4298 rs7014346(A;G) 46.0% plus 0.326 rs871135(G;T) 50.8% plus 0.4298 rs7000448(C;T) 39.1% plus 0.416 rs16902104(C;T) 31.0% plus 0.1561 rs672888(C;T) 44.6% minus 0.449 rs921146(A;C) 27.7% minus 0.309 rs6985504(A;G) 37.2% plus 0.2828 rs6470517(A;G) 23.9% plus 0.1217 rs10094872(A;T) plus rs4410871(C;T) plus 0.2984 rs2019960(C;T) plus 0.2433 rs11775199(A;G) 47.7% plus rs975730(C;T) minus 0.4743 rs1561927(A;A) 57.5% minus rs891835(G;T) plus 0.1593 rs10098310(A;G) plus rs1991866(G;G) 28.3% minus 0.4559 rs6470745(A;G) 21.2% plus rs2128382(C;T) 24.6% plus 0.1299 rs2608053(A;G) minus 0.4385 rs16904191(A;G) 46.2% plus 0.4463 rs4601326(A;G) 46.0% plus 0.2796 rs4596632(A;A) 49.6% plus 0.4527 rs10108033(C;C) 96.9% plus 0.2254 rs2294025(A;G) plus 0.4151 rs2929970(A;A) 18.5% plus rs2272651(C;T) plus 0.2603 rs10106540(A;G) 38.5% plus rs2736871(A;G) plus rs3057(A;A) 31.9% minus 0.3719 rs2945733(C;C) 77.9% minus rs6577655(C;T) 38.9% plus 0.4348 rs11166629(T;T) 54.9% plus rs12680655(C;G) 38.9% plus 0.4775 rs733254(G;T) minus 0.3848 rs12541063(G;G) 69.2% plus rs4909801(C;T) plus rs6997956(A;T) plus 0.359 rs4385494(G;T) plus 0.4867 rs12680546(G;G) 8.0% plus 0.1671 rs2958832(G;G) 67.2% plus 0.1855 rs10875423(A;A) 68.8% plus rs11166827(C;T) 38.9% plus 0.4073 rs2873892(A;G) plus 0.2401 rs2468677(G;T) 41.6% plus 0.4128 rs1870805(C;T) 49.6% minus 0.3994 rs6992848(C;T) plus 0.2309 rs2292779(C;G) minus 0.4513 rs2944755(C;C) 49.5% minus 0.1488 rs4961252(G;G) 14.2% plus 0.4449 rs9657451(A;G) 21.2% plus 0.2525 rs62531686(C;T) plus 0.3779 rs2705293(A;G) 14.3% minus 0.1157 rs4129585(G;T) 46.0% minus rs7465272(A;T) plus 0.2043 rs2978974(A;G) plus 0.3641 rs9297976(C;T) plus 0.3903 rs2294008(C;T) 50.4% plus 0.432 rs13263959(C;C) 65.2% plus 0.2576 rs4072286(A;C) minus 0.4702 rs7845056(T;T) 36.3% plus 0.4353 rs7837045(A;C) 38.1% plus 0.4036 rs3802230(A;A) 23.0% plus 0.4265 rs4536(A;A) 0.0% minus 0.1648 rs4539(G;G) minus 0.3632 rs1799998(C;C) 17.9% minus 0.3618 rs380904(C;C) 54.1% minus 0.2649 rs4874147(C;C) 23.3% plus 0.2094 rs7464572(C;G) 46.0% plus rs11136341(A;G) 43.1% plus 0.3228 rs11785060(C;T) 46.2% plus 0.2429 rs2976391(A;C) plus 0.4063 rs2976392(A;G) plus 0.4311 rs10216533(A;G) plus rs12155758(A;A) 8.0% plus 0.2135 rs6387(A;A) minus 0.4426 rs6410(G;G) 24.1% minus 0.4229 rs17855765(T;T) 24.6% plus 0.4348 rs2280838(A;A) 29.7% minus 0.4803 rs10813766(G;G) 44.2% plus 0.3655 rs912062(T;T) 90.3% minus 0.1515 rs755383(C;T) 43.8% plus 0.4472 rs364477(A;G) 31.0% minus 0.2254 rs12550729(T;T) 86.7% plus rs1412259(A;G) 42.5% minus 0.3343 rs574865(A;G) minus 0.1648 rs4741652(T;T) 51.3% plus 0.2291 rs6475600(C;T) 44.6% plus rs10812227(C;T) 23.1% plus 0.2507 rs12237653(C;T) plus 0.2475 rs1454626(A;C) plus 0.3205 rs10738760(A;G) 60.2% plus 0.433 rs930811(A;G) plus rs2034764(C;T) plus 0.3733 rs717423(A;A) 8.0% plus rs1571583(C;T) 34.5% minus 0.2888 rs7041847(A;G) 46.9% plus 0.3825 rs7034200(A;C) plus 0.4715 rs7020673(C;G) 45.1% plus 0.4008 rs10758593(A;G) plus 0.4564 rs10814916(A;C) 44.2% plus 0.4435 rs10814969(C;T) plus rs10974531(A;C) plus 0.1961 rs7856675(A;G) 12.4% plus 0.09091 rs514716(A;A) 77.9% minus 0.214 rs3087879(C;G) plus 0.2374 rs423955(A;A) 49.6% minus rs457287(G;G) 80.5% plus 0.1433 rs10758669(A;A) 37.5% plus 0.3085 rs7849191(T;T) 16.1% plus 0.4835 rs3758239(A;G) 37.2% plus 0.2071 rs2079(T;T) 14.2% minus 0.2649 rs7032572(A;G) 27.9% plus 0.1093 rs72699186(A;T) plus rs1342326(G;T) 24.8% minus 0.1547 rs2228622(A;G) plus 0.3108 rs3780413(C;G) 36.9% minus 0.3884 rs3780412(A;G) minus 0.4137 rs12249377(A;C) plus rs4586057(G;T) plus 0.2456 rs1329650(A;C) 38.1% minus 0.3678 rs1028936(A;C) 27.4% plus 0.2819 rs1340420(A;G) 42.5% plus rs61461737(A;G) plus 0.07622 rs640090(G;G) 95.3% minus rs11599672(G;T) plus 0.213 rs9663362(C;G) plus 0.382 rs932764(A;G) 47.7% plus 0.4458 rs9419788(A;A) 31.9% plus 0.303 rs2274224(C;G) plus 0.4683 rs3765524(C;T) 46.9% plus 0.281 rs3781264(C;T) 46.0% minus 0.2089 rs2497306(G;T) 42.9% minus 0.3186 rs2068888(A;A) 25.7% plus 0.4963 rs10882165(A;T) 54.7% plus 0.2888 rs12415204(A;C) plus rs10882272(C;T) plus 0.3701 rs11187545(A;G) 8.8% plus 0.08264 rs10882280(A;C) plus 0.07622 rs3203713(A;G) 23.7% plus 0.09642 rs17109928(G;T) plus 0.1809 rs12772169(C;T) 35.4% plus 0.2934 rs12572351(A;G) plus 0.1653 rs7089580(A;T) 41.6% plus 0.1423 rs1341164(C;T) plus 0.2016 rs1934980(C;T) 28.3% minus 0.2397 rs1341162(A;G) 31.0% minus 0.3292 rs1113129(C;G) plus 0.3292 rs1058930(C;G) plus 0.02571 rs2071426(A;G) minus rs17110453(A;C) 16.8% plus 0.1584 rs1074145(A;G) plus rs4918758(C;T) plus 0.3526 rs4918918(C;C) 35.4% plus rs2274491(A;T) plus 0.2475 rs7072055(A;C) plus 0.1336 rs2784917(C;C) 66.2% minus 0.3246 rs2636802(G;G) 62.8% minus 0.3264 rs2636797(C;C) 66.2% plus 0.3237 rs2236575(A;A) 23.1% plus 0.4178 rs12767760(A;A) 61.9% plus rs531676(C;T) minus 0.4986 rs4345897(G;G) 6.2% plus 0.4816 rs2147896(C;C) minus rs7072216(C;C) 7.2% plus 0.4467 rs498055(C;T) plus 0.4068 rs3949478(C;T) 31.0% minus 0.2824 rs7071836(A;G) 50.4% plus rs10748643(A;G) 50.4% plus 0.4816 rs7098785(A;G) 59.3% plus rs7895244(A;T) plus 0.1515 rs12773465(A;G) 21.5% plus rs2860975(G;G) 29.5% minus 0.4086 rs1934955(C;T) 53.8% minus rs1058932(C;T) minus 0.2787 rs11572177(A;G) minus 0.2516 rs1934953(A;A) 40.7% minus 0.3572 rs1934951(A;G) 28.3% minus 0.2787 rs11188072(C;T) plus 0.1534 rs4986894(C;T) plus rs6583954(C;T) 21.2% plus 0.2062 rs17878459(C;G) plus 0.01653 carrier of one CYP2C19*2B allele carrier of one CYP2C19*2B allele rs12769205(A;G) plus rs12767583(C;T) 22.7% plus 0.1988 rs1927702(C;T) plus 0.4692 rs1340043(C;C) 48.7% plus 0.377 rs13299349(A;G) plus rs776776(C;T) 53.1% minus rs541686(A;A) 63.1% plus 0.2736 rs1571228(A;A) 78.8% plus 0.208 rs3780215(C;T) minus 0.3085 rs4258076(G;T) 44.2% plus 0.253 rs2039461(C;T) minus 0.3251 rs4446809(A;G) 26.8% plus 0.1979 rs7875153(A;G) 23.0% plus 0.1667 rs6475216(C;T) 58.1% plus rs7867456(G;T) 1.6% plus 0.4146 rs10811474(A;G) 51.3% plus rs7849420(C;C) 32.8% plus rs7848524(C;T) plus 0.3944 rs4636294(A;G) 51.3% plus 0.3751 rs2218220(C;T) 51.3% plus 0.3733 rs7023329(A;G) 49.5% plus 0.4752 rs7027989(A;G) Bad 49.6% plus 0.3352 1.26x increased myocardial infarction risk 1.26x increased myocardial infarction risk rs11515(C;C) 76.9% minus 0.1148 rs3731211(T;T) 52.3% minus 0.264 rs3731201(A;A) 83.2% minus 0.1125 rs10964859(C;G) 43.4% plus 0.2718 rs10964862(A;C) plus 0.2998 rs6475526(T;T) 13.3% plus rs3217992(A;A) 16.2% minus 0.3595 1.24x increased myocardial infarction risk 1.24x increased myocardial infarction risk rs1063192(T;T) 1.0 Good 31.0% minus 0.236 Normal risk of myocardial infarction Normal risk of myocardial infarction rs2069416(A;T) minus rs7044859(A;T) plus 0.3783 rs523096(A;G) minus 0.2185 rs518394(C;G) minus 0.2176 rs615552(C;T) minus 0.2172 rs7049105(G;G) 26.5% plus 0.3627 rs7865618(A;A) 31.0% plus 0.2094 rs2157719(A;A) 31.9% minus 0.2089 rs2151280(T;T) 27.4% minus 0.4734 rs1360590(G;G) 29.2% minus 0.3485 rs10965219(G;G) 27.4% plus 0.3549 rs10120688(A;A) 26.5% plus 0.4325 rs1537378(C;C) 41.5% minus 0.2002 rs1333039(C;C) 40.0% plus 0.3044 rs4977756(A;A) 34.5% plus 0.3049 rs10757269(G;G) 24.6% plus 0.3196 rs9632884(C;C) 22.5% plus 0.332 rs10116277(T;T) 21.2% plus 0.3466 rs6475606(T;T) 21.2% plus 0.3466 rs1333040(T;T) Bad 31.0% plus 0.3783 1.52x increased myocardial infarction risk, 1.67x increased aneurysm risk 1.52x increased myocardial infarction risk, 1.67x increased aneurysm risk rs1537370(T;T) 21.2% plus 0.4073 rs7857345(C;C) 52.3% plus 0.208 rs10757274(G;G) Bad plus 0.4229 ~1.3x increased risk for heart disease ~1.3x increased risk for heart disease rs2891168(G;G) 21.2% plus 0.4201 rs1333042(G;G) 21.4% plus 0.343 rs944797(C;C) 22.1% plus 0.4913 rs1004638(A;A) 24.6% minus 0.3315 rs1537375(C;C) 22.1% plus 0.3903 rs10738610(C;C) 24.6% plus 0.4376 rs1333047(A;T) 52.3% plus rs10757283(C;T) 55.4% plus 0.4963 rs7018475(G;T) plus 0.2984 rs7853123(G;G) 24.8% plus 0.2553 rs1537377(C;T) plus 0.4334 rs1679013(C;T) 53.8% plus 0.4871 rs639225(C;T) 41.6% minus 0.438 rs7849973(C;C) 41.1% plus 0.2759 rs997675(C;T) minus 0.4128 rs10967875(C;T) plus rs17779457(G;T) plus 0.2677 rs868856(C;T) 38.1% minus 0.3701 rs7046653(A;G) 38.1% plus 0.3701 rs774359(C;T) plus 0.1997 rs2889829(G;G) 43.8% plus 0.3297 rs10968280(A;T) plus 0.1001 rs586716(A;G) plus rs10811771(A;G) 39.8% plus 0.2658 rs12348435(A;C) 15.4% plus rs4576506(G;G) 93.8% plus 0.07897 rs7855483(T;T) 64.6% plus 0.2406 rs10813813(A;T) 43.1% plus 0.275 rs7032871(A;T) plus 0.3026 rs669260(A;G) minus rs10813831(A;G) plus 0.191 rs17290760(A;G) 22.1% plus 0.07897 rs629566(C;T) minus 0.1694 rs10758161(T;T) 78.8% plus 0.1878 rs1133071(C;T) 36.3% minus rs560764(A;C) 50.4% minus 0.432 rs601162(C;C) 64.1% minus rs3205166(A;C) minus 0.3471 rs12377462(T;T) 69.2% plus 0.4022 rs2297216(C;T) minus 0.1345 rs216345(C;T) plus 0.3269 rs7871764(G;G) 44.2% plus 0.3145 rs4879809(C;C) 100.0% plus rs1800866(G;T) minus 0.2199 rs1061758(A;G) 26.5% plus 0.315 rs2812378(T;T) 41.5% minus 0.2801 rs951005(C;T) minus 0.1892 rs13293020(C;T) 36.3% plus 0.1286 rs300622(A;A) 68.1% plus rs10121009(C;T) plus 0.3485 rs2281999(A;G) 46.2% minus 0.3972 rs3138083(C;T) 48.7% minus 0.466 rs4879926(T;T) 93.8% plus rs11788747(A;G) 40.7% plus 0.2608 rs10972727(A;T) plus 0.2498 rs16933812(T;T) 58.7% plus 0.4036 rs7042509(G;T) 43.4% plus 0.219 rs7873102(G;G) 34.5% plus 0.4807 rs10758278(A;G) plus rs2074549(C;C) 0.0% plus 0.1414 rs4744712(C;C) 35.9% plus 0.3811 rs6560397(C;T) 46.0% plus 0.3884 rs3750552(T;T) 56.8% plus 0.3007 rs10780944(A;G) plus 0.1001 rs4745062(C;T) 47.8% plus 0.4242 rs1796993(C;T) minus 0.2746 rs168351(A;G) 20.0% plus 0.08081 rs610529(C;T) 47.8% minus 0.4982 rs2811226(A;A) 38.1% plus rs7039377(A;A) 18.6% plus rs7864204(G;G) 45.1% plus 0.4725 rs3750420(C;T) 48.2% plus 0.3577 rs10512049(C;T) 13.3% plus 0.04959 rs12344488(A;G) plus 0.04316 rs7047865(G;T) plus 0.4656 rs11144766(C;T) 26.5% plus 0.1988 rs11144782(C;G) 32.1% plus 0.2167 rs10746997(T;T) 37.2% plus 0.4128 rs2261722(A;A) 5.4% plus 0.3127 rs6560517(G;T) plus 0.3343 rs35804026(C;T) plus 0.006887 rs10491929(C;T) plus 0.259 rs1757948(G;T) 45.1% minus 0.2902 rs2769967(C;G) plus 0.4977 rs914715(T;T) 85.7% minus 0.0326 rs2151145(C;T) minus 0.2029 rs815847(A;G) plus 0.4972 rs2796441(T;T) 15.0% minus rs2129107(A;G) minus 0.3499 rs11139399(C;T) plus 0.489 rs668853(C;T) minus 0.4353 rs12554086(A;G) plus 0.2121 rs4745661(G;G) 50.8% plus 0.4086 rs1411916(A;A) 3.1% plus 0.05418 rs1998303(A;G) 47.8% plus 0.3939 rs942280(A;A) 38.9% minus 0.4247 rs1982151(G;G) 61.1% plus 0.2916 rs1212171(T;T) 32.7% plus 0.4807 rs17400257(A;C) plus 0.07668 rs1211166(A;A) 67.7% plus 0.2332 rs10868236(T;T) 60.9% plus 0.1524 rs2769605(A;A) 32.4% minus 0.3577 rs2841498(C;C) 69.9% plus 0.1331 rs533106(C;G) plus rs8181166(C;C) 35.1% plus 0.3646 rs3095748(T;T) 85.8% minus 0.1107 rs3118867(A;G) 56.6% plus rs2814828(C;T) plus 0.3655 rs2778031(C;T) plus 0.4729 rs4132699(C;C) 14.3% plus 0.382 rs10908907(A;A) 8.0% plus 0.4591 rs883924(A;G) plus 0.3343 rs1831521(C;T) 34.5% minus 0.3944 rs290258(G;G) minus 0.2599 rs290986(C;T) 40.2% minus 0.2677 rs9792548(A;A) 16.1% plus 0.4564 rs4877365(A;G) plus 0.3237 rs1421001(C;C) 61.1% minus rs4878104(C;T) 38.9% plus 0.4972 rs290227(C;T) minus 0.3866 rs2275848(T;T) 73.5% plus 0.2048 rs7027203(A;C) 48.7% plus 0.3067 rs1257763(G;G) 95.2% plus 0.01423 rs7851179(A;A) plus 0.1814 rs1769259(A;G) 8.8% minus 0.0225 rs4744411(A;G) plus 0.3099 rs10821415(A;C) plus 0.309 rs1412488(G;G) 76.1% plus 0.168 rs1000735(C;G) minus 0.4945 rs158689(A;T) 52.2% minus 0.4366 rs430794(A;C) 42.3% minus 0.3962 rs4743820(C;T) 38.9% plus 0.3788 rs773506(A;G) minus 0.4261 rs10761129(C;T) 38.4% plus 0.2158 rs4744107(C;C) 18.5% plus 0.4876 rs2895201(C;T) 38.5% plus 0.4697 rs9969804(C;C) 30.6% plus 0.2635 rs9696357(C;T) 25.4% plus 0.2204 rs17054265(C;T) 39.3% plus 0.2112 rs1875620(A;A) 34.5% plus 0.3705 rs17127114(A;G) plus 0.1703 rs11208534(A;G) 22.5% plus 0.1905 rs310230(A;G) plus 0.3251 rs3021089(A;A) 4.8% plus 0.02713 rs228669(G;G) 85.7% minus rs228644(A;A) 14.2% plus rs2453021(T;T) 11.5% plus rs28357980(G;G) 9.4% plus 0.03461 also known as is a mitochondrial snp 4917G PLoS this snp predicts the presence of age related macular degeneration (OR = 2.16, 95%CI 1.20–3.91, p = 0.01). This genotype is likely to have many other effects rs11209003(G;T) 44.2% plus 0.2957 rs6682925(C;T) 52.2% plus 0.4674 rs11465754(A;G) 41.4% plus rs990871(C;T) 45.9% plus 0.3329 rs7531118(C;T) plus 0.3476 rs10789336(A;G) plus 0.3099 rs435066(C;T) minus 0.3163 rs4147141(A;A) 32.8% plus 0.4789 rs11209454(A;G) plus rs3931020(A;G) minus 0.2594 rs11161851(C;T) plus 0.4651 rs211718(C;C) 47.8% plus 0.2025 rs1277203(C;T) 46.0% plus 0.4036 rs7523050(A;C) plus rs660240(G;G) 55.8% minus 0.2039 rs10888935(A;A) 37.2% plus 0.4844 rs10443215(T;T) 40.7% plus rs715405(G;G) 23.0% minus 0.4729 rs2207790(C;T) minus 0.3967 rs1056513(A;G) plus 0.4862 rs1167998(A;A) 42.5% plus 0.3848 rs1360382(A;G) 42.5% plus 0.3356 rs2821557(T;T) 23.9% plus 0.4146 rs2885805(A;C) plus 0.2723 rs1264899(A;G) 50.9% minus 0.4743 rs1969253(A;C) 54.0% plus 0.4913 rs6769511(C;T) plus 0.4128 rs11705701(A;G) plus 0.4642 rs720390(A;G) plus 0.3062 rs6444087(A;G) plus 0.2837 rs10049246(G;G) 28.4% plus 0.2897 rs1516725(C;C) 81.5% plus 0.1194 rs7647305(C;C) 67.0% plus 0.2241 Obesity risk Obesity risk rs9816226(T;T) 72.6% plus 0.1492 rs4686799(C;C) 63.4% plus 0.27 rs710448(A;G) minus 0.3618 rs698078(C;T) 50.4% minus 0.4169 rs710446(A;G) minus 0.4192 rs266714(G;G) minus 0.1433 rs266719(C;C) 53.1% plus rs266717(C;T) minus 0.4242 rs10937273(A;A) 14.2% plus 0.3255 rs864265(G;G) 77.9% plus 0.1171 rs11711353(A;A) plus 0.3297 rs1868152(C;C) 75.0% minus rs2248690(A;A) 53.6% plus 0.2521 rs2077119(G;T) plus 0.3792 0.91x decreased risk for T2D 0.91x decreased risk for T2D rs2593813(C;T) minus 0.3393 rs2070633(C;T) plus 0.494 rs2070635(A;G) 42.5% plus 0.3903 rs4917(C;T) plus 0.2943 rs2518136(C;T) plus 0.4927 rs4918(C;G) plus 0.3104 rs1071592(C;C) 53.6% plus 0.2121 rs822395(A;A) plus 0.2938 rs822396(A;A) 71.7% plus 0.1644 rs12495941(T;T) 9.7% plus 0.3453 rs9882205(A;G) plus 0.3402 rs2241766(G;T) plus 0.1446 rs2241767(A;G) 20.4% plus 0.1433 rs3774261(A;G) 45.1% plus 0.4885 rs3774262(A;G) plus rs2082940(C;T) plus 0.1924 rs6773957(A;G) 45.1% plus 0.4885 rs822391(T;T) 73.0% plus 0.1244 rs16861329(C;T) 19.5% plus 0.152 rs7652995(A;A) 69.9% plus 0.1313 rs11710456(A;G) plus 0.3214 rs3852053(A;C) minus rs6764050(A;A) 99.1% plus 0.03306 rs9820070(A;C) 49.6% plus 0.3719 rs16862782(A;C) plus 0.1276 rs10937329(A;T) plus 0.2723 rs1063537(C;T) 21.2% plus 0.141 rs1063538(C;T) plus 0.4885 rs1063539(C;G) plus 0.1465 rs6808574(C;T) plus rs1975991(C;C) 55.4% minus 0.3581 rs9865818(A;G) 54.0% plus 0.3145 rs9851967(C;T) 56.6% plus 0.3186 rs13076312(C;T) 51.3% plus 0.4945 rs1464510(G;T) minus 0.4532 rs9860547(A;G) plus 0.3278 rs10937355(C;T) 38.5% plus 0.3632 rs1152846(G;G) 66.4% minus 0.4137 rs1553091(A;G) 44.6% plus 0.2879 rs4686914(C;T) 45.1% plus 0.2718 rs9290877(C;C) 13.3% plus 0.1644 rs17429138(A;G) 40.7% plus 0.2006 rs4396880(A;A) 17.7% plus 0.3338 rs4488809(C;C) 27.4% plus 0.4472 rs13314271(C;C) plus rs10937405(T;T) 19.5% plus 0.3567 rs34201045(-;AGAG) plus rs16864880(C;G) 25.2% plus 0.1249 rs893051(G;G) 14.2% minus 0.4587 rs12696600(A;A) 32.8% plus rs17501976(C;T) plus rs9290929(A;A) 36.9% plus 0.2645 rs4624606(T;T) 58.4% plus rs9877502(A;G) plus 0.4027 rs7637404(G;T) plus rs10937470(T;T) 36.3% plus 0.4766 rs1516489(A;C) 16.8% plus 0.06566 rs779293(A;A) plus 0.3324 rs17501010(G;T) 27.4% plus 0.1414 rs2676917(G;T) plus rs2278034(C;T) minus 0.3673 rs4927850(C;C) 54.2% plus 0.2677 rs9859260(T;T) 40.0% plus 0.3701 rs3817672(A;A) 37.2% minus 0.3283 rs11915082(A;A) 16.9% plus 0.2328 rs11717368(C;C) 27.7% plus 0.3489 rs11924930(A;G) plus 0.3457 rs7642243(G;G) 28.8% plus rs4585146(A;G) plus 0.3549 rs4453795(A;G) 50.4% plus 0.455 rs604222(A;G) plus 0.1717 rs6774852(T;T) 68.1% plus 0.08861 rs2342371(A;A) 48.7% plus rs2084385(G;G) 75.5% plus 0.08953 rs4234853(A;G) plus 0.1915 rs6599388(T;T) plus 0.3044 rs6599389(A;G) plus 0.1042 rs2045065(C;T) 28.3% minus 0.2282 rs1670533(C;T) minus 0.2332 rs3796619(C;T) 43.4% minus 0.4568 rs712012(C;T) 41.6% plus 0.2452 rs6599400(A;C) 44.2% plus 0.298 rs1923775(C;T) 41.6% plus 0.3962 rs4602560(A;G) 47.7% plus rs3733223(G;T) minus 0.4876 rs1801058(C;T) plus 0.3618 rs1313770(A;G) plus 0.4614 rs2857936(A;G) minus 0.4752 rs762855(C;T) 47.8% minus 0.4591 rs3856973(C;T) minus 0.4302 rs2024115(C;T) 45.1% minus 0.4027 rs13108904(G;T) plus rs13118159(C;T) plus 0.4339 rs363064(A;G) 33.8% minus 0.2498 rs4690073(A;G) plus 0.4477 rs363096(A;G) minus 0.4568 rs2298967(C;T) plus 0.2626 rs82334(A;C) plus 0.3108 rs362272(C;T) minus 0.2466 rs1006798(A;G) 49.2% plus 0.3168 rs16835979(A;C) plus rs870142(C;T) 42.5% plus 0.2071 rs2063413(G;G) 50.4% minus rs4476553(T;T) 23.1% plus 0.4233 rs41451149(C;T) minus rs6446693(T;T) 25.0% plus 0.4394 rs3821947(A;G) 44.2% plus 0.4091 rs3775261(A;C) plus 0.3797 rs6824295(C;T) 39.8% plus rs12532(A;G) 33.6% plus 0.4298 rs4464513(G;T) plus 0.3655 rs13128441(T;T) 53.1% plus rs2008242(C;C) 56.6% plus 0.3177 rs4689278(C;T) plus 0.2374 rs3774856(A;G) plus rs6414624(C;T) plus 0.2264 rs2302075(T;T) 66.1% minus 0.1662 rs1383180(C;T) minus 0.3361 rs4333127(A;A) 87.6% plus 0.1084 rs10937705(G;G) 59.3% plus 0.2594 rs4689388(A;G) plus 0.2594 rs4320200(A;T) 46.2% plus rs13107806(C;T) plus rs730469(C;T) plus 0.4972 rs13127445(C;G) plus rs752854(A;G) 41.6% minus 0.1951 rs4458523(G;T) plus 0.2897 rs10010131(A;G) 50.4% plus 0.2677 rs10012946(C;T) plus 0.2677 rs4234798(G;T) plus 0.3168 rs3846421(A;G) plus 0.3127 rs1949733(A;G) 38.9% plus 0.2984 rs1967550(A;A) minus 0.4008 rs3733591(A;G) 30.3% minus 0.2938 rs734553(A;A) 53.1% minus 0.2557 rs6832439(G;G) 58.4% plus 0.2346 rs938554(G;G) 48.4% plus rs13129697(G;T) plus 0.4229 rs6446482(C;G) 43.1% plus 0.2741 rs1801212(A;G) plus 0.1364 rs1801214(C;T) 45.3% plus 0.2677 rs734312(A;G) plus 0.4803 rs1046320(A;G) plus 0.3618 rs7661864(A;G) plus 0.3361 rs3894944(T;T) 58.4% minus 0.2094 rs6838021(C;C) 47.7% plus rs9993410(C;T) 46.2% plus 0.4077 rs4455410(C;T) plus 0.3907 rs9994266(A;G) plus 0.4017 rs7376948(A;G) plus 0.3893 rs7378305(C;T) 46.2% plus 0.4004 rs7378340(C;T) 44.2% plus 0.3994 rs4519796(A;G) 44.8% plus 0.4004 rs4311316(A;C) plus 0.4004 rs4314284(C;T) 44.2% plus 0.4004 rs1159918(G;G) 46.0% minus 0.4298 rs1229982(G;G) 65.5% plus 0.2287 rs3733197(A;G) plus 0.2502 rs4699030(C;G) plus 0.4467 rs3774959(A;G) plus 0.3623 rs4648068(A;G) 48.7% plus rs3774968(A;G) 40.0% plus 0.3701 rs7665090(A;G) 55.8% plus 0.4504 rs228614(A;G) plus 0.4931 rs227368(A;G) 58.4% minus 0.3972 rs223469(C;T) plus 0.008264 rs223371(C;T) plus 0.4316 rs6533014(A;G) 50.4% plus rs6533015(C;G) 50.4% plus 0.4293 rs28362491(-;ATTG) plus 0.4472 rs3774932(A;G) 41.3% plus 0.4008 rs3774937(C;T) plus 0.292 rs230530(C;T) 53.1% minus 0.3737 rs230529(A;G) minus 0.4463 rs2306985(G;G) 13.8% plus 0.4922 rs2298735(G;T) 52.2% minus 0.4536 rs61203457(C;T) plus rs2276939(G;T) plus rs13107740(C;G) 29.0% plus 0.1809 rs17030795(A;G) 29.2% plus rs890448(A;G) 45.1% minus rs4522865(A;G) plus 0.3921 rs17266594(C;T) plus 0.225 rs4473653(A;G) 44.4% plus 0.3912 rs13103879(C;C) 25.0% plus 0.4293 rs6852441(C;T) 47.6% plus 0.3916 rs6449201(C;T) 47.7% plus 0.3926 rs16868246(G;G) 57.1% plus rs13131257(C;C) 62.8% plus 0.2355 rs7660895(A;G) 38.9% plus rs13113918(G;G) 57.5% plus 0.1607 rs7658170(C;T) plus 0.4022 rs7676733(A;G) plus 0.4008 rs10017674(C;T) plus 0.399 rs7435196(A;C) 48.4% plus 0.4128 rs6449176(A;G) plus 0.4008 rs6449178(C;T) 46.0% plus 0.3907 rs6449179(A;G) plus 0.4017 rs7677710(G;T) plus 0.4013 rs1014290(C;T) minus 0.3076 rs717615(C;C) 25.0% minus 0.4509 rs7699512(T;T) 23.0% plus rs12510549(C;T) plus 0.1736 rs4698014(C;T) 37.2% plus 0.1648 rs4698036(G;T) plus 0.1892 rs13142500(C;C) plus 0.4105 rs6448799(C;C) 47.7% plus rs7671189(C;C) 51.3% plus 0.2805 rs16887552(C;C) 3.5% plus rs733175(C;T) 31.9% plus 0.2948 rs7671266(C;T) plus 0.2153 rs6834555(A;G) plus 0.314 rs6820756(A;G) 33.6% plus 0.3131 rs733048(A;G) plus 0.242 rs35333254(A;G) plus rs9918079(A;G) plus rs11931532(C;T) plus 0.2351 rs12645693(A;G) plus 0.1869 rs6449182(G;G) plus 0.1671 rs16892645(C;T) 15.4% plus 0.1088 rs4698433(G;T) 40.7% plus 0.2984 rs2531154(A;A) 85.8% minus 0.146 rs2677780(T;T) 85.8% minus 0.1405 rs10022537(T;T) 68.4% plus 0.309 rs1483012(A;G) plus 0.4444 rs6819013(A;G) 39.4% plus 0.3384 rs744731(A;G) minus 0.225 rs1008375(A;G) minus rs6842303(G;T) plus 0.3301 rs925098(C;T) minus 0.3682 rs2724475(A;G) minus 0.3577 rs3130(C;T) plus 0.4399 rs7686732(C;C) 82.3% plus 0.1084 rs17387100(A;G) 18.6% plus rs1604805(C;T) plus rs6448119(C;T) 42.5% plus rs3099557(C;T) minus rs6821591(T;T) 27.4% plus 0.4229 rs1873532(A;A) 17.7% plus 0.3641 rs3755863(A;A) 17.7% minus 0.371 rs8192678(A;G) Bad 39.8% minus 0.2911 higher blood pressure if <50 higher blood pressure if <50 rs2970856(A;A) 55.4% plus 0.1703 rs4697046(T;T) 38.5% plus 0.377 rs724577(A;C) 43.4% plus 0.3577 rs1503874(C;T) minus rs666088(T;T) minus 0.2002 rs13117172(C;T) 16.1% plus 0.3356 rs2970869(A;G) minus 0.2525 rs7657071(A;C) plus 0.2502 rs12500612(G;T) 27.7% plus 0.08999 rs2284659(G;G) 39.8% plus rs699473(T;T) 1.0 Good 41.1% plus 0.45 Normal brain tumor risk Normal brain tumor risk rs2536512(A;A) 12.3% plus 0.4183 rs10939038(T;T) 18.5% plus 0.2732 rs1553153(G;G) 67.3% minus 0.2282 rs2133507(G;G) 64.6% plus 0.2254 rs7672915(C;T) 46.2% plus 0.4734 rs11724368(A;T) 36.3% plus 0.2149 rs4235308(C;T) plus rs7656250(C;T) 38.1% plus 0.2654 rs13131226(C;T) 29.0% plus 0.3517 rs12501856(C;C) 15.0% plus 0.2649 rs10019888(G;G) 9.2% plus rs10517086(A;A) 10.6% plus 0.2185 rs6448432(A;A) 15.4% plus rs874040(G;G) 10.6% minus 0.2296 rs11933540(C;C) 15.4% plus rs907499(A;A) 100.0% minus rs6844153(C;T) 26.5% plus 0.2135 rs4692256(C;T) 50.4% plus 0.3742 rs7442317(A;A) 10.6% plus 0.3558 rs6856768(A;G) plus 0.4858 rs7654585(G;G) 43.4% plus 0.4169 rs6448771(A;A) 48.2% plus 0.4201 rs17390445(A;G) 38.9% plus 0.3508 rs1317830(C;T) 43.4% minus 0.32 rs437943(G;G) 6.2% minus 0.4812 rs1567482(C;C) minus 0.1364 rs10010758(C;T) plus 0.2893 rs637797(A;T) 47.6% plus 0.3007 rs4073968(A;G) 45.1% minus 0.1129 rs337629(G;G) 55.4% plus 0.2507 rs4833079(C;T) plus 0.1947 rs13146789(G;T) 54.5% plus rs6531656(T;T) 69.2% plus 0.2126 rs11096956(G;T) minus rs11466653(C;T) 8.0% minus 0.07392 rs11096957(A;C) minus rs10856839(A;C) minus rs4833103(A;C) 47.8% plus 0.2319 0.75x decreased risk for Non-hodgkin's lymphoma 0.75x decreased risk for Non-hodgkin's lymphoma rs7696175(C;T) plus 0.2608 rs5743827(A;G) minus 0.213 rs3775073(A;G) minus rs5743810(C;T) 46.0% minus 0.1873 rs1039559(C;T) minus 0.3407 rs10008492(C;T) Bad 48.7% plus 0.2576 Very small 1.1x increased risk for Non-hodgkin's lymphoma Very small 1.1x increased risk for Non-hodgkin's lymphoma rs4504265(A;C) 0.0% minus rs6844176(C;T) plus 0.4279 rs6832151(T;T) 48.7% plus 0.2961 rs73229797(A;G) plus rs56159866(C;T) plus 0.1263 rs6819385(G;G) 18.6% plus 0.4619 rs13133980(C;G) plus 0.4986 rs2585590(A;G) plus 0.3788 rs4861387(A;G) plus 0.1993 rs4349633(A;A) 8.0% plus rs4345220(G;G) 33.8% plus 0.4288 rs1047626(G;G) 55.0% plus rs12639920(G;T) plus 0.3581 rs6850606(A;A) 24.8% plus 0.421 rs16858082(C;C) 21.2% plus rs348495(T;T) 25.4% minus 0.4674 rs55633891(C;T) plus 0.1442 rs10009228(A;G) 33.6% plus 0.242 rs4466078(A;A) 97.3% plus 0.06474 rs17536211(A;C) 29.2% plus 0.09642 rs1391166(A;T) plus 0.433 rs7654165(C;T) 52.2% plus 0.4467 rs511310(G;G) 80.5% plus rs567926(T;T) 31.0% minus rs497068(A;A) minus 0.4247 rs279844(A;T) 53.8% plus 0.4917 rs279845(A;T) plus 0.4412 rs279826(A;G) 49.5% plus 0.4949 rs279827(A;G) plus 0.4426 rs7674482(C;T) plus 0.2801 rs6447493(C;T) 37.7% plus 0.4876 rs1497571(A;G) 50.4% minus 0.4885 rs279828(A;C) 52.3% plus 0.4426 rs7660336(C;G) plus 0.4316 rs1912960(C;G) plus 0.3214 rs2280073(C;G) minus 0.41 rs2351299(G;T) 1.0 Good 27.0% plus 0.2374 possible reduced risk of Autism possible reduced risk of Autism rs2351791(G;G) 55.9% minus 0.2493 rs12500534(C;T) plus rs7664091(G;G) 31.8% plus rs2664035(A;G) plus 0.3958 rs931734(A;A) 26.5% plus 0.2906 rs10003447(T;T) 10.6% plus rs2048894(A;A) minus 0.3361 rs5333(C;C) 10.6% plus 0.326 rs964170(A;A) 91.2% minus 0.2502 rs5534(A;G) minus 0.4412 rs1040288(C;G) plus 0.4421 rs11099680(A;G) plus 0.2296 rs2883929(A;A) 58.1% plus rs2070951(C;G) minus 0.4931 rs6841581(A;G) plus 0.214 rs1801708(A;G) plus rs6841473(C;T) 32.3% plus rs893629(G;G) 98.2% plus 0.02617 rs7696323(T;T) 11.5% plus 0.2511 rs4696480(A;A) 0.0% plus 0.4601 rs1816702(C;C) 74.8% plus 0.163 rs4235232(T;T) 98.4% plus 0.02709 rs3804099(C;T) plus 0.4307 rs7656411(G;T) plus 0.4091 rs17030434(C;T) plus 0.2057 rs13135284(C;C) 56.6% plus 0.3434 rs2358462(C;C) 16.1% plus 0.3104 rs10519980(C;T) 35.5% plus 0.1708 rs10028213(C;G) 29.7% plus 0.1837 rs10032216(C;C) 1.8% plus 0.2401 rs10030601(C;T) plus 0.2815 rs361147(A;C) 49.6% minus 0.3962 rs360929(A;A) 71.7% plus 0.2374 rs360932(C;T) minus 0.4477 rs6535847(C;T) plus 0.4991 rs11099864(A;A) 54.0% plus 0.4541 rs11133373(C;G) 32.3% plus 0.3365 rs753129(C;T) 40.7% minus 0.3039 rs4865047(C;T) 14.2% plus 0.174 rs4371677(A;G) plus 0.4931 rs1713985(A;C) 18.6% minus 0.1396 rs2227902(G;T) 12.5% plus 0.0753 rs10049992(G;T) plus 0.1814 rs10517437(A;G) plus 0.4215 rs1869463(A;G) 41.6% plus 0.421 rs10517480(A;T) 41.5% minus 0.2782 rs4599440(C;C) 58.4% plus 0.3797 rs7678046(C;T) 55.8% plus 0.2204 rs1901223(A;G) plus 0.4982 rs2345039(C;G) minus rs6813183(C;G) plus 0.3898 rs1355368(A;G) 44.6% plus 0.4559 rs734644(C;T) plus rs7692181(C;T) 53.1% plus 0.2815 rs7656244(A;C) plus 0.2245 rs1425392(A;G) minus 0.2415 rs4404602(C;T) plus 0.3315 rs10518025(C;T) plus 0.135 rs6551665(A;G) plus rs1947274(A;C) plus rs1947275(C;C) 72.6% plus rs13138607(A;G) plus 0.4536 rs3756159(A;G) plus 0.4564 rs12644822(A;G) plus 0.3237 rs10025771(T;T) 70.8% plus 0.4986 rs7435827(G;G) 21.5% plus 0.4187 rs6552182(C;C) 100.0% plus 0.05464 rs3100(T;T) minus rs4148269(C;C) minus 0.3255 rs6837575(A;A) plus rs1038426(A;A) 24.2% plus 0.3572 rs2045100(A;T) minus 0.2626 rs1902023(G;G) minus 0.4371 rs9994887(G;G) plus 0.4348 rs13112099(G;G) plus 0.4348 rs7686914(C;C) plus 0.4353 rs7696472(A;A) plus 0.4348 rs451632(A;G) 47.5% minus 0.4513 rs835315(A;A) plus rs2942857(A;A) plus rs1841055(A;C) 24.8% plus 0.4692 rs7668258(C;T) plus rs7439366(C;T) plus 0.4679 rs4356975(C;T) 52.2% plus 0.4541 rs13129471(A;G) plus 0.3866 rs4148298(C;T) 41.4% minus 0.2374 rs1109501(A;A) 3.6% plus 0.2631 rs293428(C;T) 42.5% minus 0.4486 rs4694362(C;T) 41.1% plus 0.4665 rs2579330(A;A) 98.2% minus 0.1033 rs12512631(C;T) plus 0.326 rs222054(C;G) 38.5% minus 0.2668 rs705117(A;A) 68.1% minus 0.4109 rs842999(G;G) 29.0% minus 0.365 rs705120(G;G) 33.9% minus 0.4096 rs222040(T;T) 30.2% minus 0.4977 rs7041(G;G) 32.1% minus 0.3857 rs222035(G;G) minus 0.3802 rs3775289(G;G) 85.7% minus 0.1928 rs1851024(A;A) 95.5% plus 0.1006 rs7697556(C;C) 31.9% plus 0.4481 rs6834059(C;G) 34.4% plus 0.2695 rs3796678(A;T) minus 0.4839 rs3796677(A;T) minus 0.4839 rs3796676(A;T) minus 0.466 rs28532518(C;T) plus 0.466 rs2298839(A;G) 59.6% plus 0.4532 rs12506899(G;T) plus 0.4086 rs10020432(A;G) 55.8% plus 0.4417 rs222016(A;A) 68.8% plus 0.3246 rs222029(A;A) 66.2% plus 0.2718 rs4073(A;T) plus 0.4972 rs2227307(G;T) plus 0.4219 rs2227306(C;T) 47.7% plus 0.2943 rs1126647(A;T) plus 0.298 rs4074(A;G) 41.6% plus 0.4683 rs8180167(A;T) 24.6% plus 0.3508 rs1350666(C;C) 55.5% plus 0.3664 rs6845297(A;A) 35.4% plus 0.432 rs62314947(C;C) plus 0.2906 rs6852678(C;T) 39.8% plus 0.1928 rs10336(C;C) 24.8% minus 0.2883 rs3733236(C;T) minus 0.1382 rs8878(C;C) 23.9% minus 0.2975 rs3921(C;C) 24.2% minus 0.3113 rs6836703(A;G) plus 0.2383 1.34x increased risk for azoospermia in males 1.34x increased risk for azoospermia in males rs6824953(C;G) 42.2% plus 0.4371 rs168449(C;C) plus 0.1667 rs2472649(C;T) 23.2% minus 0.3508 rs425535(A;G) minus 0.1763 rs352046(C;G) minus 0.1786 rs352038(A;A) minus 0.0854 rs546829(A;A) 41.6% minus 0.3751 rs1371799(C;C) 38.5% plus 0.466 rs6825004(C;G) 40.7% plus 0.3049 rs4241591(A;G) 49.6% plus 0.2622 rs6812193(C;T) 1.0 Good 51.3% plus 0.3007 normal risk of developing Parkinson's Disease normal risk of developing Parkinson's Disease rs9992101(A;G) plus 0.2231 rs10032549(A;G) 47.8% plus 0.3926 rs4859682(A;C) plus 0.2865 rs13146355(A;G) plus 0.292 rs13106227(A;G) plus 0.4477 rs1986734(C;T) 49.5% plus 0.4371 rs3733242(A;G) 59.3% minus 0.4876 rs1268789(G;G) 41.6% minus 0.4288 rs4389526(A;T) plus 0.3471 rs4333130(C;T) 54.0% plus 0.3471 rs12509658(C;G) plus 0.3205 rs6818557(C;C) 79.4% plus 0.3691 rs13140055(T;T) 11.6% plus 0.3283 rs1458038(A;G) 40.7% minus 0.2521 rs11099098(G;T) 40.0% plus 0.2493 rs16998073(A;T) 26.8% plus 0.2516 rs3733336(A;G) 52.2% plus 0.309 rs7677281(C;T) plus rs958617(C;T) 38.1% minus rs17002988(T;T) 40.7% plus 0.4766 rs13138132(C;C) plus 0.3343 rs1662853(C;C) 6.2% minus 0.337 rs710841(T;T) minus 0.3361 rs788867(G;G) minus 0.3623 rs994014(G;G) 9.7% minus 0.3774 rs1878528(C;C) 10.6% minus 0.3554 rs6856901(G;G) plus 0.2314 rs4364254(C;T) 37.2% plus 0.3402 rs11099592(C;C) 60.4% plus 0.1919 rs12501123(A;A) 59.3% plus 0.1915 rs1385890(A;A) 63.7% plus 0.4054 rs4693089(A;G) 51.9% plus 0.3737 rs1494961(C;T) 56.6% plus 0.3737 rs13137008(G;T) 47.7% plus rs11732231(C;G) plus 0.3269 rs7687906(T;T) 76.1% plus rs4478147(A;A) 32.4% plus 0.4467 rs3113494(A;A) 33.6% plus 0.3733 rs340635(C;C) minus 0.1855 rs340630(A;G) plus 0.4394 rs442177(A;A) 44.6% minus 0.4458 rs4610302(A;G) 56.6% plus rs2616262(A;A) 20.5% minus 0.4725 rs7692808(A;G) 47.7% plus 0.3691 rs7660702(C;T) plus 0.4284 rs6532023(G;G) 35.4% plus 0.3411 rs1471403(C;C) 36.3% plus 0.3425 rs1463104(C;T) plus rs11730582(C;C) 18.6% plus 0.3407 rs11728697(T;T) 28.3% plus 0.4206 rs6532040(A;G) 45.2% plus 0.2314 rs4754(C;T) plus 0.3751 rs10516799(C;G) 38.1% minus 0.2121 rs1054627(A;A) 8.0% plus 0.1855 rs3114018(C;C) 24.8% plus 0.4862 rs2622604(C;C) 57.5% plus 0.1832 rs3822072(C;T) minus rs6830970(A;G) 53.6% plus rs2609255(G;T) 33.6% plus 0.309 rs4416442(C;T) plus rs2869966(C;T) 54.0% plus rs2869967(C;T) plus 0.4968 rs2045517(C;T) 54.0% plus 0.4963 rs1964516(C;T) plus 0.45 rs1126616(C;T) plus 0.3751 rs1126772(A;G) 30.1% plus 0.1878 rs9138(A;C) 32.3% plus 0.3751 rs2231164(A;A) 81.4% minus 0.3981 rs7671167(C;T) 50.4% plus 0.4858 rs1903003(T;T) 32.4% plus rs356165(A;G) plus 0.4885 rs7684318(C;T) plus 0.303 rs3822086(C;T) plus 0.3522 rs3857059(A;G) 14.2% plus rs356186(A;G) 22.2% plus 0.1703 rs2737029(A;G) minus rs10005233(C;T) 50.4% plus rs2035268(G;T) plus 0.1318 rs3756063(C;G) plus rs10007590(A;G) 38.1% plus rs356229(A;A) 35.4% minus 0.259 rs181489(C;C) 47.7% plus 0.1979 rs11931074(G;T) 14.3% plus 0.3545 rs356221(A;T) 51.3% plus 0.4013 rs3775478(A;G) 16.1% plus 0.1887 rs4128705(G;G) 11.7% plus rs13130787(C;C) 18.0% plus 0.326 rs17021463(G;T) plus 0.3981 rs10008257(A;A) 24.6% plus 0.3976 rs2433320(A;A) 18.6% plus 0.3104 rs2433322(C;C) 17.7% minus 0.3095 rs2438146(T;T) 17.0% plus 0.3163 rs2452600(C;T) 42.9% plus 0.2755 rs12500426(C;C) 30.1% plus 0.4642 rs2301135(C;G) minus 0.3393 rs2301134(C;T) 53.2% minus 0.3485 rs7687945(C;T) 54.5% plus rs6532194(C;T) 15.0% plus 0.3448 rs17021918(C;T) 40.7% plus 0.3108 rs11097470(C;T) 23.9% plus 0.1235 rs2602836(A;G) 43.2% plus rs1042364(A;G) minus 0.1414 rs4148887(C;T) 12.4% minus 0.2484 rs1800759(A;C) minus 0.4605 normal; increased agreeableness (?) normal; increased agreeableness (?) rs1984362(A;G) minus 0.1373 rs3857224(C;T) 46.9% plus 0.4371 rs2201728(A;G) plus 0.3347 rs975833(C;G) plus 0.3815 rs1042026(A;G) minus 0.3485 rs13133845(A;G) 15.4% plus rs1614972(C;T) 40.0% plus 0.4711 rs698(A;G) minus 0.2415 rs1789903(C;G) 50.4% plus rs1693482(C;T) 44.4% plus 0.2397 rs283411(G;T) minus 0.04729 rs1789924(C;T) 50.4% plus 0.2424 rs1154460(A;G) plus 0.444 rs2654849(A;C) 43.4% minus 0.4711 rs13126513(C;C) 24.6% plus 0.3466 rs1859156(G;T) 32.1% plus 0.2291 rs10021303(A;G) plus 0.3843 rs1970801(A;A) 31.0% minus 0.4197 rs11097457(G;G) 31.9% plus 0.4201 rs10032931(C;T) plus rs1502050(A;G) minus 0.2782 rs795544(G;T) 34.5% minus 0.1841 rs682748(C;T) 54.1% minus 0.4858 rs10520861(C;C) 15.2% plus rs780179(C;T) plus 0.4995 rs1874165(T;T) 89.4% plus 0.2066 rs3932338(A;A) 31.9% plus rs1910358(T;T) 47.8% plus 0.3095 rs12518307(G;G) 54.8% plus 0.3682 rs2047267(A;A) 100.0% plus 0.04637 rs193741(A;A) 71.7% plus 0.225 rs6870564(A;G) 29.2% plus 0.2089 rs11750694(A;A) 4.4% plus 0.2507 rs488884(A;C) minus 0.3503 rs4397141(C;T) 16.8% plus 0.1823 rs9292394(G;T) 28.3% plus 0.303 rs10940923(G;G) 69.0% plus rs6888304(A;G) 40.6% plus 0.3007 rs642321(C;C) 58.9% plus 0.32 rs10719(C;C) 61.9% minus 0.4697 rs7727656(T;T) 55.8% plus 0.4206 rs396045(A;A) minus 0.281 rs7704909(C;C) 12.4% plus 0.2392 rs12518194(G;G) 12.4% plus 0.2369 rs1330645(C;T) 46.0% minus 0.332 rs6885387(A;A) 33.0% plus rs12054895(T;T) 14.3% plus 0.3444 rs16897978(A;A) 93.8% plus rs2962370(C;G) minus 0.3159 rs4866334(C;T) 12.4% plus 0.08494 rs230526(C;T) 58.4% minus 0.4472 rs230525(C;T) minus 0.343 rs230519(A;G) minus 0.3324 rs4648011(G;T) 57.5% plus rs230496(A;G) plus 0.4421 rs2720460(A;G) 44.2% plus 0.3416 rs4699052(C;T) 42.5% plus 0.4279 rs10005603(G;G) 0.0% plus 0.1125 rs1541374(C;C) 33.8% minus 0.2259 rs7679673(A;C) plus 0.4206 rs9790517(C;T) 35.4% plus 0.2948 rs10010325(A;A) 23.9% plus 0.4927 rs2636697(A;A) 93.8% plus 0.08953 rs12499086(A;G) plus 0.4991 rs11730243(C;T) 49.2% plus 0.4986 rs11097912(C;T) 50.8% plus 0.2828 rs10516541(A;A) 18.5% plus 0.3085 rs1384401(A;G) plus 0.4118 rs4956145(C;T) plus 0.1074 rs6851442(A;G) 18.6% plus rs898518(A;C) plus 0.4917 rs956237(A;G) plus 0.3916 rs10029851(A;C) 32.7% plus rs13134663(A;G) 45.1% plus 0.4238 rs4698775(G;T) 49.5% plus 0.2241 rs2301717(G;T) plus 0.3388 rs13117504(C;G) 54.7% plus 0.4105 rs10033900(C;C) 30.1% plus 0.4972 rs6822976(A;A) 26.8% plus rs7671905(C;C) 56.9% plus rs4698790(G;G) 54.9% plus rs718768(C;T) minus 0.191 rs13144621(C;C) 52.3% plus 0.326 rs10011926(C;T) 31.0% plus 0.3802 rs13148252(A;G) plus 0.2498 rs2634073(A;G) minus rs12646447(C;T) plus rs6817105(C;T) plus 0.2764 rs17042171(A;C) plus 0.2759 rs4611994(C;T) plus 0.2759 rs13143308(G;T) plus 0.4082 rs6843082(A;G) plus 0.4082 rs3853444(G;G) 15.0% minus rs2087160(A;A) 62.8% minus 0.3669 rs6838973(C;T) 40.7% plus 0.4086 rs1585471(G;G) 11.5% plus 0.3503 rs4833407(A;C) plus 0.4325 rs11726117(C;T) plus 0.3255 rs231247(A;G) 48.7% plus 0.3232 rs231253(C;G) 47.8% plus 0.3242 rs6834538(C;C) 44.2% plus rs13136737(T;T) 31.9% plus rs6850768(T;T) 8.8% plus 0.3315 rs10014072(G;G) 58.2% plus 0.3994 rs7694725(C;C) 65.2% plus 0.3136 rs10034228(C;C) 10.6% plus 0.3623 rs6534347(G;G) 35.4% plus 0.4399 rs2069779(C;T) minus 0.03673 rs2069762(G;T) 45.9% minus 0.247 rs45475795(C;T) minus rs6852535(A;G) plus 0.247 rs4492018(A;G) plus 0.376 rs7682241(T;T) 8.0% plus 0.3099 rs4833837(A;A) 39.8% plus 0.1997 rs2221903(A;A) 39.8% minus 0.1997 rs2055979(A;C) minus 0.2594 rs1880529(T;T) 32.7% plus 0.3159 rs6858698(C;G) plus 0.1818 rs4460079(C;T) 49.2% plus rs7658266(C;T) plus rs17586843(C;T) plus 0.141 rs2389202(T;T) 77.9% plus 0.2443 rs7698598(G;G) plus rs11098499(C;T) 41.4% plus 0.298 rs11724758(A;G) plus 0.4674 rs1799883(C;T) minus 0.2521 rs5861422(-;A) plus 0.4132 rs2583612(T;T) 89.4% plus rs1845344(G;T) 49.6% plus 0.2365 rs4833652(G;G) 10.7% plus 0.2971 rs11575945(C;T) minus rs4374642(C;T) plus 0.1006 rs2389339(T;T) 7.9% plus 0.1497 rs10433903(C;T) plus 0.3737 rs11098403(A;G) 38.1% plus 0.2282 rs4422476(C;C) 20.4% plus 0.4017 rs3987(A;G) 43.8% plus rs13138932(C;T) plus 0.2833 rs844644(A;C) 52.2% plus 0.4192 rs12039904(C;T) 33.9% plus 0.1933 rs844648(A;G) plus 0.4339 rs704840(G;T) plus 0.2916 rs3820541(C;G) minus 0.08494 rs7517566(A;G) 15.9% plus 0.1175 rs4970988(A;G) plus 0.3448 rs9286879(A;G) 33.6% plus 0.478 rs2157453(A;G) plus rs12035082(C;C) 13.3% plus 0.3388 rs7555523(A;A) 73.5% plus 0.1157 rs7518099(T;T) 73.5% plus 0.09734 rs4657482(G;G) 46.0% plus 0.3462 rs1341320(T;T) 85.0% minus rs35738462(C;T) plus rs2932538(C;T) 38.1% minus 0.2084 rs1049434(A;A) 35.7% minus 0.3425 rs1112085(A;G) plus rs2994809(C;C) 85.8% plus 0.1777 rs6600671(C;C) 15.9% minus 0.3131 rs12405132(A;G) minus rs2794521(C;T) plus 0.2075 rs2808634(C;T) plus 0.2066 rs10799824(A;G) plus 0.1726 rs12048904(C;T) plus 0.4417 rs11581062(A;G) 37.2% plus 0.2351 rs2338971(C;C) plus rs670523(G;G) 41.6% plus 0.3526 rs759330(C;T) minus rs6684514(A;G) plus 0.2112 rs1047303(A;A) 98.5% plus 0.1965 rs478093(G;G) 45.5% plus 0.2259 rs477992(G;G) 43.4% plus 0.2534 rs12046117(C;T) 17.2% plus 0.202 rs7534091(G;G) 12.3% plus 0.2736 rs4839516(A;C) plus 0.1501 rs624988(G;G) 33.6% minus rs13505(G;T) minus rs2769264(A;C) minus 0.27 rs12566232(A;C) 41.4% plus rs6685187(A;G) 50.5% plus rs7483(C;T) minus 0.3806 rs484959(A;G) minus 0.4991 rs28359178(A;A) 14.1% plus 0.07103 rs6695223(T;T) 76.1% plus 0.1685 rs233100(A;G) minus 0.4279 rs233115(C;T) minus 0.3209 rs7538490(C;T) plus 0.3343 rs12734991(T;T) 31.9% plus 0.3466 rs1800808(C;T) 21.5% minus 0.1134 rs1800805(A;A) 23.1% minus 0.2608 rs1800807(C;C) minus 0.4835 rs1569476(A;G) 48.7% minus 0.2888 rs1801160(A;G) minus rs11165846(C;G) plus 0.314 rs6685859(C;G) plus 0.3411 rs628117(A;A) 31.0% minus 0.3994 rs2769668(G;G) 91.2% minus 0.08035 rs7521681(A;G) plus rs9861887(C;T) 41.6% plus 0.2769 rs10510333(C;T) plus 0.2259 rs11928865(A;T) plus rs9870680(T;T) 17.7% plus 0.4789 rs1450100(C;C) 28.2% minus 0.3393 rs1450099(C;C) 29.7% minus 0.3503 rs11708896(A;G) plus 0.3228 rs161927(A;G) plus 0.1598 rs4591494(C;T) plus 0.275 rs6762644(A;G) 46.0% plus 0.2975 rs6442925(C;T) plus 0.1566 rs6771148(C;C) 59.3% plus 0.2062 rs1669338(G;G) 79.6% minus 0.258 rs9874556(A;G) 41.3% plus 0.3655 rs17684824(A;C) 21.2% plus rs9815663(C;T) 32.7% plus 0.2112 rs1601875(C;T) 47.8% minus 0.4674 rs2819590(C;T) minus 0.1428 rs2322734(A;A) 88.5% plus 0.08127 rs6774280(C;T) plus 0.1621 rs271066(A;T) 56.9% plus 0.3962 rs11571297(A;G) minus 0.3898 rs6435326(T;T) 21.5% plus 0.4908 rs1801318(A;G) minus 0.3269 rs4675644(C;G) plus 0.2461 rs2284932(C;T) minus rs2551640(A;G) plus 0.427 rs2254137(A;C) plus 0.4178 rs2551645(C;T) 46.9% plus 0.4376 rs6785(A;G) 35.4% plus 0.1097 rs10153620(C;G) plus 0.2727 rs11681930(A;G) plus 0.2709 rs4675502(A;G) plus 0.433 rs849230(T;T) 86.7% minus rs11884476(C;G) 7.1% plus 0.08127 rs10932125(G;G) 23.3% plus 0.3907 rs1053517(C;C) 13.8% minus 0.4876 rs2952768(C;T) 1.0 Good plus 0.3581 slightly less drug dependence, decreased effectiveness of analgesics slightly less drug dependence, decreased effectiveness of analgesics rs2289917(A;G) plus 0.2305 rs1509569(C;T) 38.9% minus rs1047883(A;G) 44.6% plus 0.4362 rs12468557(C;T) 41.6% plus 0.2241 rs1047891(A;C) plus 0.2681 rs715(C;T) plus 0.2355 rs2216405(C;T) 27.4% minus 0.1446 rs1595066(A;G) 44.2% minus rs16845990(C;T) plus rs7598440(T;T) 32.7% plus 0.4261 rs2242073(A;C) minus 0.169 rs707284(C;C) minus 0.4463 rs1879637(T;T) 46.9% plus rs7588550(A;A) 92.2% plus 0.06198 rs1505368(A;G) plus rs6707387(A;G) plus rs10498015(T;T) 16.8% minus 0.3884 rs9789347(T;T) 6.2% plus rs1510552(G;G) 69.7% minus rs7585356(A;G) plus 0.2759 rs3768716(A;G) Bad minus 0.1442 1.7x higher risk of aggressive neuroblastoma 1.7x higher risk of aggressive neuroblastoma rs2229571(C;G) 47.7% minus 0.4876 rs7587476(C;T) plus 0.247 rs1464443(A;A) 50.4% plus rs6707530(G;T) plus rs2304573(C;T) 38.9% minus 0.4252 rs1250215(C;G) minus 0.3953 rs3796123(A;T) minus 0.4605 rs1250248(G;G) 62.5% plus 0.1607 rs1250229(C;T) plus rs4674024(C;T) 44.6% plus rs3770549(A;T) 41.5% plus 0.3365 rs7590720(A;A) 53.1% plus 0.2759 rs7586969(A;G) plus 0.343 rs16853834(C;T) 26.5% plus 0.168 rs207906(G;G) 74.1% plus 0.1065 rs9288518(A;G) 45.1% plus 0.4665 rs2440(A;G) minus 0.4665 rs9288520(A;G) plus 0.1864 rs2241193(G;G) 77.9% minus 0.2259 rs13015993(A;A) 44.6% plus 0.3972 rs10932688(C;G) 35.4% plus 0.3976 rs6435957(C;T) plus 0.4054 rs4491709(C;T) plus 0.4656 rs11685387(T;T) 8.8% plus 0.4187 rs6721996(A;G) plus rs12613955(G;G) 10.9% plus rs4442975(G;T) 46.2% plus rs1549738(C;T) minus 0.2819 rs11689435(C;T) plus 0.09688 rs2571445(C;T) 50.9% minus 0.3398 rs3791950(T;T) 33.8% minus 0.3306 rs4674258(T;T) 23.9% plus 0.4394 rs4674259(A;A) 28.3% plus 0.4591 rs6723449(C;C) 28.3% plus 0.449 rs1126579(C;C) 29.2% plus rs11676348(T;T) 23.9% plus 0.4568 rs1008563(A;A) minus 0.3586 rs6759952(C;T) plus 0.4082 rs1351164(C;T) plus 0.337 rs16857609(C;T) 46.0% plus 0.3448 rs13403276(C;T) plus 0.03306 rs3731859(A;G) plus 0.4752 rs2382817(A;C) 37.2% plus 0.3733 rs2695343(G;G) 41.6% plus 0.4366 rs7607369(G;G) 35.7% plus 0.477 rs10187066(G;G) 35.4% plus 0.466 rs2303565(C;T) plus 0.4605 rs4674344(A;T) 42.1% plus rs13404754(G;G) 35.4% plus 0.4261 rs6436122(G;G) 92.9% plus 0.241 rs12612347(A;G) 44.2% plus 0.4532 rs3815854(A;A) 16.8% minus 0.4426 rs10498070(A;C) 40.7% plus 0.4408 rs10932886(A;G) plus 0.2782 rs10498091(A;G) 28.6% minus 0.1827 rs715021(C;G) plus 0.2456 rs824931(T;T) 48.6% plus 0.4444 rs7559271(A;A) 38.1% plus 0.4904 rs12995399(C;T) plus rs7600206(C;T) plus rs6754024(G;T) plus rs1043160(C;C) 36.3% minus 0.4316 rs16863886(C;C) 11.7% plus 0.2746 rs12621643(G;T) plus 0.3356 rs1440072(C;T) 11.5% plus 0.05096 rs960246(G;T) plus 0.08632 rs6734100(C;G) 21.2% plus 0.1116 rs729631(C;G) 26.2% minus 0.3072 rs7583463(A;C) plus 0.4555 rs6748795(C;G) plus 0.4545 rs840088(C;C) 42.5% plus 0.3857 rs17496827(C;C) 30.1% plus 0.4803 rs7606754(A;G) 43.4% plus 0.3517 rs997363(A;A) 37.2% minus rs11691652(G;T) plus rs10175070(A;G) plus 0.3503 rs7594321(C;T) plus 0.2314 rs1861612(A;A) 31.9% plus rs6707272(T;T) 7.1% plus 0.2943 rs722555(A;G) 46.9% minus 0.4881 rs1498095(C;T) minus 0.07071 rs8192472(A;A) 17.2% minus 0.3705 rs4377469(A;A) 85.0% minus 0.2663 rs437876(A;G) 46.9% minus 0.388 rs9677(T;T) plus 0.371 rs339665(A;A) 91.9% minus rs4683336(T;T) 44.4% plus 0.3356 rs2228468(C;C) 15.0% plus 0.4628 rs3919627(T;T) 15.0% minus 0.4578 rs6599077(A;A) 9.2% plus 0.3136 rs7629386(T;T) 9.7% plus 0.2273 rs10490823(A;G) 53.1% minus 0.3416 rs430727(A;G) minus 0.4986 rs87938(A;G) 52.2% plus 0.4651 rs6599175(C;T) plus 0.2961 rs10212536(A;G) 41.6% plus 0.2819 rs1052501(A;G) 41.6% minus 0.2934 rs1717027(C;T) plus rs2272007(A;G) minus 0.3026 rs6599001(C;T) plus rs2669845(C;C) 81.1% plus 0.1074 rs28930679(A;A) plus 0.1703 rs1427294(T;T) 75.9% minus 0.06244 rs13397985(G;T) plus 0.1139 rs6716753(C;T) plus 0.1341 rs10201872(C;T) 35.4% plus 0.09963 rs7423615(C;T) 37.5% plus 0.1111 rs3111754(A;G) minus 0.45 rs745962(C;C) 59.3% plus rs7580717(A;G) plus rs1669070(C;T) 60.0% plus 0.3365 rs13030174(A;C) 41.6% plus 0.2282 rs12475512(A;G) plus 0.433 rs6750795(C;T) plus 0.4229 rs3103267(G;G) 39.1% minus 0.4096 rs6717918(C;T) plus 0.4683 rs12466358(G;T) plus 0.2704 rs17275498(A;C) 18.8% plus 0.073 rs1881492(G;G) 61.9% plus 0.1887 rs1656402(A;G) 38.9% minus 0.3301 rs12994997(A;G) plus 0.3875 rs3828309(C;T) 55.4% minus 0.3742 rs2241879(C;T) minus 0.3889 rs3792109(C;T) minus 0.3774 rs7587633(C;T) plus 0.3848 rs3792106(A;G) minus 0.4789 rs13005285(G;T) plus 0.4904 rs1550532(G;G) 46.9% plus rs838705(A;A) 36.3% plus 0.3581 rs10933436(A;A) 33.3% plus 0.472 rs10210302(C;T) Bad 54.0% plus 0.3903 1.2x risk 1.2x risk rs2741034(G;G) 1.5% plus 0.1478 rs2602381(C;C) 30.1% plus 0.4054 rs7586110(G;G) 12.4% plus 0.292 rs11692021(C;C) plus 0.2916 rs6759892(G;G) 14.2% plus 0.3444 rs2070959(G;G) 8.8% plus 0.2668 rs1105879(G;G) 10.7% minus 0.3039 rs6744284(C;T) 41.6% plus 0.3297 rs11891311(A;G) plus 0.3489 rs4124874(C;C) 21.2% minus 0.4968 rs1597944(T;T) 18.3% plus 0.4394 rs2361502(C;T) plus 0.241 rs12151790(A;G) plus 0.1313 rs4663476(G;G) 50.8% plus 0.1947 rs6736997(C;C) 35.1% plus 0.3076 rs2042831(A;G) 16.1% plus 0.1809 rs11676855(C;C) 10.6% plus 0.4444 rs10174126(C;C) 25.7% plus 0.4247 rs1991705(C;T) 9.7% minus rs6431393(G;G) 12.3% plus 0.4568 rs1131296(C;T) minus 0.3792 rs10929302(A;G) plus 0.2617 rs3755319(G;G) 21.4% minus rs34983651(AT;AT) plus normal risk normal risk rs4148324(G;G) 8.0% plus rs4148325(T;T) 8.0% plus 0.3113 rs1042640(C;G) plus rs8330(C;G) plus rs6717546(A;G) 49.1% plus rs1500482(A;G) 33.6% minus rs2292884(A;G) 30.1% plus 0.331 rs2292873(A;G) 20.4% minus rs3754701(A;T) 49.2% minus 0.4807 rs1584243(C;C) 75.0% plus 0.1033 rs10199956(G;G) 24.6% plus 0.4426 rs7590387(C;G) plus 0.4899 rs7602358(G;T) 34.5% plus 0.1625 rs56013859(C;C) plus 0.1166 rs4663302(C;C) 41.5% plus 0.2893 rs2270669(C;C) 60.3% minus 0.1965 rs7584330(A;G) 34.5% plus 0.3627 rs6706785(G;T) 18.6% plus rs4852140(A;G) 38.1% plus 0.3177 rs12618573(A;G) plus 0.4541 rs2292832(C;T) plus 0.4123 rs4305276(C;G) 47.7% minus 0.3301 rs2953145(G;G) 63.7% minus 0.1437 2.1x risk 2.1x risk rs1133353(A;A) 70.8% minus 0.1051 rs4676410(C;T) minus 0.2815 rs3749171(C;T) 26.8% plus 0.1552 rs3739070(A;C) 15.2% plus 0.0551 rs3769124(A;G) plus rs9287638(A;C) plus 0.4192 rs11683401(C;T) plus 0.3228 rs12477314(C;T) 19.7% plus 0.1781 rs757978(C;T) minus 0.07851 rs12479254(T;T) 38.1% plus 0.3352 rs2227981(C;C) minus 0.3806 rs11917787(A;G) 9.2% plus rs331894(A;A) 19.6% minus 0.4504 rs2272522(T;T) 3.6% plus 0.3108 rs892295(G;G) 98.5% plus rs4684585(A;G) plus 0.4734 rs35964523(C;T) plus 0.3944 rs6764623(A;C) 38.2% plus 0.3329 rs4676406(A;C) 54.0% minus 0.3664 rs4675874(C;T) minus rs9815195(A;C) plus rs9866825(A;C) 46.9% plus 0.3999 rs1008642(C;T) 34.5% plus 0.3682 rs237872(C;T) 41.7% plus 0.4867 rs2268490(C;T) 23.9% plus 0.2704 rs2268491(C;T) 16.8% plus 0.2176 rs2254298(A;G) plus 0.2144 rs237889(C;T) plus 0.3191 rs237895(C;T) plus 0.4307 rs237897(A;G) 47.3% plus 0.4275 rs6763848(A;C) plus 0.3958 rs2727943(C;C) 79.3% plus 0.309 rs975334(T;T) 13.3% minus 0.4059 rs11713158(C;T) plus 0.2415 rs3804797(A;G) minus 0.1772 rs334809(A;A) 43.1% minus 0.2622 rs3804795(A;G) minus 0.1088 rs9831572(G;G) plus 0.3173 rs6806528(C;T) 24.1% plus 0.07713 rs922948(C;T) minus 0.3044 rs7647307(G;T) 46.9% plus 0.4646 rs2687201(C;C) 46.9% plus rs13093086(A;A) 23.9% plus rs13072512(A;G) 51.3% plus 0.4986 rs6549438(A;A) 24.2% plus 0.3691 rs4532099(G;G) 57.5% minus 0.1763 rs9832740(C;C) 35.9% plus 0.3806 rs11128271(C;C) 81.5% plus 0.1382 rs1036797(C;T) 39.8% minus 0.2126 rs704454(A;G) 39.8% minus 0.258 rs6764388(C;T) plus 0.3783 rs1016553(C;C) minus rs7649739(A;A) 44.2% plus 0.3545 rs1524976(A;G) 29.2% plus 0.1157 rs17045031(A;G) plus 0.08999 rs2363709(T;T) 78.5% minus 0.07668 rs1490265(A;C) plus 0.2883 rs6792584(A;A) 46.9% plus 0.2107 rs1231831(G;G) 8.8% minus rs580384(T;T) 85.9% plus 0.118 rs1975649(C;T) plus rs1552244(A;G) 33.6% plus rs1678607(C;C) 80.0% minus 0.208 rs35683(C;C) 31.9% plus 0.2994 rs35682(A;A) 32.8% plus 0.3081 rs42451(C;T) 39.8% plus 0.2094 rs35680(A;A) 35.4% minus 0.287 rs26802(G;T) plus 0.2553 rs27647(T;T) 43.4% plus 0.2507 rs35678(C;T) 52.2% plus 0.4734 rs237899(A;G) plus 0.2911 rs2228485(C;T) minus 0.3209 rs237911(A;A) plus 0.1534 rs4564970(C;G) plus 0.1226 rs2268498(C;T) plus 0.382 rs1488467(C;G) plus 0.07851 rs159153(C;T) plus 0.2626 rs6807064(T;T) 4.5% plus 0.3287 rs1682825(T;T) 66.4% plus 0.2062 rs1809529(T;T) 10.7% plus 0.4587 rs4684059(C;G) plus 0.3489 rs347591(T;T) 43.1% plus 0.3949 rs2606736(A;A) 36.3% minus rs6802119(T;T) 36.3% plus 0.4339 rs4684792(C;T) plus rs2307981(-;TTG) minus 0.3724 rs2278556(A;G) plus 0.4017 rs308971(A;A) 80.4% plus 0.186 rs3773364(A;G) 26.5% plus 0.2264 rs17035945(C;T) plus 0.1745 rs3755724(C;T) 41.6% plus 0.3682 rs795009(A;C) 25.0% minus 0.286 rs310762(C;T) plus 0.4339 rs7616006(A;G) 49.5% plus 0.4504 rs17036101(A;G) plus 0.03444 rs13081389(A;G) 6.2% plus 0.03398 rs6809631(A;T) 32.3% plus 0.3301 rs9817428(A;C) plus 0.3517 rs308963(C;G) plus 0.3678 rs10510411(A;G) plus 0.2902 rs12629293(A;G) plus 0.2681 rs10865710(C;G) 36.3% plus 0.2686 rs13073869(A;G) plus 0.2686 rs12636454(C;T) plus 0.2856 rs709158(G;G) plus 0.2934 rs1175540(A;A) 13.3% plus 0.4348 rs1175543(G;G) 13.3% plus 0.2952 rs1175544(T;T) 11.5% plus 0.2769 rs1797912(C;C) 15.9% plus 0.3384 rs4684854(C;G) plus 0.4702 rs709160(C;C) 30.8% plus 0.4803 rs3729931(C;T) minus 0.3815 rs2290159(C;G) plus 0.2029 rs2569991(A;A) 65.5% plus rs17036314(C;G) Bad plus 0.2681 risk of progressing from IGT to T2D; reduced by exercise risk of progressing from IGT to T2D; reduced by exercise rs11128603(A;G) 11.1% plus 0.1107 rs4684847(C;T) 15.9% plus 0.0652 rs6802898(C;T) 15.9% plus 0.2163 rs2197423(C;T) minus 0.107 rs1899951(A;G) 16.1% minus 0.2153 rs4135247(A;A) 33.9% plus 0.4118 rs6807885(C;T) 10.8% plus 0.1313 rs6442522(C;T) 47.8% plus 0.478 rs878945(C;G) 36.7% minus 0.4793 rs7651039(C;C) 20.4% plus 0.3609 rs6771632(C;T) plus rs690037(T;T) minus 0.4968 rs10510468(G;T) 6.2% plus 0.06749 rs9821630(A;G) 38.9% plus 0.2998 rs4535211(G;G) 28.3% plus 0.4004 rs4618210(A;G) 46.0% plus rs9864101(C;T) 47.3% plus 0.4522 rs354476(A;G) 39.3% plus 0.4201 rs2597513(T;T) 74.3% plus 0.09137 rs1043953(A;G) 41.6% plus rs2228001(A;A) 35.4% minus 0.3439 rs2279017(G;G) 35.4% plus rs2470353(C;C) 24.2% plus 0.3324 rs2607737(T;T) 23.0% plus 0.4536 rs2227998(C;T) minus 0.2158 rs2228000(C;T) minus 0.2484 normal normal rs3731108(A;G) minus 0.1419 rs6790433(C;T) plus 0.287 rs7641175(A;A) 66.4% plus 0.1437 rs6577641(C;T) 46.0% plus rs13073817(A;A) 13.3% plus 0.185 rs4373084(G;T) 47.8% plus 0.3173 rs2053506(A;G) plus 0.2259 rs1915919(C;T) 54.9% plus rs9874923(C;T) 49.5% plus rs9871864(C;T) plus rs1395103(A;A) 8.8% plus 0.2567 rs6787231(C;C) 86.2% plus 0.04224 rs6770065(A;G) 42.5% plus 0.2456 rs409974(C;T) minus rs1490157(T;T) 59.3% plus 0.3053 rs4256159(A;A) 0.9% minus 0.1134 rs2593321(A;G) 36.6% minus 0.2365 rs6797769(A;T) 46.8% plus 0.4798 rs1402366(G;T) plus 0.1042 rs826221(C;T) 17.7% minus rs9310736(A;G) 38.9% plus 0.2815 rs322668(A;A) minus 0.1699 rs1529672(A;C) plus 0.2466 rs1997352(A;C) plus 0.3765 rs7644516(A;A) 82.3% plus 0.06841 rs653465(A;G) 60.2% minus rs4973768(C;T) 59.8% plus 0.3669 rs2307032(C;T) plus 0.3315 rs2724509(A;G) plus rs9310709(C;T) plus 0.416 rs11129182(C;C) 72.1% plus 0.1993 rs3806624(C;T) 56.6% minus 0.3255 rs11129295(C;T) 49.6% plus 0.494 rs10510628(A;G) plus 0.286 rs9838682(G;G) 38.3% plus 0.4504 rs6785358(A;G) plus 0.1552 rs764522(C;G) plus 0.2172 rs3087465(A;G) 41.6% plus 0.3375 rs1036095(C;G) 33.8% minus 0.2553 rs3773643(A;G) plus 0.1837 rs744751(C;T) minus 0.1855 rs1506203(A;C) 27.7% minus 0.1933 rs1902341(A;G) 48.7% minus 0.4619 rs7617877(G;G) 43.8% plus 0.3365 rs2221154(G;G) 18.6% plus 0.4252 rs6549915(C;T) plus 0.4334 rs9832625(A;A) 84.1% plus rs9862154(C;G) plus 0.3315 rs9825310(A;A) 23.0% plus 0.3407 rs4376071(C;T) 37.2% plus 0.3586 rs6776297(A;A) 62.8% plus 0.2319 rs9310995(C;C) 21.2% plus 0.3871 rs7648704(G;T) 47.3% plus 0.354 rs13314993(T;T) 29.2% plus 0.4307 rs4678680(T;T) 67.3% plus 0.2351 rs7613051(A;G) plus 0.2883 rs6781182(C;C) 50.0% plus 0.4669 rs950146(A;C) 49.6% minus 0.4775 rs13072940(A;T) plus 0.2824 rs9834970(C;T) plus 0.4927 rs9845475(G;T) plus 0.07438 rs12053903(C;C) 9.7% plus 0.4559 rs7638909(G;T) plus 0.4155 rs1805124(A;G) minus 0.2057 rs12632942(A;G) 41.6% plus 0.2378 rs7430477(C;T) 53.1% plus 0.4068 rs6795970(A;G) 55.8% plus 0.264 rs6801957(C;T) plus 0.3049 rs6800541(C;T) 55.8% plus 0.259 rs10428132(G;T) plus 0.2957 rs6798015(T;T) 37.2% plus 0.2759 rs1871922(A;C) minus 0.4555 rs6439167(C;C) 61.9% plus 0.1515 rs7984(A;G) 15.9% plus 0.4706 rs4688761(T;T) 50.4% plus 0.4582 rs2669858(C;T) 23.9% minus 0.1387 rs218498(A;G) 43.4% minus 0.3861 rs1320900(A;C) 50.4% minus 0.314 rs6439371(A;A) 41.3% plus 0.36 rs2369955(A;C) 29.2% plus 0.1276 rs7617456(A;A) 16.9% plus 0.3264 rs11718498(A;G) plus 0.4261 rs7650365(A;G) plus 0.3476 rs7431368(A;C) plus rs1573949(A;A) 49.2% minus rs10934857(C;T) minus rs2860228(C;T) minus 0.3636 rs9854612(A;G) plus rs4857855(C;T) 27.4% plus 0.2126 rs6806253(A;G) 24.8% plus 0.2126 rs4328821(A;G) 15.0% plus 0.1832 rs2712381(G;T) 46.0% minus 0.337 rs4234284(A;A) 14.2% plus rs13075436(T;T) 7.9% plus 0.2938 rs664910(A;A) 51.3% plus 0.4417 rs13063604(A;G) plus 0.185 rs1800734(A;A) 4.4% plus 0.3145 rs2212020(C;T) 49.6% plus 0.2879 rs189897(A;T) minus 0.1129 rs3923518(A;C) minus 0.1942 rs883565(C;T) 38.5% plus rs2853707(T;T) 59.7% minus 0.1639 rs2133579(G;G) 9.2% plus 0.258 rs7641291(A;A) 100.0% plus 0.1175 rs538867(C;T) 7.1% plus 0.1134 rs1768208(C;C) 51.8% plus 0.3489 rs562545(A;G) 48.2% plus rs1599903(C;C) 11.1% plus 0.4904 rs267567(C;T) minus 0.4725 rs166508(A;G) minus 0.4871 rs9825420(G;T) plus rs9311171(G;T) plus 0.1997 rs7372209(C;T) plus 0.2493 rs1805126(C;T) 40.7% minus 0.4936 rs993925(A;G) 53.1% minus 0.3503 rs6711012(C;C) 74.3% plus 0.1263 rs2903492(T;T) 74.3% minus 0.1263 rs12463617(C;C) 76.6% plus 0.1579 rs4854344(T;T) 74.3% plus 0.1543 rs7561317(G;G) 74.3% plus 0.1667 rs10189761(A;A) 74.3% plus 0.1547 rs10190052(C;C) 75.4% plus rs7596758(G;T) plus rs4380275(T;T) 38.1% plus 0.2695 rs4612666(C;C) 58.4% plus rs2791553(C;C) 39.3% minus 0.4913 rs11118346(T;T) 21.4% plus 0.4073 rs4373767(T;T) 17.0% plus 0.3636 rs994767(C;C) 31.7% minus rs7512221(T;T) 90.3% plus rs3737296(A;G) 41.5% plus 0.2429 rs12410279(A;G) 22.1% plus 0.2112 rs337161(G;T) minus 0.3118 rs12145418(G;T) 45.5% plus 0.2796 rs12757165(A;G) 46.4% plus 0.2805 rs1436900(T;T) 34.5% plus 0.4564 rs1339219(A;C) plus 0.3802 rs10754644(G;G) 17.7% plus 0.3613 rs2689154(C;G) 36.4% minus 0.2893 rs1915279(A;G) 42.5% plus 0.3182 rs1339738(T;T) 80.5% plus 0.07622 rs2820037(A;T) Bad 25.0% plus 0.1809 1.5x risk 1.5x risk rs10802789(C;T) 43.4% plus 0.4913 rs685550(A;G) minus 0.3012 rs536477(G;G) 31.9% plus 0.4757 rs12129547(C;T) 31.0% plus rs4844880(T;T) 69.6% plus 0.3549 rs3753519(G;G) 80.5% minus 0.2828 rs12086634(G;T) plus 0.1961 rs11807619(G;T) 27.0% plus 0.1804 rs11119328(A;C) plus 0.1873 rs1000283(C;T) minus 0.1667 rs932335(C;G) plus 0.2011 rs590223(A;G) plus 0.3627 rs2076153(A;G) 38.4% plus 0.4669 rs3737002(C;T) 26.5% plus 0.2658 rs10922153(G;G) 25.0% plus 0.3173 rs2990510(G;G) 11.5% plus 0.2397 rs6003(A;A) 83.0% minus 0.1938 rs7410943(G;G) 26.2% plus 0.4522 rs2786111(A;A) 36.3% minus rs701157(C;T) plus 0.4642 rs1202524(A;G) plus 0.2034 rs751229(C;C) minus 0.4389 rs11122319(G;G) 18.8% plus 0.4591 rs1572899(C;G) minus 0.4118 rs3738401(A;G) plus 0.2805 rs1417584(G;G) 21.2% minus 0.3981 rs11558492(C;T) 28.3% minus 0.1437 rs967244(A;A) 74.3% plus 0.1736 rs6675281(C;T) 27.9% plus 0.09275 None rs4658890(G;T) 46.9% plus rs1407599(A;C) 42.9% minus rs10746514(A;G) plus 0.3526 rs9725031(C;T) 21.4% plus rs4649444(A;C) plus rs10910200(C;C) 53.8% plus 0.2824 rs10489896(C;T) 30.8% plus 0.2984 rs12044355(A;C) 45.5% plus 0.3255 rs2812385(G;T) 48.7% plus rs2793092(C;T) minus 0.4008 rs2793086(A;C) minus 0.1093 rs2812393(C;G) plus 0.3994 rs1322784(T;T) 61.9% minus 0.3039 rs12042938(T;T) 18.8% plus 0.4247 rs2303425(C;T) plus rs2303426(G;G) plus 0.3843 rs3732183(A;A) 12.5% plus 0.4669 rs2969775(A;A) 40.7% minus 0.2879 rs2020908(C;G) 1.5% plus 0.004132 rs7565792(C;T) plus 0.4624 rs2293275(G;G) 36.9% minus 0.3655 rs7591064(C;T) 24.8% plus 0.1253 rs2268361(A;A) 46.9% minus 0.4959 rs1922464(G;G) 53.1% minus 0.4596 rs6708637(A;G) plus 0.4803 rs2091787(C;T) 48.7% minus 0.3848 rs10495970(A;G) plus rs6544997(A;G) 42.5% plus 0.45 rs9636436(A;G) plus rs11681792(T;T) 1.8% plus rs6750634(A;G) plus 0.3815 rs3850333(C;C) 37.2% minus rs2193225(A;G) minus 0.326 rs10202118(T;T) 61.1% plus 0.36 rs11125375(A;A) 46.8% plus 0.4141 rs1533428(G;G) 53.1% minus 0.3365 rs12619788(A;A) 26.5% plus 0.4688 rs1160297(C;C) 36.9% plus 0.3425 rs1356888(C;C) 66.4% plus 0.1488 rs17042407(C;T) plus 0.2011 rs17207494(C;C) 18.5% plus 0.2498 rs315931(A;A) 40.7% plus 0.4683 rs17042917(A;G) plus 0.1791 rs4251961(C;C) 12.4% plus 0.23 rs2637988(A;A) 32.7% plus 0.478 rs928940(T;T) 77.9% plus 0.3163 rs380092(A;A) 43.8% plus 0.477 rs1374281(C;C) 12.3% minus 0.2787 rs931471(T;T) 48.7% plus 0.461 rs3105491(A;C) 39.8% minus rs3917368(A;G) 43.4% minus 0.3255 rs2853550(C;C) 92.3% minus 0.1657 rs1143643(A;G) 46.2% minus 0.3269 rs1143642(C;C) minus 0.0978 rs2357013(T;T) 34.5% plus 0.3361 rs1367228(A;A) 19.5% plus 0.3627 rs6751715(C;T) plus 0.3466 rs737030(C;T) minus 0.3875 rs2717068(G;T) 58.5% minus 0.2916 rs2312147(C;T) plus 0.2764 rs6731302(A;G) 45.1% plus 0.315 rs17552189(C;T) 45.1% plus 0.2553 rs991964(A;G) minus 0.4017 rs887912(A;G) minus 0.1359 rs6712720(C;G) plus 0.4972 rs243088(A;A) 15.4% minus rs62164511(A;G) plus rs2540917(A;G) minus 0.2025 rs243070(A;T) minus 0.1497 rs1427407(G;G) 69.9% plus 0.2011 rs766432(A;A) 69.9% plus 0.2153 rs11886868(T;T) 48.7% plus 0.4963 rs10195871(G;G) 49.6% plus 0.4954 rs4671393(G;G) 76.9% plus 0.213 rs2556378(G;G) 69.0% plus 0.2213 rs1432295(A;A) 31.0% plus 0.2282 rs842647(A;G) plus 0.4826 rs243021(T;T) 15.9% minus 0.4982 rs9309331(C;G) plus 0.1607 rs13003464(A;G) 45.1% plus 0.3994 rs7608910(A;G) 45.5% plus 0.2883 rs10188217(C;T) plus 0.4665 rs10181042(C;T) 45.1% plus 0.3333 rs721048(A;G) plus 0.1088 None rs2710646(A;C) plus 0.1088 rs2710642(A;A) 46.0% plus rs2710647(C;C) 25.9% plus 0.4385 rs6545977(A;G) plus 0.4293 rs6733160(C;T) plus 0.3118 rs1529102(C;T) minus 0.4059 rs10211524(A;G) plus 0.3921 rs2160387(A;G) minus 0.4151 rs6545883(A;G) 53.6% plus 0.4027 rs7572857(A;A) 1.8% plus 0.112 rs1858037(A;T) plus rs1876518(A;G) 47.8% minus 0.3967 rs6740462(A;A) 53.1% plus 0.1951 rs3845817(A;G) minus 0.4665 rs897876(C;T) 42.5% plus rs2699783(C;C) 85.8% plus rs1320851(G;G) 75.0% plus rs4544423(G;T) plus 0.4238 rs3891585(A;G) 47.8% plus 0.3448 rs10865355(A;G) 47.3% plus 0.3448 rs934734(C;T) minus 0.3981 rs2192954(A;G) 41.1% plus 0.4481 rs2901879(C;T) 44.6% plus rs1833219(C;C) 55.6% plus rs6739392(T;T) 29.2% plus rs4141819(T;T) 54.0% plus 0.253 rs724568(A;A) 35.7% plus 0.4036 rs1868402(C;T) minus 0.2507 rs9309413(C;G) plus 0.3664 intermediate sphingomyelin values intermediate sphingomyelin values rs7592330(A;A) 28.8% plus 0.36 rs7595037(T;T) 27.4% plus 0.3522 rs9789535(A;G) 59.3% plus 0.4118 rs11897119(C;T) plus 0.332 rs34590960(A;G) plus 0.449 rs7597155(A;A) 23.2% plus 0.4348 rs10205487(A;G) 59.4% plus rs2166975(A;G) plus 0.208 rs3771497(G;T) 55.7% minus rs11466212(C;T) 18.6% minus rs432203(A;C) minus 0.4504 rs3771475(A;G) minus rs3755351(A;C) Bad 45.1% minus 0.3448 1.3x risk for hypertension 1.3x risk for hypertension rs741326(C;T) 54.0% minus 0.461 rs6759808(A;A) 38.1% plus rs11126185(A;A) 39.8% plus rs4627609(C;C) 11.5% plus 0.444 rs6731838(G;G) 21.4% plus 0.3944 rs283895(C;T) plus 0.3017 rs2100290(A;G) 47.8% plus rs4907240(A;G) plus 0.2975 rs953320(A;G) minus 0.1823 rs4608580(T;T) 33.8% plus 0.3949 rs12617721(A;C) 36.3% plus 0.2879 rs2278206(C;T) 35.4% minus 0.275 normal normal rs6733011(A;G) 50.8% plus 0.4399 rs7583877(C;T) 27.4% plus 0.3958 rs11676922(A;T) plus 0.4922 rs4851266(C;T) 52.3% plus 0.3292 rs9653442(C;T) 53.6% plus 0.4637 rs2197076(A;G) plus 0.2447 rs1805165(G;T) minus 0.2879 rs13045(A;G) minus 0.3471 rs7571971(C;T) plus 0.2874 rs17037621(A;T) plus rs867529(C;G) plus 0.2883 rs11684404(C;T) plus 0.3365 rs6547787(G;T) plus 0.3365 rs7574862(A;G) 45.9% plus 0.2723 rs1724120(A;G) minus 0.4105 rs6547537(G;G) 57.1% plus 0.2663 rs6886(G;G) 48.7% minus rs7577642(C;T) 44.6% plus 0.2493 rs1130866(T;T) 32.7% minus 0.4913 if sclerotic, reduced risk of lung disease if sclerotic, reduced risk of lung disease rs6547705(A;A) 63.7% plus 0.1253 rs9636470(A;G) minus rs12714207(T;T) 52.8% plus 0.3246 rs2970925(G;G) 70.5% minus 0.1437 rs2919856(A;A) 30.2% minus 0.3838 rs399885(C;C) 1.8% plus 0.3944 rs11695685(C;T) 46.4% plus 0.2883 rs6736587(A;C) 41.1% plus rs1534238(A;T) plus 0.4417 rs1150256(C;T) minus 0.3641 rs1150258(A;G) minus 0.3641 rs7525160(C;G) plus 0.3448 rs9429942(T;T) plus rs4844600(G;G) 58.9% plus rs6656401(G;G) 60.7% plus 0.0877 rs6701713(G;G) 58.4% plus 0.2691 rs2296160(C;C) 57.8% minus rs12034383(A;A) 37.2% plus 0.4564 rs1408077(G;G) 59.3% minus 0.1855 rs10494885(C;T) 43.0% minus rs10863962(C;T) 37.2% plus 0.3173 rs1856746(C;T) 48.7% minus rs1652333(T;T) 50.4% minus rs2564978(C;C) 50.4% plus 0.2856 rs3813946(A;G) minus 0.1552 rs1048971(A;G) plus 0.4022 rs17615(A;G) plus 0.2686 rs4308977(C;T) plus 0.2975 rs17616(A;G) plus 0.2677 rs7561268(C;C) 28.3% plus rs2292813(C;C) 88.5% plus 0.18 rs1400816(C;C) 89.2% plus rs908670(C;C) 12.4% plus 0.2782 rs2016394(A;A) minus 0.3205 rs13027811(A;G) 19.5% plus 0.05969 rs836589(G;G) 65.5% plus 0.1869 rs4668356(T;T) 88.4% plus 0.141 rs10183486(C;T) 46.9% plus 0.3306 rs34729309(G;T) minus 0.1938 rs1051929(G;G) minus 0.236 rs1529093(C;T) plus 0.4559 rs2706110(G;G) 68.1% minus rs10183914(C;T) 42.9% plus 0.2557 rs6726395(A;G) 42.5% plus 0.4518 rs1550623(T;T) 72.6% minus 0.1648 rs4972593(A;T) plus 0.1938 rs13009079(C;T) plus rs2600683(G;G) 80.5% minus 0.1593 rs3755486(T;T) 30.1% plus 0.3421 rs4972755(A;A) 3.2% plus 0.3765 rs2461751(C;T) minus 0.298 rs2972146(A;C) 33.9% minus 0.2259 rs2972144(C;T) 43.4% minus 0.2557 rs2943650(C;T) 37.7% plus 0.3329 rs1515110(A;C) 42.5% minus 0.2856 rs10167219(C;T) 28.1% plus 0.2704 rs2673142(C;G) minus 0.3558 rs925735(C;G) 35.4% minus 0.2645 rs3820928(A;G) minus 0.4146 rs35212277(A;A) plus 0.455 rs2042086(C;T) minus 0.3402 rs1843834(A;G) 52.2% plus rs4674973(A;C) plus rs1473307(C;T) 47.7% plus 0.4169 rs7578326(A;G) 41.6% plus 0.3044 rs2943634(A;C) 42.5% plus 0.3214 rs2943636(A;G) plus 0.4348 rs1515104(A;T) plus 0.2199 rs2943640(A;C) 40.7% plus 0.1974 rs2943641(C;T) plus 0.2686 increased risk for type 2 diabetes increased risk for type 2 diabetes rs1806649(C;T) 38.1% plus 0.1382 rs6721961(G;T) plus 0.1501 rs13413635(A;G) 0.0% plus 0.275 rs17362588(A;G) plus 0.045 rs6733818(A;G) plus 0.4477 rs13403289(A;C) plus 0.4922 rs16866933(A;G) plus 0.1492 rs11885327(T;T) 13.0% plus rs1964081(G;G) 0.9% minus rs16867321(C;T) 31.9% plus 0.2713 rs10931041(T;T) 38.1% plus 0.4614 rs17430279(A;G) 34.4% plus 0.1763 rs359895(A;A) 32.3% plus 0.4568 rs4380187(C;C) 18.0% plus rs11678036(T;T) 37.5% plus 0.4564 rs2046593(A;A) 75.2% plus 0.1579 rs3911238(G;G) 9.2% minus 0.3522 rs10174098(A;A) 45.1% plus 0.3586 rs2290083(C;C) plus 0.4619 rs840616(C;C) 51.3% plus 0.3843 rs6759535(C;C) 35.7% plus 0.4183 rs4667193(C;C) 56.6% plus rs7582658(A;G) 48.7% plus 0.472 rs7597593(C;C) 34.5% plus 0.4536 rs7603001(A;G) 56.2% plus rs13423388(A;G) plus 0.1235 rs6755404(C;C) 62.5% plus 0.1364 rs12476147(T;T) 34.9% plus 0.3393 rs7606224(C;C) 100.0% plus rs5742933(C;G) plus 0.2346 rs62184315(C;T) plus rs7570532(A;G) 29.2% plus 0.3466 rs3791783(C;T) plus 0.3655 rs10931468(A;C) plus 0.2415 rs2280232(G;T) minus 0.2443 rs10199181(A;T) 54.5% plus 0.4757 rs10208033(C;T) plus rs3106796(A;G) 48.7% plus 0.3825 rs1800255(A;G) 1.0 plus 0.2094 benign benign In heterozygous form, this is considered a benign (or 'likely benign') SNP. rs3024877(A;G) 39.3% minus 0.405 rs16833215(A;G) 40.7% plus rs3024866(C;T) minus 0.4642 rs1517352(A;C) 45.1% plus 0.4486 rs10168266(C;T) 33.6% plus 0.2328 rs7601754(A;A) 65.5% plus 0.314 rs10181656(C;G) Bad plus 0.253 1.7x increased SLE risk 1.7x increased SLE risk rs7582694(C;G) 31.5% plus 0.2668 1.71x increased SLE risk 1.71x increased SLE risk rs1823913(C;T) plus 0.478 rs13007495(C;T) plus 0.06107 rs1385351(C;T) 31.9% plus 0.2612 rs10174573(C;T) 49.6% plus 0.4591 rs801350(T;T) 92.0% minus rs10172965(T;T) 5.4% plus 0.3163 rs2565163(G;G) 49.1% minus 0.3062 rs2340690(C;T) 31.0% minus 0.1726 rs2305560(C;T) 28.3% plus 0.1602 rs11685878(C;T) plus 0.4885 rs7574070(A;C) 38.9% plus 0.4839 rs7561832(C;T) plus 0.3719 rs7572482(A;G) 39.6% plus 0.4757 rs897200(A;G) minus 0.4885 rs700675(A;A) minus 0.3017 rs1016883(C;T) minus 0.213 rs6738825(A;G) 52.2% plus 0.438 rs67031482(C;T) plus 0.4027 rs10497813(G;T) 52.2% plus 0.3843 rs7572733(C;T) 53.1% plus rs3771362(C;T) 39.3% plus 0.1905 rs17229285(T;T) 27.4% plus 0.3402 rs11893063(A;G) plus rs700651(A;A) 1.0 Good 48.6% plus 0.3021 Normal risk of aneurysm Normal risk of aneurysm rs1992950(A;G) 48.7% plus 0.4284 rs7605378(C;C) 34.3% plus 0.388 rs2949006(G;G) plus rs769951(C;G) 13.8% minus 0.1524 rs281761(A;T) minus 0.1529 rs4673727(C;T) 9.0% plus 0.1455 rs1569175(A;G) minus 0.1607 rs1881539(A;A) 94.7% minus 0.1258 rs295137(C;T) minus 0.3751 rs7558475(A;G) plus rs12471454(C;C) 36.2% plus 0.3774 rs3219156(A;G) 19.5% minus 0.101 rs16838917(A;G) plus rs6435133(C;C) 75.7% plus 0.1194 rs3769817(G;G) 76.1% minus 0.1125 rs7599810(A;G) plus 0.5 rs6761234(A;G) plus 0.4977 rs12473579(A;A) 9.4% plus 0.1983 rs2351524(C;C) 69.0% plus rs3769821(A;G) 39.7% minus 0.416 rs6723097(A;C) 50.4% plus 0.4265 rs3769818(C;T) minus 0.3081 rs231777(C;C) 74.8% plus 0.1529 rs231779(C;T) 50.4% plus 0.4738 rs231725(A;G) plus 0.4518 rs1427676(C;T) 53.1% plus 0.4582 rs231727(A;G) plus 0.4518 rs11571302(A;C) minus 0.3779 rs12992492(A;G) 54.1% plus 0.4692 rs1863800(C;T) plus 0.3577 rs13113(A;T) plus 0.3407 rs1035140(A;T) plus 0.4385 rs700635(A;C) plus rs13016963(A;G) 44.2% plus 0.4027 rs1830298(C;T) plus rs10201587(A;G) 53.1% plus 0.4757 rs13014235(C;G) 53.1% plus rs12748961(C;C) 0.0% plus 0.1961 rs823114(A;A) 32.7% plus 0.4197 rs823144(A;A) 56.6% plus 0.4307 rs947211(G;G) 56.6% plus 0.4298 rs11240594(A;G) plus 0.2888 rs1346751(T;T) 45.1% plus rs1722419(A;G) minus 0.05969 rs12185578(A;T) plus 0.247 rs4038131(A;G) 16.9% plus 0.1295 rs214034(A;C) plus 0.2172 rs10495669(G;G) 36.9% plus 0.3958 rs1031772(C;T) 39.7% minus 0.2576 rs1031771(A;G) 44.2% minus 0.292 rs4075511(A;C) 45.1% plus 0.3659 rs2544523(C;C) 43.8% plus rs2544527(C;C) 52.2% plus 0.1873 rs7580332(A;G) 50.4% plus 0.3512 rs17564315(A;G) plus 0.1258 rs6728440(A;G) plus 0.09642 rs10178256(A;A) 21.2% plus 0.3994 rs7565124(A;G) plus 0.247 rs6531209(T;T) 47.6% plus rs13021401(C;T) 44.2% plus 0.3113 rs3072(A;G) minus rs10495712(G;G) 59.8% plus 0.1648 rs6725189(G;T) 29.2% plus 0.1703 rs12710696(C;T) plus 0.3866 rs996712(C;T) 31.0% minus 0.3095 rs1402901(A;G) 12.4% plus rs4233949(G;G) 35.7% plus 0.2622 rs6752877(T;T) 36.3% plus 0.1763 rs11898505(G;G) 36.3% plus 0.1988 rs12713280(C;T) 43.4% plus 0.1694 rs6726292(A;G) plus 0.3044 rs2589113(A;C) minus 0.1621 rs7577894(C;C) 22.1% plus 0.3898 rs1367226(C;C) 39.8% minus 0.2801 rs6721498(A;A) 21.5% plus 0.4844 rs6754640(A;A) 9.2% plus 0.3402 rs10176705(T;T) 10.0% plus 0.2484 rs1042031(A;G) 27.9% minus 0.1529 rs693(C;T) minus 0.2741 elevated lipids elevated lipids rs10189050(A;A) 81.4% plus 0.04867 rs2681019(A;C) plus 0.3572 rs41458646(A;G) 34.5% plus 0.1938 rs2577720(G;T) 51.3% minus 0.4509 rs4665630(T;T) 80.0% plus 0.1846 rs7608623(G;T) 41.5% plus rs11674248(A;C) 43.4% plus rs7561273(A;G) 50.0% plus 0.3884 rs2288073(A;G) 36.3% plus 0.2149 rs13015955(A;G) plus 0.1185 rs713586(C;T) plus 0.4472 rs713587(C;T) 50.4% plus 0.4472 rs1172294(A;G) 51.8% plus 0.4385 rs478222(A;T) 50.0% plus 0.3916 rs734693(C;T) 40.2% plus rs13428812(G;G) 8.8% plus 0.298 rs13401241(A;A) 26.5% plus 0.4307 rs1550117(G;G) 85.0% plus 0.1309 rs7560488(C;C) 10.2% plus rs10180663(C;T) plus 0.472 rs13031859(A;G) plus 0.281 rs1011108(C;T) 53.1% plus 0.2769 rs2289360(G;G) 35.8% minus 0.404 rs2304682(G;G) 36.5% minus 0.3338 rs1530016(C;T) 48.7% plus 0.3907 rs13428823(A;A) 42.5% plus 0.3916 rs1042571(A;G) minus 0.1286 rs1009388(C;G) minus 0.1566 rs3754860(C;T) plus 0.219 rs11695471(A;T) plus 0.163 rs2165738(C;C) 47.8% minus 0.4118 rs1127568(G;G) 45.1% minus 0.3026 rs7604576(G;G) 23.2% plus 0.483 rs753529(A;A) 40.0% plus 0.4555 rs13407913(A;G) 56.6% plus 0.4862 rs2033654(G;T) minus 0.4862 rs7586879(C;T) 52.2% plus 0.4628 rs6545800(C;T) 56.6% plus 0.4922 rs6545814(A;G) 56.6% plus 0.4945 rs10182181(A;G) 53.1% plus 0.4596 rs1948368(A;G) plus 0.4674 rs1376359(C;C) 51.3% plus rs2990245(C;T) 54.9% plus 0.3563 rs1045253(C;T) minus 0.4908 rs12724079(C;C) 40.7% plus rs3753841(T;T) 37.5% minus 0.4674 rs12138977(T;T) 46.0% plus rs11809524(C;T) 20.4% plus rs6659783(A;T) 56.5% plus 0.4798 rs5277(C;G) 30.2% minus 0.09458 rs12042763(G;T) 32.8% plus 0.1974 rs4332358(C;T) 30.1% plus 0.4555 rs11102930(C;T) minus 0.472 rs7552722(C;T) plus 0.2709 rs2073655(C;T) minus rs2516839(A;A) 45.5% minus 0.4302 rs2516838(C;G) 48.7% minus 0.214 rs10493485(A;T) 42.5% plus 0.3131 rs954299(G;T) minus rs2422021(C;T) 43.5% plus rs7515577(A;C) plus 0.1116 rs11808092(A;C) plus 0.1478 rs11810217(C;T) 35.4% plus 0.1534 rs1739843(C;C) 30.8% plus 0.359 rs6660197(C;T) 20.4% plus 0.146 rs2292096(A;G) 19.6% plus 0.1515 rs7554511(A;C) plus 0.1543 rs7522462(A;G) plus 0.1497 rs296547(A;G) minus 0.4945 rs11584383(C;T) plus 0.169 rs1417437(A;G) minus 0.2746 rs6691577(G;G) 27.4% plus 0.4789 rs2226284(C;C) 27.4% plus 0.4752 rs12122100(T;T) 8.8% plus 0.197 rs583583(A;G) 41.6% minus 0.2718 rs3820129(A;G) 49.1% minus 0.2176 rs1464816(G;G) 38.9% plus 0.3058 rs6693954(A;T) plus 0.2897 rs11240688(A;G) plus 0.2603 rs7556371(A;A) 48.7% plus 0.3737 rs1380576(C;G) minus 0.432 rs2169137(G;G) 57.8% minus 0.2089 rs2290854(C;C) 45.5% minus 0.4298 rs1801159(A;G) minus 0.2048 rs1702294(G;G) minus rs1234313(A;G) 49.6% plus 0.3825 rs1234314(C;G) 53.8% plus 0.382 rs1234317(C;T) 31.0% plus 0.2135 rs2205960(G;T) 31.9% plus 0.191 rs424950(C;G) plus 0.3783 rs6670655(C;C) 62.8% plus 0.3104 rs4387163(A;G) plus 0.4183 rs1168029(T;T) minus 0.3829 rs1168013(G;G) 42.5% plus 0.3747 rs2131925(T;T) 46.2% plus 0.3783 rs1410996(C;T) minus 0.461 rs12144939(G;T) 34.4% plus 0.1905 rs380390(C;G) minus 0.2576 None rs7540032(C;T) 40.0% plus 0.4408 rs1329428(A;G) 49.1% minus 0.4408 ? ? rs590368(C;T) minus rs602633(C;C) 51.6% minus rs599839(A;A) Bad 53.1% plus 0.3127 1.29x increased risk for heart disease 1.29x increased risk for heart disease rs1933182(G;T) 36.9% minus 0.2925 rs6427339(C;T) 42.5% plus rs822585(T;T) plus rs6427356(A;G) 36.9% plus 0.4793 rs11264799(C;T) 41.6% plus 0.2879 rs2317230(G;T) plus rs6686886(A;A) 81.4% plus 0.2466 rs2274316(A;A) 41.6% plus 0.4307 rs3790455(T;T) 41.6% plus 0.4307 rs1497406(C;C) 34.4% minus 0.4908 rs3128296(T;T) 76.1% plus 0.07392 rs228727(G;G) 31.0% minus rs1175550(G;G) minus 0.2346 rs34188929(T;T) plus rs2857284(T;T) 100.0% plus 0.4079 rs1061631(A;G) plus rs228729(A;G) minus rs2254135(A;A) 51.7% minus 0.3756 rs1048261(T;T) 40.3% plus 0.2355 rs425277(C;T) 35.4% plus 0.2346 rs2295283(A;G) 46.0% plus 0.3416 rs2248727(T;T) 100.0% plus 0.4079 rs1149336(A;G) 41.5% minus rs3131972(C;C) 68.1% minus rs2015352(T;T) plus 0.4036 rs6537883(C;T) plus 0.4656 rs333960(C;T) 32.7% plus rs333970(A;C) plus 0.4472 rs1921(A;G) plus 0.3407 rs7543130(A;C) plus 0.2837 rs6689305(A;A) 61.1% plus 0.2755 rs1953652(T;T) 10.6% plus 0.2837 rs561104(A;A) 38.1% minus 0.3636 rs7553864(C;T) plus 0.3214 rs1891320(C;T) 36.3% plus 0.185 rs11163585(C;T) 46.8% plus 0.1772 rs10465746(G;T) plus rs12103(C;T) plus 0.3921 rs7513898(A;G) plus 0.4532 rs4839431(C;T) plus 0.1033 rs1319782(A;G) 43.4% minus 0.3531 rs4648356(A;C) plus 0.4197 rs953070(G;G) 54.9% minus 0.2801 rs11574(G;G) 51.4% minus 0.1354 rs2503706(C;T) 42.6% minus 0.1657 rs752010(A;A) 27.0% minus rs4645978(A;A) minus 0.3985 rs2042370(T;T) 28.3% minus 0.4008 rs678849(C;T) 54.9% plus 0.4536 rs2076600(T;T) 1.8% minus 0.3875 rs1149048(A;G) 47.7% plus 0.3788 rs841853(G;G) 52.2% minus 0.3398 rs6426833(A;G) plus 0.4362 rs6426749(C;G) plus 0.2167 rs1061624(G;G) 18.0% plus 0.4688 rs7549888(G;T) 44.2% plus 0.4945 rs10917468(C;T) plus 0.3251 rs10917477(A;G) 54.0% plus 0.3779 rs1077514(A;A) 73.5% minus rs1748031(A;T) minus 0.3613 rs4660531(T;T) 9.9% plus 0.2121 rs28411352(C;T) 41.6% plus 0.2323 rs4409675(A;T) 47.7% minus 0.4624 rs2819332(A;A) 6.2% plus 0.23 rs11573156(C;G) minus 0.1304 rs2298298(G;G) 76.1% plus 0.1713 rs4654925(C;G) plus 0.4008 rs841847(G;G) 58.5% minus 0.168 rs2506991(C;T) 43.4% minus 0.461 rs1889899(A;G) 54.9% plus 0.2727 rs7532266(A;C) 47.3% plus 0.314 rs2210430(C;C) 96.9% plus 0.07071 rs1009080(C;T) minus 0.4449 rs1317209(C;T) minus 0.2672 rs2295633(C;C) 44.2% minus 0.3535 rs6677188(A;T) plus 0.2837 rs1495965(A;G) Bad 45.9% minus 0.4522 1.2x higher risk for spondylitis 1.2x higher risk for spondylitis rs924080(C;T) plus 0.3972 rs6665776(A;C) plus 0.1001 rs594454(T;T) 40.0% plus 0.3701 rs2050066(C;T) plus 0.05142 rs532545(A;G) 43.4% minus 0.2057 rs6698181(C;T) 55.0% plus 0.2975 rs12145922(A;C) plus 0.4242 rs4237(C;T) minus rs12063142(C;T) 37.2% plus 0.2052 rs2236824(C;G) minus 0.3393 rs12030900(A;G) 30.1% plus rs11102637(A;G) plus rs1343125(C;T) 26.5% minus 0.3338 rs1799809(A;G) plus rs1799810(A;T) 39.3% plus 0.3494 rs1158867(C;T) 42.5% plus 0.3829 rs2069912(C;T) plus 0.3159 sepsis risk in East Asians sepsis risk in East Asians rs2069919(A;G) plus 0.2158 rs1401296(C;T) 40.0% plus 0.3255 rs4662834(A;G) 41.6% plus 0.3985 rs7561966(A;G) 1.6% plus 0.2778 rs1660895(T;T) 26.2% plus rs2952621(C;C) 23.0% plus rs4150506(C;T) minus 0.2025 rs6761391(C;G) 52.3% plus 0.3981 rs7580658(A;G) plus rs985162(A;G) minus 0.4605 rs10928927(T;T) plus 0.3003 rs7588567(C;C) 13.3% plus 0.4697 rs1901440(A;A) 46.8% plus 0.3567 rs1867898(A;A) 3.1% plus 0.2489 rs1257169(A;A) minus 0.2782 rs539588(A;A) 13.3% minus 0.3035 rs10179686(C;T) 4.7% plus rs6723108(T;T) 25.0% plus 0.1612 rs6430538(T;T) 14.2% plus 0.2397 rs7567687(T;T) 23.0% plus rs6430553(T;T) 13.8% plus rs6430585(A;C) 21.2% plus 0.2911 rs882300(G;G) 27.4% minus 0.2755 rs1582861(A;G) 58.7% minus 0.4522 rs1427593(G;G) 44.6% minus 0.2332 rs979976(C;C) 40.5% plus 0.3944 rs892877(C;T) 18.5% minus rs10496768(A;G) plus 0.06933 rs10170310(A;A) 66.7% plus 0.2433 rs58938945(G;G) plus 0.4614 rs4954218(T;T) 51.3% plus 0.0978 rs7570971(A;A) 7.1% plus 0.2287 rs12474609(A;T) 27.7% plus 0.213 rs12472911(C;T) 25.7% plus 0.2815 rs10928195(G;G) 80.5% plus 0.2006 rs787151(C;T) 29.2% minus 0.1846 rs7584099(A;G) 46.0% plus 0.4164 rs1424954(A;G) plus rs1014064(A;G) 54.0% plus 0.388 rs2161983(C;T) minus 0.3953 rs3768687(A;G) 52.4% minus 0.3875 rs2307394(A;G) minus 0.388 rs10191411(C;C) 47.8% plus 0.4343 rs2121433(A;G) minus 0.4646 rs7583748(A;A) 82.3% plus 0.09275 rs10197940(C;C) 17.9% plus 0.405 rs1061305(A;G) minus 0.3719 rs7426114(T;T) 67.3% plus 0.4302 rs11675841(C;T) 44.6% plus 0.3664 rs10196189(A;G) 22.1% plus rs958672(T;T) 58.5% plus 0.1364 rs707040(C;T) plus 0.3953 rs12621256(A;G) 28.3% plus rs17268364(A;G) plus 0.3609 rs4675374(C;C) 68.1% plus 0.3962 rs11571314(A;G) 44.1% plus 0.2645 rs10183087(A;C) 38.9% plus 0.2622 rs4404254(C;T) plus 0.2635 rs10932037(C;T) 26.8% plus 0.07025 rs1559931(A;G) plus 0.2617 rs6726035(C;T) plus 0.4082 rs6738181(A;G) plus 0.2989 rs2335704(G;T) minus 0.1065 rs11675251(A;G) 53.2% plus 0.3811 rs1376877(C;T) 48.2% plus 0.3829 rs3116494(A;A) 59.3% plus 0.2043 rs1980422(T;T) 61.9% plus 0.2006 rs231735(G;T) 50.4% plus 0.399 rs231806(C;G) 53.8% plus 0.3577 rs1024161(C;T) plus 0.4982 rs11571316(C;T) minus 0.3136 rs231775(A;G) 49.6% plus 0.4522 rs4544377(A;A) 78.6% plus rs4664774(G;T) plus rs1918172(C;C) 89.3% minus 0.2011 rs16839962(A;T) 23.1% plus 0.2369 rs1150143(C;G) plus 0.4963 rs1150144(A;G) plus 0.494 rs12803(G;T) 54.9% minus 0.3081 rs834835(C;T) 43.4% plus 0.4853 rs834830(A;G) plus 0.3517 rs707132(A;G) plus 0.3095 rs1405735(G;G) 56.9% plus 0.2805 rs7594648(G;T) 42.9% plus rs7601713(C;C) 45.1% plus 0.1974 rs1146031(A;A) 98.2% minus rs16843372(C;C) 29.5% plus rs174230(G;G) 98.2% minus 0.1331 rs2667011(A;A) 66.4% plus rs35771982(G;G) 30.0% minus 0.3196 rs4664308(A;G) 54.0% plus 0.2824 rs7593730(C;C) 70.8% plus 0.2401 rs6718526(C;C) Bad 72.7% plus 0.1671 1.9x risk of type-2 diabetes 1.9x risk of type-2 diabetes rs10192369(A;A) 25.0% plus 0.4917 rs17810398(C;T) 23.0% plus rs1829975(A;G) 29.2% minus 0.2277 rs7608798(A;G) plus 0.4362 rs3788979(A;G) 25.7% minus 0.2388 rs13015258(G;T) plus 0.4949 rs13422767(A;G) plus 0.1483 rs3747517(A;G) minus 0.3912 rs3788964(G;G) 1.8% minus 0.1506 rs984971(G;G) 13.3% plus rs2068330(C;C) 13.8% minus 0.4174 rs12476047(C;T) plus 0.2548 rs982393(T;T) 92.3% plus rs7568498(G;T) plus rs12617656(C;T) plus rs12692709(C;C) 26.5% plus 0.3792 rs6432832(A;C) 44.6% plus rs2304003(A;G) minus rs2298771(A;G) 44.6% minus 0.2144 rs2118674(T;T) 92.0% plus 0.1612 rs13035033(C;G) 39.8% plus 0.1442 rs12185692(A;C) plus 0.2934 rs3762555(C;G) 25.4% minus 0.3053 rs3749034(C;T) minus 0.1814 rs2241165(A;G) 31.9% minus 0.3669 rs11542313(C;T) plus 0.3645 rs3828275(A;G) 49.6% minus 0.3223 rs2058725(A;G) minus 0.2071 rs3791850(A;G) minus 0.1593 rs563694(T;T) 38.9% minus 0.1846 rs484066(A;A) 40.0% minus rs569805(A;A) 44.1% minus 0.1988 rs497692(G;G) 27.4% minus rs552976(C;C) 37.2% minus 0.2645 rs2075252(A;G) minus 0.258 rs2228171(A;G) minus 0.3232 rs830998(C;C) 59.3% plus 0.1621 rs2544390(C;T) 45.5% plus 0.4669 rs1399634(A;T) minus 0.4036 rs10930201(A;C) plus 0.2847 rs11904006(C;T) plus 0.1846 rs11890028(G;G) 9.7% plus 0.1974 rs41268673(G;T) plus 0.01561 rs3791251(C;G) 15.4% plus rs1446468(G;G) 17.2% minus 0.3815 rs8192673(A;A) minus rs3812718(C;T) 49.6% plus 0.483 rs6738031(A;C) plus rs7565062(G;T) 44.0% plus rs13408808(G;G) 1.8% plus 0.1754 rs1004368(C;C) 9.2% minus rs6433027(C;T) plus 0.4417 rs35929607(A;G) plus 0.36 rs1402837(A;G) 40.7% minus 0.2888 rs573225(T;T) 41.6% minus 0.1749 higher insulinogenic index in obese children higher insulinogenic index in obese children rs4423615(A;G) plus 0.4454 rs2119067(A;A) 58.4% minus 0.2016 rs10184275(A;A) 66.4% plus 0.1561 rs17183814(A;G) plus 0.073 rs2082366(C;C) 49.6% minus rs20563(A;G) 48.7% plus 0.4665 rs20558(C;T) plus 0.4665 rs1413390(C;T) minus 0.4665 rs525410(A;G) 40.7% plus 0.4803 rs4652795(T;T) 34.5% plus rs17849502(G;T) plus 0.02571 rs17849501(C;T) plus 0.02571 rs2274064(C;C) 20.4% plus 0.4977 rs10911363(G;T) 36.1% plus 0.3673 rs971572(G;T) minus 0.3549 rs2480054(A;G) 53.1% plus rs604708(C;C) 96.5% plus 0.04362 rs1750491(G;G) 46.0% minus 0.2805 rs10782529(T;T) 46.9% plus 0.348 rs1616122(A;G) 45.1% minus 0.4178 rs7543472(T;T) 56.6% plus 0.2002 ~2x increased risk for cataracts ~2x increased risk for cataracts rs516243(C;T) 53.1% minus 0.3857 rs10492972(C;T) plus 0.3512 conflicting reports; possible slight increased risk for multiple sclerosis conflicting reports; possible slight increased risk for multiple sclerosis rs9308447(T;T) 6.2% plus 0.2888 rs7533315(C;C) 46.2% plus 0.2034 rs734999(C;T) 46.9% plus 0.4233 rs2245218(A;A) 75.4% minus 0.1685 rs11121382(C;G) plus 0.23 rs2871776(G;G) 18.6% minus 0.3884 rs976881(A;G) minus 0.2709 rs228642(T;T) 27.4% plus 0.4059 rs3934834(C;T) 21.2% plus 0.1983 rs11587438(C;T) 19.5% plus 0.2314 rs2120461(T;T) 44.4% plus rs3748816(C;T) 40.7% minus 0.477 rs2376803(A;A) 60.0% minus 0.2759 rs6675668(G;G) 22.1% plus 0.3756 rs9437689(T;T) 26.6% plus 0.3017 rs1414896(A;A) 33.6% plus 0.4477 rs2697962(G;G) 1.0 Good 74.3% minus 0.1561 Normal risk of developing Parkinson's Disease Normal risk of developing Parkinson's Disease rs438895(T;T) 87.6% minus 0.1428 rs2977227(C;T) plus 0.478 rs4846048(A;A) 46.0% plus 0.2544 rs6603859(T;T) 29.2% plus 0.4417 rs2428736(C;T) minus 0.376 rs6688832(A;G) plus 0.3636 rs3738814(C;C) 14.3% minus 0.4242 rs1002076(C;T) minus rs4846049(G;G) 38.5% plus 0.3104 rs10915437(A;G) 42.5% plus 0.2851 rs3890745(A;G) minus 0.4307 rs3737964(G;G) 49.6% minus 0.1997 rs2477134(A;A) 42.0% minus 0.3278 rs12080794(C;T) 28.3% plus 0.1754 rs1052576(G;G) 1.0 Bad 28.3% minus 0.4004 Increased risk of multiple myeloma, B-cell neoplasms, and cancer in general Increased risk of multiple myeloma, B-cell neoplasms, and cancer in general A number of small studies with lowish p-values but low heterogeneity across studies suggest the A allele is protective against cancer. B-cell neoplasms may be particularly affected. Most studies showed a protective role for the A allele, which, by inference, means a higher (but not quantified) risk for the G allele. rs1621005(C;G) 36.5% minus 0.3659 rs1010069(T;T) 20.6% minus rs11806366(C;G) plus 0.3747 rs2885135(C;G) minus rs6690993(A;A) Good 54.2% plus 0.3627 0.7x decreased risk for ALS 0.7x decreased risk for ALS rs1470407(C;C) 79.7% plus 0.2117 rs7528859(A;T) plus 0.4109 rs10776733(G;G) 33.6% plus 0.3861 rs494453(G;G) 7.7% minus 0.4307 rs6573(A;A) 3.5% plus 0.123 rs6685648(C;C) 7.1% plus 0.3641 rs10927887(G;G) plus 0.3751 rs6684865(A;G) Bad plus 0.4178 1.2x risk 1.2x risk rs2076602(A;A) 0.0% minus 0.3085 rs2275166(G;G) 35.4% plus 0.2975 rs3397(T;T) 20.6% plus 0.4486 rs1005753(G;T) minus 0.3797 rs1748035(A;G) minus 0.3655 rs4908449(C;T) plus 0.303 rs1149332(A;G) 40.7% minus rs2640480(G;T) minus 0.3499 rs1058184(G;T) 43.4% minus 0.3535 rs2840381(T;T) minus 0.3095 rs863931(A;G) 54.0% plus 0.376 rs1251078(C;C) 40.0% minus 0.3646 rs10873876(C;T) plus 0.3003 rs12144344(C;T) 53.1% plus rs1336472(C;T) minus 0.3797 rs6588131(A;C) plus 0.4725 rs2375699(T;T) 31.9% minus 0.4578 rs4950806(C;T) plus 0.4343 rs10920531(A;C) 48.7% plus 0.4945 rs7539542(C;G) plus 0.4986 0.59x decreased breast cancer risk 0.59x decreased breast cancer risk rs1342387(A;G) minus 0.4568 rs12733285(C;T) 40.7% plus 0.208 rs10753929(C;C) 75.0% plus 0.1387 rs2798334(C;C) 61.5% plus 0.1644 rs17029069(C;T) 53.1% plus 0.2984 rs7555668(C;T) 41.6% plus 0.1644 rs548726(C;C) 53.1% plus 0.2098 rs6693036(C;T) plus rs28397767(A;A) plus 0.01403 rs1635579(C;T) minus 0.377 rs3094315(T;T) 68.8% minus 0.2521 rs2274327(T;T) 10.6% plus 0.292 rs630431(A;G) plus 0.3219 rs13312(C;G) plus 0.186 rs6673324(A;G) plus 0.3985 rs1805134(C;T) plus 0.1919 rs1137101(A;G) 53.6% plus 0.4105 rs3766379(C;T) Bad plus 0.4656 1.37x increased risk for rheumatoid arthritis 1.37x increased risk for rheumatoid arthritis rs6682654(A;G) Bad plus 0.4256 1.34x increased risk for rheumatoid arthritis 1.34x increased risk for rheumatoid arthritis rs2274907(T;T) 39.8% plus 0.3903 rs12750249(C;T) plus 0.2236 rs3354(C;T) 48.3% plus 0.3081 rs1324214(A;G) plus 0.2199 rs1800872(C;C) 62.8% minus 0.4091 rs1800896(G;G) 1.0 Good 27.4% minus 0.3026 Normal prostate cancer risk Normal prostate cancer risk rs1800893(A;A) 27.4% minus 0.3108 rs6703630(C;T) plus 0.1736 rs1800890(A;A) 12.7% minus 0.2259 rs10494879(G;G) 18.8% plus 0.2658 rs6676671(A;A) plus 0.2236 rs1772408(C;C) 69.9% minus 0.2897 rs926938(C;T) minus rs7530810(A;G) plus 0.4045 rs1321108(C;T) 50.0% minus 0.4288 rs4745(A;T) 46.0% plus rs12904(A;G) plus 0.4798 rs12079081(A;G) 31.0% plus 0.2553 rs1930293(A;G) minus 0.1708 rs4568789(A;A) 8.2% plus 0.4123 rs3736757(A;G) plus 0.3953 rs682331(A;G) 50.4% plus rs2146098(A;G) 56.6% plus 0.4564 rs28357672(T;T) 100.0% plus 0.0421 rs2134095(C;T) minus 0.4725 rs2651860(G;T) 38.1% minus 0.1483 rs466639(C;T) plus 0.1258 rs3934285(A;G) plus 0.2117 rs7543757(C;T) plus 0.3476 rs17496332(A;G) 43.4% plus 0.241 rs2341263(C;T) 38.9% plus rs4630083(G;G) 41.6% plus rs11210359(A;G) plus 0.3522 rs17412175(A;T) plus 0.2443 rs9436746(A;C) 40.2% plus 0.405 rs9436748(G;T) 57.8% plus 0.2608 rs3820185(A;C) 42.5% minus 0.4298 rs330700(A;C) plus 0.1896 rs953554(A;G) minus rs655167(C;T) 20.5% minus 0.1648 rs4657015(G;G) 35.7% plus 0.332 rs72717009(C;T) plus rs7511868(A;G) plus 0.4343 rs10802047(A;T) 56.2% plus rs984222(C;G) 53.8% plus 0.4697 rs17023457(C;T) plus rs6131(A;G) 35.4% minus 0.214 rs3917687(A;G) minus 0.1304 rs3917657(C;T) minus 0.1125 rs732314(G;G) 31.9% minus 0.4826 rs2479415(A;G) 52.2% minus 0.4063 rs2479409(A;G) plus 0.4362 rs12744221(A;G) minus rs1967017(C;T) minus 0.3361 rs1471633(A;C) 43.1% minus 0.3352 rs1237682(C;T) plus 0.2952 rs1217388(A;G) plus rs1310182(C;T) minus 0.4614 rs12757998(C;T) 37.2% plus 0.1584 rs627839(G;T) 55.8% plus 0.4068 rs533259(C;C) 88.5% minus 0.107 rs627928(G;T) 51.3% minus 0.4743 rs10752881(A;G) 49.6% plus rs3112831(A;G) minus 0.247 rs6334(A;G) plus 0.2135 rs2768759(A;C) plus 0.3861 rs6670818(A;A) 50.0% plus 0.2888 rs1541160(A;G) 35.4% minus 0.1534 rs522444(C;G) plus 0.152 rs3903239(C;T) 43.5% minus 0.4063 rs6687840(C;T) 43.4% plus 0.4734 rs4446959(C;T) plus 0.4743 rs4133289(A;G) 24.8% minus 0.1129 rs3754446(G;T) 45.0% minus 0.3728 rs3768490(A;C) 47.7% minus 0.3848 rs1342913(A;G) plus 0.3788 rs815160(G;G) 30.8% plus 0.3939 rs10494634(T;T) 18.8% plus 0.3545 rs2053302(C;C) minus 0.2365 rs10801047(T;T) 80.5% plus 0.1878 rs2816316(G;T) minus 0.2227 rs10797432(C;T) 45.1% plus 0.4766 rs1085093(C;C) 66.2% plus 0.1598 rs315553(A;A) 91.2% minus rs3738573(G;G) 11.5% minus 0.3003 rs529989(A;C) plus rs12711445(C;C) 60.0% plus 0.1855 rs6537825(G;G) 85.0% plus rs1200150(G;T) 42.5% minus 0.3714 rs6427196(G;G) 88.3% plus 0.07897 rs1554597(C;T) 44.2% plus rs11161637(G;G) 12.4% plus 0.3425 rs954353(C;T) 58.5% minus 0.3958 rs4657412(A;G) plus 0.3283 rs1532815(A;T) plus 0.3425 rs283696(C;T) plus 0.1405 rs6427384(T;T) 73.5% plus 0.2902 rs12036228(C;T) 41.5% plus 0.2089 rs2777963(C;T) minus rs6661961(C;T) plus 0.4114 rs908922(A;G) plus 0.2245 rs2274908(A;G) plus 0.3926 rs2274910(C;C) 38.4% plus 0.3976 rs4656958(G;G) 40.7% plus 0.3182 rs983332(A;A) 4.4% minus 0.2493 rs10923038(A;C) plus rs6699417(C;T) 53.1% plus 0.3889 rs11264736(C;T) 45.1% plus 0.3095 rs952146(A;G) 44.2% plus 0.3439 rs4845617(A;G) plus 0.3825 rs2808635(G;T) 43.1% plus 0.2562 rs10737175(C;T) plus 0.382 rs928655(A;G) plus 0.4408 rs922107(C;T) 47.8% minus 0.4197 rs922106(G;T) minus 0.3232 rs41350144(A;T) 51.3% minus 0.4688 rs1125777(A;G) 51.8% minus 0.4812 rs9436640(G;T) plus 0.427 rs6703865(A;G) plus 0.08586 rs2235302(A;A) 30.8% minus 0.3999 rs3917733(A;G) minus 0.1295 rs12725861(A;G) plus 0.3393 rs6428503(C;T) plus 0.3388 rs10922573(A;G) 53.8% plus 0.3393 rs2025805(C;T) minus 0.2475 rs2767485(C;T) plus 0.1657 rs1751492(T;T) 46.9% plus 0.4334 rs11162922(A;G) Bad 13.3% plus 0.1938 1.3x risk 1.3x risk rs11162963(C;T) 49.2% plus 0.4431 rs11163372(C;T) 32.7% plus 0.1768 rs1127091(C;T) 44.2% minus 0.348 rs7414227(A;G) plus 0.3076 rs2252508(C;T) 45.1% minus 0.309 rs285480(A;G) plus 0.2323 rs2194899(A;G) 38.9% plus 0.4307 rs10918196(C;T) plus 0.4582 rs2774279(C;T) 48.7% plus 0.2121 rs4073054(G;T) minus 0.247 rs10912580(A;G) 34.5% plus 0.2039 rs1342038(T;T) 15.9% minus 0.4669 rs10798269(G;G) 34.5% plus 0.3678 rs2105325(C;C) plus 0.1639 rs1361600(A;G) 46.9% minus 0.4435 rs2022309(T;T) 8.0% plus 0.2227 rs12029080(G;G) 7.8% plus 0.2273 rs2274328(C;C) 19.6% plus 0.4936 rs7531806(A;G) Bad plus rs1131498(C;T) 40.7% minus 0.1377 rs2076059(C;T) 56.9% plus rs5361(A;C) minus 0.0551 normal risk normal risk rs2064689(A;G) plus 0.3081 rs17375018(A;G) plus 0.3104 rs10158674(C;T) minus 0.1447 rs997251(A;G) minus 0.2952 rs1884139(G;T) plus rs11265452(A;G) 42.5% plus 0.2998 rs576523(A;A) 100.0% plus 0.06749 rs1413885(T;T) 33.9% plus 0.2291 rs3790433(C;T) minus 0.3352 rs1045895(A;G) plus 0.2153 rs4654438(C;T) plus rs2229238(C;T) plus 0.1928 rs6674171(A;G) 31.9% plus 0.1818 rs2072660(C;C) 57.1% plus 0.3191 rs2340721(A;C) 43.1% plus 0.4389 rs10918215(A;G) plus 0.4128 rs7514053(A;G) 25.7% plus 0.4132 rs7542900(C;C) 64.9% plus 0.2796 rs4474258(C;T) 50.0% plus rs860873(A;A) 23.0% plus rs4524(A;G) minus 0.2438 rs1018827(G;G) 85.7% plus 0.06152 rs2252865(G;G) 46.9% minus 0.2167 rs2078371(C;T) plus 0.1267 rs12134493(A;C) plus 0.08081 rs6330(C;T) minus 0.3058 normal normal rs1474747(C;T) 50.4% plus 0.3287 rs3027009(A;G) 14.2% plus 0.04132 rs12075(A;A) 28.3% plus 0.4619 rs67418890(A;A) plus 0.06657 rs1058405(A;G) 36.6% plus 0.2121 rs3767633(A;T) minus 0.08953 rs11264341(C;T) 58.4% plus 0.4867 rs9426886(A;T) 52.3% plus 0.4963 rs2070803(C;T) minus 0.4614 rs1891498(C;C) 57.5% minus 0.1309 rs791295(T;T) 29.2% minus rs3754048(C;G) minus 0.4077 rs239339(G;T) 36.6% plus 0.129 rs2486253(G;G) 58.4% minus rs61822012(A;G) plus rs2275703(A;C) plus 0.3361 rs10789166(A;G) 25.8% plus 0.2521 rs2780885(C;T) 42.2% plus 0.3434 rs310236(C;G) plus 0.3682 rs9434741(A;G) 29.2% plus 0.2635 rs10789322(A;G) plus rs12740031(A;G) plus rs6659202(A;T) plus rs12078839(C;G) 31.0% plus 0.2943 rs10912899(A;A) 9.7% plus rs2269650(A;C) 45.1% minus rs2861158(A;G) plus rs6427598(A;T) plus rs10127939(A;T) minus 0.03581 rs2808630(C;T) 43.8% plus 0.2149 rs4650376(T;T) 69.2% plus 0.1373 rs1937020(A;G) 41.6% minus 0.4307 rs6687262(C;T) plus 0.4536 rs1572970(A;G) plus 0.4017 rs876538(A;G) minus 0.1249 rs10489849(C;T) 27.4% plus 0.2713 rs3845624(G;G) 15.2% minus 0.4252 rs2494262(A;C) plus 0.4601 rs6030(A;G) minus 0.2925 rs4525(A;G) minus 0.2438 rs1230666(C;C) 72.6% minus rs1217413(A;G) plus 0.2906 rs2476599(A;G) plus 0.2938 rs6686643(C;T) plus 0.219 rs3845536(A;G) minus rs12756253(T;T) 26.5% plus 0.3765 rs1023008(T;T) plus rs482843(A;G) 39.3% plus rs2180335(C;C) 24.1% minus rs472952(C;C) 32.7% minus rs1321177(A;A) 42.5% minus rs6679002(T;T) 38.5% plus rs4630153(C;T) plus 0.219 rs1333739(A;T) 53.1% plus 0.2801 rs28757217(A;G) plus 0.05096 rs2842030(G;T) 55.4% plus 0.4894 rs10759(A;C) 39.3% minus 0.2764 rs412852(C;T) minus rs16840639(C;T) plus 0.1887 rs6428370(A;G) 42.0% plus 0.3402 rs10801575(C;T) plus 0.376 rs1853883(C;G) minus 0.2824 rs6667243(C;T) plus 0.3012 rs7522061(C;T) plus 0.4876 rs945635(C;G) 58.7% plus 0.4444 rs3761959(A;G) 53.1% minus 0.4995 rs1514177(C;G) 53.1% minus 0.3994 rs1514175(C;T) 53.1% minus 0.3857 rs1514174(A;G) 51.8% minus 0.3434 rs10489629(A;G) minus 0.4472 0.83x lower risk for spondylitis 0.83x lower risk for spondylitis rs1343151(C;T) Good minus 0.3237 0.8x lower risk for spondylitis 0.8x lower risk for spondylitis rs6669582(A;G) plus 0.2805 rs61779296(A;G) plus 0.2557 rs2811893(C;T) plus 0.3898 rs6700125(C;C) Good 52.2% plus 0.444 0.7x decreased risk for ALS 0.7x decreased risk for ALS rs4112788(C;T) 45.1% minus 0.332 rs6693105(C;T) plus rs6701216(C;T) 22.1% plus 0.2475 rs12141041(C;T) plus rs2854964(A;A) 46.2% plus 0.2966 rs1819698(A;G) 23.0% minus 0.2691 rs4072037(A;G) 55.8% minus 0.3186 rs2974937(A;G) minus rs2049805(A;G) minus 0.3526 rs629301(A;A) 54.9% minus 0.2135 rs3902354(T;T) minus rs2228099(C;G) 40.5% minus 0.4279 rs3768016(A;G) minus 0.3563 rs2134688(A;G) plus 0.1713 rs197412(C;C) plus rs197414(A;A) 2.7% plus 0.1547 rs2788612(C;C) 92.3% plus rs2144719(A;A) 32.7% minus rs497710(G;G) 67.3% plus 0.1175 rs11209002(C;T) plus 0.2195 rs17038182(C;C) 6.3% plus 0.2833 rs12735613(A;A) 4.4% plus 0.2388 rs7511673(A;T) 47.7% plus 0.3751 rs11576175(A;G) plus 0.0854 rs2230061(C;T) minus 0.3517 rs4845783(A;G) plus 0.1951 rs499697(C;T) minus 0.1951 rs4085613(A;C) minus 0.4123 rs1993709(C;C) 72.6% minus 0.112 rs10789369(G;G) 36.3% plus rs2341260(T;T) 87.1% plus 0.1474 rs718265(A;G) 46.0% plus 0.4022 rs600491(C;T) 58.7% plus 0.3788 rs638944(G;T) plus 0.4761 rs2455012(C;C) 89.3% minus rs4655595(A;G) 20.4% plus 0.1777 1.4 risk 1.4 risk rs1040716(A;A) 17.7% minus rs12126655(A;G) 42.0% plus rs345299(A;C) 45.5% plus rs2801219(G;T) minus 0.3531 rs4263970(C;T) plus 0.3595 rs2501431(A;G) plus 0.3627 rs3003336(C;T) plus rs3091242(C;T) 54.0% plus 0.376 rs2295632(C;C) minus 0.4298 rs333662(T;T) 83.1% minus 0.1488 rs334699(G;G) 90.3% plus 0.07576 rs6691768(A;G) plus 0.4624 rs10903122(A;G) 56.6% plus 0.3825 rs9659092(A;G) 42.0% plus 0.2952 rs3811464(A;G) minus 0.3251 rs1780324(C;T) 48.7% minus 0.4743 rs11165354(A;C) plus 0.4766 rs1805110(C;T) minus 0.2016 rs2489188(A;G) 44.2% minus 0.3007 rs12133337(C;T) plus 0.168 rs10918706(C;T) 46.2% plus 0.2456 rs2066446(A;G) minus 0.23 rs17129789(C;T) plus rs10489202(G;T) 38.1% plus 0.1772 rs1412337(C;T) minus 0.1942 rs1320976(A;A) 1.8% plus 0.1713 rs4657616(A;G) 54.0% plus 0.348 rs861318(C;C) 69.9% minus 0.3196 rs855873(G;G) 87.6% plus rs487230(C;T) 34.5% minus 0.2975 rs1165226(C;T) 50.4% plus 0.4357 rs287235(C;G) plus 0.2612 This genotype appears to have increased risk for late-onset Parkinson's disease rs6427419(A;A) 27.4% plus 0.4555 rs973742(A;G) plus 0.4486 rs411089(C;T) 38.9% plus 0.4826 rs6677719(C;T) 53.8% plus 0.1864 rs4233356(G;G) 50.4% plus 0.3425 rs6659742(C;T) 45.1% plus 0.3691 rs2301022(G;G) 36.6% minus rs560426(C;T) minus 0.3985 rs481931(A;C) minus rs2427827(C;T) plus 0.3026 rs2494250(C;C) 52.3% plus 0.2062 rs2494251(A;G) plus 0.3108 rs2902440(A;G) plus 0.3815 rs7517847(G;T) plus 0.4031 possibly reduced risk for Crohn's disease possibly reduced risk for Crohn's disease rs33996649(C;T) plus 0.0124 rs2243471(C;T) minus 0.2902 rs1217414(C;T) minus 0.3095 rs1323292(C;T) minus 0.168 rs1152746(A;G) 47.3% minus 0.2351 rs965972(T;T) 91.2% minus 0.2094 rs606149(A;G) 45.1% minus 0.4421 rs3001167(C;T) 14.2% minus 0.3049 rs1582156(A;T) plus rs6660685(G;G) 42.4% plus 0.2433 rs2780889(A;T) 50.8% plus 0.4605 rs2780815(G;T) plus 0.2975 rs310241(C;T) 35.4% minus 0.354 rs4949718(C;T) plus rs648425(C;C) 100.0% plus rs3753380(A;G) minus 0.241 rs12132032(A;G) 43.8% plus 0.3549 rs903263(G;T) 48.7% plus 0.4357 rs594631(A;T) 27.6% plus 0.3912 rs6696854(C;C) 57.5% plus 0.3632 rs12746613(C;T) 24.8% plus rs10800309(A;G) 45.1% plus 0.4385 rs2072661(A;G) plus 0.2782 rs2229857(A;G) minus 0.3797 rs3753555(A;A) 29.2% minus rs3766680(A;G) minus 0.4578 rs859427(T;T) 42.5% plus 0.2994 rs4471226(T;T) 76.9% plus rs2502815(C;T) minus 0.3416 rs3003596(A;G) 53.1% plus 0.4913 rs2501873(A;G) 46.9% minus 0.4559 rs164898(A;A) 58.0% plus 0.2199 rs1192415(A;A) 64.6% plus 0.1938 rs284875(A;G) 4.6% plus 0.101 rs11588062(T;T) plus rs1042114(G;T) 22.1% plus 0.06841 rs11583200(C;T) 44.6% plus 0.3898 rs1298637(A;G) 47.8% minus rs3902720(C;T) plus 0.477 rs203674(A;C) 51.8% minus 0.2576 rs3753395(A;T) 41.5% plus 0.4582 rs6677604(A;G) plus 0.1873 rs393955(A;C) minus 0.259 rs379489(C;T) 51.4% minus 0.2576 rs3766405(C;T) plus rs13303344(T;T) 48.7% minus 0.427 rs2501401(A;G) 30.4% plus rs2236852(A;G) 42.5% plus 0.4793 rs4649203(A;A) 58.4% plus 0.4008 rs3795299(G;G) 18.5% minus 0.4399 rs3768043(A;A) 52.3% plus 0.3829 rs2473277(T;T) 24.8% minus 0.4715 rs3101336(A;G) minus 0.3012 rs2568958(A;G) plus 0.3007 rs2815752(C;T) minus 0.3007 rs2985334(G;T) plus rs4660456(G;G) 6.2% plus 0.2631 rs3765945(T;T) 34.5% minus 0.3691 rs6428830(G;G) 45.5% plus 0.1869 rs6203(C;T) 58.5% plus 0.3962 rs873917(C;C) 44.2% minus 0.4247 rs11590421(A;A) 8.0% plus rs6671200(C;C) 87.5% plus 0.0831 rs6593669(C;T) 32.7% plus 0.331 rs6693882(G;G) 25.7% plus 0.3131 rs6686842(C;C) 36.3% plus 0.3705 rs11205641(A;G) 42.5% plus 0.314 rs6429703(C;C) 75.2% plus 0.1506 rs1780316(C;C) 87.6% plus rs1467465(C;T) 38.9% minus 0.3857 slightly reduced breast cancer odds? slightly reduced breast cancer odds? rs7515106(C;C) 7.1% plus rs204076(A;T) minus rs10794501(A;T) 37.2% plus 0.2769 rs172378(A;G) plus 0.4155 rs6683419(A;G) plus rs6598955(C;T) 37.2% plus rs11802770(C;C) 22.3% plus 0.3994 rs589249(G;G) 10.6% plus 0.4541 rs2072671(A;C) 45.1% plus 0.2144 rs10917469(A;G) 31.9% plus 0.1731 rs2502992(A;G) minus rs1780329(G;T) minus 0.3159 rs1043879(C;T) minus 0.1451 rs12568930(C;T) plus 0.2273 rs10753575(C;T) 54.0% plus 0.2998 rs16826658(G;T) plus 0.3393 rs665691(C;G) 45.1% minus 0.376 rs2501276(A;G) 14.2% minus 0.06336 rs3767155(A;G) 46.0% minus 0.2934 rs10799701(A;G) 47.8% plus 0.489 rs4654903(A;G) 51.3% plus 0.4674 rs4926831(C;T) 42.5% plus 0.3131 rs28573847(G;G) 100.0% plus 0.3452 rs4612601(A;G) plus 0.3765 rs525380(C;C) 25.7% plus 0.4399 rs294223(C;C) minus 0.3044 rs581111(C;T) 42.5% minus 0.3108 rs6586513(A;A) 51.7% plus 0.253 rs12045693(A;C) plus 0.472 rs1415985(C;T) plus 0.3173 rs3738815(A;A) 0.9% minus 0.3081 rs6691847(C;C) 79.6% plus 0.1818 rs11582540(A;C) plus 0.1648 rs771390(C;C) 73.5% plus 0.1648 rs2229579(C;T) minus 0.1001 rs2072749(A;G) minus 0.2608 rs6588505(C;T) 37.2% plus 0.3613 rs1776421(C;T) 28.3% plus rs1748033(A;G) minus 0.3774 rs10903129(A;G) 54.0% plus 0.4959 rs2494876(T;T) plus 0.2879 rs2842576(T;T) 86.7% plus 0.06887 rs1976403(G;T) 53.1% minus 0.2975 rs13375749(C;T) plus rs4246511(C;C) 71.4% plus 0.4917 rs6694545(A;G) 44.2% plus 0.4013 rs2271933(C;T) 44.2% minus 0.4293 rs685001(A;A) 20.0% plus rs2860031(A;G) 54.5% plus 0.376 rs4074961(A;A) 12.4% minus 0.4279 rs586178(C;G) plus 0.3421 rs1738475(C;G) 50.8% plus 0.4972 rs10914367(A;G) 38.4% plus 0.2837 rs3131513(A;A) 37.2% plus rs3200254(C;T) plus 0.2787 rs3131713(A;A) 76.1% plus 0.1745 rs10799655(C;C) 60.7% plus 0.3072 rs6672420(A;T) 53.8% plus 0.4545 rs7524102(A;G) 33.6% plus 0.2259 rs12744386(C;T) 50.0% plus 0.3613 rs324419(G;G) 72.3% minus 0.08815 rs11249215(A;G) plus 0.4743 rs4499362(C;T) 37.2% plus 0.2929 rs6435387(G;G) 89.4% plus 0.01791 rs7578361(T;T) 61.1% plus 0.3375 rs10170236(A;A) 59.3% plus 0.3104 rs16827293(C;T) 19.5% plus 0.225 rs11889862(G;G) 60.4% plus 0.2874 rs6716455(A;G) plus 0.1368 rs6757804(C;T) 57.5% plus 0.4316 rs11683487(T;T) 18.3% plus 0.3448 rs1011397(C;T) 31.0% plus 0.2227 rs2252641(A;G) minus rs10445672(C;T) plus 0.2071 rs1040173(C;T) minus 0.4481 rs10427255(C;T) 46.9% plus 0.4366 rs1369481(G;G) 54.9% minus 0.2383 rs6725296(A;G) plus rs13025524(A;G) plus 0.2681 rs895521(G;G) 58.0% minus 0.1093 rs11674199(A;G) plus 0.2401 rs2305160(C;T) 38.1% minus 0.2314 rs1542178(C;T) 37.2% minus 0.2355 rs11123857(A;G) 33.6% plus 0.1933 rs3739008(C;T) 42.5% plus 0.2424 rs1160542(A;G) plus 0.4522 rs10865035(A;G) 56.2% plus 0.4339 rs1053096(C;C) 47.8% plus rs2278729(A;G) plus 0.2057 rs2236935(A;G) 29.2% minus 0.1419 rs12712127(A;G) 54.9% plus rs3917225(G;G) 25.7% plus 0.3632 rs2192752(A;A) 58.4% minus 0.1561 rs2110726(T;T) 13.3% minus 0.281 rs1420103(G;T) 38.5% minus 0.2695 rs17639215(A;G) plus rs1921622(A;G) plus 0.4109 rs10208293(A;G) plus 0.2989 rs13424006(C;T) plus 0.4027 rs6711606(G;G) 65.5% plus 0.1074 rs12620464(C;T) plus 0.1304 rs9807989(C;T) plus 0.4013 rs13015714(G;T) 33.6% plus 0.2695 rs3755276(A;G) 51.3% minus rs3771166(C;T) minus 0.382 rs1974675(C;T) minus rs2058660(A;G) minus 0.2778 rs7559479(A;G) plus rs917997(A;G) minus 0.2773 rs1014286(C;T) minus rs869833(A;G) minus 0.4628 rs4988957(C;T) plus 0.4031 rs10204137(A;G) 51.3% plus 0.3209 rs6735786(C;T) 42.5% plus 0.4036 rs264943(A;C) plus 0.3104 rs6712932(C;C) 12.5% plus 0.2819 rs1357692(G;T) 46.9% plus 0.3228 rs1402467(C;G) 35.4% plus 0.3554 rs4849121(A;G) plus 0.4747 rs6732565(A;G) plus 0.4008 rs13401811(A;G) plus 0.1924 rs3789119(A;G) 41.6% minus 0.2957 rs4849303(T;T) 24.8% plus rs13390641(A;G) plus rs10207392(A;G) 46.0% plus 0.4858 rs1439287(C;T) minus rs6746608(G;G) 29.5% plus 0.4541 rs12613243(C;T) plus 0.1152 rs724710(C;C) 46.9% plus 0.2709 rs3789068(C;T) 51.3% minus 0.3962 rs6738028(C;C) 38.5% plus 0.376 rs6720394(G;T) plus 0.07989 rs11122895(C;T) 46.9% plus 0.2521 rs17040773(A;C) 38.9% plus 0.1538 rs17483466(A;G) 33.0% plus 0.118 rs3789080(A;G) 29.2% minus 0.197 rs869016(C;T) minus 0.4559 rs1143633(A;G) 43.8% minus 0.3522 rs1143630(G;G) minus 0.1529 rs3917356(A;G) minus 0.3884 rs1143627(C;T) minus 0.4803 rs1143623(C;G) 41.3% minus 0.2984 rs4848306(A;G) plus 0.3935 rs12621220(C;T) 40.7% plus rs2708973(C;C) 100.0% minus rs10864907(C;T) 54.0% plus 0.376 rs7604639(A;G) plus 0.4821 rs2230515(A;G) 47.8% plus 0.4816 rs4374383(A;G) 49.6% plus 0.4835 rs6542095(C;T) 38.9% plus 0.4229 rs3783553(-;TGAA) minus rs3783550(A;C) 39.3% minus rs2071376(A;C) minus 0.4219 rs2856838(C;T) minus 0.3191 rs2071373(C;T) minus 0.3783 rs13010713(A;G) 58.4% plus 0.4472 rs1018326(A;G) minus 0.4472 rs7602460(G;G) 36.3% plus 0.4798 rs6740847(A;G) 49.1% plus 0.4839 rs1449263(A;G) 48.7% minus 0.4816 rs2124440(C;T) minus 0.4848 rs993648(A;G) 44.2% minus 0.4192 rs1801262(C;C) minus 0.2658 rs2437896(C;C) 7.1% plus 0.4692 rs7566934(A;G) 42.0% plus 0.2236 rs1020410(C;C) 9.7% plus rs2592394(C;C) 47.8% minus 0.3448 rs4972806(C;T) 44.2% plus 0.4793 rs1867863(A;C) 44.4% minus 0.3664 rs4972504(C;C) 41.6% plus 0.2332 rs12467847(A;G) plus 0.3944 rs6761276(C;C) 33.0% plus 0.4784 rs6743376(A;A) 42.9% plus rs6734238(G;G) 15.9% plus 0.3163 rs2053724(C;G) minus 0.4284 rs272000(G;G) 33.8% minus 0.4366 rs17586756(C;T) 11.5% plus 0.04086 rs10185316(C;G) 46.0% plus 0.2612 rs17047764(C;G) plus 0.1905 rs6726538(A;T) plus rs17189298(A;A) 19.5% plus 0.3489 rs2084202(C;C) 67.2% minus 0.1134 rs1374313(A;G) minus 0.4798 rs7576192(A;G) 56.6% plus 0.2888 rs7579169(C;T) plus 0.2879 rs12711941(G;T) plus 0.2691 rs4849887(C;T) plus 0.1639 rs2030746(T;T) 16.8% plus rs1869026(G;T) minus rs735557(A;G) minus 0.4229 rs1878526(T;T) 4.4% minus 0.2594 rs1438852(C;T) 54.0% plus 0.4853 rs17795618(A;T) plus 0.1579 rs1371562(G;T) 47.8% plus 0.2851 rs2011839(C;T) 46.0% plus 0.242 rs4848632(A;G) 46.0% plus 0.4596 rs11122834(C;C) 99.1% plus 0.1152 rs4848143(A;G) 44.2% plus 0.4798 rs1527243(T;T) 74.3% plus 0.3039 rs13400652(C;T) 47.5% plus 0.3765 rs1170612(C;C) 68.8% plus 0.1534 rs17727261(C;T) 11.5% plus 0.02663 rs10207628(C;G) plus 0.1818 rs7561528(A;G) plus 0.2351 rs7567389(T;T) 58.6% plus 0.2475 rs1352083(C;T) minus 0.197 rs2161829(C;T) 50.4% minus 0.4821 rs889904(A;A) 23.0% minus 0.41 rs9308762(T;T) 58.4% plus 0.2755 rs292001(A;G) plus 0.3907 rs12027135(A;T) 49.2% plus 0.433 rs10902723(C;T) plus rs12748152(C;T) 15.9% plus rs3918018(C;T) minus 0.01469 rs7532866(A;G) 40.4% plus 0.303 rs6667686(C;T) plus rs6659176(C;G) 16.9% plus 0.04729 rs647955(C;G) 52.5% minus 0.4146 rs4601530(C;T) 36.3% plus 0.3613 rs4659382(C;G) 38.9% plus 0.2369 rs96067(C;T) minus 0.371 rs1764391(C;T) 41.6% plus 0.3333 rs564148(T;T) 73.2% plus 0.09045 rs4478858(A;G) minus 0.4298 rs10751776(A;C) 61.0% plus 0.3379 rs760805(A;T) 43.8% plus 0.4229 increased risk for bladder cancer if part of risk haplotype increased risk for bladder cancer if part of risk haplotype rs2269231(T;T) plus rs7552167(G;G) 78.8% plus rs10794657(A;G) 29.2% plus 0.2204 rs213045(G;T) 38.1% plus 0.4688 rs17568(A;G) minus 0.4559 rs12138950(A;C) 31.9% plus 0.1667 rs897471(T;T) 54.0% minus 0.2576 rs2376805(T;T) minus 0.2011 rs2234918(C;T) plus 0.4077 rs1799821(A;G) plus 0.4995 rs4660306(C;C) 49.6% plus 0.1979 rs476463(A;G) plus 0.1653 rs2281597(C;C) 59.8% plus 0.1538 rs10798959(C;T) 42.5% plus 0.2893 rs2473307(G;G) 21.5% minus 0.494 rs3480(A;G) plus rs3827730(C;T) plus 0.4307 rs1741981(C;C) 15.0% plus 0.4876 rs11249206(C;T) 42.5% plus 0.4747 rs11582300(A;A) 31.9% plus 0.354 rs3748570(A;A) 34.5% plus 0.2695 rs12145743(G;T) plus rs7528484(C;T) plus 0.4669 rs10916814(C;T) 38.9% plus rs1884444(G;T) 52.7% plus 0.4816 rs11465788(C;T) plus 0.4784 rs9727115(A;G) plus 0.3691 rs10747502(A;G) 13.5% plus 0.112 rs303386(T;T) 58.4% plus 0.3916 rs9803659(C;C) 12.4% plus 0.3232 rs2146727(A;G) plus 0.3815 rs2056626(G;T) plus 0.2314 rs4325129(A;G) 25.4% plus rs1374486(C;T) minus 0.3765 rs2592887(A;G) 44.1% minus 0.4789 rs1325195(C;T) minus 0.3875 rs1044925(A;C) plus 0.2585 rs61747728(C;T) plus 0.02158 rs12754041(G;T) plus 0.4265 rs1697421(A;G) 52.7% minus 0.4105 rs12125250(A;C) plus 0.2052 rs12142669(C;T) plus rs10489759(A;G) 3.5% minus 0.157 rs10737562(G;G) 25.7% plus 0.461 rs1400544(A;T) 49.2% minus 0.2746 rs1935881(A;G) minus 0.2094 rs4604727(G;G) 3.1% plus 0.3122 rs2421992(C;T) 46.3% plus 0.3549 rs7517810(C;T) 33.6% plus 0.4481 rs4460629(C;T) plus 0.3554 rs4971088(A;T) plus 0.354 rs4971092(T;T) 69.9% plus 0.06244 rs3917406(C;T) 27.7% minus 0.3903 rs1805193(A;C) minus 0.05923 rs10800469(A;G) plus 0.4541 rs7543618(C;T) plus 0.2787 rs12023718(C;T) plus rs4650994(A;G) plus rs3922812(C;T) minus 0.3586 rs2773080(C;T) plus 0.3604 rs6666258(C;C) 11.3% plus 0.2479 rs1218582(T;T) 26.6% minus 0.3416 rs7512769(A;T) plus 0.1474 rs1329424(A;C) minus 0.2654 rs572515(C;T) 49.6% minus 0.2342 rs3766404(C;T) plus 0.1887 rs1061147(A;C) 1.0 Good 49.6% plus 0.2952 Normal 0.97x risk for Age Related Macular Degeneration. Normal 0.97x risk for Age Related Macular Degeneration. When the retina cells in the eye get damaged with age, it is known as Age Related Macular Degeneration. This SNP has about the average risk. The SENS Research Foundation is working on a promising cure for Age Related Macular Degeneration: http://www.sens.org/outreach/conferences/lysosens-synthetic-biology-approach-treat-age-related-macular-degeneration rs4971052(C;T) 48.1% plus 0.4702 rs10908458(C;T) plus 0.4702 rs4276913(A;G) 47.8% plus 0.4986 rs1599971(A;G) minus 0.337 rs1217407(A;G) 32.7% plus 0.3375 rs4845384(A;G) 38.7% plus 0.3145 rs6691316(T;T) 49.6% plus rs1702176(T;T) 4.6% minus 0.2626 rs3124314(C;T) plus 0.4463 rs877776(C;G) 21.2% minus 0.3972 rs1933063(G;G) 88.5% plus rs1430740(G;G) 55.4% minus rs11209261(A;A) 59.3% plus 0.2824 rs6662617(A;G) 45.5% plus 0.2819 rs652785(G;T) minus 0.3278 rs3006458(G;G) 74.5% plus rs3014864(T;T) 75.2% plus rs4845552(A;A) 68.1% plus 0.1272 rs1539143(T;T) 61.9% minus rs13303128(T;T) plus 0.3402 rs1541252(C;C) 82.3% plus 0.1327 rs10900585(T;T) plus 0.152 rs2293335(A;A) plus rs3795578(C;T) minus 0.4086 rs2368564(C;T) 44.2% plus 0.3567 rs7526484(C;T) plus 0.2236 rs3762318(T;T) 64.6% minus 0.1644 rs12069782(T;T) plus rs12044149(G;T) plus rs3737787(C;T) minus 0.2158 rs2073658(A;G) minus 0.2158 rs2774276(G;G) 58.5% minus rs12068388(A;G) plus 0.4527 rs10754283(T;T) 32.8% plus rs2136093(C;C) 41.5% plus 0.4927 rs3843306(A;T) plus 0.2902 rs672203(C;T) 49.5% minus rs977214(A;G) 15.0% plus 0.1028 rs10801555(A;G) 49.6% plus 0.2778 rs514943(A;G) 49.6% minus 0.2342 rs1831282(G;T) 51.3% minus 0.2929 rs10737680(A;C) 48.7% plus 0.4376 rs7535263(A;G) plus 0.4573 rs2274700(C;T) minus 0.4366 rs10788817(C;G) 43.8% plus rs10788819(C;T) 30.1% plus 0.2672 rs6693388(C;T) plus rs11548103(A;G) minus 0.3439 rs9426935(C;T) 43.4% plus 0.3072 rs4434872(C;T) plus 0.3411 rs6427595(A;A) 57.5% plus 0.365 rs7535475(A;C) plus 0.4288 rs7512140(A;G) plus 0.4761 rs6679356(C;T) 36.3% plus 0.1869 rs3790567(A;G) 46.9% plus 0.3604 rs1367448(T;T) 14.2% minus 0.405 rs2297909(C;T) minus 0.2498 rs12122721(A;G) plus 0.202 rs17419032(C;T) 45.1% plus 0.1396 rs2281845(A;G) 40.2% minus 0.4238 rs860554(A;G) 43.4% minus 0.1786 rs3729547(T;T) 52.2% minus 0.3283 rs1256335(T;T) 59.3% minus rs659580(C;C) 51.3% plus 0.2782 rs2020862(T;T) 9.7% plus 0.3604 rs2421853(A;G) plus 0.2952 rs11211631(A;C) 46.9% plus 0.4187 rs2987763(A;T) plus rs3006440(A;G) plus rs3006448(A;A) 75.2% plus rs1411478(A;G) 48.7% plus 0.4256 rs3845441(T;T) 70.8% plus 0.1818 rs10911021(C;T) 44.2% plus rs1689800(C;T) 39.8% minus 0.3053 rs7521023(A;A) 32.1% plus 0.3118 rs3010396(A;G) 58.2% plus 0.3512 rs7366407(A;T) plus 0.2769 rs2786098(A;C) minus 0.1965 rs1775453(C;T) 34.5% plus rs1775456(A;G) plus 0.1428 rs10922438(A;G) plus 0.09412 rs7536180(A;C) plus 0.05188 rs2359952(A;G) 41.6% plus rs4507975(A;G) 46.8% plus 0.2805 rs1572511(C;C) 19.0% plus rs12140439(A;C) plus 0.2089 rs316274(A;G) plus 0.2314 rs903361(C;T) minus 0.3471 rs17511192(C;T) 49.6% plus 0.2241 rs10399931(C;T) plus 0.2727 rs946261(C;T) 49.6% plus 0.4132 rs2494303(A;C) plus 0.2617 rs7521233(T;T) plus rs7553831(G;G) 62.2% plus rs1912453(C;T) 45.1% minus 0.4591 rs17360053(C;C) 11.5% plus rs622525(T;T) 77.0% plus 0.1579 rs7551188(C;T) plus 0.4844 rs10874746(C;C) 43.4% plus 0.3264 rs11164838(C;T) Bad 47.8% plus 0.4408 1.11x risk 1.11x risk rs12024204(G;G) 27.7% plus 0.4894 rs1546766(A;T) 35.4% minus 0.4646 rs10493631(A;G) minus rs1563828(C;T) 42.9% minus 0.4417 rs4245739(A;A) 48.7% plus 0.2149 rs10900598(G;T) 39.1% plus 0.3324 rs12143943(A;A) 23.2% plus 0.3526 rs7552806(A;C) 0.0% plus 0.1093 rs2247208(A;A) 71.7% plus rs2802808(C;G) 41.5% plus 0.3099 rs12090415(G;G) 26.8% plus 0.4059 rs10789491(G;G) 56.2% plus 0.1446 rs6686929(C;T) 49.6% plus rs3820201(A;G) 43.4% plus 0.3618 rs909814(C;C) 36.9% plus 0.3691 rs3123554(A;G) 49.6% plus 0.3623 rs4949316(C;G) plus 0.3815 rs3219476(G;G) minus 0.4619 rs621559(A;A) 0.0% plus 0.2236 rs946836(C;T) 43.4% plus 0.4022 rs10914967(A;G) plus 0.3834 rs877674(C;T) minus rs7526035(A;G) plus 0.4183 rs885814(C;T) 40.7% plus 0.2603 rs2501432(C;T) plus 0.4835 rs4949526(C;T) plus 0.4339 rs797906(A;C) plus 0.4426 rs682705(C;T) minus 0.3375 rs34920465(A;G) plus rs2488457(C;G) minus 0.2916 rs1217401(G;G) 8.0% plus rs2774307(C;C) 58.4% minus 0.1492 rs8050910(T;T) 32.7% plus 0.4348 rs11641231(C;G) 32.7% plus 0.2002 rs9936833(C;T) 55.4% plus 0.32 rs7187365(C;C) 76.1% plus 0.1901 rs300032(A;G) plus 0.3301 rs1867485(A;G) plus rs7188801(A;G) plus rs8061121(C;C) 79.6% plus rs1062746(A;G) minus rs9646303(A;G) plus 0.2571 rs13333054(T;T) 2.7% plus 0.3017 rs2280381(A;A) 37.2% minus 0.3035 rs13330176(A;A) 4.6% plus rs8050326(A;A) 17.7% plus 0.4513 rs4843747(A;C) 23.0% plus 0.1648 rs12447690(C;T) 34.5% plus 0.4128 rs6540223(T;T) 47.8% plus 0.2057 rs9938149(A;A) 44.2% plus 0.2567 rs904790(C;C) plus rs7195830(A;G) 51.8% plus 0.2782 rs1049255(A;G) 47.8% minus 0.4738 rs3794624(A;A) 15.2% plus 0.2346 rs2334207(G;T) plus 0.4679 rs9932581(C;T) 48.7% plus 0.3843 rs750740(A;G) minus 0.4587 rs750124(A;A) 36.3% plus 0.4729 rs9933309(C;T) plus rs533581(C;T) plus rs3096299(C;T) minus 0.4467 rs2086824(A;C) 55.8% plus 0.2498 rs2292954(C;T) 21.2% minus 0.1189 rs12960(A;G) plus 0.118 rs16965867(C;T) 23.0% plus 0.1575 rs154657(A;G) minus 0.2562 rs8052560(A;C) plus 0.1777 rs6860(A;G) 49.6% minus 0.247 rs154663(C;C) 78.1% plus 0.186 rs623323(A;G) minus 0.1951 rs3752826(A;C) 51.3% plus 0.314 rs1873827(C;T) plus 0.4688 rs9913583(A;C) plus 0.1001 rs12603825(A;A) 4.4% plus 0.3095 rs4790881(A;A) 35.5% plus 0.3159 rs2281727(C;T) 48.7% minus rs1231206(A;G) minus 0.3421 rs258322(C;C) 73.5% minus 0.2677 rs1061646(C;T) minus 0.4775 1.08x increased risk for breast cancer 1.08x increased risk for breast cancer rs9926296(A;G) plus 0.3444 rs7190823(C;T) plus 0.3425 rs1805005(G;T) 16.1% plus 0.05096 rs7217319(C;C) 41.6% plus 0.3306 rs684232(G;G) 17.7% minus 0.4881 rs216172(C;G) minus 0.3343 rs10852932(G;T) 50.0% plus 0.3962 rs11078884(C;T) plus 0.08081 rs17761864(A;C) plus 0.2493 rs3744270(C;T) minus 0.2245 rs4523957(G;T) 48.7% plus rs391300(A;G) minus 0.3848 rs12449465(C;T) plus 0.1648 rs923375(C;C) 4.4% plus 0.2594 rs7813(T;T) 26.8% minus 0.3113 rs3744741(C;T) 19.5% plus 0.2479 rs910925(G;G) 21.5% minus 0.3095 rs7217270(A;G) 50.4% plus 0.3228 rs224547(G;G) 22.7% plus rs8065080(C;C) 11.5% plus 0.3893 rs1051009(C;T) minus 0.3163 rs3744700(G;G) 38.9% plus 0.2851 rs2277680(A;G) plus 0.4518 rs2250333(C;T) 25.7% minus 0.2828 rs7503953(C;C) 63.4% plus 0.2245 rs12449580(C;G) 28.6% plus 0.2245 rs3840880(-;-) minus 0.4325 rs9904779(G;G) plus 0.4394 rs9897850(T;T) plus 0.4421 rs2292350(A;A) 17.7% plus 0.3145 rs312470(A;A) 88.5% plus 0.2066 rs1126667(G;G) 36.0% plus 0.3884 rs2920421(G;G) 46.0% plus rs2271316(G;G) 46.0% plus rs8073787(C;C) 27.8% plus 0.275 rs9899177(A;A) 45.5% plus 0.3972 rs12150220(A;T) Bad 59.5% plus 0.2314 slightly increased risk for several autoimmune diseases slightly increased risk for several autoimmune diseases rs2670660(A;G) plus 0.337 2.96x 2.96x rs220470(A;G) 34.5% plus 0.4054 rs758642(T;T) 15.0% minus 0.2961 rs2619112(A;G) 54.0% plus 0.4481 rs7217186(C;T) 56.2% plus 0.4729 rs3786047(A;G) 38.1% plus 0.3361 rs1045280(C;T) 40.7% plus 0.3264 rs2036657(A;G) plus 0.326 rs222747(C;C) 66.2% minus 0.3007 rs7350721(A;G) 41.6% plus 0.2351 rs11851015(A;G) 23.9% plus 0.2034 rs7144649(A;G) plus 0.3994 rs1092015(C;C) 94.6% minus 0.1364 rs808225(A;G) 55.4% plus 0.4486 rs2348071(A;G) 44.6% plus 0.3691 rs4901869(A;G) 55.2% plus 0.2649 rs17098356(G;T) plus 0.3214 rs1957894(G;G) 84.6% plus 0.3191 rs1957895(T;T) 80.5% plus 0.3209 rs7143164(C;G) plus 0.2397 rs1951795(A;C) 23.0% plus 0.359 rs8005745(A;T) plus 0.2672 rs1957757(C;T) plus 0.2732 rs11158358(C;G) plus rs10873142(C;T) 22.3% plus rs11158345(C;T) plus 0.2429 rs2057482(C;C) 82.3% plus 0.213 rs869834(C;C) 16.8% plus 0.3237 rs8012941(A;G) 40.7% plus 0.4316 rs11158493(C;T) 25.7% plus 0.3554 rs1255722(C;C) 7.1% minus 0.489 rs17101394(A;G) plus 0.1584 rs4902243(A;G) 18.8% plus rs7157785(G;T) 23.2% plus 0.2117 rs7144584(C;C) 85.0% plus 0.03719 rs2301113(A;C) plus 0.4275 rs1256065(A;C) 45.1% minus 0.32 rs4986938(A;G) 47.8% minus 0.2718 rs1256059(A;G) minus 0.3191 rs1256040(A;G) minus 0.4371 rs1269056(A;G) minus 0.3214 rs1256033(A;G) minus 0.4316 rs1256031(A;G) minus 0.432 rs1256030(A;G) minus 0.3724 rs17179740(A;G) plus 0.3829 rs1152591(C;T) 47.8% minus 0.3287 rs915057(C;T) 46.0% minus 0.2998 rs928554(A;G) 46.0% minus 0.3104 rs2978381(C;T) plus 0.4963 rs3020450(A;G) 38.9% minus 0.3053 rs3020449(C;T) 46.9% minus 0.4977 rs3020443(A;C) minus 0.186 rs2236225(C;T) minus 0.3462 rs2236224(C;T) minus 0.3122 rs35955841(A;G) plus rs2071566(A;G) minus 0.4472 rs4902346(A;G) 32.8% plus 0.2231 rs7158173(C;C) 31.0% plus 0.4435 rs1256531(A;G) 11.5% plus 0.2466 rs7159888(A;A) 15.0% plus 0.4008 rs11847263(G;G) 9.7% plus 0.4725 rs7147624(G;G) 70.8% plus 0.1483 rs1076991(A;G) minus 0.4871 rs8003379(A;C) 31.9% plus 0.1699 rs1950902(C;C) 63.7% minus 0.191 rs10483776(A;G) 34.8% plus 0.1309 rs17104363(C;C) 0.9% plus 0.1327 rs8022206(A;G) plus 0.1382 rs1314913(T;T) 0.9% plus 0.1084 rs17105278(C;T) plus 0.303 rs3784099(A;G) plus 0.3779 rs8008961(C;T) 42.5% plus rs911263(A;G) 42.5% minus 0.3815 rs1950897(A;G) minus 0.3797 rs8017304(A;G) plus 0.478 rs1956529(A;G) 45.5% minus 0.4343 rs35949016(A;C) plus 0.1318 rs7494064(T;T) 86.7% plus 0.08264 rs8020095(A;G) plus 0.4027 rs4902566(C;T) plus 0.3958 rs1570106(C;T) minus 0.1217 rs10483810(T;T) 0.0% plus rs2180611(A;G) 51.3% minus 0.4927 rs7141529(C;C) 22.1% plus 0.4054 rs1465788(G;G) 54.0% minus 0.2902 rs4899260(C;T) 46.0% plus 0.1988 rs1009145(C;T) minus 0.3857 rs2268983(C;T) minus 0.3361 rs761899(T;T) 18.6% plus 0.3875 rs7144886(A;G) 18.6% plus 0.1492 rs11158820(G;G) 49.6% plus 0.3407 rs11627546(C;C) 68.3% plus 0.2952 rs4899329(A;A) 34.5% plus 0.2796 rs7146198(A;C) 26.8% plus 0.1947 rs4902642(A;G) plus 0.3283 rs4902647(C;T) 48.7% plus 0.4972 rs11625206(T;T) 13.4% plus 0.1818 rs36563(A;C) minus 0.1717 rs2810114(G;T) minus 0.3196 rs11848070(A;A) 53.6% plus 0.123 rs11848785(A;A) 51.3% plus 0.1556 rs847354(A;G) minus 0.3834 rs2681735(A;G) 43.1% plus rs10131300(A;C) plus rs2526932(C;T) 57.5% minus 0.2668 rs8688(G;T) 51.3% plus 0.4481 rs17125721(A;G) 1.6% plus 0.009183 rs177415(C;C) 32.7% minus 0.3632 rs11628713(C;T) 27.4% plus 0.1336 rs2041073(A;G) minus rs8018967(C;T) plus rs862034(C;C) 22.2% minus 0.3251 rs8014204(A;A) 20.4% plus 0.3811 rs722599(C;C) 4.6% plus 0.3985 rs11850328(A;G) plus 0.3182 rs108621(C;C) 13.3% plus rs175080(A;A) 19.0% plus rs4899554(C;T) 34.5% plus 0.1446 rs2333194(A;G) plus 0.405 rs1019075(A;G) 39.7% minus rs84044(G;G) 50.4% plus rs741846(A;G) plus 0.3003 rs175646(C;T) plus 0.2388 rs8215(C;T) plus 0.4403 rs3917192(G;G) 68.1% minus 0.2351 rs4252338(-;-) minus 0.1074 rs2268624(C;C) 55.4% plus 0.2741 rs2268626(T;T) 61.1% plus 0.2452 rs9323624(C;C) 20.4% plus rs935334(C;T) plus 0.208 rs11621969(C;T) plus 0.1483 rs2360997(C;G) plus 0.1488 rs7157192(A;G) plus rs183266(A;A) 69.0% plus 0.1524 rs1986116(G;G) 58.4% minus 0.2686 rs4467006(C;G) 42.5% plus 0.3104 rs2287375(A;T) 42.5% plus 0.2994 rs3850370(G;T) 37.2% plus 0.3163 rs7155434(A;C) 46.4% plus rs11624704(A;C) 22.1% plus 0.1148 rs6574433(G;G) 21.2% plus 0.4114 rs2121070(C;T) plus 0.2268 rs7147705(C;T) plus 0.4233 rs8019381(C;T) plus 0.09275 rs10220309(C;C) 52.2% plus rs12885300(T;T) 15.2% plus 0.2287 rs179247(G;G) 19.5% plus 0.3806 rs1990595(A;C) plus 0.4229 rs3783938(A;G) 19.1% minus 0.1635 rs17111530(C;T) plus rs7144481(T;T) 73.5% plus rs10144398(A;G) 43.5% plus 0.3228 rs2217887(C;C) 11.5% plus 0.287 rs2196447(A;G) 46.9% plus rs6574644(A;G) plus 0.2498 rs12589327(T;T) 46.4% plus rs1959122(A;A) 96.9% minus rs1242541(C;T) 34.5% minus 0.3017 rs10130259(C;T) plus 0.1139 rs12050412(G;T) plus 0.2374 rs7152554(A;A) 92.2% plus 0.1846 rs1864169(G;T) 36.5% plus rs1779553(C;T) plus rs1550584(C;T) minus 0.4073 rs1867082(C;C) 34.8% minus 0.4587 rs12882718(T;T) 22.1% plus 0.3958 rs1756650(A;A) 77.9% minus 0.1809 rs4322600(A;G) 34.5% plus 0.1795 rs6574988(C;C) 73.9% plus 0.06382 rs12589060(A;G) 63.1% plus rs8004664(A;A) 35.6% plus 0.331 rs2093746(C;G) 43.8% minus 0.3972 rs10132223(T;T) 6.2% plus rs8021963(C;T) 13.3% plus 0.1474 rs12100561(A;G) 21.6% plus 0.292 rs7147996(A;T) plus 0.2957 rs8017423(C;C) 33.6% plus 0.5 rs12885713(C;T) plus 0.3462 rs941764(A;G) 42.9% plus 0.3944 rs1298989(C;C) 51.3% minus 0.1983 rs1285635(G;G) 51.3% plus 0.1988 rs2018736(A;C) plus rs12589592(A;A) 11.5% plus rs8007661(C;T) 46.9% plus 0.4821 rs4900022(A;A) 98.5% plus 0.04408 rs2402130(A;A) 67.3% plus 0.264 rs1884679(T;T) 37.8% minus 0.4307 rs1884677(T;T) 38.1% minus 0.343 rs12435905(G;G) 32.3% plus 0.3999 rs12435920(G;G) 30.1% plus 0.3999 rs8019291(G;T) 21.4% plus 0.1451 rs4904947(C;T) 39.6% plus 0.2062 rs11627032(C;T) plus rs754388(C;C) 73.9% plus rs1040835(C;C) minus 0.1832 rs1009170(A;T) 33.6% plus 0.3324 rs8006385(A;G) 21.9% plus 0.1157 rs6575353(A;G) plus 0.2502 rs1243168(C;T) 29.2% minus 0.1263 rs11832(A;G) minus 0.4449 rs6647(C;T) 31.9% minus 0.2438 rs2753934(C;C) 69.9% minus 0.1437 rs6575424(C;T) 49.6% plus 0.3669 rs17751769(A;A) 17.0% plus 0.4913 rs8004738(A;A) 31.7% plus 0.4532 rs11628722(G;G) 73.5% plus 0.3081 rs1884082(T;T) 23.0% plus 0.4807 rs11624776(A;C) 43.2% plus 0.2415 rs1268843(C;C) 51.4% plus 0.2796 rs17128941(C;T) 16.2% plus 0.1024 rs12882384(A;G) 38.5% plus 0.3751 rs3742330(A;G) 15.0% plus 0.1474 rs13078(A;T) 27.9% plus 0.1097 rs7157322(C;C) 7.1% plus rs12323635(T;T) 17.1% plus 0.4729 rs1187614(G;T) minus 0.3301 rs999986(A;A) minus 0.3062 rs11622887(A;C) 48.7% plus 0.4867 rs734313(C;G) minus 0.3283 rs7148498(C;T) 14.2% plus rs1064017(A;G) plus 0.2805 rs4934(A;A) Bad 21.2% plus 0.4362 2.5x increased risk of Azheimer's and decreased age at onset 2.5x increased risk of Azheimer's and decreased age at onset rs8005845(C;T) 46.0% plus 0.2493 rs10133840(G;G) 49.5% plus 0.1556 rs945032(A;G) minus 0.169 rs1799722(T;T) 20.4% plus 0.3783 rs4900318(C;C) 33.8% plus 0.4624 rs4905558(A;A) 41.6% plus 0.4959 rs8016620(T;T) 100.0% plus rs724210(T;T) minus 0.1547 rs10142119(A;G) plus rs1456988(G;T) 33.6% plus 0.4192 rs4900384(A;G) 35.4% plus 0.4614 rs10144042(A;G) plus 0.281 rs7152623(A;G) plus 0.2911 rs7152530(A;G) plus rs857228(G;T) 50.5% minus 0.3691 rs11160533(T;T) 61.3% plus 0.3838 rs4905865(G;G) 61.3% plus 0.3802 rs2895811(C;C) 17.0% plus 0.3214 rs8022296(A;G) plus 0.2984 rs876188(A;A) 69.0% plus rs8003602(C;C) plus 0.3517 rs3783320(G;G) 64.3% plus 0.3508 rs754203(C;T) minus 0.2897 rs4900442(T;T) 22.1% plus 0.4431 rs730570(A;A) 72.6% plus 0.483 rs7149242(G;T) plus 0.4017 rs1802710(C;C) 26.5% plus 0.2516 rs941576(A;G) 43.5% plus 0.4128 rs6575836(A;A) 60.0% plus rs2400997(C;T) 46.0% plus 0.3659 rs1190596(C;C) 73.0% minus rs11628318(A;A) 60.9% plus 0.4045 rs8126(C;T) plus 0.3737 rs1052823(G;T) plus 0.1175 rs2766692(G;G) 52.7% plus 0.32 rs1052912(A;G) plus 0.09458 rs12432907(T;T) 2.7% plus 0.3007 rs1799794(G;G) 3.2% minus 0.2645 rs7141928(C;T) 50.4% plus rs11622475(C;T) Bad 33.6% plus 0.2314 1.1x risk 1.1x risk rs2494732(C;T) plus 0.4472 rs10149779(A;G) plus 0.2452 rs2494746(G;G) 81.5% plus 0.3609 rs1130214(G;T) minus 0.2433 rs2498786(C;G) minus rs74090038(C;T) plus rs11623869(G;T) 49.1% plus 0.2567 rs8007903(G;G) 2.7% plus 0.3356 rs2582532(C;C) plus rs1057744(A;G) 55.4% minus 0.4601 rs3000073(A;G) plus 0.2498 rs10569304(-;GCC) plus 0.3912 rs10136766(G;G) plus 0.2897 rs2003168(C;T) 47.5% minus 0.4417 rs17113284(C;T) plus 0.2544 rs8005468(A;G) plus 0.2553 rs2007467(A;G) 32.3% minus 0.2571 rs10150241(A;A) 8.3% plus 0.3182 rs2494750(C;C) 79.7% plus rs2494751(A;A) plus rs5811155(T;T) plus rs2494752(G;G) 81.4% plus rs10141867(A;G) plus 0.2282 rs33925946(G;T) plus 0.225 rs4983559(A;G) plus rs2841233(C;C) 49.2% plus 0.489 rs2028414(G;G) 48.6% minus 0.4977 rs12590667(T;T) 8.3% plus 0.32 rs1009153(T;T) 15.0% plus 0.399 rs7174119(C;C) minus rs2732029(A;G) plus 0.3958 rs780(G;G) 59.5% minus 0.3829 rs3816800(C;G) 50.8% minus 0.4417 rs4906844(A;G) 51.8% plus 0.377 rs547843(G;G) 7.8% plus 0.3815 rs2912602(C;T) minus 0.1377 rs2912600(C;T) 23.2% minus 0.2718 rs8025575(C;C) 15.2% plus rs61996546(C;C) plus rs4778334(A;G) plus 0.2291 rs11631421(C;T) plus rs981778(A;G) plus 0.2718 rs6576618(A;C) 50.8% plus 0.3269 rs4477673(C;T) plus 0.3898 rs6576629(A;A) plus 0.1639 rs2075716(C;T) plus rs35399885(C;T) plus rs7179575(C;T) plus rs17565841(A;G) plus 0.09642 rs1800419(C;T) 50.8% minus 0.4518 rs8024564(A;A) 30.1% plus rs878960(A;G) 48.7% minus 0.4913 rs74653330(A;G) minus 0.01515 rs4778137(C;G) 52.4% plus 0.4674 rs4778138(A;G) 21.2% plus 0.4467 rs4778241(A;C) 28.3% plus 0.4752 usually brown eye color usually brown eye color rs7495174(A;G) 9.7% plus 0.2585 blue/gray eyes less likely blue/gray eyes less likely rs1129038(A;G) minus 0.2929 brown eye color brown eye color rs12913832(A;G) 34.5% plus 0.2911 brown eye color brown eye color rs7183877(A;C) plus 0.1703 usually brown eye color usually brown eye color rs3935591(A;G) minus 0.4917 usually brown eye color usually brown eye color rs7173419(C;T) plus 0.4371 rs7170989(C;T) plus 0.449 rs4778214(A;G) 20.4% plus rs7170852(A;T) plus 0.4977 usually brown eye color usually brown eye color rs2238289(C;T) 21.9% minus 0.4568 usually brown eye color usually brown eye color rs3940272(A;C) minus 0.4959 usually brown eye color usually brown eye color rs11631797(A;G) 23.1% plus 0.4894 usually brown eye color usually brown eye color rs916977(A;G) minus 0.4646 brown eye color is more likely brown eye color is more likely rs1667394(A;G) 27.0% minus 0.4582 rs8033165(C;T) 47.5% plus 0.1919 rs1873283(C;T) 15.0% plus rs2636061(C;C) 100.0% minus 0.05785 rs11856574(A;G) plus 0.2089 rs1471225(C;T) plus 0.4201 rs785422(C;T) 17.7% plus 0.08999 rs711355(G;G) 32.7% minus 0.4031 rs7178375(T;T) 0.0% plus 0.1901 rs8042404(A;G) plus 0.3884 rs2125623(C;T) 41.6% plus 0.3214 rs3087454(T;T) minus 0.4463 rs17680945(A;G) plus 0.1272 rs2337506(G;G) plus rs4779969(C;C) 86.7% plus rs1355920(A;A) 79.6% plus 0.2112 rs2133965(C;C) 87.7% minus rs6494223(C;T) 50.4% plus 0.4578 in ALZ patients, increased risk of delusions in ALZ patients, increased risk of delusions rs2337980(C;T) 48.2% plus 0.4114 rs8037818(T;T) 63.7% plus rs11632715(A;A) 19.8% plus 0.4656 rs1919364(C;C) minus 0.2796 rs883473(C;C) 52.3% minus 0.4426 rs73376930(A;G) plus rs10318(C;T) 29.4% plus 0.2351 rs1258763(C;T) minus 0.4605 rs2229116(G;G) 8.0% plus 0.2185 rs7177922(A;A) 7.1% plus 0.2034 rs1044129(A;G) 39.8% plus 0.4275 rs533021(C;C) 42.0% plus 0.4766 rs589759(C;T) 38.9% plus 0.365 rs1370154(A;G) 40.4% minus 0.2778 rs2070664(A;A) 33.0% minus 0.3834 rs525720(A;G) 18.2% minus 0.1451 rs670957(A;G) plus 0.4959 rs640249(A;A) 21.9% minus 0.4192 rs974379(A;A) 85.8% plus 0.2231 rs2676071(T;T) 36.3% plus rs4923705(A;A) 59.3% plus 0.3563 rs10520045(G;T) 48.2% plus 0.2925 rs8028529(C;T) 36.7% plus 0.2117 rs8041675(C;T) plus 0.4467 rs4625687(A;G) plus 0.4339 rs587847(A;A) 43.4% plus rs10468092(G;G) plus rs8029989(A;G) 49.1% plus rs7403531(C;T) plus 0.2617 rs1874252(A;C) 40.7% minus rs1055356(A;G) minus 0.3255 rs6495785(G;G) 51.3% plus rs2947253(A;A) 80.5% plus 0.1364 rs2643217(C;T) minus 0.1194 rs12907914(C;G) plus 0.3007 rs12595668(G;G) 2.7% plus 0.1428 rs746265(C;C) 2.7% plus 0.1497 rs11070188(G;G) 81.4% plus 0.2893 rs11070192(A;A) 81.4% plus 0.2309 rs2412459(C;T) 14.2% plus rs2250402(A;C) 9.7% minus 0.1065 rs4924410(A;C) 46.9% plus 0.1979 rs7181230(A;G) 50.9% plus 0.2681 rs8023845(G;T) 34.8% plus rs1801376(A;G) plus 0.3774 rs17691453(C;C) 34.5% plus rs2034650(A;A) minus 0.4839 rs12911738(A;G) 20.0% plus 0.2994 rs2412541(G;T) 26.5% plus 0.3416 rs11858113(C;T) plus 0.348 rs8040502(A;G) 20.0% plus 0.2994 rs5030789(G;G) plus 0.2677 rs2412546(A;A) 20.4% plus 0.4224 rs4417527(C;G) 20.3% plus 0.3466 rs7180135(A;A) 28.1% plus 0.2732 rs7177192(C;G) plus 0.3416 rs1869901(C;T) minus 0.3471 rs10518693(T;T) 14.2% plus 0.466 rs9635324(G;G) 9.4% plus rs2304583(A;G) 50.4% plus 0.2328 rs7163862(A;T) plus 0.3627 rs690347(G;G) 54.9% plus 0.1841 rs2289743(C;G) 33.3% plus 0.2695 rs1356410(G;G) 49.6% minus rs8023524(A;A) 6.2% plus 0.2107 rs12917189(C;C) 6.2% plus 0.3857 rs2255235(G;T) plus 0.1657 rs2413775(A;T) minus 0.4876 rs1060896(A;C) plus 0.3421 rs2453533(A;A) 9.1% plus 0.3118 rs1153858(T;T) 4.5% plus rs2297381(C;T) 38.1% plus 0.405 rs2467853(G;G) 9.4% plus 0.3113 rs17536527(C;C) 16.9% plus 0.4201 rs9806699(A;A) 3.7% plus rs950027(C;C) 23.9% plus 0.2672 rs815198(T;T) 17.0% plus 0.41 rs4775671(C;C) 39.1% plus 0.4298 rs1898111(A;G) plus 0.3007 rs12904216(G;G) 66.4% plus 0.4743 rs3784621(T;T) 67.7% plus 0.4174 rs11637235(T;T) 56.6% plus 0.365 rs4775748(T;T) 67.2% plus 0.2709 rs2303500(C;C) 57.5% minus 0.3632 rs607541(G;T) minus rs4775302(A;G) plus 0.4293 rs10502386(G;T) 55.4% plus 0.3315 rs510110(G;T) 51.3% minus 0.3939 rs12962340(A;T) plus rs4148965(G;G) 53.1% plus 0.3829 rs473938(A;T) minus 0.3669 rs11661859(C;C) plus 0.2851 rs11663391(A;C) plus 0.376 rs11082304(G;T) 60.2% plus 0.4174 rs1788799(C;G) 44.6% plus 0.1809 rs4800148(A;A) 57.5% plus 0.2622 rs11082762(A;G) 53.1% plus 0.3866 rs2847297(G;G) 6.2% plus 0.3714 rs7234029(A;G) 15.9% plus 0.2856 rs7243066(A;A) 71.7% plus 0.3549 rs11080466(A;G) 44.6% plus 0.2906 rs264272(A;C) 55.8% minus 0.449 rs12455924(C;T) 19.5% plus 0.1373 rs7230480(C;C) 55.8% plus rs4796955(G;T) plus rs8083786(A;G) plus rs602201(A;T) plus 0.3558 rs7235440(C;T) 40.2% plus rs487202(G;G) 11.7% minus 0.2498 rs9635963(A;A) 51.3% plus 0.4798 rs12969041(T;T) 11.5% plus rs12456874(A;G) 34.5% plus 0.1478 rs1840440(C;T) plus 0.4761 rs1429934(C;T) 44.0% plus 0.2273 rs1436904(G;G) 20.4% plus 0.3967 rs12954803(A;G) 25.7% plus 0.0978 rs4369779(C;C) 57.5% plus 0.2149 rs1893220(A;C) 54.7% minus 0.3108 rs12606866(A;C) 55.0% plus 0.2847 rs1893219(C;T) 48.7% minus 0.4477 rs1902618(A;A) 70.8% plus 0.2539 rs3809566(A;G) 39.8% plus 0.3416 rs4075583(A;G) plus 0.4725 rs11071720(C;T) plus 0.472 rs12148828(C;T) 46.0% plus 0.4899 rs1972041(A;G) minus 0.4582 rs2652834(C;C) 72.9% minus 0.186 rs2652822(G;G) 29.7% minus 0.3154 rs1472631(C;C) 31.9% minus rs938952(C;T) 42.5% plus 0.1938 rs2456930(A;G) 42.0% minus rs12595433(A;G) plus 0.4169 rs1873147(C;T) minus 0.4587 rs7179658(C;T) plus rs6494537(T;T) 15.0% plus 0.3926 rs2572207(C;T) 35.1% plus 0.3903 rs1477798(G;G) 44.2% minus 0.2176 rs2053423(C;T) 40.2% plus 0.2603 rs755451(G;T) minus 0.4146 rs4147407(C;T) 20.0% minus 0.09504 rs7178347(C;T) plus 0.3209 rs12901499(A;G) plus 0.4431 rs1465841(C;G) 47.7% minus 0.4174 rs4776342(A;G) 35.9% plus 0.3972 rs2289263(A;C) minus rs17293632(C;T) 37.2% plus 0.1079 rs17228058(A;G) 43.1% plus 0.1088 rs12913547(C;T) plus 0.3062 rs4489954(G;G) 1.0 Bad 50.0% plus 0.4637 Normal risk of developing restless legs syndrome Normal risk of developing restless legs syndrome rs448720(A;A) 23.0% minus 0.4899 rs7164335(A;G) 38.5% plus 0.2897 rs7164503(C;T) plus 0.3457 rs311904(C;C) 93.8% plus 0.2608 rs1392635(A;G) plus 0.2438 rs17294280(A;G) 42.0% plus rs7166081(A;A) 61.1% plus 0.3062 rs7359257(C;C) 26.2% plus 0.3613 rs7172582(C;T) plus 0.3678 rs3743353(C;T) plus 0.1896 rs3743354(C;T) plus 0.1901 rs8026898(A;G) plus rs17374222(A;C) plus 0.4045 rs7176508(A;G) 46.0% plus 0.3177 rs11630316(C;T) plus rs11072158(A;T) 23.4% plus 0.2695 rs8034004(C;T) 54.0% plus 0.4568 rs1549318(T;T) 36.3% plus 0.455 rs9806183(C;G) plus rs1442779(C;T) 31.1% minus rs17786786(A;C) 46.0% plus rs2044029(A;G) 41.1% plus 0.3632 rs12050794(A;A) plus 0.4646 rs7178130(A;A) 46.4% plus 0.4431 rs1971791(A;G) plus 0.4449 rs8038465(T;T) 20.4% plus 0.2433 rs1038094(G;G) 75.0% plus 0.2273 rs16958477(A;C) 41.6% plus 0.2608 rs893817(A;A) 39.8% plus 0.3636 rs750460(T;T) 18.5% minus 0.2929 rs8039584(C;T) 8.0% plus 0.03903 rs2959008(C;C) 43.8% minus 0.4927 rs2959003(C;C) 45.1% minus 0.4821 rs2279357(C;C) 50.9% plus 0.3613 rs11632698(G;G) 35.4% plus 0.4068 rs2472299(A;G) 37.2% plus 0.3503 rs35694136(-;T) plus 0.3209 carrier of one CYP1A2*1D allele carrier of one CYP1A2*1D allele rs11636419(A;G) plus rs17861162(C;G) plus rs936229(A;G) 36.3% plus 0.3232 rs2120019(C;T) plus 0.3705 rs12148488(G;T) 51.8% plus 0.41 rs7172677(C;C) 51.4% plus 0.2681 rs4077582(T;T) 32.8% plus 0.4385 rs8028182(G;T) 31.2% plus 0.3136 rs4886707(C;T) 33.6% plus 0.3655 rs11072566(G;G) 22.3% plus 0.489 rs1914816(T;T) 3.1% minus 0.1919 rs2404602(C;T) 47.3% minus rs7178572(A;G) 42.5% plus 0.4334 rs2137111(A;G) plus 0.2034 rs3743481(C;T) minus rs2271397(C;C) 41.6% plus rs2271398(A;A) 41.6% plus rs4886670(G;T) 28.3% plus 0.3448 rs7402844(C;G) plus 0.3747 rs4462560(C;G) plus 0.41 rs7163013(C;T) 53.8% plus 0.4077 rs7164594(C;T) 36.9% plus 0.399 rs10519203(A;A) 37.2% plus 0.2521 rs931794(A;A) 33.8% plus 0.3159 rs2036534(C;T) plus 0.3205 rs1979907(A;G) minus 0.2544 rs1979906(A;G) 42.9% minus 0.2544 rs1979905(G;T) 36.9% minus 0.2544 rs12907966(C;T) 42.9% plus rs12910984(A;G) plus 0.3733 rs3743078(C;G) 32.8% minus 0.4757 rs3743077(A;G) 38.9% minus rs938682(C;T) minus 0.3535 rs6495308(C;T) plus 0.4389 rs8042374(A;G) 33.0% plus 0.4385 rs3743073(G;T) minus 0.3838 rs8023462(C;T) plus 0.2406 rs6495309(C;T) 29.5% plus 0.3356 rs1948(A;G) minus 0.3177 rs880395(A;G) 36.9% plus 0.2489 rs905740(A;G) minus 0.2498 rs7164030(A;G) plus 0.2489 rs3829787(A;G) minus 0.2039 rs503464(A;T) minus 0.359 rs684513(C;G) 35.4% plus 0.2456 rs667282(C;T) plus 0.3655 rs588765(C;T) plus 0.2759 rs6495306(A;G) plus 0.2764 rs680244(A;G) minus 0.3274 rs569207(C;T) minus 0.3618 rs11637635(A;G) 40.0% plus 0.2447 rs17408276(C;T) plus 0.2208 rs660652(A;G) 40.7% plus 0.2539 rs578776(A;G) minus 0.4564 rs3825807(C;T) 52.3% minus 0.2672 rs2289700(C;T) 17.0% plus 0.3186 rs939661(C;T) 53.1% minus 0.3434 rs939658(C;T) 47.7% minus 0.4334 rs8027411(G;T) 52.2% plus rs1474256(C;T) 40.0% plus 0.4256 rs7164400(A;T) 40.2% plus 0.2498 rs2692194(A;C) minus 0.3609 rs2278702(A;T) 28.2% minus 0.2259 rs2663905(A;G) plus 0.3095 rs17875486(T;T) plus 0.3701 rs12324805(A;C) plus 0.2691 rs11638815(A;C) 41.5% plus 0.2002 rs1256429(A;A) 62.8% minus rs2562784(C;T) 26.5% minus 0.3264 rs2554380(T;T) 67.6% plus 0.1102 rs4779031(A;A) 63.7% plus 0.3324 rs10906982(A;A) 27.7% plus 0.3274 rs7183263(G;G) 27.4% plus 0.3278 rs11259933(A;A) 27.7% plus 0.3278 rs11259936(C;C) 27.7% plus 0.3278 rs4842838(T;T) 27.4% plus 0.3274 rs8040855(C;C) 41.5% plus 0.2668 rs6496932(A;C) plus 0.3108 rs6496044(A;G) plus 0.3636 rs4262906(C;C) 15.0% plus rs12901001(A;G) 40.7% plus 0.461 rs2011905(G;T) 47.3% plus 0.4789 rs2469184(A;G) 54.0% plus 0.4633 rs11636768(A;G) plus 0.08219 rs1017412(A;G) minus 0.3448 rs7176429(G;T) plus 0.3834 rs950169(A;G) 35.4% minus 0.1492 rs7180849(C;C) 69.2% plus 0.1028 rs2290272(C;T) minus 0.3485 rs2242048(C;C) 80.5% minus 0.07208 rs2242046(C;T) minus 0.2571 rs8041863(A;T) plus 0.3489 rs2280470(A;G) 45.3% plus 0.4366 rs2351491(C;T) minus 0.3972 rs1042631(C;C) 62.8% plus rs420017(C;T) 43.1% plus 0.3765 rs2307449(C;C) 15.0% minus 0.4555 rs758130(G;G) 15.9% plus 0.3494 rs2238296(C;C) minus 0.4578 rs2856268(G;G) minus 0.3384 rs4932217(C;C) 15.4% plus 0.4931 rs28521337(C;G) plus 0.3104 rs894157(T;T) 85.0% plus 0.1497 rs1052700(A;A) 9.2% minus rs2304796(T;T) minus rs894160(A;G) 42.9% minus 0.3324 rs6496589(C;C) 100.0% plus rs11635252(C;C) plus 0.1327 rs3862434(A;G) 53.1% plus 0.3926 rs12915189(A;G) 45.1% plus 0.3893 rs6226(C;G) plus 0.2994 rs4702(A;G) plus rs2677744(A;A) 4.5% plus 0.3228 rs8042680(A;A) 4.4% plus 0.3113 rs11073964(T;T) 9.7% plus 0.2796 rs12899811(G;G) 3.5% plus rs7164176(A;G) plus 0.3145 rs25651(A;G) 49.6% minus 0.3154 rs1042538(A;A) 83.1% plus 0.2309 rs7495052(C;T) plus 0.477 rs1517618(G;G) 53.8% minus rs207959(G;G) 49.6% minus rs207954(G;G) 45.1% minus 0.3039 rs2238355(A;G) minus rs1406714(G;G) 31.2% plus 0.3627 rs7168353(C;G) plus 0.1713 rs4984390(A;A) 37.8% plus 0.4619 rs7173947(T;T) 31.2% plus 0.3806 rs6496074(A;G) 46.4% plus 0.4036 rs933769(A;A) 77.0% minus 0.213 rs10520789(A;G) plus 0.09137 rs4321143(G;G) 9.8% plus 0.2695 rs2567426(C;T) 50.9% minus 0.2617 rs4304977(A;G) plus 0.4513 rs12905014(C;T) plus 0.01515 rs12441404(A;G) plus 0.4082 rs1437588(A;G) 50.5% plus 0.4086 rs11637980(A;G) 37.7% plus 0.2016 rs4533251(G;G) 67.7% plus 0.1566 rs1513859(T;T) 100.0% minus 0.03214 rs4965121(C;G) 34.4% plus 0.4077 rs1993976(A;G) plus rs1480090(G;T) minus 0.3994 rs12719740(A;G) plus 0.2121 rs8023580(C;C) 1.5% plus 0.3173 rs7166348(A;G) plus 0.2883 rs6598541(A;G) 46.9% plus 0.4279 rs2715439(A;G) 50.0% minus 0.3636 rs8034284(C;T) 49.6% plus 0.4646 rs8038415(C;C) plus rs12440962(C;T) 41.6% plus 0.1322 rs2033547(A;T) 62.5% minus 0.3976 rs1823874(C;C) 8.2% plus 0.3604 rs2086452(A;A) 42.0% plus 0.4633 rs4533267(A;G) 45.1% plus 0.3384 rs11247226(G;G) 23.0% minus 0.3163 rs930847(A;C) 36.3% minus 0.2883 rs12910524(C;C) 47.8% plus 0.2507 rs12917258(G;G) plus 0.1469 rs4965814(T;T) 70.5% plus 0.4385 rs34713741(C;T) plus 0.2668 rs900414(G;G) 12.3% plus 0.4045 rs7182874(C;C) 46.9% plus rs11855415(T;T) 58.6% plus 0.1928 rs752092(A;G) minus 0.3678 rs2858942(A;C) 38.1% plus rs1211375(A;C) 44.2% plus 0.3682 rs1203981(T;T) 30.4% plus 0.3939 rs7189020(A;T) 50.0% plus 0.405 rs1805105(C;T) minus rs1981483(A;G) plus 0.4761 rs2017567(C;T) plus 0.478 rs7204439(C;T) plus 0.4601 rs763014(C;T) plus 0.4605 rs2744148(A;G) 31.0% plus 0.1024 rs197056(G;G) 36.3% plus 0.4848 rs197057(G;G) plus 0.427 rs7187167(C;C) 44.2% plus 0.2704 rs11248866(A;A) 38.1% plus 0.4114 rs9921222(C;T) 49.6% plus 0.4178 rs13336428(A;G) plus 0.4174 rs2575369(T;T) 25.7% plus 0.377 rs2076431(C;C) 58.5% plus rs2575352(C;C) 68.2% minus 0.1878 rs1065656(G;G) 50.8% plus 0.3347 rs40433(A;A) minus 0.09275 rs26868(A;T) minus 0.3664 rs224204(C;T) minus 0.4793 rs56240109(A;G) plus 0.06152 rs2444217(C;T) minus 0.432 rs2235632(A;G) plus 0.3636 rs1132358(C;T) 39.8% plus 0.3462 rs1045643(C;T) 18.6% plus 0.18 rs870288(A;G) 37.2% plus 0.438 rs12926282(A;C) plus 0.2245 rs1906060(C;T) 33.9% plus rs6500742(C;T) plus 0.4421 rs6500744(C;T) 55.4% plus 0.4679 rs4124065(G;T) 37.2% plus 0.1749 rs889699(A;G) 48.3% plus 0.4403 rs4786816(A;G) 47.8% plus rs716508(C;T) 44.2% plus 0.3935 rs2601828(A;G) minus 0.2975 rs11645781(G;G) 54.9% plus 0.1993 rs12921846(A;T) 13.3% plus 0.3062 rs11861787(A;C) 33.3% plus rs1731017(C;C) 37.5% minus 0.4513 rs1299926(A;A) 87.6% plus rs1529916(T;T) 14.3% minus 0.2787 rs3743832(G;T) 51.3% minus rs4782151(C;T) 62.8% plus rs1397142(C;T) minus rs1213205(A;G) 51.4% plus 0.3522 rs17550532(A;G) 37.2% plus 0.1469 rs11866781(C;T) plus rs10500355(A;T) plus 0.2241 rs17648524(C;G) plus 0.2268 rs9924951(A;G) plus 0.3512 rs7191721(G;G) 28.3% plus rs12444931(A;A) 19.5% plus 0.3489 rs8045405(A;A) 54.9% plus 0.1157 rs11866328(G;T) 54.9% plus 0.3315 rs8058295(A;C) plus 0.2567 rs12920919(C;T) plus 0.2672 rs2650427(C;T) plus 0.4605 rs8057394(C;G) 43.1% plus 0.41 rs13335336(A;G) 2.7% plus 0.0932 rs6498068(A;A) plus 0.2029 rs11074889(G;G) 69.0% plus 0.1869 rs2221433(G;G) 45.2% plus 0.2736 rs11074932(C;T) plus 0.4766 rs3087456(A;G) plus 0.4027 rs4781011(G;T) plus 0.4775 rs8048002(C;T) plus 0.1561 rs6498122(A;G) plus 0.2351 rs1463132(G;G) minus 0.3333 rs7203315(G;T) 23.9% plus 0.1483 rs194328(G;G) 0.0% minus 0.005969 rs11074938(G;G) 38.4% plus 0.4826 rs7200786(G;G) 20.4% plus 0.4922 rs12708716(A;G) Bad 42.5% plus 0.3283 1.2x risk of type-1 diabetes 1.2x risk of type-1 diabetes rs12924729(A;G) plus 0.3072 rs12917716(C;G) plus 0.477 rs12599402(C;T) plus 0.477 rs998592(A;G) 46.0% minus 0.348 rs2080272(G;G) 37.2% plus 0.3655 rs2903692(A;G) plus 0.3058 rs7206912(C;C) 29.7% plus 0.4477 rs6498142(G;G) 68.8% plus 0.1965 rs887864(C;T) minus 0.3085 rs11865121(A;C) plus 0.3508 rs725613(A;C) Bad minus 0.3714 1.2x increased type-1 diabetes risk; 1.2x increased multiple sclerosis risk 1.2x increased type-1 diabetes risk; 1.2x increased multiple sclerosis risk rs2041670(A;G) minus 0.3388 rs416603(A;T) 42.5% plus 0.3815 rs529866(C;T) 33.6% plus 0.1313 rs737008(A;A) 51.3% minus 0.4899 rs12928822(C;T) 30.1% plus 0.09091 rs7191700(C;T) 45.1% plus 0.2089 rs7203193(A;G) 48.7% plus 0.4513 rs4280262(A;G) minus 0.129 rs8049607(C;T) plus 0.4977 rs4780401(G;T) plus 0.4977 rs10852344(C;T) 50.9% plus 0.3347 rs4780355(C;T) plus 0.4784 rs33989964(-;CA) minus rs243330(A;G) 39.8% minus rs243327(A;G) minus 0.4279 rs243325(A;G) minus 0.466 rs243324(C;T) 40.7% minus 0.4265 rs12922317(A;G) 50.4% plus 0.4164 rs153091(A;C) 37.2% minus 0.2043 rs4780521(A;C) plus rs2903308(G;G) 18.8% plus 0.3526 rs231130(C;T) plus 0.4123 rs2113334(A;G) minus 0.4559 rs254942(T;T) 93.8% minus 0.06933 rs1799801(C;T) plus 0.2264 rs2276466(C;G) 32.3% plus 0.2245 rs4985167(A;G) 47.7% minus 0.3108 rs7192086(A;T) plus 0.2241 rs4465599(A;G) plus 0.2874 rs4781415(A;G) 56.6% plus rs150063(A;G) minus rs4985155(C;T) 45.5% minus 0.4105 rs3198697(C;T) plus rs7200543(A;G) 41.6% plus 0.3315 rs1741(C;G) minus rs6498540(A;G) 44.6% plus rs1136001(G;T) 42.0% plus 0.332 rs2740(C;T) 42.0% minus rs4500751(C;T) 44.2% plus 0.3186 rs2280018(G;T) 39.8% minus rs4148330(A;A) 46.0% plus 0.4591 rs504348(C;C) 69.2% minus 0.2388 rs4781699(G;G) 46.0% plus 0.3604 rs3784862(A;A) 60.2% plus 0.404 rs924135(A;T) 47.7% plus rs2062541(C;T) minus rs246234(C;G) 51.7% plus rs246221(C;T) plus 0.4444 rs35592(C;T) plus 0.3857 rs3765129(C;T) 28.3% plus 0.1079 rs34792(C;C) 47.6% minus rs3743527(C;T) 27.4% plus 0.2649 rs212090(A;T) plus 0.2998 rs212093(A;G) 44.6% plus 0.4605 rs2238472(A;G) 31.0% minus 0.1938 rs3213473(G;G) 71.4% plus 0.2626 rs2856585(A;G) plus 0.1364 rs212077(C;G) minus 0.1171 rs9940825(T;T) plus 0.2383 rs7186128(A;G) plus 0.2847 rs35605(C;T) plus 0.1809 rs4265793(C;C) 91.1% plus 0.09734 rs226849(A;A) 15.9% plus 0.3618 rs1858973(A;G) minus rs12444979(C;T) 10.9% plus 0.07254 rs12446554(G;T) 21.5% plus 0.07254 rs12446632(A;G) plus 0.07254 rs11639988(A;G) 26.5% plus 0.1139 rs7201408(A;G) 37.2% plus 0.2401 rs7185264(A;G) plus 0.2401 rs2608200(G;G) 60.2% plus 0.2071 rs6497436(C;C) 63.5% plus 0.2084 rs4780805(G;G) 75.2% plus 0.1639 rs12597579(C;T) 13.3% plus 0.118 rs12446492(A;T) plus 0.4513 rs11647589(A;G) 34.2% plus rs6497490(T;T) 72.6% plus rs1394678(C;T) 39.3% plus rs16970881(A;G) plus 0.0831 rs8049603(G;T) plus 0.2107 rs4401050(C;T) 27.7% plus rs11649420(A;G) plus 0.1846 rs889299(C;T) minus 0.2677 rs11859916(A;G) plus 0.2167 rs16940342(A;G) 19.5% plus 0.1873 rs7404095(C;T) plus 0.416 rs7404928(C;T) plus 0.2461 rs17177078(C;T) 14.2% plus 0.03306 rs274068(A;C) plus rs4788439(C;T) 20.4% plus rs4787294(A;T) 18.8% plus rs120963(C;T) 27.4% minus 0.2952 rs3096145(C;T) 19.0% minus 0.2631 rs2203512(A;G) plus 0.1942 rs2107356(A;A) minus 0.3457 rs8832(A;G) 46.9% plus 0.438 rs1029489(A;G) minus 0.4582 rs3024685(C;T) plus 0.4545 rs4787956(A;G) 43.4% plus 0.4169 rs7199138(C;C) 11.5% plus 0.3926 rs8057551(G;G) 11.1% plus 0.3949 rs8061992(A;A) 11.5% plus 0.3935 rs3093301(C;C) plus 0.4086 rs205391(C;T) plus 0.1511 rs151181(C;T) minus 0.2544 rs180743(C;G) 57.6% minus 0.2837 rs181206(C;T) minus rs26528(A;G) minus 0.3962 rs153109(C;T) plus 0.3962 rs2107357(C;C) 76.3% minus 0.1804 rs750155(C;T) plus 0.4008 rs3760091(C;G) plus 0.3838 rs1968752(A;C) minus 0.3113 rs8049439(C;T) plus 0.3581 rs4788099(A;G) 47.8% plus 0.2658 rs4788102(A;G) plus 0.2649 rs7498665(A;G) 47.8% plus 0.2654 rs28433345(C;T) plus 0.3173 rs62037369(C;T) plus 0.2176 rs7359397(C;T) 47.8% plus 0.2176 rs4788084(A;G) 51.4% minus 0.3104 rs1042157(C;T) minus 0.2952 rs6839(A;G) minus 0.2314 rs1801030(A;A) 100.0% minus 0.1074 rs2904880(C;G) 52.4% plus 0.1827 rs35979293(G;T) 42.5% plus 0.2631 rs4788196(A;G) 46.9% plus 0.4036 rs4583255(C;T) 51.3% minus 0.3379 rs11150589(C;T) plus 0.4077 rs1046276(C;T) plus rs1458201(C;T) minus rs10782001(A;G) plus 0.3756 rs9938550(A;G) 49.1% plus 0.3765 rs7197717(A;C) 46.9% plus rs7184597(C;T) plus 0.1942 rs929867(C;C) minus rs741810(A;C) plus 0.2199 rs1052352(C;T) 46.0% plus 0.4646 rs9937837(G;T) plus 0.3099 rs9888739(C;T) 17.0% plus 0.2172 rs11860650(C;T) 17.3% plus 0.107 rs11574637(C;T) plus 0.1579 rs2454908(A;G) 52.2% minus 0.3347 rs2080501(A;A) 23.0% plus 0.4311 rs11865038(C;T) 49.5% plus 0.3522 rs7199949(C;G) plus 0.3526 rs7294(A;G) 47.8% minus 0.3108 rs2359612(G;G) 39.8% plus 0.4986 rs17708472(A;G) plus 0.118 rs17880887(A;C) minus 0.1552 rs61162043(G;G) plus 0.4325 rs8046148(G;G) 56.6% plus 0.2612 rs9302752(C;C) 55.8% plus 0.438 rs8057341(G;G) 52.2% plus 0.4325 rs2066842(T;T) 7.1% plus 0.1249 rs17313265(T;T) 7.1% plus rs5743289(T;T) 1.0 Bad 2.7% plus 0.07668 Risk for IBD Risk for IBD rs2076756(G;G) Bad 7.3% plus 0.1148 1.7x increased risk for Crohn's disease 1.7x increased risk for Crohn's disease rs1077861(A;A) 50.4% minus 0.3893 rs7185923(C;C) 19.5% plus 0.3981 rs1362756(C;C) 54.0% minus 0.2328 rs4784165(G;T) plus 0.3365 rs8051542(C;T) plus 0.3444 rs12443621(A;G) 43.8% plus 0.4986 rs3112562(C;G) 30.8% minus 0.3375 rs3104767(G;T) 47.8% plus 0.3949 rs3112625(C;T) 46.9% minus 0.4091 rs3112612(C;T) minus 0.4426 rs10852453(A;A) 26.7% plus 0.4164 rs7204230(C;T) plus rs1074182(C;C) 16.1% minus 0.4555 rs10748(C;C) 16.8% plus 0.4555 rs9302648(T;T) 16.8% plus 0.4518 rs7189819(T;T) 8.0% plus 0.253 rs4784319(A;T) 41.5% plus 0.4325 rs6499640(A;A) 42.5% plus 0.483 rs1861868(A;G) 50.0% minus 0.3485 rs1477196(A;G) 39.8% plus 0.2819 rs3104788(C;T) plus rs3104793(C;T) plus 0.393 rs8046994(C;T) 41.5% plus 0.4201 rs11075995(T;T) 56.9% plus 0.2355 rs17219084(A;G) 55.8% plus 0.3136 rs11075996(C;T) 56.4% plus 0.3848 rs11075997(C;T) 54.9% plus 0.3751 rs3826169(A;A) minus 0.236 rs8061518(A;G) 51.3% plus 0.3696 rs17818902(G;T) plus 0.2576 rs7190053(C;T) 35.4% plus 0.1171 rs8053740(C;C) 15.9% plus 0.4904 rs57103849(G;G) plus 0.3912 rs17820875(A;G) 23.9% plus 0.135 rs8062891(C;T) plus rs7199196(C;T) 20.0% plus 0.06933 rs2001970(C;C) 19.5% plus 0.4876 rs11643630(G;T) plus 0.4775 rs17859821(A;G) plus 0.1602 rs2285053(C;T) plus 0.1726 rs1030868(A;G) minus 0.3655 rs2241145(C;G) plus 0.4931 rs9928731(C;T) plus 0.4968 rs243847(C;C) 18.6% plus 0.3343 rs243832(C;G) 55.6% plus 0.4821 rs6499766(T;T) 22.1% plus 0.4059 rs9921518(A;G) 30.1% plus 0.208 rs4622507(C;C) 2.7% plus rs28386840(A;T) plus 0.3893 rs2397771(C;G) plus 0.3471 rs2242446(C;T) 39.8% plus 0.2635 rs3785143(C;T) 1.0 17.7% plus 0.1038 may be associated with ADHD may be associated with ADHD rs36029(C;T) 54.0% minus 0.3949 rs1532701(A;G) plus 0.4477 rs36020(A;G) 16.8% minus 0.1263 rs36017(G;G) 15.9% minus 0.4408 rs2244613(A;A) minus 0.3081 rs8192935(C;C) minus 0.4591 rs2270837(G;G) plus 0.2713 rs7196890(A;C) plus rs11076161(G;G) 54.0% plus 0.3393 rs11640851(A;C) plus 0.4816 rs8064100(A;G) 48.7% plus 0.2475 rs4329913(A;G) minus 0.1006 rs4564560(C;C) 17.7% minus 0.4995 rs5568(C;C) 8.8% plus 0.2755 rs1566652(T;T) 9.7% plus 0.2815 rs2242447(T;T) 48.2% plus 0.4463 rs12708965(C;T) 2.7% plus 0.03673 rs12447924(C;T) 36.6% plus 0.2805 rs4783961(A;G) plus 0.4063 rs9939224(G;G) 64.1% plus 0.2406 rs1532624(G;T) minus 0.3062 rs1566439(G;G) 13.3% minus 0.4068 rs4359426(C;C) 91.2% plus 0.07759 rs223818(C;C) 81.5% minus rs170359(A;A) 91.1% plus 0.2057 rs2217332(A;G) minus 0.1166 rs9989419(A;G) 53.1% plus 0.3893 rs223828(C;C) 92.0% plus rs4937(C;T) plus 0.2741 rs7188697(A;A) 50.0% plus 0.2897 rs149428(A;G) plus 0.1983 rs12709013(C;T) plus rs2059252(C;C) plus 0.05418 rs2639889(A;A) 34.8% minus 0.3691 rs2911292(C;T) 41.5% plus 0.4187 rs2962462(G;T) 31.0% plus rs1381102(C;T) minus 0.3999 rs170364(G;T) plus 0.2773 rs614230(C;T) 45.1% plus 0.4013 rs223895(C;T) plus rs223899(A;C) minus 0.2553 rs92397(A;G) plus rs8050896(A;T) 15.3% plus 0.1331 rs1049970(C;C) 45.1% plus 0.2943 rs9033(C;C) 19.5% minus 0.4417 rs6979(A;G) 55.8% plus 0.4812 rs12449157(A;G) 22.1% plus 0.2663 rs2271293(A;G) plus 0.09091 rs8060686(C;T) plus 0.2929 rs16942887(A;G) plus 0.1318 rs255049(C;T) plus 0.3127 rs7187376(C;T) plus rs1126179(C;C) 25.7% minus 0.3641 rs255052(A;G) plus 0.163 rs8056893(A;A) 51.6% plus rs6499165(C;C) 50.4% plus 0.1694 rs2863979(T;T) 50.4% minus rs7197653(C;G) plus 0.1662 rs12597188(A;A) 10.6% plus 0.2883 rs9929218(A;A) 4.5% plus 0.2475 rs1862748(T;T) 4.4% plus 0.2388 rs1801552(C;T) plus 0.3067 rs9935563(C;C) 29.5% plus 0.3058 rs8047014(A;C) plus 0.3838 rs2232228(A;G) 38.9% plus 0.3714 rs3785074(A;G) 38.1% plus 0.2369 rs744972(A;C) 28.3% plus rs7193778(C;T) 29.2% plus 0.08999 rs1728785(C;C) 71.7% plus 0.1745 rs6499188(A;A) 67.3% plus 0.2213 rs16260(A;A) Bad 4.4% plus 0.2323 2.6x increased risk of prostate cancer 2.6x increased risk of prostate cancer rs3213422(A;C) 51.3% plus 0.4302 rs17668704(A;T) 45.1% plus 0.2521 rs6499600(T;T) 17.7% plus rs7193343(C;C) 69.0% plus 0.3118 rs764255(T;T) 42.5% plus 0.3953 rs427576(A;C) 54.9% plus 0.4793 rs2716601(C;T) 41.6% minus 0.4348 rs10871290(C;T) 40.7% plus 0.3756 rs4888262(C;T) 41.6% plus 0.3696 rs689456(A;G) minus rs2917666(C;G) 46.2% minus 0.4949 rs4788815(A;T) 49.2% plus 0.2883 rs2334880(C;C) minus 0.1717 rs1579333(G;G) 45.5% minus 0.3154 rs7195303(A;A) 79.6% plus 0.1111 rs7193230(C;C) 56.2% plus 0.2185 rs17679567(C;T) plus 0.1524 rs2735413(T;T) 56.7% plus rs1079572(C;T) minus rs12716850(A;G) 54.7% plus 0.4412 rs8056446(A;G) plus 0.4421 rs12716852(A;G) plus 0.4421 rs2059238(G;T) 38.9% minus 0.1488 rs12918952(A;G) plus 0.3269 rs3764340(C;G) 8.8% plus 0.07759 rs11150078(A;C) plus rs17706989(C;G) 6.2% plus 0.01561 rs12935229(C;T) 21.2% plus 0.1258 rs2859631(A;G) plus 0.06152 rs8046508(C;T) 24.8% plus 0.1855 rs9929635(A;T) 50.9% plus 0.2709 rs383362(T;T) 29.5% plus 0.3508 rs2288034(C;C) 38.5% minus 0.4688 rs2288033(G;G) 40.7% minus 0.4702 rs7191820(G;G) 40.7% plus 0.472 rs4888966(C;C) 99.1% plus 0.1056 rs4888024(A;G) 36.3% plus 0.4729 rs2549513(A;A) 82.3% plus 0.1529 rs1079635(A;G) minus 0.2957 rs17713676(C;T) 10.8% plus 0.02617 rs1424233(G;G) 18.6% minus 0.404 rs4889009(C;G) plus rs7188445(A;G) plus 0.2925 rs17767419(C;T) 43.4% plus 0.2778 rs3813579(A;G) plus 0.4959 rs3813582(C;T) plus 0.2819 rs4575545(A;G) plus rs11859036(A;C) plus 0.2236 rs4889240(C;T) plus 0.3999 rs11645428(A;A) 10.6% plus 0.1841 rs889472(T;T) 43.4% minus 0.4816 rs386965(A;G) 31.9% minus 0.3737 rs67333(T;T) 74.3% plus 0.1382 rs2608555(C;T) 44.2% plus 0.157 rs2925979(A;G) minus 0.315 rs12446319(C;T) plus 0.4954 rs7185362(A;G) plus 0.2112 rs4243229(G;G) 98.2% plus 0.08815 rs7201637(A;T) plus 0.1433 rs1424151(C;T) 11.5% minus 0.124 rs2967374(G;G) 58.7% plus rs12934922(T;T) 1.0 19.0% plus 0.2691 Reduced conversion of beta-carotene to retinol Reduced conversion of beta-carotene to retinol Associated with Rs7501331 and reduced BCMO1, lower ability to convert beta-carotene to retinyl esters and higher serum beta-carotene levels. See also Rs7501331 rs4889294(C;C) 16.8% plus 0.2585 rs11646213(A;T) 49.2% plus 0.3669 rs3844412(C;T) 48.7% minus rs3865188(A;T) 54.0% minus 0.3802 rs7193788(A;G) 27.4% plus 0.2388 rs736719(C;T) 26.5% plus rs6565051(A;A) 57.5% plus rs7204454(C;C) 46.4% plus rs12444338(G;T) plus 0.3646 rs1991867(A;G) 20.5% minus 0.2185 rs4783244(G;T) 52.2% plus 0.3393 Adiponectin levels significantly decreased x0.34 SD Adiponectin levels significantly decreased x0.34 SD rs17675602(A;T) 32.3% plus 0.06428 rs6565105(A;G) plus 0.4624 rs6565113(T;T) 25.7% plus 0.3861 rs8055236(G;T) Bad 33.6% plus 0.2447 1.9x risk 1.9x risk rs10514585(C;T) minus 0.3067 rs11644424(A;C) plus rs6563898(G;G) 53.1% plus rs11649622(A;G) plus rs8058532(C;T) 44.2% plus 0.4991 rs3784962(G;G) 23.0% plus 0.3673 rs8057927(C;C) 0.0% plus 0.1639 rs3096277(C;C) 55.4% plus 0.3136 rs444881(C;C) 40.7% plus 0.4578 rs1048612(C;T) 32.1% minus 0.1795 rs8056413(T;T) 36.5% plus 0.4568 rs746080(C;C) 47.3% minus 0.1951 rs8048576(A;G) plus 0.2424 rs10514604(C;G) 43.4% plus 0.4399 rs1546124(C;C) 46.8% plus 0.3646 rs4240810(G;T) 41.1% plus rs709805(C;T) minus 0.1869 rs11648716(A;G) 7.7% plus 0.04683 rs391023(A;A) 7.1% minus 0.4812 rs391525(G;G) 10.6% plus 0.3425 rs424971(C;C) 15.9% plus 0.4674 rs8046526(C;T) plus 0.0854 rs1044873(T;T) 15.9% plus rs450443(G;T) plus 0.3641 rs305061(T;T) 44.2% plus 0.2346 rs4782675(T;T) 8.0% plus rs2326458(A;C) plus 0.3255 rs2277862(A;G) 22.3% minus 0.1474 rs4911494(C;T) 43.4% plus 0.4073 rs6060369(C;T) plus 0.4298 0.44cm taller 0.44cm taller rs5741812(A;T) 15.6% plus 0.2557 rs6060371(G;T) 44.6% plus 0.4298 rs6024905(A;G) plus 0.3765 rs2236164(A;G) minus 0.3278 rs8119351(A;G) plus 0.08173 rs6088792(C;T) 35.4% plus 0.1938 rs11167260(A;G) plus rs4297946(C;C) 22.1% plus rs926392(C;T) 53.1% minus 0.4325 rs6072161(C;T) plus 0.4444 rs6102185(A;A) 42.5% plus 0.3439 rs13041247(C;T) plus 0.365 rs6031882(C;T) plus 0.3297 rs7270785(T;T) plus 0.4403 rs17194885(A;C) 7.1% plus 0.1198 rs4358188(A;A) plus rs4811528(A;A) plus 0.309 rs1341023(C;T) plus rs8124695(A;A) 2.7% plus 0.1042 rs11696257(C;T) 55.8% plus rs6065259(A;G) plus rs6102059(T;T) 7.1% plus 0.3875 rs6017340(C;T) plus 0.4334 rs4812466(G;T) 35.4% plus 0.3136 rs3890324(G;T) minus rs6127471(T;T) 15.0% plus 0.4132 rs619289(C;C) 81.4% plus 0.2268 rs2425752(C;C) 53.1% plus 0.2277 rs460703(A;G) plus 0.3926 rs6102085(A;G) plus 0.3678 rs826943(T;T) plus 0.2103 rs6074022(T;T) 55.8% plus 0.2489 rs6130608(C;T) plus rs1028583(G;T) plus 0.4835 rs826944(C;C) plus 0.1892 rs456210(A;G) 51.3% plus 0.3926 rs9303196(A;T) 30.1% plus 0.1671 rs312457(T;T) 99.1% minus rs314253(A;G) minus 0.4063 rs507506(G;G) 27.7% plus 0.4968 rs4562(G;G) 29.2% plus 0.315 rs222857(T;T) 27.4% plus rs17856697(A;G) plus 0.1713 rs2302765(A;G) minus 0.1731 rs2302762(C;C) 49.6% plus 0.4844 rs9217(A;G) minus 0.3154 rs2071504(C;T) 18.6% plus 0.1777 rs6761(C;T) 41.6% plus 0.45 rs3803800(A;G) 24.8% plus 0.3728 rs4227(G;T) 33.6% plus 0.3099 rs858518(A;A) minus 0.4256 rs727428(G;G) 31.9% minus 0.4646 rs5415(C;C) 42.5% plus 0.2649 rs5417(A;A) 28.1% plus rs5435(C;C) 31.9% plus rs61749665(G;T) plus 0.3765 rs9914077(G;G) 18.6% plus 0.315 rs2585408(T;T) 19.5% plus 0.3035 rs2735611(T;T) 67.3% minus 0.4091 rs3027188(G;G) 66.2% minus 0.3884 rs885747(G;G) 15.9% minus 0.3508 rs1150(G;G) 53.1% plus rs1059476(G;G) 82.3% plus 0.2502 rs1641537(G;G) 80.0% minus 0.287 rs1642764(C;T) plus rs1641511(T;T) 59.3% minus 0.3136 rs1625895(G;G) 79.6% minus 0.1373 rs1391768(C;C) 15.0% minus 0.4109 rs4791707(T;T) 13.3% plus 0.4013 rs10521157(A;G) plus 0.1419 rs3786094(G;G) 28.3% minus 0.4509 rs12150284(C;T) 45.1% plus rs8069834(G;G) 43.1% plus 0.4959 rs8076431(A;C) plus 0.2006 rs1877644(A;A) 3.5% plus rs4792143(T;T) 2.7% plus rs2969180(A;G) plus 0.3949 rs4792192(T;T) 81.4% plus 0.3035 rs3826392(A;A) 54.0% minus 0.3154 rs8076457(C;C) 53.6% plus 0.1635 rs1714984(G;G) 56.6% plus 0.3783 rs9905820(G;T) plus 0.4963 rs11651483(G;G) 83.2% plus 0.2828 rs10521232(C;T) plus 0.2952 rs3848445(T;T) 92.9% plus 0.1483 rs9899891(A;G) plus 0.2934 rs1380181(C;C) 52.3% minus 0.2163 rs7208480(T;T) 9.7% plus rs7477(C;C) minus 0.2792 rs11867934(C;T) plus 0.18 rs4244593(C;C) 37.2% minus 0.3994 rs4646356(C;T) minus rs2278952(C;T) minus rs2297508(C;G) 32.3% minus 0.4578 1.08x increased risk for T2D 1.08x increased risk for T2D rs7215286(C;G) 4.6% plus 0.08448 rs9902941(C;T) 39.8% plus 0.4192 rs1889018(C;T) minus 0.3214 1.12x increased risk for T2D 1.12x increased risk for T2D rs854777(G;G) 55.9% minus 0.2466 rs8077577(C;T) plus rs1563634(C;C) minus 0.3118 rs9909104(C;T) plus 0.3122 rs2621515(A;G) plus rs4924935(T;T) 47.8% plus 0.2176 rs3866958(G;G) 100.0% minus 0.1217 rs2252281(C;T) plus 0.3255 rs2245639(A;C) plus rs962801(A;G) 39.8% minus rs12943590(A;G) plus 0.3039 rs397969(G;G) 14.2% minus 0.371 rs2071242(A;G) minus 0.2424 rs203462(C;C) minus 0.3953 rs7226229(T;T) 65.0% plus 0.3462 rs1975974(A;G) 29.2% plus 0.1749 rs8079482(A;G) 39.8% plus 0.4412 rs4795519(A;C) 39.8% plus 0.4399 rs12602978(C;T) 6.3% plus 0.1625 rs2945412(C;T) minus 0.4215 rs7215373(C;C) 12.5% plus 0.4302 rs2255929(A;T) plus 0.4536 rs8068149(A;G) plus 0.4596 rs1060826(A;G) minus 0.3085 rs2013441(C;T) minus 0.2126 rs2621515(C;C) plus rs2297510(C;T) plus 0.3095 rs944722(C;T) 53.8% plus 0.3131 rs1060822(C;T) minus 0.3085 rs9282801(G;T) minus rs2297518(A;G) plus 0.1726 rs2274894(G;T) plus 0.3104 rs2248814(A;G) 52.3% plus 0.3095 rs1137933(C;T) minus 0.2039 rs2297520(C;T) plus rs16949(C;T) plus rs2779249(A;C) plus 0.2626 rs2779251(A;G) plus 0.1244 rs3751972(A;A) 61.1% plus rs2006933(G;T) plus 0.2291 rs34517613(C;T) plus rs2239907(A;G) minus rs8076604(A;G) plus rs559972(T;T) minus 0.2787 rs550818(A;G) 40.7% plus 0.1882 rs3729508(A;G) minus 0.3572 rs6505469(A;T) plus 0.4238 rs8072199(T;T) 26.5% plus 0.259 rs3813034(A;C) 58.4% plus 0.4949 rs1042173(G;T) 58.4% minus 0.494 normal normal rs12449783(A;C) plus 0.4789 rs3794808(A;G) 53.2% minus 0.4674 rs34388196(A;G) plus 0.3967 rs4583306(A;G) 54.1% plus 0.4793 rs8076005(A;G) plus 0.2943 rs11080122(C;T) plus 0.1818 rs6354(G;T) minus 0.213 rs735555(A;A) 19.5% minus 0.2208 rs225212(A;A) 10.6% minus 0.4679 rs17183295(C;T) 25.7% plus 0.0955 rs2521984(A;G) minus 0.2608 rs28936(G;G) 8.8% minus 0.4628 rs17808461(T;T) 5.3% plus rs1354492(A;G) minus 0.3985 rs967293(C;G) plus rs11650066(A;G) plus 0.3017 rs1860190(A;T) minus 0.4513 rs25528(G;T) minus 0.2686 rs2020936(C;T) minus 0.2296 rs12150214(C;G) 43.3% plus 0.2323 rs8071667(C;T) plus 0.1768 rs16965628(C;G) plus 0.1267 rs1024610(A;A) 2.7% minus 0.1249 rs2857656(C;G) plus 0.4513 rs2857657(C;C) plus 0.1152 rs4586(C;T) plus 0.4541 rs13900(C;T) 50.4% plus 0.4059 rs991804(A;G) 50.4% minus 0.444 rs3091315(A;G) 51.3% plus 0.4463 rs3091316(A;G) plus 0.41 rs159294(T;T) 73.5% plus 0.2649 rs2074518(A;G) 55.8% minus 0.3255 rs1052536(C;T) 57.1% plus 0.3223 rs9909601(A;G) 35.4% plus 0.2713 rs1838149(C;T) minus 0.3173 rs8070473(G;T) plus 0.3196 rs10512472(C;T) plus 0.2314 rs2840044(A;G) 41.6% plus rs16971217(C;G) 14.3% plus 0.2521 rs226088(G;G) minus 0.3994 rs1133763(A;C) 20.9% plus 0.1956 rs14304(A;A) 10.6% minus 0.2323 rs1130371(T;T) 6.2% minus 0.2241 rs4796217(C;T) 37.2% plus 0.4063 rs1266175(G;G) 15.9% plus 0.3792 rs9906543(T;T) 39.8% plus 0.4054 rs12453407(A;G) plus 0.241 rs712039(C;T) 34.5% plus 0.4348 rs2074409(G;T) 37.2% plus 0.3985 rs6607284(T;T) 42.5% plus 0.3912 rs11868513(A;G) plus 0.1745 rs2074429(A;A) 63.0% minus 0.2195 rs3094509(C;T) 40.7% minus 0.477 rs1016990(C;G) minus 0.2686 rs2306658(C;G) minus 0.3173 rs757210(A;G) minus 0.3788 rs7501939(C;T) plus 0.3861 rs9906595(C;C) 89.4% plus rs7208487(G;T) plus 0.2227 rs1877030(C;T) plus 0.1869 rs4795390(C;G) plus 0.309 rs879606(A;G) 24.8% plus 0.3384 rs907094(C;T) minus 0.4458 rs3764352(A;G) 27.7% minus 0.4458 rs9972882(A;C) 38.1% plus 0.3949 rs881844(C;G) 46.2% minus 0.4858 rs11869286(C;G) plus 0.4977 rs8074124(T;T) 60.2% plus 0.3476 rs12051836(T;T) 70.8% plus 0.2994 rs1043515(C;T) 51.3% minus 0.3815 rs2517951(C;T) plus 0.4885 rs2952155(C;T) plus 0.3664 rs1810132(C;T) 45.9% plus 0.4146 rs903506(A;G) plus 0.4894 rs907092(A;G) plus 0.3466 rs4795397(A;G) 50.9% plus 0.3567 rs9303280(C;C) 21.0% plus 0.3747 rs1877031(C;T) minus 0.4913 rs2517956(A;G) plus rs17609240(G;G) 56.1% plus 0.3062 rs3894194(C;T) minus 0.4261 rs7212938(G;T) 48.7% plus rs3859192(C;T) 49.6% plus 0.4229 rs4794822(C;T) 41.5% plus 0.3705 rs8078723(C;T) plus 0.3673 rs2071427(A;G) 35.4% minus 0.466 rs12941497(A;G) plus 0.393 rs7221109(C;T) plus 0.2998 rs757411(C;T) 50.4% plus 0.3127 rs7224129(A;G) plus 0.4454 rs4065275(A;G) 54.9% plus 0.4155 rs8076131(A;A) 28.3% plus 0.3444 rs12603332(C;T) plus 0.4826 rs3744246(C;C) 58.4% plus 0.2865 rs4794820(A;G) 46.0% plus 0.4399 rs6503525(C;G) plus 0.4651 rs2315504(A;C) plus 0.242 rs9257(C;C) 15.0% plus 0.4399 rs3826550(T;T) 20.3% plus 0.2984 rs4523977(A;A) 4.4% plus 0.2011 rs6503659(A;T) 25.9% plus 0.1295 rs1126821(T;T) 50.8% minus 0.4279 rs2070106(A;G) plus 0.2626 rs11079041(A;T) plus rs4029774(A;G) 42.5% plus 0.3581 rs16967637(A;C) plus 0.2851 rs2293157(G;T) minus rs2272087(C;T) 27.7% minus 0.2415 rs1053023(A;G) minus 0.2801 rs1053005(A;G) minus 0.2746 rs1053004(C;T) minus rs2293152(C;G) minus 0.3792 rs8069645(A;G) 37.2% plus 0.3095 rs3816769(C;T) plus 0.3586 rs9891119(A;C) 40.7% plus 0.3714 rs744166(C;T) 40.7% minus 0.4541 rs12942547(A;G) 41.1% plus 0.3898 rs7211777(A;G) plus 0.4697 rs4796793(C;G) plus 0.3411 rs2071046(C;C) 50.8% plus 0.2493 rs86312(G;G) 92.3% plus 0.1162 rs12602084(T;T) 12.4% plus 0.4068 rs2010750(A;A) minus 0.4045 rs2074439(G;T) 50.4% plus rs6503695(C;T) plus 0.3315 rs1230399(C;T) plus 0.2938 rs8077889(A;C) 34.5% plus rs231513(C;G) 31.0% minus rs2070592(A;G) 50.9% minus 0.4573 rs228769(C;G) plus 0.4187 rs227584(G;G) 12.4% minus 0.4256 rs12602486(G;T) plus rs2072081(A;C) 39.8% minus 0.4371 rs2879096(A;G) 41.5% minus 0.36 rs4792938(C;G) plus 0.4086 rs2134808(G;T) plus 0.1341 rs4792909(G;T) 50.4% plus 0.4885 rs1513670(G;G) 36.3% minus 0.4082 rs7222094(C;T) plus 0.3632 rs9908330(A;G) 43.4% plus 0.432 rs4792847(A;G) plus 0.3802 rs4792814(C;C) 46.9% plus 0.4004 rs11655470(C;T) 55.8% plus 0.3678 rs1880753(A;G) plus 0.4679 rs1880756(A;G) 46.0% minus 0.2769 rs4076452(C;G) minus 0.1529 rs7209436(C;T) 46.2% plus 0.4706 rs4792887(C;T) 12.3% plus 0.1258 rs3169733(A;G) minus rs736866(A;C) plus rs744281(C;T) minus rs1007190(C;T) 18.6% plus 0.1492 rs110402(C;T) minus 0.4628 rs242924(A;C) 53.2% minus 0.4578 rs173365(C;C) 29.5% minus 0.3719 rs242559(A;A) 57.5% plus 0.2479 rs242562(A;A) 15.9% plus 0.4109 rs3785883(G;G) 71.7% plus 0.1708 rs17651507(A;T) 35.4% plus 0.1561 rs2258689(C;T) plus 0.3242 rs199515(C;C) 62.2% plus 0.1253 rs415430(A;A) 62.8% minus 0.1253 rs2074404(G;T) plus 0.348 rs11079764(A;G) 56.6% plus 0.3802 rs2317385(C;T) minus 0.303 rs7206971(A;A) 27.7% plus 0.3981 rs9910408(G;G) 21.2% plus 0.3632 rs2074190(C;C) 4.4% minus 0.2401 2.2x risk for AIA 2.2x risk for AIA rs16947078(G;G) 2.7% plus 0.146 8x risk for allergic asthma 8x risk for allergic asthma rs12950390(C;C) 4.5% plus 0.2066 rs11651000(A;A) 3.1% plus 0.1084 rs2597167(C;C) 97.3% plus rs72823592(A;G) plus 0.129 rs7209700(A;G) 48.6% plus 0.3503 rs4634(A;G) plus 0.2948 rs12603582(G;T) 33.6% plus 0.1882 rs3809865(A;A) 41.3% plus 0.2769 rs2229304(A;A) minus 0.343 rs9299(A;A) 40.7% minus 0.4848 rs7405887(C;C) plus rs2303486(A;T) 42.9% plus rs2326017(C;T) 38.9% plus 0.3962 rs8074700(A;C) 33.9% plus 0.3508 rs3096644(A;A) 14.2% minus rs8556(C;T) minus rs46522(C;T) 51.4% plus 0.4679 rs15563(C;T) 52.2% minus rs6504340(G;G) 63.4% plus 0.2309 rs2291725(C;T) plus 0.4651 rs2291726(C;T) plus 0.4927 rs937301(C;T) 52.2% minus 0.4977 rs3848460(A;G) 52.2% plus 0.4977 rs3895874(A;G) plus 0.4982 rs9899404(C;T) plus 0.3613 rs2411759(C;T) 46.9% plus 0.3421 rs1390154(C;T) 42.5% minus rs1994969(A;C) 41.5% minus 0.4977 rs9674544(A;G) plus 0.4835 rs1035050(C;T) plus 0.4261 rs2537710(A;C) plus rs741071(C;T) plus rs741073(A;G) plus rs6504618(A;G) 51.3% plus 0.4826 rs271674(A;G) 38.9% minus rs2278163(C;T) minus rs16948627(A;C) plus 0.1396 rs2285524(A;G) minus 0.2658 rs2230392(A;G) plus 0.1313 rs627386(C;C) 94.7% minus 0.02893 rs12940887(C;T) 50.9% plus 0.2332 rs16948048(A;G) 49.6% plus 0.3113 rs2411984(A;G) plus 0.2856 rs2696297(A;G) 29.2% minus 0.1286 rs2075559(C;G) minus 0.4669 rs1007086(A;G) minus 0.3893 rs2586494(C;C) 69.9% plus 0.258 rs2141279(C;T) plus 0.1593 rs2075555(C;C) 68.1% minus 0.2452 rs2075554(G;G) 62.0% minus 0.2461 rs2586502(A;C) plus 0.1152 rs1062484(C;T) 44.2% plus rs12450550(C;T) plus 0.1561 rs6504663(A;G) 31.2% plus 0.3278 rs12603112(G;G) 20.4% plus 0.4192 rs16949649(C;T) plus 0.4027 rs3760468(A;T) 50.9% plus 0.4017 rs34214448(G;T) plus rs4605213(C;G) plus 0.4412 rs9635758(A;G) plus 0.3049 rs9635759(A;G) plus 0.2989 rs2106329(G;G) 75.9% plus 0.2567 rs967676(A;G) minus 0.2851 rs1607979(A;G) plus 0.4132 rs9891263(T;T) 30.1% plus rs10515083(A;T) plus 0.3972 rs16955329(G;G) 12.4% plus 0.4192 rs7224610(A;C) plus 0.259 rs12941878(G;G) 38.6% plus 0.2755 rs1431318(C;T) 49.6% minus 0.315 rs8065311(G;T) 49.1% plus 0.3338 rs1019238(A;G) plus 0.3329 rs227731(A;C) minus 0.4876 rs8073783(C;T) 51.3% plus 0.3283 rs8077059(T;T) 57.5% plus 0.2971 rs12938916(A;G) plus 0.04775 rs7208693(A;C) plus rs2302189(A;C) 50.4% plus 0.4091 rs758377(C;C) 61.9% plus 0.1235 rs9905704(G;T) 42.5% plus 0.1612 rs412000(C;G) plus 0.4082 rs7221274(A;G) 49.6% plus 0.3439 rs6503905(G;G) 31.9% plus 0.3549 rs11650106(C;T) 50.0% plus 0.3944 rs227724(A;T) 51.3% minus 0.2998 rs205498(C;T) minus 0.2236 rs792376(A;G) minus 0.1515 rs180515(C;T) 50.4% minus 0.3669 rs11868441(A;G) 27.4% plus 0.3861 rs9895661(C;T) 26.5% plus 0.3802 rs8068318(C;T) 42.9% plus 0.4826 rs2079795(A;G) minus 0.3926 rs757608(C;T) 46.9% minus 0.2897 rs17610181(A;G) plus rs11079454(A;T) plus 0.3843 rs7213430(A;A) 34.8% plus rs1292053(C;T) 49.6% minus 0.494 rs4986763(C;C) 33.6% minus 0.332 rs4986764(C;C) 34.8% minus 0.3269 rs2191249(A;C) minus 0.2158 rs733025(C;T) minus 0.2475 rs2245092(A;G) plus 0.3315 rs2251393(C;T) minus 0.169 rs3087776(C;T) 46.0% plus 0.4472 rs4291(A;A) plus 0.3701 rs4292(T;T) plus 0.2916 rs4293(A;A) 34.5% plus 0.4867 rs4305(G;G) 36.9% plus 0.4908 rs4309(C;T) 46.9% plus 0.421 rs34289250(C;T) plus 0.002296 rs8077088(G;T) 39.8% plus rs12937080(G;G) 0.9% plus 0.01515 rs11658329(C;G) plus 0.32 rs721575(A;G) 50.4% minus 0.3402 rs6919(A;T) plus rs2665838(C;G) 41.3% minus 0.1901 rs2854160(G;G) 42.5% minus 0.3613 rs2941551(A;G) 41.5% plus 0.241 rs2665802(A;T) plus 0.3292 rs2005172(G;G) minus 0.4091 rs7921(C;T) minus 0.1869 rs4311(C;T) plus 0.3503 rs4316(C;T) 44.4% plus rs4329(A;G) 46.9% plus 0.4835 rs4332(C;T) plus 0.483 rs4341(C;G) plus 0.4826 rs4343(A;G) plus 0.3815 rs4344(A;G) plus 0.4853 slower responder slower responder rs4267385(C;T) 52.7% plus 0.4692 rs8066276(C;T) plus 0.4307 rs8066114(C;G) 52.2% plus 0.3177 rs7209435(C;T) plus 0.3237 rs2070776(C;C) 42.5% minus 0.4013 rs6504218(A;G) 44.6% plus 0.3976 rs8077696(A;C) plus 0.2534 rs8070231(A;G) 15.4% plus 0.264 rs2292593(A;G) minus 0.2603 rs7591(A;T) 45.1% plus rs4072245(A;G) minus 0.06657 rs1133683(C;T) minus 0.449 rs11867417(C;C) 44.2% plus rs4791171(G;G) 45.1% minus 0.4555 rs10853057(T;T) 87.5% plus rs3923087(G;G) 58.4% minus 0.4789 rs3923086(G;T) 45.5% minus 0.3177 rs2240308(A;G) plus 0.348 rs10048158(C;C) 27.4% plus 0.2461 rs9912468(C;C) 25.7% plus 0.4123 rs11079657(G;G) 61.1% plus 0.4141 rs1005651(A;C) plus 0.2911 rs228883(C;T) plus 0.298 rs11651708(A;T) plus 0.3512 rs873417(A;C) plus 0.1602 rs7224000(A;G) 55.8% plus rs2017854(C;G) minus 0.4917 rs8074751(A;A) 33.0% plus 0.2002 rs7216064(A;A) 5.3% plus 0.3287 rs180088(C;T) minus 0.2094 rs180082(C;G) minus 0.2089 rs180067(C;G) minus 0.1612 rs12936361(C;T) plus rs623011(A;G) 45.0% plus 0.3398 rs6501384(C;T) 48.2% plus 0.2934 rs312691(C;T) plus 0.3205 rs6501431(C;T) 27.9% plus rs17779747(G;T) 42.5% plus 0.1974 rs7217932(A;G) 50.0% plus 0.4555 rs817565(C;C) 32.4% minus rs7219669(T;T) 20.4% plus 0.4568 rs871443(C;T) plus 0.4114 rs4969170(A;G) 46.0% plus 0.4192 rs718073(A;G) 28.3% minus rs4793501(C;T) 48.7% plus 0.4284 rs4793529(C;T) plus rs1990193(A;C) plus 0.4288 rs9913017(C;C) 70.8% plus rs8072254(A;G) 55.4% plus 0.3531 rs1015657(A;G) minus 0.3659 rs2567519(T;T) 46.0% minus rs7207618(C;T) plus 0.3526 rs4969054(C;C) 67.3% plus rs8066857(T;T) 4.4% plus 0.2989 rs7214479(C;T) plus 0.4063 rs8081059(A;A) 73.5% plus rs9913711(C;C) 38.9% plus 0.2948 rs903107(A;G) minus rs9915657(C;C) 12.4% plus 0.4408 rs743554(C;T) minus 0.1373 2x higher ER- breast cancer risk 2x higher ER- breast cancer risk rs7219585(A;G) 21.2% plus 0.09642 rs1126690(A;A) 61.5% plus 0.3049 rs745570(C;T) 49.6% minus rs4796827(A;G) 48.7% plus rs11077654(C;C) 77.9% plus rs9904341(C;G) plus 0.4109 rs3744061(A;A) 33.6% plus 0.4063 rs9904078(A;G) plus 0.3168 rs72925845(A;G) plus rs9900972(G;G) 60.2% plus 0.2874 rs2279913(G;T) 50.4% minus 0.3967 rs2239680(C;T) plus 0.2319 rs4969168(G;G) 72.6% plus 0.3462 rs3760138(T;T) 26.2% plus 0.3962 rs1868823(G;T) minus rs1466113(G;G) 33.6% plus 0.3297 rs2034310(C;C) 68.1% plus 0.2792 rs9912608(C;G) plus 0.3701 rs1135640(G;G) 41.6% minus 0.427 rs11653989(A;T) 15.4% plus 0.07943 rs4238989(G;G) plus 0.4256 rs820200(T;T) 15.0% minus 0.3792 rs10512597(C;C) 71.7% plus 0.3554 rs16970672(A;A) 5.4% plus 0.3246 rs1867561(C;G) plus 0.2264 rs12953258(G;T) plus 0.1809 rs820196(C;T) plus 0.2557 rs820186(A;A) 14.2% plus rs12952093(A;C) plus 0.3774 rs4129767(T;T) 24.8% minus 0.4449 rs3764383(A;G) 39.8% minus 0.2195 rs4788985(A;G) 46.4% plus rs1042542(C;T) plus 0.3875 rs4969169(C;T) plus rs4789400(G;G) 83.1% plus 0.04178 rs4789932(C;T) minus 0.4711 rs10445407(A;A) 23.2% plus 0.4862 rs7208422(A;T) 48.2% plus rs643507(A;A) 97.3% minus 0.06428 rs2009196(G;G) 57.4% plus rs8081523(C;G) 38.1% plus 0.2507 rs7215564(T;T) 82.3% plus 0.1263 rs1056534(G;G) 36.7% plus 0.3632 rs8097348(A;G) plus 0.2365 rs1800309(A;G) plus 0.09045 rs7503807(A;C) 52.2% plus 0.3985 rs1467979(C;T) 29.2% plus 0.259 rs1291183(G;T) 48.7% minus 0.3655 rs1042395(A;A) 51.3% plus 0.3866 rs1316453(G;G) 15.0% minus 0.2732 rs7502935(A;A) 8.8% plus rs6565681(A;G) 23.9% plus 0.2374 rs1042393(G;G) 49.1% plus 0.382 rs2290279(C;T) 45.1% minus 0.377 rs2019154(C;T) minus 0.1942 rs2361701(C;T) minus 0.2649 rs1046896(C;T) 38.1% plus 0.3861 rs2278619(C;C) 58.5% minus rs4247357(A;A) 17.7% minus 0.3926 rs8067235(A;G) plus rs7224668(C;C) 31.0% plus 0.4426 rs11652075(T;T) 28.6% plus 0.4229 rs502396(T;T) 24.8% plus 0.4022 rs7504165(C;C) 40.7% plus 0.2153 rs9894429(T;T) 18.6% plus 0.377 rs6506122(C;T) plus rs2677879(A;A) 38.7% minus 0.4187 rs12051723(G;T) 28.3% plus 0.14 rs9901648(A;G) plus rs8070488(C;T) plus 0.2626 rs3934492(C;G) 34.9% minus rs644435(C;T) 39.8% minus rs3848403(T;T) 23.0% plus rs1826508(T;T) 88.5% plus rs2853542(C;G) plus 0.3852 rs1046875(A;G) 38.1% plus rs6502097(C;G) 20.6% plus 0.1699 rs3204270(C;T) 18.6% plus 0.05096 rs6506569(C;T) plus rs4398173(A;G) 48.2% plus 0.3747 rs977581(G;G) 44.6% plus 0.4715 rs4246444(G;T) plus 0.3205 rs9303029(C;T) 25.7% plus 0.2043 rs9949006(G;G) 35.1% plus rs3744165(A;C) minus 0.1625 rs8090011(C;G) 47.7% plus 0.4279 rs1146075(A;A) minus rs206530(C;T) minus 0.3168 rs2567261(A;G) minus rs12457997(T;T) 47.8% plus rs906807(G;G) 71.9% minus 0.2406 rs7237848(T;T) 30.1% plus 0.4812 rs1402627(C;C) 64.6% plus 0.1272 rs329007(A;G) plus rs1557305(T;T) 9.7% plus 0.3889 rs1893154(C;C) 54.0% minus rs3914785(G;G) plus rs597503(T;T) 73.5% minus 0.1511 rs12964965(C;T) plus rs3786431(C;G) 1.6% minus rs11662297(G;G) 24.8% plus rs3810046(A;C) 49.6% minus 0.3687 rs11662763(C;T) 25.7% plus 0.123 rs9989532(T;T) 97.3% plus rs206626(C;C) 26.2% minus rs617040(A;C) plus 0.3466 rs948426(C;T) 57.5% minus 0.2195 rs1539808(C;T) 1.5% plus 0.1203 rs2865126(C;C) 61.5% minus 0.1561 rs7233332(A;G) plus rs11661542(A;C) plus 0.3646 rs473518(G;G) 85.5% plus 0.202 rs2027756(C;T) 41.5% plus rs1455244(C;C) 13.3% plus 0.4215 rs495484(A;T) minus 0.3893 rs4800452(T;T) 57.5% plus 0.2599 rs527790(A;A) 14.4% minus 0.2961 rs4474794(A;A) 37.8% plus 0.4578 rs1788776(A;G) plus rs9304261(C;C) 53.1% plus 0.3136 rs8087945(A;G) 49.6% plus 0.388 rs9961915(C;T) 32.7% plus 0.4431 rs4131805(A;G) minus 0.3035 rs1791780(A;A) 16.1% plus 0.4784 rs574913(T;T) 75.4% minus 0.1492 rs9949617(C;T) 35.4% plus 0.2489 rs12373237(A;A) 30.4% plus 0.3765 rs8087457(A;C) 55.8% plus rs1800458(A;G) plus 0.03398 rs4890568(A;A) 87.6% plus 0.1093 rs11083271(C;T) 47.8% plus 0.3095 rs527616(C;C) 38.5% minus 0.259 rs6507016(T;T) 10.9% plus 0.4532 rs12605662(A;G) plus rs7226408(C;T) 23.1% plus rs879500(A;C) plus rs1420956(A;G) minus 0.4183 rs11083241(A;G) plus 0.4789 rs162004(G;G) 46.0% plus 0.3425 rs9953270(C;T) plus 0.3682 rs11659841(C;T) 22.1% plus rs4145170(A;G) plus 0.3173 rs4800843(C;T) plus 0.4747 rs2155929(A;A) 1.8% plus 0.2227 rs1941184(G;T) 45.1% minus 0.3678 rs1521791(G;T) 40.7% plus 0.2856 rs1380836(A;G) 47.3% minus rs1123617(T;T) 1.8% minus 0.1731 rs6507022(C;C) 36.3% plus rs966376(A;G) minus 0.3388 rs516514(C;T) 54.5% plus 0.4848 rs2276314(G;G) 2.7% plus 0.242 rs1058396(A;G) plus 0.45 rs917692(T;T) 100.0% minus rs2289278(C;G) 9.2% plus rs4078252(C;T) 40.7% plus rs6594713(A;C) 41.6% plus rs4621553(A;A) 55.8% plus 0.1965 rs2016167(A;C) 30.8% minus 0.1768 rs17136627(C;T) 2.7% plus 0.06198 rs400028(A;G) 41.6% minus 0.2429 rs13174348(A;G) plus 0.3985 rs3756555(C;T) minus 0.3903 rs253959(C;T) minus 0.4656 rs26595(T;T) 35.4% minus 0.3806 rs17135859(C;T) plus 0.1322 rs2972219(A;A) 56.6% plus rs25640(A;A) 22.1% plus 0.3994 rs2956540(C;G) minus rs890749(A;A) 62.8% minus 0.146 rs2115172(G;G) 15.2% plus 0.4417 rs7705033(C;C) 8.8% plus 0.3659 rs30107(G;G) plus 0.3246 rs257016(G;G) 42.5% plus 0.1974 rs7448080(C;C) 88.5% plus rs17501712(T;T) 3.1% plus 0.08678 rs6595551(C;T) 28.3% plus rs4836133(A;C) plus 0.3274 rs2447820(G;T) 15.0% plus 0.2498 rs186749(C;T) 49.6% minus rs1582931(T;T) 21.2% minus 0.4412 rs13169113(A;C) 46.9% plus 0.3898 rs2306617(C;T) 39.8% plus 0.2645 rs959573(C;T) minus 0.2911 rs11241936(C;C) 12.4% plus rs4835929(G;T) plus 0.1056 rs12513840(A;G) 1.8% plus 0.1033 rs12523164(C;T) plus 0.1033 rs10463832(A;C) plus 0.1038 rs10463833(A;G) plus 0.1915 rs1910003(C;T) minus rs1515641(A;G) plus 0.1056 rs1421746(C;C) 12.4% minus 0.4711 rs245178(A;A) 45.1% minus 0.3049 rs27855(C;T) 47.3% minus 0.4449 rs154001(T;T) 45.1% plus 0.27 rs374748(A;A) 73.5% plus 0.1276 rs4836519(C;T) plus 0.1795 rs12518350(A;G) 49.6% plus rs7722425(C;T) plus 0.1892 rs6867265(A;G) 18.6% plus 0.1543 rs9791170(C;C) 44.2% plus 0.432 rs7727544(T;T) 29.2% plus rs419291(C;C) 36.3% plus rs11950562(C;C) 19.5% plus rs273914(A;A) 43.1% minus rs273913(C;C) 35.4% plus rs272893(G;G) 36.3% minus 0.4146 rs272889(C;C) 36.3% minus 0.4141 rs272879(C;C) 36.5% minus 0.4399 rs3864283(C;C) 10.6% plus 0.3613 rs30735(T;T) 4.4% minus 0.477 rs1355095(A;A) 67.9% minus 0.1203 normal normal rs667437(A;A) 4.4% plus 0.421 rs31400(C;T) plus 0.4288 rs40401(C;T) 38.4% plus 0.4178 rs2069803(C;T) plus 0.2383 rs273900(T;T) minus 0.4417 rs274546(C;C) 35.4% minus 0.4197 rs17622208(A;A) 19.5% plus 0.2447 rs2073643(C;C) 31.9% plus 0.393 rs11739135(C;G) plus 0.1832 rs2405522(G;G) 64.6% plus rs6596075(C;C) Bad 63.7% plus 0.2452 2x risk of Crohn's disease 2x risk of Crohn's disease rs11242111(G;G) 88.4% plus rs2188962(C;T) 58.9% plus 0.1896 rs12521868(G;T) 58.0% plus 0.1896 rs272869(C;C) 36.3% minus rs10058074(A;G) plus 0.2204 rs4143832(C;C) 68.1% minus 0.2002 rs2069812(C;T) 42.5% minus 0.4536 rs2237060(A;C) minus 0.2176 rs1881457(A;C) 32.7% plus 0.2048 rs1295686(C;C) minus 0.388 rs20541(G;G) minus 0.2681 rs1295685(C;C) 59.3% minus 0.2296 rs848(G;G) 58.4% minus 0.3499 rs2070874(T;T) 1.8% plus 0.4279 rs11745587(A;G) plus 0.4022 rs6894249(A;G) 61.3% plus rs2549003(T;T) 38.1% minus rs4705952(A;G) plus 0.4421 rs2227284(A;C) minus 0.4008 rs2243266(A;G) plus 0.4036 rs2243267(C;G) plus 0.404 rs2243270(A;G) 24.8% plus 0.4706 rs2243274(A;G) plus 0.4669 rs10062446(A;A) 53.1% plus 0.4702 rs11740584(C;C) 49.2% plus 0.4697 rs2897442(A;G) 43.1% minus 0.3944 rs2457174(A;G) 50.8% minus rs1644305(C;T) minus 0.3053 rs756699(T;T) 82.1% plus 0.1961 rs13187289(C;G) 36.9% plus 0.1589 rs299362(A;G) plus 0.07851 rs526896(G;T) plus 0.3352 rs479632(C;G) 42.9% minus 0.3182 rs3805663(G;G) 15.9% plus 0.4743 rs6596140(T;T) 7.1% plus 0.3333 rs17166496(C;C) Bad 34.5% plus 0.4568 1.1x risk for type-1 diabetes 1.1x risk for type-1 diabetes rs647161(A;A) 39.7% plus 0.472 rs634308(A;G) 44.2% minus 0.3388 rs2603014(G;G) 9.7% minus 0.3848 rs8192558(A;C) minus 0.1919 rs2344484(C;T) 48.7% minus 0.4481 rs13178541(A;C) 20.0% plus 0.32 rs31564(A;C) 48.7% minus 0.3728 rs30740(G;G) minus 0.3012 rs7719624(C;T) 48.6% plus rs11959298(A;G) 15.6% plus 0.202 rs6872664(C;T) 10.5% plus 0.1598 rs6596189(C;T) 23.0% plus 0.1607 rs31198(C;T) plus 0.3219 rs13179769(A;C) plus 0.3705 rs13166063(C;T) plus 0.3682 rs1109158(A;T) minus 0.3655 rs4585442(A;G) 33.6% plus 0.3669 rs4146185(A;T) minus 0.3678 rs12719481(A;G) 31.9% plus 0.3678 rs6865297(A;G) 31.9% plus 0.3682 rs3206634(C;T) plus 0.3664 rs6871224(A;G) plus 0.3655 rs1057898(C;T) plus 0.3669 rs3764941(A;C) minus 0.3669 rs10085013(A;T) plus 0.3714 rs6596284(C;T) plus 0.3719 rs7356756(C;T) plus 0.371 rs13357391(C;T) plus 0.2163 normal normal rs1859345(C;T) plus 0.2241 normal normal rs1541364(A;G) plus 0.4982 rs6596428(C;T) 49.1% plus 0.4022 rs3734166(A;G) plus rs4257763(A;A) plus 0.4059 rs11950646(A;A) 38.1% plus 0.4027 rs13181561(A;A) 54.0% plus 0.4702 rs7031(G;T) 29.2% plus 0.3714 rs13385(C;T) minus 0.2158 rs2563298(A;C) plus rs2569190(G;G) 22.6% plus 0.4734 rs5744455(C;T) minus 0.219 rs2569191(T;T) plus 0.4734 rs2915863(T;T) plus rs251379(A;G) minus 0.3682 rs1119032(A;G) 26.5% plus 0.1295 rs17119271(C;T) plus 0.03489 rs31872(T;T) 44.2% minus 0.2957 rs7447927(G;G) plus rs10482682(A;G) 53.2% minus 0.2484 rs852977(A;G) 43.4% plus 0.2576 rs860457(C;T) plus 0.2424 rs4986593(C;T) 38.1% minus rs860458(A;G) plus 0.1345 rs41423247(C;C) plus 0.2769 rs10052957(A;G) plus 0.2516 rs9324924(G;T) 42.5% plus rs4912911(A;G) plus 0.4467 rs12656106(C;G) plus rs166040(A;G) 23.9% plus 0.1901 rs11167764(C;C) 61.9% plus 0.2025 rs6863411(A;T) 38.5% plus 0.3306 rs1062158(C;T) 41.1% plus 0.331 rs7727832(C;T) 13.8% plus 0.08953 rs3776331(A;G) minus 0.2681 rs6196(A;G) 18.6% plus 0.1382 rs258750(A;G) minus 0.2599 rs17209251(A;G) 37.2% plus 0.1524 rs928815(A;C) minus 0.3444 rs2857602(C;T) minus rs2844484(C;T) 50.4% minus 0.3453 rs2071590(C;C) 34.9% minus 0.3186 rs1800683(A;G) plus 0.3985 rs2239704(G;T) 50.4% minus 0.3476 rs909253(C;T) 55.4% minus 0.3985 rs746868(C;G) minus 0.3453 rs1041981(A;C) plus 0.3994 rs769177(A;G) 3.5% minus 0.04086 rs3115667(G;G) 50.4% minus 0.1873 rs9267551(G;G) 59.4% plus 0.0528 rs4959083(C;T) plus rs4959084(C;T) plus rs6457477(C;T) plus rs2857009(C;G) minus 0.2534 rs3117181(C;G) 35.6% minus 0.07897 rs2269426(C;T) minus 0.3393 rs3130342(G;T) 26.5% minus 0.07484 rs8111(A;G) 38.9% minus 0.2103 rs2228628(C;G) minus 0.2149 rs2242665(A;A) 30.1% minus 0.3898 rs2736428(A;A) 15.0% minus 0.2856 rs535586(G;G) 45.1% minus 0.1896 rs404860(C;T) plus 0.2713 rs422951(A;G) minus 0.3347 rs520692(A;G) minus rs443198(C;T) 47.8% minus 0.4233 rs3134931(G;G) 9.7% minus 0.416 rs367398(A;G) plus rs3096702(C;C) 29.2% minus 0.2544 rs387071(A;G) minus rs3134928(A;A) minus rs1048709(G;G) 59.3% plus 0.174 rs537160(C;C) 48.2% minus 0.2654 rs4151657(C;C) 13.3% plus 0.2865 rs2072633(C;C) 38.4% minus 0.388 rs2075800(A;A) 14.2% minus 0.2906 rs506770(C;C) plus 0.1657 rs539689(C;C) minus 0.4357 rs644827(C;C) 30.1% plus 0.3893 rs494620(A;A) 21.2% plus 0.45 rs1560661(T;T) 31.0% plus rs4958842(A;G) plus 0.2048 rs4958843(C;T) plus 0.275 rs4958846(C;T) plus 0.354 rs9637876(C;T) plus 0.2388 rs10065172(C;T) 4.7% plus 0.2764 rs1000113(C;T) Bad 8.8% plus 0.2121 1.5x risk of Crohn's disease 1.5x risk of Crohn's disease rs11747270(A;G) 9.7% plus 0.2828 rs7714584(A;G) 8.8% plus 0.2828 rs11741861(A;G) 8.8% plus 0.1713 rs4958427(C;T) 17.7% plus 0.4164 rs3828599(C;T) 46.0% minus 0.3861 rs3792796(C;G) minus 0.4435 rs8177447(C;T) plus rs76956521(C;C) plus rs17728338(A;A) 1.8% plus 0.07759 rs153477(G;G) 39.3% plus 0.3618 rs153478(G;G) 48.2% plus 0.185 rs10061997(C;T) plus 0.2608 rs10463316(A;G) 40.3% plus rs1062177(C;T) 31.0% plus rs170020(T;T) 31.9% minus 0.477 rs294958(C;C) 31.9% minus rs4262150(G;T) plus 0.3154 rs1438949(C;C) 87.6% minus 0.06703 rs10037814(C;T) plus 0.4541 rs9324677(A;C) 48.7% plus 0.4096 rs979455(G;G) 8.0% minus 0.2736 rs727809(C;C) 10.6% plus rs3112530(C;C) 86.7% minus 0.2782 rs13165478(A;A) 7.3% plus 0.3994 rs4958803(C;G) plus 0.3994 rs10476823(C;T) plus rs267015(C;T) 40.7% minus 0.1474 rs244960(A;T) minus 0.4215 rs249878(C;T) minus 0.1414 rs6882076(C;T) plus 0.3871 rs1501908(C;G) minus 0.3843 rs548294(G;G) 41.6% minus 0.3287 rs10065813(C;T) 26.5% plus rs4958351(A;G) plus rs10070447(C;T) 44.2% plus rs2033195(C;T) plus 0.3747 rs7708584(A;G) 45.2% plus 0.4477 rs10037670(A;G) 31.0% plus rs2279804(A;G) 51.3% minus 0.4977 rs1553318(C;G) minus 0.3669 rs12522248(C;T) plus 0.23 rs1553316(A;G) minus 0.1001 rs41297579(A;G) minus 0.1561 rs41297577(C;G) minus 0.2608 rs4704846(A;G) plus 0.1639 rs1036199(A;C) plus 0.1304 rs10515746(A;C) 21.4% plus 0.1667 rs11742259(C;T) plus 0.2484 rs2036402(A;G) minus 0.1924 rs246871(C;T) plus rs25855(G;G) 59.3% plus rs31223(C;C) 5.4% plus rs9313772(C;T) 42.5% plus 0.2447 rs2149954(A;G) 43.4% minus rs11953630(C;T) 52.3% plus 0.2163 rs1432679(T;T) 35.7% plus 0.3898 rs1368297(A;A) 41.6% plus 0.4366 rs10040979(A;G) plus 0.4587 rs6865969(C;T) plus 0.4867 rs1473247(C;T) plus 0.4376 rs10076782(A;G) plus 0.4376 rs871012(C;C) 17.2% plus 0.4871 rs17599222(T;T) 20.5% plus 0.4261 rs2082412(A;G) plus 0.3563 rs2853694(A;C) 54.0% minus 0.3554 rs2288831(C;T) plus 0.3398 rs3213094(A;G) 36.3% minus 0.3398 rs3212220(G;T) minus 0.343 rs3212217(C;G) 36.3% minus rs2546890(A;G) 1.0 Bad 54.0% plus 0.4334 Higher risk of multiple sclerosis Higher risk of multiple sclerosis rs7709212(C;T) plus 0.393 rs4921482(C;T) plus rs6556412(A;G) plus 0.3811 rs6897260(G;G) plus rs10045431(C;C) 56.6% plus 0.1758 rs6556416(C;C) 54.0% plus 0.2006 rs6887695(C;G) plus 0.3976 rs918518(C;C) 63.1% minus rs10065906(A;A) 50.4% plus 0.2723 rs2030373(A;C) minus 0.3375 rs6884105(A;G) plus 0.4798 rs6892282(G;T) 44.2% plus 0.4959 rs10515807(C;T) minus 0.1933 rs62377586(A;G) plus rs2431697(C;T) plus 0.365 rs2961920(A;A) 59.3% plus 0.3834 rs1592749(G;T) plus rs834387(T;T) 54.7% plus 0.1134 rs1816071(A;G) minus 0.3567 rs183294(C;T) plus rs209356(A;G) plus rs211037(C;T) 37.8% plus 0.3976 rs10515808(A;C) plus 0.05647 rs1895320(C;T) 32.4% minus 0.1492 rs13183712(G;T) 31.0% plus 0.208 rs10515860(A;G) plus 0.07071 rs294588(C;C) 43.4% plus 0.2222 rs292404(A;G) 25.7% plus rs6556756(G;T) 15.9% plus 0.1749 rs10515889(A;G) 18.6% plus 0.1469 rs958994(C;T) minus 0.2502 rs2937573(A;A) 40.7% plus rs211014(A;C) plus 0.365 rs299290(C;T) plus 0.3223 rs4242220(G;G) 41.6% plus rs11134527(A;G) plus 0.3274 rs4282339(A;G) plus 0.1878 rs13156607(C;T) plus 0.2617 rs1895302(C;T) plus 0.4633 rs315721(A;G) 40.7% plus 0.3421 rs11960314(A;G) plus rs11134654(C;C) 64.6% plus 0.1455 rs3806929(C;T) minus 0.432 rs6892884(C;T) plus 0.2851 rs244895(G;G) 48.7% plus 0.2429 rs153750(A;C) minus 0.314 rs322351(C;T) 52.2% plus 0.3219 rs6890783(A;G) plus rs703752(A;A) 11.5% plus rs3095870(A;A) 13.3% minus 0.2328 normal risk normal risk rs359457(T;T) 34.5% plus 0.4692 rs1106693(A;A) 93.8% plus 0.05142 rs6863418(C;T) plus 0.3182 rs10475598(C;T) plus 0.4385 rs12659144(C;T) plus 0.2236 rs4336372(C;C) 50.4% plus 0.4412 rs12652255(A;C) plus 0.1772 rs251925(C;T) plus 0.3623 rs889014(C;T) 43.1% plus 0.3623 rs890835(A;C) 17.1% plus 0.1263 rs365132(G;T) 49.1% plus 0.4334 rs244715(A;G) minus 0.4008 rs422421(A;G) minus 0.1511 rs376618(A;G) 39.3% minus 0.185 rs31777(G;T) minus 0.1515 rs10037055(G;G) 69.9% plus 0.3609 rs1801020(C;C) 1.0 Good 70.8% minus 0.4201 Normal risk of developing heart disease Normal risk of developing heart disease rs2545801(G;G) 69.9% minus 0.483 rs10476160(G;G) 2.7% plus 0.3173 rs1472606(A;G) plus 0.2769 rs1366116(T;T) 42.5% plus rs3892909(T;T) 49.6% plus rs2961663(C;T) 17.0% plus rs2910124(C;T) plus 0.2893 rs6894268(G;G) 47.6% plus 0.3242 rs6893300(A;C) plus rs17617068(C;T) plus rs730012(A;C) 42.5% plus 0.1993 rs6879260(C;T) plus 0.3742 rs2731672(G;G) 69.0% minus 0.4316 rs11739089(C;T) plus rs448012(C;C) plus 0.4729 rs12211228(C;G) plus 0.124 rs9378805(A;C) 51.3% plus 0.3306 rs9378815(C;G) plus 0.4697 rs4959270(A;C) plus 0.3737 rs1540771(A;G) 58.6% minus 0.3489 rs6918152(G;G) 35.4% plus 0.4766 rs9504361(G;G) 20.4% plus 0.3903 rs1572438(A;A) 14.3% minus 0.3356 rs10085109(C;C) 32.7% plus 0.4477 rs12186500(G;G) 31.0% plus 0.3352 rs6859974(C;T) 23.4% plus 0.3609 rs11242675(T;T) 44.2% plus 0.4665 rs9502893(C;T) 49.6% plus 0.4867 rs2569872(C;G) plus 0.09412 rs3800131(A;C) 46.0% plus rs9378688(A;G) plus 0.1116 rs2505675(A;A) 11.5% minus rs4959677(C;C) 27.4% plus rs318497(A;A) 21.2% plus 0.4793 rs2070999(A;G) 42.5% plus 0.3007 rs2071002(A;C) 40.2% plus 0.3182 rs1143684(T;T) 61.1% plus 0.1979 rs1711973(G;G) 57.5% minus rs2272990(G;G) 90.3% minus 0.152 rs17309827(G;T) plus 0.3306 rs17318866(A;G) plus 0.2576 rs2224391(A;C) 37.2% plus 0.3926 rs1050783(A;G) 29.2% minus 0.1488 rs5988(C;G) 43.1% minus 0.1882 rs3024409(G;T) minus 0.2502 rs3024405(A;T) minus 0.4885 rs749005(A;C) 25.7% minus 0.1373 rs2815822(G;G) 80.9% plus rs9391988(A;G) plus rs9392653(C;T) 38.1% plus 0.2406 rs1318606(C;T) minus 0.4206 rs11243081(C;T) 49.6% plus 0.2534 rs17142067(A;C) 42.6% plus 0.2525 rs554653(G;T) minus 0.3365 rs1334710(A;A) 61.5% plus 0.1235 average average rs977785(C;C) 46.9% plus 0.298 increased risk increased risk rs7740529(C;T) 17.1% plus 0.259 rs2326810(C;G) plus 0.08999 rs2764085(C;T) 44.6% plus 0.2181 rs7739678(A;G) 43.1% plus 0.1249 rs1885486(C;T) minus 0.3476 rs12198986(A;G) plus 0.3283 rs3812163(A;T) 44.6% minus 0.3352 rs2068361(A;G) 27.4% minus 0.241 rs270393(C;C) 63.1% plus rs443861(A;G) 46.0% plus 0.2961 rs13209404(C;T) plus 0.3118 rs1294410(C;T) plus rs1294421(G;T) plus 0.4573 rs675209(C;C) 52.2% plus 0.4931 rs2234246(A;G) 47.8% minus rs1817537(C;G) 47.8% minus rs3804277(A;G) 55.4% minus rs4711668(C;T) plus rs7762544(A;A) 69.0% plus 0.1515 rs1983891(C;T) 42.5% plus 0.3724 rs2842643(A;A) 51.3% minus 0.2576 rs9462856(C;C) 32.1% plus 0.4848 rs10948059(T;T) 24.3% plus rs9472155(C;T) 34.5% plus 0.2452 rs11755845(C;T) 27.4% plus 0.2006 rs4513773(G;G) 23.2% plus 0.4151 rs6921438(A;A) 25.0% plus 0.4559 rs4416670(C;T) plus 0.4633 rs3734693(C;T) plus 0.3981 rs7742824(A;G) plus 0.2736 rs713050(G;T) plus 0.1226 rs35131064(C;T) plus rs543844(A;G) 55.8% plus 0.3696 rs3025000(T;T) 9.7% plus 0.2645 rs3025006(T;T) plus 0.4403 rs3025020(C;T) plus 0.2447 rs3025021(C;T) plus 0.2608 rs10434(A;G) 54.0% plus 0.3242 rs998584(G;T) minus 0.4513 rs6905288(A;G) plus 0.3788 rs1358980(C;T) 52.2% plus 0.4389 rs943072(A;A) 85.8% minus 0.1791 rs729761(G;G) 54.9% plus 0.1758 rs2651206(T;T) 8.8% plus 0.4619 rs7764257(G;G) 7.1% plus 0.3278 rs4149178(G;G) 0.9% plus 0.1786 rs2257082(C;T) minus 0.3508 rs833052(A;C) 15.9% plus 0.1708 rs699946(A;G) 32.7% plus 0.2576 rs833060(G;T) 38.5% plus 0.2893 rs1129187(A;A) 23.9% minus 0.3287 rs833061(T;T) 25.7% plus 0.3802 rs13207351(G;G) plus 0.3646 rs1570360(G;G) Good plus 0.2241 normal normal rs1413711(G;G) minus 0.3581 rs833068(A;A) 10.6% plus 0.3939 rs833069(G;G) 10.6% minus 0.4238 rs833070(G;G) 24.8% minus 0.3522 rs3024997(A;A) 10.6% plus 0.3499 rs3024998(T;T) plus 0.3499 rs4715166(A;G) 47.8% plus 0.4803 rs552655(A;G) minus 0.4793 rs204247(A;A) 27.4% plus 0.4334 rs853360(C;T) plus 0.2397 rs9230(C;T) plus 0.2218 rs12213875(G;G) 39.8% plus 0.4674 rs707824(G;G) 80.5% minus 0.2195 rs17119(C;T) minus 0.2654 rs6941421(C;C) 18.6% plus 0.3444 rs13211739(A;G) 34.5% plus rs742105(C;T) plus 0.4963 rs2619539(C;G) 45.3% plus 0.4945 rs1011313(G;G) 83.2% minus 0.1171 rs909706(A;G) minus 0.4183 rs9476886(C;T) 39.4% plus 0.3393 rs9370867(A;G) 52.3% plus 0.258 rs10484358(G;T) 13.3% plus 0.04545 rs6459467(A;A) 15.9% plus rs1042391(A;A) 9.8% plus 0.3549 rs179997(A;T) minus 0.2401 rs9370822(A;C) 36.9% plus 0.444 rs1322846(C;T) plus 0.3444 rs2328136(G;G) 68.1% plus 0.1781 rs10949483(A;G) plus 0.3687 rs16882214(C;G) 24.8% plus 0.1198 rs7739264(T;T) 31.9% plus 0.3375 rs6907340(T;T) 16.8% plus 0.4904 rs7773456(G;T) plus rs73725220(A;G) plus rs7756992(A;G) Bad 38.1% plus 0.4054 1.3x increased risk for type-2 diabetes 1.3x increased risk for type-2 diabetes rs9356744(C;T) plus 0.4128 rs9465871(C;T) Bad plus 0.3627 1.2x risk type-2 diabetes 1.2x risk type-2 diabetes rs7747752(C;G) plus 0.3783 rs7747724(C;C) 21.2% plus rs4510656(A;A) 21.8% plus rs9358372(A;G) plus 0.4045 rs12663356(C;T) plus 0.4844 rs2457335(T;T) 55.7% minus rs555017(G;G) 33.6% plus rs1570155(A;G) plus rs4712523(A;G) 47.8% plus 0.4164 rs4712524(A;G) plus 0.4091 rs10946398(A;C) 47.8% plus 0.4082 rs2078543(G;G) 46.9% plus 0.2401 rs1928168(G;G) 20.2% minus 0.2631 rs4236016(T;T) 100.0% plus 0.008264 rs2244502(A;A) 58.6% minus 0.3669 rs1341239(G;G) 39.8% minus 0.264 rs1341238(C;C) minus 0.3476 rs9358531(G;G) plus rs9466930(G;G) 55.8% plus 0.3517 rs6922632(A;C) plus 0.118 rs1419228(A;G) plus 0.2319 rs2027584(A;C) 18.6% minus 0.141 rs9467075(A;G) plus 0.112 rs9467076(C;T) plus 0.09229 rs807726(C;T) 34.4% minus 0.2365 rs10498712(C;T) 51.8% minus 0.2778 rs1205923(C;C) minus 0.3806 rs2038137(G;T) minus 0.2484 rs4256430(A;A) 23.9% plus rs9358856(A;G) plus rs12526480(G;T) plus 0.3104 rs441460(A;G) plus 0.4587 rs742132(C;T) 46.0% minus 0.2943 rs2274305(A;G) minus 0.4504 rs6922023(A;G) plus 0.2635 rs1883415(A;C) 42.5% plus 0.2984 rs16889440(C;T) 23.0% plus 0.1566 rs12193738(C;T) plus 0.2815 rs4504469(C;T) 46.8% plus 0.2332 1.5x risk 1.5x risk rs4712972(G;G) 77.9% plus 0.1974 rs11754288(A;G) plus 0.2415 rs3757131(C;T) 42.2% plus 0.2415 rs3799344(C;T) 50.4% plus 0.3531 rs1179086(A;T) minus 0.477 rs2762353(C;T) 46.0% minus rs1165215(A;G) minus 0.2585 rs1165209(A;G) plus 0.2585 rs1165196(C;T) minus 0.2599 rs1165153(C;T) 42.2% minus 0.259 rs1185567(C;T) 42.2% minus rs17270561(A;C) plus 0.1552 rs1165151(A;C) minus 0.2672 rs1183201(A;T) 46.0% minus 0.2713 rs1165176(C;T) 48.7% minus 0.2654 rs1165205(A;T) Good minus 0.2824 0.85x decreased gout risk 0.85x decreased gout risk rs10484434(A;G) plus 0.08081 rs807212(C;C) 36.9% minus 0.2075 rs1572982(A;A) 16.8% plus 0.3985 rs6918586(C;C) 12.4% plus 0.3838 rs806794(A;G) 42.9% plus 0.4711 rs10946808(A;G) 47.8% plus 0.3751 rs6929846(C;C) 69.0% plus 0.247 rs12216125(C;T) 45.1% plus 0.1869 rs1679709(C;C) 78.8% minus rs1237485(C;T) minus 0.3586 rs2032502(A;G) 21.2% minus 0.1065 rs4947339(C;T) 43.4% plus 0.3893 rs9257408(C;G) plus rs28757581(A;G) 1.0 plus 0.186 lowered ability to smell cut grass lowered ability to smell cut grass rs3749977(C;T) 1.0 minus 0.3219 lower ability to smell cut grass lower ability to smell cut grass rs3129109(C;T) plus 0.3884 rs9257616(A;G) plus rs9257691(A;C) plus 0.3742 rs1056667(C;C) 24.8% plus 0.4518 rs3094548(G;G) 47.7% minus 0.3696 rs2523395(C;T) minus 0.3953 rs1736913(A;G) minus rs2523393(C;T) 39.1% minus 0.3944 rs1633038(C;T) 17.2% minus rs1610677(A;G) minus 0.4977 rs1632947(C;T) minus rs1233334(C;G) minus rs3117292(A;G) 42.5% plus rs2747442(A;G) 36.3% plus rs29232(A;G) 35.4% minus 0.4325 rs3117294(G;T) plus rs2523809(A;C) 19.5% minus 0.09596 rs78529783(A;C) plus rs2860580(C;T) 54.0% minus 0.3802 rs9260118(C;T) plus 0.3274 rs9260119(A;T) plus 0.3251 rs9260123(C;G) plus 0.4899 rs1059418(A;C) plus 0.1809 rs41541123(G;T) plus rs9256982(G;T) plus 0.3503 rs2249863(A;C) minus rs915670(C;T) minus rs1610696(C;G) 58.7% minus 0.2406 rs1710(C;G) plus 0.4504 rs1063320(C;G) 48.7% minus 0.4481 rs9260313(C;T) plus 0.4307 rs2517713(A;C) 49.5% minus 0.3237 rs2975042(A;C) 49.1% minus 0.3242 rs6457110(A;T) plus 0.4073 rs9260997(C;T) plus rs7758512(G;T) plus 0.1846 rs4313034(C;T) 16.9% plus 0.2153 rs9261129(C;T) plus 0.1846 rs9261174(C;T) plus 0.1846 rs3869068(A;G) 13.4% minus 0.1846 rs1136695(A;G) plus 0.365 rs1136700(C;T) plus 0.2686 rs1059517(A;C) plus 0.2925 rs1059526(A;G) plus 0.06107 rs2735112(C;T) minus 0.4697 rs2735111(C;T) minus rs79222956(A;G) plus 0.3246 rs9260166(C;T) plus rs9260167(A;G) plus rs3179982(C;T) plus 0.466 rs1141891(C;T) plus 0.314 rs3823323(A;G) plus 0.4734 rs3823324(A;T) plus 0.4734 rs3823339(C;G) 12.3% plus 0.04224 rs2735101(A;G) minus 0.1887 rs3823343(A;G) 23.0% plus 0.1887 rs1061156(G;T) plus 0.1928 rs13395(A;C) minus 0.2438 rs79244404(C;T) plus 0.1892 rs6917603(C;T) plus 0.1506 rs3132130(C;G) 13.1% minus rs2301753(A;C) 15.7% minus 0.1846 rs2074480(A;C) minus 0.1846 rs1264511(G;G) 30.1% minus 0.3508 rs1264459(T;T) 74.3% minus 0.1437 rs1059510(G;G) 39.8% minus 0.3085 rs1264457(C;T) minus 0.4922 rs2844724(A;A) 35.4% minus 0.3283 rs3132613(C;C) minus 0.2865 rs12526186(T;T) 0.0% plus 0.2342 rs3130783(A;A) 66.4% plus 0.2626 rs7749924(C;T) 23.0% plus 0.1345 rs2074479(C;T) 13.3% minus 0.1846 rs1052693(T;T) 4.4% plus 0.3535 rs2074508(T;T) 4.4% minus 0.3517 rs2074511(G;G) 4.4% minus 0.2994 rs4248154(C;T) 27.4% plus 0.2043 rs2517532(C;C) 26.8% minus 0.4233 rs9262638(C;T) 36.3% plus 0.2342 rs2517510(C;C) 15.9% minus rs4947296(C;T) plus 0.09504 rs9501030(A;A) plus rs7756521(C;C) 4.4% plus 0.3512 rs1264328(C;C) 20.6% minus 0.494 rs4618569(A;A) 4.4% plus 0.3517 rs1264323(T;T) 17.7% minus 0.494 rs1049623(G;G) 17.7% minus 0.4927 rs2267641(C;C) 3.1% plus 0.2392 rs2239518(T;T) 4.4% plus 0.2994 rs4959053(A;G) plus 0.0652 rs1265093(C;T) minus 0.2764 rs2285803(G;G) 54.0% minus 0.2727 rs9263739(C;T) 25.7% plus 0.1373 rs130067(A;C) minus 0.2447 rs3130453(C;T) 47.8% plus 0.4564 rs1419881(C;T) minus 0.4766 rs3130932(G;T) minus 0.3214 rs3130931(A;G) minus rs3130501(A;G) 39.8% plus 0.2296 rs6457327(C;C) 35.4% plus 0.3347 rs3094212(C;T) minus 0.3814 rs3130559(C;T) 26.5% plus 0.315 rs3132524(A;G) minus rs879882(C;T) plus 0.4334 rs887466(T;T) 21.2% minus 0.4298 rs3131018(G;G) 38.4% minus 0.3324 rs887464(A;G) 50.8% minus 0.4004 rs3130941(C;G) 25.7% minus rs9264082(C;T) plus 0.2424 rs3130542(G;G) 61.9% plus rs1065711(T;T) minus 0.1304 rs9264594(G;G) 37.5% plus 0.2208 rs2894204(T;T) plus 0.281 rs1130838(G;G) minus 0.2204 rs35708511(G;G) plus 0.2204 rs2523609(T;T) minus 0.2548 rs66620546(G;G) plus 0.2204 rs3869109(C;C) 38.1% minus 0.4403 rs3095254(C;G) 47.7% minus 0.4477 rs34794906(C;T) plus 0.3806 rs2234776(A;G) minus 0.2438 rs1050716(G;G) minus 0.225 rs1050344(T;T) minus 0.225 rs9264636(T;T) 40.0% plus 0.225 rs9264640(G;G) plus 0.2213 rs9264641(C;C) plus 0.06107 rs9264642(C;C) plus 0.2704 rs9264643(A;A) plus 0.2204 rs9264647(G;G) 36.9% plus 0.2199 rs75141084(A;A) plus 0.2539 rs9264606(C;C) 36.9% plus 0.2231 rs9264607(A;G) plus 0.2296 rs9264608(G;G) 38.7% plus 0.2218 rs17886880(C;T) minus 0.399 rs2524079(C;T) minus rs2524054(G;G) 44.6% minus 0.1625 rs9468925(A;G) plus 0.4518 rs2247056(C;C) 58.4% plus 0.1708 rs9461688(A;G) 43.4% plus 0.3421 rs2442728(A;A) 9.2% minus 0.371 rs1058026(G;T) 21.2% minus rs1054111(G;T) minus 0.2466 rs9264651(C;C) plus rs17884428(A;A) minus 0.3287 rs9264652(C;C) plus 0.2195 rs2308604(G;G) minus 0.2112 rs713032(A;C) minus 0.3581 rs1131118(A;T) minus rs41543814(A;G) minus 0.4844 rs17192932(C;G) plus 0.05739 rs3819305(C;G) minus 0.3567 rs2308655(C;G) minus 0.4348 rs3819299(A;C) minus 0.107 rs2442718(A;G) minus 0.2153 rs2507992(A;G) minus 0.2163 rs2507991(G;G) minus 0.2612 rs2523608(T;T) 31.0% minus 0.421 rs2523590(A;G) minus 0.2098 rs13202464(A;G) 10.6% plus 0.06152 rs1521(T;T) 55.9% plus 0.2117 rs13437082(C;T) 33.0% plus 0.3512 rs13437088(C;T) 32.1% plus 0.3512 rs6924962(C;T) plus rs7751505(A;C) 32.7% plus 0.3352 rs66609536(A;G) plus 0.3306 rs4349859(A;G) plus 0.01791 rs2596542(A;G) 44.2% minus 0.41 rs2596498(A;G) minus 0.2163 rs2596496(C;C) minus 0.2925 rs3819282(A;G) minus 0.05739 rs1051488(A;G) minus 0.4725 rs1131500(A;G) minus 0.4931 rs2854001(C;T) minus 0.1451 rs1050341(A;G) minus 0.2658 rs3897530(A;C) minus 0.2603 rs2523604(G;G) minus 0.1745 rs11423052(C;C) plus 0.2984 rs2596494(C;C) minus 0.1561 rs1050696(C;T) minus 0.08907 rs709053(C;G) minus 0.3701 rs1050654(A;A) minus 0.4201 rs1050642(A;G) minus 0.07254 rs1050518(A;T) minus 0.1928 rs1050517(C;G) minus 0.3806 rs2596492(C;T) minus 0.1635 rs12175489(A;G) plus 0.152 rs1051792(A;G) plus 0.3655 rs1051794(A;G) plus 0.365 rs1063635(A;A) 12.9% plus rs2256183(G;G) 21.5% plus 0.2934 rs2256184(G;G) plus 0.4495 rs9348876(C;T) 19.6% plus 0.1107 rs2259571(C;C) 14.2% minus 0.3609 rs2857597(T;T) 44.6% minus 0.1942 rs2736172(A;A) 14.2% minus rs2260000(C;C) 14.2% minus 0.3659 rs1046080(A;A) plus rs2736155(G;G) 13.8% minus 0.494 rs750332(A;A) minus 0.1593 rs805297(T;T) 8.8% minus 0.2759 rs2248462(A;G) plus 0.2011 rs3749946(A;C) plus rs2507971(A;T) minus 0.3783 rs3828903(A;A) 8.8% plus 0.3687 rs3132468(A;A) 46.9% minus 0.2011 rs3132464(A;A) 31.9% minus 0.1667 rs3853601(C;G) 21.4% minus 0.1107 rs2071592(A;T) minus 0.3893 rs2230365(C;T) 23.9% plus 0.1442 rs2848713(A;G) plus rs2516448(G;G) 23.9% minus 0.2934 rs4418214(C;T) plus 0.06979 rs3128982(A;G) 45.1% plus 0.1304 rs6928289(A;G) plus 0.4495 rs675520(G;G) 20.3% plus 0.4844 rs9376293(C;T) 47.7% plus 0.3347 rs609438(T;T) 33.3% minus 0.3058 rs7753394(C;T) Bad 55.4% plus 0.4343 1.2x risk 1.2x risk rs582757(A;G) minus 0.2548 rs610604(A;C) 49.6% minus 0.3627 rs642627(A;G) plus rs2484067(C;C) 19.6% plus 0.3283 rs1184860(C;T) plus 0.3678 rs1167846(C;C) 56.9% plus 0.326 rs1167849(A;G) 44.6% plus 0.3618 rs556493(C;T) minus 0.4114 rs7772697(C;C) 21.2% plus 0.3545 rs636864(T;T) 8.1% plus 0.2617 rs9485370(T;T) 2.7% plus rs9485372(A;A) 2.7% plus 0.2576 rs1853665(A;G) 31.9% minus 0.2957 rs1591830(A;G) plus 0.477 rs670292(C;G) 45.1% minus rs9372078(A;A) 50.8% plus 0.2782 rs17427389(A;G) plus 0.1364 rs9390459(A;G) 54.9% plus 0.4835 rs9373523(G;T) plus 0.3664 rs9399599(A;T) 48.4% plus 0.4605 rs9403856(C;T) 28.3% plus 0.1203 rs9390537(T;T) 61.1% plus 0.3774 rs9497965(C;T) 50.8% plus 0.3774 rs6930576(A;G) plus 0.3007 rs605066(T;T) 31.7% plus 0.461 rs679582(A;A) 32.3% plus 0.489 rs632057(G;G) 35.4% plus rs668459(T;T) 31.9% plus 0.4394 rs628751(A;A) 22.2% plus 0.3531 rs592423(C;C) 28.6% plus 0.4293 rs590856(A;A) 29.2% plus 0.4412 rs12664111(A;G) 16.2% plus 0.1506 rs1556640(C;T) 21.2% plus 0.1878 rs17071124(A;G) 1.6% plus 0.05739 rs225675(A;G) 52.3% plus 0.2952 rs225694(G;G) 69.2% plus 0.1217 rs225717(T;T) 60.2% plus 0.1538 rs9390123(C;C) 33.6% plus 0.4481 rs6931865(A;G) 38.9% plus 0.3517 rs2328686(C;C) plus 0.2016 rs6923492(C;T) plus rs3134950(G;T) minus 0.3788 rs1061808(A;C) minus 0.3797 rs1035798(C;T) minus rs1800624(A;T) 25.0% minus 0.1928 rs204993(C;T) 42.5% minus 0.2879 rs2071277(A;G) minus 0.4215 rs549182(A;G) plus rs9267911(C;C) 12.4% plus 0.416 rs424232(A;G) 32.7% minus 0.2961 rs9267972(G;G) 35.2% plus rs926070(C;T) minus rs3129900(T;T) 66.4% plus 0.1428 rs910049(G;G) 54.1% minus 0.2163 rs2073048(C;T) minus 0.1993 rs3129943(A;G) 39.8% plus 0.2874 rs9268402(A;A) 31.9% plus 0.4399 rs3117099(C;T) minus 0.314 rs3117098(T;T) 49.6% minus 0.2645 rs3115573(C;T) 45.1% minus 0.4371 rs9296015(A;G) plus 0.2438 rs3130320(C;C) 36.3% plus 0.286 rs2076529(G;G) 23.0% minus 0.3655 rs3817963(A;G) minus 0.2323 rs3763304(C;T) plus 0.197 rs2076523(A;G) minus 0.371 rs10947261(G;T) 11.5% plus 0.1644 rs10947262(C;T) 11.5% plus 0.1703 rs3806156(G;T) 46.0% plus 0.3714 rs9268494(A;C) 44.2% plus 0.3595 rs41521946(A;A) minus 0.1208 rs28362677(A;A) minus 0.1584 rs28362678(T;T) minus 0.1589 rs2076533(A;A) 23.0% minus 0.365 rs4959027(G;G) 50.0% plus 0.1465 rs3129860(A;G) 29.5% plus 0.09734 rs3135338(A;G) 46.0% minus 0.3705 rs3129871(A;C) 46.4% plus 0.4054 rs3129882(A;G) plus 0.4697 rs3129888(A;A) 61.9% plus 0.1598 rs3177928(A;G) plus 0.1198 rs9268499(A;G) plus 0.3315 rs3763313(A;C) 31.9% plus 0.2227 rs3763317(T;T) 28.3% plus 0.4522 rs9405098(A;G) plus 0.08356 rs7194(A;G) plus rs2395182(G;T) 31.9% plus 0.2135 rs2227139(C;T) minus 0.3678 rs3129889(A;A) 66.4% plus 0.06428 rs3129890(C;T) plus 0.3108 rs6903608(T;T) 50.4% plus 0.3352 rs9268839(A;G) plus 0.377 rs9268856(A;C) plus rs9268877(A;G) 44.6% plus 0.4164 rs9270986(A;C) 31.9% plus 0.1561 rs3021304(C;G) minus rs4530903(C;T) 19.5% plus 0.08264 rs9271348(A;G) plus rs3135005(C;T) 35.4% minus 0.1382 rs9271366(A;G) plus 0.1382 rs17533090(G;T) 26.5% plus 0.1561 rs9271588(C;T) plus rs9272105(A;G) plus 0.4665 rs6906021(C;T) plus 0.461 rs6457594(G;G) plus rs4713580(C;T) plus 0.4174 rs9275245(A;G) 51.3% plus 0.4201 rs3129720(C;C) 52.4% plus 0.2039 rs6457620(C;G) plus 0.4389 rs2647012(G;G) 41.6% minus 0.2984 rs10484561(G;T) plus 0.1203 rs2647045(A;G) plus 0.3237 rs2647046(C;C) 42.9% plus 0.2948 rs2647050(C;T) plus rs2856683(A;C) minus 0.298 rs9469220(A;A) Bad 20.4% plus 0.4192 1.5x risk of Crohn's disease 1.5x risk of Crohn's disease rs9275224(A;G) 51.3% plus 0.4164 rs9275524(C;C) 38.9% plus 0.3737 rs4273729(G;G) 30.8% plus 0.3742 rs9275572(G;G) 38.9% plus 0.3751 rs2858331(C;C) 15.0% minus 0.4394 rs3104402(G;G) 81.4% plus 0.02893 rs9275698(A;G) 43.8% plus 0.32 rs2858884(G;T) 30.8% minus 0.1772 rs2858881(A;G) minus 0.07208 rs9275406(G;T) 42.5% plus rs2856718(A;G) 46.8% minus 0.3848 rs9275428(A;G) 42.5% plus 0.3209 rs13192471(C;T) plus 0.1988 rs1794275(C;T) minus 0.2264 rs7453920(G;G) 31.0% plus 0.2975 rs2051549(T;T) 31.0% minus 0.2971 rs2621416(A;G) minus 0.2948 rs2857151(C;C) 36.0% minus 0.332 rs2071554(A;G) 8.8% minus rs1135216(A;G) minus 0.1873 rs1057141(A;G) minus 0.2034 rs2071480(G;T) minus 0.3939 rs1351383(G;T) 49.6% minus 0.4045 rs9276370(T;T) 30.1% plus rs7769979(A;G) plus 0.4362 rs7756516(C;T) 47.8% plus rs2301271(C;C) 31.0% minus 0.3343 rs1049110(A;G) 44.6% minus rs2127675(C;T) 48.7% minus 0.3393 rs3097645(C;C) 81.5% plus 0.1125 rs9296068(G;T) plus 0.4518 rs2395309(A;G) 24.1% plus 0.3981 rs3077(C;T) 23.9% minus 0.3962 rs1042178(A;G) minus 0.3958 rs9277341(C;T) plus 0.4656 rs6914849(A;G) plus 0.3875 rs987870(C;T) 17.7% minus 0.1837 rs9277359(A;C) plus 0.4307 rs9277378(A;G) 41.6% plus 0.4642 rs9277534(A;G) 38.5% plus rs2581(A;C) 38.1% minus 0.4118 rs378352(A;G) plus rs399604(A;G) minus 0.4013 rs365066(C;T) 37.2% plus 0.4013 rs9277535(A;G) 36.3% plus 0.3264 rs9277554(C;T) 40.2% plus 0.4417 rs9277555(A;G) plus rs3128965(A;G) plus 0.1396 rs3128968(A;T) plus 0.3264 rs3117225(C;T) minus 0.4426 rs2281389(C;T) 26.5% minus 0.141 rs3128917(G;T) plus 0.3825 rs3117242(C;T) 36.3% minus 0.3852 rs3117027(T;T) 8.0% minus 0.247 rs2254287(C;C) 10.5% minus 0.4573 rs2855429(G;G) 47.8% minus 0.1699 rs2076310(C;C) 5.3% minus 0.3636 rs421446(C;C) 8.1% minus 0.393 rs107822(A;A) 5.3% minus 0.3623 rs439121(G;T) 40.7% minus 0.3545 rs9277952(A;G) plus 0.1524 rs2071888(C;G) minus 0.4431 rs2239839(G;T) minus 0.2401 rs2064479(A;G) 37.2% minus rs3117230(C;T) 31.9% minus 0.258 rs3128930(C;T) 34.5% plus 0.2994 rs1883414(T;T) 10.6% minus 0.2438 rs1059231(C;T) 38.1% minus 0.2401 rs2073524(A;T) plus 0.4858 rs9394152(T;T) plus 0.4132 rs9296092(G;G) 34.5% plus 0.3783 rs6910233(G;T) 50.4% plus rs210134(G;G) 54.9% plus 0.2709 rs513349(A;G) 49.6% plus 0.4174 rs210138(A;G) 29.2% plus 0.241 rs210142(C;C) 58.9% plus 0.2493 rs9394159(T;T) 13.8% plus 0.4601 rs2296336(C;G) Bad 46.2% minus 0.2943 1.3x risk of type-1 diabetes 1.3x risk of type-1 diabetes rs2229634(C;T) 42.5% plus 0.292 rs2395402(C;T) minus 0.4793 rs751728(A;G) minus 0.438 rs2894342(G;T) minus 0.2314 rs4713693(C;T) plus 0.4151 rs2104362(A;A) 58.4% plus 0.3549 rs733457(T;T) 36.9% plus rs1759645(T;T) 70.8% plus 0.286 rs2780226(A;A) 81.4% minus 0.2126 rs4711336(A;G) plus 0.472 rs3227(C;G) plus 0.4913 rs2296743(C;T) 47.6% plus 0.4008 rs2764208(G;G) 12.4% plus rs3734266(G;G) 1.8% minus 0.1584 rs11755393(G;G) 15.0% plus 0.4669 rs4646949(C;C) 4.4% minus 0.4619 rs847845(A;G) plus 0.2635 rs1535001(G;G) 5.3% plus 0.4518 rs2140418(A;G) minus 0.3999 rs13210323(A;C) 42.5% plus 0.4004 rs2005(A;G) 21.3% plus rs2395609(C;G) plus 0.3462 rs6938239(A;A) 85.0% plus 0.1116 rs7769719(A;G) plus 0.1148 rs2267668(A;G) plus 0.1612 rs2076169(C;T) 21.4% minus 0.1051 rs9794(C;G) plus 0.1566 rs4713858(A;G) 25.0% plus 0.152 rs2064318(G;G) minus 0.1465 rs7764472(C;C) plus 0.1129 rs9380516(C;C) 69.0% plus 0.1433 rs3800374(G;G) 66.4% minus 0.1653 rs3800373(T;T) 54.0% minus 0.2971 rs6902123(C;T) plus 0.213 rs6922548(A;G) 12.4% plus 0.2094 rs7748266(C;C) 71.7% plus 0.1524 rs9394309(A;A) 50.4% plus 0.2351 rs9470080(C;C) 47.8% plus 0.3471 rs4713916(G;G) plus 0.219 rs3748051(A;G) minus 0.1777 rs3748050(A;G) minus 0.2098 rs3748048(C;T) minus rs72925892(C;T) plus rs2234067(G;T) minus 0.08081 rs7757037(A;G) Good plus 0.4991 0.68x decreased risk for bipolar disorder 0.68x decreased risk for bipolar disorder rs9296158(G;G) 50.0% plus 0.3375 rs3777747(A;G) 50.4% plus 0.4931 rs1406945(G;G) 6.2% plus 0.4821 rs3829963(A;C) plus 0.2796 rs762624(A;C) plus 0.4233 rs2395655(A;G) 45.1% plus 0.4858 rs3176336(A;T) plus 0.3797 ? ? rs1801270(A;C) Bad plus 0.247 increased risk for lung cancer increased risk for lung cancer rs3176352(C;G) 44.6% plus 0.4738 rs1059234(C;T) 7.1% plus 0.2245 rs1405069(G;T) 49.6% minus 0.4343 rs7759778(G;G) 3.2% plus 0.2691 rs1680005(A;G) 50.4% plus 0.3242 rs1224329(A;G) plus 0.2337 rs1150790(A;G) 34.5% plus 0.1961 rs149709(A;G) minus rs904251(T;T) 44.2% plus 0.4972 rs1757171(G;G) 46.9% minus 0.4646 rs9394438(A;G) plus 0.4063 rs9462343(A;G) plus 0.2796 rs10807187(G;T) 46.9% plus 0.3067 rs7769372(C;T) 18.6% plus 0.2185 rs2395670(A;G) 46.4% plus 0.2374 rs17589516(A;G) 10.6% plus 0.03581 rs4746(C;C) 26.2% minus 0.303 rs10484854(A;A) 10.6% minus 0.1272 rs1049346(T;T) 36.3% minus rs2115200(A;C) minus 0.1455 rs10947789(C;T) plus rs12214600(T;T) 2.7% plus rs10456100(C;T) 27.6% plus 0.1795 rs12195376(C;T) 17.6% plus rs2758912(G;G) 18.6% plus rs1535500(T;T) 19.0% plus 0.4325 rs6923737(C;T) plus 0.332 rs9471077(A;G) 55.4% plus 0.4692 rs9462535(A;C) plus 0.4784 rs20455(C;T) 51.3% minus 0.4904 rs9296295(A;C) plus rs2479717(A;A) plus 0.1621 rs9357377(A;A) plus 0.1382 rs2492937(A;G) plus rs7762152(A;G) 18.8% plus 0.0877 rs434102(C;C) 61.1% plus 0.219 rs390659(C;C) 60.3% plus 0.2199 rs7764439(A;G) 55.8% plus 0.4252 rs6458307(C;T) 37.2% plus 0.3439 0.8x risk 0.8x risk rs9296404(C;C) plus rs6937133(A;G) 36.3% plus 0.2856 rs2504106(C;T) 47.6% minus 0.4017 rs2038868(A;G) minus rs10484761(A;G) minus 0.258 rs550448(A;A) 70.8% plus 0.1097 rs11765845(G;G) 51.4% plus 0.3444 rs2237349(C;T) 55.8% plus 0.4747 rs10238623(A;G) 39.8% plus rs2018683(G;T) 48.2% plus 0.3976 rs2252521(C;C) 52.2% plus 0.4279 rs39059(A;G) 42.5% plus rs2023908(A;C) plus rs1002630(A;G) plus rs1362363(C;T) plus rs849141(A;G) 35.4% plus 0.1423 rs849142(A;G) minus 0.2833 rs1029534(G;T) plus 0.1469 rs1635852(C;T) plus 0.3586 rs1708299(C;T) 44.6% minus 0.146 rs849134(A;G) 41.3% plus 0.3531 rs849135(A;G) plus rs3750103(C;T) 8.0% minus 0.1111 rs1049402(G;G) 63.1% plus 0.3343 rs2284219(A;G) 47.6% plus rs2267715(A;G) plus 0.4417 rs2284220(A;G) plus 0.225 rs7793837(A;T) plus 0.365 rs4988496(A;G) plus 0.1162 rs2267735(C;G) 1.0 Bad 46.9% plus 0.4651 One copy of risk allele = associated with mildly increased chance of PTSD, hyperarousal, impaired fear discrimination in traumatized females, but not males One copy of risk allele = associated with mildly increased chance of PTSD, hyperarousal, impaired fear discrimination in traumatized females, but not males '''Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor.''' (2011). [http://www.ncbi.nlm.nih.gov/pubmed/21350482] rs1558477(C;C) 26.2% plus 0.3545 rs2075820(A;G) 30.1% minus 0.2975 rs2075818(C;G) minus 0.3209 rs6963573(A;G) plus 0.07713 rs17329669(A;G) 35.4% plus 0.07668 rs741301(A;G) 51.3% minus 0.4151 rs11769038(G;T) 50.4% plus 0.3994 rs10488023(A;G) 35.4% plus 0.08173 rs1882080(A;G) plus 0.4114 rs13230047(C;T) 10.1% plus 0.01515 rs10488029(A;G) 20.4% plus 0.1446 rs1345365(A;A) 45.1% plus 0.3751 rs10951509(A;A) 52.3% plus 0.3632 rs2270221(T;T) 6.2% plus 0.2966 rs11975235(A;C) 45.0% plus 0.4564 rs215738(A;A) 99.1% plus rs10272438(A;G) 37.5% plus 0.146 rs10262453(A;C) 35.5% plus 0.2075 rs6972158(A;G) 44.6% plus 0.3039 rs2392362(C;T) plus 0.2365 rs6954895(C;C) 7.1% plus rs6973609(A;A) 12.4% plus rs8192496(C;T) minus rs2190242(A;C) plus rs2284218(C;T) 45.1% plus rs881858(A;A) 49.2% plus 0.3457 rs4711751(C;C) plus 0.3489 rs927485(A;G) plus rs556621(C;C) 49.6% minus 0.3182 rs632728(G;G) 51.3% minus rs3799977(G;T) plus 0.3246 rs10948197(C;T) plus 0.3384 rs9395066(A;C) 54.9% plus 0.4568 rs10948222(C;T) plus 0.4513 rs910586(C;C) 46.9% plus 0.219 rs2819861(C;C) 43.4% minus 0.2029 rs1934328(A;T) 44.2% plus 0.4619 rs6904353(C;T) 43.4% plus 0.3884 rs7748231(A;G) 43.4% plus 0.3811 rs1932040(C;C) 70.8% minus 0.4008 rs11755164(C;T) plus 0.3315 rs1342371(A;G) 28.3% minus rs10948172(A;G) 47.8% plus 0.2199 rs2270450(C;T) 30.1% plus 0.2599 rs1051931(A;G) 35.9% plus 0.2066 rs7756935(A;C) plus 0.2071 rs1362931(A;C) 38.9% plus 0.1713 rs1805017(A;G) 26.5% minus 0.2525 rs9473132(A;G) plus rs12209128(G;T) plus rs9369898(A;A) 40.7% plus 0.4761 rs9473555(C;C) 12.7% plus rs9473582(A;C) 46.0% plus 0.4651 rs2817419(A;G) plus 0.2443 rs2635727(C;T) plus 0.2319 rs9473924(G;T) 38.1% plus rs190759(A;G) 21.2% plus 0.1171 rs283566(C;C) 23.0% minus 0.388 rs2025751(G;G) 33.0% minus rs728996(A;A) 37.5% minus 0.3655 rs9296669(A;G) plus 0.3972 rs2744475(C;G) minus rs2206271(A;T) minus 0.3398 rs2180314(C;G) 53.2% plus 0.4449 rs2070774(A;G) minus 0.2075 rs3957357(A;G) 49.6% plus rs2816345(A;G) 37.2% minus 0.281 rs735860(C;T) plus 0.3439 rs1883633(A;G) 15.2% plus 0.1749 rs9296736(C;T) plus 0.4803 rs1058768(C;T) plus 0.2498 rs3122169(A;C) plus 0.2631 rs9370096(A;G) plus 0.41 rs4711998(G;G) 62.8% plus 0.461 rs8193036(T;T) 55.4% plus 0.3779 rs41271330(A;G) plus 0.1074 rs921126(A;G) 22.0% minus 0.1474 rs16887812(C;T) 38.5% plus 0.303 rs11758339(C;T) 39.8% plus 0.2034 rs4715630(C;T) 37.2% plus 0.1915 rs11756977(C;T) 42.5% plus 0.3104 rs13194995(A;T) plus 0.2672 rs9382658(A;G) plus 0.3701 rs9476082(A;T) plus rs4513829(A;G) plus rs682238(C;G) 7.4% plus 0.1253 rs789942(G;T) minus rs9449312(C;C) 27.4% plus 0.4747 rs1889497(T;T) 75.2% plus rs7743515(A;A) 68.1% plus 0.1607 rs2753977(A;A) 76.1% minus 0.1341 rs17254301(C;T) 31.9% plus 0.1194 rs4710520(C;T) plus 0.08632 rs10455590(A;A) 19.6% plus 0.287 rs11970254(G;T) 52.7% plus 0.2911 rs28631020(A;G) plus 0.07346 rs4710654(C;T) plus 0.3765 rs9351730(A;G) plus 0.4766 rs2585617(C;C) 73.5% minus 0.07346 rs314218(C;T) minus 0.1226 rs3793039(A;G) 42.9% plus 0.2617 rs10484939(A;G) minus 0.08356 rs6922893(G;G) 47.8% plus rs9351814(A;C) 54.1% plus rs4707930(G;G) 56.8% plus rs10455248(C;T) 40.0% plus 0.191 rs2249625(G;G) 15.9% plus rs1334346(A;C) plus rs7744813(A;A) 37.2% plus 0.2851 rs9447004(A;G) 51.3% plus rs6907989(A;T) 51.3% plus rs2460691(G;G) 10.6% minus 0.4692 rs1936166(T;T) 95.4% minus rs13212041(T;T) 61.9% plus 0.2911 rs11568817(C;C) minus 0.2805 rs623155(C;T) minus 0.4665 rs12204683(C;T) 42.5% minus 0.1754 rs1321847(G;G) 85.8% plus 0.1203 rs346291(C;T) 47.8% plus 0.3742 rs2322633(C;C) 11.6% plus 0.4421 rs10943724(A;C) plus 0.3039 rs310405(A;G) plus 0.3921 rs4235898(A;G) plus 0.2622 rs1419026(A;G) 55.4% minus 0.2415 rs17530068(C;T) plus 0.1983 rs1538138(C;T) plus 0.2332 rs1547251(C;T) 46.0% plus 0.4881 rs1171113(T;T) 47.6% plus 0.2213 rs16876385(C;G) 3.1% plus rs806606(C;C) Good 61.0% plus 0.1579 http://www.diygenomics.org/webapp/gen_data.php rs1577917(C;T) 42.5% plus 0.2153 rs1853639(A;G) plus 0.3733 rs2509458(A;G) minus 0.07025 rs366676(C;C) 16.8% minus 0.4587 rs806365(C;T) plus 0.3972 rs7766029(C;T) plus 0.3806 rs12720071(A;G) minus 0.0831 rs2180619(A;A) 33.6% plus 0.4417 rs2610739(A;A) 63.4% plus 0.1185 rs12527253(G;G) 9.7% plus 0.169 rs12201676(C;T) plus 0.1579 rs6939321(C;C) 100.0% plus rs3748085(C;C) 73.5% minus 0.1612 rs9344950(A;G) plus 0.1841 rs404256(C;C) 38.9% plus 0.4298 rs12529935(C;T) 11.7% plus 0.0854 rs806276(G;G) 13.8% plus 0.4206 rs4424056(G;T) plus rs2811670(C;T) plus rs7775554(A;C) 53.1% plus rs6918777(G;T) 51.8% plus 0.4541 rs594442(A;T) 24.8% plus 0.1281 rs9363058(T;T) 7.1% plus rs2246786(G;G) 50.4% plus 0.1983 rs2380220(C;C) 72.3% plus rs12333032(C;C) 22.1% plus 0.3223 rs3811070(A;A) 21.5% minus 0.478 rs13208321(G;G) 63.1% plus rs2505059(C;T) 54.0% minus 0.4669 rs9351265(C;T) plus 0.4417 rs6909430(A;G) plus 0.1717 rs2086512(A;G) 15.0% plus 0.1538 rs1383808(A;A) 100.0% minus rs528808(C;C) minus rs4840086(A;G) 50.8% plus 0.3292 rs4840097(T;T) 38.1% plus 0.286 rs7746743(T;T) 23.0% plus 0.4279 rs3734353(A;C) minus 0.3517 rs2797369(C;T) plus 0.2686 rs2518344(G;G) 20.5% plus 0.3072 rs2213553(G;T) plus 0.2732 rs1556995(A;A) 58.5% minus 0.2511 rs1417182(T;T) 35.4% minus 0.3228 rs9499708(C;T) 50.4% plus 0.258 rs156244(T;T) 100.0% minus 0.04362 rs11156429(G;G) 14.1% plus 0.4904 rs4946651(G;G) 18.9% plus 0.4899 rs7759938(T;T) 34.5% plus 0.3893 normal normal rs314263(T;T) 34.5% plus 0.3255 rs314280(C;C) 20.4% minus 0.4899 rs314279(A;A) 79.6% plus 0.07346 rs314277(C;C) 75.0% plus 0.197 rs994988(A;A) 35.4% minus 0.4614 rs1190271(C;C) plus 0.3085 rs9386463(A;G) 46.0% plus 0.3549 rs6568401(T;T) 53.1% plus 0.3145 rs1355023(A;G) minus 0.3595 rs7750345(A;G) 40.6% plus 0.2929 rs9386485(T;T) 19.5% plus 0.4968 rs6568421(A;G) 46.0% plus 0.1713 rs7746082(C;G) plus 0.1345 rs6911490(C;T) plus 0.101 rs548234(T;T) 42.9% plus 0.23 rs314276(C;C) 35.4% plus 0.3641 rs314268(T;T) 34.8% minus 0.3696 rs364663(T;T) 21.5% minus 0.4844 rs369065(T;T) 34.5% plus 0.3916 rs1190286(T;T) 71.7% plus 0.3104 rs2245214(C;G) 54.7% plus rs510432(A;G) minus 0.4151 rs6568433(C;C) 15.0% plus 0.4972 rs2430457(T;T) 98.5% minus 0.05142 rs17041(C;T) 55.8% minus rs1536057(A;G) 39.8% minus 0.2773 rs479744(A;C) 35.4% minus 0.2865 rs6937876(A;A) 32.7% plus 0.2865 rs6568431(C;C) 31.0% plus 0.3751 rs2798641(C;T) 23.0% plus 0.1947 rs13210693(A;A) 19.5% plus 0.4054 rs9386791(C;T) 50.9% plus 0.483 rs9374080(C;T) plus 0.3049 rs1008084(C;T) minus 0.3099 rs11966072(A;G) 45.1% plus 0.2052 rs9487094(A;G) plus 0.4725 rs1046943(C;T) 54.9% minus 0.4545 rs1741930(T;T) 15.4% minus rs4947019(C;G) 16.9% plus 0.1391 rs6910580(C;T) plus rs465646(A;A) 78.5% plus 0.2034 rs240993(C;T) plus 0.4821 rs462779(T;T) 63.7% minus 0.4082 rs458017(C;T) plus 0.0404 rs11153292(A;G) plus 0.3788 rs7760535(C;C) 33.6% plus 0.4187 rs6900341(G;T) plus 0.3163 rs3851228(A;T) 8.0% plus 0.07346 rs13196377(A;G) plus 0.04729 rs13190932(A;G) plus 0.03765 rs714368(G;G) 2.7% minus 0.3058 rs2796749(G;G) 75.4% plus 0.3113 rs9400467(C;T) 41.6% plus rs14399(A;C) plus 0.3788 rs6901004(C;G) 56.2% plus rs6916861(A;C) 30.1% plus 0.219 rs3730353(C;T) 31.0% minus 0.2199 rs1465061(A;G) plus 0.3678 rs6914091(C;T) 54.1% plus 0.4734 rs12910(A;C) 48.7% minus rs7768046(A;A) 35.4% plus rs6934970(C;T) 22.1% plus rs13210247(A;G) 14.2% plus 0.09642 rs9488822(A;T) 38.5% plus 0.3127 rs720446(A;G) plus 0.1612 rs339331(C;T) plus 0.3182 rs9489065(C;T) plus 0.3283 rs961764(C;C) 38.5% minus 0.3792 rs2273601(C;T) minus 0.2971 rs9387478(A;C) plus 0.4238 rs2057314(C;C) 31.2% minus 0.4275 rs210648(G;G) minus 0.3691 rs9285425(A;A) 27.0% plus 0.3696 rs1413846(C;C) 46.9% minus 0.4334 rs3812111(A;T) plus 0.4215 rs11965969(G;G) 20.0% plus 0.4761 rs1204798(G;G) 2.7% plus 0.4316 rs2858829(A;G) 52.7% plus rs784133(C;T) plus 0.3421 rs654128(G;T) minus 0.09871 rs7765175(C;T) 46.9% plus 0.2736 rs2030926(C;T) plus 0.4885 rs10782174(A;G) plus rs2185710(C;C) 40.0% minus 0.4766 rs2473967(A;C) 12.5% minus 0.1162 rs2475631(C;T) plus 0.3044 rs2499618(C;T) 39.6% plus 0.3044 rs9488343(A;A) 19.5% plus rs9488363(A;G) 51.3% plus 0.4697 rs12508721(C;T) 49.2% plus 0.2732 rs17005931(C;T) 49.6% plus rs1398553(C;C) 39.8% minus 0.1979 rs308447(T;T) 15.2% plus 0.3976 rs308393(A;C) 18.5% plus 0.2713 rs308395(C;G) 25.7% plus 0.281 rs308379(T;T) 13.8% minus 0.3255 rs41348645(A;A) plus 0.4747 rs6854081(G;T) plus 0.09137 rs7683093(C;G) 23.9% plus 0.07208 rs11737764(C;T) plus 0.2029 rs6820411(A;C) plus 0.06474 rs2125000(C;T) 40.7% plus 0.23 rs6534441(T;T) 46.0% plus 0.3664 rs1039808(A;G) 52.3% minus 0.4141 rs1395241(A;G) 54.9% plus 0.3802 rs167428(C;C) 8.8% plus 0.3751 rs724950(C;T) plus rs2090104(C;T) 37.5% minus 0.4637 rs2305957(A;G) 36.3% plus rs1974942(C;C) 78.5% minus 0.2897 rs4864201(C;T) plus 0.4045 rs11933661(C;T) 58.4% plus rs1024020(G;G) 62.2% minus 0.3269 rs1478091(T;T) 83.2% plus 0.1671 rs1494978(C;T) minus rs1567047(C;T) minus 0.2585 rs12639834(C;T) 36.3% plus 0.3021 rs950063(C;T) 36.3% plus 0.2649 rs1320267(C;G) plus 0.4183 rs75900745(A;G) plus rs10519410(C;T) 28.3% minus 0.1951 rs4416533(C;T) minus 0.4477 rs1450439(A;G) 32.7% plus rs938836(A;G) plus rs9684900(G;G) 54.5% plus 0.3379 rs1531070(A;G) plus 0.2507 rs987360(C;T) 48.7% plus 0.4614 rs1425967(C;T) 51.8% minus 0.4564 rs17007017(A;G) 43.4% plus 0.41 rs3806798(A;T) plus rs1519551(A;A) 29.2% plus rs6819823(G;T) plus rs10833(G;G) 42.5% minus 0.2057 rs2667100(G;G) 85.8% plus rs3805246(C;T) minus 0.2833 rs3805236(C;T) 46.9% minus 0.3893 rs6857360(C;T) 50.0% plus rs1550057(C;T) 40.2% minus 0.3347 rs1112714(C;T) minus 0.3017 rs11938298(G;G) 74.3% plus 0.4197 rs12504628(C;T) plus 0.3062 rs13147758(A;G) 45.1% plus 0.2952 rs1828591(A;G) 44.6% plus 0.388 rs1980057(C;T) 44.2% plus 0.2943 rs13118928(A;G) 44.2% plus 0.3039 rs6537296(A;G) 41.4% plus 0.3375 rs1542725(A;G) minus 0.2943 rs13141641(C;T) plus 0.2994 rs2353397(T;T) 29.6% plus 0.3007 rs2353398(A;A) 20.0% plus 0.314 rs7690204(A;T) 54.9% plus rs6854783(A;A) 29.5% plus 0.4376 rs1492820(T;T) 23.9% minus 0.4954 rs2048161(A;G) minus 0.03719 rs723794(G;T) 38.1% plus 0.416 rs1395821(A;G) 31.0% minus 0.3113 rs1429138(C;T) plus 0.09871 rs1429107(A;G) 8.0% plus rs1878406(C;T) 25.7% plus 0.1823 rs6842241(A;C) plus 0.2475 rs7689420(C;C) 68.8% plus 0.2571 rs1812175(C;C) 68.8% minus 0.2585 rs506500(C;T) plus 0.2135 rs3733890(A;G) plus 0.3012 rs585800(A;T) plus 0.1478 rs2290639(A;T) 50.8% minus 0.4054 rs26279(A;G) plus 0.3118 rs401758(A;G) minus 0.2406 rs4703822(A;A) 11.5% plus 0.2635 rs10514211(A;G) 19.8% plus 0.07759 rs7729671(A;A) 24.8% plus rs4703516(G;G) 77.9% plus 0.1956 rs410644(T;T) 33.9% plus 0.3393 rs10514231(T;T) 43.4% plus 0.3393 rs7707921(A;A) plus rs1864183(A;G) 44.6% minus rs1643659(A;G) minus 0.2016 rs1677693(A;C) 34.5% minus 0.2016 rs1643649(C;T) plus 0.2029 rs10514279(C;T) 23.0% plus rs1493354(G;G) 27.4% plus rs2471042(G;G) 43.4% plus rs2544677(G;G) Bad 54.0% minus 0.1171 1.7x risk of type-1 diabetes 1.7x risk of type-1 diabetes rs35148638(A;C) 30.1% plus rs2230641(C;T) 26.6% minus 0.1382 rs3093816(C;C) 17.7% minus rs1673101(A;G) plus 0.2966 rs16903275(A;C) plus rs6893807(A;G) 31.9% plus rs1864182(G;T) minus 0.4151 rs7727691(C;T) 40.0% plus 0.2112 rs2075685(G;T) 51.3% plus 0.3852 rs17284420(C;G) plus 0.0528 rs310501(A;G) plus 0.287 rs179851(A;G) minus 0.3829 rs4466137(G;G) 61.9% plus 0.2121 rs4552569(C;T) 37.2% plus 0.2672 rs347344(G;G) 24.8% minus 0.3912 rs4920799(C;C) 72.6% plus 0.2429 rs6817170(C;T) plus 0.3315 rs1466662(A;T) 53.8% minus 0.3604 rs7673587(C;T) 47.7% plus 0.1887 rs1044291(C;T) 46.9% plus 0.1993 rs2070022(C;T) minus 0.1612 rs2070006(A;G) minus 0.4454 rs13109457(A;G) plus 0.3003 rs7659024(A;G) plus 0.3177 rs1118823(T;T) 50.4% plus 0.3765 rs2066865(C;T) minus 0.3186 rs1049636(T;T) 50.4% minus 0.2736 rs7672337(A;G) 45.1% plus 0.3219 rs902464(C;C) 99.1% plus 0.09137 rs2066861(A;G) 33.6% minus 0.3173 rs1800792(A;G) minus 0.3062 rs7681423(C;T) 38.5% plus 0.3177 rs6536024(C;C) 33.6% plus 0.4922 rs2880415(C;T) minus 0.3402 rs1842896(T;T) 22.1% plus 0.449 rs7692387(A;G) plus rs13139571(A;A) 9.2% plus 0.2084 rs13122250(C;T) 47.8% plus rs4234898(C;C) 75.0% plus 0.1331 rs1425486(C;T) 45.0% plus 0.4486 rs4691380(C;T) 46.0% plus 0.4307 rs28999109(C;T) minus 0.03903 rs1902491(G;T) minus 0.4752 rs12649641(A;C) plus 0.4982 rs4403097(C;T) plus 0.4968 rs9784453(A;G) plus 0.3246 rs11559290(T;T) 73.5% plus 0.2773 rs4690909(C;C) 50.4% plus rs6856902(G;G) 50.8% plus 0.3453 rs7675998(A;G) 24.6% plus rs11100479(C;T) 37.2% plus 0.2006 rs4057797(A;T) minus 0.4706 rs4302506(C;C) 42.0% plus 0.3306 rs3733418(C;T) 22.1% minus rs4691139(G;G) 23.9% plus 0.4077 rs1503298(C;T) plus rs1963569(C;C) minus 0.4637 rs2710833(C;C) 64.0% plus 0.1529 rs12510359(A;G) plus 0.4128 rs7439293(A;G) plus 0.3329 increased risk of coronary heart disease; better response to statins increased risk of coronary heart disease; better response to statins rs11723530(A;G) plus 0.3039 rs4552421(A;G) 19.6% plus 0.1208 rs6837793(A;G) Bad 18.6% plus 0.1148 more likely to gain weight if taking risperidone more likely to gain weight if taking risperidone rs4533720(G;G) 16.8% plus rs967616(C;T) minus rs4521323(A;C) 53.1% plus 0.4275 rs12507634(A;G) 51.6% plus 0.2879 rs6844282(G;G) 29.0% plus 0.4954 rs1365611(T;T) 15.6% plus 0.275 rs2332897(A;A) 14.2% plus 0.2874 rs8752(A;A) 32.7% minus rs2555639(A;G) minus 0.3765 rs6858430(C;T) plus 0.3338 rs12640626(A;A) 35.4% plus 0.4683 rs9284954(A;A) 35.4% plus 0.4949 rs4695888(C;T) 49.6% plus rs3775194(C;C) 36.5% minus 0.4509 rs4557213(A;A) 85.0% plus 0.1455 rs1395479(A;C) plus 0.1882 rs2702449(A;G) plus rs6811556(C;T) plus rs2716816(T;T) 73.8% plus 0.1602 rs17746001(C;T) 14.2% plus 0.05739 rs2383393(C;C) 35.7% minus 0.2934 rs1485766(A;C) minus 0.3806 rs6844851(T;T) 16.2% plus 0.477 rs11495908(G;G) 4.4% plus rs1994816(A;G) plus 0.2782 rs12641856(A;G) plus 0.05739 rs10520514(T;T) 10.6% minus rs2726807(C;T) plus 0.4826 rs11724903(A;G) 25.9% plus rs4862046(G;G) 73.8% plus 0.1869 rs10013166(A;G) plus rs4862110(C;T) plus 0.2075 rs955748(C;C) 52.2% minus 0.3627 rs4862307(A;T) 41.5% plus rs17834666(A;G) plus 0.1561 rs17183114(G;T) 24.8% plus 0.1065 rs7672826(A;G) plus 0.3577 rs1439283(T;T) 19.5% plus rs6815916(A;G) 13.4% plus 0.09091 rs1049253(A;G) minus 0.08861 rs6948(A;C) 42.9% minus 0.4412 rs2705897(G;G) 58.4% plus 0.4036 rs4647603(A;G) 22.1% minus 0.07254 rs72689236(C;T) rs12108497(C;T) 30.1% plus rs2130392(A;G) plus 0.4752 rs6552828(A;G) 44.2% plus 0.4431 rs12503643(G;T) 47.8% plus 0.4991 rs793814(A;T) minus 0.2176 rs3775572(A;A) 94.7% plus 0.2218 rs1879026(A;C) minus 0.1639 rs3775292(C;C) 64.6% minus 0.1529 rs10025405(A;G) 46.9% plus 0.4123 rs1519309(A;A) 48.7% minus 0.4155 rs13146272(A;A) 35.8% plus 0.4555 rs34745240(A;G) plus 0.02984 rs4253238(T;T) 29.2% plus 0.3701 rs1912826(A;A) 28.6% plus 0.4013 rs4241816(T;T) plus 0.4008 rs4376189(A;G) plus 0.07713 rs10021308(A;A) 19.5% plus 0.4743 rs11721827(A;C) 28.3% plus 0.1446 rs4253311(G;G) 30.8% plus rs3756008(A;T) 47.8% plus 0.3315 rs925451(A;G) plus rs4253399(G;T) plus 0.2833 rs2036914(C;C) 31.0% plus 0.3678 rs1593(T;T) 79.4% minus 0.1047 rs2289252(C;T) 46.4% plus 0.3343 rs6553010(A;G) plus 0.3306 rs13140012(A;A) 9.8% plus 0.4642 rs925642(A;A) 36.6% minus 0.4826 rs4253252(G;G) 28.3% plus 0.4031 rs3733402(A;A) plus 0.3719 rs1979255(C;C) 40.7% minus rs4957014(G;G) 60.3% plus 0.3756 rs3756712(G;G) 40.7% minus 0.4096 rs12188164(A;A) 18.8% plus 0.1878 rs10078(A;A) 68.1% minus rs4957061(T;T) 20.0% plus 0.4008 rs4478239(A;C) plus 0.09137 rs1431005(C;T) minus 0.3792 rs71607999(A;G) plus rs386057(A;G) plus rs4975596(A;G) 33.9% minus rs7736074(C;G) plus rs7728646(C;T) plus 0.259 rs4975623(C;G) minus 0.1607 rs7447815(C;G) 46.2% plus 0.3398 rs13172201(C;T) plus rs4975605(A;C) plus 0.3297 rs10069690(C;T) 47.8% plus 0.3182 rs1709544(C;T) 52.4% plus 0.2943 rs2736098(A;A) Bad 10.8% minus 0.2126 slightly increased risk for several types of cancers slightly increased risk for several types of cancers rs2853669(G;G) minus 0.2351 rs2736109(A;A) minus 0.2792 rs2736108(A;A) 9.7% minus 0.2153 rs402710(T;T) 11.1% plus 0.3618 rs401681(T;T) 19.5% plus 0.4435 normal normal rs414965(T;T) 17.9% minus 0.3499 rs31490(A;A) 18.6% plus 0.3737 rs3863145(A;A) minus 0.1924 rs2853677(A;G) minus 0.3512 rs10052016(A;G) 33.0% plus 0.1892 rs463379(C;G) minus 0.3953 rs460000(A;C) 38.1% minus 0.3985 rs2937639(A;G) minus 0.3994 rs2963238(A;C) minus 0.399 rs2652511(C;T) minus 0.4013 rs2617596(C;G) minus 0.3636 rs2652510(A;G) minus 0.3554 rs2550948(A;G) 49.6% minus 0.3567 rs37022(A;T) 32.3% minus 0.3448 rs7737692(A;G) plus 0.3962 rs6873793(T;T) 29.2% plus 0.494 rs61670327(A;G) plus rs492478(A;G) plus 0.1983 rs490556(T;T) 17.5% minus 0.3889 rs521660(G;G) 21.9% minus 0.3623 rs4702522(G;G) 91.2% plus rs10043296(C;C) 93.8% plus rs6555254(G;G) 93.8% plus rs10079205(G;G) 93.8% plus rs6879627(C;C) 70.3% plus 0.2071 rs2173226(G;G) 15.9% minus rs6555259(G;G) 92.9% plus rs6555260(C;C) 93.8% plus rs6555261(C;C) 92.9% plus rs6555262(C;C) 92.9% plus rs6882308(G;G) 92.9% plus rs10036180(T;T) 93.8% plus rs10036225(G;G) 93.8% plus rs7712941(T;T) 92.9% plus rs11134044(A;G) 29.2% plus rs10462794(T;T) 61.6% plus 0.2319 rs2964433(C;T) minus 0.1189 rs16875288(A;T) 32.7% plus rs7723605(C;T) plus 0.2695 rs2964475(A;C) minus 0.4619 rs3852160(A;G) 54.9% minus rs7728043(C;T) plus 0.4591 rs6876835(A;G) 50.4% plus 0.4968 rs6894281(G;G) 92.9% plus rs6555263(T;T) 92.9% plus rs6555264(C;C) 92.9% plus rs6884552(C;T) 49.6% plus 0.2961 rs3797177(A;G) minus 0.2231 rs12520016(G;T) plus 0.04408 rs275456(A;C) 41.1% minus 0.2199 rs275437(C;C) 41.5% plus rs4702435(T;T) 84.6% plus 0.146 rs13172324(C;G) plus 0.03673 rs10038196(G;T) plus 0.4252 rs4702473(C;T) plus 0.4734 rs1946468(C;C) 46.0% minus 0.4187 rs248793(C;G) plus rs472402(C;G) plus 0.4986 rs501999(A;G) minus 0.4991 rs166050(A;G) plus 0.1368 rs3822430(C;T) 49.6% minus rs162036(A;G) 28.3% plus 0.2309 rs162049(A;A) plus 0.2824 rs3776455(A;G) 40.7% minus 0.4871 rs10380(C;T) 27.7% plus 0.1901 rs9332(C;T) minus 0.2231 rs10520873(A;G) minus 0.1997 rs10475407(C;T) 35.7% plus 0.3375 rs340669(C;T) minus 0.3278 rs12187557(C;T) plus 0.314 rs6555545(A;G) plus 0.2902 rs2914295(C;T) 39.8% plus 0.3866 rs2966952(C;C) 70.8% plus 0.1878 rs326118(G;T) plus 0.2314 rs3776467(C;T) minus 0.4541 rs161870(C;T) plus rs11134338(A;G) plus rs433755(G;T) 39.8% minus rs7725217(A;C) 42.5% plus 0.2231 rs553169(C;T) plus 0.3081 rs2009501(A;G) minus 0.3411 rs60701(T;T) 56.6% plus 0.3815 rs267939(A;A) 37.5% minus 0.376 rs6555546(A;C) plus 0.2658 rs2388449(C;T) 42.5% minus 0.3131 rs7702187(A;A) 63.9% plus 0.32 rs6882716(A;A) 85.0% plus rs6884431(G;G) 17.7% plus 0.4495 rs6885224(C;T) 55.0% plus 0.3471 rs2530215(C;C) 22.1% plus 0.4105 rs1479617(T;T) minus 0.4063 rs1530498(C;T) minus 0.4555 rs163818(C;T) plus rs875525(C;T) 44.2% plus 0.3361 rs835154(C;T) minus rs1447276(A;G) plus 0.2489 rs1978633(G;G) 23.9% plus 0.4862 rs10044254(A;G) 30.1% plus rs1039443(C;T) plus 0.1676 rs10066447(C;T) 36.6% plus 0.2741 rs3734110(A;G) minus 0.4913 rs30168(A;A) 22.1% plus 0.4421 rs6554809(C;T) 28.3% plus 0.2397 rs2896103(C;T) minus 0.2759 rs7715811(C;T) 38.9% plus 0.2778 rs2918419(A;G) minus 0.135 rs17778257(A;T) 47.8% plus 0.3466 rs2400707(A;G) 47.3% plus 0.3659 rs2053044(A;G) 46.0% plus 0.3669 rs1042711(C;T) plus 0.2429 rs1801704(C;T) 46.0% plus 0.2429 rs1042714(C;G) plus 0.2383 complex; see details for increased risks complex; see details for increased risks rs7720260(C;C) 35.4% plus 0.4624 rs741581(C;T) minus 0.05142 rs9325032(T;T) 57.1% plus 0.4008 rs1432982(A;G) plus rs2303064(A;G) plus 0.3021 rs2304069(T;T) 61.1% plus 0.2346 rs216146(C;C) 38.1% plus 0.4596 rs6865659(A;G) 46.8% plus 0.3214 rs3828610(A;C) 42.5% plus 0.4807 rs3776082(A;G) plus 0.494 rs3776083(A;G) plus 0.3421 rs2053053(A;G) minus 0.2691 rs15251(C;T) 32.7% plus 0.2144 rs1368304(G;G) minus 0.05785 rs10043775(C;T) plus 0.2557 rs11168048(C;C) 12.5% plus 0.4591 rs3995090(C;C) 13.3% plus 0.4679 rs7733088(A;A) 12.4% plus 0.449 rs9325104(A;G) 50.4% plus 0.4826 rs2963155(A;G) 26.5% plus 0.2117 rs2963156(C;T) plus 0.1602 rs1866388(A;G) 43.4% plus 0.2392 rs17100498(C;T) plus 0.09596 rs1981626(G;G) 84.1% minus rs7713855(C;T) plus 0.1226 rs681591(C;T) 45.1% plus 0.4302 rs1054020(C;T) plus 0.3457 rs7718446(A;G) 48.2% plus 0.4353 rs2548003(C;G) minus 0.3829 rs10054504(C;T) plus 0.4155 rs1532269(C;G) 44.2% minus 0.433 rs7729447(A;G) plus rs1421811(C;G) 42.9% minus rs6889608(C;T) 35.4% plus 0.3861 rs700926(G;T) 39.8% minus 0.3278 rs1173766(C;T) plus 0.4054 rs1173771(A;G) minus 0.3453 rs9292468(C;T) plus 0.3751 rs6877842(C;G) plus 0.1391 rs7719829(G;G) 38.4% plus rs10472828(C;T) 44.2% plus 0.4178 rs256603(A;A) minus 0.4573 rs256792(T;T) 11.5% plus 0.4518 rs6868223(A;G) plus 0.4591 rs1364044(T;T) 8.0% plus 0.377 rs35414(C;C) 47.8% plus 0.36 rs1173727(A;G) minus 0.3462 rs16899974(A;C) plus 0.2383 rs7717823(T;T) 14.2% plus rs180749(A;A) plus rs37370(T;T) 82.3% plus rs28305(C;C) 80.5% minus rs40200(G;G) 82.3% plus rs10941235(C;T) 57.7% plus 0.292 rs3822735(C;C) 43.4% minus 0.2626 rs931555(A;G) 37.2% minus 0.2149 rs6890853(A;G) plus 0.2392 rs6867641(C;C) plus rs13289(C;C) 49.2% minus 0.4582 rs2278008(T;T) 66.1% plus 0.2332 rs10941112(A;G) 53.1% minus 0.3517 rs3195676(A;G) 50.8% minus 0.3811 rs409045(C;T) 46.0% plus 0.2833 rs37439(A;A) 69.0% plus 0.3444 rs10213865(A;C) 36.5% plus 0.2383 rs987106(A;T) 52.2% minus 0.4601 rs6871748(C;T) plus 0.1938 rs2303137(A;A) 19.5% minus 0.4812 rs1445898(A;A) 19.5% minus 0.4844 rs10491431(G;T) minus rs270545(A;A) 9.2% plus 0.2879 rs2071237(C;G) 53.8% minus 0.3168 rs6862038(A;G) 58.4% plus 0.4917 rs2043112(T;T) 20.5% minus 0.3916 rs13160161(A;A) 17.9% plus 0.3866 rs358501(A;G) 30.4% minus 0.2401 rs2161612(C;T) 50.4% minus 0.2681 rs379707(G;T) minus 0.4798 rs860413(A;C) minus 0.214 rs6863066(C;T) plus 0.3632 rs11959928(A;A) 18.5% plus 0.3425 rs2548145(A;G) plus 0.3719 rs348601(A;G) minus 0.477 rs348594(A;G) 50.4% plus 0.4917 rs10512734(A;G) 42.5% plus 0.4017 rs1992662(C;T) 46.2% minus 0.4013 ? ? rs11742570(C;T) plus 0.4619 rs6451493(G;T) 49.6% plus 0.4619 rs1992660(A;G) 52.3% minus 0.4619 ? ? rs6896969(A;C) 50.0% plus 0.4601 rs1373692(G;T) 49.6% minus 0.4761 rs9292777(C;T) 50.5% plus 0.4738 rs4495224(A;C) plus 0.4844 rs7720838(G;T) 45.1% plus 0.4206 rs10440635(A;G) plus 0.4628 rs979233(G;T) 45.1% minus 0.4288 rs2940944(G;T) 48.7% minus 0.4141 rs6898743(G;G) 51.6% plus 0.3131 rs6180(A;C) 54.9% plus 0.4426 rs230813(C;G) plus 0.4591 rs7579(A;G) 38.1% minus 0.2709 rs230819(A;C) plus 0.4945 rs11951515(C;T) plus rs13170645(A;A) 39.7% plus 0.4844 rs10074991(A;G) plus rs13361707(C;T) 35.4% plus 0.3669 rs154268(C;T) 46.0% plus rs1063499(G;G) 31.9% minus 0.4894 rs4957374(C;C) 72.3% plus 0.1552 rs7443270(C;T) 46.9% plus 0.3379 rs1448037(G;G) 46.8% minus 0.3618 rs2121875(T;T) 38.9% minus 0.4826 rs339501(T;T) 100.0% plus 0.08861 rs11750845(T;T) 25.7% plus 0.3788 rs7716600(C;C) 63.1% plus 0.2713 rs7705343(A;A) 38.9% plus 0.4761 rs10941694(A;G) plus 0.1364 rs981782(G;T) 44.6% minus 0.3278 rs6449586(T;T) 30.4% plus rs1011814(C;C) minus 0.4853 rs4865673(A;A) 11.5% plus 0.2392 rs10042348(G;G) 67.9% plus 0.3967 rs6889746(A;G) 43.4% plus 0.2833 rs830884(T;T) 94.7% plus 0.1157 rs6867040(C;T) 46.4% plus 0.2323 rs2432143(C;C) 0.9% plus 0.1134 rs2447867(C;T) plus 0.2489 rs26680(C;C) 77.0% plus rs1126643(C;T) 47.8% plus 0.3632 rs27323(A;A) 38.9% plus 0.455 rs1017(T;T) plus 0.3669 rs702634(A;G) plus rs273218(G;G) 59.3% minus 0.2833 rs35951(G;T) 0.0% plus rs2548621(T;T) 98.2% minus 0.1212 rs2112938(A;C) 36.3% minus 0.309 rs415407(G;T) 49.1% minus 0.4692 rs6859219(A;A) 0.9% plus 0.1556 rs10065637(T;T) 2.7% plus 0.1152 rs7731626(A;A) plus rs38055(C;C) 50.9% minus rs1020388(C;C) 16.1% minus 0.2479 rs30360(A;C) 42.7% minus rs16886113(G;T) plus rs4700485(G;G) 44.6% plus 0.3673 rs10461617(G;G) 65.2% plus 0.3315 rs702689(A;A) 46.4% plus 0.4986 rs96844(T;T) 54.0% minus 0.4798 rs10052004(A;G) plus 0.2456 rs10041935(A;C) 31.9% plus rs459193(C;T) 37.5% minus rs456867(C;T) 28.3% plus 0.2254 rs2964186(T;T) plus rs181736(A;G) plus 0.3889 rs2607347(A;G) minus 0.3246 rs702543(A;G) 42.5% minus 0.4669 rs295978(C;C) plus rs1588265(A;G) 50.4% plus 0.3774 rs1544791(C;T) minus 0.4325 rs966221(C;T) Bad 57.1% minus 0.4922 1.5x increased stroke risk 1.5x increased stroke risk rs26949(C;T) minus 0.3861 rs171748(C;T) minus rs1844437(C;G) 32.8% plus 0.1685 rs6859725(T;T) 33.6% plus rs7709645(C;G) plus 0.4963 rs11738335(G;T) plus 0.2002 rs1402915(G;G) 21.2% plus rs255414(A;A) 71.9% plus 0.1823 rs10042968(A;G) plus 0.1492 rs7714850(A;C) plus 0.2534 rs1364043(G;T) plus 0.3154 rs878567(C;C) 25.7% minus 0.3834 rs6449693(A;A) 25.7% plus 0.3806 rs6295(C;C) minus 0.4789 rs10042486(T;T) 26.1% plus 0.3861 rs4699982(A;T) 32.3% plus 0.2172 rs40110(A;G) plus 0.4761 rs266590(G;G) minus 0.4835 rs10067755(A;G) 46.9% plus 0.4463 rs1823023(A;G) 45.1% plus 0.4068 rs2239670(G;G) 80.4% plus 0.1713 rs2199161(C;C) 51.3% plus 0.287 rs7445013(A;G) 56.2% plus 0.4151 rs10515148(C;G) 30.8% plus 0.1864 rs17632159(C;G) plus 0.2727 rs17663555(C;G) 41.6% plus 0.2695 rs283610(C;T) 33.3% minus rs17206779(T;T) 31.9% plus 0.3976 rs10069397(C;T) plus 0.2957 rs39861(C;C) 4.4% minus 0.2755 rs4704187(C;C) plus 0.331 rs7703051(A;A) 16.8% plus 0.4201 rs3931914(G;G) 4.6% minus 0.253 rs10045497(A;A) 19.0% plus rs17238484(T;T) plus rs12654264(T;T) 16.8% plus 0.4164 rs3846662(C;C) 19.5% minus 0.4155 rs3846663(T;T) 16.8% plus 0.3976 rs12916(C;C) 16.8% plus 0.4096 rs4629571(A;G) plus 0.09826 rs11952583(C;C) 87.5% plus rs888789(G;G) 14.2% plus rs2307111(G;G) 11.6% minus 0.4376 rs73117804(C;T) plus rs457717(A;G) 46.2% plus 0.3935 rs2227744(A;G) plus rs253061(A;A) 61.1% plus 0.2654 rs37243(A;G) plus 0.4747 rs253072(A;G) 48.3% plus 0.4105 rs153311(C;C) 56.6% plus 0.2075 rs253088(C;T) plus 0.3641 rs2460504(C;G) minus 0.2461 rs2112347(G;G) 15.6% plus 0.4509 rs6453204(G;G) 90.8% plus rs4704296(C;G) plus 0.2971 rs4704560(C;T) 51.3% plus 0.3526 rs10942891(C;G) 29.2% plus 0.2319 rs7713917(A;G) 48.7% plus 0.4242 rs259067(A;G) 35.4% minus rs7735699(A;C) 38.9% plus 0.2103 rs4704591(C;G) plus rs17878919(A;G) plus rs1866389(C;G) minus 0.1359 rs7387(A;T) plus 0.2025 rs1875999(G;G) 13.4% minus rs4457053(A;A) 55.0% plus 0.214 rs7714529(A;G) plus 0.3205 rs251421(C;T) 38.1% minus 0.1584 rs6453373(A;T) 11.5% plus 0.1864 rs1065757(A;G) 47.8% minus 0.3398 rs337847(A;A) 77.9% plus 0.1405 rs2431332(G;G) 8.8% plus rs532964(C;T) 53.6% minus 0.3921 rs2842895(C;G) plus 0.2828 rs11755724(A;G) 45.1% plus 0.3558 rs2714337(A;T) 58.2% plus 0.331 rs9502570(C;T) 41.6% plus rs438259(A;G) plus 0.2888 rs6918936(C;C) 15.6% plus 0.354 rs4713103(T;T) 15.4% plus 0.3512 rs17606561(A;G) plus 0.185 rs3734398(C;C) 18.6% plus 0.455 rs3798713(C;C) 16.9% plus 0.4936 rs953413(A;A) 18.6% plus 0.3457 rs3798722(A;G) 46.9% plus 0.3719 rs9393903(A;G) plus 0.1933 rs9393915(C;T) 40.0% plus rs3812162(A;C) minus 0.3264 rs4711171(T;T) 16.8% plus 0.3173 rs1321535(G;G) 15.9% plus 0.4816 rs4713169(C;C) 15.4% plus rs1476046(A;G) plus 0.2126 rs5369(G;G) 77.0% plus 0.09871 rs2071942(A;G) plus 0.208 rs6912834(A;G) 13.3% plus 0.09091 rs2026458(C;T) 52.2% plus rs1332844(T;T) 38.9% plus 0.3076 rs9369640(A;A) 38.9% plus rs9349379(A;G) 46.0% plus 0.4073 rs760678(C;G) 38.5% minus 0.2984 rs479526(C;T) plus 0.4821 rs2294426(C;T) 55.8% minus rs6903956(A;G) 44.2% plus 0.2815 rs3950186(A;A) 7.1% minus rs1570989(C;C) 63.7% minus 0.1919 rs1800997(-;A) plus rs4716055(T;T) 80.5% plus 0.05601 rs855394(C;T) 40.5% plus 0.3526 rs13195786(A;G) 34.5% plus 0.1148 rs1556547(A;G) plus 0.4977 rs3798696(A;G) 15.0% minus rs9295535(C;T) plus rs9379896(T;T) 65.5% plus 0.2227 rs12521522(A;T) plus 0.03122 rs11951031(C;T) 9.7% plus 0.03168 rs700585(A;A) 49.2% minus 0.1667 rs190982(A;G) plus rs6894139(G;G) 24.8% plus rs10037512(C;C) 24.8% plus 0.3783 rs1366594(G;G) 25.7% minus 0.3747 rs10514310(A;G) 23.9% plus 0.1221 rs6864869(C;G) plus rs2562519(A;A) 59.3% minus 0.3039 rs770189(C;G) minus 0.4555 rs10074525(C;T) 46.4% plus 0.1749 rs421379(C;C) 86.2% plus 0.2268 rs12519773(C;T) plus 0.405 rs13173682(C;T) plus rs6869388(C;C) 3.5% plus 0.2117 rs469339(A;A) 95.3% plus 0.08448 rs17418283(C;T) plus 0.1653 rs147295(C;T) plus 0.4068 rs3777200(A;G) 38.5% minus 0.3558 rs10069748(C;T) plus 0.4132 rs3777193(C;T) minus 0.416 rs11738945(C;T) 26.2% plus 0.2112 rs7700895(A;T) plus 0.3696 rs918629(A;G) plus 0.4894 rs7734985(A;A) 33.8% plus 0.3972 rs4869266(G;G) 41.6% plus 0.3783 rs13179048(A;A) 4.6% plus 0.2539 rs10515237(G;G) 5.3% plus 0.275 rs3811951(G;G) 4.6% plus 0.2764 rs155979(G;G) 68.8% minus 0.1547 rs3762986(T;T) 20.4% plus 0.4977 rs4434401(C;C) 23.2% plus 0.4008 rs27037(G;T) plus 0.292 rs27524(A;G) 46.9% plus 0.3664 rs13160562(A;G) plus 0.1878 rs27044(C;G) Bad plus 0.3517 1.4x higher risk for spondylitis 1.4x higher risk for spondylitis rs271939(A;A) 43.8% minus rs6235(C;C) 4.6% minus 0.2461 rs6234(G;G) 4.7% minus 0.258 rs156019(T;T) 43.4% plus 0.4265 rs155971(C;C) 44.2% plus 0.4403 rs17482078(C;T) Good 34.8% plus 0.1304 0.76x lower risk for spondylitis 0.76x lower risk for spondylitis rs27434(A;G) 34.5% plus 0.3522 rs2287987(C;T) Good plus 0.1304 0.71x lower risk for spondylitis 0.71x lower risk for spondylitis rs26653(C;G) 43.1% plus 0.4284 rs2549794(T;T) 33.6% plus 0.348 rs31017(G;G) 100.0% plus 0.004591 rs4703129(A;C) plus 0.3985 rs467650(C;C) 9.7% plus 0.3457 rs17736767(C;G) 44.6% plus 0.1905 rs1500251(A;G) plus rs1829883(C;T) 44.2% plus 0.3871 rs10067427(G;G) 15.9% plus 0.4206 rs34750(C;G) plus 0.433 rs2248374(G;G) plus 0.4458 rs575018(T;T) 45.1% plus rs13188771(A;C) plus 0.1419 rs6861497(A;G) 51.3% plus 0.4045 rs261097(G;T) minus 0.1993 rs6878284(T;T) plus rs1502844(T;T) 38.9% plus 0.3921 rs7705924(A;G) 8.0% plus 0.06015 rs26232(C;T) 41.6% plus 0.2828 rs2561477(A;G) plus rs4702982(C;T) 13.3% plus 0.1295 rs161645(G;G) 53.8% plus 0.1717 rs13178964(A;G) 33.8% plus rs1001579(C;T) minus 0.1074 rs4571457(C;T) 42.5% plus rs10447248(A;G) 42.5% plus 0.3939 rs12656502(A;G) plus rs4957796(C;T) plus rs7710527(A;G) plus rs367615(T;T) 62.5% plus 0.3131 rs2015698(G;T) plus 0.4265 rs3776932(A;C) minus 0.2727 rs10074959(A;G) plus 0.3049 rs1438673(A;G) 46.0% minus 0.3884 rs25925(C;G) minus rs11241130(A;A) 86.2% plus rs11954856(G;G) 21.9% plus 0.3898 rs2431238(C;C) 45.1% plus 0.258 rs454886(G;G) minus 0.3655 rs2229992(C;C) 33.9% plus 0.4674 rs351771(A;A) minus 0.3393 rs459552(A;A) 3.5% minus 0.1382 rs4460176(G;T) plus 0.4954 rs17132261(C;T) 3.6% plus 0.1102 rs17513503(C;G) 12.3% plus 0.06244 rs3853750(A;G) minus rs10056340(G;T) plus 0.2801 rs764917(A;C) plus 0.3411 rs1898671(C;T) 38.5% plus 0.1873 rs13189969(G;G) 28.3% plus 0.348 rs252817(C;T) 44.2% plus 0.4233 rs10074258(C;T) 46.0% plus 0.3728 rs1422438(A;A) 46.0% minus 0.4265 rs770182(A;C) 38.1% minus 0.3039 rs288139(C;T) minus 0.2314 rs4811971(A;A) 47.8% plus 0.3439 rs6089829(G;G) 46.9% plus 0.3159 rs737092(A;G) minus 0.4334 rs6025590(G;G) 38.1% plus rs328506(C;T) plus 0.1961 rs7121(C;T) 54.0% plus 0.3861 rs6026990(A;T) plus 0.2121 rs6062509(T;T) 45.1% plus 0.3214 rs6027506(A;G) 46.9% plus 0.3292 rs860148(C;T) 48.7% plus rs6027755(A;A) 17.7% plus 0.3136 rs3810548(G;G) 95.4% plus 0.1919 rs6011914(G;G) 41.3% plus 0.4362 rs1044396(T;T) 37.2% minus 0.3609 rs259964(G;G) 25.5% plus 0.4008 rs944260(C;T) minus 0.3113 rs6026584(C;T) plus 0.281 rs13831(C;T) 38.1% minus 0.2314 rs3787137(A;A) plus 0.4036 rs13043313(C;T) plus 0.242 rs1970546(G;G) 59.3% plus 0.275 rs2024714(A;A) 23.1% minus 0.3705 rs2297441(A;A) 55.8% plus 0.2865 rs4468878(C;T) plus 0.4871 rs4925386(C;T) plus 0.4118 rs944895(C;T) minus 0.3324 rs6090453(C;G) 53.8% plus 0.4256 rs2427308(C;T) 24.6% plus rs6062504(G;G) 42.5% plus 0.3742 rs4522666(A;A) 39.8% plus 0.4504 rs2315008(G;G) 43.4% plus 0.3747 rs4809330(G;G) 44.2% plus 0.3251 rs6089838(G;G) 40.6% plus rs4603829(T;T) 43.4% plus 0.449 rs6011674(C;T) 15.9% plus rs879471(C;T) 42.3% plus 0.3407 rs1598848(A;G) 46.0% plus rs311499(C;C) 80.5% plus 0.06198 rs2297440(C;C) 54.2% plus 0.3113 rs1801475(C;C) minus 0.4118 rs2275294(A;G) plus 0.3324 rs1735884(A;A) 52.7% minus 0.2034 rs2244305(C;T) 46.0% plus 0.4073 rs2823615(A;T) 45.5% plus rs6062314(T;T) 88.5% plus 0.08724 rs243588(G;G) 17.1% minus 0.4991 rs2315656(A;G) plus rs2822432(C;T) 39.7% plus 0.3186 rs457603(T;T) 77.9% plus rs2823962(A;G) 41.6% plus 0.4913 rs2826659(C;C) 4.4% plus rs154739(T;T) plus 0.1671 rs2823357(A;A) 15.9% plus 0.4601 rs2823093(A;G) plus 0.2567 rs2829887(C;T) 54.9% plus 0.337 rs466448(A;G) 46.0% plus rs11088680(G;G) plus rs385806(A;G) 26.6% minus 0.08586 rs2826891(C;T) 49.5% plus 0.4073 rs1888414(C;C) 35.4% plus 0.3641 rs2824292(A;A) 29.2% plus 0.4559 rs2229741(A;G) 43.8% minus 0.4091 rs2055011(C;T) minus 0.2461 rs457581(A;G) plus 0.1644 rs8127977(C;T) plus 0.4431 rs1022442(A;G) plus 0.3586 rs928883(G;G) 78.5% plus 0.2539 rs2828520(A;A) 49.1% plus 0.2897 rs2827196(C;T) plus 0.4826 rs2040273(A;A) 36.3% plus rs2829866(A;T) plus 0.3797 rs2830487(A;G) plus 0.3861 rs2409191(G;G) 82.3% plus 0.2264 rs1059004(A;A) plus 0.3503 rs226794(G;G) 81.8% plus 0.2236 rs372883(G;G) 28.3% minus 0.4734 rs9977253(T;T) 42.5% plus 0.1671 rs9975851(C;T) 56.9% plus 0.4224 rs2830840(C;C) 52.3% plus 0.4858 rs2832191(A;C) 48.2% plus 0.4826 rs239713(C;T) plus 0.292 rs411697(A;A) 15.0% plus 0.3017 rs457352(C;T) 17.5% plus rs2284552(G;T) 37.3% plus rs2832270(A;G) plus rs455804(G;G) 59.3% minus 0.2971 rs2832387(A;G) 31.9% plus 0.4669 rs1943950(C;T) minus 0.1919 rs2284553(A;G) 49.6% plus 0.3058 rs2186305(A;G) 38.1% minus 0.3448 rs7283316(A;G) plus 0.4729 rs2833556(A;A) 8.0% plus 0.3223 rs13046373(A;G) 46.9% plus 0.4656 rs2833610(A;G) 40.7% plus 0.4578 rs999788(C;T) 28.6% plus 0.2906 rs1475591(C;C) 84.1% plus 0.1478 rs2832407(A;C) plus 0.4481 rs2834442(A;T) plus 0.3838 rs2832616(C;T) 25.9% plus 0.1951 rs1041740(C;T) 41.1% plus 0.2626 rs2834215(G;G) 27.4% plus 0.3825 rs762178(G;G) 40.7% plus 0.4458 rs2835740(C;T) plus 0.2231 rs762237(C;T) 49.6% plus 0.2337 rs2834655(A;G) plus 0.2319 rs11910494(G;G) 11.5% plus 0.371 rs1698064(C;T) minus 0.4458 rs2850015(C;T) plus rs2836754(C;T) plus 0.4302 rs170183(C;T) minus rs2236609(A;G) plus 0.3434 rs9976971(A;G) 47.8% plus 0.3168 rs1805127(A;G) minus 0.3315 rs3787728(C;T) plus rs1013063(C;T) plus 0.4743 rs2222956(T;T) 25.0% minus 0.4362 rs2833607(A;G) plus 0.1864 rs2242714(A;G) plus 0.1974 rs35796750(C;T) plus 0.4284 rs2834072(G;G) 21.2% plus 0.4403 rs2834188(A;G) 39.3% plus rs8126696(C;T) plus 0.4086 rs10483028(C;T) 37.2% plus 0.1928 rs2032314(C;C) 85.0% plus 0.1864 rs8133843(A;A) 100.0% plus rs2834902(C;C) 57.5% plus 0.2952 rs10854398(C;T) plus rs2154545(A;A) 14.5% plus 0.4298 rs2835345(A;C) plus 0.2948 rs2836016(A;A) 31.9% plus 0.3398 rs2051179(A;T) 61.5% plus 0.4013 rs10483032(G;G) 82.3% plus 0.1084 rs2014300(G;G) 70.0% plus 0.2548 rs2835267(C;T) plus rs1003719(G;G) 36.0% plus 0.4449 rs8133052(A;A) 27.3% plus 0.4045 rs2070995(A;G) minus 0.1979 rs2074560(A;G) 42.0% plus rs2835762(C;T) 28.3% plus 0.09091 rs1044317(A;G) 55.4% plus 0.41 rs7279297(A;G) 38.1% plus 0.3958 rs9981861(C;T) plus 0.3343 rs711(A;G) plus 0.3659 rs743446(G;G) 30.1% minus 0.4995 rs2212596(C;C) 16.8% plus 0.4316 rs2839619(A;G) plus 0.4729 rs1137600(A;G) 40.4% plus 0.3012 rs2839471(C;T) 49.6% plus 0.4068 1.6x increased risk for high myopia in Japanese (but not Chinese) 1.6x increased risk for high myopia in Japanese (but not Chinese) rs2070530(C;G) plus 0.3168 rs8132976(A;A) 23.8% plus 0.4839 rs2835761(C;C) 70.3% plus 0.07392 rs383510(C;C) plus rs1893590(A;C) plus rs933151(C;T) 35.9% plus 0.2429 rs461155(A;G) 30.6% plus 0.3636 rs459482(C;G) 45.3% plus 0.4747 rs4818065(A;G) 31.9% plus 0.3232 rs6517656(A;G) plus 0.2906 rs1209950(C;T) 55.8% plus 0.2273 rs1018351(C;C) 72.3% plus 0.298 rs1735151(C;T) plus 0.3269 rs2836823(C;T) 46.0% plus 0.2521 rs2837253(A;G) plus rs1734920(G;T) plus rs2230528(A;G) 33.9% minus 0.1896 rs1378577(A;C) minus rs2410182(G;G) 36.3% plus rs441810(A;G) 31.9% plus 0.3388 rs464138(A;C) plus 0.4045 rs57137919(A;G) plus 0.1598 rs11203203(A;G) plus 0.2011 rs45430(A;G) 42.0% minus 0.4417 rs915832(G;G) 54.0% plus 0.3159 rs2234714(A;G) plus 0.3627 rs3788013(A;C) plus 0.4077 rs2839440(C;T) 23.9% plus 0.202 rs9976767(A;G) 51.3% plus 0.4201 rs7499(A;A) 14.2% plus 0.4669 rs876498(C;T) minus 0.4008 rs7280422(C;G) 28.1% plus rs12481805(A;G) plus 0.1547 rs235326(C;T) 41.6% minus 0.2332 rs1547374(A;G) 44.5% plus 0.3609 rs4148102(A;G) plus 0.1823 rs425215(C;C) 28.1% minus 0.433 rs2070788(T;T) 24.8% minus rs2838088(C;T) 22.1% plus rs1618355(A;C) plus 0.2911 rs643608(A;G) 39.8% minus 0.3641 rs1051296(G;G) 14.3% minus rs8127571(G;G) 68.8% plus 0.06566 rs1051298(T;T) 15.6% minus 0.4949 rs9306160(C;C) 33.3% plus 0.2323 normal normal rs2236479(A;A) 9.8% plus 0.3866 rs749909(C;T) minus 0.1483 rs7435(A;G) 38.1% plus 0.3466 rs1133779(C;T) plus 0.4573 rs1556314(G;T) plus 0.2117 rs11911275(A;G) plus rs933150(A;G) plus rs1785437(C;T) plus 0.2603 rs1052773(A;G) plus 0.1961 rs496300(A;A) 37.2% minus 0.247 rs1785467(C;T) plus 0.09688 rs1888530(T;T) 15.5% plus 0.472 rs450046(C;T) 12.5% plus 0.08678 rs4818917(C;T) plus 0.2231 rs4819388(C;C) 58.4% plus 0.287 rs12482346(T;T) 15.0% plus 0.4959 rs2236484(A;A) 18.8% plus 0.4959 rs2070565(C;T) plus 0.2222 rs5748469(A;C) plus 0.4894 rs165722(C;T) plus 0.4334 rs879574(A;T) plus 0.1841 rs2249057(A;C) plus 0.3099 rs4819756(G;G) 28.6% plus 0.2571 rs2075507(A;A) plus 0.3545 rs4646312(C;T) plus 0.3136 rs2838956(G;G) 10.2% plus rs4819143(A;G) plus 0.1226 rs4819833(C;T) plus 0.3421 rs2839186(C;T) 47.3% plus 0.3724 rs3804047(C;T) 33.9% minus rs2266959(T;T) 2.7% plus 0.2273 rs3788205(C;T) plus 0.2052 rs1052763(C;T) 31.2% plus 0.2447 rs2073376(G;G) 46.4% plus 0.3237 rs1042917(A;A) 27.4% plus 0.4421 rs2268524(C;T) plus 0.2268 rs5746647(T;T) 90.3% plus 0.09458 rs3788265(G;T) 26.6% plus 0.2185 rs165774(A;G) plus 0.2287 rs2073380(A;C) 26.2% plus 0.2346 rs2020917(T;T) 9.7% plus 0.2282 rs1052756(C;T) 23.1% plus 0.135 rs165656(C;G) plus rs737865(C;C) 9.8% minus 0.2392 rs11913319(C;G) 49.2% plus rs4680(A;G) plus 0.3903 multiple associations, see details multiple associations, see details rs4646316(C;T) 32.7% plus 0.2466 rs3788266(A;G) plus 0.4339 rs2300403(C;T) plus 0.382 rs2241049(A;G) 44.2% plus rs1051169(C;G) 44.2% minus 0.4252 rs8141691(A;G) plus rs737866(G;G) 9.7% minus 0.2392 rs807669(C;T) plus 0.2135 rs6269(A;G) plus 0.3719 rs712964(C;T) plus 0.388 rs3788317(G;T) 39.3% plus 0.287 rs165599(A;G) 1.0 plus 0.4656 rs165849(A;G) plus 0.4803 rs5993890(A;G) plus 0.07117 rs175174(G;G) 20.5% plus 0.4949 rs701427(A;C) 32.3% plus rs2269726(C;T) plus 0.4587 rs4818(C;G) plus 0.3232 rs140490(A;A) minus rs887199(A;G) 27.4% plus 0.3416 rs2239395(G;T) plus 0.118 rs3757(A;G) plus 0.2135 rs2518824(G;T) 41.8% plus rs165815(C;T) 27.4% plus 0.3411 rs5993891(C;T) 14.2% plus 0.1272 rs9606250(A;T) plus 0.1272 rs3087869(C;C) minus 0.4977 rs2239393(A;G) 45.1% plus 0.3811 rs740603(G;G) 26.2% plus 0.4738 rs181359(A;A) minus 0.2759 rs384262(A;G) plus 0.4238 rs6518604(A;A) 96.9% plus 0.1056 rs2073743(C;G) 30.3% minus 0.1855 rs460106(C;T) plus 0.4555 rs1640299(G;G) 26.5% plus rs131408(C;T) plus rs5751168(C;C) 89.1% plus 0.1368 rs1034566(C;T) 32.3% plus 0.1814 rs400946(C;T) plus rs2073748(T;T) 13.5% minus 0.3255 rs2240717(C;C) 10.8% minus 0.3751 rs887205(A;G) plus 0.4096 rs463426(C;T) plus 0.4385 rs175162(G;G) 11.5% plus 0.2355 rs4821116(T;T) 2.7% plus rs412050(C;G) plus 0.141 rs701428(A;G) 46.0% plus 0.4688 rs11089937(A;C) 29.0% plus rs875643(C;T) minus 0.4086 rs10433310(A;G) plus 0.343 rs4820599(A;G) 39.8% plus 0.4155 rs2739330(C;C) 36.9% plus 0.433 rs140504(G;G) 74.3% plus 0.2025 normal risk normal risk rs131451(T;T) 87.6% plus 0.2213 rs743409(C;T) 42.5% minus 0.4449 rs5754217(T;T) 2.7% plus 0.3627 rs2298428(T;T) 2.7% plus 0.2259 rs2283792(G;T) plus 0.4591 rs2267076(C;C) 42.5% plus 0.3646 rs3761418(A;G) 39.8% plus 0.3145 1.3x increased risk for depression 1.3x increased risk for depression rs131654(T;T) 44.2% plus 0.2906 rs4820539(A;G) 46.9% plus rs5760410(A;A) 25.2% plus 0.4665 rs4821112(A;A) 2.7% plus 0.2755 rs2267015(A;T) 50.8% plus 0.354 1.3x increased risk for depression 1.3x increased risk for depression rs1007888(T;T) minus 0.4518 rs11089637(C;C) 0.9% plus 0.3499 rs2330809(C;T) plus rs4630(T;T) minus 0.3802 rs6003941(G;G) plus 0.23 rs3761422(C;C) 37.5% plus 0.3802 rs5751862(A;A) 20.7% plus 0.4169 rs8135987(C;T) plus 0.3884 rs16983214(A;G) plus rs6519442(G;T) plus 0.1988 rs2186369(G;T) plus 0.1465 rs6519520(A;G) 39.8% plus 0.4164 rs4822489(G;G) 33.8% plus 0.4826 rs5751901(C;T) plus 0.3907 rs2331291(C;T) 26.5% plus 0.1134 rs2236624(C;C) 59.3% plus 0.2314 rs5751902(C;T) 54.0% plus rs1207393(G;G) 36.9% plus 0.2819 rs929271(G;T) plus 0.3003 rs133885(A;A) 18.6% plus 0.3186 rs713998(C;C) 80.5% plus rs4822752(C;T) 50.4% plus 0.3485 rs2014410(C;C) 26.2% plus rs5762746(C;T) plus 0.4017 rs6005835(C;C) 46.2% plus 0.2438 rs2106294(A;A) 50.4% minus 0.1777 rs4823006(G;G) 15.9% plus 0.449 rs4417(C;C) 74.3% plus rs2301523(A;G) plus 0.1419 rs738722(C;T) plus 0.32 rs5762430(A;G) 23.0% plus 0.2213 rs36600(C;T) plus 0.1772 rs2236142(C;G) plus 0.3939 rs718772(A;G) 36.3% plus rs4820792(C;T) plus 0.2709 rs743184(C;T) minus 0.382 rs136176(A;A) 62.5% plus 0.1584 rs9609538(C;T) plus rs2017309(A;T) plus 0.2851 rs5752638(C;C) 5.3% plus 0.1451 rs4822983(C;T) 44.6% plus 0.3072 rs2412971(A;A) 16.8% plus 0.4922 rs7289941(C;C) 17.7% plus 0.3788 rs5749131(G;G) 28.8% plus 0.4743 rs132390(T;T) 96.9% plus 0.02709 rs4035540(C;C) 48.7% plus 0.2351 rs1547014(C;T) plus 0.3205 rs17745316(A;G) plus 0.06657 rs2076054(T;T) 57.5% plus 0.3306 rs2412980(C;T) plus 0.05372 rs1962223(C;C) 1.5% minus 0.1965 rs1801198(C;C) 35.4% plus 0.4128 rs12537(T;T) 8.8% plus 0.3384 rs1043099(C;C) minus rs731991(A;G) 37.5% plus 0.3779 rs9606756(G;G) 0.9% plus rs4821083(C;T) plus rs12530(C;T) plus 0.07117 rs4141404(G;G) 50.4% minus 0.1763 rs2412970(G;G) 16.8% plus 0.4927 rs2246704(C;T) plus 0.36 rs9609078(A;G) plus 0.1928 rs5749446(C;T) plus 0.489 rs9862(C;C) 28.4% plus 0.3581 rs5754312(A;T) 41.6% plus 0.4715 rs1034394(G;G) 8.0% plus 0.421 rs9609643(A;G) plus 0.08264 rs9619311(C;T) plus 0.3356 rs133945(C;T) 53.1% plus 0.4141 rs3788470(G;T) plus 0.3191 rs2234921(A;G) plus rs2267193(C;C) 4.7% plus 0.2654 rs5749482(C;G) plus rs130293(A;A) minus rs133946(C;G) plus 0.4141 rs9609565(A;G) plus 0.2328 rs1056484(G;G) 31.9% minus 0.4233 rs9621532(A;C) 10.6% plus rs743793(C;T) plus 0.3613 rs4821132(C;T) 46.9% plus 0.3604 rs739097(A;A) 33.0% plus 0.4949 rs138777(C;T) 47.3% minus rs132617(C;T) 42.5% plus 0.3219 rs130575(A;G) 22.1% plus 0.1359 rs2284031(C;C) plus 0.4954 rs909486(T;T) 22.1% plus 0.4775 rs735854(C;C) 42.5% plus 0.4275 rs361863(C;C) 51.3% minus 0.2355 rs2016586(G;G) 51.3% plus rs136175(A;A) 61.9% plus 0.1607 rs5754891(G;G) 16.9% plus 0.4688 rs2071749(A;G) 50.4% plus 0.348 rs5755703(A;A) 18.6% plus rs2071747(C;G) plus 0.05005 rs2267337(C;C) 56.9% plus 0.3558 rs4820255(C;C) 82.5% plus 0.09275 rs6000200(C;G) 30.8% plus 0.2475 rs2072707(G;T) plus 0.2787 rs2284017(C;T) plus 0.4449 rs35504497(-;A) plus rs9619497(A;G) plus 0.3384 rs4821261(C;T) plus rs2239785(A;A) 61.9% plus 0.2957 rs2157249(C;T) plus 0.1924 rs2413338(C;T) 41.5% plus 0.4624 rs743777(A;G) 46.9% plus 0.2828 rs3752462(C;C) 46.9% plus 0.4532 rs4821494(T;T) 47.7% plus 0.494 rs28624811(A;G) plus rs5995288(C;T) plus 0.4784 rs3761439(A;G) plus 0.359 rs2071746(A;T) 38.5% plus 0.4995 normal normal rs9610449(C;T) plus 0.2475 rs1883112(A;A) 18.6% plus 0.4458 rs3788556(C;C) 23.1% plus 0.3072 rs739031(T;T) 80.0% plus rs228953(C;T) minus rs2281082(G;G) 59.3% plus 0.3535 rs5750285(C;G) Good 52.3% plus 0.4862 Better response to lithium treatment Better response to lithium treatment rs2003813(A;G) 54.7% minus 0.186 rs228942(A;C) 30.1% minus rs4820268(A;G) plus 0.4564 rs743776(C;T) plus rs1894644(C;C) 75.2% plus 0.1221 rs4821941(A;G) 52.3% plus 0.3476 rs5757037(A;G) 46.9% plus 0.3742 rs5757949(C;C) 9.7% plus 0.2388 rs1014971(A;G) 47.8% minus 0.4858 rs130650(A;G) minus 0.169 rs909674(A;A) 55.4% plus 0.135 rs13058338(A;T) plus 0.1804 rs228918(A;G) minus rs13053175(C;T) 48.7% plus 0.258 rs5756506(C;G) plus 0.4757 rs855791(C;T) 46.9% minus 0.3981 0.1 g/dL lower hemoglobin on average 0.1 g/dL lower hemoglobin on average rs12484776(A;G) 37.2% plus 0.2342 rs139909(C;T) 40.7% plus 0.3186 rs1421312(C;T) 54.0% minus 0.4454 rs2413450(C;T) plus 0.4265 rs5756504(C;T) 50.4% plus rs79102241(A;G) minus rs228921(C;T) 47.7% minus rs713729(A;A) plus 0.1818 rs909685(A;T) plus 0.4927 rs2284033(A;G) plus 0.4591 rs7291467(A;A) 43.1% plus 0.4389 rs2075984(A;C) plus 0.3953 rs5757676(C;C) 64.6% plus 0.09826 rs139887(C;C) 32.3% plus 0.3866 rs2076369(G;G) 37.2% plus 0.2911 rs1800818(A;G) minus rs12628051(C;T) plus 0.3512 rs229541(C;T) minus 0.4371 rs5750504(T;T) 26.6% plus 0.3613 rs4821897(G;G) 54.9% plus 0.1841 rs135745(C;G) plus 0.4132 rs5757463(C;C) plus 0.07254 rs132770(G;G) 62.8% plus 0.1561 rs738144(A;A) 61.1% plus 0.1483 rs132793(G;G) 64.3% plus 0.1561 rs137686(G;G) 64.6% plus 0.1938 rs137699(A;G) 41.5% plus 0.3701 rs133072(G;G) 40.0% plus 0.2879 rs5757133(C;T) 39.8% plus 0.2686 rs28371730(A;G) minus 0.3177 rs2235316(A;C) plus 0.489 rs133065(A;A) plus rs2284082(T;T) 57.8% plus 0.2874 rs28371701(C;G) plus rs12169962(C;T) plus rs28371699(G;T) minus 0.3756 rs138597(A;A) 57.1% plus 0.4522 rs132774(G;G) 69.2% plus 0.2874 rs4894(A;C) plus 0.2534 1.78x increased risk for schizophrenia in males 1.78x increased risk for schizophrenia in males rs9611198(C;C) plus 0.3104 rs132788(T;T) 18.8% plus 0.2424 rs78340630(-;TGT) plus 0.3947 rs2294369(A;G) plus rs28633410(C;T) plus 0.2392 rs5996074(A;A) 57.3% plus 0.2879 rs2267439(T;T) 58.4% plus 0.2897 rs61736911(C;G) plus rs16999349(A;G) plus 0.1194 rs1058164(C;G) minus 0.3898 rs6971(G;G) minus 0.1823 rs4987144(C;T) minus rs5751129(T;T) 63.7% plus 0.2879 rs139014(C;T) plus 0.1561 rs35028622(A;C) plus 0.3981 rs1081004(A;G) minus 0.02525 rs5759167(G;T) 60.2% plus 0.3705 rs134882(C;T) plus 0.3361 rs71328650(A;C) plus 0.382 rs28371702(A;C) minus rs71328651(A;C) plus rs5771069(A;G) 55.8% plus 0.4435 rs56091001(C;T) plus rs470089(A;G) plus 0.2034 rs470093(G;G) 71.7% plus rs79125935(A;G) plus rs1985842(G;T) plus 0.2879 rs9611741(G;T) plus rs28371725(A;G) minus 0.05556 carrier of one CYP2D6*41 allele carrier of one CYP2D6*41 allele rs60979881(A;G) plus rs28735595(C;T) plus 0.3517 rs28680494(A;C) plus 0.4013 rs28439297(C;T) plus 0.4013 rs5771040(G;G) 36.6% plus 0.2397 rs6519955(T;T) 18.5% plus 0.4376 rs1985671(G;T) minus 0.3503 rs138060(C;C) 26.5% plus 0.4917 rs742134(A;G) 22.1% plus 0.1217 rs5766691(A;G) 44.2% plus 0.214 rs2267447(C;T) plus rs2267448(A;G) plus 0.3733 rs1883264(C;G) plus 0.1589 rs5765956(T;T) 36.3% plus 0.4812 rs138110(A;G) 55.4% plus 0.4927 rs4407(A;G) 51.3% plus rs5767992(C;C) 72.6% plus rs138097(G;G) minus 0.2663 rs3747238(C;T) 42.5% plus 0.3641 rs117294(A;C) 50.4% plus 0.4711 rs1055271(C;G) plus 0.2828 rs5771934(C;C) 64.1% plus 0.08999 rs5768709(A;G) 44.2% plus 0.3269 rs138880(A;C) 42.5% plus 0.3338 rs738490(A;G) plus 0.1781 rs6630351(G;G) 26.2% plus 0.367 rs6526342(C;C) 73.8% plus 0.3875 rs928931(T;T) plus 0.4154 rs6009824(A;G) plus 0.2094 rs1555048(A;G) 41.6% plus 0.1758 rs761745(C;T) plus 0.23 rs9616906(A;A) 19.5% plus 0.2902 rs179012(T;T) 10.8% minus 0.3658 rs5961794(G;G) 18.5% plus 0.2406 rs1540283(T;T) 58.5% plus 0.2177 rs179008(T;T) 6.2% plus 0.1518 rs4646174(C;C) 55.4% minus rs4646156(A;A) 52.7% minus rs743616(C;G) plus 0.4261 rs9616915(C;C) 23.1% plus 0.3581 rs179019(G;G) 68.3% minus 0.2122 rs5771242(C;C) 51.8% plus rs1978124(C;C) 40.0% plus rs179010(C;C) 61.3% plus 0.2557 rs518329(C;C) minus 0.3356 rs179009(C;C) 7.7% minus 0.2195 rs5935970(C;C) 55.6% plus 0.3936 rs6628506(G;G) 38.7% plus 0.4008 rs5979785(T;T) 68.5% plus 0.4069 rs4827155(T;T) 40.0% plus 0.4855 rs5963411(A;A) plus 0.312 rs2497938(C;C) 10.8% plus 0.3011 rs3827440(G;G) 46.0% minus 0.4885 rs5963409(G;G) Good plus 0.3071 normal normal rs1801187(T;T) minus 0.448 rs2074192(T;T) 33.8% plus rs5980075(G;G) 54.9% plus 0.4686 rs5937843(G;G) 69.2% plus 0.4021 rs1204038(T;T) 9.2% minus 0.2878 rs3764885(C;C) 75.4% minus 0.3392 rs2806489(A;A) minus 0.2696 rs4240023(C;C) 98.5% plus rs321029(G;G) 69.2% plus 0.2739 rs5918007(C;C) plus 0.08706 rs1337080(A;A) 95.3% plus 0.1034 rs3006142(T;T) 72.3% plus 0.2437 rs498177(C;C) 23.1% minus 0.4782 rs1034428(C;C) 70.8% minus 0.156 2.19x increased risk for schizophrenia in females 2.19x increased risk for schizophrenia in females rs1327301(T;T) 28.3% plus 0.2098 rs2280883(C;C) 24.6% plus 0.26 rs5906957(G;G) 75.4% plus 0.3561 rs471205(A;A) 15.9% minus 0.4698 rs7471388(G;G) 82.1% plus 0.3682 rs12007229(A;A) 4.4% plus 0.101 rs6611365(A;A) 11.6% plus 0.2975 rs2232365(G;G) 42.5% minus 0.4462 rs2294021(C;C) 41.5% plus rs5905587(C;C) 47.7% plus 0.4674 rs241389(G;G) minus 0.4129 rs4844096(G;G) 47.7% plus 0.2267 rs12014709(G;G) 9.2% plus 0.1475 rs414960(C;C) 55.4% minus 0.3235 rs1263237(C;C) 15.4% minus 0.4607 rs6622126(A;A) 36.9% plus 0.2932 rs5982533(T;T) 67.7% plus 0.3761 rs5912838(C;C) 41.3% plus 0.4849 rs5936487(A;A) 44.6% plus 0.2497 rs1972809(G;G) 26.1% plus 0.4746 rs5941047(T;T) 51.3% plus 0.4849 rs5941160(G;G) 40.0% plus rs5968205(T;T) 79.6% plus 0.2449 rs320995(T;T) 67.0% minus 0.3253 rs4568761(T;T) 49.2% plus 0.3077 rs2755459(G;G) 58.3% plus 0.2823 rs1206634(C;C) 90.8% minus 0.0532 rs5910578(C;C) 62.8% plus 0.266 rs5921979(C;C) plus 0.1076 rs2710057(T;T) 60.0% plus 0.2304 rs697829(A;A) 52.3% plus 0.214 rs1324805(C;C) 53.8% minus 0.3531 rs1403543(A;A) 46.2% plus 0.4631 rs1414334(G;G) 75.9% plus 0.1856 rs2227098(A;A) 40.0% minus 0.4281 rs3813929(T;T) Good plus 0.1167 normal normal rs4559365(T;T) 28.1% plus 0.3549 rs498207(C;C) 25.5% minus 0.2938 rs989638(A;A) 60.2% minus 0.1892 rs3788848(G;G) 18.5% minus 0.2932 rs2239464(G;G) 69.0% plus 0.48 rs561077(G;G) 28.6% plus rs5194(G;G) plus 0.4335 rs5907577(T;T) 18.9% plus 0.2122 rs204340(G;G) minus rs5929706(C;C) 99.1% plus rs5930817(A;A) 98.1% plus rs7892161(T;T) 32.4% plus rs12010175(G;G) 91.2% plus 0.1608 rs2075596(G;G) 73.8% plus rs7892898(A;A) plus 0.1117 rs35108305(A;A) plus rs9786537(C;C) plus 0.008753 rs9786460(G;G) plus 0.01425 rs28819996(C;C) plus 0.009029 rs9786076(T;T) plus 0.2207 rs2191146(G;G) minus rs9785723(T;T) plus 0.009009 rs9786910(A;A) plus 0.009009 rs9785865(C;C) plus rs9785659(A;A) 34.5% plus 0.2094 rs52812045(C;T) minus 0.1435 rs1125978(C;C) minus rs2082033(C;C) plus 0.2381 rs2704706(A;G) plus rs2690775(C;T) minus rs9786283(A;A) plus 0.245 rs2704707(A;G) plus rs2704708(A;G) plus rs2178500(T;T) plus rs1800972(C;C) 0.5 Bad minus 0.1538 normal risk normal risk rs1268524(A;G) 0.2 38.9% minus 0.2961 gs233 0.1 normal pain sensitivity You probably experience typical sensitivity to pain according to See also gs232, gs234, and gs235 rs324650(A;T) 0.1 plus 0.4421 rs10246939(C;T) 0.1 plus 0.4509 can taste bitter can taste bitter rs1726866(C;T) 0.1 minus 0.4082 can taste bitter can taste bitter rs891512(G;G) 0.1 Good 66.1% plus 0.1244 Lower blood pressure than those with an A allele Lower blood pressure than those with an A allele rs1143674(G;G) 0.1 Good plus 0.4118 normal (risk of Autism) normal (risk of Autism) rs16947(A;G) 0.1 plus 0.3425 a common variant a common variant rs1080985(C;C) 0.1 minus 0.1699 a common variant a common variant rs1080983(A;G) 0.1 minus 0.2378 common common rs12021720(C;T) 0.05 Good plus 0.1015 a relatively common variant, which is linked to Maple Syrup Urine Disease, but appears harmless. In 1998 this paper published about a patient with MSUD who had 2 mutations 'The third patient was a compound heterozygote for a C to G transversion at nucleotide 309 in exon 4 and a G to A transition at nucleotide 1165 in exon 9, causing an Ile-to-Met substitution at amino acid 37 and a Gly-to-Ser substitution at amino acid 323.' It is that second mutation (Gly-to-Ser substitution at amino acid 323 also known as rs12021720) which was found in your data. It isn't clear from the paper if that mutation was somehow the cause of MSUD, influences its progression, or is completely harmless. In more recent years we have some additional information about this mutation, we now know it's frequency in cauc... rs500760(G;G) 0.02 8.0% minus 0.2911 rs2274159(A;G) 0.0 Good 48.7% plus 0.4219 rs6478078(C;C) 0.0 Good 100.0% plus 0.003673 common in complete genomics common in complete genomics rs942519(A;G) 0.0 Good 53.1% plus 0.4876 rs10817610(T;T) 0.0 Good 100.0% plus 0.01423 common in complete genomics common in complete genomics rs6478105(A;A) 0.0 Good 83.1% plus 0.05234 rs1953126(C;C) 0.0 38.9% plus 0.3177 normal normal rs2808415(A;A) 0.0 Good 100.0% plus 0.002755 common in complete genomics common in complete genomics rs2488601(C;C) 0.0 Good minus 0.02204 common in complete genomics common in complete genomics rs583134(C;C) 0.0 Good 99.1% plus 0.01148 common in complete genomics common in complete genomics rs7128311(T;T) 0.0 Good 100.0% plus 0.1345 common in complete genomics common in complete genomics rs925946(G;G) 0.0 Good 48.7% plus 0.2282 common in complete genomics common in complete genomics rs1467558(G;G) 0.0 Good 64.6% minus 0.08356 common on affy axiom data common on affy axiom data rs908832(G;G) 0.0 Good plus 0.03765 normal normal rs10794720(C;C) 0.0 Good 85.8% plus 0.1061 common in complete genomics common in complete genomics rs6560749(G;G) 0.0 Good 96.5% plus 0.1148 common in complete genomics common in complete genomics rs6602024(G;G) 0.0 Good 81.4% plus 0.1079 normal normal rs4143094(G;G) 0.0 58.5% plus common common rs523747(G;G) 0.0 Good 100.0% plus 0.008724 rs12258967(C;G) 0.0 Good 48.4% plus 0.2034 common in complete genomics common in complete genomics rs1334893(A;A) 0.0 Good 82.3% plus 0.05096 rs2142991(A;A) 0.0 Good 69.9% minus 0.1414 common on affy axiom data common on affy axiom data rs2435357(A;G) 0.0 minus 0.2507 normal normal rs1800858(A;G) 0.0 48.7% plus 0.2842 probably normal probably normal rs4838508(C;C) 0.0 Good 100.0% plus 0.03627 common in complete genomics common in complete genomics rs4838544(A;A) 0.0 Good 100.0% plus 0.03214 common in complete genomics common in complete genomics rs7076156(G;G) 0.0 61.1% plus 0.152 rs7895833(A;A) 0.0 Good 71.7% plus 0.3604 common in complete genomics common in complete genomics rs1248696(C;C) 0.0 Good 77.5% plus 0.04178 common on affy axiom data common on affy axiom data rs588517(G;G) 0.0 Good 70.8% minus 0.05647 common in complete genomics common in complete genomics rs4933824(G;G) 0.0 Good 92.9% plus 0.1175 common in complete genomics common in complete genomics rs9664222(C;C) 0.0 Good 59.3% plus 0.1722 common in complete genomics common in complete genomics rs1784919(G;G) 0.0 Good 96.9% minus 0.06107 common in complete genomics common in complete genomics rs1792124(G;G) 0.0 Good 95.6% plus 0.06061 common in complete genomics common in complete genomics rs1699103(G;G) 0.0 36.3% minus 0.3209 0.85x risk for Alzheimers 0.85x risk for Alzheimers rs1792113(G;G) 0.0 44.2% plus 0.4307 0.90x risk for Alzheimers 0.90x risk for Alzheimers rs1784931(A;A) 0.0 40.2% plus 0.3287 normal normal rs3923890(A;T) 0.0 44.2% plus 0.3714 rs544368(G;G) 0.0 Good 82.3% minus 0.07851 common on affy axiom data common on affy axiom data rs911541(A;A) 0.0 Good 80.5% plus 0.185 normal normal rs927344(T;T) 0.0 Good 100.0% plus 0.004132 common in complete genomics common in complete genomics rs805722(C;C) 0.0 62.7% plus 0.2755 rs805708(A;A) 0.0 47.8% plus 0.3994 rs1320448(G;G) 0.0 Good 100.0% plus 0.0932 common in complete genomics common in complete genomics rs1359645(A;A) 0.0 Good 96.4% plus 0.146 common in complete genomics common in complete genomics rs82625(G;G) 0.0 Good 87.6% minus 0.06703 common in complete genomics common in complete genomics rs1312895(G;G) 0.0 Good 73.5% minus 0.2029 common in complete genomics common in complete genomics rs1247118(C;C) 0.0 Good 75.4% minus 0.2075 common in complete genomics common in complete genomics rs568404(C;C) 0.0 Good 100.0% minus 0.03122 common in complete genomics common in complete genomics rs4751185(C;C) 0.0 Good 77.0% plus 0.1065 common in complete genomics common in complete genomics rs915909(C;C) 0.0 Good 100.0% plus 0.02663 normal normal rs1061501(A;A) 0.0 Good minus 0.1786 common in complete genomics common in complete genomics rs2740379(C;C) 0.0 Good minus 0.01928 common in complete genomics common in complete genomics rs5743867(T;T) 0.0 Good 90.3% minus 0.2057 common in complete genomics common in complete genomics rs1003483(G;T) 0.0 plus 0.3829 rs4910742(A;A) 0.0 Good 94.7% plus 0.04775 common in complete genomics common in complete genomics rs3206824(G;G) 0.0 Good 54.9% minus 0.2075 common in complete genomics common in complete genomics rs2291599(C;C) 0.0 Good 61.3% plus 0.1639 common in complete genomics common in complete genomics rs7120489(G;G) 0.0 Good 86.2% plus 0.1024 common in complete genomics common in complete genomics rs5219(C;C) 0.0 Good plus 0.2741 normal normal rs28720026(G;G) 0.0 Good plus 0.03949 rs3824886(G;G) 0.0 Good 92.3% plus 0.2888 common in complete genomics common in complete genomics rs1402279(A;A) 0.0 Good 92.0% minus 0.06933 common on affy axiom data common on affy axiom data rs7297018(G;G) 0.0 Good 70.8% plus 0.1056 common on affy axiom data common on affy axiom data rs7394570(G;G) 0.0 Good 92.9% plus 0.09275 common in complete genomics common in complete genomics rs2292912(C;C) 0.0 Good 54.8% minus 0.4945 common in complete genomics common in complete genomics rs10742772(T;T) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs2521572(G;G) 0.0 Good 88.5% plus 0.2199 common in complete genomics common in complete genomics rs1894111(G;G) 0.0 Good 97.3% minus 0.06749 common in complete genomics common in complete genomics rs527589(A;A) 0.0 Good 87.6% minus 0.06152 common in complete genomics common in complete genomics rs217086(G;G) 0.0 Good 67.9% plus 0.08815 common on affy axiom data common on affy axiom data rs471767(A;A) 0.0 46.9% plus 0.2264 rs2852894(C;C) 0.0 Good 83.3% minus 0.04821 common in complete genomics common in complete genomics rs503362(G;G) 0.0 53.6% plus 0.2135 rs1799750(-;-) 0.0 Good minus 0.4509 normal normal rs497116(T;T) 0.0 Good 100.0% minus 0.03994 common in complete genomics common in complete genomics rs659243(G;G) 0.0 99.1% plus rs11212617(A;A) 0.0 Good 26.5% plus 0.4706 normal response to Metformin normal response to Metformin rs3802842(A;A) 0.0 59.3% plus 0.3136 normal normal rs664143(C;C) 0.0 27.4% minus 0.404 normal normal rs7105056(C;C) 0.0 Good 99.1% plus 0.04086 rs1150226(C;C) 0.0 Good 89.4% minus 0.1129 common in complete genomics common in complete genomics rs7350481(C;C) 0.0 Good 83.2% plus 0.1162 common on affy axiom data common on affy axiom data rs1558861(T;T) 0.0 Good 91.7% plus 0.118 common on affy axiom data common on affy axiom data rs10790162(G;G) 0.0 Good 92.3% plus 0.1134 common on affy axiom data common on affy axiom data rs964184(C;C) 0.0 76.8% plus 0.2002 rs6589566(A;A) 0.0 Good 85.7% plus 0.1129 common on affy axiom data common on affy axiom data rs2266788(T;T) 0.0 Good 84.1% minus 0.1134 common on affy axiom data common on affy axiom data rs2072560(C;C) 0.0 Good plus 0.1088 rs662799(A;A) 0.0 Good 96.9% plus 0.1524 normal normal rs6421571(C;C) 0.0 Good 63.4% plus 0.1722 common in complete genomics common in complete genomics rs2052383(T;T) 0.0 Good 67.3% plus 0.3242 common in complete genomics common in complete genomics rs1372791(C;C) 0.0 Good 99.1% plus 0.04913 rs7338333(G;G) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs4397868(T;T) 0.0 Good 63.4% plus 0.107 common on affy axiom data common on affy axiom data rs956868(C;C) 0.0 76.9% plus 0.1529 rs7955371(C;C) 0.0 Good 100.0% plus 0.01056 common in complete genomics common in complete genomics rs10849033(A;A) 0.0 Good 98.2% plus 0.2649 common in complete genomics common in complete genomics rs4238010(A;A) 0.0 77.9% plus 0.1354 rs216321(C;C) 0.0 Good 80.4% plus 0.1028 common on affy axiom data common on affy axiom data rs2617170(C;C) 0.0 Good 50.0% plus 0.4017 Normal Normal rs1050283(T;T) 0.0 25.0% minus 0.3466 normal risk normal risk rs2160525(G;G) 0.0 Good 65.5% plus 0.1373 common in complete genomics common in complete genomics rs34330(C;C) 0.0 Good 54.9% plus 0.3421 normal risk for endometrial/breast cancer normal risk for endometrial/breast cancer rs2302685(T;T) 0.0 Good 65.5% plus 0.1212 common in complete genomics common in complete genomics rs1805477(C;C) 0.0 Good 99.1% plus 0.07943 common in complete genomics common in complete genomics rs3764028(C;C) 0.0 Good minus 0.2107 common in complete genomics common in complete genomics rs10743430(T;T) 0.0 Good 91.2% plus 0.191 common in complete genomics common in complete genomics rs10743465(G;G) 0.0 Good 97.3% plus 0.124 common in complete genomics common in complete genomics rs7961152(C;C) 0.0 30.1% plus 0.3242 normal normal rs2306677(C;C) 0.0 74.3% minus 0.1901 rs6582584(G;G) 0.0 Good 100.0% plus 0.03444 common in complete genomics common in complete genomics rs1520832(C;C) 0.0 Good 90.8% minus 0.05464 common in complete genomics common in complete genomics rs1880887(A;A) 0.0 Good 94.7% minus 0.1194 common in complete genomics common in complete genomics rs1034762(G;G) 0.0 74.3% minus 0.2994 rs2070615(A;G) 0.0 Good 46.9% plus 0.382 common in complete genomics common in complete genomics rs296766(C;C) 0.0 Good 99.1% plus 0.1084 common in complete genomics common in complete genomics rs11614913(C;T) 0.0 44.2% plus 0.388 normal normal rs1800974(A;G) 0.0 Good 57.8% minus 0.4118 common in complete genomics common in complete genomics rs7302017(A;A) 0.0 Good 75.8% plus 0.2704 common in complete genomics common in complete genomics rs4775765(T;T) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs7169431(G;G) 0.0 Good 79.6% plus 0.1221 common in complete genomics common in complete genomics rs1724577(G;G) 0.0 Good 100.0% plus 0.08448 common in complete genomics common in complete genomics rs3829462(T;T) 0.0 Good 97.3% minus 0.06979 common in complete genomics common in complete genomics rs261334(G;G) 0.0 Good 56.9% minus 0.3044 common in complete genomics common in complete genomics rs261332(G;G) 0.0 Good 58.9% plus 0.1924 common in complete genomics common in complete genomics rs261342(G;G) 0.0 Good 53.8% minus 0.4394 common in complete genomics common in complete genomics rs4630362(C;C) 0.0 Good 76.2% plus 0.05234 common in complete genomics common in complete genomics rs3184504(C;C) 0.0 Good 33.0% plus 0.2181 normal normal rs1169305(C;C) 0.0 Good 100.0% minus 0.009183 common in complete genomics common in complete genomics rs1154510(G;G) 0.0 Good 77.0% minus 0.1322 common in complete genomics common in complete genomics rs830124(G;G) 0.0 Good 77.0% plus 0.1534 common in complete genomics common in complete genomics rs968566(A;A) 0.0 Good minus 0.01699 common in complete genomics common in complete genomics rs327127(C;C) 0.0 Good 90.8% minus 0.1589 common in complete genomics common in complete genomics rs1305088(G;G) 0.0 Good 85.8% minus 0.202 common in complete genomics common in complete genomics rs169547(G;G) 0.0 Good 100.0% minus 0.0225 common in complete genomics common in complete genomics rs2249358(A;A) 0.0 51.6% plus 0.3274 normal risk for priapism in SCA patients normal risk for priapism in SCA patients rs1777672(T;T) 0.0 Good 100.0% minus 0.04683 common in complete genomics common in complete genomics rs912428(C;C) 0.0 Good 64.6% minus 0.1309 common in complete genomics common in complete genomics rs7997012(A;G) 0.0 51.6% plus 0.2741 normal risk normal risk rs1328674(G;G) 0.0 Good 92.9% minus 0.0528 average average rs9534505(G;G) 0.0 Good 81.5% plus 0.112 common in complete genomics common in complete genomics rs4884357(G;G) 0.0 Good 100.0% plus common in clinvar common in clinvar rs548097(A;A) 0.0 Good 95.6% minus 0.06198 common in complete genomics common in complete genomics rs828199(C;C) 0.0 Good 100.0% plus 0.01882 common in complete genomics common in complete genomics rs431670(T;T) 0.0 Good minus 0.0124 common in complete genomics common in complete genomics rs9517668(A;A) 0.0 Good 81.4% plus 0.2571 common in complete genomics common in complete genomics rs7335046(C;C) 0.0 Good 77.8% plus 0.253 common in complete genomics common in complete genomics rs9514067(C;C) 0.0 Good plus 0.0005 common in complete genomics common in complete genomics rs3021119(C;C) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs7140561(C;C) 0.0 Good 90.7% plus 0.06107 common in complete genomics common in complete genomics rs2566671(C;C) 0.0 Good plus common on affy axiom data common on affy axiom data rs34276300(C;C) 0.0 Good plus 0.1864 common on affy axiom data common on affy axiom data rs4799570(C;C) 0.0 Good 79.3% plus 0.04086 common on affy axiom data common on affy axiom data rs608781(A;A) 0.0 Good minus 0.1556 common in complete genomics common in complete genomics rs2156552(A;A) 0.0 Good 64.6% minus 0.129 common on affy axiom data common on affy axiom data rs7241918(T;T) 0.0 Good 66.7% plus 0.1139 common on affy axiom data common on affy axiom data rs9951523(C;C) 0.0 Good 92.3% plus 0.009183 common in complete genomics common in complete genomics rs613872(T;T) 0.0 Good 67.3% plus 0.0831 common in complete genomics common in complete genomics rs222581(T;T) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs8093550(T;T) 0.0 Bad 84.1% plus 0.03489 http://www.diygenomics.org/webapp/gen_data.php rs713041(C;C) 0.0 31.9% plus 0.4036 normal normal rs890334(C;C) 0.0 Good minus 0.07668 common in complete genomics common in complete genomics rs12717111(A;A) 0.0 Good 100.0% plus 0.07438 common in complete genomics common in complete genomics rs890335(C;C) 0.0 Good 100.0% minus 0.08402 common in complete genomics common in complete genomics rs890336(A;A) 0.0 Good 100.0% minus 0.1051 common in complete genomics common in complete genomics rs3752246(C;C) 0.0 Good 64.6% plus 0.1763 common on affy axiom data common on affy axiom data rs10407022(T;T) 0.0 67.3% plus 0.3269 rs10417628(C;C) 0.0 Good plus 0.005969 rs344560(G;G) 0.0 Good 90.3% minus 0.04178 common in complete genomics common in complete genomics rs107251(C;C) 0.0 Good 69.0% plus 0.1786 common in complete genomics common in complete genomics rs1051690(G;G) 0.0 Good 54.0% minus 0.1249 common in complete genomics common in complete genomics rs7252299(C;C) 0.0 Good plus common in complete genomics common in complete genomics rs7508518(C;C) 0.0 Good plus 0.1102 common in complete genomics common in complete genomics rs892086(C;T) 0.0 minus 0.4743 normal normal rs2305795(A;G) 0.0 plus 0.3623 normal risk of narcolepsy normal risk of narcolepsy rs688(C;T) 0.0 44.2% plus 0.2796 normal risk for Alzheimer's; higher total and LDL cholesterol in females normal risk for Alzheimer's; higher total and LDL cholesterol in females rs1043994(G;G) 0.0 minus 0.1442 common common rs7253363(G;G) 0.0 Good 86.7% plus 0.01837 common on affy axiom data common on affy axiom data rs3764563(C;C) 0.0 Good 78.8% minus 0.0652 common in complete genomics common in complete genomics rs7250581(A;G) 0.0 29.2% plus 0.07668 normal normal rs17608(T;T) 0.0 Good 48.7% minus 0.4063 rs7249230(G;G) 0.0 Good 74.3% plus 0.1313 common on affy axiom data common on affy axiom data rs7249222(G;G) 0.0 Good 99.1% plus common in complete genomics common in complete genomics rs670950(C;C) 0.0 Good 81.4% plus 0.1313 common in complete genomics common in complete genomics rs2735839(G;G) 0.0 75.2% plus 0.2916 rs648298(G;G) 0.0 23.8% minus 0.3549 rs1613662(A;A) 0.0 Good 68.1% plus 0.1309 common in complete genomics common in complete genomics rs1671152(G;G) 0.0 Good 67.6% plus 0.1423 common in complete genomics common in complete genomics rs2207418(T;T) 0.0 54.0% minus 0.3609 rs235756(C;C) 0.0 14.2% minus 0.3246 normal normal rs4911414(G;G) 0.0 Good 46.0% plus 0.2305 normal normal rs4911442(A;A) 0.0 Good 90.7% plus 0.03949 rs1885120(G;G) 0.0 Good 86.7% plus 0.01974 rs291671(A;A) 0.0 Good 86.7% plus 0.1299 common on affy axiom data common on affy axiom data rs2250889(C;C) 0.0 Bad 90.8% plus 0.1543 1.69x higher risk for lung cancer 1.69x higher risk for lung cancer appears to be common on the 23andMe platform rs1047972(G;G) 0.0 67.7% minus 0.1561 rs3024490(G;G) 0.0 61.9% minus 0.4077 rs6667764(G;G) 0.0 Good 46.2% plus 0.4362 common in complete genomics common in complete genomics rs2039620(T;T) 0.0 Good plus 0.1579 common in complete genomics common in complete genomics rs12034829(A;A) 0.0 Good 74.3% plus 0.1566 common in complete genomics common in complete genomics rs2867125(G;G) 0.0 74.3% minus 0.1276 rs1670283(C;C) 0.0 Good 100.0% plus 0.006887 common in complete genomics common in complete genomics rs7581919(T;T) 0.0 Good 86.7% plus 0.01837 common on affy axiom data common on affy axiom data rs758386(C;C) 0.0 Good 90.1% minus 0.05188 rs7652331(C;T) 0.0 plus 0.1511 normal risk normal risk rs6784615(T;T) 0.0 Good 92.0% plus 0.03949 common on affy axiom data common on affy axiom data rs312481(C;C) 0.0 Good 54.0% minus 0.1823 better response to certain calcium channel blockers better response to certain calcium channel blockers rs514636(A;A) 0.0 Good 82.1% plus 0.118 common in complete genomics common in complete genomics rs683395(T;T) 0.0 Good 81.4% minus 0.1175 normal normal rs2172397(G;G) 0.0 Good 89.0% minus 0.0124 common in complete genomics common in complete genomics rs832081(C;C) 0.0 Good 97.3% minus 0.02433 common in complete genomics common in complete genomics rs4450776(C;C) 0.0 Good 90.8% plus 0.06428 common on affy axiom data common on affy axiom data rs9288952(A;A) 0.0 Good 92.9% plus 0.3095 common in complete genomics common in complete genomics rs2931761(A;A) 0.0 Good 100.0% minus 0.009642 common in complete genomics common in complete genomics rs6280(C;T) 0.0 40.7% plus 0.4518 normal normal rs1464603(T;T) 0.0 Good minus 0.4725 common in complete genomics common in complete genomics rs1464602(T;T) 0.0 Good minus 0.4229 common in complete genomics common in complete genomics rs2692696(C;C) 0.0 Good 100.0% minus 0.007805 common in complete genomics common in complete genomics rs1511412(G;G) 0.0 Good 81.4% plus 0.06336 common on affy axiom data common on affy axiom data rs1873668(G;G) 0.0 Good 95.6% plus 0.0854 common in complete genomics common in complete genomics rs4243399(A;A) 0.0 Good 95.6% plus 0.1074 common in complete genomics common in complete genomics rs1492099(G;G) 0.0 74.3% minus 0.0955 rs701753(A;A) 0.0 Good 86.2% plus 0.1139 common in complete genomics common in complete genomics rs2665390(T;T) 0.0 Good 86.7% plus 0.06061 common in complete genomics common in complete genomics rs4855271(T;T) 0.0 Good 89.2% plus 0.07438 common on affy axiom data common on affy axiom data rs1635498(A;A) 0.0 Good 94.7% minus 0.08402 common on affy axiom data common on affy axiom data rs10733113(G;G) 0.0 77.0% plus 0.1662 rs1126497(C;C) 0.0 22.1% plus 0.3398 normal normal rs6544718(C;C) 0.0 63.4% plus 0.1065 rs2817937(A;A) 0.0 Good 81.4% minus 0.06612 common on affy axiom data common on affy axiom data rs1535435(G;G) 0.0 85.8% plus 0.2098 rs4730751(A;C) 0.0 plus 0.1552 rs10244329(A;T) 0.0 Good 49.6% plus 0.4527 common in complete genomics common in complete genomics rs10954174(G;G) 0.0 Good 100.0% plus 0.03673 common in complete genomics common in complete genomics rs2179922(G;G) 0.0 93.8% plus 0.1534 common common rs220733(C;C) 0.0 Good minus 0.01469 common in complete genomics common in complete genomics rs3016539(A;A) 0.0 Good 84.1% minus 0.1079 common in complete genomics common in complete genomics rs645106(G;G) 0.0 Good 44.2% minus 0.2094 common in complete genomics common in complete genomics rs2228006(G;G) 0.0 Good 73.2% minus 0.1208 common on affy axiom data common on affy axiom data rs6971925(C;C) 0.0 Good 100.0% plus 0.04729 common in complete genomics common in complete genomics rs1468271(A;A) 0.0 Good minus 0.01607 rs11136000(C;C) 0.0 40.7% plus 0.3848 normal normal rs9986786(C;C) 0.0 Good 70.8% plus 0.05418 rs6264(G;G) 0.0 Good 100.0% minus 0.007805 common in complete genomics common in complete genomics rs763317(G;G) 0.0 36.3% plus 0.3485 normal normal rs4948088(C;C) 0.0 Good 92.9% plus 0.02525 common on affy axiom data common on affy axiom data rs2522943(C;C) 0.0 Good 92.3% plus 0.009183 common in complete genomics common in complete genomics rs9640663(A;G) 0.0 plus 0.2392 rs31653(G;G) 0.0 Good 77.0% plus 0.1318 common in complete genomics common in complete genomics rs1128503(C;C) 0.0 26.5% minus 0.4219 normal normal rs2214102(G;G) 0.0 Good 82.3% minus 0.0404 common in complete genomics common in complete genomics rs10(C;C) 0.0 Good 93.8% plus 0.03122 rs2257401(G;G) 0.0 Good 87.7% plus 0.2686 common in complete genomics common in complete genomics rs2740574(A;A) 0.0 Good minus 0.2011 normal normal rs1637001(A;A) 0.0 Good 54.9% plus 0.3797 common in complete genomics common in complete genomics rs13224682(A;A) 0.0 Good 85.0% plus 0.03306 common on affy axiom data common on affy axiom data rs2974938(A;A) 0.0 Good 100.0% minus 0.02755 common in complete genomics common in complete genomics rs2974942(A;A) 0.0 Good 100.0% minus 0.02479 common in complete genomics common in complete genomics rs7037276(T;T) 0.0 Good 85.8% plus 0.03949 rs719725(C;C) 0.0 18.5% plus 0.3255 normal normal rs682632(G;G) 0.0 Good 92.0% minus 0.01607 common in complete genomics common in complete genomics rs1408799(C;C) 0.0 47.8% plus 0.3499 rs1360517(G;G) 0.0 Good 81.2% minus 0.1148 rs357394(C;C) 0.0 Good 81.5% minus 0.101 common on affy axiom data common on affy axiom data rs10282312(T;T) 0.0 Good 96.9% plus 0.009183 common on affy axiom data common on affy axiom data rs1718101(G;G) 0.0 Good 88.5% minus 0.02204 rs1799983(G;G) 0.0 38.5% plus 0.197 normal risk normal risk rs855913(G;G) 0.0 Good 92.9% minus 0.02893 common in complete genomics common in complete genomics rs1861973(C;C) 0.0 Good 54.0% plus 0.2181 rs1130495(C;C) 0.0 Good 76.2% minus 0.1139 common on affy axiom data common on affy axiom data rs2515569(G;G) 0.0 Good 100.0% plus 0.009183 common in complete genomics common in complete genomics rs1129703(G;G) 0.0 Good 62.2% plus 0.3053 common in complete genomics common in complete genomics rs1129706(G;G) 0.0 Good 62.5% plus 0.3039 common in complete genomics common in complete genomics rs2034143(C;C) 0.0 Good 62.8% minus 0.3044 common in complete genomics common in complete genomics rs9987289(G;G) 0.0 Good 86.2% plus 0.09871 common on affy axiom data common on affy axiom data rs6601299(C;C) 0.0 86.9% plus 0.0955 rs2126259(G;G) 0.0 Good 84.1% minus 0.1056 rs2720508(T;T) 0.0 Good 100.0% plus 0.08264 common in complete genomics common in complete genomics rs10103355(G;G) 0.0 Good 94.7% plus 0.1437 common in complete genomics common in complete genomics rs1208(A;A) 0.0 38.1% plus 0.3145 rs4921914(T;T) 0.0 Good 53.1% plus 0.3765 common in complete genomics common in complete genomics rs1495741(A;A) 0.0 Good 53.1% plus 0.3774 common in complete genomics common in complete genomics Predicted to be a NAT2 slow metabolizer. rs1495743(C;C) 0.0 Good 53.1% plus 0.3747 common in complete genomics common in complete genomics rs10987883(A;A) 0.0 Good 72.3% plus 0.1758 common in complete genomics common in complete genomics rs7024934(A;A) 0.0 Good 90.3% plus 0.1042 rs103612(C;T) 0.0 50.4% plus 0.3343 rs2296949(G;G) 0.0 85.8% plus 0.1341 rs4740283(A;A) 0.0 76.1% plus 0.1593 rs2905072(T;T) 0.0 Good 67.3% minus 0.2185 common in complete genomics common in complete genomics rs2609653(T;T) 0.0 Good 90.3% plus 0.05418 normal normal rs6468442(G;G) 0.0 Good 60.7% plus 0.1501 common on affy axiom data common on affy axiom data rs903027(T;T) 0.0 Good 69.0% plus 0.2135 common in complete genomics common in complete genomics rs10087163(G;G) 0.0 Good 98.2% plus 0.008264 common on affy axiom data common on affy axiom data rs13264970(C;T) 0.0 Good 36.3% plus 0.4082 common in complete genomics common in complete genomics rs6471482(C;C) 0.0 Good 71.7% plus 0.06841 common on affy axiom data common on affy axiom data rs4397449(G;G) 0.0 Good 100.0% plus 0.0202 common in complete genomics common in complete genomics rs1805874(A;C) 0.0 40.7% plus 0.4357 rs977396(T;T) 0.0 Good 77.9% minus 0.1286 common on affy axiom data common on affy axiom data rs13266634(T;T) 0.0 Good 4.4% plus 0.2824 Normal risk for type-2 diabetes Normal risk for type-2 diabetes rs3802177(T;T) 0.0 4.4% minus 0.2833 normal normal rs1447295(C;C) 0.0 86.7% plus 0.1818 normal normal rs10109700(G;G) 0.0 Good 90.0% plus 0.1814 rs7832031(G;G) 0.0 Good 89.1% plus 0.09871 rs4242382(G;G) 0.0 86.7% plus 0.1607 normal risk normal risk rs4242384(A;A) 0.0 86.7% plus 0.1221 rs7017300(A;A) 0.0 79.6% plus 0.2185 normal risk normal risk rs10090154(C;C) 0.0 89.1% plus 0.1295 normal normal rs2929973(T;T) 0.0 Good 73.5% plus 0.1708 common in complete genomics common in complete genomics rs2572886(G;G) 0.0 Good 86.0% plus 0.1446 normal normal rs2977838(C;C) 0.0 Good 88.5% minus 0.03535 common in complete genomics common in complete genomics rs1934968(G;G) 0.0 Good 81.4% plus 0.1465 common in complete genomics common in complete genomics rs6584066(G;G) 0.0 Good 98.2% plus 0.007346 common in complete genomics common in complete genomics rs3731239(C;T) 0.0 Good 50.4% minus 0.1988 ? ? rs1329568(C;C) 0.0 Good 99.1% minus 0.06152 common in complete genomics common in complete genomics rs2309428(A;A) 0.0 Good 68.2% plus 0.1938 common in complete genomics common in complete genomics rs291766(A;A) 0.0 Good 96.9% minus 0.02709 common in complete genomics common in complete genomics rs10937275(G;G) 0.0 Good 85.0% plus 0.08356 rs710466(T;T) 0.0 Good 100.0% minus 0.0202 common in complete genomics common in complete genomics rs4686484(A;G) 0.0 plus 0.3797 neutral/common neutral/common rs7610017(G;G) 0.0 Good 93.7% plus 0.09642 common in complete genomics common in complete genomics rs789852(C;C) 0.0 Good 85.0% plus 0.04867 common in complete genomics common in complete genomics rs10902758(A;A) 0.0 Good plus 0.0005 common in complete genomics common in complete genomics rs1850744(G;G) 0.0 Good 92.9% minus 0.1006 rs2866413(A;G) 0.0 plus 0.449 rs6449213(T;T) 0.0 Good 63.7% plus 0.1299 normal normal rs573332(T;T) 0.0 Good 100.0% plus 0.01331 common in complete genomics common in complete genomics rs491376(C;C) 0.0 Good 100.0% plus 0.01331 common in complete genomics common in complete genomics rs1379659(A;A) 0.0 Good 69.6% plus 0.1345 common on affy axiom data common on affy axiom data rs3816587(T;T) 0.0 33.0% plus 0.4683 normal normal rs5522(A;A) 0.0 Good 80.5% minus 0.1175 common on affy axiom data common on affy axiom data rs1155865(A;A) 0.0 Good 66.4% plus 0.2094 common in complete genomics common in complete genomics rs7436338(G;G) 0.0 Good 100.0% plus 0.02571 common in complete genomics common in complete genomics rs222020(T;T) 0.0 69.0% plus 0.3251 rs7698623(C;C) 0.0 Good 84.1% plus 0.07622 common in complete genomics common in complete genomics rs12644436(A;G) 0.0 Good 46.9% plus 0.4215 common in complete genomics common in complete genomics rs966845(A;A) 0.0 Good 98.5% plus common in complete genomics common in complete genomics rs13107595(A;A) 0.0 Good 99.1% plus 0.01056 common in complete genomics common in complete genomics rs283413(G;G) 0.0 Good 99.1% minus 0.06887 normal normal rs2291109(A;A) 0.0 Good 96.9% minus 0.06566 common in complete genomics common in complete genomics rs527409(C;C) 0.0 Good 88.5% plus 0.04408 common in complete genomics common in complete genomics rs1341665(A;G) 0.0 Good plus 0.3811 common in complete genomics common in complete genomics rs10754339(A;A) 0.0 Good 85.0% plus 0.2388 normal normal rs1332018(G;T) 0.0 Good 54.0% plus 0.2782 common in complete genomics common in complete genomics rs10494366(G;T) 0.0 48.7% plus 0.4761 average QT interval average QT interval rs1207421(C;C) 0.0 Good 82.3% minus 0.1327 common on affy axiom data common on affy axiom data rs7560008(T;T) 0.0 Good 100.0% plus 0.001837 common in complete genomics common in complete genomics rs1250204(G;G) 0.0 Good 92.0% minus 0.05647 common in complete genomics common in complete genomics rs2854386(G;G) 0.0 Good 89.2% minus 0.146 common in complete genomics common in complete genomics rs975278(A;G) 0.0 minus 0.3085 rs6436669(A;G) 0.0 18.6% plus 0.191 rs3948464(C;C) 0.0 70.8% minus 0.1028 rs754635(G;G) 0.0 Good 84.6% plus 0.2319 common in complete genomics common in complete genomics rs4972946(A;A) 0.0 Good 83.2% plus 0.03949 common on affy axiom data common on affy axiom data rs11689432(G;G) 0.0 Good 23.1% plus 0.4679 common in clinvar common in clinvar rs2975766(G;G) 0.0 Good 95.4% plus 0.01331 common in complete genomics common in complete genomics rs2619566(T;T) 0.0 83.2% minus 0.3416 rs279552(G;G) 0.0 Good 98.2% plus 0.006428 common in complete genomics common in complete genomics rs2675163(T;T) 0.0 Good 57.5% plus 0.2314 common in complete genomics common in complete genomics rs4399848(G;G) 0.0 82.3% plus 0.05142 normal normal rs4302331(G;G) 0.0 Good 98.2% plus 0.05923 common in complete genomics common in complete genomics rs816488(T;T) 0.0 Good 94.7% plus 0.07668 common in complete genomics common in complete genomics rs6548238(C;C) 0.0 73.6% plus 0.1281 rs2355230(A;A) 0.0 41.4% plus 0.2406 rs2165870(G;G) 0.0 52.3% plus 0.2397 rs846910(G;G) 0.0 Good 84.6% plus 0.1139 common in complete genomics common in complete genomics rs964201(G;G) 0.0 Good 98.2% plus 0.002755 common in complete genomics common in complete genomics rs2063871(C;C) 0.0 Good 76.9% minus 0.1841 common in complete genomics common in complete genomics rs10865331(G;G) 0.0 48.7% plus 0.4201 normal risk ankylosing spondylitis normal risk ankylosing spondylitis rs3818361(C;C) 0.0 58.4% minus 0.2691 normal normal rs4668338(C;C) 0.0 Good 100.0% plus 0.1414 common in complete genomics common in complete genomics rs2141698(G;G) 0.0 Good 72.6% minus 0.1465 common in complete genomics common in complete genomics rs11895564(A;G) 0.0 plus 0.2383 rs6433379(A;A) 0.0 Good 72.5% plus 0.1942 common in complete genomics common in complete genomics rs2676527(C;C) 0.0 Good 92.9% minus 0.02801 common in complete genomics common in complete genomics rs2072590(G;G) 0.0 40.2% minus 0.2378 rs2588882(A;A) 0.0 Good 84.1% minus 0.1185 common in complete genomics common in complete genomics rs2001350(A;A) 0.0 Good 82.3% minus 0.1451 common in complete genomics common in complete genomics rs1962142(C;C) 0.0 Good 83.2% minus 0.1267 common in complete genomics common in complete genomics rs10178458(C;T) 0.0 plus 0.191 rs1516446(G;G) 0.0 Good 100.0% plus 0.003214 common in complete genomics common in complete genomics rs788016(A;G) 0.0 plus 0.3871 rs7595412(A;A) 0.0 Good 73.5% plus 0.06198 common on affy axiom data common on affy axiom data rs1521882(T;T) 0.0 Good 58.0% minus 0.2025 common in complete genomics common in complete genomics rs11888559(C;C) 0.0 Good 91.2% plus 0.2029 common in complete genomics common in complete genomics rs231778(A;A) 0.0 Good 100.0% plus 0.009642 common in complete genomics common in complete genomics rs823128(A;A) 0.0 Good 96.4% plus 0.1511 common in complete genomics common in complete genomics rs823156(A;A) 0.0 Good 67.3% plus 0.3118 common in complete genomics common in complete genomics rs7586898(C;C) 0.0 Good 69.2% plus 0.393 common in complete genomics common in complete genomics rs6431731(T;T) 0.0 Good 87.7% plus 0.01699 common in complete genomics common in complete genomics rs1042034(T;T) 0.0 minus 0.3384 rs568413(C;C) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs6707600(T;T) 0.0 Good 97.3% plus 0.02433 common in complete genomics common in complete genomics rs1676486(G;G) 0.0 60.9% plus 0.1846 rs2206593(G;G) 0.0 Good 91.1% plus 0.04316 common in complete genomics common in complete genomics rs2745557(G;G) 0.0 Good 76.1% plus 0.1387 normal normal rs1801265(T;T) 0.0 Good 71.7% minus 0.2305 common in clinvar common in clinvar rs7528684(A;G) 0.0 52.7% plus 0.4357 normal normal rs307377(C;C) 0.0 Good plus 0.0404 common in complete genomics common in complete genomics rs5253(C;C) 0.0 Good 98.5% plus 0.1657 common in complete genomics common in complete genomics rs7539409(A;A) 0.0 Good 69.0% plus 0.08173 common on affy axiom data common on affy axiom data rs2853826(A;A) 0.0 Good 90.3% plus 0.4832 common in clinvar common in clinvar rs7538427(T;T) 0.0 Good 92.9% plus 0.08081 rs4954449(C;C) 0.0 Good 100.0% plus 0.01882 common in complete genomics common in complete genomics rs6711382(G;G) 0.0 Good 81.2% plus 0.2599 common in complete genomics common in complete genomics rs6735208(A;A) 0.0 Good 59.4% plus 0.3811 rs295791(C;C) 0.0 Good 100.0% plus 0.0101 common in complete genomics common in complete genomics rs13022357(G;G) 0.0 Good 85.8% plus 0.2195 common in complete genomics common in complete genomics rs4665058(C;C) 0.0 Good 93.8% plus 0.1111 common in complete genomics common in complete genomics rs6746030(G;G) 0.0 Good 77.0% plus 0.1088 Normal perception of pain Normal perception of pain rs10797919(C;G) 0.0 Good plus 0.4454 common in complete genomics common in complete genomics rs7520292(C;C) 0.0 Good 67.3% plus 0.2801 common in complete genomics common in complete genomics rs2501796(A;A) 0.0 Good 100.0% plus 0.09917 common in complete genomics common in complete genomics rs6587852(C;C) 0.0 64.6% plus 0.225 rs4846051(A;A) 0.0 Good 100.0% plus 0.07438 common in complete genomics common in complete genomics rs4846033(G;G) 0.0 Good 98.4% plus 0.04775 common on affy axiom data common on affy axiom data rs2482965(C;C) 0.0 Good plus 0.003214 common in complete genomics common in complete genomics rs1101999(T;T) 0.0 Good 100.0% plus 0.07208 common in complete genomics common in complete genomics rs35744813(G;G) 0.0 minus 0.253 rs307355(C;C) 0.0 plus 0.2181 rs505151(A;A) 0.0 Good 93.8% plus 0.09826 common in complete genomics common in complete genomics rs1800871(C;C) 0.0 66.1% minus 0.4086 0.5x decreased risk for endometriosis 0.5x decreased risk for endometriosis rs2745559(C;C) 0.0 Good 76.1% plus 0.1015 common in complete genomics common in complete genomics rs4140564(T;T) 0.0 Good 85.9% minus 0.04408 common in complete genomics common in complete genomics rs562556(A;A) 0.0 Good 68.3% plus 0.1474 common in complete genomics common in complete genomics rs926103(A;G) 0.0 Good minus 0.382 No increased risk. No increased risk. Not reported to be associated with an increased risk of multiple sclerosis. See The SH2D2A gene and susceptibility to multiple sclerosis. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis rs926103 and a GA repeat polymorphism forming a risk haplotype for Multiple sclerosis rs650985(A;A) 0.0 Good 88.4% minus 0.02388 rs6687813(C;C) 0.0 Good 87.5% plus 0.06152 common on affy axiom data common on affy axiom data rs7553007(A;G) 0.0 Good plus 0.3705 common in complete genomics common in complete genomics rs5082(C;T) 0.0 minus 0.2521 normal risk normal risk rs509749(A;G) 0.0 56.6% plus 0.3747 common; slight increase in SLE risk common; slight increase in SLE risk rs6025(G;G) 0.0 Good 96.5% minus 0.005969 normal/common normal/common rs396991(G;G) 0.0 minus 0.2447 normal normal rs2794520(C;T) 0.0 Good 45.1% plus 0.3687 common in complete genomics common in complete genomics rs1205(C;T) 0.0 Good 45.1% plus 0.365 common in complete genomics common in complete genomics rs876537(C;T) 0.0 Good 45.1% plus 0.3852 common in complete genomics common in complete genomics rs2420371(A;A) 0.0 Good 88.4% plus 0.0303 rs4656461(A;A) 0.0 73.5% plus 0.1405 normal normal rs10903034(C;T) 0.0 Good 55.4% plus 0.4963 common in complete genomics common in complete genomics rs4145462(G;G) 0.0 Good 92.9% plus 0.01286 rs7530511(C;C) 0.0 77.0% plus 0.1309 normal normal rs1466731(G;G) 0.0 Good 100.0% minus 0.002296 common in complete genomics common in complete genomics rs1874792(G;G) 0.0 Good 100.0% minus 0.01882 common in complete genomics common in complete genomics rs989994(C;C) 0.0 Good 100.0% plus 0.05372 common in complete genomics common in complete genomics rs10195263(A;A) 0.0 Good 96.5% plus 0.04913 rs7355746(C;C) 0.0 Good 98.2% plus 0.05096 rs1811399(T;T) 0.0 Good 64.6% minus 0.281 rs260630(C;C) 0.0 Good minus 0.0652 common in complete genomics common in complete genomics rs155100(A;T) 0.0 Good minus 0.4229 common in complete genomics common in complete genomics rs1446495(T;T) 0.0 Good 100.0% minus 0.02938 common in complete genomics common in complete genomics rs7566605(G;G) 0.0 54.0% plus 0.2957 common common rs6659553(C;C) 0.0 Good 100.0% plus 0.04821 common in complete genomics common in complete genomics rs2476601(G;G) 0.0 Good 77.5% plus 0.04224 Normal risk for autoimmune disorders Normal risk for autoimmune disorders rs1013579(A;A) 0.0 Good 92.9% minus 0.01882 common in complete genomics common in complete genomics rs3219468(G;G) 0.0 Good minus 0.006428 common in complete genomics common in complete genomics rs10914144(C;C) 0.0 Good 70.8% plus 0.214 common in complete genomics common in complete genomics rs7536563(G;G) 0.0 Good 40.7% plus 0.343 common common rs1265883(A;A) 0.0 Good minus 0.04454 rs6427528(G;G) 0.0 Good 88.9% plus 0.1974 common common rs2696835(G;G) 0.0 Good 89.2% plus 0.0101 common in complete genomics common in complete genomics rs4673(C;C) 0.0 Good 46.9% minus 0.3026 normal normal rs2740348(G;G) 0.0 Good 67.7% minus 0.1244 common on affy axiom data common on affy axiom data rs4785763(C;C) 0.0 Good 34.5% plus 0.2847 common common rs238238(G;G) 0.0 46.0% plus 0.4004 rs6502867(T;T) 0.0 53.1% plus 0.1483 rs161400(T;T) 0.0 Good 98.5% plus 0.1598 common in complete genomics common in complete genomics rs973968(A;A) 0.0 Good 69.0% plus 0.1451 rs699363(T;T) 0.0 Good 95.6% minus 0.03903 common in complete genomics common in complete genomics rs175081(C;C) 0.0 Good 99.1% plus 0.006887 common in complete genomics common in complete genomics rs1991517(C;C) 0.0 Good 84.6% plus 0.1088 common on affy axiom data common on affy axiom data rs229813(C;C) 0.0 Good 100.0% plus 0.004591 common in complete genomics common in complete genomics rs421262(C;C) 0.0 Good 100.0% plus 0.06107 common in complete genomics common in complete genomics rs3803300(G;G) 0.0 minus 0.2902 rs12593929(A;A) 0.0 Good 88.5% plus 0.3053 blue eye color more likely blue eye color more likely rs7163702(G;T) 0.0 Good minus common in complete genomics common in complete genomics rs2555364(G;G) 0.0 Good 100.0% plus 0.2883 common in complete genomics common in complete genomics rs1552311(C;C) 0.0 Good 99.1% plus 0.001377 common in complete genomics common in complete genomics rs2542151(T;T) 0.0 79.6% plus 0.1561 normal normal rs4331426(A;A) 0.0 Good 92.9% plus 0.1474 common in complete genomics common in complete genomics rs2679117(C;C) 0.0 Good 100.0% plus 0.01056 common in complete genomics common in complete genomics rs2679118(C;C) 0.0 Good 100.0% plus 0.01056 common in complete genomics common in complete genomics rs884202(A;A) 0.0 46.9% plus 0.4601 <0.69x risk for restless legs <0.69x risk for restless legs rs11072089(T;T) 0.0 Good 93.8% plus 0.2599 common in complete genomics common in complete genomics rs1800431(G;G) 0.0 Good 100.0% minus 0.101 common in complete genomics common in complete genomics rs2277598(G;G) 0.0 46.4% minus 0.4509 rs7168796(T;T) 0.0 Good 100.0% plus 0.04454 common in complete genomics common in complete genomics rs12901682(C;C) 0.0 Good 99.1% plus 0.08586 common in complete genomics common in complete genomics rs1455782(C;C) 0.0 Good 50.9% minus 0.1635 common on affy axiom data common on affy axiom data rs2398162(A;G) 0.0 36.3% plus 0.3095 normal normal rs1976667(A;A) 0.0 Good 74.8% plus 0.1754 common in complete genomics common in complete genomics rs3176364(C;C) 0.0 Good plus 0.3526 common in complete genomics common in complete genomics rs2858056(C;C) 0.0 Good plus 0.2911 common in complete genomics common in complete genomics rs2541632(A;A) 0.0 Good 77.0% minus 0.3343 common in complete genomics common in complete genomics rs1114620(A;A) 0.0 Good 81.4% minus 0.1272 common in complete genomics common in complete genomics rs4787008(G;G) 0.0 Good 64.1% plus 0.09366 common on affy axiom data common on affy axiom data rs8046121(G;G) 0.0 Good 100.0% plus 0.01056 common in complete genomics common in complete genomics rs7197779(G;G) 0.0 Good 98.2% plus 0.05372 common in complete genomics common in complete genomics rs373496(C;C) 0.0 Good 95.6% minus 0.03765 common in complete genomics common in complete genomics rs7500834(C;C) 0.0 Good 100.0% plus 0.0202 common in complete genomics common in complete genomics rs4078023(A;A) 0.0 Good 96.5% minus 0.07025 rs7201268(G;G) 0.0 78.8% plus 0.0326 rs3803662(C;C) 0.0 Good 57.5% minus 0.4578 normal normal rs4614723(T;T) 0.0 Good plus 0.02204 common in complete genomics common in complete genomics rs3785152(C;C) 0.0 Good 85.8% plus 0.1249 common in complete genomics common in complete genomics rs4784677(T;T) 0.0 Good 97.3% plus 0.004132 common in complete genomics common in complete genomics rs1529927(G;G) 0.0 Good 83.1% plus 0.01791 common in complete genomics common in complete genomics rs7498403(T;T) 0.0 Good 81.4% plus 0.1318 common in complete genomics common in complete genomics rs9923451(G;G) 0.0 Good 96.5% plus 0.07438 common in complete genomics common in complete genomics rs619865(G;G) 0.0 Good 75.2% plus 0.03306 common on affy axiom data common on affy axiom data rs9891361(A;A) 0.0 Good 86.2% plus 0.2732 common in complete genomics common in complete genomics rs4261597(C;C) 0.0 Good plus 0.001837 common in complete genomics common in complete genomics rs242941(G;G) 0.0 Good minus 0.3122 better response to inhaled corticosteroid in patients with COPD better response to inhaled corticosteroid in patients with COPD rs242939(A;A) 0.0 Good 85.8% minus 0.1033 common in complete genomics common in complete genomics rs242936(C;C) 0.0 Good 81.4% minus 0.07117 common in complete genomics common in complete genomics rs242557(A;G) 0.0 plus 0.4174 normal normal rs1800215(G;G) 0.0 Good 93.8% minus 0.02388 common in complete genomics common in complete genomics rs1107946(C;C) 0.0 Good plus 0.2525 common in complete genomics common in complete genomics rs6504649(C;G) 0.0 Good 35.6% plus 0.2718 common in complete genomics common in complete genomics rs2643103(G;G) 0.0 Good 100.0% plus 0.2153 common in complete genomics common in complete genomics rs7224837(A;A) 0.0 Good 73.5% plus 0.1162 common in complete genomics common in complete genomics rs9915936(C;C) 0.0 Good plus 0.1097 common in complete genomics common in complete genomics rs1859962(G;T) 0.0 Good 57.5% plus 0.3976 normal risk normal risk rs4789939(G;G) 0.0 Good 67.0% minus 0.3053 common in complete genomics common in complete genomics rs2071214(A;A) 0.0 Good 88.5% plus 0.08402 rs6506640(A;A) 0.0 Good plus 0.2094 common in complete genomics common in complete genomics rs1156044(T;T) 0.0 Good 69.0% minus 0.2153 common in complete genomics common in complete genomics rs9951307(A;A) 0.0 44.2% plus 0.2957 normal normal rs1154233(G;G) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs1380866(G;G) 0.0 Good 99.1% plus 0.001377 common in complete genomics common in complete genomics rs1426310(A;G) 0.0 57.5% plus 0.3457 rs2637496(C;C) 0.0 Good 84.1% plus 0.1552 common in complete genomics common in complete genomics rs246246(T;T) 0.0 Good 86.7% plus 0.03627 rs6467(T;T) 0.0 Good minus 0.3356 common/normal common/normal rs3132946(G;G) 0.0 Good 69.1% plus 0.0528 rs2227956(T;T) 0.0 57.5% minus 0.1221 rs30832(G;G) 0.0 Good 98.2% minus 0.002755 common in complete genomics common in complete genomics rs157350(A;A) 0.0 Good 74.3% plus 0.0629 common in complete genomics common in complete genomics rs2910164(G;G) 0.0 Good 59.3% plus 0.3815 normal normal rs2122554(C;C) 0.0 Good 94.7% minus 0.1997 common in complete genomics common in complete genomics rs2973662(C;C) 0.0 Good 100.0% minus 0.01194 rs4242182(C;C) 0.0 78.8% plus 0.2135 rs17876030(C;C) 0.0 Good minus 0.05372 common in complete genomics common in complete genomics rs155417(C;C) 0.0 Good 96.9% plus 0.007346 common in complete genomics common in complete genomics rs7445271(C;C) 0.0 Good plus 0.001377 common in complete genomics common in complete genomics rs4959235(C;C) 0.0 Good 82.3% plus 0.04683 common in complete genomics common in complete genomics rs699947(C;C) 0.0 25.0% plus 0.3439 normal normal rs6914079(G;G) 0.0 Good 60.2% plus 0.1837 common in complete genomics common in complete genomics rs2842951(C;C) 0.0 Good 61.9% plus 0.3163 common in complete genomics common in complete genomics rs1202199(C;C) 0.0 84.1% plus 0.09963 rs4352670(A;A) 0.0 89.1% plus 0.06015 rs4236032(A;A) 0.0 82.3% plus 0.05969 rs761100(G;T) 0.0 Good 57.1% minus 0.3173 normal risk normal risk rs4576240(G;G) 0.0 Good 82.3% plus 0.05831 common on affy axiom data common on affy axiom data rs3094093(T;T) 0.0 Good 89.2% minus 0.0303 rs2844665(G;G) 0.0 Good 36.3% minus 0.3843 common in complete genomics common in complete genomics rs2428496(A;A) 0.0 Good minus 0.1841 common in complete genomics common in complete genomics rs2442717(C;C) 0.0 Good minus 0.1538 common in complete genomics common in complete genomics rs2596497(C;C) 0.0 Good minus 0.1538 common in complete genomics common in complete genomics rs1140546(C;C) 0.0 Good minus 0.2153 common in complete genomics common in complete genomics rs1050747(C;C) 0.0 Good minus 0.1781 common in complete genomics common in complete genomics rs2523605(G;G) 0.0 Good 59.5% minus 0.1538 common in complete genomics common in complete genomics rs3132453(C;C) 0.0 Good 84.8% minus 0.02755 common on affy axiom data common on affy axiom data rs3130062(T;T) 0.0 Good 80.0% plus 0.02938 common on affy axiom data common on affy axiom data rs2500535(G;G) 0.0 Good 93.8% plus 0.1368 common on affy axiom data common on affy axiom data rs1302019(A;A) 0.0 Good 94.7% minus 0.0528 rs2076530(G;G) 0.0 23.2% minus 0.3779 normal normal rs3135391(C;C) 0.0 Good 66.4% minus 0.06612 normal normal Rs3135391(C;C) is highly correlated with the HLA-DRB1*1501 allele. There is no additional risk of multiple sclerosis associated with the (C;C) genotype. rs3135388(C;C) 0.0 Good 66.4% minus 0.06428 normal normal Rs3135388(C;C) is highly correlated with the HLA-DRB1*1501 allele. There is no additional risk of multiple sclerosis associated with the (C;C) genotype. rs9275596(T;T) 0.0 Good 46.0% plus 0.2645 common/normal common/normal rs1776897(A;A) 0.0 Good 81.4% minus 0.2126 common in complete genomics common in complete genomics rs1150781(C;C) 0.0 Good 85.7% minus 0.2323 common in complete genomics common in complete genomics rs6918981(A;A) 0.0 Good 66.4% plus 0.3154 common in complete genomics common in complete genomics rs1360780(C;C) 0.0 Good 52.7% plus 0.2994 normal normal rs2435322(G;G) 0.0 Good minus 0.03214 common in complete genomics common in complete genomics rs1925690(C;C) 0.0 Good 77.7% plus 0.05188 common on affy axiom data common on affy axiom data rs6454764(C;C) 0.0 Good 92.0% plus 0.2199 common in complete genomics common in complete genomics rs783396(C;C) 0.0 Good 82.3% plus 0.07208 common in complete genomics common in complete genomics rs9400317(G;G) 0.0 Good 75.2% plus 0.05923 common on affy axiom data common on affy axiom data rs4479731(A;A) 0.0 Good plus 0.01377 common in complete genomics common in complete genomics rs2313132(A;A) 0.0 Good 77.0% plus 0.07163 common on affy axiom data common on affy axiom data rs1509269(C;C) 0.0 Good 80.0% plus 0.09458 common in complete genomics common in complete genomics rs6847679(T;T) 0.0 Good 77.9% plus 0.09458 common in complete genomics common in complete genomics rs2313982(C;C) 0.0 Good 83.2% minus 0.08127 common in complete genomics common in complete genomics rs4470583(G;G) 0.0 Good 98.2% plus 0.0528 common in complete genomics common in complete genomics rs13111850(T;T) 0.0 Good 88.5% plus 0.04132 rs2228119(G;G) 0.0 Good 100.0% minus 0.06566 common in complete genomics common in complete genomics rs2923318(A;G) 0.0 Good minus common in complete genomics common in complete genomics rs403636(G;G) 0.0 Good 69.0% minus 0.2475 common in complete genomics common in complete genomics rs27048(T;T) 0.0 23.9% plus 0.3255 normal normal rs2086310(C;C) 0.0 Good 54.7% minus 0.3122 common in complete genomics common in complete genomics rs1801394(A;G) 0.0 34.9% plus 0.376 normal normal rs2607292(G;G) 0.0 Good 81.2% minus 0.3627 common in complete genomics common in complete genomics rs339445(C;C) 0.0 Good 83.6% plus 0.08494 common in complete genomics common in complete genomics rs2255796(C;T) 0.0 Good minus 0.3972 common in complete genomics common in complete genomics rs4705423(T;T) 0.0 Good 69.9% plus 0.0831 common in complete genomics common in complete genomics rs35390(A;A) 0.0 Good 100.0% plus 0.3182 common in complete genomics common in complete genomics rs35391(C;C) 0.0 Good 99.1% plus 0.3177 common in complete genomics common in complete genomics rs28777(A;A) 0.0 Good 95.6% plus 0.4894 common in complete genomics common in complete genomics rs2287939(C;C) 0.0 54.9% minus 0.2374 rs1494558(A;G) 0.0 Good minus 0.3871 rs1494555(C;T) 0.0 Good minus 0.326 rs267759(G;G) 0.0 Good 99.1% plus 0.1267 common in complete genomics common in complete genomics rs2255280(A;A) 0.0 Good 100.0% plus 0.1056 common in complete genomics common in complete genomics rs889312(A;A) 0.0 47.7% plus 0.3898 normal normal rs1697144(G;G) 0.0 Good 100.0% minus 0.007346 common in complete genomics common in complete genomics rs820878(C;C) 0.0 Good 89.8% plus 0.02066 common in complete genomics common in complete genomics rs2052550(G;G) 0.0 Good 63.1% minus 0.4885 common in complete genomics common in complete genomics rs2549782(T;T) 0.0 27.7% plus 0.4458 rs6594681(C;C) 0.0 Good 97.3% plus 0.002296 common in complete genomics common in complete genomics rs36785(G;G) 0.0 Good 100.0% minus common in complete genomics common in complete genomics rs1837253(C;C) 0.0 48.7% plus 0.3627 normal/common in clinvar normal/common in clinvar Found in 56% of all Caucasians on average, this genotype leads to a relative risk of 1.00, which is the most common risk, for late-onset (adult) asthma. rs10479334(T;T) 0.0 Good 89.4% plus 0.05188 common on affy axiom data common on affy axiom data rs6010718(C;C) 0.0 Good plus 0.05188 common in complete genomics common in complete genomics rs2236196(A;A) 0.0 Good plus 0.337 common in complete genomics common in complete genomics rs1044394(C;C) 0.0 Good 90.3% minus 0.1276 common in complete genomics common in complete genomics rs7283442(A;A) 0.0 100.0% plus rs2824721(A;A) 0.0 60.2% plus 0.2966 rs9305406(A;A) 0.0 Good 68.3% plus 0.3549 common in complete genomics common in complete genomics rs2834167(A;G) 0.0 41.6% plus 0.3448 normal normal rs9976946(T;T) 0.0 Good 91.2% plus 0.007346 rs17846179(C;T) 0.0 minus rs2150410(A;A) 0.0 Good 81.4% plus 0.1547 common in complete genomics common in complete genomics rs2837960(G;T) 0.0 plus 0.2071 normal normal rs1053312(A;G) 0.0 plus 0.2773 rs235330(A;A) 0.0 Good 100.0% plus common in complete genomics common in complete genomics rs2839110(A;A) 0.0 68.8% plus 0.2094 rs4819554(A;A) 0.0 Good 61.9% plus 0.2507 common in complete genomics common in complete genomics rs5761170(C;C) 0.0 Good 94.6% plus 0.08356 common in complete genomics common in complete genomics rs131690(A;A) 0.0 15.2% plus 0.4399 normal risk normal risk rs2298383(T;T) 0.0 35.5% plus 0.4816 rs738792(T;T) 0.0 Good 88.5% plus 0.2291 common in complete genomics common in complete genomics rs5751876(C;C) 0.0 Good plus 0.4807 None rs4822492(G;G) 0.0 33.8% plus 0.4766 rs3859866(C;C) 0.0 Good 95.6% plus 0.05556 common in complete genomics common in complete genomics rs2857461(T;T) 0.0 Good 93.8% plus 0.02158 common in complete genomics common in complete genomics rs5750248(C;C) 0.0 Good 89.2% plus 0.1598 common in complete genomics common in complete genomics rs5750250(A;A) 0.0 Good 88.5% plus 0.1529 common in complete genomics common in complete genomics rs2032487(T;T) 0.0 Good plus 0.1809 common in complete genomics common in complete genomics rs2413396(T;T) 0.0 Good 79.6% plus 0.1947 common in complete genomics common in complete genomics rs4821481(T;T) 0.0 Good 88.5% plus 0.1795 common in complete genomics common in complete genomics rs4821480(T;T) 0.0 Good 88.7% plus 0.1795 common in complete genomics common in complete genomics rs1534891(C;C) 0.0 82.3% plus 0.09642 rs54211(G;G) 0.0 Good 76.1% plus 0.06152 common on affy axiom data common on affy axiom data rs1800280(A;A) 0.0 Good 90.1% minus 0.06348 common on affy axiom data common on affy axiom data rs4825476(A;A) 0.0 65.5% plus 0.3392 normal normal rs228406(C;C) 0.0 54.0% plus 0.2703 rs551492(T;T) 0.0 Good 100.0% plus